PT J
AU Paramasivam, A
   Meena, AK
   Pedaparthi, L
   Jyothi, V
   Uppin, MS
   Jabeen, SA
   Sundaram, C
   Thangaraj, K
AF Paramasivam, Arumugam
   Meena, Angamuthu Kannan
   Pedaparthi, Lalitha
   Jyothi, Vuskamalla
   Uppin, Megha S.
   Jabeen, Shaikh Afshan
   Sundaram, Challa
   Thangaraj, Kumarasamy
TI Novel mutation in <i>C10orf2</i> associated with multiple mtDNA deletions, chronic progressive external ophthalmoplegia and premature aging
SO MITOCHONDRION
LA English
DT Article
DE Ptosis; CPEO; mtDNA; Multiple mtDNA deletions; C10orf2 mutation
ID recessive twinkle mutations; mitochondrial; gene; protein; polg
AB Chronic progressive external ophthalmoplegia (CPEO) is caused by defects in both mitochondrial and nuclear genes, however, the causal genetic factors in large number of patients remains undetermined. Therefore, our aim was to screen 12 unrelated patients with CPEO for mutation/multiple deletions in mtDNA and mutations in the coding regions of C10orf2, which is essential for mtDNA replication. Histopathological study of muscle biopsy revealed cytochrome c oxidase-deficient fibers and ragged blue fibers in all the patients. Long-range PCR of DNA from skeletal muscle revealed multiple mtDNA deletions in all the 12 patients. Further, sequencing coding regions of C10orf2 revealed three variants in three different patients, of which two were novel (c.1964G > A/p.G655D; c.204G > A/p.G68G) variants and one was reported (c.1052A > G/p.N351S). Sequencing of other nuclear genes that are associated with CPEO and multiple mtDNA deletions, such as; POLG1, POLG2, TK2, ANTI, DGUOK, MPV17 and RRM2B did not reveal any pathogenic mutation in patients with C10orf2 mutation. Since in silico analyses revealed p.G655D could be a potentially pathogenic and it was absent in 200 healthy controls, p.G655D could be the causative factor for CPEO. Therefore, we suggest that C10orf2 gene should be screened in CPEO individuals with multiple mtDNA deletions, which might help in prognosis of this disease and appropriate genetic counseling. (C) 2015 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Paramasivam, Arumugam; Jyothi, Vuskamalla; Thangaraj, Kumarasamy] CSIR Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India.
   [Meena, Angamuthu Kannan; Pedaparthi, Lalitha; Jabeen, Shaikh Afshan] Nizams Inst Med Sci, Dept Neurol, Hyderabad, Andhra Pradesh, India.
   [Uppin, Megha S.; Sundaram, Challa] Nizams Inst Med Sci, Dept Pathol, Hyderabad, Andhra Pradesh, India.
C3 Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Nizam's Institute of Medical Sciences; Nizam's Institute of Medical Sciences
RP Thangaraj, K (corresponding author), CSIR Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India.
EM thangs@ccmb.res.in
FU Department of Biotechnology (DBT), Government of India [BT/PR7470/MED]; Council of Scientific and Industrial Research (CSIR), Government of India [BioAge-BSC0208]
CR Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   Blakely E, 2008, NEUROMUSCULAR DISORD, V18, P557, DOI 10.1016/j.nmd.2008.04.014
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   Garone C, 2012, ARCH NEUROL-CHICAGO, V69, P1648, DOI 10.1001/archneurol.2012.405
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Hartley JN, 2012, CASE REP PEDIAT, V2012, P0, DOI 10.1155/2012/303096
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Lönnqvist T, 2009, BRAIN, V132, P1553, DOI 10.1093/brain/awp045
   Mathe E, 2006, NUCLEIC ACIDS RES, V34, P1317, DOI 10.1093/nar/gkj518
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967
   Ronchi D, 2012, BRAIN, V135, P3404, DOI 10.1093/brain/aws258
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Thangaraj K, 2002, J ANDROL, V23, P815
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
NR 27
TC 12
Z9 16
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JAN 15
PY 2016
VL 26
IS 
BP 81
EP 85
DI 10.1016/j.mito.2015.12.006
PG 5
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA DE6UC
UT WOS:000370768100009
PM 26689116
DA 2024-11-01
ER

PT J
AU Vincent, AE
   Grady, JP
   Rocha, MC
   Alston, CL
   Rygiel, KA
   Barresi, R
   Taylor, RW
   Turnbull, DM
AF Vincent, Amy E.
   Grady, John P.
   Rocha, Mariana C.
   Alston, Charlotte L.
   Rygiel, Karolina A.
   Barresi, Rita
   Taylor, Robert W.
   Turnbull, Doug M.
TI Mitochondrial dysfunction in myofibrillar myopathy
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Myofibrillar myopathy; Mitochondria; Mitochondrial DNA deletion; Immunofluorescence; Histochemistry; Cytochrome c oxidase deficiency
ID inclusion-body myositis; dna deletions; muscular-dystrophy; parkinson-disease; mutations; muscle; desmin; abnormality; cells; phosphorylation
AB Myofibrillar myopathies (MFM) are characterised by focal myofibrillar destruction and accumulation of myofibrillar elements as protein aggregates. They are caused by mutations in the DES, MYOT, CRYAB, FLNC, BAG3, DNAJB6 and ZASP genes as well as other as yet unidentified genes. Previous studies have reported changes in mitochondrial morphology and cellular positioning, as well as clonally-expanded, large-scale mitochondrial DNA (mtDNA) deletions and focal respiratory chain deficiency in muscle of MFM patients. Here we examine skeletal muscle from patients with desmin (n = 6), ZASP (n = 1) and myotilin (n = 2) mutations and MFM protein aggregates, to understand how mitochondrial dysfunction may contribute to the underlying mechanisms causing disease pathology. We have used a validated quantitative immunofluorescent assay to study respiratory chain protein levels, together with oxidative enzyme histochemistry and single cell mitochondrial DNA analysis, to examine mitochondrial changes. Results demonstrate a small number of clonally-expanded mitochondrial DNA deletions, which we conclude are due to both ageing and disease pathology. Further to this we report higher levels of respiratory chain complex I and IV deficiency compared to age matched controls, although overall levels of respiratory deficient muscle fibres in patient biopsies are low. More strikingly, a significantly higher percentage of myofibrillar myopathy patient muscle fibres have a low mitochondrial mass compared to controls. We concluded this is mechanistically unrelated to desmin and myotilin protein aggregates; however, correlation between mitochondrial mass and muscle fibre area is found. We suggest this may be due to reduced mitochondrial biogenesis in combination with muscle fibre hypertrophy. (C) 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
C1 [Vincent, Amy E.; Grady, John P.; Rocha, Mariana C.; Alston, Charlotte L.; Rygiel, Karolina A.; Taylor, Robert W.; Turnbull, Doug M.] Newcastle Univ, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Barresi, Rita] Newcastle Upon Tyne Hosp NHS Fdn Trust, Muscle Immunoanal Unit, Rare Dis Advisory Grp, Serv Neuromuscular Dis, Newcastle Upon Tyne NE2 4AZ, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust
RP Turnbull, DM (corresponding author), Newcastle Univ, Sch Med, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM doug.turnbull@ncl.ac.uk
FU Medical Research Council [MC_G0802536, MR/L016354/1, MR/K501074/1, G0800674, G0700718, MR/K000608/1, G0601943] Funding Source: Medline; Wellcome Trust [096919Z/11/Z] Funding Source: Medline; Department of Health [NIHR-HCS-D12-03-04] Funding Source: Medline; MRC [G0601943, MC_G0802536, G0800674, MR/K000608/1, MR/L016354/1, G0700718] Funding Source: UKRI
CR Askanas V, 2006, NEUROLOGY, V66, PS39, DOI 10.1212/01.wnl.0000192128.13875.1e
   Askanas V, 2012, J NEUROPATH EXP NEUR, V71, P680, DOI 10.1097/NEN.0b013e31826183c8
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Chariot P, 1996, ACTA NEUROPATHOL, V91, P530, DOI 10.1007/s004010050462
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Claeys KG, 2008, NEUROMUSCULAR DISORD, V18, P656, DOI 10.1016/j.nmd.2008.06.367
   Dold T, 2012, NEUROMUSCULAR DISORD, V22, P822, DOI 10.1016/j.nmd.2012.06.070
   Goldfarb LG, 1998, NAT GENET, V19, P402, DOI 10.1038/1300
   Greaves LC, 2010, INVEST OPHTH VIS SCI, V51, P3340, DOI 10.1167/iovs.09-4659
   Grünewald A, 2016, ANN NEUROL, V79, P366, DOI 10.1002/ana.24571
   Han XJ, 2008, J CELL BIOL, V182, P573, DOI 10.1083/jcb.200802164
   Henderson M, 2013, ACTA NEUROPATHOL, V125, P917, DOI 10.1007/s00401-013-1113-x
   Joshi PR, 2014, CLIN NEUROPATHOL, V33, P134, DOI 10.5414/NP300693
   McKenzie D, 2002, EUR J BIOCHEM, V269, P2010, DOI 10.1046/j.1432-1033.2002.02867.x
   Moslemi AR, 1997, HUM MUTAT, V10, P381, DOI 10.1002/(SICI)1098-1004(1997)10:5<381::AID-HUMU8>3.0.CO;2-I
   Oldfors A, 2006, NEUROLOGY, V66, PS49, DOI 10.1212/01.wnl.0000192127.63013.8d
   OLDFORS A, 1993, BRAIN, V116, P325, DOI 10.1093/brain/116.2.325
   OLDFORS A, 1995, J NEUROPATH EXP NEUR, V54, P581, DOI 10.1097/00005072-199507000-00012
   Pitceathly RDS, 2012, BRAIN, V135, P3392, DOI 10.1093/brain/aws231
   Rocha MC, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep15037
   Rygiel KA, 2015, NEUROPATH APPL NEURO, V41, P288, DOI 10.1111/nan.12149
   Rygiel KA, 2016, NUCLEIC ACIDS RES, V44, P5313, DOI 10.1093/nar/gkw382
   Rygiel KA, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep09906
   Santorelli FM, 1996, ANN NEUROL, V39, P789, DOI 10.1002/ana.410390615
   Schröder R, 2003, HUM MOL GENET, V12, P657, DOI 10.1093/hmg/ddg060
   Selcen D, 2005, ANN NEUROL, V57, P269, DOI 10.1002/ana.20376
   Selcen D, 2004, NEUROLOGY, V62, P1363, DOI 10.1212/01.WNL.0000123576.74801.75
   Selcen D, 2009, ANN NEUROL, V65, P83, DOI 10.1002/ana.21553
   Smolina N, 2014, CELL CALCIUM, V56, P269, DOI 10.1016/j.ceca.2014.08.001
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765
   Vorgerd M, 2005, AM J HUM GENET, V77, P297, DOI 10.1086/431959
NR 32
TC 31
Z9 34
U1 0
U2 18
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD OCT 15
PY 2016
VL 26
IS 10
BP 691
EP 701
DI 10.1016/j.nmd.2016.08.004
PG 11
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA EA2FL
UT WOS:000386408100010
PM 27618136
DA 2024-11-01
ER

PT J
AU Gehrig, SM
   Mihaylova, V
   Frese, S
   Mueller, SM
   Ligon-Auer, M
   Spengler, CM
   Petersen, JA
   Lundby, C
   Jung, HH
AF Gehrig, Saskia Maria
   Mihaylova, Violeta
   Frese, Sebastian
   Mueller, Sandro Manuel
   Ligon-Auer, Maria
   Spengler, Christina M.
   Petersen, Jens A.
   Lundby, Carsten
   Jung, Hans H.
TI Altered skeletal muscle (mitochondrial) properties in patients with mitochondrial DNA single deletion myopathy
SO ORPHANET JOURNAL OF RARE DISEASES
LA English
DT Article
DE Bioenergetics; Fat oxidation; Mitochondria; Mitochondrial cytopathy; Neuromuscular disease; Skeletal muscle phenotype
ID respiratory-chain dysfunction; exercise performance; endurance exercise; oxygen-uptake; metabolism; capacity; adaptations; limitation; diagnosis; increase
AB Background: Mitochondrial myopathy severely affects skeletal muscle structure and function resulting in defective oxidative phosphorylation. However, the major pathomechanisms and therewith effective treatment approaches remain elusive. Therefore, the aim of the present study was to investigate disease-related impairments in skeletal muscle properties in patients with mitochondrial myopathy. Accordingly, skeletal muscle biopsies were obtained from six patients with moleculargenetically diagnosed mitochondrial myopathy (one male and five females, 53 +/- 9 years) and eight age-and gender-matched healthy controls (two males and six females, 58 +/- 14 years) to determine mitochondrial respiratory capacity of complex I-V, mitochondrial volume density and fiber type distribution. Results: Mitochondrial volume density (4.0 +/- 0.5 vs. 5.1 +/- 0.8 %) as well as respiratory capacity of complex I-V were lower (P < 0.05) in mitochondrial myopathy and associated with a higher (P < 0.001) proportion of type II fibers (65.2 +/- 3.6 vs. 44.3 +/- 5.9 %). Additionally, mitochondrial volume density and maximal oxidative phosphorylation capacity correlated positively (P < 0.05) to peak oxygen uptake. Conclusion: Mitochondrial myopathy leads to impaired mitochondrial quantity and quality and a shift towards a more glycolytic skeletal muscle phenotype.
C1 [Gehrig, Saskia Maria; Mihaylova, Violeta; Frese, Sebastian; Mueller, Sandro Manuel; Ligon-Auer, Maria; Petersen, Jens A.; Jung, Hans H.] Univ Zurich Hosp, Dept Neurol, Frauenklinikstr 26, CH-8091 Zurich, Switzerland.
   [Gehrig, Saskia Maria; Lundby, Carsten] Univ Zurich, Inst Physiol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.
   [Gehrig, Saskia Maria; Spengler, Christina M.; Lundby, Carsten; Jung, Hans H.] Zurich Ctr Integrat Human Physiol ZIHP, Winterthurerstr 190, CH-8057 Zurich, Switzerland.
   [Spengler, Christina M.] Swiss Fed Inst Technol, Inst Human Movement Sci, Exercise Physiol Lab, Winterthurerstr 190, CH-8057 Zurich, Switzerland.
C3 University of Zurich; University Zurich Hospital; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Swiss Federal Institutes of Technology Domain; ETH Zurich
RP Jung, HH (corresponding author), Univ Zurich Hosp, Dept Neurol, Frauenklinikstr 26, CH-8091 Zurich, Switzerland.; Jung, HH (corresponding author), Zurich Ctr Integrat Human Physiol ZIHP, Winterthurerstr 190, CH-8057 Zurich, Switzerland.
EM hans.jung@usz.ch
FU Zurich Center for Integrative Human Physiology (ZIHP); Neuromuscular Research Association Basel (NeRAB)
CR Aydin J, 2009, HUM MOL GENET, V18, P278, DOI 10.1093/hmg/ddn355
   Barrientos Antoni, 2009, CURR PROTOC HUM GENET, VChapter 19, P0, DOI 10.1002/0471142905.hg1903s63
   Bassett DR, 2000, MED SCI SPORT EXER, V32, P70, DOI 10.1097/00005768-200001000-00012
   BOOTH FW, 1983, MED SCI SPORT EXER, V15, P415
   DANDURAND RJ, 1995, CHEST, V108, P182, DOI 10.1378/chest.108.1.182
   DiMauro S, 2004, BBA-BIOENERGETICS, V1659, P107, DOI 10.1016/j.bbabio.2004.08.003
   DiMauro S, 2010, ACTA MYOL, V29, P333
   DIMAURO S, 1985, ANN NEUROL, V17, P521, DOI 10.1002/ana.410170602
   Enns GM, 2005, CLIN GENET, V68, P337, DOI 10.1111/j.1399-0004.2005.00499.x
   Ferreira R, 2010, PROTEOMICS, V10, P3142, DOI 10.1002/pmic.201000173
   Flaherty KR, 2001, AM J RESP CRIT CARE, V164, P425, DOI 10.1164/ajrccm.164.3.2005110
   GALLANTI A, 1992, NEUROPEDIATRICS, V23, P10, DOI 10.1055/s-2008-1071303
   Gineste C, 2015, HUM MOL GENET, V24, P6580, DOI 10.1093/hmg/ddv361
   Gnaiger E, 2009, INT J BIOCHEM CELL B, V41, P1837, DOI 10.1016/j.biocel.2009.03.013
   Gouspillou G, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0103044
   Gram M, 2014, EXP GERONTOL, V58, P269, DOI 10.1016/j.exger.2014.08.013
   Hassani A, 2010, CURR OPIN NEUROL, V23, P459, DOI 10.1097/WCO.0b013e32833d1096
   Heinicke K, 2011, AM J PHYSIOL-REG I, V301, PR873, DOI 10.1152/ajpregu.00001.2011
   HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831
   HOLT IJ, 1989, ANN NEUROL, V26, P699, DOI 10.1002/ana.410260603
   HOPPELER H, 1987, J PHYSIOL-LONDON, V385, P661, DOI 10.1113/jphysiol.1987.sp016513
   Iqbal S, 2013, MUSCLE NERVE, V48, P963, DOI 10.1002/mus.23838
   Jacobs RA, 2013, J APPL PHYSIOL, V114, P344, DOI 10.1152/japplphysiol.01081.2012
   Jacobs RA, 2012, FASEB J, V26, P5192, DOI 10.1096/fj.12-218206
   Jacobs RA, 2013, J APPL PHYSIOL, V115, P785, DOI 10.1152/japplphysiol.00445.2013
   Jeppesen TD, 2003, ANN NEUROL, V54, P86, DOI 10.1002/ana.10594
   Jeppesen TD, 2013, NEUROMUSCULAR DISORD, V23, P629, DOI 10.1016/j.nmd.2013.05.007
   Larsson NG, 2001, ACTA PHYSIOL SCAND, V171, P385, DOI 10.1046/j.1365-201x.2001.00842.x
   LINDERHOLM H, 1969, ACTA MED SCAND, V185, P153
   Milone M, 2013, MOL GENET METAB, V110, P35, DOI 10.1016/j.ymgme.2013.07.007
   Moggio Maurizio, 2014, ACTA MYOL, V33, P86
   Montero D, 2015, J PHYSIOL-LONDON, V593, P4677, DOI 10.1113/JP270250
   MORGANHUGHES JA, 1990, BIOCHIM BIOPHYS ACTA, V1018, P217, DOI 10.1016/0005-2728(90)90252-Y
   Muranaka H, 1997, BRAIN DEV-JPN, V19, P362, DOI 10.1016/S0387-7604(97)00036-3
   NASHEF L, 1989, J NEUROL NEUROSUR PS, V52, P1090, DOI 10.1136/jnnp.52.9.1090
   Picard M, 2011, J PHYSIOL-LONDON, V589, P4413, DOI 10.1113/jphysiol.2011.212712
   REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208
   Rollins S, 2001, AM J CLIN PATHOL, V116, P326
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   SALTIN B, 1992, MED SCI SPORT EXER, V24, P30
   Taivassalo T, 2005, MED SCI SPORT EXER, V37, P2094, DOI 10.1249/01.mss.0000177446.97671.2a
   Taivassalo T, 2002, ANN NEUROL, V51, P38, DOI 10.1002/ana.10027
   Taivassalo T, 2003, BRAIN, V126, P413, DOI 10.1093/brain/awg028
   Taivassalo T, 2004, BBA-BIOENERGETICS, V1659, P221, DOI 10.1016/j.bbabio.2004.09.007
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
   Tarnopolsky MA, 2005, MED SCI SPORT EXER, V37, P2086, DOI 10.1249/01.mss.0000177341.89478.06
   Tryon LD, 2014, INTEGR MED RES, V3, P161, DOI 10.1016/j.imr.2014.09.001
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Venhoff N, 2012, ARTHRITIS RES THER, V14, P0, DOI 10.1186/ar4076
   Vissing J, 1996, ANN NEUROL, V40, P655, DOI 10.1002/ana.410400416
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wenz T, 2009, J APPL PHYSIOL, V106, P1712, DOI 10.1152/japplphysiol.91571.2008
   West Mark J, 2012, COLD SPRING HARB PROTOC, V2012, P1129, DOI 10.1101/pdb.top071787
   Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499
   Zhong H, 2005, J APPL PHYSIOL, V99, P1494, DOI 10.1152/japplphysiol.00394.2005
NR 55
TC 17
Z9 18
U1 0
U2 7
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1750-1172
EI 
J9 ORPHANET J RARE DIS
JI Orphanet J. Rare Dis.
PD JUL 29
PY 2016
VL 11
IS 
BP 
EP 
DI 10.1186/s13023-016-0488-x
PG 12
WC Genetics & Heredity; Medicine, Research & Experimental
SC Genetics & Heredity; Research & Experimental Medicine
GA DT9EM
UT WOS:000381798600002
PM 27473873
DA 2024-11-01
ER

PT J
AU Malik, AN
   Czajka, A
   Cunningham, P
AF Malik, Afshan N.
   Czajka, Anna
   Cunningham, Phil
TI Accurate quantification of mouse mitochondrial DNA without co-amplification of nuclear mitochondrial insertion sequences
SO MITOCHONDRION
LA English
DT Article
DE Mitochondrial DNA; Mitochondrial pseudogenes; NumtS; Real time PCR; Mouse mitochondrial genome
ID oxidative stress; disease; genome; biogenesis; pseudogenes; dysfunction; apoptosis; biomarker; tissue; muscle
AB Background: Mitochondria contain an extra-nuclear genome in the form of mitochondrial DNA (MtDNA), damage to which can lead to inflammation and bioenergetic deficit. Changes in MtDNA levels are increasingly used as a biomarker of mitochondrial dysfunction. We previously reported that in humans, fragments in the nuclear genome known as nuclear mitochondrial insertion sequences (NumtS) affect accurate quantification of MtDNA. In the current paper our aim was to determine whether mouse NumtS affect the quantification of MtDNA and to establish a method designed to avoid this. Methods: The existence of NumtS in the mouse genome was confirmed using blast N, unique MtDNA regions were identified using FASTA, and MtDNA primers which do not co-amplify NumtS were designed and tested. MtDNA copy numbers were determined in a range of mouse tissues as the ratio of the mitochondrial and nuclear genome using real time qPCR and absolute quantification. Results: Approximately 95% of mouse MtDNA was duplicated in the nuclear genome as NumtS which were located in 15 out of 21 chromosomes. A unique region was identified and primers flanking this region were used. MtDNA levels differed significantly in mouse tissues being the highest in the heart, with levels in descending order (highest to lowest) in kidney, liver, blood, brain, islets and lung. Conclusion: The presence of NumtS in the nuclear genome of mouse could lead to erroneous data when studying MtDNA content or mutation. The unique primers described here will allow accurate quantification of MtDNA content in mouse models without co-amplification of NumtS. (C) 2016 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Malik, Afshan N.; Czajka, Anna; Cunningham, Phil] Kings Coll London, Diabet Res Grp, Div Diabet & Nutr Sci, Sch Life Sci & Med, London SE1 1UL, England.
C3 University of London; King's College London
RP Malik, AN (corresponding author), Kings Coll London, Diabet Res Grp, Div Diabet & Nutr Sci, Sch Life Sci & Med, London SE1 1UL, England.
EM afshan.malik@kcl.ac.uk
CR Ajaz Saima, 2015, METHODS MOL BIOL, V1264, P117, DOI 10.1007/978-1-4939-2257-4_12
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Arnoult D, 2011, EMBO REP, V12, P901, DOI 10.1038/embor.2011.157
   Bayona-Bafaluy MP, 2005, P NATL ACAD SCI USA, V102, P14392, DOI 10.1073/pnas.0502896102
   Bogenhagen DF, 2012, BBA-GENE REGUL MECH, V1819, P914, DOI 10.1016/j.bbagrm.2011.11.005
   Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601
   Calabrese FM, 2012, BMC BIOINFORMATICS, V13, P0, DOI 10.1186/1471-2105-13-S4-S15
   Caro P, 2010, MITOCHONDRION, V10, P479, DOI 10.1016/j.mito.2010.05.004
   Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   Fernández-Vizarra E, 2011, MITOCHONDRION, V11, P207, DOI 10.1016/j.mito.2010.09.011
   Flicek P, 2010, NUCLEIC ACIDS RES, V38, PD557, DOI 10.1093/nar/gkp972
   Goios A, 2007, GENOME RES, V17, P293, DOI 10.1101/gr.5941007
   Goo HG, 2013, BBA-MOL CELL RES, V1833, P1866, DOI 10.1016/j.bbamcr.2013.03.016
   Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309
   Guo JB, 2014, EUR J PHARMACOL, V737, P117, DOI 10.1016/j.ejphar.2014.05.017
   Guo W, 2009, MITOCHONDRION, V9, P261, DOI 10.1016/j.mito.2009.03.003
   Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119
   Liu B, 2015, BBA-MOL BASIS DIS, V1852, P2086, DOI 10.1016/j.bbadis.2015.07.002
   Malik AN, 2013, MITOCHONDRION, V13, P481, DOI 10.1016/j.mito.2012.10.011
   Malik AN, 2011, BIOCHEM BIOPH RES CO, V412, P1, DOI 10.1016/j.bbrc.2011.06.067
   Malik Afshan N, 2009, DIABETES RES CLIN PRACT, V86, Pe22, DOI 10.1016/j.diabres.2009.07.002
   Mercer TR, 2011, CELL, V146, P645, DOI 10.1016/j.cell.2011.06.051
   Morscher RJ, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0129802
   PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444
   Perier C, 2013, BRAIN, V136, P2369, DOI 10.1093/brain/awt196
   Richly E, 2004, MOL BIOL EVOL, V21, P1081, DOI 10.1093/molbev/msh110
   Schatz G, 1996, J BIOL CHEM, V271, P31763, DOI 10.1074/jbc.271.50.31763
   Stangenberg S, 2015, INT J BIOCHEM CELL B, V64, P81, DOI 10.1016/j.biocel.2015.03.017
   Supale S, 2013, DIABETES, V62, P3488, DOI 10.2337/db13-0152
   Wallace DC, 1997, P NATL ACAD SCI USA, V94, P14900, DOI 10.1073/pnas.94.26.14900
   Wallace DC, 2009, GENE DEV, V23, P1714, DOI 10.1101/gad.1784909
   WILLIAMS RS, 1986, J BIOL CHEM, V261, P2390
   Woischnik M, 2002, GENOME RES, V12, P885, DOI 10.1101/gr.227202
   Yao YG, 2008, J MED GENET, V45, P769, DOI 10.1136/jmg.2008.059782
   Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780
   Zhao M, 2014, BIOCHEM BIOPH RES CO, V450, P1446, DOI 10.1016/j.bbrc.2014.07.010
NR 37
TC 83
Z9 87
U1 3
U2 25
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JUL 15
PY 2016
VL 29
IS 
BP 59
EP 64
DI 10.1016/j.mito.2016.05.003
PG 6
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA DQ8IF
UT WOS:000379452700008
PM 27181048
DA 2024-11-01
ER

PT J
AU Kauppila, JHK
   Baines, HL
   Bratic, A
   Simard, ML
   Freyer, C
   Mourier, A
   Stamp, C
   Filograna, R
   Larsson, NG
   Greaves, LC
   Stewart, JB
AF Kauppila, Johanna H. K.
   Baines, Holly L.
   Bratic, Ana
   Simard, Marie-Lune
   Freyer, Christoph
   Mourier, Arnaud
   Stamp, Craig
   Filograna, Roberta
   Larsson, Nils-Goeran
   Greaves, Laura C.
   Stewart, James B.
TI A Phenotype-Driven Approach to Generate Mouse Models with Pathogenic mtDNA Mutations Causing Mitochondrial Disease
SO CELL REPORTS
LA English
DT Article
ID kearns-sayre syndrome; dna mutations; transmitochondrial mice; respiratory-chain; germline; patient; cells; heteroplasmy; deletions; myopathy
AB Mutations of mtDNA are an important cause of human disease, but few animal models exist. Because mammalian mitochondria cannot be transfected, the development of mice with pathogenic mtDNA mutations has been challenging, and the main strategy has therefore been to introduce mutations found in cell lines into mouse embryos. Here, we describe a phenotype-driven strategy that is based on detecting clonal expansion of pathogenic mtDNA mutations in colonic crypts of founder mice derived from heterozygous mtDNA mutator mice. As proof of concept, we report the generation of a mouse line transmitting a heteroplasmic pathogenic mutation in the alanine tRNA gene of mtDNA displaying typical characteristics of classic mitochondrial disease. In summary, we describe a straightforward and technically simple strategy based on mouse breeding and histology to generate animal models of mtDNA-mutation disease, which will be of great importance for studies of disease pathophysiology and preclinical treatment trials.
C1 [Kauppila, Johanna H. K.; Bratic, Ana; Simard, Marie-Lune; Mourier, Arnaud; Larsson, Nils-Goeran; Stewart, James B.] Max Planck Inst Biol Ageing, Dept Mitochondrial Biol, D-50931 Cologne, Germany.
   [Baines, Holly L.; Simard, Marie-Lune; Greaves, Laura C.] Newcastle Univ, LLHW Ctr Ageing & Vital, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Freyer, Christoph; Filograna, Roberta; Larsson, Nils-Goeran] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden.
   [Greaves, Laura C.] Newcastle Univ, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Max Planck Society; Newcastle University - UK; Karolinska Institutet; Newcastle University - UK
RP Larsson, NG; Stewart, JB (corresponding author), Max Planck Inst Biol Ageing, Dept Mitochondrial Biol, D-50931 Cologne, Germany.; Larsson, NG (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden.
EM larsson@age.mpg.de; jstewart@age.mpg.de
FU United Mitochondrial Disease Foundation [13-053R]; Swedish Research Council [2015-00418]; Knut and Alice Wallenberg Foundation; Newcastle University Centre for Ageing and Vitality (Biotechnology and Biological Sciences Research Council, Engineering and Physical Sciences Research Council, Economic and Social Research Council, and Medical Research Council) [G0700718]; Wellcome Trust Centre for Mitochondrial Research [G096919]; Ake-Wiberg foundation [367990950]; MRC [G0700718] Funding Source: UKRI; Swedish Research Council [2015-00418] Funding Source: Swedish Research Council
CR Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261
   Bai YD, 1998, EMBO J, V17, P4848, DOI 10.1093/emboj/17.16.4848
   Baines HL, 2014, MECH AGEING DEV, V139, P22, DOI 10.1016/j.mad.2014.06.003
   Bayona-Bafaluy MP, 2005, P NATL ACAD SCI USA, V102, P14392, DOI 10.1073/pnas.0502896102
   CIAFALONI E, 1991, NEUROLOGY, V41, P1663, DOI 10.1212/WNL.41.10.1663
   Davies SMK, 2012, FEBS LETT, V586, P3555, DOI 10.1016/j.febslet.2012.07.043
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Finnilä S, 2001, J MOL MED, V79, P641, DOI 10.1007/s001090100268
   Freyer C, 2012, NAT GENET, V44, P1282, DOI 10.1038/ng.2427
   Gammage PA, 2014, EMBO MOL MED, V6, P458, DOI 10.1002/emmm.201303672
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   Greaves LC, 2010, EXP GERONTOL, V45, P573, DOI 10.1016/j.exger.2010.01.013
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Keogh MJ, 2015, BBA-BIOENERGETICS, V1847, P1401, DOI 10.1016/j.bbabio.2015.05.015
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055
   LARSSON NG, 1992, AM J HUM GENET, V51, P1201
   LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Leman G, 2015, INT J BIOCHEM CELL B, V65, P91, DOI 10.1016/j.biocel.2015.05.017
   Leshinsky-Silver E, 2010, MOL GENET METAB, V100, P65, DOI 10.1016/j.ymgme.2010.02.002
   Levy SE, 1999, TRANSGENIC RES, V8, P137, DOI 10.1023/A:1008967412955
   Lim SC, 2016, FASEB J, V30, P2236, DOI 10.1096/fj.201500137R
   Lin CS, 2012, P NATL ACAD SCI USA, V109, P20065, DOI 10.1073/pnas.1217113109
   Marchington DR, 1999, NAT MED, V5, P957, DOI 10.1038/11403
   McFarland R, 2008, NEUROMUSCULAR DISORD, V18, P63, DOI 10.1016/j.nmd.2007.07.007
   Minczuk M, 2006, P NATL ACAD SCI USA, V103, P19689, DOI 10.1073/pnas.0609502103
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORAES CT, 1992, AM J HUM GENET, V50, P934
   Mourier A, 2014, CELL METAB, V20, P1069, DOI 10.1016/j.cmet.2014.11.005
   Nakada K, 2004, BIOCHEM BIOPH RES CO, V323, P175, DOI 10.1016/j.bbrc.2004.08.073
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Reddy P, 2015, CELL, V161, P459, DOI 10.1016/j.cell.2015.03.051
   Rocha MC, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep15037
   Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   Shimizu A, 2015, BIOCHEM BIOPH RES CO, V459, P66, DOI 10.1016/j.bbrc.2015.02.070
   Shimizu A, 2014, P NATL ACAD SCI USA, V111, P3104, DOI 10.1073/pnas.1318109111
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Stewart JB, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004670
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tyynismaa H, 2009, EMBO REP, V10, P137, DOI 10.1038/embor.2008.242
   WATANABE T, 1978, P NATL ACAD SCI USA, V75, P5113, DOI 10.1073/pnas.75.10.5113
   Wonnapinij P, 2008, AM J HUM GENET, V83, P582, DOI 10.1016/j.ajhg.2008.10.007
NR 48
TC 91
Z9 99
U1 0
U2 19
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
EI 
J9 CELL REP
JI Cell Reports
PD SEP 13
PY 2016
VL 16
IS 11
BP 2980
EP 2990
DI 10.1016/j.celrep.2016.08.037
PG 11
WC Cell Biology
SC Cell Biology
GA DW8CZ
UT WOS:000383882300018
PM 27626666
DA 2024-11-01
ER

PT J
AU Gorman, GS
   Chinnery, PF
   DiMauro, S
   Hirano, M
   Koga, Y
   McFarland, R
   Suomalainen, A
   Thorburn, DR
   Zeviani, M
   Turnbull, DM
AF Gorman, Grainne S.
   Chinnery, Patrick F.
   DiMauro, Salvatore
   Hirano, Michio
   Koga, Yasutoshi
   McFarland, Robert
   Suomalainen, Anu
   Thorburn, David R.
   Zeviani, Massimo
   Turnbull, Douglass M.
TI Mitochondrial diseases
SO NATURE REVIEWS DISEASE PRIMERS
LA English
DT Article
ID progressive external ophthalmoplegia; hereditary optic neuropathy; impair mtdna replication; transfer-rna synthetase; dna deletions; pronuclear transfer; adult patients; mouse model; mutations; deficiency
AB Mitochondrial diseases are a group of genetic disorders that are characterized by defects in oxidative phosphorylation and caused by mutations in genes in the nuclear DNA (nDNA) and mitochondrial DNA (mtDNA) that encode structural mitochondrial proteins or proteins involved in mitochondrial function. Mitochondrial diseases are the most common group of inherited metabolic disorders and are among the most common forms of inherited neurological disorders. One of the challenges of mitochondrial diseases is the marked clinical variation seen in patients, which can delay diagnosis. However, advances in next-generation sequencing techniques have substantially improved diagnosis, particularly in children. Establishing a genetic diagnosis allows patients with mitochondrial diseases to have reproductive options, but this is more challenging for women with pathogenetic mtDNA mutations that are strictly maternally inherited. Recent advances in in vitro fertilization techniques, including mitochondrial donation, will offer a better reproductive choice for these women in the future. The treatment of patients with mitochondrial diseases remains a challenge, but guidelines are available to manage the complications of disease. Moreover, an increasing number of therapeutic options are being considered, and with the development of large cohorts of patients and biomarkers, several clinical trials are in progress.
C1 [Gorman, Grainne S.; McFarland, Robert; Turnbull, Douglass M.] Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Inst Neurosci, Sch Med, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Chinnery, Patrick F.] Univ Cambridge, Dept Clin Neurosci, Cambridge, England.
   [DiMauro, Salvatore; Hirano, Michio] Columbia Univ, Houston Merritt Clin Res Ctr, New York, NY USA.
   [DiMauro, Salvatore; Hirano, Michio] Coll Phys & Surg, Dept Neurol, New York, NY USA.
   [Koga, Yasutoshi] Kurume Univ, Grad Sch Med, Dept Paediat & Child Hlth, Kurume, Fukuoka, Japan.
   [Suomalainen, Anu] Univ Helsinki, Res Programs Unit, Mol Neurol, Helsinki, Finland.
   [Suomalainen, Anu] Univ Helsinki, Ctr Neurosci, Helsinki, Finland.
   [Suomalainen, Anu] Helsinki Univ Hosp, Dept Neurol, Helsinki, Finland.
   [Thorburn, David R.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia.
   [Thorburn, David R.] Royal Childrens Hosp, Victorian Clin Genet Serv, Melbourne, Vic, Australia.
   [Thorburn, David R.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia.
   [Zeviani, Massimo] MRC, Mitochondrial Biol Unit, Cambridge, England.
C3 Newcastle University - UK; University of Cambridge; Columbia University; Kurume University; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; Victorian Clinical Genetics Services; Royal Children's Hospital Melbourne; University of Melbourne
RP Turnbull, DM (corresponding author), Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Inst Neurosci, Sch Med, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM doug.turnbull@newcastle.ac.uk
FU Japan Agency for Medical Research and Development; Australian National Health and Medical Research Council Principal Research Fellowship; Victorian Government's Operational Infrastructure Support Program; Wellcome Trust Centre for Mitochondrial Research, Newcastle University Centre for Ageing and Vitality (Biotechnology and Biological Sciences Research Council); Wellcome Trust Centre for Mitochondrial Research, Newcastle University Centre for Ageing and Vitality (Medical Research Council (MRC)); MRC Centre for Neuromuscular Disease; MRC Centre for Translational Research in Neuromuscular Disease Mitochondrial Disease Patient Cohort (UK); Lily Foundation; UK National Institute for Health Research (NIHR) Biomedical Research Centre in Age and Age Related Diseases; UK NHS Specialist Commissioners 'Rare Mitochondrial Disorders of Adults and Children' Service; European Research Council; Sigrid Juselius Foundation; Academy of Finland; MRC; MRC [G0900652, G0502157, G0400074, G1100540, MC_UP_1002/1] Funding Source: UKRI
CR Ahola-Erkkilä S, 2010, HUM MOL GENET, V19, P1974, DOI 10.1093/hmg/ddq076
   Al-Hassnan ZN, 2015, J MED GENET, V52, P186, DOI 10.1136/jmedgenet-2014-102592
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Ashley N, 2007, HUM MOL GENET, V16, P1400, DOI 10.1093/hmg/ddm090
   Avula S, 2014, CURR TREAT OPTION NE, V16, P0, DOI 10.1007/s11940-014-0292-7
   Bax BE, 2013, NEUROLOGY, V81, P1269, DOI 10.1212/WNL.0b013e3182a6cb4b
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bianco A, 2016, BRAIN, V139, P0, DOI 10.1093/brain/awv216
   Boles RG, 2005, AM J MED GENET B, V137B, P20, DOI 10.1002/ajmg.b.30199
   Bonfante E, 2016, PEDIATR RADIOL, V46, P443, DOI 10.1007/s00247-015-3523-5
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Brito S, 2015, FRONT GENET, V6, P0, DOI 10.3389/fgene.2015.00102
   Calvo SE, 2012, SCI TRANSL MED, V4, P0, DOI 10.1126/scitranslmed.3003310
   Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720
   Cámara Y, 2014, HUM MOL GENET, V23, P2459, DOI 10.1093/hmg/ddt641
   Camp KM, 2016, MOL GENET METAB, V119, P187, DOI 10.1016/j.ymgme.2016.09.002
   Carrozzo R, 2016, J INHERIT METAB DIS, V39, P243, DOI 10.1007/s10545-015-9894-9
   Castro-Gago M, 2006, PEDIATR NEUROL, V34, P204, DOI 10.1016/j.pediatrneurol.2005.07.011
   Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001
   Chinnery PF, 2012, INT J EPIDEMIOL, V41, P177, DOI 10.1093/ije/dyr232
   Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143
   Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   Davis RL, 2013, NEUROLOGY, V81, P1819, DOI 10.1212/01.wnl.0000436068.43384.ef
   Di Meo I, 2012, EMBO MOL MED, V4, P1008, DOI 10.1002/emmm.201201433
   Diogo L, 2009, PEDIATR NEUROL, V40, P351, DOI 10.1016/j.pediatrneurol.2008.11.012
   Dionisi-Vici C, 2016, BRAIN, V139, P1045, DOI 10.1093/brain/aww013
   Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895
   Duchen Michael R, 2004, MOLECULAR ASPECTS OF MEDICINE, V25, P365, DOI 10.1016/j.mam.2004.03.001
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Elo JM, 2012, HUM MOL GENET, V21, P4521, DOI 10.1093/hmg/dds294
   Emmanuele V, 2012, ARCH NEUROL-CHICAGO, V69, P978, DOI 10.1001/archneurol.2012.206
   Enns GM, 2014, J CHILD NEUROL, V29, P1235, DOI 10.1177/0883073814538509
   Falk MJ, 2015, MOL GENET METAB, V114, P388, DOI 10.1016/j.ymgme.2014.11.016
   Ferreira M, 2011, NEUROGENETICS, V12, P9, DOI 10.1007/s10048-010-0265-2
   Gal A, 2015, CLIN NEUROPATHOL, V34, P89, DOI 10.5414/NP300789
   Garone C, 2014, EMBO MOL MED, V6, P1016, DOI 10.15252/emmm.201404092
   Garone C, 2012, ARCH NEUROL-CHICAGO, V69, P1648, DOI 10.1001/archneurol.2012.405
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   Ghezzi D, 2012, AM J HUM GENET, V90, P1079, DOI 10.1016/j.ajhg.2012.04.011
   Ghezzi D, 2010, AM J HUM GENET, V86, P639, DOI 10.1016/j.ajhg.2010.03.002
   Gilkerson RW, 2012, HUM MOL GENET, V21, P978, DOI 10.1093/hmg/ddr529
   Giordano C, 2011, BRAIN, V134, P220, DOI 10.1093/brain/awq276
   González-Vioque E, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002035
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Gorman GS, 2015, JAMA NEUROL, V72, P106, DOI 10.1001/jamaneurol.2014.1753
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Götz A, 2011, AM J HUM GENET, V88, P635, DOI 10.1016/j.ajhg.2011.04.006
   Grabhorn E, 2014, LIVER TRANSPLANT, V20, P464, DOI 10.1002/lt.23830
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   Haack TB, 2010, NAT GENET, V42, P1131, DOI 10.1038/ng.706
   Haas RH, 2007, PEDIATRICS, V120, P1326, DOI 10.1542/peds.2007-0391
   Haghighi A, 2014, ORPHANET J RARE DIS, V9, P0, DOI 10.1186/s13023-014-0119-3
   Hakonen AH, 2007, EUR J HUM GENET, V15, P779, DOI 10.1038/sj.ejhg.5201831
   Halter JP, 2015, BRAIN, V138, P2847, DOI 10.1093/brain/awv226
   Hashimoto M, 2015, MOL THER, V23, P1592, DOI 10.1038/mt.2015.126
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Honzík T, 2010, ARCH DIS CHILD, V95, P296, DOI 10.1136/adc.2009.168096
   Hopper RK, 2006, BIOCHEMISTRY-US, V45, P2524, DOI 10.1021/bi052475e
   Horvath R, 2009, BRAIN, V132, P3165, DOI 10.1093/brain/awp221
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394
   Huemer M, 2015, J INHERIT METAB DIS, V38, P905, DOI 10.1007/s10545-015-9836-6
   Hughes DA, 2009, BMC EVOL BIOL, V9, P0, DOI 10.1186/1471-2148-9-4
   Hyslop LA, 2016, NATURE, V534, P383, DOI 10.1038/nature183030
   Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184
   Jain IH, 2016, SCIENCE, V352, P54, DOI 10.1126/science.aad9642
   Janer A, 2015, EUR J HUM GENET, V23, P1301, DOI 10.1038/ejhg.2014.293
   Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360
   Kang HC, 2007, EPILEPSIA, V48, P82, DOI 10.1111/j.1528-1167.2006.00906.x
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kazak L, 2012, NAT REV MOL CELL BIO, V13, P659, DOI 10.1038/nrm3439
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943
   Kim KR, 2010, PEDIATR NEUROL, V42, P271, DOI 10.1016/j.pediatrneurol.2009.11.012
   Kirkman MA, 2009, BRAIN, V132, P2317, DOI 10.1093/brain/awp158
   Klopstock T, 2013, BRAIN, V136, P0, DOI 10.1093/brain/aws279
   Klopstock T, 2011, BRAIN, V134, P2677, DOI 10.1093/brain/awr170
   Koenig MK, 2016, JAMA NEUROL, V73, P591, DOI 10.1001/jamaneurol.2015.5072
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Koga Y, 2007, MITOCHONDRION, V7, P133, DOI 10.1016/j.mito.2006.11.006
   Koopman WJH, 2016, EMBO MOL MED, V8, P311, DOI 10.15252/emmm.201506131
   Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Kratz L, 2009, FAM SYST HEALTH, V27, P303, DOI 10.1037/a0018114
   Lake NJ, 2016, ANN NEUROL, V79, P190, DOI 10.1002/ana.24551
   Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381
   Leber T, 1871, ARCH OPHTHALMOL-CHIC, V17, P249
   Lebon S, 2003, J MED GENET, V40, P896, DOI 10.1136/jmg.40.12.896
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   Locasale JW, 2013, NAT REV CANCER, V13, P572, DOI 10.1038/nrc3557
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   López LC, 2009, HUM MOL GENET, V18, P714, DOI 10.1093/hmg/ddn401
   Luo LF, 2013, GENE, V520, P79, DOI 10.1016/j.gene.2013.03.041
   Macmillan C, 1998, NEUROLOGY, V50, P417, DOI 10.1212/WNL.50.2.417
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Marriage BJ, 2004, MOL GENET METAB, V81, P263, DOI 10.1016/j.ymgme.2003.12.008
   Martinelli D, 2012, MOL GENET METAB, V107, P383, DOI 10.1016/j.ymgme.2012.09.007
   Matthews L, 2015, J NEUROL NEUROSUR PS, V86, P537, DOI 10.1136/jnnp-2014-308186
   MATTHEWS PM, 1993, NEUROLOGY, V43, P884, DOI 10.1212/WNL.43.5.884
   Mayr JA, 2012, AM J HUM GENET, V90, P314, DOI 10.1016/j.ajhg.2011.12.005
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Minczuk M, 2008, NUCLEIC ACIDS RES, V36, P3926, DOI 10.1093/nar/gkn313
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Napolitano A, 2000, NEUROL SCI, V21, PS981, DOI 10.1007/s100720070015
   National Academies Press, 2016, MIT REPL TECHN ETH S, V0, P0
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nesbitt V, 2011, J NEONATAL PERINATAL, V4, P179
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Ng YS, 2016, EUR HEART J, V37, P2552, DOI 10.1093/eurheartj/ehv306
   NICHOLLS P, 1975, BIOCHEM BIOPH RES CO, V67, P610, DOI 10.1016/0006-291X(75)90856-6
   Nikkanen J, 2016, CELL METAB, V23, P635, DOI 10.1016/j.cmet.2016.01.019
   Nishigaki Y, 2003, J CLIN INVEST, V111, P1913, DOI 10.1172/JCI200317828
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Noorda G, 2007, J INHERIT METAB DIS, V30, P333, DOI 10.1007/s10545-007-0426-0
   Nouws J, 2014, JIMD REP, V12, P37, DOI 10.1007/8904_2013_242
   Nuffield Council on Bioethics, 2012, NOV TECHN PREV MIT D, V0, P0
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Oldfors A, 2006, NEUROLOGY, V66, PS49, DOI 10.1212/01.wnl.0000192127.63013.8d
   Orsucci D, 2012, NEUROEPIDEMIOLOGY, V38, P195, DOI 10.1159/000337161
   ORTIZ RG, 1993, ARCH OPHTHALMOL-CHIC, V111, P1525, DOI 10.1001/archopht.1993.01090110091031
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Panetta J, 2004, J INHERIT METAB DIS, V27, P487, DOI 10.1023/B:BOLI.0000037354.66587.38
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Pfeffer G, 2012, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD004426.pub3
   Pfeffer G, 2014, BRAIN, V137, P1323, DOI 10.1093/brain/awu060
   Pfeffer G, 2013, NEUROLOGY, V81, P2073, DOI 10.1212/01.wnl.0000437308.22603.43
   Pietiläinen KH, 2008, PLOS MED, V5, P0, DOI 10.1371/journal.pmed.0050051
   Pirinen E, 2014, CELL METAB, V19, P1034, DOI 10.1016/j.cmet.2014.04.002
   Quinzii CM, 2014, MOL SYNDROMOL, V5, P141, DOI 10.1159/000360490
   Rantamäki MT, 2005, ANN NEUROL, V58, P337, DOI 10.1002/ana.20555
   Read Catherine Yetter, 2003, J PEDIATR NURS, V18, P181, DOI 10.1053/jpdn.2003.36
   Reddy P, 2015, CELL, V161, P459, DOI 10.1016/j.cell.2015.03.051
   Reyes A, 2015, AM J HUM GENET, V97, P186, DOI 10.1016/j.ajhg.2015.05.013
   Richter R, 2010, BIOCHEM SOC T, V38, P1523, DOI 10.1042/BST0381523
   Rocha MC, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep15037
   Rodriguez MC, 2007, MUSCLE NERVE, V35, P235, DOI 10.1002/mus.20688
   Rogac M, 2011, PEDIATR NEUROL, V44, P340, DOI 10.1016/j.pediatrneurol.2010.12.004
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Ronchi D, 2012, BRAIN, V135, P3404, DOI 10.1093/brain/aws258
   ROTIG A, 1995, HUM MOL GENET, V4, P1327, DOI 10.1093/hmg/4.8.1327
   ROTIG A, 1989, LANCET, V1, P902
   Ryan E, 2006, IR MED J, V99, P262
   Saneto RP, 2013, PEDIATR NEUROL, V48, P167, DOI 10.1016/j.pediatrneurol.2012.09.014
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Schiff M, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0028823
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Seidowsky A, 2013, CLIN NEPHROL, V80, P456, DOI 10.5414/CN107063
   Sexton A C, 2008, J GENET COUNS, V17, P261, DOI 10.1007/s10897-007-9145-9
   Shaham O, 2010, P NATL ACAD SCI USA, V107, P1571, DOI 10.1073/pnas.0906039107
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Sofou K, 2015, MOL GENET GENOM MED, V3, P59, DOI 10.1002/mgg3.115
   Sommerville Ewen W, 2014, J NEUROMUSCUL DIS, V1, P119
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Steffann J, 2006, J MED GENET, V43, P244, DOI 10.1136/jmg.2005.032326
   Steinfeld R, 2009, AM J HUM GENET, V85, P354, DOI 10.1016/j.ajhg.2009.08.005
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368
   Taivassalo T, 2005, MED SCI SPORT EXER, V37, P2094, DOI 10.1249/01.mss.0000177446.97671.2a
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
   Tarnopolsky MA, 1997, MUSCLE NERVE, V20, P1502, DOI 10.1002/(SICI)1097-4598(199712)20:12<1502::AID-MUS4>3.0.CO;2-C
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Thommasen Harvey V, 2006, RURAL REMOTE HEALTH, V6, P528
   Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55
   Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907
   Torres-Torronteras J, 2014, MOL THER, V22, P901, DOI 10.1038/mt.2014.6
   Tyynismaa H, 2014, EMBO MOL MED, V6, P155, DOI 10.1002/emmm.201303586
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Uittenbogaard M, 2014, CURR PHARM DESIGN, V20, P5574, DOI 10.2174/1381612820666140305224906
   Uluc K, 2008, J NEUROL SCI, V273, P118, DOI 10.1016/j.jns.2008.06.002
   Uusimaa J, 2000, PEDIATRICS, V105, P598, DOI 10.1542/peds.105.3.598
   Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Varvogli L, 1999, J INHERIT METAB DIS, V22, P615, DOI 10.1023/A:1005521828360
   Verhoeven K, 2006, BRAIN, V129, P2093, DOI 10.1093/brain/awl126
   Viscomi C, 2011, CELL METAB, V14, P80, DOI 10.1016/j.cmet.2011.04.011
   Viscomi C, 2010, NAT MED, V16, P869, DOI 10.1038/nm.2188
   Wahbi K, 2010, NEUROLOGY, V74, P674, DOI 10.1212/WNL.0b013e3181d0ccf4
   Wai T, 2015, SCIENCE, V350, P0, DOI 10.1126/science.aad0116
   Wedatilake Y, 2013, ORPHANET J RARE DIS, V8, P0, DOI 10.1186/1750-1172-8-96
   Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006
   White SL, 1999, AM J HUM GENET, V65, P474, DOI 10.1086/302488
   Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d
   Wortmann SB, 2013, J INHERIT METAB DIS, V36, P913, DOI 10.1007/s10545-012-9579-6
   Wortmann SB, 2012, NAT GENET, V44, P797, DOI 10.1038/ng.2325
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
   Yatsuga S, 2012, HUM MOL GENET, V21, P526, DOI 10.1093/hmg/ddr482
   Yelverton JC, 2013, OTOLARYNG HEAD NECK, V148, P1017, DOI 10.1177/0194599813482705
   Yu-Wai-Man P, 2009, J MED GENET, V46, P145, DOI 10.1136/jmg.2007.054270
   Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024
NR 204
TC 942
Z9 1026
U1 13
U2 189
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2056-676X
EI 
J9 NAT REV DIS PRIMERS
JI Nat. Rev. Dis. Primers
PD OCT 20
PY 2016
VL 2
IS 
BP 1
EP 22
DI 10.1038/nrdp.2016.80
PG 22
WC Medicine, General & Internal
SC General & Internal Medicine
GA EQ1YW
UT WOS:000397866500001
PM 27775730
DA 2024-11-01
ER

PT J
AU Pitayu, L
   Baruffini, E
   Rodier, C
   Rötig, A
   Lodi, T
   Delahodde, A
AF Pitayu, Laras
   Baruffini, Enrico
   Rodier, Celine
   Roetig, Agnes
   Lodi, Tiziana
   Delahodde, Agnes
TI Combined use of <i>Saccharomyces cerevisiae</i>, <i>Caenorhabditis elegans</i> and patient fibroblasts leads to the identification of clofilium tosylate as a potential therapeutic chemical against POLG-related diseases
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID dna-polymerase-gamma; mitochondrial genome; resistance mutations; phosphate-transport; yeast mitochondria; protein; genes; supplementation; phenotype; depletion
AB Mitochondria are organelles that have their own DNA (mitochondrial DNA, mtDNA) whose maintenance is necessary for the majority of ATP production in eukaryotic cells. Defects in mtDNA maintenance or integrity are responsible for numerous diseases. The DNA polymerase. (POLG) ensures proper mtDNA replication and repair. Mutations in POLG are a major cause of mitochondrial disorders including hepatic insufficiency, Alpers syndrome, progressive external ophthalmoplegia, sensory neuropathy and ataxia. Mutations in POLG are also associated with parkinsonism. To date, no effective therapy is available. Based on the conservation of mitochondrial function from yeast to human, we used Saccharomyces cerevisiae and Caenorhabditis elegans as first pass filters to identify a chemical that suppresses mtDNA instability in cultured fibroblasts of a POLG-deficient patient. We showed that this unsuspected compound, clofilium tosylate (CLO), belonging to a class of anti-arrhythmic agents, prevents mtDNA loss of all yeast mitochondrial polymerase mutants tested, improves behavior and mtDNA content of polg-1-deficient worms and increases mtDNA content of quiescent POLG-deficient fibroblasts. Furthermore, the mode of action of the drug seems conserved as CLO increases POLG steady-state level in yeast and human cells. Two other anti-arrhythmic agents (FDA-approved) sharing common pharmacological properties and chemical structure also show potential benefit for POLG deficiency in C. elegans. Our findings provide evidence of the first mtDNA-stabilizing compound that may be an effective pharmacological alternative for the treatment of POLG-related diseases.
C1 [Pitayu, Laras; Rodier, Celine; Delahodde, Agnes] Univ Paris Saclay, Univ Paris Sud, CNRS, CEA,Inst Integrat Biol Cell I2BC, F-91198 Gif Sur Yvette, France.
   [Baruffini, Enrico; Lodi, Tiziana] Univ Parma, Dept Life Sci, Parco Area Sci 11 A, I-43124 Parma, Italy.
   [Roetig, Agnes] Paris Descartes Sorbonne Paris Cite Univ, INSERM, Imagine Inst, Lab Genet Mitochondrial Disorders,UMR 1163, 24 Blvd Montparnasse, F-75015 Paris, France.
C3 Universite Paris Cite; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CEA; University of Parma; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)
RP Delahodde, A (corresponding author), Univ Paris Saclay, Univ Paris Sud, CNRS, CEA,Inst Integrat Biol Cell I2BC, F-91198 Gif Sur Yvette, France.
EM agnes.delahodde@i2bc.paris-saclay.fr
FU Indonesian government (Beasiswa Unggulan Kemendiknas RI); University Paris-Sud; Fondation pour la Recherche Medicale [DRM20101220457]; Asociation Francaise contre les Myopathies [MitoScreen 17122]; Telethon (Italia) [GGP11011]
CR Addo MG, 2010, BBA-MOL BASIS DIS, V1802, P765, DOI 10.1016/j.bbadis.2010.05.007
   Aiyar RS, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms6585
   Baruffini E, 2007, BBA-MOL BASIS DIS, V1772, P1225, DOI 10.1016/j.bbadis.2007.10.002
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Baruffini E, 2015, MITOCHONDRION, V20, P52, DOI 10.1016/j.mito.2014.11.003
   Baruffini E, 2011, MITOCHONDRION, V11, P182, DOI 10.1016/j.mito.2010.09.007
   Baruffini E, 2010, MITOCHONDRION, V10, P183, DOI 10.1016/j.mito.2009.10.002
   BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0
   Bratic I, 2009, NUCLEIC ACIDS RES, V37, P1817, DOI 10.1093/nar/gkp018
   Bulst S, 2012, MOL GENET METAB, V107, P95, DOI 10.1016/j.ymgme.2012.04.022
   Cámara Y, 2014, HUM MOL GENET, V23, P2459, DOI 10.1093/hmg/ddt641
   Chinnery P, 2006, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD004426.pub2
   Chinnery PF, 2001, AM J MED GENET, V106, P94, DOI 10.1002/ajmg.1426
   Contamine V, 2000, MICROBIOL MOL BIOL R, V64, P281, DOI 10.1128/MMBR.64.2.281-315.2000
   Couplan E, 2011, P NATL ACAD SCI USA, V108, P11989, DOI 10.1073/pnas.1101478108
   Gietz RD, 2007, NAT PROTOC, V2, P35, DOI 10.1038/nprot.2007.14
   Hamel P, 2004, MOL MICROBIOL, V51, P307, DOI 10.1046/j.1365-2958.2003.03810.x
   Haynes CM, 2010, J CELL SCI, V123, P3849, DOI 10.1242/jcs.075119
   Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021
   Ho CH, 2009, NAT BIOTECHNOL, V27, P369, DOI 10.1038/nbt.1534
   Hofmann L, 2009, J CELL SCI, V122, P3673, DOI 10.1242/jcs.050229
   Hoon S, 2008, NAT CHEM BIOL, V4, P498, DOI 10.1038/nchembio.100
   Hudson G, 2006, HUM MOL GENET, V15, PR244, DOI 10.1093/hmg/ddl233
   LAHAYE A, 1991, EMBO J, V10, P997, DOI 10.1002/j.1460-2075.1991.tb08034.x
   Lebedeva MA, 2007, CELL CYCLE, V6, P2048, DOI 10.4161/cc.6.16.4572
   LECRENIER N, 1995, MOL GEN GENET, V249, P1, DOI 10.1007/BF00290229
   Lodi T, 2015, FRONT GENET, V6, P0, DOI 10.3389/fgene.2015.00106
   Meeusen S, 2003, J CELL BIOL, V163, P503, DOI 10.1083/jcb.200304040
   Murley A, 2013, ELIFE, V2, P0, DOI 10.7554/eLife.00422
   PUTRAMENT A, 1973, MOL GEN GENET, V126, P357, DOI 10.1007/BF00269445
   Qian YF, 2014, J BIOL CHEM, V289, P5970, DOI 10.1074/jbc.M113.526418
   Rötig A, 2007, MITOCHONDRION, V7, PS112, DOI 10.1016/j.mito.2007.02.008
   SOR F, 1984, NUCLEIC ACIDS RES, V12, P8313, DOI 10.1093/nar/12.22.8313
   Spinazzola A, 2007, BIOSCIENCE REP, V27, P39, DOI 10.1007/s10540-007-9036-1
   Stumpf JD, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a011395
   Taanman JW, 2009, HUM MUTAT, V30, P248, DOI 10.1002/humu.20852
   Taanman JW, 2003, HUM MOL GENET, V12, P1839, DOI 10.1093/hmg/ddg192
   Tejada MD, 2012, BIOL-TARGETS THER, V6, P465, DOI 10.2147/BTT.S33827
   Tsang WY, 2002, BIOCHEM BIOPH RES CO, V291, P8, DOI 10.1006/bbrc.2002.6394
   Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275
   Zara V, 1996, MOL CELL BIOL, V16, P6524
   Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4
NR 42
TC 18
Z9 18
U1 0
U2 3
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD FEB 15
PY 2016
VL 25
IS 4
BP 715
EP 727
DI 10.1093/hmg/ddv509
PG 13
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA DG5WS
UT WOS:000372151000009
PM 26692522
DA 2024-11-01
ER

PT J
AU Kang, EJ
   Wang, XJ
   Tippner-Hedges, R
   Ma, H
   Folmes, CDL
   Gutierrez, NM
   Lee, YM
   Van Dyken, C
   Ahmed, R
   Li, Y
   Koski, A
   Hayama, T
   Luo, SY
   Harding, CO
   Amato, P
   Jensen, J
   Battaglia, D
   Lee, D
   Wu, D
   Terzic, A
   Wolf, DP
   Huang, TS
   Mitalipov, S
AF Kang, Eunju
   Wang, Xinjian
   Tippner-Hedges, Rebecca
   Ma, Hong
   Folmes, Clifford D. L.
   Gutierrez, Nuria Marti
   Lee, Yeonmi
   Van Dyken, Crystal
   Ahmed, Riffat
   Li, Ying
   Koski, Amy
   Hayama, Tomonari
   Luo, Shiyu
   Harding, Cary O.
   Amato, Paula
   Jensen, Jeffrey
   Battaglia, David
   Lee, David
   Wu, Diana
   Terzic, Andre
   Wolf, Don P.
   Huang, Taosheng
   Mitalipov, Shoukhrat
TI Age-Related Accumulation of Somatic Mitochondrial DNA Mutations in Adult-Derived Human iPSCs
SO CELL STEM CELL
LA English
DT Article
ID pluripotent stem-cells; human skeletal-muscle; respiratory-chain; nuclear transfer; copy number; disease; deletions; heteroplasmy; genome; cancer
AB The genetic integrity of iPSCs is an important consideration for therapeutic application. In this study, we examine the accumulation of somatic mitochondrial genome (mtDNA) mutations in skin fibroblasts, blood, and iPSCs derived from young and elderly subjects (24-72 years). We found that pooled skin and blood mtDNA contained low heteroplasmic point mutations, but a panel of ten individual iPSC lines from each tissue or clonally expanded fibroblasts carried an elevated load of heteroplasmic or homoplasmic mutations, suggesting that somatic mutations randomly arise within individual cells but are not detectable in whole tissues. The frequency of mtDNA defects in iPSCs increased with age, and many mutations were non-synonymous or resided in RNA coding genes and thus can lead to respiratory defects. Our results highlight a need to monitor mtDNA mutations in iPSCs, especially those generated from older patients, and to examine the metabolic status of iPSCs destined for clinical applications.
C1 [Kang, Eunju; Tippner-Hedges, Rebecca; Ma, Hong; Gutierrez, Nuria Marti; Lee, Yeonmi; Van Dyken, Crystal; Ahmed, Riffat; Li, Ying; Koski, Amy; Hayama, Tomonari; Wolf, Don P.; Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Ctr Embryon Cell & Gene Therapy, 3303 SW Bond Ave, Portland, OR 97239 USA.
   [Kang, Eunju; Tippner-Hedges, Rebecca; Ma, Hong; Gutierrez, Nuria Marti; Lee, Yeonmi; Van Dyken, Crystal; Ahmed, Riffat; Li, Ying; Koski, Amy; Hayama, Tomonari; Wolf, Don P.; Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Div Reprod & Dev Sci, 505 NW 185th Ave, Beaverton, OR 97006 USA.
   [Wang, Xinjian; Luo, Shiyu; Huang, Taosheng] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, 3333 Burnet Ave, Cincinnati, OH 45229 USA.
   [Folmes, Clifford D. L.; Terzic, Andre] Mayo Clin, Div Cardiovasc Dis, Dept Med, Rochester, MN 55905 USA.
   [Harding, Cary O.; Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.
   [Amato, Paula; Jensen, Jeffrey; Battaglia, David; Lee, David; Wu, Diana; Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Div Reprod Endocrinol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.
   [Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.
   [Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Dept Biomed Engn, 3303 SW Bond Ave, Portland, OR 97239 USA.
C3 Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; Cincinnati Children's Hospital Medical Center; Mayo Clinic; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University
RP Mitalipov, S (corresponding author), Oregon Hlth & Sci Univ, Ctr Embryon Cell & Gene Therapy, 3303 SW Bond Ave, Portland, OR 97239 USA.; Mitalipov, S (corresponding author), Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Div Reprod & Dev Sci, 505 NW 185th Ave, Beaverton, OR 97006 USA.; Huang, TS (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Human Genet, 3333 Burnet Ave, Cincinnati, OH 45229 USA.; Mitalipov, S (corresponding author), Oregon Hlth & Sci Univ, Dept Mol & Med Genet, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.; Mitalipov, S (corresponding author), Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Div Reprod Endocrinol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.; Mitalipov, S (corresponding author), Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.; Mitalipov, S (corresponding author), Oregon Hlth & Sci Univ, Dept Biomed Engn, 3303 SW Bond Ave, Portland, OR 97239 USA.
EM taosheng.huang@cchmc.org; mitalipo@ohsu.edu
FU Leducq Foundation; OHSU; Mayo Clinic Center for Regenerative Medicine; Collins Medical Trust
CR Abyzov A, 2012, NATURE, V492, P438, DOI 10.1038/nature11629
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604
   Chinnery PF, 2000, MOL MED TODAY, V6, P425, DOI 10.1016/S1357-4310(00)01805-0
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Eshaghian A, 2006, J INVEST DERMATOL, V126, P336, DOI 10.1038/sj.jid.5700088
   Fauser S, 2002, BIOCHEM BIOPH RES CO, V295, P342, DOI 10.1016/S0006-291X(02)00672-1
   Folmes CDL, 2013, STEM CELLS, V31, P1298, DOI 10.1002/stem.1389
   Garinis GA, 2008, NAT CELL BIOL, V10, P1241, DOI 10.1038/ncb1108-1241
   Greaves LC, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004620
   Greaves LC, 2010, EXP GERONTOL, V45, P573, DOI 10.1016/j.exger.2010.01.013
   Hashizume O, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep10434
   He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802
   Horvath R, 2009, J NEUROL, V256, P810, DOI 10.1007/s00415-009-5023-8
   Johannesson B, 2014, CELL STEM CELL, V15, P634, DOI 10.1016/j.stem.2014.10.002
   Ju YS, 2014, ELIFE, V3, P0, DOI 10.7554/eLife.02935
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003
   Lee HS, 2012, CELL REP, V1, P506, DOI 10.1016/j.celrep.2012.03.011
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028
   Ma H, 2015, NATURE, V524, P234, DOI 10.1038/nature14546
   Ma H, 2014, NATURE, V511, P177, DOI 10.1038/nature13551
   Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Mohamed SA, 2006, EXP GERONTOL, V41, P508, DOI 10.1016/j.exger.2006.03.014
   Paull D, 2013, NATURE, V493, P632, DOI 10.1038/nature11800
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102
   Prasad GN, 2006, INT J CARDIOL, V109, P432, DOI 10.1016/j.ijcard.2005.07.065
   Prigione A, 2011, STEM CELLS, V29, P1338, DOI 10.1002/stem.683
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058
   Tachibana M, 2013, CELL, V153, P1228, DOI 10.1016/j.cell.2013.05.006
   Tang S, 2010, BIOTECHNIQUES, V48, P287, DOI 10.2144/000113389
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   WALLACE DC, 1986, SOMAT CELL MOLEC GEN, V12, P41, DOI 10.1007/BF01560726
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   WALLACE DC, 1994, P NATL ACAD SCI USA, V91, P8739, DOI 10.1073/pnas.91.19.8739
   Yan XK, 2011, J MED GENET, V48, P682, DOI 10.1136/jmedgenet-2011-100219
   Yao YG, 2015, MUTAT RES-FUND MOL M, V779, P68, DOI 10.1016/j.mrfmmm.2015.06.009
   Yu EPK, 2014, TRENDS ENDOCRIN MET, V25, P481, DOI 10.1016/j.tem.2014.06.008
NR 47
TC 168
Z9 181
U1 1
U2 37
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1934-5909
EI 1875-9777
J9 CELL STEM CELL
JI Cell Stem Cell
PD MAY 5
PY 2016
VL 18
IS 5
BP 625
EP 636
DI 10.1016/j.stem.2016.02.005
PG 12
WC Cell & Tissue Engineering; Cell Biology
SC Cell Biology
GA DL4HE
UT WOS:000375594200013
PM 27151456
DA 2024-11-01
ER

PT J
AU Kim, J
   Medsinge, A
   Chauhan, B
   Wiest, C
   Scanga, H
   Monaghan, R
   Moore, WH
   Nischal, KK
AF Kim, Jocelyn
   Medsinge, Anagha
   Chauhan, Bharesh
   Wiest, Cara
   Scanga, Hannah
   Monaghan, Rachael
   Moore, William H.
   Nischal, Ken K.
TI Coenzyme Q10 in the Treatment of Corneal Edema in Kearns-Sayre: Is There an Application in Fuchs Endothelial Corneal Dystrophy?
SO CORNEA
LA English
DT Article
DE Fuchs endothelial corneal dystrophy; mitochondrial disease; 4977 bp; CoQ10
ID mitochondrial-dna deletion; ophthalmoplegia-plus; disease; disorder; muscle; mutations; apoptosis; membrane; myopathy; q(10)
AB Purpose: Corneal involvement in mitochondrial disease is seldom described. Kearns-Sayre syndrome (KSS) is a mitochondrial disorder characterized by retinitis pigmentosa, external ophthalmoplegia, and heart block. We report 2 patients with KSS with corneal lesions involving the endothelium, which improved with Coenzyme Q10 (CoQ10). Based on recent research regarding the role of dysfunctional oxidative metabolism in Fuchs Endothelial Corneal Dystrophy (FECD), we propose that mitochondrial diseases and FECD share a final pathway. Methods: A chart review was performed and a review of the literature was completed with a PubMed search using the terms "Kearns-Sayre Syndrome", "mitochondria", "endothelium", "Fuchs endothelial corneal dystrophy", and "cornea". Results: There are 19 reports of corneal involvement in clinical phenotypes of mitochondrial disease. Nine of these 19 cases had findings consistent with KSS. Our patients with KSS had microcystic changes throughout the cornea and excrescences on the endothelial surface seen with ultrasound biomicroscopy, similar to the clinical findings in FECD. CoQ10 improved corneal disease in both children. CoQ10 deficiency has been reported in a variety of mitochondrial diseases, and efficacy of supplementation has been demonstrated. It may be beneficial in these patients because of its antioxidant properties and role in oxidative phosphorylation. Conclusions: The common deletion found in patients with KSS has recently been implicated in FECD, which has recently been shown to be a disease related to dysfunctional oxidative metabolism. Future research should explore the use of antioxidants, such as CoQ10 in patients with FECD.
C1 [Kim, Jocelyn; Nischal, Ken K.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA.
   [Medsinge, Anagha; Chauhan, Bharesh; Scanga, Hannah; Monaghan, Rachael; Nischal, Ken K.] Childrens Hosp Pittsburgh, UPMC Eye Ctr, Pediat Ophthalmol Strabismus & Adult Motil, Pittsburgh, PA 15213 USA.
   [Wiest, Cara] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA.
   [Moore, William H.] Great Ormond St Hosp Sick Children, Clin & Acad Dept Ophthalmol, London, England.
   [Nischal, Ken K.] UPMC Eye Ctr, Pittsburgh, PA USA.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Drexel University; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust
RP Nischal, KK (corresponding author), UPMC, Childrens Hosp Pittsburgh, Dept Pediat Ophthalmol, 4401 Penn Ave,FP 5105, Pittsburgh, PA 15224 USA.
EM nischalkk@upmc.edu
CR BACHYNSKI BN, 1986, OPHTHALMOLOGY, V93, P391
   BERENBERG RA, 1977, ANN NEUROL, V1, P37, DOI 10.1002/ana.410010104
   Bergmanson JPG, 1999, OPHTHAL PHYSL OPT, V19, P210, DOI 10.1046/j.1475-1313.1999.00408.x
   Bourne WM, 2003, EYE, V17, P912, DOI 10.1038/sj.eye.6700559
   BOURNE WM, 1982, ARCH OPHTHALMOL-CHIC, V100, P1952, DOI 10.1001/archopht.1982.01030040932013
   BROCKINGTON M, 1995, J NEUROL SCI, V131, P78, DOI 10.1016/0022-510X(95)00091-F
   CHANG TS, 1994, CORNEA, V13, P269, DOI 10.1097/00003226-199405000-00014
   Chen CC, 2013, J BIOL CHEM, V288, P11689, DOI 10.1074/jbc.M112.401844
   Colyer MH, 2007, BRIT J OPHTHALMOL, V91, P696, DOI 10.1136/bjo.2006.101055
   Czarny P, 2014, MUTAT RES-FUND MOL M, V760, P42, DOI 10.1016/j.mrfmmm.2013.12.001
   Elhalis H, 2010, OCUL SURF, V8, P173, DOI 10.1016/S1542-0124(12)70232-X
   Haas RH, 2007, MITOCHONDRION, V7, PS136, DOI 10.1016/j.mito.2007.03.008
   HOWELL N, 1994, AM J HUM GENET, V55, P219
   JOHNS DR, 1995, NEW ENGL J MED, V333, P638, DOI 10.1056/NEJM199509073331007
   Jurkunas UV, 2010, AM J PATHOL, V177, P2278, DOI 10.2353/ajpath.2010.100279
   Kanpolat A, 2003, CORNEA, V22, P726, DOI 10.1097/00003226-200311000-00004
   Kasbekar SA, 2013, OPHTHALMIC GENET, V34, P55, DOI 10.3109/13816810.2011.610862
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   KOSMORSKY GS, 1989, NEURO-OPHTHALMOLOGY, V9, P271, DOI 10.3109/01658108908997367
   Lee HF, 2006, PEDIATR NEUROL, V34, P464, DOI 10.1016/j.pediatrneurol.2005.12.002
   Lee JJ, 2012, PEDIATR NEPHROL, V27, P869, DOI 10.1007/s00467-011-2096-2
   Malbran E S, 1966, INT OPHTHALMOL CLIN, V6, P711, DOI 10.1097/00004397-196600630-00020
   Miles MV, 2008, MITOCHONDRION, V8, P170, DOI 10.1016/j.mito.2008.01.003
   Mkaouar-Rebai E, 2010, MITOCHONDRION, V10, P449, DOI 10.1016/j.mito.2010.04.003
   OHKOSHI K, 1989, CORNEA, V8, P210
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   Sacconi S, 2010, NEUROMUSCULAR DISORD, V20, P44, DOI 10.1016/j.nmd.2009.10.014
   Seneca S, 2001, ARCH NEUROL-CHICAGO, V58, P1113, DOI 10.1001/archneur.58.7.1113
   SHY GM, 1967, AM J MED, V42, P163, DOI 10.1016/0002-9343(67)90015-0
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012
   Zarnowski T, 2003, ACTA OPHTHALMOL SCAN, V81, P543, DOI 10.1034/j.1600-0420.2003.00120.x
   Zhang J, 2015, EXP EYE RES, V130, P97, DOI 10.1016/j.exer.2014.10.023
   Ziaei A, 2013, INVEST OPHTH VIS SCI, V54, P6724, DOI 10.1167/iovs.13-12699
NR 34
TC 11
Z9 11
U1 1
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0277-3740
EI 1536-4798
J9 CORNEA
JI Cornea
PD SEP 15
PY 2016
VL 35
IS 9
BP 1250
EP 1254
DI 
PG 5
WC Ophthalmology
SC Ophthalmology
GA DT4GA
UT WOS:000381437000026
PM 27442316
DA 2024-11-01
ER

PT J
AU Sunde, K
   Blackburn, PR
   Cheema, A
   Gass, J
   Jackson, J
   Macklin, S
   Atwal, PS
AF Sunde, Kiri
   Blackburn, Patrick R.
   Cheema, Anvir
   Gass, Jennifer
   Jackson, Jessica
   Macklin, Sarah
   Atwal, Paldeep S.
TI Case report: 5 year follow-up of adult late-onset mitochondrial encephalomyopathy with lactic acid and stroke-like episodes (MELAS)
SO MOLECULAR GENETICS AND METABOLISM REPORTS
LA English
DT Article
ID point mutation; arginine; encephalopathy; heteroplasmy; diagnosis; myopathy
AB Mitochondrial encephalomyopathy with lactic acid and stroke-like episodes(MELAS) is a multisystem mitochondrial disorder that typically presents in childhood. We describe the follow-up of a patient who was diagnosed with late-onset MELAS at the age of 49. Her clinical course includes sensorineural hearing loss, seizures, and multiple episodes of stroke-like metabolic crises. Molecular genetic testing on whole blood revealed 31% heteroplasmy of a m.3243A>G variant in the mtDNA, the causative variant in approximately 80% of MELAS cases. The original diagnostic criteria for MELAS required the onset of stroke-like episodes prior to 40 years of age but this case and others demonstrate that onset may be delayed in certain individuals. Therefore, MELAS should be included in the differential diagnosis of stroke-like episodes in patients of any age. (C) 2016 The Authors. Published by Elsevier Inc.
C1 [Sunde, Kiri] Mayo Clin, Mayo Med Sch, Rochester, MN USA.
   [Blackburn, Patrick R.; Cheema, Anvir; Gass, Jennifer; Jackson, Jessica; Macklin, Sarah; Atwal, Paldeep S.] Mayo Clin, Ctr Individualized Med, Dept Clin Genom, Jacksonville, FL 32224 USA.
C3 Mayo Clinic; Mayo Clinic
RP Atwal, PS (corresponding author), Mayo Clin, Ctr Individualized Med, Dept Clin Genom, Jacksonville, FL 32224 USA.
EM Atwal.Paldeep@mayo.edu
CR Bataillard M, 2001, NEUROLOGY, V56, P405, DOI 10.1212/WNL.56.3.405
   DiMauro S, 1993, GENEREVIEWS, V0, P0
   El-Hattab AW, 2016, MOL GENET METAB, V117, P407, DOI 10.1016/j.ymgme.2016.01.010
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Jeppesen TD, 2003, J NEUROL SCI, V214, P17, DOI 10.1016/S0022-510X(03)00168-0
   Kimata KG, 1998, ARCH NEUROL-CHICAGO, V55, P722, DOI 10.1001/archneur.55.5.722
   Kisanuki YY, 2006, ARCH NEUROL-CHICAGO, V63, P1200, DOI 10.1001/archneur.63.8.1200
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Koga Y, 2007, MITOCHONDRION, V7, P133, DOI 10.1016/j.mito.2006.11.006
   Leff AP, 1998, EPILEPSIA, V39, P438, DOI 10.1111/j.1528-1157.1998.tb01397.x
   MACMILLAN C, 1993, NEUROLOGY, V43, P1586, DOI 10.1212/WNL.43.8.1586
   Narita Hiroyuki, 2004, NO TO SHINKEI, V56, P345
   Olsson C, 1998, HUM MUTAT, V12, P52, DOI 10.1002/(SICI)1098-1004(1998)12:1<52::AID-HUMU8>3.0.CO;2-K
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Picard M, 2014, P NATL ACAD SCI USA, V111, PE4033, DOI 10.1073/pnas.1414028111
   Sharfstein SR, 1999, ARCH NEUROL-CHICAGO, V56, P241, DOI 10.1001/archneur.56.2.241
   Vanniarajan A, 2006, AM J MED GENET B, V141B, P440, DOI 10.1002/ajmg.b.30302
   Wilichowski E, 1999, NEUROPEDIATRICS, V30, P256, DOI 10.1055/s-2007-973500
NR 19
TC 18
Z9 21
U1 1
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2214-4269
EI 
J9 MOL GENET METAB REP
JI Molec. Genet. Metab. Rep.
PD DEC 15
PY 2016
VL 9
IS 
BP 94
EP 97
DI 10.1016/j.ymgmr.2016.11.002
PG 4
WC Genetics & Heredity
SC Genetics & Heredity
GA EE8FN
UT WOS:000389860800021
PM 27896131
DA 2024-11-01
ER

PT J
AU White, MA
   Sreedharan, J
AF White, Matthew A.
   Sreedharan, Jemeen
TI Amyotrophic lateral sclerosis: recent genetic highlights
SO CURRENT OPINION IN NEUROLOGY
LA English
DT Review
DE amyotrophic lateral sclerosis; C9orf72; genetics; RNA processing; TDP-43
ID messenger-rna export; dominant distal myopathy; frontotemporal dementia; chchd10 mutations; repeat expansions; cyclin-f; c9orf72; tbk1; gle1; als
AB Purpose of reviewAmyotrophic lateral sclerosis (ALS), like other neurodegenerative diseases, remains incurable, but gene mutations linked to ALS are providing clues as to how to target therapies. It is important for researchers to keep abreast of the rapid influx of new data in ALS, and we aim to summarize the major genetic advances made in the field over the past 2 years.Recent findingsSignificant variation in seven genes has recently been found in ALS: TBK1, CCNF, GLE1, MATR3, TUBA4A, CHCHD10 and NEK1. These have mostly been identified through large exome screening studies, though traditional linkage approaches and candidate gene screening remain important. We briefly update C9orf72 research, noting in particular the development of reagents to better understand the normal role of C9orf72 protein.SummaryStriking advances in our understanding of the genetic heterogeneity of ALS continue to be made, year on year. These implicate proteostasis, RNA export, nuclear transport, the cytoskeleton, mitochondrial function, the cell cycle and DNA repair. Functional studies to integrate these hits are needed. By building a web of knowledge with interlinked genes and mechanisms, it is hoped we can better understand ALS and work toward effective therapies.
C1 [White, Matthew A.; Sreedharan, Jemeen] Babraham Inst, Cambridge CB22 3AT, England.
C3 UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute
RP Sreedharan, J (corresponding author), Babraham Inst, Cambridge CB22 3AT, England.
EM jemeen.sreedharan@babraham.ac.uk
FU Medical Research Council; Motor Neuron Disease Association; MRC [MR/K010611/1] Funding Source: UKRI
CR Alcázar-Román AR, 2010, J BIOL CHEM, V285, P16683, DOI 10.1074/jbc.M109.082370
   Appert-Collin A, 2006, LIFE SCI, V79, P484, DOI 10.1016/j.lfs.2006.01.032
   Atanasio A, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep23204
   BAI C, 1994, EMBO J, V13, P6087, DOI 10.1002/j.1460-2075.1994.tb06955.x
   Bannwarth S, 2014, BRAIN, V137, P2329, DOI 10.1093/brain/awu138
   Bolger TA, 2011, J BIOL CHEM, V286, P39750, DOI 10.1074/jbc.M111.299321
   Bolger Timothy A, 2008, CELL, V134, P624, DOI 10.1016/j.cell.2008.06.027
   Borghero G, 2016, NEUROBIOL AGING, V43, P0, DOI 10.1016/j.neurobiolaging.2016.03.028
   Brenner D, 2016, BRAIN, V139, PCP14, DOI 10.1093/brain/aww033
   Chaussenot A, 2014, NEUROBIOL AGING, V35, P0, DOI 10.1016/j.neurobiolaging.2014.07.022
   Chen YM, 2011, CELL CYCLE, V10, P655, DOI 10.4161/cc.10.4.14814
   Chen Y, 2009, CELL CYCLE, V8, P257, DOI 10.4161/cc.8.2.7551
   Chew J, 2015, SCIENCE, V348, P1151, DOI 10.1126/science.aaa9344
   Cirulli ET, 2015, SCIENCE, V347, P1436, DOI 10.1126/science.aaa3650
   Cooper-Knock J, 2015, NEUROTHERAPEUTICS, V12, P326, DOI 10.1007/s13311-015-0342-1
   Dekker AM, 2016, NEUROBIOL AGING, V39, P0, DOI 10.1016/j.neurobiolaging.2015.12.012
   Dols-Icardo O, 2015, BRAIN, V138, PE400, DOI 10.1093/brain/awv175
   Fang X, 2015, ACTA BIOCH BIOPH SIN, V47, P834, DOI 10.1093/abbs/gmv076
   Fecto F, 2011, ARCH NEUROL-CHICAGO, V68, P1440, DOI 10.1001/archneurol.2011.250
   Feige E, 2006, BBA-MOL CELL RES, V1763, P272, DOI 10.1016/j.bbamcr.2006.01.009
   Feit H, 1998, AM J HUM GENET, V63, P1732, DOI 10.1086/302166
   Folkmann Andrew W, 2014, ADVANCES IN BIOLOGICAL REGULATION, V54, P74, DOI 10.1016/j.jbior.2013.10.002
   Folkmann AW, 2013, CELL, V155, P582, DOI 10.1016/j.cell.2013.09.023
   Freischmidt A, 2015, NAT NEUROSCI, V18, P631, DOI 10.1038/nn.4000
   Fung TK, 2002, J BIOL CHEM, V277, P35140, DOI 10.1074/jbc.M205503200
   Gallego-Iradi MC, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0142144
   Genin EC, 2016, EMBO MOL MED, V8, P58, DOI 10.15252/emmm.201505496
   Gijselinck I, 2015, NEUROLOGY, V85, P2116, DOI 10.1212/WNL.0000000000002220
   Haeusler AR, 2016, NAT REV NEUROSCI, V17, P383, DOI 10.1038/nrn.2016.38
   Heo JM, 2015, MOL CELL, V60, P7, DOI 10.1016/j.molcel.2015.08.016
   Jiang J, 2016, NEURON, V90, P535, DOI 10.1016/j.neuron.2016.04.006
   Jiao B, 2016, BRAIN, V139, P0, DOI 10.1093/brain/awv367
   Johnson JO, 2014, BRAIN, V137, P0, DOI 10.1093/brain/awu265
   Johnson JO, 2014, NAT NEUROSCI, V17, P664, DOI 10.1038/nn.3688
   Joyce PI, 2015, HUM MOL GENET, V24, P1883, DOI 10.1093/hmg/ddu605
   Kaneb HM, 2015, HUM MOL GENET, V24, P1363, DOI 10.1093/hmg/ddu545
   Kendirgi F, 2005, MOL BIOL CELL, V16, P4304, DOI 10.1091/mbc.E04-11-0998
   Kurzwelly D, 2015, BRAIN, V138, P0, DOI 10.1093/brain/awv014
   Kwon I, 2014, SCIENCE, V345, P1139, DOI 10.1126/science.1254917
   Lattante S, 2014, NEUROLOGY, V83, P990, DOI 10.1212/WNL.0000000000000778
   Le Ber I, 2015, NEUROBIOL AGING, V36, P0, DOI 10.1016/j.neurobiolaging.2015.08.009
   Leblond CS, 2016, NEUROBIOL AGING, V37, P0, DOI 10.1016/j.neurobiolaging.2015.09.013
   Li XL, 2016, AMYOTROPH LAT SCL FR, V17, P458, DOI 10.3109/21678421.2016.1170151
   Lin KP, 2015, NEUROBIOL AGING, V36, P2005, DOI 10.1016/j.neurobiolaging.2015.02.008
   Ling JP, 2015, SCIENCE, V349, P650, DOI 10.1126/science.aab0983
   Ling SC, 2010, P NATL ACAD SCI USA, V107, P13318, DOI 10.1073/pnas.1008227107
   Liu YJ, 2016, NEURON, V90, P521, DOI 10.1016/j.neuron.2016.04.005
   Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971
   Matsumoto G, 2015, HUM MOL GENET, V24, P4429, DOI 10.1093/hmg/ddv179
   Millecamps S, 2014, NEUROBIOL AGING, V35, P0, DOI 10.1016/j.neurobiolaging.2014.07.016
   Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015
   Movsesyan V, 1996, EXP CELL RES, V227, P203, DOI 10.1006/excr.1996.0268
   Müller K, 2014, BRAIN, V137, P0, DOI 10.1093/brain/awu227
   Müller TJ, 2014, ANN NEUROL, V76, P669, DOI 10.1002/ana.24255
   Murakami T, 2015, NEURON, V88, P678, DOI 10.1016/j.neuron.2015.10.030
   Nousiainen HO, 2008, NAT GENET, V40, P155, DOI 10.1038/ng.2007.65
   ORourke JG, 2016, SCIENCE, V351, P1324, DOI 10.1126/science.aaf1064
   ORourke JG, 2015, NEURON, V88, P892, DOI 10.1016/j.neuron.2015.10.027
   Özoguz A, 2015, NEUROBIOL AGING, V36, P0, DOI 10.1016/j.neurobiolaging.2014.12.032
   Pasanen P, 2016, ACTA NEUROL SCAND, V133, P361, DOI 10.1111/ane.12470
   Pelegrini AL, 2010, MUTAGENESIS, V25, P447, DOI 10.1093/mutage/geq026
   Peters OM, 2015, NEURON, V88, P902, DOI 10.1016/j.neuron.2015.11.018
   Pottier C, 2015, ACTA NEUROPATHOL, V130, P77, DOI 10.1007/s00401-015-1436-x
   Rayala HJ, 2004, MOL CELL PROTEOMICS, V3, P145, DOI 10.1074/mcp.M300106-MCP200
   Richter B, 2016, P NATL ACAD SCI USA, V113, P4039, DOI 10.1073/pnas.1523926113
   Ronchi D, 2015, BRAIN, V138, PE372, DOI 10.1093/brain/awu384
   Senderek J, 2009, AM J HUM GENET, V84, P511, DOI 10.1016/j.ajhg.2009.03.006
   Smith BN, 2014, NEURON, V84, P324, DOI 10.1016/j.neuron.2014.09.027
   Sreedharan J, 2015, CURR BIOL, V25, P2130, DOI 10.1016/j.cub.2015.06.045
   Sudria-Lopez E, 2016, ACTA NEUROPATHOL, V132, P145, DOI 10.1007/s00401-016-1581-x
   Sullivan PM, 2016, ACTA NEUROPATHOL COM, V4, P0, DOI 10.1186/s40478-016-0324-5
   Teyssou E, 2016, NEUROBIOL AGING, V42, P0, DOI 10.1016/j.neurobiolaging.2016.03.022
   Tsai PC, 2016, NEUROBIOL AGING, V40, P0, DOI 10.1016/j.neurobiolaging.2015.12.022
   Van Blitterswijk M, 2014, NEUROBIOL AGING, V35, P0, DOI 10.1016/j.neurobiolaging.2014.04.016
   Williams KL, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms11253
   Williams KL, 2015, NEUROBIOL AGING, V36, P0, DOI 10.1016/j.neurobiolaging.2015.08.013
   Xiang SH, 2015, CELL, V163, P829, DOI 10.1016/j.cell.2015.10.040
   Xiao SX, 2015, ANN NEUROL, V78, P568, DOI 10.1002/ana.24469
NR 85
TC 29
Z9 34
U1 0
U2 47
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1350-7540
EI 1473-6551
J9 CURR OPIN NEUROL
JI Curr. Opin. Neurol.
PD OCT 15
PY 2016
VL 29
IS 5
BP 557
EP 564
DI 10.1097/WCO.0000000000000367
PG 8
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA DW9SR
UT WOS:000384003500004
PM 27538057
DA 2024-11-01
ER

PT J
AU Vanlander, AV
   Mosquera, LM
   Panzer, J
   Deconinck, T
   Smet, J
   Seneca, S
   Van Dorpe, J
   Ferdinande, L
   Ceuterick-de Groote, C
   De Jonghe, P
   Van Coster, R
   Baets, J
AF Vanlander, Arnaud V.
   Mosquera, Laura Muino
   Panzer, Joseph
   Deconinck, Tine
   Smet, Joel
   Seneca, Sara
   Van Dorpe, Jo
   Ferdinande, Liesbeth
   Ceuterick-de Groote, Chantal
   De Jonghe, Peter
   Van Coster, Rudy
   Baets, Jonathan
TI Megaconial muscular dystrophy caused by mitochondrial membrane homeostasis defect, new insights from skeletal and heart muscle analyses
SO MITOCHONDRION
LA English
DT Article
DE CHKB; Mitochondria; OXPHOS; Microscopy; Heart transplantation
ID chkb gene; mutations; myopathy; tool
AB Megaconial congenital muscular dystrophy is a disease caused by pathogenic mutations in the gene encoding choline kinase beta (CHKB). Microscopically, the disease is hallmarked by the presence of enlarged mitochondria at the periphery of skeletal muscle fibres leaving the centre devoid of mitochondria. Clinical characteristics are delayed motor development, intellectual disability and dilated cardiomyopathy in half of reported cases. This study describes a patient presenting with the cardinal clinical features, in whom a homozygous nonsense mutation (c.248_249insT; p.Arg84Profs*209) was identified in CHKB and who was treated by heart transplantation. Microscopic evaluation of skeletal and heart muscles typically showed enlarged mitochondria. Spectrophotometric evaluation in both tissues revealed a mild decrease of all OXPHOS complexes. Using BN-PAGE analysis followed by activity staining subcomplexes of complex V were detected in both tissues, indicating incomplete complex V assembly. Mitochondrial DNA content was not depleted in analysed tissues. This is the first report describing the microscopic and biochemical abnormalities in the heart from an affected patient. A likely hypothesis is that the biochemical findings are caused by an abnormal lipid profile in the inner mitochondrial membrane resulting from a defective choline kinase B activity. (C) 2016 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Vanlander, Arnaud V.; Smet, Joel; Van Coster, Rudy] Univ Hosp Ghent, Div Pediat Neurol & Metab, Dept Pediat, De Pintelaan 185, B-9000 Ghent, Belgium.
   [Mosquera, Laura Muino; Panzer, Joseph] Univ Hosp Ghent, Div Pediat Cardiol, Dept Pediat, De Pintelaan 185, B-9000 Ghent, Belgium.
   [Deconinck, Tine; Ceuterick-de Groote, Chantal; De Jonghe, Peter; Baets, Jonathan] Univ Antwerp, Labs Neurogenet & Ultrastruct Neuropathol, Inst Born Bunge, Univ Pl 1, B-2610 Antwerp, Belgium.
   [Deconinck, Tine; Ceuterick-de Groote, Chantal; De Jonghe, Peter; Baets, Jonathan] Univ Antwerp, Biobank, Inst Born Bunge, Univ Pl 1, B-2610 Antwerp, Belgium.
   [Deconinck, Tine; De Jonghe, Peter; Baets, Jonathan] VIB, Dept Mol Genet, Neurogenet Grp, Univ Pl 1, B-2610 Antwerp, Belgium.
   [Seneca, Sara] Vrije Univ Brussel, Res Grp Reprod & Genet REGE, Laarbeeklaan 101, B-1090 Brussels, Belgium.
   [Seneca, Sara] Vrije Univ Brussel, Ctr Med Genet, UZ Brussel, Laarbeeklaan 101, B-1090 Brussels, Belgium.
   [Van Dorpe, Jo; Ferdinande, Liesbeth] Univ Hosp Ghent, Dept Pathol, De Pintelaan 185, B-9000 Ghent, Belgium.
   [De Jonghe, Peter; Baets, Jonathan] Univ Antwerp Hosp, Dept Neurol, Wilrijkstr 10, B-2650 Edegem, Belgium.
C3 Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; University of Antwerp; University of Antwerp; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; University Hospital Brussels; Vrije Universiteit Brussel; Ghent University; Ghent University Hospital; University of Antwerp
RP Van Coster, R (corresponding author), Univ Hosp Ghent, Div Pediat Neurol & Metab, Dept Pediat, De Pintelaan 185, B-9000 Ghent, Belgium.
EM rudy.vancoster@ugent.be
FU Association Belge contre les Maladies Neuromusculaires (ABMM); EU [2012-305121]; Ghent University (Ugent, BOF) [01DI2714]; Steunfonds Marguerite-Marie Delacroix; Fund for Scientific Research (FWO, Belgium) [G.0666.06]
CR BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5
   Bolar NA, 2013, HUM MOL GENET, V22, P2590, DOI 10.1093/hmg/ddt107
   Cabrera-Serrano Macarena, 2015, MUSCLE NERVE, V51, P140, DOI 10.1002/mus.24446
   Castro-Gago M, 2014, EUR J PAEDIATR NEURO, V18, P796, DOI 10.1016/j.ejpn.2014.06.005
   Kalra AA, 2012, ARCH NEUROL-CHICAGO, V69, P657, DOI 10.1001/archneurol.2011.2333
   Martin JJ, 1997, NEUROMUSCULAR DISORD, V7, P512, DOI 10.1016/S0960-8966(97)00119-3
   Mayr JA, 2012, AM J HUM GENET, V90, P314, DOI 10.1016/j.ajhg.2011.12.005
   Mitsuhashi S, 2013, CURR OPIN NEUROL, V26, P536, DOI 10.1097/WCO.0b013e328364c82d
   Mitsuhashi S, 2011, HUM MOL GENET, V20, P3841, DOI 10.1093/hmg/ddr305
   Mitsuhashi S, 2011, AM J HUM GENET, V88, P845, DOI 10.1016/j.ajhg.2011.05.010
   Nishino I, 1998, MUSCLE NERVE, V21, P40, DOI 10.1002/(SICI)1097-4598(199801)21:1<40::AID-MUS6>3.0.CO;2-G
   Oliveira J, 2015, J HUM GENET, V60, P305, DOI 10.1038/jhg.2015.20
   Quinlivan R, 2013, NEUROMUSCULAR DISORD, V23, P549, DOI 10.1016/j.nmd.2013.04.002
   Rozen S, 2000, METHODS MOL BIOL, V132, P365
   Shaikh SR, 2014, BIOCHEMISTRY-US, V53, P5589, DOI 10.1021/bi500868g
   Smet J, 2009, ELECTROPHORESIS, V30, P3565, DOI 10.1002/elps.200900213
   Van Coster R, 2001, PEDIATR RES, V50, P658, DOI 10.1203/00006450-200111000-00020
   van der Westhuizen FH, 2010, J INHERIT METAB DIS, V33, PS55, DOI 10.1007/s10545-009-9020-y
   Weckx S, 2005, GENOME RES, V15, P436, DOI 10.1101/gr.2754005
   Wittig I, 2010, BBA-BIOENERGETICS, V1797, P1004, DOI 10.1016/j.bbabio.2010.02.021
   Wortmann S, 2006, MOL GENET METAB, V88, P47, DOI 10.1016/j.ymgme.2006.01.013
NR 21
TC 8
Z9 8
U1 0
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD MAR 15
PY 2016
VL 27
IS 
BP 32
EP 38
DI 10.1016/j.mito.2016.02.001
PG 7
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA DH3CQ
UT WOS:000372665500005
PM 26855408
DA 2024-11-01
ER

PT J
AU Masser, DR
   Clark, NW
   Van Remmen, H
   Freeman, WM
AF Masser, Dustin R.
   Clark, Nicholas W.
   Van Remmen, Holly
   Freeman, Willard M.
TI Loss of the antioxidant enzyme CuZnSOD (<i>Sod1</i>) mimics an age-related increase in absolute mitochondrial DNA copy number in the skeletal muscle
SO AGE
LA English
DT Article
DE Mitochondria; Digital PCR; mtDNA; mtDNA copy number; Aging; Sod1; Synaptosomes
ID droplet digital pcr; oxidative stress; quantitative pcr; transcription; dysfunction; disease; mtdna; mutations; deletion; distinct
AB Mitochondria contain multiple copies of the circular mitochondrial genome (mtDNA) that encodes ribosomal RNAs and proteins locally translated for oxidative phosphorylation. Loss of mtDNA integrity, both altered copy number and increased mutations, is implicated in cellular dysfunction with aging. Published data on mtDNA copy number and aging is discordant which may be due to methodological limitations for quantifying mtDNA copy number. Existing quantitative PCR (qPCR) mtDNA copy number quantification methods provide only relative abundances and are problematic to normalize to different template input amounts and across tissues/sample types. As well, existing methods cannot quantify mtDNA copy number in subcellular isolates, such as isolated mitochondria and neuronal synaptic terminals, which lack nuclear genomic DNA for normalization. We have developed and validated a novel absolute mtDNA copy number quantitation method that uses chip-based digital polymerase chain reaction (dPCR) to count the number of copies of mtDNA and used this novel method to assess the literature discrepancy in which there is no clear consensus whether mtDNA numbers change with aging in skeletal muscle. Skeletal muscle in old mice was found to have increased absolute mtDNA numbers compared to young controls. Furthermore, young Sod1 (-/-) mice were assessed and show an age-mimicking increase in skeletal muscle mtDNA. These findings reproduce a number of previous studies that demonstrate age-related increases in mtDNA. This simple and cost effective dPCR approach should enable precise and accurate mtDNA copy number quantitation in mitochondrial studies, eliminating contradictory studies of mitochondrial DNA content with aging.
C1 [Masser, Dustin R.; Clark, Nicholas W.; Freeman, Willard M.] Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK 73104 USA.
   [Masser, Dustin R.; Freeman, Willard M.] Univ Oklahoma, Dept Geriatr Med, Hlth Sci Ctr, Oklahoma City, OK 73104 USA.
   [Masser, Dustin R.; Freeman, Willard M.] Univ Oklahoma, Harold Hamm Diabet Ctr, Hlth Sci Ctr, Oklahoma City, OK 73104 USA.
   [Masser, Dustin R.; Van Remmen, Holly; Freeman, Willard M.] Oklahoma Nathan Shock Ctr Aging, Oklahoma City, OK 73104 USA.
   [Van Remmen, Holly] Oklahoma Med Res Fdn, Oklahoma City, OK 73102 USA.
C3 University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Oklahoma Medical Research Foundation
RP Freeman, WM (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK 73104 USA.
EM dmasser@ouhsc.edu; Nicholas-clark@ouhsc.edu; Holly-vanremmen@omrf.org; wfreeman@ouhsc.edu
FU National Institutes of Health [National Eye Institute] [R01EY02176, R21EY024520, T32EY023202]; National Institute on Aging Oklahoma Nathan Shock Center [P30AG050911]; Donald W. Reynolds Foundation; University of Oklahoma Health Sciences Center Graduate Student Association; Harold Hamm Diabetes Center at the University of Oklahoma
CR Anson RM, 2000, J AM AGING ASSOC, V23, P199, DOI 10.1007/s11357-000-0020-y
   Bai RK, 2004, ANN NY ACAD SCI, V1011, P304, DOI 10.1196/annals.1293.029
   Baker M, 2012, NAT METHODS, V9, P541, DOI 10.1038/nmeth.2027
   Barja G, 2013, ANTIOXID REDOX SIGN, V19, P1420, DOI 10.1089/ars.2012.5148
   Barrientos A, 1997, MOL BRAIN RES, V52, P284, DOI 10.1016/S0169-328X(97)00278-7
   Barrientos A, 1997, BIOCHEM MOL MED, V62, P165, DOI 10.1006/bmme.1997.2647
   Benz CC, 2008, NAT REV CANCER, V8, P875, DOI 10.1038/nrc2522
   Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604
   Chaturvedi RK, 2013, FREE RADICAL BIO MED, V63, P1, DOI 10.1016/j.freeradbiomed.2013.03.018
   DErchia AM, 2015, MITOCHONDRION, V20, P13, DOI 10.1016/j.mito.2014.10.005
   Dickinson A, 2013, CELL DEATH DIFFER, V20, P1644, DOI 10.1038/cdd.2013.115
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Fernández-Vizarra E, 2011, MITOCHONDRION, V11, P207, DOI 10.1016/j.mito.2010.09.011
   Ferreira R, 2010, PROTEOMICS, V10, P3142, DOI 10.1002/pmic.201000173
   GADALETA MN, 1992, MUTAT RES, V275, P181, DOI 10.1016/0921-8734(92)90022-H
   Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g
   Hindson CM, 2013, NAT METHODS, V10, P1003, DOI 10.1038/nmeth.2633
   Huang JH, 2009, IUBMB LIFE, V61, P201, DOI 10.1002/iub.164
   Jang YC, 2010, FASEB J, V24, P1376, DOI 10.1096/fj.09-146308
   Kowluru RA, 2013, CURR MED CHEM, V20, P3226, DOI 10.2174/09298673113209990029
   Lanza IR, 2008, DIABETES, V57, P2933, DOI 10.2337/db08-0349
   Lee HC, 2000, BIOCHEM J, V348, P425, DOI 10.1042/0264-6021:3480425
   Malik AN, 2013, MITOCHONDRION, V13, P481, DOI 10.1016/j.mito.2012.10.011
   Masser DR, 2014, J GERONTOL A-BIOL, V69, P1311, DOI 10.1093/gerona/glu091
   Masser DR, 2013, EPIGENET CHROMATIN, V6, P0, DOI 10.1186/1756-8935-6-33
   Masuyama M, 2005, BBA-GEN SUBJECTS, V1723, P302, DOI 10.1016/j.bbagen.2005.03.001
   McInerny SC, 2009, MECH AGEING DEV, V130, P343, DOI 10.1016/j.mad.2009.01.008
   Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5
   Morrison T, 2006, NUCLEIC ACIDS RES, V34, P0, DOI 10.1093/nar/gkl639
   Muller FL, 2006, FREE RADICAL BIO MED, V40, P1993, DOI 10.1016/j.freeradbiomed.2006.01.036
   Nagahisa H, 2016, OXID MED CELL LONGEV, V2016, P0, DOI 10.1155/2016/9345970
   Nicklas JA, 2004, ENVIRON MOL MUTAGEN, V44, P313, DOI 10.1002/em.20050
   Pesce V, 2001, FREE RADICAL BIO MED, V30, P1223, DOI 10.1016/S0891-5849(01)00517-2
   Phillips NR, 2014, SCI REP-UK, V4, P0, DOI 10.1038/srep03887
   REIS RJS, 1983, J BIOL CHEM, V258, P9078
   Sanz A, 2007, EXP GERONTOL, V42, P173, DOI 10.1016/j.exger.2006.10.003
   Sharma K, 2015, DIABETES, V64, P663, DOI 10.2337/db14-0874
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   van Leeuwen N, 2014, AGE, V36, P1463, DOI 10.1007/s11357-014-9629-0
   VanGuilder HD, 2008, EUR J NEUROSCI, V28, P1, DOI 10.1111/j.1460-9568.2008.06322.x
   VELTRI KL, 1990, J CELL PHYSIOL, V143, P160, DOI 10.1002/jcp.1041430122
   Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236
   Wanagat J, 2015, EXP GERONTOL, V61, P15, DOI 10.1016/j.exger.2014.11.012
   Wang T, 2014, CELL, V157, P1591, DOI 10.1016/j.cell.2014.04.042
   Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103
   Welle S, 2003, J APPL PHYSIOL, V94, P1479, DOI 10.1152/japplphysiol.01061.2002
NR 49
TC 18
Z9 22
U1 5
U2 20
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0161-9152
EI 1574-4647
J9 AGE
JI Age
PD AUG 15
PY 2016
VL 38
IS 4
BP 323
EP 333
DI 10.1007/s11357-016-9930-1
PG 11
WC Geriatrics & Gerontology
SC Geriatrics & Gerontology
GA DY8SJ
UT WOS:000385400700007
PM 27444179
DA 2024-11-01
ER

PT J
AU Yu, M
   Zhang, Z
   Wang, QQ
   Liu, J
   Zuo, YH
   Yu, L
   Xiao, JX
   Zhang, W
   Yuan, Y
   Wang, ZX
AF Yu, Meng
   Zhang, Zhe
   Wang, Qing-Qing
   Liu, Jing
   Zuo, Yue-Huan
   Yu, Lei
   Xiao, Jiang-Xi
   Zhang, Wei
   Yuan, Yun
   Wang, Zhao-Xia
TI Clinical and Brain Magnetic Resonance Imaging Features in a Cohort of Chinese Patients with Kearns-Sayre Syndrome
SO CHINESE MEDICAL JOURNAL
LA English
DT Article
DE Brain Magnetic Resonance Imaging; Heart Conduction Block; Kearns-Sayre Syndrome
ID mitochondrial-dna deletions; external ophthalmoplegia; mri findings; disease; single
AB Background: Kearns-Sayre syndrome (KSS) is a mitochondrial DNA (mtDNA) deletion disorder characterized by a triad of onset before 20 years of age, ophthalmoplegia, and pigmentary retinopathy. The heart and central nervous system are commonly involved. We summarized clinical and brain magnetic resonance imaging (MRI) features of a cohort of Chinese KSS patients. Methods: Nineteen patients confirmed by muscle biopsy and mtDNA analysis were enrolled. We examined clinical profiles, mainly focusing on changes in electrocardiogram (ECG) and brain MRL The correlation between genotype and phenotype was statistically analyzed. Results: The mean age of onset was 9.6 +/- 4.3 years, with all developing the classic triad at the time of diagnosis. Heart conduction block was detected in 63.2%, with four initially presenting as bundle branch block and developing into complete atrioventricular block over 3-72 months. Brain MRI showed symmetric high-T2 signals in 100% of cerebral and cerebellar white matter, as well as brainstem, 46.7% of basal ganglia, and 53.3% of thalamus. There were two patterns of cerebral white matter involvements, one with selective subcortical U-fibers and the other with periventricular white matter. The size of mtDNA deletion did not significantly correlate with age of onset or percentage of ragged blue fibers on muscle pathology. Conclusions: The clinical features of KSS evolve dynamically, affecting the cardiac conduction system predominantly, highlighting the significance of ECG monitoring. Brain MRI showed changes involving both the white matter and deep gray nuclei. Clinical presentation or severity of muscle pathological changes is not related to the size of mtDNA deletions.
C1 [Yu, Meng; Zhang, Zhe; Wang, Qing-Qing; Liu, Jing; Zuo, Yue-Huan; Zhang, Wei; Yuan, Yun; Wang, Zhao-Xia] Peking Univ, Dept Neurol, Hosp 1, 8 Xishiku St, Beijing 100034, Peoples R China.
   [Yu, Lei; Xiao, Jiang-Xi] Peking Univ, Dept Radiol, Hosp 1, Beijing 100034, Peoples R China.
C3 Peking University; Peking University
RP Wang, ZX (corresponding author), Peking Univ, Dept Neurol, Hosp 1, 8 Xishiku St, Beijing 100034, Peoples R China.
EM drwangzx@163.com
FU Ministry of Science and Technology of China [2011ZX09307-001-07]; Beijing Municipal Science and Technology Commission [Z151100003915126]
CR Agrawal H, 2013, PEDIATR CARDIOL, V34, P1044, DOI 10.1007/s00246-012-0365-x
   Berardo A, 2010, CURR NEUROL NEUROSCI, V10, P118, DOI 10.1007/s11910-010-0096-4
   [方方 Fang Fang], 2011, 中国循证儿科杂志 CHINESE JOURNAL OF EVIDENCE BASED PEDIATRICS, V6, P431
   Filosto M, 2007, BIOSCIENCE REP, V27, P23, DOI 10.1007/s10540-007-9034-3
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   Kabunga P, 2015, INT J CARDIOL, V181, P303, DOI 10.1016/j.ijcard.2014.12.038
   Kamata Y, 1998, J NEURO-OPHTHALMOL, V18, P284
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Khambatta S, 2014, INT J GEN MED, V7, P325, DOI 10.2147/IJGM.S65560
   KOSINSKI C, 1995, STROKE, V26, P1950, DOI 10.1161/01.STR.26.10.1950
   Lerman-Sagie T, 2005, MOL GENET METAB, V84, P127, DOI 10.1016/j.ymgme.2004.09.008
   [刘祺 Liu Qi], 2015, 中华神经科杂志 CHINESE JOURNAL OF NEUROLOGY, V48, P382
   Liu YH, 2014, CHINESE MED J-PEKING, V127, P2304, DOI 10.3760/cma.j.issn.0366-6999.20132799
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   NAKAGAWA E, 1994, BRAIN DEV-JPN, V16, P416, DOI 10.1016/0387-7604(94)90133-3
   Park SB, 2004, YONSEI MED J, V45, P727, DOI 10.3349/ymj.2004.45.4.727
   Phadke M, 2012, INDIAN J PEDIATR, V79, P650, DOI 10.1007/s12098-011-0618-3
   Sacher M, 2005, NEURORADIOLOGY, V47, P241, DOI 10.1007/s00234-004-1314-z
   Saneto RP, 2008, MITOCHONDRION, V8, P396, DOI 10.1016/j.mito.2008.05.003
   Schoser BGH, 2006, STRABISMUS, V14, P107, DOI 10.1080/09273970600701218
   Serrano M, 2010, MITOCHONDRION, V10, P429, DOI 10.1016/j.mito.2010.04.001
   van Beynum I, 2012, JIMD REP, V2, P7, DOI 10.1007/8904_2011_32
   WRAY SH, 1995, AM J NEURORADIOL, V16, P1167
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
   Yau Eric KC, 2009, HONG KONG MEDICAL JOURNAL, V15, P374
   Zeviani M, 1998, NEUROLOGY, V51, P1525, DOI 10.1212/WNL.51.6.1525-a
NR 26
TC 18
Z9 20
U1 0
U2 8
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA
SN 0366-6999
EI 
J9 CHINESE MED J-PEKING
JI Chin. Med. J.
PD JUN 20
PY 2016
VL 129
IS 12
BP 1419
EP 1424
DI 10.4103/0366-6999.183417
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA DT1DC
UT WOS:000381220900006
PM 27270536
DA 2024-11-01
ER

PT J
AU Yu, EPK
   Bennett, MR
AF Yu, Emma P. K.
   Bennett, Martin R.
TI The role of mitochondrial DNA damage in the development of atherosclerosis
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Review
DE Mitochondria; Atherosclerosis; Inflammation
ID permeability transition pore; smooth-muscle-cells; nlrp3 inflammasome; oxidative stress; accelerates atherosclerosis; promotes atherosclerosis; energy homeostasis; metabolic syndrome; mtdna mutations; atp synthase
AB Mitochondria are the cellular powerhouses, fuelling metabolic processes through their generation of ATP. However we now recognise that these organelles also have pivotal roles in producing reactive oxygen species (ROS) and in regulating cell death, inflammation and metabolism. Mitochondrial dysfunction therefore leads to oxidative stress, cell death, metabolic dysfunction and inflammation, which can all promote atherosclerosis. Recent evidence indicates that mitochondrial DNA (mtDNA) damage is present and promotes atherosclerosis through mitochondrial dysfunction. We will review the mechanisms that link mtDNA damage with atherosclerotic disease, and identify mitochondrial processes that may have therapeutic benefit. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Yu, Emma P. K.; Bennett, Martin R.] Univ Cambridge, Addenbrookes Hosp, Addenbrookes Ctr Clin Invest, Div Cardiovasc Med, Box 110, Cambridge CB2 2QQ, England.
C3 University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital
RP Yu, EPK (corresponding author), Univ Cambridge, Addenbrookes Hosp, Addenbrookes Ctr Clin Invest, Div Cardiovasc Med, Box 110, Cambridge CB2 2QQ, England.
EM epky2@cam.ac.uk
FU British Heart Foundation [PG/14/69/31032, RG/13/14/30314]; National Institute for Health Research Cambridge Biomedical Research Centre; Academy of Medical Sciences
CR Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105
   Alavian KN, 2014, P NATL ACAD SCI USA, V111, P10580, DOI 10.1073/pnas.1401591111
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Ballinger SW, 2002, CIRCULATION, V106, P544, DOI 10.1161/01.CIR.0000023921.93743.89
   BERLINER JA, 1995, CIRCULATION, V91, P2488, DOI 10.1161/01.CIR.91.9.2488
   Botto N, 2005, MUTAT RES-FUND MOL M, V570, P81, DOI 10.1016/j.mrfmmm.2004.10.003
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen YH, 2011, EMBO REP, V12, P534, DOI 10.1038/embor.2011.65
   Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031
   Chu CT, 2013, NAT CELL BIOL, V15, P1197, DOI 10.1038/ncb2837
   Cimen H, 2010, BIOCHEMISTRY-US, V49, P304, DOI 10.1021/bi901627u
   Clarke MCH, 2008, CIRC RES, V102, P1529, DOI 10.1161/CIRCRESAHA.108.175976
   Clarke MCH, 2006, NAT MED, V12, P1075, DOI 10.1038/nm1459
   Cochemé HM, 2012, NAT PROTOC, V7, P946, DOI 10.1038/nprot.2012.035
   CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G
   Cuchel M, 2006, CIRCULATION, V113, P2548, DOI 10.1161/CIRCULATIONAHA.104.475715
   Dai DF, 2010, AGING CELL, V9, P536, DOI 10.1111/j.1474-9726.2010.00581.x
   Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938
   Freigang S, 2013, NAT IMMUNOL, V14, P1045, DOI 10.1038/ni.2704
   Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025
   Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985
   Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012
   Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110
   Goossens P, 2010, CELL METAB, V12, P142, DOI 10.1016/j.cmet.2010.06.008
   Gorenne I, 2013, CIRCULATION, V127, P386, DOI 10.1161/CIRCULATIONAHA.112.124404
   Gray K, 2015, CIRC RES, V116, P816, DOI 10.1161/CIRCRESAHA.116.304921
   Halestrap AP, 2004, CARDIOVASC RES, V61, P372, DOI 10.1016/S0008-6363(03)00533-9
   Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778
   Hotta Y, 2009, ENDOCRINOLOGY, V150, P4625, DOI 10.1210/en.2009-0119
   Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907
   Iyer SS, 2013, IMMUNITY, V39, P311, DOI 10.1016/j.immuni.2013.08.001
   Jiang X, 2014, P NATL ACAD SCI USA, V111, P14782, DOI 10.1073/pnas.1417253111
   Karunakaran D, 2015, CIRC RES, V117, P266, DOI 10.1161/CIRCRESAHA.117.305624
   Kazak L, 2012, NAT REV MOL CELL BIO, V13, P659, DOI 10.1038/nrm3439
   Kim KH, 2013, NAT MED, V19, P83, DOI 10.1038/nm.3014
   Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kwong JQ, 2015, CELL METAB, V21, P206, DOI 10.1016/j.cmet.2014.12.001
   Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893
   Lewis P, 2007, CIRCULATION, V115, P2178, DOI 10.1161/CIRCULATIONAHA.106.664250
   Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1
   Liao XH, 2012, CELL METAB, V15, P545, DOI 10.1016/j.cmet.2012.01.022
   Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353
   Logan A, 2014, AGING CELL, V0, P0
   Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96
   Mercer JR, 2012, FREE RADICAL BIO MED, V52, P841, DOI 10.1016/j.freeradbiomed.2011.11.026
   Mercer JR, 2010, CIRC RES, V107, P1021, DOI 10.1161/CIRCRESAHA.110.218966
   Misawa T, 2013, NAT IMMUNOL, V14, P454, DOI 10.1038/ni.2550
   Montessuit S, 2010, CELL, V142, P889, DOI 10.1016/j.cell.2010.08.017
   Myung SK, 2013, BMJ-BRIT MED J, V346, P0, DOI 10.1136/bmj.f10
   Narendra DP, 2010, PLOS BIOL, V8, P0, DOI 10.1371/journal.pbio.1000298
   Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200
   Niessner A, 2006, CIRCULATION, V114, P2482, DOI 10.1161/CIRCULATIONAHA.106.642801
   Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992
   Pohjoismäki JLO, 2013, P NATL ACAD SCI USA, V110, P19408, DOI 10.1073/pnas.1303046110
   Pohjoismäki JLO, 2009, J BIOL CHEM, V284, P21446, DOI 10.1074/jbc.M109.016600
   Qiu X, 2010, CELL METAB, V12, P0
   Rikka S, 2011, CELL DEATH DIFFER, V18, P721, DOI 10.1038/cdd.2010.146
   Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354
   Sack MN, 2012, COLD SPRING HARB PERSPECT BIOL, V4, P0
   Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048
   Schrijvers DM, 2005, ARTERIOSCL THROM VAS, V25, P1256, DOI 10.1161/01.ATV.0000166517.18801.a7
   Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011
   Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009
   Stoneman V, 2007, CIRC RES, V100, P884, DOI 10.1161/01.RES.0000260802.75766.00
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Tabas I, 2015, J CELL BIOL, V209, P13, DOI 10.1083/jcb.201412052
   Thorp E, 2009, ARTERIOSCL THROM VAS, V29, P169, DOI 10.1161/ATVBAHA.108.176495
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a021220
   Wang Y, 2014, CIRC RES, V114, P421, DOI 10.1161/CIRCRESAHA.114.302153
   Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538
   West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156
   White MJ, 2014, CELL, V159, P1549, DOI 10.1016/j.cell.2014.11.036
   Yee C, 2014, CELL, V157, P897, DOI 10.1016/j.cell.2014.02.055
   Yu E, 2013, CIRCULATION, V128, P702, DOI 10.1161/CIRCULATIONAHA.113.002271
   Yu EPK, 2014, TRENDS ENDOCRIN MET, V25, P481, DOI 10.1016/j.tem.2014.06.008
   Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103
   Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780
   Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663
NR 86
TC 69
Z9 73
U1 3
U2 33
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0891-5849
EI 1873-4596
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD NOV 15
PY 2016
VL 100
IS 
BP 223
EP 230
DI 10.1016/j.freeradbiomed.2016.06.011
PG 8
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA EC3AH
UT WOS:000387995900023
PM 27320189
DA 2024-11-01
ER

PT J
AU Lee, JS
   Kim, H
   Lim, BC
   Hwang, H
   Choi, J
   Kim, KJ
   Hwang, YS
   Chae, JH
AF Lee, Jin Sook
   Kim, Hunmin
   Lim, Byung Chan
   Hwang, Hee
   Choi, Jieun
   Kim, Ki Joong
   Hwang, Yong Seung
   Chae, Jong-Hee
TI Leigh Syndrome in Childhood: Neurologic Progression and Functional Outcome
SO JOURNAL OF CLINICAL NEUROLOGY
LA English
DT Article
DE Leigh syndrome; mitochondrial DNA mutation; functional outcome; prognostic indicators
ID chinese children; greater-than; follow-up; mutation; deficiency; diagnosis
AB Background and Purpose Few studies have analyzed the clinical course and functional outcome in Leigh syndrome (LS). The aim of this study was to determine the clinical, radiological, biochemical, and genetic features of patients with LS, and identify prognostic indicators of the disease progression and neurological outcome. Methods Thirty-nine patients who had been diagnosed with LS at the Seoul National University Children's Hospital were included. Their medical records, neuroimaging findings, and histological/biochemical findings of skeletal muscle specimens were reviewed. Targeted sequencing of mitochondrial DNA was performed based on mitochondrial respiratory chain (MRC) enzyme defects. Results Isolated complex I deficiency was the most frequently observed MRC defect (in 42% of 38 investigated patients). Mitochondrial DNA mutations were identified in 11 patients, of which 81.8% were MT-ND genes. The clinical outcome varied widely, from independent daily activity to severe disability. Poor functional outcomes and neurological deterioration were significantly associated with early onset (before an age of 1 year) and the presence of other lesions additional to basal ganglia involvement in the initial neuroimaging. Conclusions The neurological severity and outcome of LS may vary widely and be better than those predicted based on previous studies. We suggest that age at onset and initial neuroimaging findings are prognostic indicators in LS.
C1 [Lee, Jin Sook] Gachon Univ, Gil Med Ctr, Dept Pediat, Inchon, South Korea.
   [Kim, Hunmin; Hwang, Hee] Seoul Natl Univ, Bundang Hosp, Dept Pediat, Songnam, South Korea.
   [Lim, Byung Chan; Kim, Ki Joong; Hwang, Yong Seung; Chae, Jong-Hee] Seoul Natl Univ, Coll Med, Seoul Natl Univ Childrens Hosp, Dept Pediat,Pediat Clin Neurosci Ctr, 101 Daehak Ro, Seoul 03080, South Korea.
   [Choi, Jieun] SMG SNU Boramae Hosp, Dept Pediat, Seoul, South Korea.
C3 Gachon University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital
RP Chae, JH (corresponding author), Seoul Natl Univ, Coll Med, Seoul Natl Univ Childrens Hosp, Dept Pediat,Pediat Clin Neurosci Ctr, 101 Daehak Ro, Seoul 03080, South Korea.
EM chaeped1@snu.ac.kr
FU Korea Health Industry Development Institute (KHIDI) - Ministry for Health & Welfare, Republic of Korea [HI12C0066]
CR Baertling F, 2014, J NEUROL NEUROSUR PS, V85, P257, DOI 10.1136/jnnp-2012-304426
   Chae JH, 2008, BRAIN DEV-JPN, V30, P387, DOI 10.1016/j.braindev.2007.11.001
   Debray FG, 2007, PEDIATRICS, V119, P722, DOI 10.1542/peds.2006-1866
   DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409
   Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013
   Ingman M, 2006, NUCLEIC ACIDS RES, V34, PD749, DOI 10.1093/nar/gkj010
   Jin TR, 2014, J CHILD NEUROL, V29, PNP143, DOI 10.1177/0883073813512524
   Koenig MK, 2008, PEDIATR NEUROL, V38, P305, DOI 10.1016/j.pediatrneurol.2007.12.001
   Lee HF, 2009, PEDIATR NEUROL, V40, P88, DOI 10.1016/j.pediatrneurol.2008.09.020
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Leng YL, 2015, MITOCHONDR DNA, V26, P208, DOI 10.3109/19401736.2014.905860
   Ma YY, 2015, CLIN GENET, V87, P179, DOI 10.1111/cge.12356
   Ma YY, 2013, J CLIN NEUROSCI, V20, P1591, DOI 10.1016/j.jocn.2013.03.034
   Mak SC, 1998, J CHILD NEUROL, V13, P349, DOI 10.1177/088307389801300709
   Naess K, 2009, BBA-BIOENERGETICS, V1787, P484, DOI 10.1016/j.bbabio.2008.11.014
   Sobreira C, 2009, J NEUROL SCI, V278, P132, DOI 10.1016/j.jns.2008.11.023
   Sofou K, 2014, ORPHANET J RARE DIS, V9, P0, DOI 10.1186/1750-1172-9-52
   Wang ZX, 2010, NEUROPATHOLOGY, V30, P606, DOI 10.1111/j.1440-1789.2010.01115.x
   Yang YL, 2006, CHINESE MED J-PEKING, V119, P373, DOI 10.1097/00029330-200603010-00004
NR 19
TC 21
Z9 25
U1 0
U2 14
PU KOREAN NEUROLOGICAL ASSOC
PI SEOUL
PA 1111 DAEIL BLD, 43 INSA-DONG, JONGNO-GU, SEOUL, 110-741, SOUTH KOREA
SN 1738-6586
EI 2005-5013
J9 J CLIN NEUROL
JI J. Clin. Neurol.
PD APR 15
PY 2016
VL 12
IS 2
BP 181
EP 187
DI 10.3988/jcn.2016.12.2.181
PG 7
WC Clinical Neurology
SC Neurosciences & Neurology
GA DI5EU
UT WOS:000373522500008
PM 27074294
DA 2024-11-01
ER

PT J
AU Claeys, KG
   Abicht, A
   Häusler, M
   Kleinle, S
   Wiesmann, M
   Schulz, JB
   Horvath, R
   Weis, J
AF Claeys, Kristl G.
   Abicht, Angela
   Haeusler, Martin
   Kleinle, Stephanie
   Wiesmann, Martin
   Schulz, Joerg B.
   Horvath, Rita
   Weis, Joachim
TI NOVEL GENETIC AND NEUROPATHOLOGICAL INSIGHTS IN NEUROGENIC MUSCLE WEAKNESS, ATAXIA, AND RETINITIS PIGMENTOSA (NARP)
SO MUSCLE & NERVE
LA English
DT Article
DE electron microscopy; genetic counseling; MILS; mitochondrial; NARP; nerve biopsy; ultrastructural
ID mitochondrial-dna heteroplasmy; leighs-syndrome; t8993g mutation; point mutation; atp synthase; disease; mtdna
AB Introduction: Neurogenic muscle weakness, ataxia, and retinitis pigmentosa (NARP) is caused by m.8993T>G/C mutations in the mitochondrial adenosine triphosphate synthase subunit 6 gene (MT-ATP6). Traditionally, heteroplasmy levels between 70% and 90% lead to NARP, and >90% result in Leigh syndrome. Methods: In this study we report a 30-year-old man with NARP and m.8993T>G in MT-ATP6. Results: Although the patient carried the mutation in homoplasmic state in blood with similarly high levels in urine (94%) and buccal swab (92%), he presented with NARP and not the expected, more severe Leigh phenotype. The mutation could not be detected in any of the 3 analyzed tissues of the mother, indicating a large genetic shift between mother and offspring. Nerve biopsy revealed peculiar endoneurial Schwann cell nuclear accumulations, clusters of concentrically arranged Schwann cells devoid of myelinated axons, and degenerated mitochondria. Conclusions: We emphasize the phenotypic variability of the m.8993T>G MT-ATP6 mutation and the need for caution in predictive counseling in such patients.
C1 [Claeys, Kristl G.] Rhein Westfal TH Aachen, Inst Neuropathol, Aachen, Germany.
   [Claeys, Kristl G.] Rhein Westfal TH Aachen, Dept Neurol, Aachen, Germany.
   [Claeys, Kristl G.] Univ Hosp Leuven, Dept Neurol, Herestr 49, B-3000 Leuven, Belgium.
   [Claeys, Kristl G.] Katholieke Univ Leuven, Univ Leuven, Herestr 49, B-3000 Leuven, Belgium.
   [Abicht, Angela; Kleinle, Stephanie] Ctr Med Genet, Munich, Germany.
   [Haeusler, Martin] Rhein Westfal TH Aachen, Div Neuropediat & Social Pediat, Dept Pediat, Aachen, Germany.
   [Wiesmann, Martin] Rhein Westfal TH Aachen, Dept Diagnost & Intervent Neuroradiol, Aachen, Germany.
   [Schulz, Joerg B.] Rhein Westfal TH Aachen, Dept Neurol, Aachen, Germany.
   [Schulz, Joerg B.] Rhein Westfal TH Aachen, Julich Aachen Res Alliance Translat Brain Med, Aachen, Germany.
   [Horvath, Rita] Newcastle Univ, Inst Med Genet, Int Ctr Life, Newcastle Upon Tyne, Tyne & Wear, England.
   [Weis, Joachim] Rhein Westfal TH Aachen, Inst Neuropathol, Aachen, Germany.
C3 RWTH Aachen University; RWTH Aachen University; KU Leuven; University Hospital Leuven; KU Leuven; RWTH Aachen University; RWTH Aachen University; RWTH Aachen University; RWTH Aachen University; Newcastle University - UK; RWTH Aachen University
RP Claeys, KG (corresponding author), Rhein Westfal TH Aachen, Inst Neuropathol, Aachen, Germany.; Claeys, KG (corresponding author), Rhein Westfal TH Aachen, Dept Neurol, Aachen, Germany.; Claeys, KG (corresponding author), Univ Hosp Leuven, Dept Neurol, Herestr 49, B-3000 Leuven, Belgium.; Claeys, KG (corresponding author), Katholieke Univ Leuven, Univ Leuven, Herestr 49, B-3000 Leuven, Belgium.
EM kristl.claeys@uzleuven.be
FU German Federal Ministry of Education and Research: mitoNET [BMBF-01GM0862]; Deutsche Gesellschaft fur Muskelkranke (DGM); Medical Research Council (UK) [G1000848]; European Research Council [309548]; European Research Council (ERC) [309548] Funding Source: European Research Council (ERC); MRC [G1000848] Funding Source: UKRI; Newton Fund [MR/N027302/1] Funding Source: UKRI
CR Bianchi MC, 2003, AM J NEURORADIOL, V24, P1958
   Blok RB, 1997, AM J HUM GENET, V60, P1495, DOI 10.1086/515453
   Carelli V, 2002, ARCH NEUROL-CHICAGO, V59, P264, DOI 10.1001/archneur.59.2.264
   Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X
   DEVRIES DD, 1993, ANN NEUROL, V34, P410, DOI 10.1002/ana.410340319
   Elbracht M, 2014, CLIN NEUROPATHOL, V33, P335, DOI 10.5414/NP300742
   García JJ, 2000, J BIOL CHEM, V275, P11075, DOI 10.1074/jbc.275.15.11075
   Hayashi N, 2000, OPHTHALMOLOGY, V107, P1397, DOI 10.1016/S0161-6420(00)00110-X
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Kirkman MA, 2009, BRAIN, V132, P2317, DOI 10.1093/brain/awp158
   LANGES K, 1985, VIRCHOWS ARCH A, V407, P97, DOI 10.1007/BF00701332
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   MAKELABENGS P, 1995, PEDIATR RES, V37, P634
   Mangold S, 2011, MOL GENET METAB, V104, P369, DOI 10.1016/j.ymgme.2011.06.004
   Nijtmans LGJ, 2001, J BIOL CHEM, V276, P6755, DOI 10.1074/jbc.M008114200
   Quijada-Fraile P, 2014, ORPHANET J RARE DIS, V9, P0, DOI 10.1186/s13023-014-0217-2
   Rojo A, 2006, ACTA NEUROPATHOL, V111, P610, DOI 10.1007/s00401-006-0040-5
   SANTORELLI FM, 1993, ANN NEUROL, V34, P827, DOI 10.1002/ana.410340612
   SCHRODER JM, 1993, BRAIN PATHOL, V3, P177, DOI 10.1111/j.1750-3639.1993.tb00742.x
   SCHRODER JM, 1985, J NEUROL, V232, P83, DOI 10.1007/BF00313906
   SHOFFNER JM, 1992, NEUROLOGY, V42, P2168, DOI 10.1212/WNL.42.11.2168
   Steffann J, 2007, J MED GENET, V44, P664, DOI 10.1136/jmg.2006.048553
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Uziel G, 1997, J NEUROL NEUROSUR PS, V63, P16, DOI 10.1136/jnnp.63.1.16
   Verhoeven K, 2006, BRAIN, V129, P2093, DOI 10.1093/brain/awl126
   White SL, 1999, J INHERIT METAB DIS, V22, P899, DOI 10.1023/A:1005639407166
   Wilson IJ, 2016, HUM MOL GENET, V25, P1031, DOI 10.1093/hmg/ddv626
NR 27
TC 18
Z9 19
U1 0
U2 6
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0148-639X
EI 1097-4598
J9 MUSCLE NERVE
JI Muscle Nerve
PD AUG 15
PY 2016
VL 54
IS 2
BP 328
EP 333
DI 10.1002/mus.25125
PG 6
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA DW2IP
UT WOS:000383466400024
PM 27015314
DA 2024-11-01
ER

PT J
AU Ng, YS
   Turnbull, DM
AF Ng, Yi Shiau
   Turnbull, Doug M.
TI Mitochondrial disease: genetics and management
SO JOURNAL OF NEUROLOGY
LA English
DT Article
DE Mitochondrial disease; Mitochondrial DNA (mtDNA); Nuclear genes; Acute and chronic neurological presentations; Treatment
ID stroke-like episodes; hereditary optic neuropathy; encephalomyopathy (mngie)-like phenotype; progressive external ophthalmoplegia; intestinal pseudoobstruction; clinical spectrum; lactic-acidosis; dna mutations; monitor progression; polg1 mutations
AB Mitochondrial disease is one of the most common groups of genetic diseases with a minimum prevalence of greater than 1 in 5000 in adults. Whilst multi-system involvement is often evident, neurological manifestation is the principal presentation in most cases. The multiple clinical phenotypes and the involvement of both the mitochondrial and nuclear genome make mitochondrial disease particularly challenging for the clinician. In this review article we cover mitochondrial genetics and common neurological presentations associated with adult mitochondrial disease. In addition, specific and supportive treatments are discussed.
C1 [Ng, Yi Shiau; Turnbull, Doug M.] Newcastle Univ, Sch Med, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK
RP Turnbull, DM (corresponding author), Newcastle Univ, Sch Med, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM doug.turnbull@ncl.ac.uk
FU Wellcome Trust [074454/Z/04/Z]; Newcastle University Centre for Ageing and Vitality - Biotechnology and Biological Sciences Research Council; Newcastle University Centre for Ageing and Vitality - Medical Research Council [M501700]; MRC Centre for Neuromuscular Disease; UK NIHR Biomedical Research Centre for Ageing and Age-related disease award; Lily Foundation; UK NHS Specialist Commissioners; MRC [MR/L016354/1] Funding Source: UKRI
CR Ahmad KE, 2015, J NEUROL, V0, P1
   Ahn J, 2008, BRIT J OPHTHALMOL, V92, P1685, DOI 10.1136/bjo.2008.144816
   Alston CL, 2013, NEUROLOGY, V81, P2051, DOI 10.1212/01.wnl.0000436931.94291.e6
   Angelini C, 2009, ACTA MYOL, V28, P16
   Aurangzeb Sidra, 2014, PRACT NEUROL, V14, P432, DOI 10.1136/practneurol-2014-000853
   Bates MGD, 2012, EUR HEART J, V33, P3023, DOI 10.1093/eurheartj/ehs275
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Betts J, 2008, NEUROLOGY, V70, P1290, DOI 10.1212/01.wnl.0000308940.38092.74
   Bindoff LA, 2012, EPILEPSIA, V53, P92, DOI 10.1111/j.1528-1167.2012.03618.x
   Bitner-Glindzicz M, 2009, NEW ENGL J MED, V360, P640, DOI 10.1056/NEJMc0806396
   Carelli V, 2015, ANN NEUROL, V78, P21, DOI 10.1002/ana.24410
   Catteruccia M, 2015, J NEUROL, V262, P701, DOI 10.1007/s00415-014-7632-0
   Cheldi A, 2013, BMC NEUROL, V13, P0, DOI 10.1186/1471-2377-13-8
   Chinnery PF, 2013, BRIT MED BULL, V106, P135, DOI 10.1093/bmb/ldt017
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Chiyonobu T, 2008, BRAIN DEV-JPN, V30, P430, DOI 10.1016/j.braindev.2007.12.006
   Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958
   Deschauer M, 2007, NEUROLOGY, V68, P1741, DOI 10.1212/01.wnl.0000261929.92478.3e
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Elliott PM, 2014, EUR HEART J, V35, P2733, DOI 10.1093/eurheartj/ehu284
   Emmanuele V, 2012, ARCH NEUROL-CHICAGO, V69, P978, DOI 10.1001/archneurol.2012.206
   Engelsen BA, 2008, BRAIN, V131, P818, DOI 10.1093/brain/awn007
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   Giordano C, 2013, HUM PATHOL, V44, P1262, DOI 10.1016/j.humpath.2012.10.011
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Gorman GS, 2015, NEW ENGL J MED, V372, P885, DOI 10.1056/NEJMc1500960
   Hakonen AH, 2007, EUR J HUM GENET, V15, P779, DOI 10.1038/sj.ejhg.5201831
   Hasselmann O, 2010, MOL GENET METAB, V99, P58, DOI 10.1016/j.ymgme.2009.08.005
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Horga A, 2014, BRAIN, V137, P3200, DOI 10.1093/brain/awu279
   Horvath R, 2009, BRAIN, V132, P3165, DOI 10.1093/brain/awp221
   Joshi CN, 2009, PEDIATR NEUROL, V40, P314, DOI 10.1016/j.pediatrneurol.2008.10.023
   Jung I, 2015, J CLIN NEUROL, V11, P104, DOI 10.3988/jcn.2015.11.1.104
   Karkos PD, 2005, EUR ARCH OTO-RHINO-L, V262, P322, DOI 10.1007/s00405-004-0817-x
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Klopstock T, 2011, BRAIN, V134, P2677, DOI 10.1093/brain/awr170
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478
   La Morgia C, 2008, NEUROLOGY, V70, P762, DOI 10.1212/01.wnl.0000295505.74234.d0
   Lax NZ, 2012, BRAIN, V135, P62, DOI 10.1093/brain/awr326
   Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Martikainen MH, 2012, EPILEPTIC DISORD, V14, P438, DOI 10.1684/epd.2012.0543
   Martinelli D, 2012, MOL GENET METAB, V107, P383, DOI 10.1016/j.ymgme.2012.09.007
   McFarland R, 2007, NEUROLOGY, V69, P911, DOI 10.1212/01.wnl.0000267843.10977.4a
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Meisinger C, 2008, CELL, V134, P22, DOI 10.1016/j.cell.2008.06.043
   Mokranjac D, 2005, BIOCHEM SOC T, V33, P1019, DOI 10.1042/BST0331019
   Nesbitt V, 2014, EUR J HUM GENET, V22, P1255, DOI 10.1038/ejhg.2014.35
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Nesbitt V, 2012, DEV MED CHILD NEUROL, V54, P500, DOI 10.1111/j.1469-8749.2012.04224.x
   Ng YS, 2016, EUR HEART J, V37, P2552, DOI 10.1093/eurheartj/ehv306
   Noack R, 2012, HUM MOL GENET, V21, P150, DOI 10.1093/hmg/ddr450
   Pfeffer G, 2012, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD004426.pub3
   Pfeffer G, 2015, NEUROLOGY, V84, P1174, DOI 10.1212/WNL.0000000000001369
   Pfeffer G, 2014, BRAIN, V137, P1323, DOI 10.1093/brain/awu060
   Pfeffer G, 2013, NEUROLOGY, V81, P2073, DOI 10.1212/01.wnl.0000437308.22603.43
   Pfeffer G, 2012, MUSCLE NERVE, V46, P593, DOI 10.1002/mus.23538
   Phoenix C, 2006, NEUROMUSCULAR DISORD, V16, P814, DOI 10.1016/j.nmd.2006.08.006
   Prasun P, 2014, J NEUROL, V261, P1818, DOI 10.1007/s00415-014-7428-2
   Prüss H, 2008, EPILEPSY RES, V82, P219, DOI 10.1016/j.eplepsyres.2008.08.005
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Rance G, 2012, J NEUROL, V259, P542, DOI 10.1007/s00415-011-6230-7
   Sadun AA, 2012, ARCH NEUROL-CHICAGO, V69, P331, DOI 10.1001/archneurol.2011.2972
   Sallevelt SCEH, 2013, J MED GENET, V50, P125, DOI 10.1136/jmedgenet-2012-101172
   Schaefer AM, 2006, NEUROLOGY, V66, P1932, DOI 10.1212/01.wnl.0000219759.72195.41
   Schaefer AM, 2013, MOL CELL ENDOCRINOL, V379, P2, DOI 10.1016/j.mce.2013.06.004
   Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Schwabe MJ, 1997, PEDIATR NEUROL, V16, P337, DOI 10.1016/S0887-8994(97)00030-1
   Sekino Y, 2012, WORLD J GASTROENTERO, V18, P4557, DOI 10.3748/wjg.v18.i33.4557
   Sicurelli F, 2012, J NEUROL, V259, P1985, DOI 10.1007/s00415-012-6500-z
   Smits P, 2010, J BIOMED BIOTECHNOL, V0, P0, DOI DOI 10.1155/2010/737385
   Sommerville Ewen W, 2014, J NEUROMUSCUL DIS, V1, P119
   Steenweg ME, 2012, BRAIN, V135, P1387, DOI 10.1093/brain/aws070
   Steriade C, 2014, PEDIATR NEUROL, V50, P498, DOI 10.1016/j.pediatrneurol.2014.01.009
   Stewart JD, 2010, HEPATOLOGY, V52, P1791, DOI 10.1002/hep.23891
   Sue CM, 1998, ANN NEUROL, V43, P350, DOI 10.1002/ana.410430313
   Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368
   Tang S, 2012, J NEUROL, V259, P862, DOI 10.1007/s00415-011-6268-6
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   Treff NR, 2012, FERTIL STERIL, V98, P1236, DOI 10.1016/j.fertnstert.2012.07.1119
   Tucker EJ, 2010, CURR NEUROL NEUROSCI, V10, P277, DOI 10.1007/s11910-010-0112-8
   van Berge L, 2014, BRAIN, V137, P1019, DOI 10.1093/brain/awu026
   Verny C, 2008, DIABETES METAB, V34, P620, DOI 10.1016/j.diabet.2008.06.001
   Visser NA, 2011, J NEUROL, V258, P218, DOI 10.1007/s00415-010-5721-2
   Vrettou CS, 2013, INTENS CARE MED, V39, P1148, DOI 10.1007/s00134-013-2884-1
   Whittaker RG, 2007, DIABETOLOGIA, V50, P2085, DOI 10.1007/s00125-007-0779-9
   Ylikallio E, 2012, ANN MED, V44, P41, DOI 10.3109/07853890.2011.598547
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
   Zimón M, 2011, NEUROLOGY, V77, P540, DOI 10.1212/WNL.0b013e318228fc70
   Zoccolella S, 2010, J NEUROL, V257, P1999, DOI 10.1007/s00415-010-5649-6
NR 96
TC 82
Z9 95
U1 2
U2 29
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5354
EI 1432-1459
J9 J NEUROL
JI J. Neurol.
PD JAN 15
PY 2016
VL 263
IS 1
BP 179
EP 191
DI 10.1007/s00415-015-7884-3
PG 13
WC Clinical Neurology
SC Neurosciences & Neurology
GA DB9HV
UT WOS:000368827900026
PM 26315846
DA 2024-11-01
ER

PT J
AU Adema, AY
   Janssen, MCH
   van der Heijden, JW
AF Adema, A. Y.
   Janssen, M. C. H.
   van der Heijden, J. W.
TI A novel mutation in mitochondrial DNA in a patient with diabetes, deafness and proteinuria
SO NETHERLANDS JOURNAL OF MEDICINE
LA English
DT Article
DE Maternally inherited deafness and diabetes; MIDD; mitochondrial DNA mutation; 09155A>G
ID clinical-features; point mutation; diagnosis; midd
AB Maternally inherited deafness and diabetes (MIDD) is characterised by a defect in insulin secretion and bilateral hearing impairment. The m.3243A>G mutation is the most reported in mitochondrial DNA (mtDNA) causing MIDD, although other, rare, mtDNA point mutations have also been mentioned. We report on a 28-year-old Caucasian woman with a history of diabetes, kidney disease, deafness, diarrhoea, myopathy and fatigue. The diagnosis of mitochondrial disease was made in this patient, which resulted from a novel 09155A>G mutation in the mtDNA. As far as we know, this mutation has never been described before as causing MIDD.
C1 [Adema, A. Y.; van der Heijden, J. W.] Vrije Univ Amsterdam, Med Ctr, Dept Nephrol, Amsterdam, Netherlands.
   [Janssen, M. C. H.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, Nijmegen, Netherlands.
C3 Vrije Universiteit Amsterdam; Radboud University Nijmegen
RP Adema, AY (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Nephrol, Amsterdam, Netherlands.
EM a.adema@vumc.nl
CR Chinnery PF, 1999, AM J MED GENET, V85, P498
   de Laat P, 2013, JIMD REP, V8, P47, DOI 10.1007/8904_2012_159
   de Laat P, 2012, J INHERIT METAB DIS, V35, P1059, DOI 10.1007/s10545-012-9465-2
   Maassen JA, 2002, ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY, V110, P186, DOI 10.1076/apab.110.3.186.8294
   Maassen JA, 2005, ANN MED, V37, P213, DOI 10.1080/07853890510007188
   McDonnell MT, 2004, EUR J HUM GENET, V12, P778, DOI 10.1038/sj.ejhg.5201216
   Murphy R, 2008, DIABETIC MED, V25, P383, DOI 10.1111/j.1464-5491.2008.02359.x
   Narbonne H, 2001, EUR J ENDOCRINOL, V145, P541, DOI 10.1530/eje.0.1450541
   REARDON W, 1992, LANCET, V340, P1376, DOI 10.1016/0140-6736(92)92560-3
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
NR 10
TC 8
Z9 10
U1 0
U2 9
PU VAN ZUIDEN COMMUNICATIONS
PI ALPHEN AAN DE RIJN
PA HENRY DUNANTWEG 40A, 2402 NR ALPHEN AAN DE RIJN, NETHERLANDS
SN 0300-2977
EI 1872-9061
J9 NETH J MED
JI Neth. J. Med.
PD DEC 15
PY 2016
VL 74
IS 10
BP 455
EP 457
DI 
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA EG7FZ
UT WOS:000391213000008
PM 27966441
DA 2024-11-01
ER

PT J
AU Yu-Wai-Man, P
   Votruba, M
   Burté, F
   La Morgia, C
   Barboni, P
   Carelli, V
AF Yu-Wai-Man, Patrick
   Votruba, Marcela
   Burte, Florence
   La Morgia, Chiara
   Barboni, Piero
   Carelli, Valerio
TI A neurodegenerative perspective on mitochondrial optic neuropathies
SO ACTA NEUROPATHOLOGICA
LA English
DT Review
DE Dominant optic atrophy; Leber hereditary optic neuropathy; Mitochondrial diseases; Neurodegenerative diseases; OPA1; Retinal ganglion cell
ID fiber layer evaluation; ganglion-cell loss; neuromyelitis-optica; opa1 mutations; multiple-sclerosis; coherence-tomography; dna deletions; external ophthalmoplegia; pronuclear transfer; nerve structure
AB Mitochondrial optic neuropathies constitute an important cause of chronic visual morbidity and registrable blindness in both the paediatric and adult population. It is a genetically heterogeneous group of disorders caused by both mitochondrial DNA (mtDNA) mutations and a growing list of nuclear genetic defects that invariably affect a critical component of the mitochondrial machinery. The two classical paradigms are Leber hereditary optic neuropathy (LHON), which is a primary mtDNA disorder, and autosomal dominant optic atrophy (DOA) secondary to pathogenic mutations within the nuclear gene OPA1 that encodes for a mitochondrial inner membrane protein. The defining neuropathological feature is the preferential loss of retinal ganglion cells (RGCs) within the inner retina but, rather strikingly, the smaller calibre RGCs that constitute the papillomacular bundle are particularly vulnerable, whereas melanopsin-containing RGCs are relatively spared. Although the majority of patients with LHON and DOA will present with isolated optic nerve involvement, some individuals will also develop additional neurological complications pointing towards a greater vulnerability of the central nervous system (CNS) in susceptible mutation carriers. These so-called "plus" phenotypes are mechanistically important as they put the loss of RGCs within the broader perspective of neuronal loss and mitochondrial dysfunction, highlighting common pathways that could be modulated to halt progressive neurodegeneration in other related CNS disorders. The management of patients with mitochondrial optic neuropathies still remains largely supportive, but the development of effective disease-modifying treatments is now within tantalising reach helped by major advances in drug discovery and delivery, and targeted genetic manipulation.
C1 [Yu-Wai-Man, Patrick; Burte, Florence] Newcastle Univ, Inst Med Genet, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.
   [Yu-Wai-Man, Patrick] Royal Victoria Infirm, Newcastle Eye Ctr, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.
   [Yu-Wai-Man, Patrick] Moorfields Eye Hosp, NIHR Biomed Res Ctr, London EC1V 2PD, England.
   [Yu-Wai-Man, Patrick] UCL Inst Ophthalmol, London EC1V 2PD, England.
   [Votruba, Marcela] Cardiff Univ, Sch Optometry & Vis Sci, Cardiff, S Glam, Wales.
   [Votruba, Marcela] Univ Wales Hosp, Cardiff Eye Unit, Cardiff, S Glam, Wales.
   [La Morgia, Chiara; Carelli, Valerio] Bellaria Hosp, IRCCS Inst Neurol Sci Bologna, Bologna, Italy.
   [La Morgia, Chiara; Carelli, Valerio] Univ Bologna, Dept Biomed & Neuromotor Sci DIBINEM, Neurol Unit, Bologna, Italy.
   [Barboni, Piero] Studio Oculist Azeglio, Bologna, Italy.
   [Barboni, Piero] Ist Sci San Raffaele, Milan, Italy.
C3 Newcastle University - UK; Newcastle University - UK; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; Cardiff University; Cardiff University; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); AUSL di Bologna; University of Bologna; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele
RP Yu-Wai-Man, P (corresponding author), Newcastle Univ, Inst Med Genet, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.; Yu-Wai-Man, P (corresponding author), Royal Victoria Infirm, Newcastle Eye Ctr, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.; Yu-Wai-Man, P (corresponding author), Moorfields Eye Hosp, NIHR Biomed Res Ctr, London EC1V 2PD, England.; Yu-Wai-Man, P (corresponding author), UCL Inst Ophthalmol, London EC1V 2PD, England.
EM Patrick.Yu-Wai-Man@ncl.ac.uk
FU Medical Research Council (UK) [G1002570]; Fight for Sight (UK); UK National Institute of Health Research (NIHR) as part of the Rare Diseases Translational Research Collaboration; NIHR Biomedical Research Centre based at Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology; Italian Ministry of Research; Italian Ministry of Health; Telethon-Italy; e-RARE; IFOND; UMDF; MITOCON; Poincenot Family; Gino Galletti Foundation; MRC [G1002570, G0701386, G0700949] Funding Source: UKRI
CR Abrams AJ, 2015, NAT GENET, V47, P926, DOI 10.1038/ng.3354
   ADAMS JH, 1966, BRAIN, V89, P15, DOI 10.1093/brain/89.1.15
   Alavi MV, 2007, BRAIN, V130, P1029, DOI 10.1093/brain/awm005
   Alavi MV, 2009, EXP NEUROL, V220, P404, DOI 10.1016/j.expneurol.2009.09.026
   Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Amati-Bonneau P, 2005, ANN NEUROL, V58, P958, DOI 10.1002/ana.20681
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Andrews RM, 1999, BRIT J OPHTHALMOL, V83, P231, DOI 10.1136/bjo.83.2.231
   Angebault C, 2015, AM J HUM GENET, V97, P754, DOI 10.1016/j.ajhg.2015.09.012
   Anikster Y, 2001, AM J HUM GENET, V69, P1218, DOI 10.1086/324651
   Antonicka H, 2010, AM J HUM GENET, V87, P115, DOI 10.1016/j.ajhg.2010.06.004
   Bailie M, 2013, ACTA OPHTHALMOL, V91, PE413, DOI 10.1111/aos.12077
   Baker MR, 2011, NEUROLOGY, V77, P1309, DOI 10.1212/WNL.0b013e318230a15a
   Balducci N, 2016, BRIT J OPHTHALMOL, V100, P1232, DOI 10.1136/bjophthalmol-2015-307326
   Barboni P, 2005, OPHTHALMOLOGY, V112, P120, DOI 10.1016/j.ophtha.2004.06.034
   Barboni P, 2014, AM J OPHTHALMOL, V158, P628, DOI 10.1016/j.ajo.2014.05.034
   Barboni P, 2013, BRAIN, V136, P0, DOI 10.1093/brain/awt014
   Barboni P, 2012, EUR J OPHTHALMOL, V22, P985, DOI 10.5301/ejo.5000154
   Barboni P, 2011, OPHTHALMOLOGY, V118, P2076, DOI 10.1016/j.ophtha.2011.02.027
   Barboni P, 2010, OPHTHALMOLOGY, V117, P1547, DOI 10.1016/j.ophtha.2009.12.042
   Barboni P, 2010, OPHTHALMOLOGY, V117, P623, DOI 10.1016/j.ophtha.2009.07.026
   Barcella V, 2010, HUM BRAIN MAPP, V31, P1900, DOI 10.1002/hbm.20985
   Bennett JL, 2015, MULT SCLER J, V21, P678, DOI 10.1177/1352458514567216
   Blakely EL, 2005, EUR J HUM GENET, V13, P623, DOI 10.1038/sj.ejhg.5201363
   Bonifert T, 2014, BRAIN, V137, P2164, DOI 10.1093/brain/awu165
   Bonneau D, 2014, BRAIN, V137, P0, DOI 10.1093/brain/awu184
   Bristow EA, 2002, ARCH OPHTHALMOL-CHIC, V120, P791
   Burté F, 2015, NAT REV NEUROL, V11, P11, DOI 10.1038/nrneurol.2014.228
   Carbonelli M, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0127906
   Carelli V, 2004, BBA-BIOENERGETICS, V1657, P70
   Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003
   Carelli V, 2002, NEUROCHEM INT, V40, P573, DOI 10.1016/S0197-0186(01)00129-2
   Carelli V, 2001, J NEUROL NEUROSUR PS, V71, P813, DOI 10.1136/jnnp.71.6.813
   Carelli V, 2008, NEUROLOGY, V70, P1075, DOI 10.1212/01.wnl.0000307668.75233.35
   Carelli V, 2015, ANN NEUROL, V78, P21, DOI 10.1002/ana.24410
   Carelli V, 2015, BRAIN, V138, P0, DOI 10.1093/brain/awu234
   Carelli V, 2014, NEURON, V84, P1126, DOI 10.1016/j.neuron.2014.11.022
   Carelli V, 2011, BRAIN, V134, P0, DOI 10.1093/brain/awr180
   Charif M, 2015, FRONT GENET, V6, P0, DOI 10.3389/fgene.2015.00311
   Chen L, 2012, EURASIP J WIREL COMM, V0, P0, DOI DOI 10.1186/1687-1499-2012-230
   Cohn AC, 2008, BRIT J OPHTHALMOL, V92, P1333, DOI 10.1136/bjo.2007.134726
   Cohn AC, 2007, AM J OPHTHALMOL, V143, P656, DOI 10.1016/j.ajo.2006.12.038
   Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958
   DAguanno S, 2008, J NEUROIMMUNOL, V193, P156, DOI 10.1016/j.jneuroim.2007.10.004
   Davey KM, 2006, J MED GENET, V43, P385, DOI 10.1136/jmg.2005.036657
   Davies VJ, 2007, HUM MOL GENET, V16, P1307, DOI 10.1093/hmg/ddm079
   Pereira WLDJ, 2015, J NEUROL SCI, V355, P7, DOI 10.1016/j.jns.2015.05.034
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   Elachouri G, 2011, GENOME RES, V21, P12, DOI 10.1101/gr.108696.110
   Ellouze S, 2008, AM J HUM GENET, V83, P373, DOI 10.1016/j.ajhg.2008.08.013
   Ferré M, 2009, HUM MUTAT, V30, PE692, DOI 10.1002/humu.21025
   Fortuna F, 2009, BRAIN, V132, P116, DOI 10.1093/brain/awn269
   Fraser JA, 2010, SURV OPHTHALMOL, V55, P299, DOI 10.1016/j.survophthal.2009.10.002
   Fuhrmann N, 2009, J MED GENET, V46, P136, DOI 10.1136/jmg.2008.062570
   Gelfand JM, 2013, JAMA NEUROL, V70, P629, DOI 10.1001/jamaneurol.2013.1832
   Giordano C, 2011, BRAIN, V134, P220, DOI 10.1093/brain/awq276
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Gorman GS, 2015, NEW ENGL J MED, V372, P885, DOI 10.1056/NEJMc1500960
   Gorman GS, 2015, JAMA NEUROL, V72, P106, DOI 10.1001/jamaneurol.2014.1753
   Greaves LC, 2010, INVEST OPHTH VIS SCI, V51, P3340, DOI 10.1167/iovs.09-4659
   Gueven N, 2013, EXP OPIN ORPH DRUG, V1, P1
   Guy J, 2002, ANN NEUROL, V52, P534, DOI 10.1002/ana.10354
   Hanein S, 2009, AM J HUM GENET, V84, P493, DOI 10.1016/j.ajhg.2009.03.003
   HARDING AE, 1992, BRAIN, V115, P979, DOI 10.1093/brain/115.4.979
   Heidary G, 2014, J NEURO-OPHTHALMOL, V34, P39, DOI 10.1097/WNO.0000000000000076
   Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Hyslop LA, 2016, NATURE, V534, P383, DOI 10.1038/nature183030
   Jacob A, 2013, J NEUROL, V260, P2134, DOI 10.1007/s00415-013-6926-y
   Janer A, 2016, EMBO MOL MED, V0, P0
   Jin H, 1996, NAT GENET, V14, P177, DOI 10.1038/ng1096-177
   JOHNSON BM, 1987, AGE, V10, P5, DOI 10.1007/BF02431765
   JOHNSTON PB, 1979, AM J OPHTHALMOL, V88, P868, DOI 10.1016/0002-9394(79)90565-8
   KERRISON JB, 1995, OPHTHALMOLOGY, V102, P1509
   Kirkman MA, 2009, BRAIN, V132, P2317, DOI 10.1093/brain/awp158
   Kirkman MA, 2009, INVEST OPHTH VIS SCI, V50, P3112, DOI 10.1167/iovs.08-3166
   KJER P, 1959, ACTA OPHTHALMOL SUPPL, V164, P1
   KJER P, 1983, ACTA OPHTHALMOL, V61, P300
   Klebe S, 2012, BRAIN, V135, P2980, DOI 10.1093/brain/aws240
   Klopstock T, 2013, BRAIN, V136, P0, DOI 10.1093/brain/aws279
   Klopstock T, 2011, BRAIN, V134, P2677, DOI 10.1093/brain/awr170
   Kovács GG, 2005, BRAIN, V128, P35, DOI 10.1093/brain/awh310
   La Morgia C, 2010, BRAIN, V133, P2426, DOI 10.1093/brain/awq155
   Levin LA, 2015, J NEURO-OPHTHALMOL, V35, P152, DOI 10.1097/WNO.0000000000000250
   Lin CS, 2012, P NATL ACAD SCI USA, V109, P20065, DOI 10.1073/pnas.1217113109
   Mahad D, 2008, BRAIN, V131, P1722, DOI 10.1093/brain/awn105
   Majander A, 2016, OPHTHALMOLOGY, V123, P1624, DOI 10.1016/j.ophtha.2016.01.007
   Man PYW, 2004, J MED GENET, V41, P0, DOI 10.1136/jmg.2003.011247
   Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015
   Manners DN, 2015, AM J NEURORADIOL, V36, P1259, DOI 10.3174/ajnr.A4272
   Marelli C, 2011, BRAIN, V134, P0, DOI 10.1093/brain/awq306
   McClelland CM, 2011, J NEURO-OPHTHALMOL, V31, P265, DOI 10.1097/WNO.0b013e318225247b
   McFarland R, 2007, NEUROLOGY, V69, P911, DOI 10.1212/01.wnl.0000267843.10977.4a
   Metodiev MD, 2014, J MED GENET, V51, P834, DOI 10.1136/jmedgenet-2014-102532
   Milesi J, 2012, J NEUROL, V259, P1801, DOI 10.1007/s00415-011-6406-1
   Misu T, 2007, BRAIN, V130, P1224, DOI 10.1093/brain/awm047
   Moura ALA, 2013, INVEST OPHTH VIS SCI, V54, P4471, DOI 10.1167/iovs.12-11137
   NEWMAN NJ, 1991, AM J OPHTHALMOL, V111, P750, DOI 10.1016/S0002-9394(14)76784-4
   NIKOSKELAINEN EK, 1995, J NEUROL NEUROSUR PS, V59, P160, DOI 10.1136/jnnp.59.2.160
   Ostojic J, 2009, ACTA NEUROL BELG, V109, P305
   Palace J, 2009, J NEUROL SCI, V286, P24, DOI 10.1016/j.jns.2009.09.009
   Pan BX, 2012, INVEST OPHTH VIS SCI, V53, P7608, DOI 10.1167/iovs.12-10452
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   Pfeffer G, 2014, BRAIN, V137, P1323, DOI 10.1093/brain/awu060
   Pfeffer G, 2013, NEUROLOGY, V81, P2073, DOI 10.1212/01.wnl.0000437308.22603.43
   Pfeffer G, 2013, NAT REV NEUROL, V9, P474, DOI 10.1038/nrneurol.2013.129
   Pyle Angela, 2014, J NEUROMUSCUL DIS, V1, P55, DOI 10.3233/JND-140003
   Qi XP, 2007, ARCH OPHTHALMOL-CHIC, V125, P268, DOI 10.1001/archopht.125.2.268
   Renaldo F, 2012, BRAIN, V135, P0, DOI 10.1093/brain/aws111
   Rendtorff ND, 2011, AM J MED GENET A, V155A, P1298, DOI 10.1002/ajmg.a.33970
   Reynier P, 2004, J MED GENET, V41, P0, DOI 10.1136/jmg.2003.016576
   Rocca MA, 2015, J NEUROL, V262, P1216, DOI 10.1007/s00415-015-7696-5
   Roemer SF, 2007, BRAIN, V130, P1194, DOI 10.1093/brain/awl371
   Roubertie A, 2015, J NEUROL SCI, V349, P154, DOI 10.1016/j.jns.2015.01.008
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Saadati HG, 1998, ARCH OPHTHALMOL-CHIC, V116, P911, DOI 10.1001/archopht.116.7.911
   Sadun A A, 2000, TRANS AM OPHTHALMOL SOC, V98, P223
   SADUN AA, 1994, CLIN NEUROSCI, V2, P165
   Sadun AA, 2012, ARCH NEUROL-CHICAGO, V69, P331, DOI 10.1001/archneurol.2011.2972
   Sarzi E, 2012, BRAIN, V135, P3599, DOI 10.1093/brain/aws303
   Savini G, 2005, OPHTHALMOLOGY, V112, P127, DOI 10.1016/j.ophtha.2004.09.033
   Shiraishi W, 2014, MULT SCLER J, V20, P258, DOI 10.1177/1352458513513057
   Spiegel R, 2016, J MED GENET, V53, P127, DOI 10.1136/jmedgenet-2015-103361
   Spruijt L, 2007, ARCH NEUROL-CHICAGO, V64, P890, DOI 10.1001/archneur.64.6.890
   Stewart JD, 2008, NEUROLOGY, V71, P1829, DOI 10.1212/01.wnl.0000335931.54095.0a
   Strom TM, 1998, HUM MOL GENET, V7, P2021, DOI 10.1093/hmg/7.13.2021
   Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647
   Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368
   Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972
   Tranebjaerg L, 2001, OPHTHALMIC GENET, V22, P207
   Tun AW, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0106779
   Turnbull HE, 2010, BBA-MOL BASIS DIS, V1802, P111, DOI 10.1016/j.bbadis.2009.07.010
   Verny C, 2008, NEUROLOGY, V70, P1152, DOI 10.1212/01.wnl.0000289194.89359.a1
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wiley SE, 2013, EMBO MOL MED, V5, P904, DOI 10.1002/emmm.201201429
   Williams PA, 2012, BRAIN, V135, P493, DOI 10.1093/brain/awr330
   Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8
   Yu-Wai-Man P, 2014, EYE, V28, P521, DOI 10.1038/eye.2014.37
   Yu-Wai-Man P, 2011, EYE, V25, P597, DOI 10.1038/eye.2011.2
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
   Yu-Wai-Man P, 2016, BRIT J OPHTHALMOL, V100, P1322, DOI 10.1136/bjophthalmol-2015-308329
   Yu-Wai-Man P, 2016, ANN CLIN TRANSL NEUR, V3, P723, DOI 10.1002/acn3.323
   Yu-Wai-Man P, 2010, OPHTHALMOLOGY, V117, P1538, DOI 10.1016/j.ophtha.2009.12.038
   Yu-Wai-Man P, 2012, BRAIN, V135, P9, DOI 10.1093/brain/awr352
   Yu-Wai-Man P, 2011, PROG RETIN EYE RES, V30, P81, DOI 10.1016/j.preteyeres.2010.11.002
   Yu-Wai-Man P, 2010, HUM MOL GENET, V19, P3043, DOI 10.1093/hmg/ddq209
   Yu-Wai-Man P, 2010, INVEST OPHTH VIS SCI, V51, P3347, DOI 10.1167/iovs.09-4660
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
   Züchner S, 2006, ANN NEUROL, V59, P276, DOI 10.1002/ana.20797
NR 149
TC 124
Z9 127
U1 1
U2 9
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0001-6322
EI 1432-0533
J9 ACTA NEUROPATHOL
JI Acta Neuropathol.
PD DEC 15
PY 2016
VL 132
IS 6
BP 789
EP 806
DI 10.1007/s00401-016-1625-2
PG 18
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA EC1DX
UT WOS:000387844900003
PM 27696015
DA 2024-11-01
ER

PT J
AU Pitceathly, RDS
   Morrow, JM
   Sinclair, CDJ
   Woodward, C
   Sweeney, MG
   Rahman, S
   Plant, GT
   Ali, N
   Bremner, F
   Davagnanam, I
   Yousry, TA
   Hanna, MG
   Thornton, JS
AF Pitceathly, Robert D. S.
   Morrow, Jasper M.
   Sinclair, Christopher D. J.
   Woodward, Cathy
   Sweeney, Mary G.
   Rahman, Shamima
   Plant, Gordon T.
   Ali, Nadeem
   Bremner, Fion
   Davagnanam, Indran
   Yousry, Tarek A.
   Hanna, Michael G.
   Thornton, John S.
TI Extra-ocular muscle MRI in genetically-defined mitochondrial disease
SO EUROPEAN RADIOLOGY
LA English
DT Article
DE Magnetic resonance imaging; Mitochondrial diseases; Mitochondrial DNA; Chronic progressive external ophthalmoplegia; Kearns-Sayre syndrome
ID progressive external ophthalmoplegia; extraocular-muscles; congenital fibrosis; relaxation-time; mutations; features
AB Conventional and quantitative MRI was performed in patients with chronic progressive external ophthalmoplegia (CPEO), a common manifestation of mitochondrial disease, to characterise MRI findings in the extra-ocular muscles (EOMs) and investigate whether quantitative MRI provides clinically relevant measures of disease. Patients with CPEO due to single mitochondrial DNA deletions were compared with controls. Range of eye movement (ROEM) measurements, peri-orbital 3 T MRI T1-weighted (T1w) and short-tau-inversion-recovery (STIR) images, and T2 relaxation time maps were obtained. Blinded observers graded muscle atrophy and T1w/STIR hyperintensity. Cross-sectional areas and EOM mean T2s were recorded and correlated with clinical parameters. Nine patients and nine healthy controls were examined. Patients had reduced ROEM (patients 13.3A degrees, controls 49.3A degrees, p < 0.001), greater mean atrophy score and increased T1w hyperintensities. EOM mean cross-sectional area was 43 % of controls and mean T2s were prolonged (patients 75.6 A +/- 7.0 ms, controls 55.2 A +/- 4.1 ms, p < 0.001). ROEM correlated negatively with EOM T2 (rho = -0.89, p < 0.01), whilst cross-sectional area failed to correlate with any clinical measures. MRI demonstrates EOM atrophy, characteristic signal changes and prolonged T2 in CPEO. Correlation between elevated EOM T2 and ROEM impairment represents a potential measure of disease severity that warrants further evaluation. aEuro cent Chronic progressive external ophthalmoplegia is a common clinical manifestation of mitochondrial disease. aEuro cent Existing extra-ocular muscle MRI data in CPEO reports variable radiological findings. aEuro cent MRI confirmed EOM atrophy and characteristic signal changes in CPEO. aEuro cent EOM T2 was significantly elevated in CPEO and correlated negatively with ocular movements. aEuro cent EOM T2 represents a potential quantitative measure of disease severity in CPEO.
C1 [Pitceathly, Robert D. S.; Morrow, Jasper M.; Sinclair, Christopher D. J.; Rahman, Shamima; Yousry, Tarek A.; Hanna, Michael G.; Thornton, John S.] UCL, MRC Ctr Neuromuscular Dis, Inst Neurol, London WC1N 3BG, England.
   [Pitceathly, Robert D. S.; Morrow, Jasper M.; Sinclair, Christopher D. J.; Rahman, Shamima; Yousry, Tarek A.; Hanna, Michael G.; Thornton, John S.] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England.
   [Sinclair, Christopher D. J.; Yousry, Tarek A.; Thornton, John S.] UCL, Inst Neurol, Dept Brain Repair & Rehabil, Neuroradiol Acad Unit, London WC1N 3BG, England.
   [Woodward, Cathy; Sweeney, Mary G.] Natl Hosp Neurol & Neurosurg, Neurogenet Unit, London WC1N 3BG, England.
   [Rahman, Shamima] UCL, Inst Child Hlth, Clin & Mol Genet Unit, Mitochondrial Res Grp, London WC1N 1EH, England.
   [Plant, Gordon T.; Ali, Nadeem; Bremner, Fion] Natl Hosp Neurol & Neurosurg, Dept Neuroophthalmol, London WC1N 3BG, England.
   [Plant, Gordon T.; Ali, Nadeem] Moorfields Eye Hosp, Dept Neuroophthalmol, London EC1V 2PD, England.
   [Davagnanam, Indran] Natl Hosp Neurol & Neurosurg, Lysholm Dept Neuroradiol, London WC1N 3BG, England.
C3 University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust
RP Pitceathly, RDS (corresponding author), UCL, MRC Ctr Neuromuscular Dis, Inst Neurol, Queen Sq, London WC1N 3BG, England.
EM r.pitceathly@ucl.ac.uk
FU MRC [G0800674]; MRC Centre [G0601943]; Great Ormond Street Hospital Children's Charity; NIHR UCLH/UCL Comprehensive Biomedical Research Centre; Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme; MRC [G0700718, MR/L016354/1, G0601943, MR/K000608/1, MC_G0802536, G0800674] Funding Source: UKRI
CR Bosley TM, 2006, BRAIN, V129, P2363, DOI 10.1093/brain/awl161
   Carlow TJ, 1998, AM J NEURORADIOL, V19, P95
   Demer JL, 2005, INVEST OPHTH VIS SCI, V46, P530, DOI 10.1167/iovs.04-1125
   Haggerty H, 2005, ARCH OPHTHALMOL-CHIC, V123, P356, DOI 10.1001/archopht.123.3.356
   Nagy EV, 2000, EUR J ENDOCRINOL, V142, P591, DOI 10.1530/eje.0.1420591
   Okamoto K, 1996, J NEURO-OPHTHALMOL, V16, P286
   Ortube MC, 2006, J AAPOS, V10, P414, DOI 10.1016/j.jaapos.2006.04.012
   Pauleit D, 1997, ROFO-FORTSCHR RONTG, V167, P557, DOI 10.1055/s-2007-1015583
   Peters S, 2006, ROFO-FORTSCHR RONTG, V178, P1030, DOI 10.1055/s-2006-926685
   Pfeffer G, 2012, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD004426.pub3
   Pitceathly RDS, 2014, CURR OPIN NEUROL, V27, P576, DOI 10.1097/WCO.0000000000000126
   Politi LS, 2014, EUR RADIOL, V24, P1118, DOI 10.1007/s00330-014-3103-3
   Richardson C, 2005, EYE, V19, P258, DOI 10.1038/sj.eye.6701488
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Ulmer JL, 1998, AM J NEURORADIOL, V19, P943
   UTECH CI, 1995, THYROID, V5, P185, DOI 10.1089/thy.1995.5.185
   Wattjes MP, 2010, EUR RADIOL, V20, P2447, DOI 10.1007/s00330-010-1799-2
   Yu-Wai-Man C, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0075048
   Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015
NR 19
TC 16
Z9 16
U1 0
U2 5
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0938-7994
EI 1432-1084
J9 EUR RADIOL
JI Eur. Radiol.
PD JAN 15
PY 2016
VL 26
IS 1
BP 130
EP 137
DI 10.1007/s00330-015-3801-5
PG 8
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA CX5EP
UT WOS:000365725200016
PM 25994195
DA 2024-11-01
ER

PT J
AU Guarani, V
   Jardel, C
   Chretien, D
   Lombes, A
   Benit, P
   Labasse, C
   Lacene, E
   Bourillon, A
   Imbard, A
   Benoist, JF
   Dorboz, I
   Gilleron, M
   Goetzman, ES
   Gaignard, P
   Slama, A
   Elmaleh-Berges, M
   Romero, NB
   Rustin, P
   de Baulny, HO
   Paulo, JA
   Harper, JW
   Schiff, M
AF Guarani, Virginia
   Jardel, Claude
   Chretien, Dominique
   Lombes, Anne
   Benit, Paule
   Labasse, Clemence
   Lacene, Emmanuelle
   Bourillon, Agnes
   Imbard, Appolline
   Benoist, Jean Francois
   Dorboz, Imen
   Gilleron, Mylene
   Goetzman, Eric S.
   Gaignard, Pauline
   Slama, Abdelhamid
   Elmaleh-Berges, Monique
   Romero, Norma B.
   Rustin, Pierre
   de Baulny, Helene Ogier
   Paulo, Joao A.
   Harper, J. Wade
   Schiff, Manuel
TI <i>QIL1</i> mutation causes MICOS disassembly and early onset fatal mitochondrial encephalopathy with liver disease
SO ELIFE
LA English
DT Article
ID cristae organizing system; contact site; drosophila-melanogaster; mitofilin complexes; inborn-errors; dna depletion; metabolism; defects; disorders; junctions
AB Previously, we identified QIL1 as a subunit of mitochondrial contact site (MICOS) complex and demonstrated a role for QIL1 in MICOS assembly, mitochondrial respiration, and cristae formation critical for mitochondrial architecture (Guarani et al., 2015). Here, we identify QIL1 null alleles in two siblings displaying multiple clinical symptoms of early-onset fatal mitochondrial encephalopathy with liver disease, including defects in respiratory chain function in patient muscle. QIL1 absence in patients fibroblasts was associated with MICOS disassembly, abnormal cristae, mild cytochrome c oxidase defect, and sensitivity to glucose withdrawal. QIL1 expression rescued cristae defects, and promoted re-accumulation of MICOS subunits to facilitate MICOS assembly. MICOS assembly and cristae morphology were not efficiently rescued by over-expression of other MICOS subunits in patient fibroblasts. Taken together, these data provide the first evidence of altered MICOS assembly linked with a human mitochondrial disease and confirm a central role for QIL1 in stable MICOS complex formation.
C1 [Guarani, Virginia; Paulo, Joao A.; Harper, J. Wade] Harvard Med Sch, Dept Cell Biol, Boston, MA USA.
   [Jardel, Claude; Lombes, Anne; Gilleron, Mylene] Inst Cochin, INSERM U1016, CNRS, UMR 8104, Paris, France.
   [Jardel, Claude; Lombes, Anne; Gilleron, Mylene] GHU Pitie Salpetriere, APHP, Dept Biochem, Paris, France.
   [Jardel, Claude; Lombes, Anne; Gilleron, Mylene] Univ Paris 05, Paris, France.
   [Chretien, Dominique; Benit, Paule; Dorboz, Imen; Rustin, Pierre; Schiff, Manuel] Univ Paris Diderot, INSERM, PROTECT, UMR1141,Sorbonne Paris Cite, Paris, France.
   [Labasse, Clemence; Lacene, Emmanuelle; Romero, Norma B.] GHU Pitie Salpetriere, APHP, Inst Myol,Neuromuscular Morphol Unit, Paris, France.
   [Bourillon, Agnes; Imbard, Appolline; Benoist, Jean Francois] APHP, Hop Robert Debre, Dept Biochem, Paris, France.
   [Goetzman, Eric S.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA USA.
   [Goetzman, Eric S.] UPMC, Childrens Hosp Pittsburgh, Pittsburgh, PA USA.
   [Gaignard, Pauline; Slama, Abdelhamid] APHP, Hop Bicetre, Dept Biochem, Paris, France.
   [Elmaleh-Berges, Monique] APHP, Hop Robert Debre, Dept Radiol, Paris, France.
   [de Baulny, Helene Ogier; Schiff, Manuel] APHP, Robert Debre Univ Hosp, Reference Ctr Inborn Errors Metab, Paris, France.
C3 Harvard University; Harvard Medical School; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Universite Paris Cite; Hopital Universitaire Hotel-Dieu - APHP; Hopital Universitaire Ambroise-Pare - APHP; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Universite Paris Cite; Hopital Universitaire Hotel-Dieu - APHP; Hopital Universitaire Ambroise-Pare - APHP; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; Hopital Universitaire Robert-Debre - APHP; Hopital Universitaire Ambroise-Pare - APHP; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Universite Paris Cite; Hopital Universitaire Hotel-Dieu - APHP; Hopital Universitaire Bicetre - APHP; Universite Paris Saclay; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Hotel-Dieu - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Robert-Debre - APHP; Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Hotel-Dieu - APHP
RP Harper, JW (corresponding author), Harvard Med Sch, Dept Cell Biol, Boston, MA USA.
EM wade_harper@hms.harvard.edu; manuel.schiff@aphp.fr
FU Fondation Maladies Rares; Ouvrir les Yeux; E-rare GENOMIT; Association contre les Maladies Mitochondriales; National Institutes of Health [GM095567, NS083524]
CR Al-Hussaini A, 2014, J PEDIATR-US, V164, P553, DOI 10.1016/j.jpeds.2013.10.082
   Alkhaja AK, 2012, MOL BIOL CELL, V23, P247, DOI 10.1091/mbc.E11-09-0774
   Anand R, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0160258
   Barbot M, 2015, CELL METAB, V21, P756, DOI 10.1016/j.cmet.2015.04.006
   Benit P, 2006, CLIN CHIM ACTA, V374, P81, DOI 10.1016/j.cca.2006.05.034
   Bohnert M, 2015, CELL METAB, V21, P747, DOI 10.1016/j.cmet.2015.04.007
   Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695
   Cingolani Pablo, 2012, FRONTIERS IN GENETICS, V3, P35, DOI 10.3389/fgene.2012.00035
   DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806
   El-Khoury R, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003182
   Gaignard P, 2013, JIMD REP, V11, P117, DOI 10.1007/8904_2013_230
   Garcia-Cazorla A, 2015, J INHERIT METAB DIS, V38, P19, DOI 10.1007/s10545-014-9776-6
   Genin EC, 2016, EMBO MOL MED, V8, P58, DOI 10.15252/emmm.201505496
   Geoffroy V, 2015, PEERJ, V3, P0, DOI 10.7717/peerj.796
   Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220
   Guarani V, 2015, ELIFE, V4, P0, DOI 10.7554/eLife.06265
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   Harner M, 2011, EMBO J, V30, P4356, DOI 10.1038/emboj.2011.379
   John GB, 2005, MOL BIOL CELL, V16, P1543, DOI 10.1091/mbc.E04-08-0697
   Kim MJ, 2008, ANTIMICROB AGENTS CH, V52, P1670, DOI 10.1128/AAC.01449-07
   Koob S, 2015, BBA-MOL CELL RES, V1853, P1551, DOI 10.1016/j.bbamcr.2015.03.004
   Lee JY, 2014, J CELL SCI, V127, P4954, DOI 10.1242/jcs.157321
   Li H, 2016, CELL DEATH DIFFER, V23, P380, DOI 10.1038/cdd.2015.102
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Lu YW, 2015, FRONT GENET, V6, P0, DOI 10.3389/fgene.2015.00003
   Malfatti E, 2014, ACTA NEUROPATHOL COM, V2, P0, DOI 10.1186/2051-5960-2-44
   Mayr JA, 2015, J INHERIT METAB DIS, V38, P137, DOI 10.1007/s10545-014-9748-x
   Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Ott C, 2012, MOL CELL BIOL, V32, P1173, DOI 10.1128/MCB.06388-11
   Pfanner N, 2014, J CELL BIOL, V204, P1083, DOI 10.1083/jcb.201401006
   ROBINSON BH, 1990, PEDIATR RES, V28, P549, DOI 10.1203/00006450-199011000-00027
   ROBINSON BH, 1992, BIOCHEM MED METAB B, V48, P122, DOI 10.1016/0885-4505(92)90056-5
   Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Schiff M, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0028823
   Stanley IA, 2014, TRENDS CELL BIOL, V24, P118, DOI 10.1016/j.tcb.2013.07.010
   Thorburn D R, 2000, HUM REPROD, V15 Suppl 2, P57
   Thorburn DR, 2001, J INHERIT METAB DIS, V24, P312, DOI 10.1023/A:1010347808082
   Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707
   van den Heuvel LP, 2004, MITOCHONDRION, V4, P395, DOI 10.1016/j.mito.2004.07.005
   van der Laan M, 2016, CURR OPIN CELL BIOL, V41, P33, DOI 10.1016/j.ceb.2016.03.013
   Weber TA, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0063683
   Wortmann SB, 2015, J INHERIT METAB DIS, V38, P99, DOI 10.1007/s10545-014-9759-7
   Wortmann SB, 2013, J INHERIT METAB DIS, V36, P923, DOI 10.1007/s10545-012-9580-0
   Yamazaki T, 2012, CELL REP, V2, P799, DOI 10.1016/j.celrep.2012.08.025
   Zerbes RM, 2016, J MOL BIOL, V428, P1485, DOI 10.1016/j.jmb.2016.02.031
   Zerbes RM, 2012, BIOL CHEM, V393, P1247, DOI 10.1515/hsz-2012-0239
NR 48
TC 43
Z9 43
U1 0
U2 7
PU ELIFE SCIENCES PUBLICATIONS LTD
PI CAMBRIDGE
PA SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND
SN 2050-084X
EI 
J9 ELIFE
JI eLife
PD SEP 13
PY 2016
VL 5
IS 
BP 
EP 
DI 10.7554/eLife.17163
PG 18
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA DX3QA
UT WOS:000384286500001
PM 27623147
DA 2024-11-01
ER

PT J
AU Finsterer, J
   Zarrouk-Mahjoub, S
   Daruich, A
AF Finsterer, Josef
   Zarrouk-Mahjoub, Sinda
   Daruich, Alejandra
TI The Eye on Mitochondrial Disorders
SO JOURNAL OF CHILD NEUROLOGY
LA English
DT Review
DE optic; nerve; ophthalmologic; eye; retina; vision; cataract; ptosis; mitochondrial disease
ID hereditary optic neuropathy; progressive external ophthalmoplegia; complex i deficiency; of-the-literature; point mutation; dna deletion; pontocerebellar hypoplasia; wolfram-syndrome; missense mutation; macular dystrophy
AB Ophthalmologic manifestations of mitochondrial disorders are frequently neglected or overlooked because they are often not regarded as part of the phenotype. This review aims at summarizing and discussing the etiology, pathogenesis, diagnosis, and treatment of ophthalmologic manifestations of mitochondrial disorders. Review of publications about ophthalmologic involvement in mitochondrial disorders by search of Medline applying appropriate search terms. The eye is frequently affected by syndromic as well as nonsyndromic mitochondrial disorders. Primary and secondary ophthalmologic manifestations can be differentiated. The most frequent ophthalmologic manifestations of mitochondrial disorders include ptosis, progressive external ophthalmoplegia, optic atrophy, retinopathy, and cataract. More rarely occurring are nystagmus and abnormalities of the cornea, ciliary body, intraocular pressure, the choroidea, or the brain secondarily affecting the eyes. It is important to recognize and diagnose ophthalmologic manifestations of mitochondrial disorders as early as possible because most are accessible to symptomatic treatment with partial or complete short-term or long-term beneficial effect. Ophthalmologic manifestations of mitochondrial disorders need to be appropriately diagnosed to initiate the most effective management and guarantee optimal outcome.
C1 [Finsterer, Josef] Krankenanstalt Rudolfstiftung Wien, Vienna, Austria.
   [Zarrouk-Mahjoub, Sinda] Pasteur Inst Tunis, Genom Platform, Tunis, Tunisia.
   [Daruich, Alejandra] Univ Lausanne, Jules Gonin Eye Hosp, Dept Ophthalmol, CH-1015 Lausanne, Switzerland.
C3 Rudolfstiftung Hospital; Pasteur Network; Universite de Tunis-El-Manar; Institut Pasteur Tunis; University of Lausanne
RP Finsterer, J (corresponding author), Postfach 20, A-1180 Vienna, Austria.
EM fifigs1@yahoo.de
CR Al-Enezi M, 2008, MIDDLE EAST AFR J OP, V15, P81, DOI 10.4103/0974-9233.51998
   ALDENHOVEL HBG, 1991, NEUROPEDIATRICS, V22, P103, DOI 10.1055/s-2008-1071426
   Ali N, 2010, J NEURO-OPHTHALMOL, V30, P153, DOI 10.1097/WNO.0b013e3181dbfdcd
   Anesi L, 2011, J MOL NEUROSCI, V43, P346, DOI 10.1007/s12031-010-9448-4
   Banerjee D, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0070760
   Barboni P, 2004, GRAEF ARCH CLIN EXP, V242, P878, DOI 10.1007/s00417-004-0914-y
   Barrientos A, 1997, HUM MUTAT, V10, P212
   Bekir NA, 2000, ACTA OPHTHALMOL SCAN, V78, P480, DOI 10.1034/j.1600-0420.2000.078004480.x
   Bekri S, 1993, GENEREVIEWS, V0, P0
   Bene J, 2003, EUR J HUM GENET, V11, P375, DOI 10.1038/sj.ejhg.5200975
   Bostan A, 2012, AUTON NEUROSCI-BASIC, V170, P70, DOI 10.1016/j.autneu.2012.06.002
   Bremner FD, 1999, INVEST OPHTH VIS SCI, V40, P2528
   Burglen L, 2012, ORPHANET J RARE DIS, V7, P0, DOI 10.1186/1750-1172-7-18
   Carelli V, 2009, BBA-BIOENERGETICS, V1787, P518, DOI 10.1016/j.bbabio.2009.02.024
   Carta A, 2005, BRIT J OPHTHALMOL, V89, P825, DOI 10.1136/bjo.2004.060590
   Chinnery PF, 1997, NEUROLOGY, V49, P1166, DOI 10.1212/WNL.49.4.1166
   Choi SY, 2012, J NEURO-OPHTHALMOL, V32, P135, DOI 10.1097/WNO.0b013e31824d2a15
   Da Pozzo P, 2009, EUR J HUM GENET, V17, P1092, DOI 10.1038/ejhg.2009.12
   Daruich A, 2014, BMC OPHTHALMOL, V14, P0, DOI 10.1186/1471-2415-14-77
   Delgado-Alvarado M, 2015, J NEUROL SCI, V350, P93, DOI 10.1016/j.jns.2015.02.011
   Dhalla MS, 2006, CAN J OPHTHALMOL, V41, P38, DOI 10.1016/S0008-4182(06)80064-5
   Dilber E, 2002, J CHILD NEUROL, V17, P64, DOI 10.1177/088307380201700119
   Filiano JJ, 2002, PEDIATR NEUROL, V26, P239, DOI 10.1016/S0887-8994(01)00377-0
   Finsterer J, 2005, ACTA OPHTHALMOL SCAN, V83, P628, DOI 10.1111/j.1600-0420.2005.00518.x
   Finsterer J, 2013, CAN J NEUROL SCI, V40, P635, DOI 10.1017/S0317167100014852
   Finsterer J, 2013, NEUROL INT, V5, P28, DOI 10.4081/ni.2013.e9
   Finsterer J, 2010, ACTA NEUROL BELG, V110, P110
   FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3
   Gendron SP, 2013, MUTAGENESIS, V28, P197, DOI 10.1093/mutage/ges071
   Gorman GS, 2011, SAUDI J OPHTHALMOL, V25, P395, DOI 10.1016/j.sjopt.2011.02.002
   Grau T, 2013, J MED GENET, V50, P848, DOI 10.1136/jmedgenet-2013-101774
   Grönlund MA, 2010, BRIT J OPHTHALMOL, V94, P121, DOI 10.1136/bjo.2008.154187
   Guillausseau PJ, 2001, ANN INTERN MED, V134, P721, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00008
   Han J, 2015, BRIT J OPHTHALMOL, V99, P528, DOI 10.1136/bjophthalmol-2014-305704
   Hanisch F, 2015, J NEUROL NEUROSUR PS, V86, P630, DOI 10.1136/jnnp-2013-306748
   Hayashi N, 2000, OPHTHALMOLOGY, V107, P1397, DOI 10.1016/S0161-6420(00)00110-X
   Heidary G, 2014, J NEURO-OPHTHALMOL, V34, P39, DOI 10.1097/WNO.0000000000000076
   Heiduschka P, 2010, INVEST OPHTH VIS SCI, V51, P1424, DOI 10.1167/iovs.09-3606
   Inagaki Y, 2006, JPN J OPHTHALMOL, V50, P128, DOI 10.1007/s10384-005-0290-0
   Isashiki Y, 1998, ACTA OPHTHALMOL SCAN, V76, P6, DOI 10.1034/j.1600-0420.1998.760103.x
   Ji JQ, 2010, MITOCHONDRION, V10, P188, DOI 10.1016/j.mito.2009.11.002
   Kasbekar SA, 2013, OPHTHALMIC GENET, V34, P55, DOI 10.3109/13816810.2011.610862
   Kiliç M, 2011, TURKISH J PEDIATR, V53, P79
   Kuncl RW, 1999, WALSH HOYTS CLIN NEU, V0, P1351
   La Morgia C, 2014, BMC NEUROL, V14, P0, DOI 10.1186/1471-2377-14-116
   Lachmund U, 2006, KLIN MONATSBL AUGENH, V223, P393, DOI 10.1055/s-2006-926559
   Lee JJ, 2012, PEDIATR NEPHROL, V27, P869, DOI 10.1007/s00467-011-2096-2
   Liskova P, 2013, ACTA OPHTHALMOL, V91, PE225, DOI 10.1111/aos.12038
   Lonnqvist Tuula, 2011, DUODECIM, V127, P1460
   Maguluri Sri, 2007, RETIN CASES BRIEF REP, V1, P239, DOI 10.1097/01.iae.0000225281.84558.84
   MAKELABENGS P, 1995, PEDIATR RES, V37, P634
   Massin P, 1999, OPHTHALMOLOGY, V106, P1821, DOI 10.1016/S0161-6420(99)90356-1
   Metodiev MD, 2014, J MED GENET, V51, P834, DOI 10.1136/jmedgenet-2014-102532
   Meulemans A, 2006, ARCH NEUROL-CHICAGO, V63, P1194, DOI 10.1001/archneur.63.8.1194
   Mori M, 2014, JIMD REP, V17, P47, DOI 10.1007/8904_2014_332
   Müller-Vahl KR, 2000, MUSCLE NERVE, V23, P647
   Nakaso K, 2012, J CLIN NEUROL, V8, P230, DOI 10.3988/jcn.2012.8.3.230
   Nikali K, 2009, GENEREVIEWS, V0, P0
   ONeill EC, 2011, OPHTHALMOLOGY, V118, P964, DOI 10.1016/j.ophtha.2010.09.002
   Pablo LE, 2011, MOL VIS, V17, P0
   Pathak D, 2011, MOL VIS, V17, P1514
   Payne M, 2004, AM J OPHTHALMOL, V138, P749, DOI 10.1016/j.ajo.2004.06.011
   Pfeffer G, 2011, CAN J NEUROL SCI, V38, P119, DOI 10.1017/S031716710001115X
   Ponjavic V, 1996, ACTA OPHTHALMOL SCAN, V74, P632
   Rath PP, 2008, BRIT J OPHTHALMOL, V92, P623, DOI 10.1136/bjo.2007.131177
   Robberecht K, 2010, OPHTHALMIC GENET, V31, P240, DOI 10.3109/13816810.2010.520297
   Rose LVT, 2008, PEDIATR NEUROL, V38, P395, DOI 10.1016/j.pediatrneurol.2008.02.003
   RUMMELT V, 1993, OPHTHALMOLOGY, V100, P1757
   Schmitz K, 2003, CORNEA, V22, P267, DOI 10.1097/00003226-200304000-00019
   Shinmei Y, 2007, J NEURO-OPHTHALMOL, V27, P22, DOI 10.1097/WNO.0b013e3180334cb0
   SIEVERDING L, 1988, KLIN PADIATR, V200, P381, DOI 10.1055/s-2008-1033738
   Sonmez FM, 2012, GENET COUNSEL, V23, P347
   Taban M, 2006, J CHILD NEUROL, V21, P956, DOI 10.1177/08830738060210111601
   Tanaka Koji, 2013, RINSHO SHINKEIGAKU, V53, P205
   Titah SMC, 2012, EUR J OPHTHALMOL, V22, P254, DOI 10.5301/EJO.2011.8370
   Tyni T, 2004, PEDIATR RES, V56, P744, DOI 10.1203/01.PDR.0000141967.52759.83
   Valentino ML, 2006, J MED GENET, V43, P0, DOI 10.1136/jmg.2005.037507
   Van Hove JLK, 2009, AM J MED GENET A, V149A, P861, DOI 10.1002/ajmg.a.32731
   Wang K, 2009, NEUROGENETICS, V10, P337, DOI 10.1007/s10048-009-0194-0
   Weitgasser L, 2015, ARCH PLAST SURG-APS, V42, P214, DOI 10.5999/aps.2015.42.2.214
   Wojcik Katarzyna A, 2013, KLIN OCZNA, V115, P311
   Yu-Wai-Man P, 2010, J MED GENET, V47, P120, DOI 10.1136/jmg.2009.067512
   Yu-Wai-Man P, 2009, J MED GENET, V46, P145, DOI 10.1136/jmg.2007.054270
   Yu-Wai-Man P, 1993, GENEREVIEWS, V0, P0
   Yu-Wai-Man P, 2010, OPHTHALMOLOGY, V117, P1538, DOI 10.1016/j.ophtha.2009.12.038
   Zeharia A, 2005, J CHILD NEUROL, V20, P449, DOI 10.1177/08830738050200051301
NR 86
TC 23
Z9 24
U1 0
U2 8
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0883-0738
EI 1708-8283
J9 J CHILD NEUROL
JI J. Child Neurol.
PD APR 15
PY 2016
VL 31
IS 5
BP 652
EP 662
DI 10.1177/0883073815599263
PG 11
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA DH5HY
UT WOS:000372818400017
PM 26275973
DA 2024-11-01
ER

PT J
AU Jiang, PP
   Jin, XF
   Peng, YY
   Wang, M
   Liu, H
   Liu, XL
   Zhang, ZJ
   Ji, YC
   Zhang, JJ
   Liang, M
   Zhao, FX
   Sun, YH
   Zhang, ML
   Zhou, XT
   Chen, Y
   Mo, JQ
   Huang, TS
   Qu, J
   Guan, MX
AF Jiang, Pingping
   Jin, Xiaofen
   Peng, Yanyan
   Wang, Meng
   Liu, Hao
   Liu, Xiaoling
   Zhang, Zengjun
   Ji, Yanchun
   Zhang, Juanjuan
   Liang, Min
   Zhao, Fuxin
   Sun, Yan-Hong
   Zhang, Minglian
   Zhou, Xiangtian
   Chen, Ye
   Mo, Jun Qin
   Huang, Taosheng
   Qu, Jia
   Guan, Min-Xin
TI The exome sequencing identified the mutation in YARS2 encoding the mitochondrial tyrosyl-tRNA synthetase as a nuclear modifier for the phenotypic manifestation of Leber's hereditary optic neuropathy-associated mitochondrial DNA mutation
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID nd4 g11778a mutation; han chinese family; lactic-acidosis; mtdna mutations; complex-i; sideroblastic anemia; oxidative stress; causes myopathy; high penetrance; cell-lines
AB Leber's hereditary optic neuropathy (LHON) is the most common mitochondrial disorder. Nuclear modifier genes are proposed to modify the phenotypic expression of LHON-associated mitochondrial DNA (mtDNA) mutations. By using an exome sequencing approach, we identified a LHON susceptibility allele (c.572G>T, p.191Gly>Val) in YARS2 gene encoding mitochondrial tyrosyl-tRNA synthetase, which interacts with m.11778G>A mutation to cause visual failure. We performed functional assays by using lymphoblastoid cell lines derived from members of Chinese families (asymptomatic individuals carrying m.11778G>A mutation, or both m.11778G>A and heterozygous p.191Gly>Val mutations and symptomatic subjects harboring m.11778G>A and homozygous p.191Gly>Val mutations) and controls lacking these mutations. The 191Gly>Val mutation reduced the YARS2 protein level in the mutant cells. The aminoacylated efficiency and steady-state level of tRNA(Tyr) were markedly decreased in the cell lines derived from patients both carrying homozygous YARS2 p.191Gly>Val and m.11778G>A mutations. The failure in tRNATyr metabolism impaired mitochondrial translation, especially for polypeptides with high content of tyrosine codon such as ND4, ND5, ND6 andCOX2 in cells lines carrying homozygous YARS2 p.191Gly>Val and m.11778G>A mutations. The YARS2 p.191Gly>Val mutation worsened the respiratory phenotypes associated with m.11778G>A mutation, especially reducing activities of complexes I and IV. The respiratory deficiency altered the efficiency of mitochondrial ATP synthesis and increased the production of reactive oxygen species. Thus, mutated YARS2 aggravates mitochondrial dysfunctions associated with the m.11778G>A mutation, exceeding the threshold for the expression of blindness phenotype. Our findings provided new insights into the pathophysiology of LHON that were manifested by interaction between mtDNA mutation and mutated nuclear-modifier YARS2.
C1 [Jiang, Pingping; Jin, Xiaofen; Peng, Yanyan; Wang, Meng; Liu, Hao; Ji, Yanchun; Zhang, Juanjuan; Liang, Min; Chen, Ye; Guan, Min-Xin] Zhejiang Univ, Sch Med, Inst Genet, 866 Yuhangtang Rd, Hangzhou 310003, Zhejiang, Peoples R China.
   [Jiang, Pingping; Chen, Ye; Guan, Min-Xin] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310027, Peoples R China.
   [Peng, Yanyan; Huang, Taosheng] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA.
   [Liu, Xiaoling; Zhang, Zengjun; Zhang, Juanjuan; Zhao, Fuxin; Zhou, Xiangtian; Qu, Jia] Wenzhou Med Univ, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China.
   [Liu, Xiaoling; Zhang, Zengjun; Zhang, Juanjuan; Zhao, Fuxin; Zhou, Xiangtian; Qu, Jia] Wenzhou Med Coll, Sch Life Sci, Attardi Inst Mitochondrial Biomed, Wenzhou, Zhejiang, Peoples R China.
   [Sun, Yan-Hong] Beijing Univ Chinese Med & Pharmacol, Dept Ophthalmol, Beijing, Peoples R China.
   [Zhang, Minglian] Hebei Prov Eye Hosp, Dept Ophthalmol, Xingtai, Hebei, Peoples R China.
   [Mo, Jun Qin] Univ Calif San Diego, Sch Med, Rady Childrens Hosp, Dept Pathol, San Diego, CA 92103 USA.
C3 Zhejiang University; Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Cincinnati Children's Hospital Medical Center; Wenzhou Medical University; Wenzhou Medical University; Beijing University of Chinese Medicine; Rady Childrens Hospital San Diego; University of California System; University of California San Diego
RP Guan, MX (corresponding author), Zhejiang Univ, Sch Med, Inst Genet, 866 Yuhangtang Rd, Hangzhou 310003, Zhejiang, Peoples R China.
EM gminxin88@zju.edu.cn
FU National Key Technologies R&D Program from the Ministry of Science and Technology of China [2012BAI09B03]; Natural Science Foundation of China [31471191, 81200724, 81400434]
CR Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Baracca A, 2005, ARCH NEUROL-CHICAGO, V62, P730, DOI 10.1001/archneur.62.5.730
   Beretta S, 2004, BRAIN, V127, P2183, DOI 10.1093/brain/awh258
   Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4
   Bonnefond L, 2005, BIOCHEMISTRY-US, V44, P4805, DOI 10.1021/bi047527z
   BROWN MD, 1995, HUM MUTAT, V6, P311, DOI 10.1002/humu.1380060405
   Brown MD, 2000, J BIOL CHEM, V275, P39831, DOI 10.1074/jbc.M006476200
   BU XD, 1992, GENET EPIDEMIOL, V9, P27, DOI 10.1002/gepi.1370090105
   Carelli V, 2009, BBA-BIOENERGETICS, V1787, P518, DOI 10.1016/j.bbabio.2009.02.024
   Chen C, 2015, PROTEIN CELL, V6, P862, DOI 10.1007/s13238-015-0175-z
   Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199
   Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005
   Enriquez J A, 1996, METHODS ENZYMOL, V264, P183, DOI 10.1016/S0076-6879(96)64019-1
   ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47
   Enriquez JA, 1996, P NATL ACAD SCI USA, V93, P8300, DOI 10.1073/pnas.93.16.8300
   Ghelli A, 2003, J BIOL CHEM, V278, P4145, DOI 10.1074/jbc.M210285200
   Giordano C, 2014, BRAIN, V137, P335, DOI 10.1093/brain/awt343
   Gong SS, 2014, NUCLEIC ACIDS RES, V42, P8039, DOI 10.1093/nar/gku466
   Guan MX, 2006, AM J HUM GENET, V79, P291, DOI 10.1086/506389
   Hayashi G, 2015, FREE RADICAL BIO MED, V88, P10, DOI 10.1016/j.freeradbiomed.2015.05.039
   Hofhaus G, 1996, J BIOL CHEM, V271, P13155, DOI 10.1074/jbc.271.22.13155
   Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176
   Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394
   Jia XY, 2006, J HUM GENET, V51, P851, DOI 10.1007/s10038-006-0032-2
   Jia ZD, 2013, HUM MOL GENET, V22, P4064, DOI 10.1093/hmg/ddt256
   Jiang PP, 2015, INVEST OPHTH VIS SCI, V56, P4778, DOI 10.1167/iovs.14-16158
   KING MP, 1993, J BIOL CHEM, V268, P10228
   Lenaz G, 2004, BBA-BIOENERGETICS, V1658, P89, DOI 10.1016/j.bbabio.2004.03.013
   Li XM, 2004, NUCLEIC ACIDS RES, V32, P867, DOI 10.1093/nar/gkh226
   Li YF, 2007, J BIOL CHEM, V282, P17557, DOI 10.1074/jbc.M701056200
   Liang M, 2014, INVEST OPHTH VIS SCI, V55, P1321, DOI 10.1167/iovs.13-13011
   Mackey DA, 1996, AM J HUM GENET, V59, P481
   Mahfouz R, 2009, FERTIL STERIL, V92, P819, DOI 10.1016/j.fertnstert.2008.05.087
   Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015
   Meiklejohn CD, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003238
   MILLER G, 1973, P NATL ACAD SCI USA, V70, P190, DOI 10.1073/pnas.70.1.190
   Newman NJ, 1993, OPHTHALMOL CLIN N AM, V50, P540
   NEWMAN NJ, 1991, AM J OPHTHALMOL, V111, P750, DOI 10.1016/S0002-9394(14)76784-4
   NIKOSKELAINEN EK, 1994, CLIN NEUROSCI, V2, P115
   Paukstelis PJ, 2008, NATURE, V451, P94, DOI 10.1038/nature06413
   Phasukkijwatana N, 2010, HUM GENET, V128, P39, DOI 10.1007/s00439-010-0821-8
   Porcelli AM, 2009, J BIOL CHEM, V284, P2045, DOI 10.1074/jbc.M807321200
   Qian YP, 2011, MITOCHONDRION, V11, P871, DOI 10.1016/j.mito.2011.06.006
   Qu J, 2006, INVEST OPHTH VIS SCI, V47, P475, DOI 10.1167/iovs.05-0665
   Qu J, 2007, MITOCHONDRION, V7, P140, DOI 10.1016/j.mito.2006.11.015
   Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967
   Riley LG, 2013, ORPHANET J RARE DIS, V8, P0, DOI 10.1186/1750-1172-8-193
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   RIORDANEVA P, 1995, BRAIN, V118, P319, DOI 10.1093/brain/118.2.319
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, PD823, DOI 10.1093/nar/gkl927
   Sasarman F, 2012, HUM MUTAT, V33, P1201, DOI 10.1002/humu.22098
   Scheffler I, 2015, J INHERIT METAB DIS, V38, P405, DOI 10.1007/s10545-014-9768-6
   Shankar SP, 2008, OPHTHALMIC GENET, V29, P17, DOI 10.1080/13816810701867607
   Simon M, 2015, PLOS GENET, V11, P0, DOI 10.1371/journal.pgen.1005097
   Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wong A, 2002, HUM MOL GENET, V11, P431, DOI 10.1093/hmg/11.4.431
   Yen MY, 2006, PROG RETIN EYE RES, V25, P381, DOI 10.1016/j.preteyeres.2006.05.002
   Yu-Wai-Man P, 2009, J MED GENET, V46, P145, DOI 10.1136/jmg.2007.054270
   Zhang JJ, 2014, MITOCHONDRION, V18, P18, DOI 10.1016/j.mito.2014.08.008
   Zhang JJ, 2013, MITOCHONDRION, V13, P772, DOI 10.1016/j.mito.2013.05.002
   Zhou XT, 2012, INVEST OPHTH VIS SCI, V53, P4586, DOI 10.1167/iovs.11-9109
   Zhou XT, 2010, MOL GENET METAB, V100, P379, DOI 10.1016/j.ymgme.2010.04.013
NR 63
TC 88
Z9 97
U1 1
U2 27
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD FEB 1
PY 2016
VL 25
IS 3
BP 584
EP 596
DI 10.1093/hmg/ddv498
PG 13
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA DG5WH
UT WOS:000372149500014
PM 26647310
DA 2024-11-01
ER

PT J
AU Korenev, S
   Morris, AAM
AF Korenev, Sergei
   Morris, Andrew A. M.
TI When to Suspect and How to Diagnose Mitochondrial Disorders?
SO INDIAN JOURNAL OF PEDIATRICS
LA English
DT Review
DE Lactic acid; Neurodegeneration; mtDNA; Exome sequencing; Muscle biopsy; Histochemistry
ID disease; mutations; deficiency; biomarker; gene
AB Disorders of the mitochondrial respiratory chain are an exceedingly diverse group. The clinical features can affect any tissue or organ and occur at any age, with any mode of inheritance. The diagnosis of mitochondrial disorders requires knowledge of the clinical phenotypes and access to a wide range of laboratory techniques. A few syndromes are associated with a specific genetic defect and in these cases it is appropriate to proceed directly to an appropriate test of blood or urine. In most cases, however, the best strategy starts with biochemical and histochemical studies on a muscle biopsy. Appropriate molecular genetic studies can then be chosen, based on these results and the clinical picture. Unfortunately, there is currently limited availability of respiratory chain studies in India. Exome sequencing is undertaken increasingly often; without preceding mitochondrial studies, this can lead to misleading results.
C1 [Korenev, Sergei; Morris, Andrew A. M.] St Marys Hosp, NHS Fdn Trust, Cent Manchester Univ Hosp, Willink Biochem Genet Unit,Manchester Ctr Genom M, Oxford Rd, Manchester M13 9WL, Lancs, England.
C3 University of Manchester; Oxford University Hospitals NHS Foundation Trust
RP Korenev, S (corresponding author), St Marys Hosp, NHS Fdn Trust, Cent Manchester Univ Hosp, Willink Biochem Genet Unit,Manchester Ctr Genom M, Oxford Rd, Manchester M13 9WL, Lancs, England.
EM sergei.korenev@cmft.nhs.uk
CR Alston CL, 2011, EUR J HUM GENET, V19, P1226, DOI 10.1038/ejhg.2011.124
   Baker PR, 2014, BRAIN, V137, P366, DOI 10.1093/brain/awt328
   Bowron A, 2013, J INHERIT METAB DIS, V36, P741, DOI 10.1007/s10545-012-9552-4
   Davis RL, 2013, NEUROLOGY, V81, P1819, DOI 10.1212/01.wnl.0000436068.43384.ef
   Dhillon VS, 2014, MUTAT RES-REV MUTAT, V759, P1, DOI 10.1016/j.mrrev.2013.09.001
   DiMauro S, 2004, BBA-BIOENERGETICS, V1658, P80, DOI 10.1016/j.bbabio.2004.03.014
   DiMauro S, 2001, GENEREVIEWS, V0, P1993
   Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227
   Friedman SD, 2010, DEV DISABIL RES REV, V16, P129, DOI 10.1002/ddrr.103
   Gropman AL, 2013, NEUROTHERAPEUTICS, V10, P273, DOI 10.1007/s13311-012-0161-6
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   Lara MC, 2007, BIOSCIENCE REP, V27, P151, DOI 10.1007/s10540-007-9043-2
   Lindroos MM, 2009, DIABETES, V58, P543, DOI 10.2337/db08-0981
   Rahman S, 2009, J NEUROL NEUROSUR PS, V80, P943, DOI 10.1136/jnnp.2008.158279
   Rodenburg RJT, 2011, J INHERIT METAB DIS, V34, P283, DOI 10.1007/s10545-010-9081-y
   Rollins S, 2001, AM J CLIN PATHOL, V116, P326
   Saneto RP, 2008, MITOCHONDRION, V8, P396, DOI 10.1016/j.mito.2008.05.003
   Saneto RP, 2013, PEDIATR NEUROL, V48, P167, DOI 10.1016/j.pediatrneurol.2012.09.014
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a021220
   Wortmann SB, 2013, J INHERIT METAB DIS, V36, P923, DOI 10.1007/s10545-012-9580-0
NR 24
TC 1
Z9 1
U1 0
U2 0
PU SPRINGER INDIA
PI NEW DELHI
PA 7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001, INDIA
SN 0019-5456
EI 0973-7693
J9 INDIAN J PEDIATR
JI Indian J. Pediatr.
PD OCT 15
PY 2016
VL 83
IS 10
BP 1157
EP 1163
DI 10.1007/s12098-015-1932-y
PG 7
WC Pediatrics
SC Pediatrics
GA DY0VI
UT WOS:000384813900018
PM 26759002
DA 2024-11-01
ER

PT J
AU Ng, YS
   Grady, JP
   Lax, NZ
   Bourke, JP
   Alston, CL
   Hardy, SA
   Falkous, G
   Schaefer, AG
   Radunovic, A
   Mohiddin, SA
   Ralph, M
   Alhakim, A
   Taylor, RW
   McFarland, R
   Turnbull, DM
   Gorman, GS
AF Ng, Yi Shiau
   Grady, John P.
   Lax, Nichola Z.
   Bourke, John P.
   Alston, Charlotte L.
   Hardy, Steven A.
   Falkous, Gavin
   Schaefer, Andrew G.
   Radunovic, Aleksandar
   Mohiddin, Saidi A.
   Ralph, Matilda
   Alhakim, Ali
   Taylor, Robert W.
   McFarland, Robert
   Turnbull, Douglass M.
   Gorman, Grainne S.
TI Sudden adult death syndrome in m.3243A&gt;G-related mitochondrial disease: an unrecognized clinical entity in young, asymptomatic adults
SO EUROPEAN HEART JOURNAL
LA English
DT Article
DE m.3243A>G; Sudden death; Cardiac; Genetic autopsy
ID stroke-like episodes; cardiac death; hypertrophic cardiomyopathy; lactic-acidosis; dna mutations; diagnosis; melas; risk; prevalence; encephalomyopathy
AB Aims To provide insight into the mechanism of sudden adult death syndrome (SADS) and to give new clinical guidelines for the cardiac management of patients with the most common mitochondrial DNA mutation, m.3243A>G. These studies were initiated after two young, asymptomatic adults harbouring the m.3243A>G mutation died suddenly and unexpectedly. The m.3243A>G mutation is present in similar to 1 in 400 of the population, although the recognized incidence of mitochondrial DNA (mtDNA) disease is similar to 1 in 5000. Methods and results Pathological studies including histochemistry and molecular genetic analyses performed on various post-mortem samples including cardiac tissues ( atrium and ventricles) showed marked respiratory chain deficiency and high levels of the m.3243A>G mutation. Systematic review of cause of death in our m.3243A>G patient cohort showed the person-time incidence rate of sudden adult death is 2.4 per 1000 person-years. A further six cases of sudden death among extended family members have been identified from interrogation of family pedigrees. Conclusion Our findings suggest that SADS is an important cause of death in patients with m.3243A>G and likely to be due to widespread respiratory chain deficiency in cardiac muscle. The involvement of asymptomatic relatives highlights the importance of family tracing in patients with m.3243A>G and the need for specific cardiac arrhythmia surveillance in the management of this common genetic disease. In addition, these findings have prompted the derivation of cardiac guidelines specific to patients with m.3243A>G-related mitochondrial disease. Finally, due to the prevalence of this mtDNA point mutation, we recommend inclusion of testing for m.3243A>G mutations in the genetic autopsy of all unexplained cases of SADS.
C1 [Ng, Yi Shiau; Grady, John P.; Lax, Nichola Z.; Alston, Charlotte L.; Hardy, Steven A.; Falkous, Gavin; Schaefer, Andrew G.; Taylor, Robert W.; McFarland, Robert; Turnbull, Douglass M.; Gorman, Grainne S.] Newcastle Univ, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [Bourke, John P.] Freeman Rd Hosp, Ctr Cardiothorac, Newcastle Upon Tyne, Tyne & Wear, England.
   [Radunovic, Aleksandar] Royal London Hosp, Dept Neurol, London, England.
   [Mohiddin, Saidi A.] London Chest Hosp, Dept Cardiol, London, England.
   [Ralph, Matilda] Hemel Hemstead Hosp, Hemel Hempstead, Herts, England.
   [Alhakim, Ali] East Surrey Hosp, Redhill, Surrey, England.
C3 Newcastle University - UK; Newcastle Freeman Hospital; Newcastle University - UK; Barts Health NHS Trust; Royal London Hospital; University of London; Queen Mary University London; East Surrey Hospital
RP Gorman, GS (corresponding author), Newcastle Univ, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
EM grainne.gorman@ncl.ac.uk
FU Wellcome Trust [074454/Z/04/Z]; Newcastle University Centre for Ageing and Vitality (Biotechnology and Biological Sciences Research Council and Medical Research Council) [M501700]; UK NIHR Biomedical Research Centre for Ageing and Age-related disease award; Lily Foundation; UK NHS Specialist Commissioners; Wellcome Trust Centre [096919/Z/11/Z]; MRC [G0800674] Funding Source: UKRI
CR Alston CL, 2011, EUR J HUM GENET, V19, P1226, DOI 10.1038/ejhg.2011.124
   Bates MGD, 2013, INT J CARDIOL, V168, P3599, DOI 10.1016/j.ijcard.2013.05.062
   Bates MGD, 2012, EUR HEART J, V33, P3023, DOI 10.1093/eurheartj/ehs275
   Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x
   Corrado D, 2003, J AM COLL CARDIOL, V42, P1959, DOI 10.1016/j.jacc.2003.03.002
   COX DR, 1972, J R STAT SOC B, V34, P187
   de la Grandmaison GL, 2001, FORENSIC SCI INT, V119, P149, DOI 10.1016/S0379-0738(00)00401-1
   DEKABAN AS, 1978, ANN NEUROL, V4, P345, DOI 10.1002/ana.410040410
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Elliott PM, 2014, EUR HEART J, V35, P2733, DOI 10.1093/eurheartj/ehu284
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Hollingsworth KG, 2012, NEUROMUSCULAR DISORD, V22, P592, DOI 10.1016/j.nmd.2012.03.001
   Holmgren D, 2003, EUR HEART J, V24, P280, DOI 10.1016/S0195-668X(02)00387-1
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Klopstock T, 1999, NEUROLOGY, V53, P855, DOI 10.1212/WNL.53.4.855
   Lax NZ, 2012, BRAIN, V135, P62, DOI 10.1093/brain/awr326
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Majamaa-Voltti K, 2008, J NEUROL NEUROSUR PS, V79, P0, DOI 10.1136/jnnp.2007.122648
   Majamaa-Voltti Kirsi, 2002, BMC CARDIOVASC DISORD, V2, P12
   Malfatti E, 2013, NEUROLOGY, V80, P100, DOI 10.1212/WNL.0b013e31827b1a2f
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   MARON BJ, 1979, CIRCULATION, V60, P685, DOI 10.1161/01.CIR.60.3.685
   MORAES CT, 1993, NEUROMUSCULAR DISORD, V3, P43, DOI 10.1016/0960-8966(93)90040-Q
   Morentín B, 2001, MED CLIN-BARCELONA, V116, P281, DOI 10.1016/S0025-7753(01)71800-3
   MORGANHUGHES JA, 1979, J NEUROL SCI, V43, P27, DOI 10.1016/0022-510X(79)90071-6
   Murphy R, 2008, DIABETIC MED, V25, P383, DOI 10.1111/j.1464-5491.2008.02359.x
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   OMahony C, 2014, EUR HEART J, V35, P2010, DOI 10.1093/eurheartj/eht439
   Okajima Y, 1998, HEART, V80, P292, DOI 10.1136/hrt.80.3.292
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Papadakis M, 2009, EUROPACE, V11, P1353, DOI 10.1093/europace/eup229
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Schaefer AM, 2014, NEWCASTLE MITOCHONDR, V0, P0
   Shirani J, 2000, J AM COLL CARDIOL, V35, P36, DOI 10.1016/S0735-1097(99)00492-1
   Shorvon S, 2011, LANCET, V378, P2028, DOI 10.1016/S0140-6736(11)60176-1
   Siler SQ, 1998, AM J PHYSIOL-ENDOC M, V275, PE897, DOI 10.1152/ajpendo.1998.275.5.E897
   Spirito P, 2000, NEW ENGL J MED, V342, P1778, DOI 10.1056/NEJM200006153422403
   Winkel BG, 2011, EUR HEART J, V32, P983, DOI 10.1093/eurheartj/ehq428
   Wisten A, 2002, J INTERN MED, V252, P529, DOI 10.1046/j.1365-2796.2002.01038.x
NR 39
TC 45
Z9 48
U1 0
U2 5
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0195-668X
EI 1522-9645
J9 EUR HEART J
JI Eur. Heart J.
PD AUG 21
PY 2016
VL 37
IS 32
BP 2552
EP 2559
DI 10.1093/eurheartj/ehv306
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DW5OV
UT WOS:000383696500015
PM 26188002
DA 2024-11-01
ER

PT J
AU Sun, N
   Youle, RJ
   Finkel, T
AF Sun, Nuo
   Youle, Richard J.
   Finkel, Toren
TI The Mitochondrial Basis of Aging
SO MOLECULAR CELL
LA English
DT Review
ID extends life-span; skeletal-muscle; pyruvate-dehydrogenase; dna mutations; stem-cells; nlrp3 inflammasome; physical-exercise; oxidative stress; quality-control; longevity
AB A decline inmitochondrial quality and activity has been associated with normal aging and correlated with the development of a wide range of age-related diseases. Here, we review the evidence that a decline in mitochondria function contributes to aging. In particular, we discuss how mitochondria contribute to specific aspects of the aging process, including cellular senescence, chronic inflammation, and the age-dependent decline in stem cell activity. Signaling pathways regulating the mitochondrial unfolded protein response and mitophagy are also reviewed, with particular emphasis placed on how these pathways might, in turn, regulate longevity. Taken together, these observations suggest that mitochondria influence or regulate a number of key aspects of aging and suggest that strategies directed at improving mitochondrial quality and function might have far-reaching beneficial effects.
C1 [Sun, Nuo; Finkel, Toren] NHLBI, Ctr Mol Med, NIH, Bldg 10, Bethesda, MD 20892 USA.
   [Youle, Richard J.] NINDS, Biochem Sect, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)
RP Finkel, T (corresponding author), NHLBI, Ctr Mol Med, NIH, Bldg 10, Bethesda, MD 20892 USA.; Youle, RJ (corresponding author), NINDS, Biochem Sect, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA.
EM richard.youle@nih.guy; finkelt@nih.gov
FU NIH Intramural Funds; Leducq Foundation Transatlantic Network Award
CR Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Argilés JM, 2015, CURR OPIN PHARMACOL, V22, P100, DOI 10.1016/j.coph.2015.04.003
   Austin S, 2012, J CELL SCI, V125, P4963, DOI 10.1242/jcs.113662
   Bennett CF, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms4483
   Bezawork-Geleta A, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep17397
   Bigarella CL, 2014, DEVELOPMENT, V141, P4206, DOI 10.1242/dev.107086
   Bingol B, 2014, NATURE, V510, P370, DOI 10.1038/nature13418
   Brown K, 2013, CELL REP, V3, P319, DOI 10.1016/j.celrep.2013.01.005
   Cantó C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023
   Carey BW, 2015, NATURE, V518, P413, DOI 10.1038/nature13981
   Chakravarty EF, 2008, ARCH INTERN MED, V168, P1638, DOI 10.1001/archinte.168.15.1638
   Chen ML, 2009, BLOOD, V114, P4045, DOI 10.1182/blood-2008-08-169474
   Clay L, 2014, ELIFE, V3, P0, DOI 10.7554/eLife.01883
   Conboy MJ, 2013, AGING CELL, V12, P525, DOI 10.1111/acel.12065
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   DellAgnello C, 2007, HUM MOL GENET, V16, P431, DOI 10.1093/hmg/ddl477
   Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780
   Durcan TM, 2015, GENE DEV, V29, P989, DOI 10.1101/gad.262758.115
   Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016
   Easlon E, 2008, GENE DEV, V22, P931, DOI 10.1101/gad.1648308
   Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012
   Egerman MA, 2014, CRIT REV BIOCHEM MOL, V49, P59, DOI 10.3109/10409238.2013.857291
   Fan J, 2014, MOL CELL, V53, P534, DOI 10.1016/j.molcel.2013.12.026
   Fang EF, 2014, CELL, V157, P882, DOI 10.1016/j.cell.2014.03.026
   Felkai S, 1999, EMBO J, V18, P1783, DOI 10.1093/emboj/18.7.1783
   Franceschi C, 2000, ANN NY ACAD SCI, V908, P244
   Giblin W, 2014, TRENDS GENET, V30, P271, DOI 10.1016/j.tig.2014.04.007
   Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037
   Goodpaster BH, 2006, J GERONTOL A-BIOL, V61, P1059, DOI 10.1093/gerona/61.10.1059
   Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100
   Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hasson SA, 2015, ACS CHEM BIOL, V10, P1188, DOI 10.1021/cb5010417
   Haynes CM, 2010, MOL CELL, V37, P529, DOI 10.1016/j.molcel.2010.01.015
   Hepple RT, 2014, FRONT AGING NEUROSCI, V6, P0, DOI 10.3389/fnagi.2014.00211
   Hertz NT, 2013, CELL, V154, P737, DOI 10.1016/j.cell.2013.07.030
   Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188
   Hughes AL, 2012, NATURE, V492, P261, DOI 10.1038/nature11654
   Hughes KA, 2005, ANNU REV ENTOMOL, V50, P421, DOI 10.1146/annurev.ento.50.071803.130409
   Itakura E, 2012, J CELL SCI, V125, P1488, DOI 10.1242/jcs.094110
   Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989
   Jensen MB, 2014, CELL METAB, V20, P214, DOI 10.1016/j.cmet.2014.05.006
   Jiang P, 2013, NATURE, V493, P689, DOI 10.1038/nature11776
   Jin SM, 2013, AUTOPHAGY, V9, P1750, DOI 10.4161/auto.26122
   Kaelin WG, 2011, COLD SH Q B, V76, P335, DOI 10.1101/sqb.2011.76.010975
   Kaplon J, 2013, NATURE, V498, P109, DOI 10.1038/nature12154
   Katajisto P, 2015, SCIENCE, V348, P340, DOI 10.1126/science.1260384
   Khrapko K, 2009, TRENDS GENET, V25, P91, DOI 10.1016/j.tig.2008.11.007
   Kosmadakis GC, 2010, NEPHRON CLIN PRACT, V115, PE7, DOI 10.1159/000286344
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893
   Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936
   Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056
   Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040
   Liu XX, 2005, GENE DEV, V19, P2424, DOI 10.1101/gad.1352905
   Liu Y, 2014, NATURE, V508, P406, DOI 10.1038/nature13204
   Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Luce K, 2009, NAT CELL BIOL, V11, P852, DOI 10.1038/ncb1893
   Macip S, 2002, EMBO J, V21, P2180, DOI 10.1093/emboj/21.9.2180
   Martinus RD, 1996, EUR J BIOCHEM, V240, P98, DOI 10.1111/j.1432-1033.1996.0098h.x
   Mathias RA, 2014, CELL, V159, P1615, DOI 10.1016/j.cell.2014.11.046
   McCormick MA, 2015, CELL METAB, V22, P895, DOI 10.1016/j.cmet.2015.09.008
   McFaline-Figueroa JR, 2011, AGING CELL, V10, P885, DOI 10.1111/j.1474-9726.2011.00731.x
   Mohrin M, 2015, SCIENCE, V347, P1374, DOI 10.1126/science.aaa2361
   Monaghan RM, 2015, NAT CELL BIOL, V17, P782, DOI 10.1038/ncb3170
   Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016
   Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980
   Nargund AM, 2015, MOL CELL, V58, P123, DOI 10.1016/j.molcel.2015.02.008
   Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560
   Norddahl GL, 2011, CELL STEM CELL, V8, P499, DOI 10.1016/j.stem.2011.03.009
   OConnor KG, 1998, J GERONTOL A-BIOL, V53, PM176, DOI 10.1093/gerona/53A.3.M176
   Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992
   Owusu-Ansah E, 2013, CELL, V155, P699, DOI 10.1016/j.cell.2013.09.021
   PACKER L, 1977, NATURE, V267, P423, DOI 10.1038/267423a0
   Palikaras K, 2015, NATURE, V521, P525, DOI 10.1038/nature14300
   Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024
   Passos JF, 2010, MOL SYST BIOL, V6, P0, DOI 10.1038/msb.2010.5
   Pellegrino MW, 2014, NATURE, V516, P414, DOI 10.1038/nature13818
   Pernas L, 2015, ANN REV PHYSL, V0, P0
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   Pickrell AM, 2015, NEURON, V87, P371, DOI 10.1016/j.neuron.2015.06.034
   Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007
   PIKO L, 1988, MECH AGEING DEV, V43, P279, DOI 10.1016/0047-6374(88)90037-1
   Pulliam DA, 2014, BIOCHEM J, V462, P359, DOI 10.1042/BJ20140291
   Quijano C, 2012, CELL CYCLE, V11, P1383, DOI 10.4161/cc.19800
   Quirós PM, 2015, NAT REV MOL CELL BIO, V16, P345, DOI 10.1038/nrm3984
   Rana A, 2013, P NATL ACAD SCI USA, V110, P8638, DOI 10.1073/pnas.1216197110
   Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106
   ROCKSTEIN M, 1963, SCIENCE, V139, P1049, DOI 10.1126/science.139.3559.1049
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Rowe GC, 2014, CIRCULATION, V129, P798, DOI 10.1161/CIRCULATIONAHA.113.001590
   Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050
   Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108
   Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787
   Sanz A, 2010, AGING-US, V2, P200, DOI 10.18632/aging.100137
   Scheibye-Knudsen M, 2014, CELL METAB, V20, P840, DOI 10.1016/j.cmet.2014.10.005
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   Schulz AM, 2015, BBA-BIOENERGETICS, V1847, P1448, DOI 10.1016/j.bbabio.2015.03.008
   Schweers RL, 2007, P NATL ACAD SCI USA, V104, P19500, DOI 10.1073/pnas.0708818104
   Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012
   Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009
   SOONG NW, 1992, NAT GENET, V2, P318
   Stein LR, 2014, EMBO J, V33, P1321, DOI 10.1002/embj.201386917
   Steiner JL, 2011, J APPL PHYSIOL, V111, P1066, DOI 10.1152/japplphysiol.00343.2011
   Stessman J, 2009, ARCH INTERN MED, V169, P1476, DOI 10.1001/archinternmed.2009.248
   Suda T, 2011, CELL STEM CELL, V9, P298, DOI 10.1016/j.stem.2011.09.010
   Sugiura A, 2014, EMBO J, V33, P2142, DOI 10.15252/embj.201488104
   Suliman HB, 2016, PHARMACOL REV, V68, P20, DOI 10.1124/pr.115.011502
   Sun N, 2015, MOL CELL, V60, P685, DOI 10.1016/j.molcel.2015.10.009
   Thomas RE, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004279
   Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Veatch JR, 2009, CELL, V137, P1247, DOI 10.1016/j.cell.2009.04.014
   Vincow ES, 2013, P NATL ACAD SCI USA, V110, P6400, DOI 10.1073/pnas.1221132110
   Wang XW, 2015, NATURE, V524, P481, DOI 10.1038/nature14859
   Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106
   West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156
   White MJ, 2014, CELL, V159, P1549, DOI 10.1016/j.cell.2014.11.036
   WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x
   Williams SL, 2010, CELL METAB, V12, P675, DOI 10.1016/j.cmet.2010.11.012
   Willis BL, 2012, ARCH INTERN MED, V172, P1333, DOI 10.1001/archinternmed.2012.3400
   Wrobel L, 2015, NATURE, V524, P485, DOI 10.1038/nature14951
   Wu CY, 2012, HUM MOL GENET, V21, P3956, DOI 10.1093/hmg/dds210
   Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163
   Wu YB, 2014, CELL, V158, P1415, DOI 10.1016/j.cell.2014.07.039
   Yang W, 2007, GENETICS, V177, P2063, DOI 10.1534/genetics.107.080788
   Yang W, 2010, PLOS BIOL, V8, P0, DOI 10.1371/journal.pbio.1000556
   Yee C, 2014, CELL, V157, P897, DOI 10.1016/j.cell.2014.02.055
   Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014
   Youm YH, 2013, CELL METAB, V18, P519, DOI 10.1016/j.cmet.2013.09.010
   Zarse K, 2012, CELL METAB, V15, P451, DOI 10.1016/j.cmet.2012.02.013
   Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780
   Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445
NR 137
TC 914
Z9 1009
U1 16
U2 272
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1097-2765
EI 1097-4164
J9 MOL CELL
JI Mol. Cell
PD MAR 3
PY 2016
VL 61
IS 5
BP 654
EP 666
DI 10.1016/j.molcel.2016.01.028
PG 13
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA DG8IJ
UT WOS:000372326800006
PM 26942670
DA 2024-11-01
ER

PT J
AU Kandul, NP
   Zhang, T
   Hay, BA
   Guo, M
AF Kandul, Nikolay P.
   Zhang, Ting
   Hay, Bruce A.
   Guo, Ming
TI Selective removal of deletion-bearing mitochondrial DNA in heteroplasmic Drosophila
SO NATURE COMMUNICATIONS
LA English
DT Article
ID skeletal-muscle; cell-growth; parkin; fusion; pink1; mtdna; dysfunction; autophagy; degradation; elimination
AB Mitochondrial DNA (mtDNA) often exists in a state of heteroplasmy, in which mutant mtDNA co-exists in cells with wild-type mtDNA. High frequencies of pathogenic mtDNA result in maternally inherited diseases; maternally and somatically acquired mutations also accumulate over time and contribute to diseases of ageing. Reducing heteroplasmy is therefore a therapeutic goal and in vivo models in post-mitotic tissues are needed to facilitate these studies. Here we describe a transgene-based model of a heteroplasmic lethal mtDNA deletion (mtDNA(Delta)) in adult Drosophila muscle. Stimulation of autophagy, activation of the PINK1/parkin pathway or decreased levels of mitofusin result in a selective decrease in mtDNA(Delta). Decreased levels of mitofusin and increased levels of ATPIF1, an inhibitor of ATP synthase reversal-dependent mitochondrial repolarization, result in a further decrease in mtDNAD levels. These results show that an adult post-mitotic tissue can be cleansed of a deleterious genome, suggesting that therapeutic removal of mutant mtDNA can be achieved.
C1 [Kandul, Nikolay P.; Hay, Bruce A.] CALTECH, Div Biol & Biol Engn, Mail Code 156-29,1200 E Calif Blvd, Pasadena, CA 91125 USA.
   [Zhang, Ting; Guo, Ming] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Brain Res Inst, Los Angeles, CA 90095 USA.
   [Zhang, Ting; Guo, Ming] Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.
C3 California Institute of Technology; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA
RP Hay, BA (corresponding author), CALTECH, Div Biol & Biol Engn, Mail Code 156-29,1200 E Calif Blvd, Pasadena, CA 91125 USA.; Guo, M (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Brain Res Inst, Los Angeles, CA 90095 USA.; Guo, M (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.
EM haybruce@caltech.edu; mingfly@ucla.edu
FU Alcott Postdoctoral Fellowship; Ellison Medical Foundation Senior Scholar Award; National Institute of Health [NIA R01]; National Institute of Health (NINDS EUREKA award); Kenneth Glenn Family Foundation; Natalie R. and Eugene S. Jones Fund in Aging and Neurodegenerative Disease Research
CR Atwal KS, 2004, J MED CHEM, V47, P1081, DOI 10.1021/jm030291x
   Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261
   Bayona-Bafaluy MP, 2005, P NATL ACAD SCI USA, V102, P14392, DOI 10.1073/pnas.0502896102
   BENZER S, 1973, SCI AM, V229, P24, DOI 10.1038/scientificamerican1273-24
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529
   Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048
   Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779
   Dai Y, 2014, HUM MOL GENET, V23, P637, DOI 10.1093/hmg/ddt450
   Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105
   Eisner V, 2014, J CELL BIOL, V205, P179, DOI 10.1083/jcb.201312066
   Feng YC, 2015, TRENDS CELL BIOL, V25, P354, DOI 10.1016/j.tcb.2015.02.002
   Gammage PA, 2014, EMBO MOL MED, V6, P458, DOI 10.1002/emmm.201303672
   Gilkerson RW, 2012, HUM MOL GENET, V21, P978, DOI 10.1093/hmg/ddr529
   Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100
   Guo M, 2012, CSH PERSPECT MED, V2, P0, DOI 10.1101/cshperspect.a009944
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   Hill JH, 2014, NAT GENET, V46, P389, DOI 10.1038/ng.2920
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Ivanes F, 2014, BRIT J PHARMACOL, V171, P4193, DOI 10.1111/bph.12638
   Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146
   Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Kukat C, 2015, P NATL ACAD SCI USA, V112, P11288, DOI 10.1073/pnas.1512131112
   Lane RK, 2015, BBA-BIOENERGETICS, V1847, P1387, DOI 10.1016/j.bbabio.2015.05.021
   Larsson C, 2004, NAT METHODS, V1, P227, DOI 10.1038/NMETH723
   Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893
   Lee SB, 2015, MOL CELL, V60, P21, DOI 10.1016/j.molcel.2015.08.011
   Lefebvre V, 2013, AUTOPHAGY, V9, P1770, DOI 10.4161/auto.25413
   Liau WS, 2007, BMC GENET, V8, P0, DOI 10.1186/1471-2156-8-8
   Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   Ma HS, 2014, NAT GENET, V46, P393, DOI 10.1038/ng.2919
   Manzanillo PS, 2013, NATURE, V501, P512, DOI 10.1038/nature12566
   Matic I, 2016, PHARMACOL RES, V103, P56, DOI 10.1016/j.phrs.2015.10.010
   MATSUURA ET, 1989, GENETICS, V122, P663
   Minczuk M, 2008, NUCLEIC ACIDS RES, V36, P3926, DOI 10.1093/nar/gkn313
   Mouli PK, 2009, BIOPHYS J, V96, P3509, DOI 10.1016/j.bpj.2008.12.3959
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Narendra DP, 2010, PLOS BIOL, V8, P0, DOI 10.1371/journal.pbio.1000298
   Neufeld TP, 2012, J CELL SCI, V125, P2359, DOI 10.1242/jcs.103333
   Nezis IP, 2009, AUTOPHAGY, V5, P298, DOI 10.4161/auto.5.3.7454
   Noda NN, 2015, CELL MOL LIFE SCI, V72, P3083, DOI 10.1007/s00018-015-1917-z
   Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788
   Patel PK, 2013, PLOS COMPUT BIOL, V9, P0, DOI 10.1371/journal.pcbi.1003108
   Payne BAI, 2015, BBA-BIOENERGETICS, V1847, P1347, DOI 10.1016/j.bbabio.2015.05.022
   Pesah Y, 2004, DEVELOPMENT, V131, P2183, DOI 10.1242/dev.01095
   Pickrell AM, 2015, NEURON, V87, P371, DOI 10.1016/j.neuron.2015.06.034
   Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105
   Poole AC, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0010054
   Rebolledo-Jaramillo B, 2014, P NATL ACAD SCI USA, V111, P15474, DOI 10.1073/pnas.1409328111
   Reddy P, 2015, CELL, V161, P459, DOI 10.1016/j.cell.2015.03.051
   Rodriguez AD, 2012, NAT METHODS, V9, P47, DOI 10.1038/nmeth.1800
   Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043
   Scarffe LA, 2014, TRENDS NEUROSCI, V37, P315, DOI 10.1016/j.tins.2014.03.004
   Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053
   Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107
   Tam ZY, 2015, PLOS COMPUT BIOL, V11, P0, DOI 10.1371/journal.pcbi.1004183
   Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013
   Tanaka M, 2002, J BIOMED SCI, V9, P534, DOI 10.1007/BF02254980
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Valenci I, 2015, MITOCHONDRION, V20, P64, DOI 10.1016/j.mito.2014.11.001
   Vincow ES, 2013, P NATL ACAD SCI USA, V110, P6400, DOI 10.1073/pnas.1221132110
   WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a021220
   Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103
   Ye KX, 2014, P NATL ACAD SCI USA, V111, P10654, DOI 10.1073/pnas.1403521111
   Yun JN, 2014, ELIFE, V3, P0, DOI 10.7554/eLife.01958
   Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107
NR 70
TC 94
Z9 107
U1 0
U2 17
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 
EI 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD NOV 14
PY 2016
VL 7
IS 
BP 
EP 
DI 10.1038/ncomms13100
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EB7HR
UT WOS:000387558100001
PM 27841259
DA 2024-11-01
ER

PT J
AU Varma, H
   Faust, PL
   Iglesias, AD
   Lagana, SM
   Wou, K
   Hirano, M
   DiMauro, S
   Mansukani, MM
   Hoff, KE
   Nagy, PL
   Copeland, WC
   Naini, AB
AF Varma, Hemant
   Faust, Phyllis L.
   Iglesias, Alejandro D.
   Lagana, Stephen M.
   Wou, Karen
   Hirano, Michio
   DiMauro, Salvatore
   Mansukani, Mahesh M.
   Hoff, Kirsten E.
   Nagy, Peter L.
   Copeland, William C.
   Naini, Ali B.
TI Whole exome sequencing identifies a homozygous <i>POLG2</i> missense variant in an infant with fulminant hepatic failure and mitochondrial DNA depletion
SO EUROPEAN JOURNAL OF MEDICAL GENETICS
LA English
DT Article
DE Mitochondrial DNA depletion; POLG2; Hepatic failure; Whole-exome sequencing; POLG
ID polymerase gamma; accessory subunit; disease
AB Mitochondrial DNA (mtDNA) depletion syndrome manifests as diverse early-onset diseases that affect skeletal muscle, brain and liver function. Mutations in several nuclear DNA-encoded genes cause mtDNA depletion. We report on a patient, a 3-month-old boy who presented with hepatic failure, and was found to have severe mtDNA depletion in liver and muscle. Whole-exome sequencing identified a homozygous missense variant (c.544C > T, p.R182W) in the accessory subunit of mitochondrial DNA polymerase gamma (POLG2), which is required for mitochondrial DNA replication. This variant is predicted to disrupt a critical region needed for homodimerization of the POLG2 protein and cause loss of processive DNA synthesis. Both parents were phenotypically normal and heterozygous for this variant. Heterozygous mutations in POLG2 were previously associated with progressive external ophthalmoplegia and mtDNA deletions. This is the first report of a patient with a homozygous mutation in POLG2 and with a clinical presentation of severe hepatic failure and mitochondrial depletion. (C) 2016 Elsevier Masson SAS. All rights reserved.
C1 [Varma, Hemant; Faust, Phyllis L.; Lagana, Stephen M.; Mansukani, Mahesh M.; Nagy, Peter L.; Naini, Ali B.] Columbia Univ, Dept Pathol & Cell Biol, 630 W,168th St, New York, NY 10032 USA.
   [Iglesias, Alejandro D.] Columbia Univ, Div Med Genet, New York Presbyterian Hosp, New York, NY 10027 USA.
   [Wou, Karen] New York Presbyterian Hosp, Div Genet, New York, NY USA.
   [Hirano, Michio; DiMauro, Salvatore] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10027 USA.
   [Mansukani, Mahesh M.; Nagy, Peter L.; Naini, Ali B.] Columbia Univ, Med Ctr, Div Personalized Genom Med, Dept Pathol & Cell Biol, New York, NY 10027 USA.
   [Hoff, Kirsten E.; Copeland, William C.] NIEHS, Genome Integr & Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA.
C3 Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Columbia University; Columbia University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)
RP Copeland, WC (corresponding author), NIEHS, Genome Integr & Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA.; Naini, AB (corresponding author), 630 W 168th St,P&S 17-401, New York, NY 10032 USA.
EM copelan1@niehs.nih.gov; abn2@cumc.columbia.edu
FU National Institutes of Health [5P01 HD080642-02 NIH/NICHD]; Intramural Research Program of the NIH, National Institute of Environmental Health Sciences [ES 065078]
CR Bourgeois JM, 2004, MITOCHONDRION, V4, P441, DOI 10.1016/j.mito.2004.07.036
   Carrodeguas JA, 2001, MOL CELL, V7, P43, DOI 10.1016/S1097-2765(01)00153-8
   Copeland WC, 2014, J CHILD NEUROL, V29, P1216, DOI 10.1177/0883073814537380
   Cossarizza A, 2003, ANTIVIR THER, V8, P315
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Fan L, 2006, J MOL BIOL, V358, P1229, DOI 10.1016/j.jmb.2006.02.073
   Finsterer J, 2013, CAN J NEUROL SCI, V40, P635, DOI 10.1017/S0317167100014852
   Humble MM, 2013, HUM MOL GENET, V22, P1017, DOI 10.1093/hmg/dds506
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Mandel H, 2001, HEPATOLOGY, V34, P776, DOI 10.1053/jhep.2001.27664
   Oliveira MT, 2015, GENOME BIOL EVOL, V7, P943, DOI 10.1093/gbe/evv042
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Poulton Joanna, 2009, NEUROMUSCUL DISORD, V19, P439, DOI 10.1016/j.nmd.2009.04.009
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Tanji K, 2001, METHOD CELL BIOL, V65, P311, DOI 10.1016/S0091-679X(01)65019-2
   Walter MC, 2010, J NEUROL, V257, P1517, DOI 10.1007/s00415-010-5565-9
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Young MJ, 2015, HUM MOL GENET, V24, P5184, DOI 10.1093/hmg/ddv240
   Young MJ, 2011, HUM MOL GENET, V20, P3052, DOI 10.1093/hmg/ddr209
   Young MJ, 2013, MITOCHONDRIAL DISORD, V0, PP49, DOI 10.1007/978-1-4614-3722-2_3
NR 21
TC 19
Z9 21
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1769-7212
EI 1878-0849
J9 EUR J MED GENET
JI Eur. J. Med. Genet.
PD OCT 15
PY 2016
VL 59
IS 10
BP 540
EP 545
DI 10.1016/j.ejmg.2016.08.012
PG 6
WC Genetics & Heredity
SC Genetics & Heredity
GA EC6YS
UT WOS:000388283200011
PM 27592148
DA 2024-11-01
ER

PT J
AU Bennett, B
   Helbling, D
   Meng, H
   Jarzembowski, J
   Geurts, AM
   Friederich, MW
   Van Hove, JLK
   Lawlor, MW
   Dimmock, DP
AF Bennett, Brian
   Helbling, Daniel
   Meng, Hui
   Jarzembowski, Jason
   Geurts, Aron M.
   Friederich, Marisa W.
   Van Hove, Johan L. K.
   Lawlor, Michael W.
   Dimmock, David P.
TI Potentially diagnostic electron paramagnetic resonance spectra elucidate the underlying mechanism of mitochondrial dysfunction in the deoxyguanosine kinase deficient rat model of a genetic mitochondrial DNA depletion syndrome
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
DE DGUOK; Redox; Oxidative; Stress; mtDNA depletion; Pathology; EPR; ESR
ID oxidoreductase complex-i; iron-sulfur clusters; cytochrome-c-oxidase; comparative genomic hybridization; nadh-ubiquinone oxidoreductase; respiratory-chain disorders; liver-failure; quinone oxidoreductase; escherichia-coli; skeletal-muscle
AB A novel rat model for a well-characterized human mitochondrial disease, mitochondrial DNA depletion syndrome with associated deoxyguanosine kinase (DGUOK) deficiency, is described. The rat model recapitulates the pathologic and biochemical signatures of the human disease. The application of electron paramagnetic (spin) resonance (EPR) spectroscopy to the identification and characterization of respiratory chain abnormalities in the mitochondria from freshly frozen tissue of the mitochondrial disease model rat is introduced. EPR is shown to be a sensitive technique for detecting mitochondrial functional abnormalities in situ and, here, is particularly useful in characterizing the redox state changes and oxidative stress that can result from depressed expression and/or diminished specific activity of the distinct respiratory chain complexes. As EPR requires no sample preparation or non-physiological reagents, it provides information on the status of the mitochondrion as it was in the functioning state. On its own, this information is of use in identifying respiratory chain dysfunction; in conjunction with other techniques, the information from EPR shows how the respiratory chain is affected at the molecular level by the dysfunction. It is proposed that EPR has a role in mechanistic pathophysiological studies of mitochondrial disease and could be used to study the impact of new treatment modalities or as an additional diagnostic tool. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Bennett, Brian] Med Coll Wisconsin, Dept Biophys, Natl Biomed EPR Ctr, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.
   [Helbling, Daniel; Dimmock, David P.] Med Coll Wisconsin, Dept Pediat, Human Mol Genet Ctr, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.
   [Helbling, Daniel; Dimmock, David P.] Med Coll Wisconsin, Dept Pediat, Div Genet, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.
   [Meng, Hui; Jarzembowski, Jason; Lawlor, Michael W.] Med Coll Wisconsin, Dept Pathol & Lab Med, Div Pediat Pathol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.
   [Geurts, Aron M.] Med Coll Wisconsin, Dept Physiol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.
   [Friederich, Marisa W.; Van Hove, Johan L. K.] Univ Colorado, Clin Genet & Metab, Dept Pediat, Mailstop 8400,13121 East 17th Ave, Aurora, CO 80045 USA.
   [Bennett, Brian] Marquette Univ, Dept Phys, 540 N 15th St, Milwaukee, WI 53233 USA.
C3 Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; University of Colorado System; University of Colorado Anschutz Medical Campus; Marquette University
RP Dimmock, DP (corresponding author), Med Coll Wisconsin, Dept Pediat, Human Mol Genet Ctr, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.; Dimmock, DP (corresponding author), Med Coll Wisconsin, Dept Pediat, Div Genet, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.
EM brian.bennett@mu.edu; dhelbling@mcw.edu; hmeng@mcw.edu; jjarzemb@mcw.edu; ageurts@mcw.edu; Marisa.Friederich@ucdenver.edu; johan.vanhove@childrenscolorado.org; mlawlor@mcw.edu; ddimmock@mcw.edu
FU Children's Hospital of Wisconsin: Children's Research Institute;  [P41EB001980]
CR AASA R, 1976, BIOCHIM BIOPHYS ACTA, V422, P260, DOI 10.1016/0005-2744(76)90137-6
   Abramovich CM, 2001, HUM PATHOL, V32, P649, DOI 10.1053/hupa.2001.24995
   BEINERT H, 1975, EUR J BIOCHEM, V54, P185, DOI 10.1111/j.1432-1033.1975.tb04128.x
   Beinert H, 1978, METHODS ENZYMOL, V54, P133
   Berardo A, 2010, CURR NEUROL NEUROSCI, V10, P118, DOI 10.1007/s11910-010-0096-4
   BINDOFF LA, 1991, J NEUROL SCI, V102, P17, DOI 10.1016/0022-510X(91)90088-O
   Bleier L, 2013, BBA-BIOENERGETICS, V1827, P1320, DOI 10.1016/j.bbabio.2012.12.002
   Borchert Astrid, 2002, SEMIN PEDIATR NEUROL, V9, P151, DOI 10.1053/spen.2002.33800
   Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162
   Brealey D, 2002, LANCET, V360, P219, DOI 10.1016/S0140-6736(02)09459-X
   Buchaklian AH, 2012, MOL GENET METAB, V107, P92, DOI 10.1016/j.ymgme.2012.04.019
   Carelli V, 2013, CURR OPIN NEUROL, V26, P52, DOI 10.1097/WCO.0b013e32835c5f0b
   Chandran K, 2009, BIOPHYS J, V96, P1388, DOI 10.1016/j.bpj.2008.10.042
   Chinnery PF, 1993, GENEREVIEWS, V0, P0
   Chitkara DK, 2003, AM J GASTROENTEROL, V98, P871, DOI 10.1016/S0002-0270(03)00049-2
   Chow C W, 2000, HUM REPROD, V15 Suppl 2, P68
   Collins J, 2009, NEUROMUSCULAR DISORD, V19, P784, DOI 10.1016/j.nmd.2009.08.002
   COOPER CE, 1991, BIOCHEM SOC T, V19, PS259, DOI 10.1042/bst019259s
   Craig AK, 2012, SEIZURE-EUR J EPILEP, V21, P17, DOI 10.1016/j.seizure.2011.08.010
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   Darras BT, 2000, PEDIATR NEUROL, V22, P87, DOI 10.1016/S0887-8994(99)00133-2
   De Camaret BM, 2007, BIOCHEM J, V402, P377, DOI 10.1042/BJ20060705
   DIMAURO S, 1990, PEDIATR RES, V28, P536, DOI 10.1203/00006450-199011000-00025
   Dimmock DP, 2008, HUM MUTAT, V29, P330, DOI 10.1002/humu.9519
   Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549
   Dimmock DP, 2008, LIVER TRANSPLANT, V14, P1480, DOI 10.1002/lt.21556
   Driessen J, 2007, PEDIATR ANESTH, V17, P16, DOI 10.1111/j.1460-9592.2006.02043.x
   EDWARDS RHT, 1983, MUSCLE NERVE, V6, P676, DOI 10.1002/mus.880060910
   FECKE W, 1994, EUR J BIOCHEM, V220, P551, DOI 10.1111/j.1432-1033.1994.tb18655.x
   FIGARELLABRANGER D, 1992, J NEUROL SCI, V108, P105, DOI 10.1016/0022-510X(92)90195-Q
   FINEL M, 1994, EUR J BIOCHEM, V226, P237, DOI 10.1111/j.1432-1033.1994.tb20046.x
   Fodale V, 2008, DRUG SAFETY, V31, P293, DOI 10.2165/00002018-200831040-00003
   Footitt EJ, 2008, BRIT J ANAESTH, V100, P436, DOI 10.1093/bja/aen014
   Friedman SD, 2010, DEV DISABIL RES REV, V16, P129, DOI 10.1002/ddrr.103
   Gellerich FN, 2004, MITOCHONDRION, V4, P427, DOI 10.1016/j.mito.2004.07.007
   Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447
   Ghosh A, 2010, FREE RADICAL BIO MED, V49, P1674, DOI 10.1016/j.freeradbiomed.2010.08.028
   Goh V, 2012, J PEDIATR GASTR NUTR, V54, P291, DOI 10.1097/MPG.0b013e318227e53c
   Goodfellow JA, 2012, POSTGRAD MED J, V88, P326, DOI 10.1136/postgradmedj-2011-130326
   Gordon N, 2006, DEV MED CHILD NEUROL, V48, P1001, DOI 10.1017/S0012162206002209
   Gropman A L, 2001, CURR NEUROL NEUROSCI REP, V1, P185
   Gropman AL, 2012, NEUROTHERAPEUTICS, V0, P0
   Gulati Sheffali, 2003, INDIAN JOURNAL OF PEDIATRICS, V70, P317, DOI 10.1007/BF02723588
   Gurrieri C, 2011, CAN J ANESTH, V58, P751, DOI 10.1007/s12630-011-9528-0
   Haas RH, 2007, PEDIATRICS, V120, P1326, DOI 10.1542/peds.2007-0391
   Haddy A, 1999, COMP BIOCHEM PHYS B, V123, P407, DOI 10.1016/S0305-0491(99)00087-5
   Hadzsiev K, 2010, NEUROMOL MED, V12, P277, DOI 10.1007/s12017-010-8115-9
   Hanson GR, 2004, J INORG BIOCHEM, V98, P903, DOI 10.1016/j.jinorgbio.2004.02.003
   Hanson GR, 2003, PROG T CHEM, V10, P197
   HARDING AE, 1989, BRIT MED BULL, V45, P760, DOI 10.1093/oxfordjournals.bmb.a072356
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Jacob HJ, 2010, TRENDS GENET, V26, P510, DOI 10.1016/j.tig.2010.08.006
   Ji JQ, 2010, MITOCHONDRION, V10, P188, DOI 10.1016/j.mito.2009.11.002
   Katzberg H, 2010, J CHILD NEUROL, V25, P1382, DOI 10.1177/0883073810367683
   Kendrick AA, 2011, BIOCHEM J, V433, P505, DOI 10.1042/BJ20100791
   Kennedy MC, 1997, J BIOL CHEM, V272, P20340, DOI 10.1074/jbc.272.33.20340
   Khurana DS, 2008, NEUROPEDIATRICS, V39, P8, DOI 10.1055/s-2008-1076737
   Kirby DM, 1999, NEUROLOGY, V52, P1255, DOI 10.1212/WNL.52.6.1255
   Kyriacou K, 2006, JOURNAL OF SUBMICROSCOPIC CYTOLOGY AND PATHOLOGY, V38, P201
   Lawlor MW, 2011, AM J PATHOL, V178, P784, DOI 10.1016/j.ajpath.2010.10.035
   Lee NC, 2009, ARCH DIS CHILD, V94, P55, DOI 10.1136/adc.2008.139584
   Lesnefsky EJ, 2001, ARCH BIOCHEM BIOPHYS, V385, P117, DOI 10.1006/abbi.2000.2066
   Longo N, 2003, NEUROL CLIN, V21, P817, DOI 10.1016/S0733-8619(03)00015-X
   Lutz RE, 2009, J PEDIATR GASTR NUTR, V49, P126, DOI 10.1097/MPG.0b013e31817d9cad
   MAILER C, 1973, BIOCHIM BIOPHYS ACTA, V322, P195, DOI 10.1016/0005-2795(73)90293-6
   Maly T, 2009, BBA-BIOENERGETICS, V1787, P584, DOI 10.1016/j.bbabio.2009.02.003
   Mari M, 2012, BIOCH BIOPHYS ACTA, V0, P0
   MAZZIOTTA MRM, 1992, J PEDIATR-US, V121, P896, DOI 10.1016/S0022-3476(05)80335-X
   McCormick E, 2012, NEUROTHERAPEUTICS, V0, P0
   McDonald DGM, 2002, AM J MED GENET, V111, P191, DOI 10.1002/ajmg.10522
   McFarland R, 2008, ARCH DIS CHILD, V93, P151, DOI 10.1136/adc.2007.122911
   Menezes MP, 2012, DEV MED CHILD NEUROL, V54, P407, DOI 10.1111/j.1469-8749.2012.04271.x
   Micaglio G, 1987, RIV NEUROL, V57, P261
   Mills DA, 2008, BIOCHEMISTRY-US, V47, P11499, DOI 10.1021/bi801156s
   Mohri I, 1998, J NEUROL SCI, V158, P106, DOI 10.1016/S0022-510X(98)00082-3
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Morris AAM, 1998, J HEPATOL, V28, P556, DOI 10.1016/S0168-8278(98)80278-X
   Morris AAM, 1999, LIVER, V19, P357, DOI 10.1111/j.1478-3231.1999.tb00063.x
   Myers CR, 2010, FREE RADICAL BIO MED, V49, P1903, DOI 10.1016/j.freeradbiomed.2010.09.020
   Nakamaru-Ogiso E, 2008, J BIOL CHEM, V283, P25979, DOI 10.1074/jbc.M804015200
   OHIRA Y, 1982, BRIT J HAEMATOL, V52, P623, DOI 10.1111/j.1365-2141.1982.tb03938.x
   Ohnishi T, 2008, BBA-BIOENERGETICS, V1777, P703, DOI 10.1016/j.bbabio.2008.04.032
   Oldfors A, 2003, J NEUROPATH EXP NEUR, V62, P217, DOI 10.1093/jnen/62.3.217
   Papaioannou V, 2008, ACTA ANAESTH BELG, V59, P79
   Parikh S, 2014, MITOCHONDRION, V14, P26, DOI 10.1016/j.mito.2013.07.116
   Pearce LL, 2009, NITRIC OXIDE-BIOL CH, V20, P135, DOI 10.1016/j.niox.2008.12.001
   Procaccio V, 2004, NEUROLOGY, V62, P1899, DOI 10.1212/01.WNL.0000125251.56131.65
   Rahman S, 2009, ARCH DIS CHILD, V94, P3, DOI 10.1136/adc.2008.147983
   RICCI E, 1992, BRAIN PATHOL, V2, P141, DOI 10.1111/j.1750-3639.1992.tb00682.x
   Rötig A, 2004, BBA-BIOENERGETICS, V1659, P129, DOI 10.1016/j.bbabio.2004.07.007
   RYLKOV VV, 1991, EUR J BIOCHEM, V197, P185, DOI 10.1111/j.1432-1033.1991.tb15897.x
   Sakushima K, 2011, NEUROLOGIST, V17, P222, DOI 10.1097/NRL.0b013e318217357a
   SALERNO JC, 1980, BIOCHEM J, V192, P769, DOI 10.1042/bj1920769
   SALERNO JC, 1984, J AM CHEM SOC, V106, P2156, DOI 10.1021/ja00319a041
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Scaglia F, 2010, DEV DISABIL RES REV, V16, P136, DOI 10.1002/ddrr.115
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Schrier SA, 2011, CURR OPIN OPHTHALMOL, V22, P325, DOI 10.1097/ICU.0b013e328349419d
   Sharma A, 2013, P NATL ACAD SCI USA, V110, P5945, DOI 10.1073/pnas.1303376110
   Shergill JK, 1996, BIOCHEM BIOPH RES CO, V228, P298, DOI 10.1006/bbrc.1996.1656
   SHERGILL JK, 1991, BIOCHEM SOC T, V19, PS256, DOI 10.1042/bst019256s
   Skladal D, 2003, CLIN PEDIATR, V42, P703, DOI 10.1177/000992280304200806
   Smet J, 2011, J INHERIT METAB DIS, V34, P741, DOI 10.1007/s10545-011-9315-7
   Smet J, 2009, ELECTROPHORESIS, V30, P3565, DOI 10.1002/elps.200900213
   Spinazzi M, 2011, MITOCHONDRION, V11, P893, DOI 10.1016/j.mito.2011.07.006
   Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025
   Suomalainen A, 2011, J INHERIT METAB DIS, V34, P277, DOI 10.1007/s10545-010-9222-3
   Svistunenko DA, 2006, BBA-BIOENERGETICS, V1757, P262, DOI 10.1016/j.bbabio.2006.03.007
   Tatke Medha, 2007, INDIAN J PATHOL MICROBIOL, V50, P467
   Thorburn DR, 2004, BBA-BIOENERGETICS, V1659, P121, DOI 10.1016/j.bbabio.2004.08.006
   Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55
   TORII K, 1970, J BIOCHEM-TOKYO, V68, P837, DOI 10.1093/oxfordjournals.jbchem.a129421
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Vallance H, 2004, PEDIATR DEVEL PATHOL, V7, P633, DOI 10.1007/s10024-004-5053-2
   Van Coster R, 2001, PEDIATR RES, V50, P658, DOI 10.1203/00006450-200111000-00020
   VANEKEREN GJ, 1993, EUR J PEDIATR, V152, P255, DOI 10.1007/BF01956157
   Venegas V, 2011, CURR PROTOC HUM GENE, V17, P0
   Vu TH, 2002, NEUROL CLIN, V20, P809, DOI 10.1016/S0733-8619(01)00017-2
   WALLACE DC, 1995, BBA-MOL BASIS DIS, V1271, P141, DOI 10.1016/0925-4439(95)00021-U
   Weil JA, 1994, ELECT PARAMAGNETIC R, V0, P568
   Wells GD, 2008, CAN J NEUROL SCI, V35, P31, DOI 10.1017/S0317167100007538
   Whitworth JR, 2006, J PEDIATR GASTR NUTR, V43, P536, DOI 10.1097/01.mpg.0000232332.00677.3d
   WILLIAMSSMITH DL, 1984, BRIT J CANCER, V50, P399, DOI 10.1038/bjc.1984.189
   Wojtovich AP, 2013, BIOCH BIOPHYS ACTA, V0, P0
   Wong LJC, 2008, CLIN CHEM, V54, P1141, DOI 10.1373/clinchem.2008.103721
   Wray CD, 2013, MITOCHONDRION, V13, P656, DOI 10.1016/j.mito.2013.09.004
   Yakovlev G, 2007, P NATL ACAD SCI USA, V104, P12720, DOI 10.1073/pnas.0705593104
   YANG AS, 1987, BIOPHYS J, V51, P55, DOI 10.1016/S0006-3495(87)83311-8
NR 129
TC 13
Z9 15
U1 0
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0891-5849
EI 1873-4596
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD MAR 15
PY 2016
VL 92
IS 
BP 141
EP 151
DI 10.1016/j.freeradbiomed.2016.01.001
PG 11
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA DE5BJ
UT WOS:000370645400012
PM 26773591
DA 2024-11-01
ER

PT J
AU Akunuru, S
   Geiger, H
AF Akunuru, Shailaja
   Geiger, Hartmut
TI Aging, Clonality, and Rejuvenation of Hematopoietic Stem Cells
SO TRENDS IN MOLECULAR MEDICINE
LA English
DT Review
ID age-related-changes; mitochondrial-dna mutations; in-vivo; oxidative stress; senescent cells; skeletal-muscle; self-renewal; bone-marrow; life-span; damage
AB Aging is associated with reduced organ function and increased disease incidence. Hematopoietic stem cell (HSC) aging driven by both cell intrinsic and extrinsic factors is linked to impaired HSC self-renewal and regeneration, aging associated immune remodeling, and increased leukemia incidence. Compromised DNA damage responses and the increased production of reactive oxygen species (ROS) have been previously causatively attributed to HSC aging. However, recent paradigm-shifting concepts, such as global epigenetic and cytoskeletal polarity shifts, cellular senescence, as well as the clonal selection of HSCs upon aging, provide new insights into HSC aging mechanisms. Rejuvenating agents that can reprogram the epigenetic status of aged HSCs or senolytic drugs that selectively deplete senescent cells provide promising translational avenues for attenuating hematopoietic aging and, potentially, alleviating aging-associated immune remodeling and myeloid malignancies.
C1 [Akunuru, Shailaja; Geiger, Hartmut] Cincinnati Childrens Res Fdn, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA.
   [Geiger, Hartmut] Univ Ulm, Inst Mol Med, D-89081 Ulm, Germany.
   [Geiger, Hartmut] Univ Ulm, Aging Res Ctr, D-89081 Ulm, Germany.
C3 Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Ulm University; Ulm University
RP Akunuru, S; Geiger, H (corresponding author), Cincinnati Childrens Res Fdn, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA.; Geiger, H (corresponding author), Univ Ulm, Inst Mol Med, D-89081 Ulm, Germany.; Geiger, H (corresponding author), Univ Ulm, Aging Res Ctr, D-89081 Ulm, Germany.
EM Shailaja.Akunuru@cchmc.org; hartmut.geiger@cchmc.org
FU Edward P. Evans foundation [T32CA117846-06A1]; NIH [HL076604, DK077762, AG040118]; DFG [SFB 1074, 1149]; BMBF; Excellence program of the Baden-Wurttemberg Foundation; European Commission (FP7 Marie Curie Initial Training Network MARRIAGE)
CR Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932
   Beerman I, 2014, CELL STEM CELL, V15, P37, DOI 10.1016/j.stem.2014.04.016
   Beerman I, 2013, CELL STEM CELL, V12, P413, DOI 10.1016/j.stem.2013.01.017
   Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107
   Behrens A, 2014, NAT CELL BIOL, V16, P201, DOI 10.1038/ncb2928
   Bernet JD, 2014, NAT MED, V20, P265, DOI 10.1038/nm.3465
   Biteau B, 2010, PLOS GENET, V6, P0, DOI 10.1371/journal.pgen.1001159
   Brown K, 2013, CELL REP, V3, P319, DOI 10.1016/j.celrep.2013.01.005
   Busch K, 2015, NATURE, V518, P542, DOI 10.1038/nature14242
   Busque L, 1996, BLOOD, V88, P59
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201
   Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010
   Chen C, 2009, SCI SIGNAL, V2, P0, DOI 10.1126/scisignal.2000559
   Chen JC, 1999, EXP HEMATOL, V27, P928, DOI 10.1016/S0301-472X(99)00018-1
   Cheng CW, 2014, CELL STEM CELL, V14, P810, DOI 10.1016/j.stem.2014.04.014
   Choi NH, 2008, AGING CELL, V7, P318, DOI 10.1111/j.1474-9726.2008.00380.x
   Collins CA, 2007, STEM CELLS, V25, P885, DOI 10.1634/stemcells.2006-0372
   Cosgrove BD, 2014, NAT MED, V20, P255, DOI 10.1038/nm.3464
   de Haan G, 1999, BLOOD, V93, P3294, DOI 10.1182/blood.V93.10.3294.410k07_3294_3301
   deHaan G, 1997, BLOOD, V89, P1543, DOI 10.1182/blood.V89.5.1543.1543_1543_1550
   Dorshkind K, 2009, NAT REV IMMUNOL, V9, P57, DOI 10.1038/nri2471
   Dykstra B, 2011, J EXP MED, V208, P2691, DOI 10.1084/jem.20111490
   Ergen AV, 2012, BLOOD, V119, P2500, DOI 10.1182/blood-2011-11-391730
   Flach J, 2014, NATURE, V512, P198, DOI 10.1038/nature13619
   Florian MC, 2013, NATURE, V503, P392, DOI 10.1038/nature12631
   Florian MC, 2012, CELL STEM CELL, V10, P520, DOI 10.1016/j.stem.2012.04.007
   Geiger H, 2005, P NATL ACAD SCI USA, V102, P5102, DOI 10.1073/pnas.0408654102
   Geiger H, 2001, BLOOD, V98, P2966, DOI 10.1182/blood.V98.10.2966
   Geiger H, 2009, TRENDS IMMUNOL, V30, P360, DOI 10.1016/j.it.2009.03.010
   Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405
   Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700
   Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HARRISON DE, 1989, J IMMUNOL, V142, P3833
   Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617
   Kamminga LM, 2005, STEM CELLS, V23, P82, DOI 10.1634/stemcells.2004-0066
   Kang EJ, 2016, CELL STEM CELL, V18, P625, DOI 10.1016/j.stem.2016.02.005
   Kollman C, 2001, BLOOD, V98, P2043, DOI 10.1182/blood.V98.7.2043
   Koubova J, 2003, GENE DEV, V17, P313, DOI 10.1101/gad.1052903
   Kuhn HG, 1996, J NEUROSCI, V16, P2027
   Kuranda K, 2011, AGING CELL, V10, P542, DOI 10.1111/j.1474-9726.2011.00675.x
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Liang FQ, 2003, EXP EYE RES, V76, P397, DOI 10.1016/S0014-4835(03)00023-X
   Liang Y, 2005, BLOOD, V106, P1479, DOI 10.1182/blood-2004-11-4282
   Maslov AY, 2004, J NEUROSCI, V24, P1726, DOI 10.1523/JNEUROSCI.4608-03.2004
   McKerrell T, 2015, CELL REP, V10, P1239, DOI 10.1016/j.celrep.2015.02.005
   Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001
   Moehrle BM, 2015, CELL REP, V13, P2412, DOI 10.1016/j.celrep.2015.11.030
   Mohrin M, 2015, SCIENCE, V347, P1374, DOI 10.1126/science.aaa2361
   Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014
   Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011
   Naka K, 2008, ANTIOXID REDOX SIGN, V10, P1883, DOI 10.1089/ars.2008.2114
   Navarro S, 2006, MOL THER, V14, P525, DOI 10.1016/j.ymthe.2006.05.018
   Nibley WE, 1998, BONE MARROW TRANSPL, V21, P345, DOI 10.1038/sj.bmt.1701097
   Norddahl GL, 2011, CELL STEM CELL, V8, P499, DOI 10.1016/j.stem.2011.03.009
   Pang WW, 2011, P NATL ACAD SCI USA, V108, P20012, DOI 10.1073/pnas.1116110108
   Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862
   Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102
   Rozhok AI, 2014, AGING-US, V6, P1033, DOI 10.18632/aging.100707
   Satoh Y, 2013, IMMUNITY, V38, P1105, DOI 10.1016/j.immuni.2013.05.014
   Scott LJ, 2016, DRUGS, V76, P889, DOI 10.1007/s40265-016-0585-0
   Sharpless NE, 2015, NAT REV CANCER, V15, P397, DOI 10.1038/nrc3960
   Signer RAJ, 2007, BLOOD, V110, P1831, DOI 10.1182/blood-2007-01-069401
   Smith BD, 2009, J CLIN ONCOL, V27, P2758, DOI 10.1200/JCO.2008.20.8983
   SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810
   Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273
   Sun DQ, 2014, CELL STEM CELL, V14, P673, DOI 10.1016/j.stem.2014.03.002
   Sun JL, 2014, NATURE, V514, P322, DOI 10.1038/nature13824
   Taiwo O, 2013, EPIGENETICS-US, V8, P1114, DOI 10.4161/epi.26017
   Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003
   van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193
   Vas V, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0042080
   Vas V, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0031523
   Verovskaya E, 2013, BLOOD, V122, P523, DOI 10.1182/blood-2013-01-481135
   Wahlestedt M, 2013, BLOOD, V121, P4257, DOI 10.1182/blood-2012-11-469080
   Xing ZL, 2006, BLOOD, V108, P2190, DOI 10.1182/blood-2005-12-010272
   Yancik R, 2005, CANCER J, V11, P437, DOI 10.1097/00130404-200511000-00002
   YANCOPOULOS GD, 1984, NATURE, V311, P727, DOI 10.1038/311727a0
NR 79
TC 115
Z9 125
U1 2
U2 33
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4914
EI 1471-499X
J9 TRENDS MOL MED
JI Trends Mol. Med
PD AUG 15
PY 2016
VL 22
IS 8
BP 701
EP 712
DI 10.1016/j.molmed.2016.06.003
PG 12
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine
GA DT5NR
UT WOS:000381530400011
PM 27380967
DA 2024-11-01
ER

PT J
AU Roos, S
   Fyhr, IM
   Sunnerhagen, KS
   Moslemi, AR
   Oldfors, A
   Ullman, M
AF Roos, Sara
   Fyhr, Ing-Marie
   Sunnerhagen, Katharina S.
   Moslemi, Ali-Reza
   Oldfors, Anders
   Ullman, Michael
TI Histopathological changes in skeletal muscle associated with chronic ischaemia
SO APMIS
LA English
DT Article
DE Chronic ischaemia; lower limb; mitochondrial DNA; morphology
ID mitochondrial-dna deletions; arterial occlusive disease; inclusion-body myositis; oxidative damage; exercise; myopathy; fibers; dysfunction; mutations; stress
AB Muscle biopsy is an essential part in the diagnostic workup in patients with suspected neuromuscular disorders. It is therefore important to be aware of morphological alterations that can be caused by systemic factors or natural ageing. Chronic limb ischaemia is frequent in elderly individuals. This study was performed to examine histopathological and mitochondrial changes in muscle in patients with chronic critical limb ischaemia. Muscle biopsy of skeletal muscle of the lower limb of patients with chronic ischaemia leading to amputation was performed and compared with muscle biopsies of healthy, age-matched controls. The histopathological abnormalities included fibrosis, necrosis, atrophy, glycogen depletion, internal nuclei, rimmed vacuoles, fibre type grouping, cytochrome c oxidase deficient fibres, MHC-I upregulation, and signs of microangiopathy. The only alteration found in age-matched controls was a few cytochrome c oxidase deficient fibres. There were also increased levels of multiple mitochondrial DNA deletions in ischaemic muscles compared with controls. Critical limb ischaemia is associated with significant histopathological changes in muscle tissue and also increased levels of mitochondrial DNA deletions. Since the alterations mimic different primary myopathic changes, chronic ischaemia is important to consider as a differential diagnosis in elderly individuals, investigated with muscle biopsy for muscle disease.
C1 [Roos, Sara; Fyhr, Ing-Marie; Moslemi, Ali-Reza; Oldfors, Anders] Univ Gothenburg, Sahlgrenska Acad, Dept Pathol, Gothenburg, Sweden.
   [Sunnerhagen, Katharina S.] Univ Gothenburg, Sahlgrenska Acad, Dept Rehabil Med, Gothenburg, Sweden.
   [Ullman, Michael] Univ Gothenburg, Sahlgrenska Acad, Dept Orthopaed, Gothenburg, Sweden.
C3 University of Gothenburg; University of Gothenburg; University of Gothenburg
RP Roos, S (corresponding author), Univ Gothenburg, Sahlgrenska Univ Hosp, Inst Biomed, Gula Straket 8, S-41345 Gothenburg, Sweden.
EM sara.roos@gu.se
FU Swedish Research Council [07122]
CR Albani M, 2002, BMC MUSCULOSKEL DIS, V3, P0, DOI 10.1186/1471-2474-3-8
   Askew CD, 2005, J VASC SURG, V41, P802, DOI 10.1016/j.jvs.2005.01.037
   Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2
   Bhat HK, 1999, CIRCULATION, V99, P807, DOI 10.1161/01.CIR.99.6.807
   Brass EP, 2000, VASC MED, V5, P225, DOI 10.1177/1358836X0000500405
   Brass EP, 2000, VASC MED, V5, P55, DOI 10.1177/1358836X0000500109
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   Dahlbom K, 2002, NEUROMUSCULAR DISORD, V12, P853, DOI 10.1016/S0960-8966(02)00098-6
   Dubowitz V, 2013, MUSCLE BIOPSY PRACTI, V0, P0
   FARINON AM, 1984, CLIN NEUROPATHOL, V3, P240
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   GOLLNICK PD, 1974, J PHYSIOL-LONDON, V241, P45, DOI 10.1113/jphysiol.1974.sp010639
   Hedberg B, 1989, EUR J VASC SURG, V3, P315, DOI 10.1016/S0950-821X(89)80067-2
   KARPATI G, 1988, ANN NEUROL, V23, P64, DOI 10.1002/ana.410230111
   Kemp GJ, 2004, MITOCHONDRION, V4, P629, DOI 10.1016/j.mito.2004.07.017
   Kollberg G, 2007, NEW ENGL J MED, V357, P1507, DOI 10.1056/NEJMoa066691
   Lejay A, 2015, EUR J VASC ENDOVASC, V49, P205, DOI 10.1016/j.ejvs.2014.12.010
   LINDBERG C, 1995, SCAND J IMMUNOL, V41, P421, DOI 10.1111/j.1365-3083.1995.tb03587.x
   MAKITIE J, 1977, ARCH PATHOL LAB MED, V101, P658
   Makris KI, 2007, VASCULAR, V15, P336, DOI 10.2310/6670.2007.00054
   McGuigan MRM, 2002, CAN J APPL PHYSIOL, V27, P415, DOI 10.1139/h02-022
   Moslemi AR, 2010, NEW ENGL J MED, V362, P1203, DOI 10.1056/NEJMoa0900661
   Moslemi AR, 1999, NEUROLOGY, V53, P79, DOI 10.1212/WNL.53.1.79
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510x(90)90006-9
   Nagaraju K, 2005, ARTHRITIS RHEUM, V52, P1824, DOI 10.1002/art.21103
   Norgren L, 2007, EUR J VASC ENDOVASC, V33, PS5, DOI 10.1016/j.ejvs.2006.09.024
   OLDFORS A, 1995, J NEUROPATH EXP NEUR, V54, P581, DOI 10.1097/00005072-199507000-00012
   Pipinos IL, 2003, J VASC SURG, V38, P827, DOI 10.1016/S0741-5214(03)00602-5
   Pipinos Iraklis I, 2007, VASC ENDOVASCULAR SURG, V41, P481, DOI 10.1177/1538574407311106
   Pipinos II, 2008, VASC ENDOVASC SURG, V42, P101, DOI 10.1177/1538574408315995
   Pipinos II, 2008, AM J PHYSIOL-REG I, V295, PR290, DOI 10.1152/ajpregu.90374.2008
   Pipinos II, 2006, FREE RADICAL BIO MED, V41, P262, DOI 10.1016/j.freeradbiomed.2006.04.003
   REGENSTEINER JG, 1993, CIRCULATION, V87, P413, DOI 10.1161/01.CIR.87.2.413
   Subherwal S, 2015, EUR J PREV CARDIOL, V22, P317, DOI 10.1177/2047487313519344
   Sunnehagen KS, 2000, SCAND J REHABIL MED, V32, P159
   Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6
   VILLANOVA M, 1993, BRAIN RES, V603, P343, DOI 10.1016/0006-8993(93)91260-Y
   Weiss DJ, 2013, J TRANSL MED, V11, P0, DOI 10.1186/1479-5876-11-230
NR 38
TC 11
Z9 12
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0903-4641
EI 1600-0463
J9 APMIS
JI APMIS
PD NOV 15
PY 2016
VL 124
IS 11
BP 935
EP 941
DI 10.1111/apm.12586
PG 7
WC Immunology; Microbiology; Pathology
SC Immunology; Microbiology; Pathology
GA EC6RT
UT WOS:000388264900003
PM 27539941
DA 2024-11-01
ER

PT J
AU Bunkar, N
   Bhargava, A
   Khare, NK
   Mishra, PK
AF Bunkar, Neha
   Bhargava, Arpit
   Khare, Naveen Kumar
   Mishra, Pradyumna Kumar
TI Mitochondrial anomalies: driver to age associated degenerative human ailments
SO FRONTIERS IN BIOSCIENCE-LANDMARK
LA English
DT Article
DE Mitochondrial Dysfunction; Oxidative Stress; Oxidative Damage; Redox Signaling; Review; Mitochondria Targeting; Review
ID amyotrophic-lateral-sclerosis; liposome-based carrier; nuclear cross-talk; oxidative stress; mito-porter; skeletal-muscle; cell-death; targeted nanoparticles; expression changes; dendritic cells
AB Mitochondria play a fundamental role in regulating a variety of complex metabolic processes to maintain adequate energy balance for cellular existence. To orchestrate these functions, an undisturbed mitochondrial dynamics is imperative through a set of tightly guided mechanisms. Interference in key signature processes by several genetic, epigenetic and age-linked factors triggers mitochondrial dysfunction through decrease in mitochondrial biogenesis, reduced mitochondrial content, aberrant mtDNA mutations, increased oxidative stress, deficient mitophagy, energy dysfunction, decrease in anti oxidant defense and impaired calcium homeostasis. Mitochondrial dysfunction is widely implicated in origin and development of various age associated degenerative human ailments including metabolic syndromes, cardiovascular diseases, cancer, diabetes and neurodegenerative disorders. The present review revisits the mitochondrial anomalies involved in aetiology of different human diseases and also highlights the translational significance of nano-vectors aimed for selective mitochondrial engineering which might pave way for development of novel therapeutics.
C1 [Bunkar, Neha; Bhargava, Arpit; Mishra, Pradyumna Kumar] Dr HS Gour Cent Univ, Sch Biol Sci, Sagar, India.
   [Bhargava, Arpit; Khare, Naveen Kumar; Mishra, Pradyumna Kumar] ACTREC, Tata Mem Ctr, Div Translat Res, Bombay, Maharashtra, India.
C3 Dr. Hari Singh Gour University; Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC)
RP Mishra, PK (corresponding author), Dr HS Gour Cent Univ, Sch Biol Sci, Translat Res Lab, Sagar 470003, India.
EM pkm_8bh@yahoo.co.uk
CR Arciuch VGA, 2012, ANTIOXID REDOX SIGN, V16, P1150, DOI 10.1089/ars.2011.4085
   Armstrong JS, 2007, BRIT J PHARMACOL, V151, P1154, DOI 10.1038/sj.bjp.0707288
   Bellizzi D, 2013, DNA RES, V20, P537, DOI 10.1093/dnares/dst029
   Bennett GJ, 2014, NAT REV NEUROL, V10, P326, DOI 10.1038/nrneurol.2014.77
   Bhargava A, 2014, NANOMEDICINE-UK, V9, P2187, DOI 10.2217/NNM.14.115
   Biala AK, 2015, J MOL CELL CARDIOL, V83, P37, DOI 10.1016/j.yjmcc.2015.04.015
   Biswas S, 2012, J CONTROL RELEASE, V159, P393, DOI 10.1016/j.jconrel.2012.01.009
   Biswas S, 2012, BIOMATERIALS, V33, P4773, DOI 10.1016/j.biomaterials.2012.03.032
   Blakely EL, 2014, NEUROMUSCULAR DISORD, V24, P533, DOI 10.1016/j.nmd.2014.03.011
   Blokhuis AM, 2013, ACTA NEUROPATHOL, V125, P777, DOI 10.1007/s00401-013-1125-6
   Boddapati SV, 2008, NANO LETT, V8, P2559, DOI 10.1021/nl801908y
   Boyer-Guittaut M, 2014, AUTOPHAGY, V10, P986, DOI 10.4161/auto.28390
   Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162
   Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125
   Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a
   Cardoso SM, 2004, NEUROBIOL AGING, V25, P105, DOI 10.1016/S0197-4580(03)00033-2
   Chan SHH, 2009, HYPERTENSION, V53, P217, DOI 10.1161/HYPERTENSIONAHA.108.116905
   Chandel NS, 2014, BMC BIOL, V12, P0, DOI 10.1186/1741-7007-12-34
   CHEN LB, 1988, ANNU REV CELL BIOL, V4, P155, DOI 10.1146/annurev.cb.04.110188.001103
   Chen Z, 2010, ONCOGENE, V29, P4362, DOI 10.1038/onc.2010.193
   Chinnery PF, 2012, INT J EPIDEMIOL, V41, P177, DOI 10.1093/ije/dyr232
   Chourasia AH, 2015, CANCER METAB, V3, P0, DOI 10.1186/s40170-015-0130-8
   Cuchelkar V, 2008, MOL PHARMACEUT, V5, P776, DOI 10.1021/mp800019g
   DSouza GGM, 2008, J DRUG TARGET, V16, P578, DOI 10.1080/10611860802228855
   DSouza GGM, 2003, J CONTROL RELEASE, V92, P189, DOI 10.1016/S0168-3659(03)00297-9
   de Cabo R, 2014, CELL, V157, P1515, DOI 10.1016/j.cell.2014.05.031
   Dexter DT, 2013, FREE RADICAL BIO MED, V62, P132, DOI 10.1016/j.freeradbiomed.2013.01.018
   Dias V, 2013, J PARKINSON DIS, V3, P461, DOI 10.3233/JPD-130230
   Dikalov SI, 2013, ANTIOXID REDOX SIGN, V19, P1085, DOI 10.1089/ars.2012.4604
   DiMauro S, 2007, J CLIN INVEST, V117, P587, DOI 10.1172/JCI31423
   Dorn GW, 2010, J CARDIOVASC TRANSL, V3, P374, DOI 10.1007/s12265-010-9174-x
   Dromparis P, 2013, ANNU REV PHYSIOL, V75, P95, DOI 10.1146/annurev-physiol-030212-183804
   Durazo SA, 2012, MITOCHONDRION, V12, P190, DOI 10.1016/j.mito.2011.11.001
   Edeas M, 2013, MITOCHONDRION, V13, P389, DOI 10.1016/j.mito.2013.03.009
   Edrey YH, 2014, FREE RADICAL BIO MED, V71, P368, DOI 10.1016/j.freeradbiomed.2014.03.038
   Eisner V, 2014, J CELL BIOL, V205, P179, DOI 10.1083/jcb.201312066
   Fernández-Checa JC, 2010, CNS NEUROL DISORD-DR, V9, P439, DOI 10.2174/187152710791556113
   Fernández-Moriano C, 2015, OXID MED CELL LONGEV, V2015, P0, DOI 10.1155/2015/408927
   Finsterer J, 2015, PEDIATR NEUROL, V52, P302, DOI 10.1016/j.pediatrneurol.2014.06.023
   Finsterer J, 2011, J NEUROL SCI, V304, P9, DOI 10.1016/j.jns.2011.02.012
   Fiorentino TV, 2013, CURR PHARM DESIGN, V19, P5695, DOI 10.2174/1381612811319320005
   Flierl A, 2003, MOL THER, V7, P550, DOI 10.1016/S1525-0016(03)00037-6
   Gage MC, 2013, ATHEROSCLEROSIS, V230, P131, DOI 10.1016/j.atherosclerosis.2013.06.017
   Gao AW, 2014, EMBO MOL MED, V6, P580, DOI 10.1002/emmm.201303782
   García-Pérez AI, 2011, LEUKEMIA RES, V35, P1395, DOI 10.1016/j.leukres.2011.03.012
   Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037
   Gonzalez-Freire M, 2014, FRONT AGING NEUROSCI, V6, P0, DOI 10.3389/fnagi.2014.00208
   Gordon PH, 2013, AGING DIS, V4, P295, DOI 10.14336/AD.2013.0400295
   Guha M, 2013, MITOCHONDRION, V13, P577, DOI 10.1016/j.mito.2013.08.007
   Gupta Ankur, 2014, NANOMEDICINE (LOND), V9, P2725, DOI 10.2217/nnm.14.180
   Handy DE, 2012, ANTIOXID REDOX SIGN, V16, P1323, DOI 10.1089/ars.2011.4123
   Hardas SS, 2013, REDOX BIOL, V1, P80, DOI 10.1016/j.redox.2013.01.002
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   Hsu CC, 2013, WORLD J GASTROENTERO, V19, P8880, DOI 10.3748/wjg.v19.i47.8880
   Inoki Y, 2000, BIOCHEM BIOPH RES CO, V278, P183, DOI 10.1006/bbrc.2000.3765
   Jauslin ML, 2003, FASEB J, V17, P1972, DOI 10.1096/fj.03-0240fje
   Kabekkodu SP, 2015, MITOCHONDRION, V0, P0
   Kajita M, 2007, FREE RADICAL RES, V41, P615, DOI 10.1080/10715760601169679
   Kang CH, 2013, EXP GERONTOL, V48, P1343, DOI 10.1016/j.exger.2013.08.004
   Khan S, 2014, INDIAN J CLIN BIOCHE, V29, P38, DOI 10.1007/s12291-013-0321-4
   Khan S, 2011, TRANSL RES, V158, P344, DOI 10.1016/j.trsl.2011.08.007
   Kim UK, 2000, BASIC RES CARDIOL, V95, P163, DOI 10.1007/s003950050178
   Kizhakekuttu TJ, 2012, ARTERIOSCL THROM VAS, V32, P2531, DOI 10.1161/ATVBAHA.112.256024
   Kluge MA, 2013, CIRC RES, V112, P1171, DOI 10.1161/CIRCRESAHA.111.300233
   Kren BT, 2009, RNA BIOL, V6, P65, DOI 10.4161/rna.6.1.7534
   Kröller-Schön S, 2014, ANTIOXID REDOX SIGN, V20, P247, DOI 10.1089/ars.2012.4953
   Kroeller-Schoen S, 2013, ARTERIOSCL THROM VAS, V33, P1928, DOI 10.1161/ATVBAHA.113.301717
   Kruk J, 1997, CHEM PHYS LIPIDS, V87, P73, DOI 10.1016/S0009-3084(97)00027-3
   Lane RK, 2015, BIOCH BIOPHYS ACTA, V0, P0
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Lee HC, 2014, WORLD J GASTROENTERO, V20, P3950, DOI 10.3748/wjg.v20.i14.3950
   Lee HC, 2012, ADV EXP MED BIOL, V942, P311, DOI 10.1007/978-94-007-2869-1_14
   Lee JH, 2013, PHARMACOL THERAPEUT, V137, P153, DOI 10.1016/j.pharmthera.2012.09.008
   Lemasters JJ, 2014, REDOX BIOL, V2, P749, DOI 10.1016/j.redox.2014.06.004
   Leszczynska G, 2014, RNA, V20, P938, DOI 10.1261/rna.044412.114
   Lezi E, 2012, ADV EXP MED BIOL, V942, P269, DOI 10.1007/978-94-007-2869-1_12
   Li RH, 2010, MOL CELL BIOL, V30, P2147, DOI 10.1128/MCB.01614-09
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   López-Armada MJ, 2013, MITOCHONDRION, V13, P106, DOI 10.1016/j.mito.2013.01.003
   Lund M, 2015, BRIT J CANCER, V112, P1134, DOI 10.1038/bjc.2015.66
   Ma ZA, 2012, EXP DIABETES RES, V0, P0, DOI DOI 10.1155/2012/703538
   Mabalirajan Ulaganathan, 2013, J ALLERGY (CAIRO), V2013, P340476, DOI 10.1155/2013/340476
   Madamanchi NR, 2013, FREE RADICAL BIO MED, V61, P473, DOI 10.1016/j.freeradbiomed.2013.04.001
   Maher RL, 2013, DNA REPAIR, V12, P964, DOI 10.1016/j.dnarep.2013.08.010
   Marrache S, 2013, ACS NANO, V7, P7392, DOI 10.1021/nn403158n
   Marrache S, 2012, P NATL ACAD SCI USA, V109, P16288, DOI 10.1073/pnas.1210096109
   Marzetti E, 2013, AM J PHYSIOL-HEART C, V305, PH459, DOI 10.1152/ajpheart.00936.2012
   Mercer JR, 2010, CIRC RES, V107, P1021, DOI 10.1161/CIRCRESAHA.110.218966
   Messaoudi S, 2012, MOL CELL ENDOCRINOL, V350, P266, DOI 10.1016/j.mce.2011.06.038
   Milane L, 2015, J CONTROL RELEASE, V207, P40, DOI 10.1016/j.jconrel.2015.03.036
   Millecamps S, 2010, J MED GENET, V47, P554, DOI 10.1136/jmg.2010.077180
   Mishra PK, 2015, REPROD TOXICOL, V52, P40, DOI 10.1016/j.reprotox.2015.02.006
   Mishra PK, 2009, FREE RADICAL RES, V43, P718, DOI 10.1080/10715760903037699
   Mishra PK, 2014, INT J TOXICOL, V33, P116, DOI 10.1177/1091581814524064
   Muftuoglu M, 2014, MITOCHONDRION, V17, P164, DOI 10.1016/j.mito.2014.03.007
   Orsucci D, 2013, CURR NEUROVASC RES, V10, P76, DOI 10.2174/156720213804805972
   Panwar H, 2013, REDOX BIOL, V1, P163, DOI 10.1016/j.redox.2013.01.009
   Pathak RK, 2015, WIRES NANOMED NANOBI, V7, P315, DOI 10.1002/wnan.1305
   Patti ME, 2010, ENDOCR REV, V31, P364, DOI 10.1210/er.2009-0027
   Paunesku T, 2007, NANO LETT, V7, P596, DOI 10.1021/nl0624723
   Pinto M, 2015, FREE RADICAL BIO MED, V85, P250, DOI 10.1016/j.freeradbiomed.2015.05.005
   Qu AJ, 2009, AM J PHYSIOL-CELL PH, V297, PC645, DOI 10.1152/ajpcell.00469.2008
   Raghuram GV, 2014, INDIAN J MED RES, V140, P120
   Reddy MK, 2008, APPL BIOCHEM BIOTECH, V151, P565, DOI 10.1007/s12010-008-8232-1
   Reddy PH, 2008, NEUROMOL MED, V10, P291, DOI 10.1007/s12017-008-8044-z
   Redmann M, 2014, INT J BIOCHEM CELL B, V53, P127, DOI 10.1016/j.biocel.2014.05.010
   Ren J, 2010, J MOL MED, V88, P993, DOI 10.1007/s00109-010-0663-9
   Rensvold JW, 2013, CELL REP, V3, P237, DOI 10.1016/j.celrep.2012.11.029
   Riehle C, 2011, CIRC RES, V109, P783, DOI 10.1161/CIRCRESAHA.111.243964
   Rodriguez-Iturbe B, 2007, J APPL PHYSIOL, V102, P255, DOI 10.1152/japplphysiol.00513.2006
   Ross MF, 2005, BIOCHEMISTRY-MOSCOW+, V70, P222, DOI 10.1007/s10541-005-0104-5
   Rubattu S, 2015, INT J MOL SCI, V16, P823, DOI 10.3390/ijms16010823
   Rubin TG, 2014, BIOESSAYS, V36, P1072, DOI 10.1002/bies.201400095
   Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787
   Salminen A, 2014, CELL SIGNAL, V26, P1598, DOI 10.1016/j.cellsig.2014.03.030
   Salnikov V, 2007, BIOPHYS J, V92, P1058, DOI 10.1529/biophysj.106.094318
   Sato F, 2011, FEBS J, V278, P1598, DOI 10.1111/j.1742-4658.2011.08089.x
   Sauvanet C, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0049639
   Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019
   Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6
   Schroeder EA, 2013, CELL METAB, V17, P954, DOI 10.1016/j.cmet.2013.04.003
   SEIBEL P, 1995, NUCLEIC ACIDS RES, V23, P10, DOI 10.1093/nar/23.1.10
   Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490
   Shantha GPS, 2013, ATHEROSCLEROSIS, V228, P249, DOI 10.1016/j.atherosclerosis.2013.02.014
   Sharma D, 2015, EXP BIOL MED, V240, P242, DOI 10.1177/1535370214551688
   Shaughnessy DT, 2014, ENVIRON HEALTH PERSP, V122, P1271, DOI 10.1289/ehp.1408418
   Shock LS, 2011, P NATL ACAD SCI USA, V108, P3630, DOI 10.1073/pnas.1012311108
   Skulachev MV, 2011, CURR DRUG TARGETS, V12, P800
   Smiraglia DJ, 2008, CANCER BIOL THER, V7, P1182, DOI 10.4161/cbt.7.8.6215
   Sobenin IA, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0068070
   Springer W, 2011, AUTOPHAGY, V7, P266, DOI 10.4161/auto.7.3.14348
   Strappazzona F, 2015, PHARM RES, V0, P0, DOI DOI 10.1.016/j.phrs.2015.0.3.0.07
   Szeto HH, 2006, AAPS J, V8, PE521, DOI 10.1208/aapsj080362
   Szeto HH, 2006, AAPS J, V8, PE277, DOI 10.1007/BF02854898
   Tamargo J, 2011, NAT REV DRUG DISCOV, V10, P536, DOI 10.1038/nrd3431
   Thouvenot E, 2012, J PROTEOMICS, V77, P394, DOI 10.1016/j.jprot.2012.09.013
   Tocchi A, 2015, BIOCH BIOPHYS ACTA, V0, P0, DOI DOI 10.1.016/j.bbabio.2015.0.7.0.09
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tsutsui H, 2009, CARDIOVASC RES, V81, P449, DOI 10.1093/cvr/cvn280
   Ungvari Z, 2007, AM J PHYSIOL-HEART C, V293, PH37, DOI 10.1152/ajpheart.01346.2006
   VESTWEBER D, 1989, NATURE, V338, P170, DOI 10.1038/338170a0
   Villa-Bellosta R, 2013, CIRCULATION, V127, P2442, DOI 10.1161/CIRCULATIONAHA.112.000571
   Villeneuve C, 2013, ANTIOXID REDOX SIGN, V18, P5, DOI 10.1089/ars.2011.4373
   Wallace DC, 2013, J CLIN INVEST, V123, P1405, DOI 10.1172/JCI61398
   Wallace DC, 2010, MITOCHONDRION, V10, P12, DOI 10.1016/j.mito.2009.09.006
   Wang LM, 2011, NANO LETT, V11, P772, DOI 10.1021/nl103992v
   Weissig V, 2001, ADV DRUG DELIVER REV, V49, P1
   Weissig V, 2007, NANOMEDICINE-UK, V2, P275, DOI 10.2217/17435889.2.3.275
   Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013
   Wilding M, 2015, FERTIL STERIL, V103, P1397, DOI 10.1016/j.fertnstert.2015.03.034
   Wohlgemuth SE, 2014, J MOL CELL CARDIOL, V71, P62, DOI 10.1016/j.yjmcc.2014.03.007
   Wong M, 2010, HUM MOL GENET, V19, P2284, DOI 10.1093/hmg/ddq106
   Wongrakpanich A, 2014, NANOMEDICINE-UK, V9, P2531, DOI 10.2217/NNM.14.161
   Wood SH, 2013, AGE, V35, P763, DOI 10.1007/s11357-012-9410-1
   Wu SB, 2014, BBA-GEN SUBJECTS, V1840, P1331, DOI 10.1016/j.bbagen.2013.10.034
   Xiong SQ, 2013, ARTERIOSCL THROM VAS, V33, P988, DOI 10.1161/ATVBAHA.112.301019
   Yamada Y, 2008, BBA-BIOMEMBRANES, V1778, P423, DOI 10.1016/j.bbamem.2007.11.002
   Yamada Y, 2013, J PHARM SCI-US, V102, P1008, DOI 10.1002/jps.23442
   Yamada Y, 2011, MOL THER, V19, P1449, DOI 10.1038/mt.2011.99
   Yasuzaki Y, 2010, BIOCHEM BIOPH RES CO, V397, P181, DOI 10.1016/j.bbrc.2010.05.070
   Youn JY, 2014, DIABETES, V63, P2344, DOI 10.2337/db13-0719
   Yu E, 2013, CIRCULATION, V128, P702, DOI 10.1161/CIRCULATIONAHA.113.002271
   Zhang SW, 2015, AM J CANCER RES, V5, P1265
   Zhao KS, 2004, J BIOL CHEM, V279, P34682, DOI 10.1074/jbc.M402999200
   Ziegler DV, 2015, AGING CELL, V14, P1, DOI 10.1111/acel.12287
NR 166
TC 19
Z9 19
U1 0
U2 23
PU FRONTIERS IN BIOSCIENCE INC
PI IRVINE
PA 16471 SCIENTIFIC WAY, IRVINE, CA 92618 USA
SN 1093-9946
EI 1093-4715
J9 FRONT BIOSCI-LANDMRK
JI Front. Biosci.
PD JAN 1
PY 2016
VL 21
IS 
BP 769
EP 793
DI 10.2741/4420
PG 25
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA DC2WT
UT WOS:000369080200007
PM 26709805
DA 2024-11-01
ER

PT J
AU Sinyov, VV
   Chicheva, MM
   Barinova, VA
   Ryzhkova, AI
   Zilinyi, RI
   Karagodin, VP
   Postnov, AY
   Sobenin, IA
   Orekhov, AN
   Sazonova, MA
AF Sinyov, V. V.
   Chicheva, M. M.
   Barinova, V. A.
   Ryzhkova, A. I.
   Zilinyi, R. I.
   Karagodin, V. P.
   Postnov, A. Yu.
   Sobenin, I. A.
   Orekhov, A. N.
   Sazonova, M. A.
TI The heteroplasmy level of some mutations in gene <i>MT-CYB</i> among women with asymptomatic atherosclerosis
SO RUSSIAN JOURNAL OF GENETICS
LA English
DT Article
DE atherosclerotic disease; mitochondrial genome; intima-media thickness; cytochrome B gene; single nucleotide substitution
ID cytochrome-b gene; exercise intolerance; mitochondrial-dna; myopathy; patient; onset
AB Atherosclerosis is a polygenic socially significant disease whose risk factors include coronary heart disease, diabetes, hypertension, and myocardial infarction. According to the literature, mutations m.14846G > A (G34S), m.15762G > A (G339Q), m.15084G > A (W113Ter), and m.15059G > A (G190Ter) of cytochrome B gene (MT-CYB) are associated with mitochondrial myopathies, myoglobinuria, and exercise intolerance. Preliminary studies carried out by the authors made it possible to discover an association of certain mitochondrial genome mutations with atherosclerotic lesions of aortic intima in people who died as a result of an accident or sudden death. The most interesting seemed to be the data on the association of mutations m.14846G > A and m.15059G > A of the cytochrome B gene with lipofibrous aortic plaques, because these mutations affect the mitochondrial respiratory chain enzyme. Defects in the given chain may be the reason for the launch of pathogenic mechanisms in the human body. Owing to the fact that mutations in the mitochondrial genome are inherited by the maternal type, it was decided to analyze cytochrome B gene mutations in a sample of female volunteers from Moscow oblast. According to the findings, mutations m.14846G > A and m.15059G > A are highly significantly associated with atherosclerotic lesions of the carotid arteries: m.14846G > A is antiatherogenic and m.15059G > A is proatherogenic.
C1 [Sinyov, V. V.; Barinova, V. A.; Postnov, A. Yu.; Sobenin, I. A.; Sazonova, M. A.] Russian Cardiol Res & Prod Complex, Moscow 121552, Russia.
   [Chicheva, M. M.; Ryzhkova, A. I.; Sobenin, I. A.; Orekhov, A. N.; Sazonova, M. A.] Res Inst Gen Pathol & Pathophysiol, Moscow 125315, Russia.
   [Ryzhkova, A. I.; Orekhov, A. N.] Skryabin Moscow State Acad Vet Med & Biotechnol, Moscow 109472, Russia.
   [Zilinyi, R. I.] Univ Debrecen, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary.
   [Karagodin, V. P.] Plekhanov Russian Univ Econ, Moscow 117997, Russia.
   [Orekhov, A. N.] Skolkovo Innovat Ctr, Inst Atherosclerosis Res, Skolkovo 121609, Moscow Oblast, Russia.
C3 National Medical Research Center of Cardiology; Russian Academy of Medical Sciences; Institute of General Pathology & Pathophysiology, RAMS; Moscow State Academy of Veterinary Medicine & Biotechnology named after K.I. Skryabin; University of Debrecen; Plekhanov Russian University of Economics
RP Sinyov, VV (corresponding author), Russian Cardiol Res & Prod Complex, Moscow 121552, Russia.
EM centaureaceanus@mail.ru
FU Russian Science Foundation [14-14-01038]; Russian Science Foundation [14-14-01038] Funding Source: Russian Science Foundation
CR Amosenko FA, 1997, RUSS J GENET, V33, P198
   AMOSENKO FA, 1995, GENETIKA+, V31, P532
   Andreassi MG, 2009, MUTAT RES-FUND MOL M, V667, P35, DOI 10.1016/j.mrfmmm.2008.10.018
   Andreu AL, 1998, NEUROLOGY, V51, P1444, DOI 10.1212/WNL.51.5.1444
   Andreu AL, 1999, ANN NEUROL, V45, P127, DOI 10.1002/1531-8249(199901)45:1<127::AID-ART20>3.0.CO;2-Y
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   [Anonymous], 1982, MOL CLONING, V0, P0
   Chol M, 2003, J MED GENET, V40, P188, DOI 10.1136/jmg.40.3.188
   Döring Y, 2012, ARTERIOSCL THROM VAS, V32, P182, DOI 10.1161/ATVBAHA.111.232686
   Han CB, 2005, WORLD J GASTROENTERO, V11, P31, DOI 10.3748/wjg.v11.i1.31
   Horváth R, 2002, J MED GENET, V39, P812, DOI 10.1136/jmg.39.11.812
   Ivanova MM, 2012, BIOMED ZH MEDLINE RU, V13, P309
   Jeppesen TD, 2003, J NEUROL SCI, V214, P17, DOI 10.1016/S0022-510X(03)00168-0
   Kazubskaya TP, 2003, 7 ROSS ONK K, V0, P137
   Maniatis T, 1984, METODY GENETICHESKOI, V0, P0
   Miasoedova V A, 2012, PATOL FIZIOL EKSP TER, V0, P104
   Myasoedova VA, 2013, POLOVYE RAZLICHIYA A, V0, P0
   Nagornev V A, 2006, PATOGENEZ ATEROSKLER, V0, P0
   Sazonova M, 2009, ATHEROSCLEROSIS, V204, P184, DOI 10.1016/j.atherosclerosis.2008.09.001
   [Сазонова МАSazonova MA], 2012, ПАТОЛОГИЧЕСКАЯ ФИЗИОЛОГИЯ И ЭКСПЕРИМЕНТАЛЬНАЯ ТЕРАПИЯ PATOLOGICHESKAYA FIZIOLOGIYA I EKSPERIMENTALNAYA TERAPIYA, V0, P67
   [Сазонова МАSazonova MA], 2012, ПАТОЛОГИЧЕСКАЯ ФИЗИОЛОГИЯ И ЭКСПЕРИМЕНТАЛЬНАЯ ТЕРАПИЯ PATOLOGICHESKAYA FIZIOLOGIYA I EKSPERIMENTALNAYA TERAPIYA, V0, P62
   [Сазонова МАSazonova MA], 2012, ПАТОЛОГИЧЕСКАЯ ФИЗИОЛОГИЯ И ЭКСПЕРИМЕНТАЛЬНАЯ ТЕРАПИЯ PATOLOGICHESKAYA FIZIOLOGIYA I EKSPERIMENTALNAYA TERAPIYA, V0, P71
   Sazonova M A, 2011, PATOL FIZIOL EKSP TER, V0, P81
   Sazonova MA, 2010, ATHEROSCLEROSIS, V209, P306, DOI 10.1016/j.atherosclerosis.2009.08.034
   Sazonova MA, 2015, PATOL FIZIOL EKSP TE, V1, P17
   Sazonova MA, 2014, MEZHDUNAR NAUCHNO IS, V20, P18
   Sazonova MA, 1999, THESIS, V0, P157
   Sazonova MA, 2005, VESTN ROSS ONKOL TSE, V0, P16
   Sazonova MA, 1997, RUSS J GENET, V33, P1313
NR 29
TC 3
Z9 4
U1 0
U2 3
PU MAIK NAUKA/INTERPERIODICA/SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013-1578 USA
SN 1022-7954
EI 1608-3369
J9 RUSS J GENET+
JI Russ. J. Genet.
PD AUG 15
PY 2016
VL 52
IS 8
BP 847
EP 852
DI 10.1134/S1022795416080123
PG 6
WC Genetics & Heredity
SC Genetics & Heredity
GA DW0NX
UT WOS:000383338200009
DA 2024-11-01
ER

PT J
AU Ficociello, G
   Salemme, A
   Uccelletti, D
   Fiorito, S
   Togna, AR
   Vallan, L
   González-Domínguez, JM
   Da Ros, T
   Francisci, S
   Montanari, A
AF Ficociello, Graziella
   Salemme, Adele
   Uccelletti, Daniela
   Fiorito, Silvana
   Togna, Anna Rita
   Vallan, Lorenzo
   Gonzalez-Dominguez, Jose M.
   Da Ros, Tatiana
   Francisci, Silvia
   Montanari, Arianna
TI Evaluation of the efficacy of carbon nanotubes for delivering peptides into mitochondria
SO RSC ADVANCES
LA English
DT Article
ID nematode caenorhabditis-elegans; targeted organs; cellular uptake; mutations; toxicity; diseases; gene; translocation; nanoparticles; trna(ile)
AB Mitochondrial (mt) diseases are devastating neurodegenerative pathologies due to mutations in nuclear or mt genes. Among mtDNA pathogenic mutations, more than one half have been identified in transfer RNA (tRNA) genes. These are responsible for a wide range of pathologies including myopathies, encephalopathies, cardiomyopathies and deafness for which no effective treatment is available at present. Therefore, new strategies to suppress their damaging effects are required to envisage therapeutic approaches for these diseases. Here we report data for carbon nanotube (CNT) derivatives showing that the conjugates bearing a specific peptide sequence are able to target the mitochondria in yeast and human monocyte cells while the control derivative without the peptide diffuses into the cytoplasm. Moreover the compounds do not affect cellular viability and cytotoxicity both in vitro and in vivo. Toxicity of the constructs is also assessed on the simple pluricellular model Caenorhabditis elegans.
C1 [Ficociello, Graziella; Uccelletti, Daniela; Francisci, Silvia; Montanari, Arianna] Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, Piazzale Aldo Moro 5, I-00185 Rome, Italy.
   [Salemme, Adele; Togna, Anna Rita] Univ Roma La Sapienza, Dept Physiol & Pharmacol Vittorio Erspamer, Piazzale Aldo Moro 5, I-00185 Rome, Italy.
   [Fiorito, Silvana] CNR, Inst Translat Pharmacol, Via Fosso Cavaliere 100, I-00133 Rome, Italy.
   [Vallan, Lorenzo; Gonzalez-Dominguez, Jose M.; Da Ros, Tatiana] Univ Trieste, INSTM Unit Trieste, Dept Chem & Pharmaceut Sci, Piazzale Europa 1, I-34127 Trieste, Italy.
   [Montanari, Arianna] Univ Roma La Sapienza, Cenci Bolognetti Fdn, Pasteur Inst, Viale Regina Elena 291, I-00161 Rome, Italy.
C3 Sapienza University Rome; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Farmacologia Traslazionale (IFT-CNR); University of Trieste; Sapienza University Rome; Fondazione Cenci Bolognetti
RP Montanari, A (corresponding author), Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, Piazzale Aldo Moro 5, I-00185 Rome, Italy.; Montanari, A (corresponding author), Univ Roma La Sapienza, Cenci Bolognetti Fdn, Pasteur Inst, Viale Regina Elena 291, I-00161 Rome, Italy.
EM graziella..cociello@uniroma1.it; adele.salemme@uniroma1.it; daniela.uccelletti@uniroma1.it; silvana..orito@i..cnr.it; annarita.togna@uniroma1.it; lor.lor.lor.zeno@gmail.com; jmgd_chemical@yahoo.es; daros@units.it; silvia.francisci@uniroma1.it; ari.montanari@uniroma1.it
FU Pasteur Institute - Cenci Bolognetti Foundation; Sapienza University of Rome [C26A144BN2]; European Union FP7 RADDEL program (ITN Marie Curie Actions) [PEOPLE-2011-290023]
CR Adhya S, 2011, MITOCHONDRION, V11, P839, DOI 10.1016/j.mito.2011.06.003
   Battigelli A, 2013, NANOSCALE, V5, P9110, DOI 10.1039/c3nr02694a
   BRENNER S, 1974, GENETICS, V77, P71
   Choi J, 2014, ENVIRON CHEM, V11, P227, DOI 10.1071/EN13187
   Coutelle O, 2014, EMBO MOL MED, V6, P624, DOI 10.1002/emmm.201303016
   De Luca C, 2006, GENE, V377, P169, DOI 10.1016/j.gene.2006.04.003
   De Luca C, 2009, MITOCHONDRION, V9, P408, DOI 10.1016/j.mito.2009.07.004
   Di Micco P, 2014, BBA-MOL CELL RES, V1843, P3065, DOI 10.1016/j.bbamcr.2014.09.011
   Francisci S, 2011, MITOCHONDRION, V11, P919, DOI 10.1016/j.mito.2011.08.006
   Handy RD, 2012, ENVIRON TOXICOL CHEM, V31, P15, DOI 10.1002/etc.706
   Jung SK, 2015, ENVIRON SCI TECHNOL, V49, P2477, DOI 10.1021/es5056462
   Kam NWS, 2004, J AM CHEM SOC, V126, P6850, DOI 10.1021/ja0486059
   Koopmans RJ, 2010, CURR OPIN MICROBIOL, V13, P327, DOI 10.1016/j.mib.2010.01.012
   Kordatos K, 2001, J ORG CHEM, V66, P4915, DOI 10.1021/jo015608k
   Kostarelos K, 2007, NAT NANOTECHNOL, V2, P108, DOI 10.1038/nnano.2006.209
   Li RH, 2010, MOL CELL BIOL, V30, P2147, DOI 10.1128/MCB.01614-09
   Lopez CF, 2004, P NATL ACAD SCI USA, V101, P4431, DOI 10.1073/pnas.0400352101
   Marrache S, 2013, CURR MED CHEM, V20, P3500, DOI 10.2174/0929867311320280007
   Ménard-Moyon C, 2011, CHEM-EUR J, V17, P3222, DOI 10.1002/chem.201003050
   Ménard-Moyon C, 2010, EXPERT OPIN DRUG DIS, V5, P691, DOI 10.1517/17460441.2010.490552
   Montanari A, 2011, RNA, V17, P1983, DOI 10.1261/rna.2878711
   Montanari A, 2010, BBA-MOL CELL RES, V1803, P1050, DOI 10.1016/j.bbamcr.2010.05.003
   Nouara A, 2013, NANOSCALE, V5, P6088, DOI 10.1039/c3nr00847a
   Park H, 2008, RNA, V14, P2407, DOI 10.1261/rna.1208808
   Pastorin G, 2006, CHEM COMMUN, V0, PP1182, DOI 10.1039/b516309a
   Pathak RK, 2015, WIRES NANOMED NANOBI, V7, P315, DOI 10.1002/wnan.1305
   Perli E, 2016, HUM MOL GENET, V25, P903, DOI 10.1093/hmg/ddv619
   Perli E, 2014, EMBO MOL MED, V6, P169, DOI 10.1002/emmm.201303198
   Perli E, 2012, HUM MOL GENET, V21, P85, DOI 10.1093/hmg/ddr440
   Rorbach J, 2008, NUCLEIC ACIDS RES, V36, P5787, DOI 10.1093/nar/gkn576
   Salvador-Morales C, 2009, BIOMATERIALS, V30, P2231, DOI 10.1016/j.biomaterials.2009.01.005
   Serpell CJ, 2016, ACS CENTRAL SCI, V2, P190, DOI 10.1021/acscentsci.6b00005
   THOMAS BJ, 1989, GENETICS, V123, P725
   Wen R, 2016, ADV DRUG DELIVER REV, V99, P52, DOI 10.1016/j.addr.2015.12.024
   Wu QL, 2013, NANOSCALE, V5, P11166, DOI 10.1039/c3nr03917j
   Yoong SL, 2015, NANOSCALE, V7, P13907, DOI 10.1039/c5nr00980d
NR 36
TC 7
Z9 7
U1 0
U2 11
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND
SN 2046-2069
EI 
J9 RSC ADV
JI RSC Adv.
PD JUN 15
PY 2016
VL 6
IS 71
BP 67232
EP 67241
DI 10.1039/c6ra14254k
PG 10
WC Chemistry, Multidisciplinary
SC Chemistry
GA DS1KD
UT WOS:000380353600102
DA 2024-11-01
ER

PT J
AU Souren, NYP
   Gerdes, LA
   Kümpfel, T
   Lutsik, P
   Klopstock, T
   Hohlfeld, R
   Walter, J
AF Souren, Nicole Y. P.
   Gerdes, Lisa A.
   Kuempfel, Tania
   Lutsik, Pavlo
   Klopstock, Thomas
   Hohlfeld, Reinhard
   Walter, Joern
TI Mitochondrial DNA Variation and Heteroplasmy in Monozygotic Twins Clinically Discordant for Multiple Sclerosis
SO HUMAN MUTATION
LA English
DT Article
DE multiple sclerosis; mtDNA; monozygotic twins; heteroplasmy; LHON
ID progressive external ophthalmoplegia; hereditary optic neuropathy; polymerase-gamma; transfer-rna; oxidative-phosphorylation; point mutations; gene; pathogenicity; genome; ms
AB We examined the debated link between mitochondrial DNA (mtDNA) variation and multiple sclerosis (MS) using 49 monozygotic (MZ) twin pairs clinically discordant for MS, which enables to associate de novo mtDNA variants, skewed heteroplasmy, and mtDNA copy number with MS manifestation. Ultra-deep sequencing of blood-derived mtDNA revealed 25 heteroplasmic variants with potentially pathogenic features in 18 pairs. All variants were pair-specific and had low and/or similar heteroplasmy levels in both cotwins. In one pair, a confirmed pathogenic variant (m.11778G>A, heteroplasmy approximate to 50%) associated with Leber hereditary optic neuropathy was detected. Detailed diagnostic investigation revealed subclinical MS signs in the prior nondiseased cotwin. Moreover, neither mtDNA deletions nor copy-number variations were involved. Furthermore, the majority of heteroplasmic variants were shared among MZ twins and exhibited more similar heteroplasmy levels in the same tissue of MZ twins as compared with different tissues of the same individual. Heteroplasmy levels were also more similar within MZ twins compared with nonidentical siblings. Our analysis excludes mtDNA variation as a major driver of the discordant clinical manifestation of MS in MZ twins, and provides valuable insights into the occurrence and distribution of heteroplasmic variants within MZ twins and nonidentical siblings, and across different tissues.
C1 [Souren, Nicole Y. P.; Lutsik, Pavlo; Walter, Joern] Univ Saarland, Dept Genet Epigenet, Saarbrucken, Germany.
   [Gerdes, Lisa A.; Kuempfel, Tania; Hohlfeld, Reinhard] Univ Munich, Inst Clin Neuroimmunol, Med Campus Grosshadern, Munich, Germany.
   [Klopstock, Thomas] Univ Munich, Friedrich Baur Inst, Dept Neurol, Munich, Germany.
   [Klopstock, Thomas; Hohlfeld, Reinhard] Munich Cluster Syst Neurol SyNergy, Munich, Germany.
   [Klopstock, Thomas] DZNE German Ctr Neurodegenerat Dis, Munich, Germany.
C3 Saarland University; University of Munich; University of Munich; University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)
RP Souren, NYP (corresponding author), Univ Saarland, FR Biowissensch 8 3, Genet Epigenet, Nat Wissensch Tech Fak 3, Postfach 151150, D-66041 Saarbrucken, Germany.
EM nicole.souren@uni-saarland.de
FU German Multiple Sclerosis Foundation (National German and Regional Bavarian Foundation); German Research Council [SFB-TR 128 SyNergy]; Krankheitsbezogenes Kompetenznetz Multiple Sklerose; Verein zur Therapieforschung fur MS Kranke; Gemeinnutzige Hertie Stiftung; Deutsches Bundesministerium fur Bildung und Forschung through the German Network for Mitochondrial Disorders [mitoNET 01GM1113A]
CR Adzhubei Ivan, 2013, CURR PROTOC HUM GENET, VChapter 7, P0, DOI 10.1002/0471142905.hg0720s76
   Andrew T, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0022332
   Avital G, 2012, HUM MOL GENET, V21, P4214, DOI 10.1093/hmg/dds245
   Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8
   Baranzini SE, 2010, NATURE, V464, P1351, DOI 10.1038/nature08990
   Barnett MH, 2004, ANN NEUROL, V55, P458, DOI 10.1002/ana.20016
   Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770
   Bénit P, 2010, TRENDS MOL MED, V16, P210, DOI 10.1016/j.molmed.2010.03.001
   Blakely EL, 2004, J MED GENET, V41, P0, DOI 10.1136/jmg.2003.011296
   Blok MJ, 2009, J MED GENET, V46, P776, DOI 10.1136/jmg.2009.067686
   Blokhin A, 2008, J MOL NEUROSCI, V35, P283, DOI 10.1007/s12031-008-9115-1
   Brown MD, 2001, HUM GENET, V109, P33, DOI 10.1007/s004390100538
   Campbell GR, 2011, ANN NEUROL, V69, P481, DOI 10.1002/ana.22109
   Castellana S, 2015, HUM MUTAT, V36, PE2413, DOI 10.1002/humu.22720
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Chinnery PF, 2001, AM J MED GENET, V98, P235, DOI 10.1002/1096-8628(20010122)98:3<235::AID-AJMG1086>3.0.CO;2-O
   Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7
   Dahl H H, 2000, HUM REPROD, V15 Suppl 2, P246
   Degos B, 2014, J CLIN NEUROSCI, V21, P186, DOI 10.1016/j.jocn.2013.03.019
   Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549
   Ebers GC, 2004, LANCET, V363, P1773, DOI 10.1016/S0140-6736(04)16304-6
   Echaniz-Laguna A, 2010, ARCH NEUROL-CHICAGO, V67, P1140, DOI 10.1001/archneurol.2010.219
   Fischer MT, 2012, BRAIN, V135, P886, DOI 10.1093/brain/aws012
   Frederiksen AL, 2006, J MED GENET, V43, P0, DOI 10.1136/jmg.2005.039339
   Freyer C, 2012, NAT GENET, V44, P1282, DOI 10.1038/ng.2427
   Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505
   Goecks J, 2010, GENOME BIOL, V11, P0, DOI 10.1186/gb-2010-11-8-r86
   Hawkes CH, 2009, MULT SCLER J, V15, P661, DOI 10.1177/1352458509104592
   Hellebrekers DMEI, 2012, HUM REPROD UPDATE, V18, P341, DOI 10.1093/humupd/dms008
   Henderson APD, 2009, ANN NEUROL, V66, P739, DOI 10.1002/ana.21800
   Hoppenbrouwers IA, 2008, ARCH NEUROL-CHICAGO, V65, P345, DOI 10.1001/archneurol.2007.63
   Howell N, 2003, AM J HUM GENET, V72, P1460, DOI 10.1086/375537
   Hudson G, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004369
   Jacobs L, 2007, MOL HUM REPROD, V13, P149, DOI 10.1093/molehr/gal112
   JOHNS DR, 1993, BIOCHEM BIOPH RES CO, V196, P810, DOI 10.1006/bbrc.1993.2321
   Jokinen R, 2010, PLOS GENET, V6, P0, DOI 10.1371/journal.pgen.1001161
   Knez J, 2016, AM J EPIDEMIOL, V183, P138, DOI 10.1093/aje/kwv175
   Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111
   LAMMINEN T, 1995, AM J HUM GENET, V56, P1238
   Langmead B, 2012, NAT METHODS, V9, P357, DOI 10.1038/NMETH.1923
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Liu SY, 2011, ASIAN J ANDROL, V13, P298, DOI 10.1038/aja.2010.91
   Lott Marie T, 2013, CURR PROTOC BIOINFORMATICS, V44, P0, DOI 10.1002/0471250953.bi0123s44
   Lutz-Bonengel S, 2008, INT J LEGAL MED, V122, P315, DOI 10.1007/s00414-008-0240-8
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Molnar MJ, 2009, J NEUROL, V256, P264, DOI 10.1007/s00415-009-0841-2
   Nakahara J, 2012, CLIN REV ALLERG IMMU, V42, P26, DOI 10.1007/s12016-011-8287-6
   Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509
   Nikic I, 2011, NAT MED, V17, P495, DOI 10.1038/nm.2324
   Orsucci D, 2011, J MOL NEUROSCI, V44, P17, DOI 10.1007/s12031-010-9488-9
   Palace J, 2009, J NEUROL SCI, V286, P24, DOI 10.1016/j.jns.2009.09.009
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   Pfeffer G, 2013, NEUROLOGY, V81, P2073, DOI 10.1212/01.wnl.0000437308.22603.43
   Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366
   Pütz J, 2007, RNA, V13, P1184, DOI 10.1261/rna.588407
   Pyle A, 2010, INTENS CARE MED, V36, P956, DOI 10.1007/s00134-010-1823-7
   Rausch T, 2012, BIOINFORMATICS, V28, PI333, DOI 10.1093/bioinformatics/bts378
   Rebolledo-Jaramillo B, 2014, P NATL ACAD SCI USA, V111, P15474, DOI 10.1073/pnas.1409328111
   Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754
   Samuels DC, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003929
   Scott Lynette, 2002, REPROD BIOMED ONLINE, V5, P276
   Shtilbans A, 1999, J CHILD NEUROL, V14, P610, DOI 10.1177/088307389901400910
   Slee M, 2011, J CLIN NEUROSCI, V18, P1318, DOI 10.1016/j.jocn.2011.02.019
   Smith C, 2010, NUCLEIC ACIDS RES, V38, PW373, DOI 10.1093/nar/gkq316
   Spyropoulos A, 2013, JAMA NEUROL, V70, P1552, DOI 10.1001/jamaneurol.2013.4111
   Stewart JD, 2010, HEPATOLOGY, V52, P1791, DOI 10.1002/hep.23891
   SWEENEY VP, 1986, CAN J NEUROL SCI, V13, P47, DOI 10.1017/S0317167100035782
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Taylor RW, 1998, BIOCHEM BIOPH RES CO, V243, P47, DOI 10.1006/bbrc.1997.8055
   Thiede C, 2000, BONE MARROW TRANSPL, V25, P575, DOI 10.1038/sj.bmt.1702170
   Tranah GJ, 2015, NEUROLOGY, V85, P325, DOI 10.1212/WNL.0000000000001744
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Vianello D, 2013, HUM MUTAT, V34, P1189, DOI 10.1002/humu.22356
   Wang J, 2012, GENET MED, V14, P620, DOI 10.1038/gim.2012.4
   Westerlind H, 2014, BRAIN, V137, P770, DOI 10.1093/brain/awt356
   Witte ME, 2014, TRENDS MOL MED, V20, P179, DOI 10.1016/j.molmed.2013.11.007
   Wolf C, 2010, BMC GENET, V11, P0, DOI 10.1186/1471-2156-11-8
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
   Yarham JW, 2012, MITOCHONDRION, V12, P533, DOI 10.1016/j.mito.2012.06.009
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
   Ye KX, 2014, P NATL ACAD SCI USA, V111, P10654, DOI 10.1073/pnas.1403521111
   Zhang W, 2012, CLIN CHEM, V58, P1322, DOI 10.1373/clinchem.2011.181438
NR 83
TC 12
Z9 12
U1 2
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1059-7794
EI 1098-1004
J9 HUM MUTAT
JI Hum. Mutat.
PD AUG 15
PY 2016
VL 37
IS 8
BP 765
EP 775
DI 10.1002/humu.23003
PG 11
WC Genetics & Heredity
SC Genetics & Heredity
GA DR5GU
UT WOS:000379932300007
PM 27119776
DA 2024-11-01
ER

PT J
AU Pinto, M
   Nissanka, N
   Peralta, S
   Brambilla, R
   Diaz, F
   Moraes, CT
AF Pinto, Milena
   Nissanka, Nadee
   Peralta, Susana
   Brambilla, Roberta
   Diaz, Francisca
   Moraes, Carlos T.
TI Pioglitazone ameliorates the phenotype of a novel Parkinson's disease mouse model by reducing neuroinflammation
SO MOLECULAR NEURODEGENERATION
LA English
DT Article
DE Mitochondria; Pioglitazone; Neuroinflammation
ID activated receptor-gamma; mitochondrial-dna deletions; skeletal-muscle; substantia-nigra; agonist pioglitazone; animal-models; complex-i; mechanisms; neurons; mptp
AB Background: Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by motor and non-motor symptoms. The cause of the motor symptoms is the loss of dopaminergic neurons in the substantia nigra with consequent depletion of dopamine in the striatum. Although the etiology of PD is unknown, mitochondrial dysfunctions, including cytochrome c oxidase (Complex IV) impairment in dopaminergic neurons, have been associated with the disease's pathophysiology. In order to analyze the role of Complex IV in PD, we knocked out Cox10 (essential for the maturation of COXI, a catalytic subunit of Complex IV) in dopaminergic neurons. We also tested whether the resulting phenotype was improved by stimulating the PPAR-gamma pathway. Results: Cox10/DAT-cre mice showed decreased numbers of TH+ and DAT+ cells in the substantia nigra, early striatal dopamine depletion, motor defects reversible with L-DOPA treatment and hypersensitivity to L-DOPA with hyperkinetic behavior. We found that chronic pioglitazone (PPAR-gamma agonist) treatment ameliorated the motor phenotype in Cox10/DAT-cre mice. Although neither mitochondrial function nor the number of dopaminergic neurons was improved, neuroinflammation in the midbrain and the striatum was decreased. Conclusions: By triggering a mitochondrial Complex IV defect in dopaminergic neurons, we created a new mouse model resembling the late stages of PD with massive degeneration of dopaminergic neurons and striatal dopamine depletion. The motor phenotypes were improved by Pioglitazone treatment, suggesting that targetable secondary pathways can influence the development of certain forms of PD.
C1 [Pinto, Milena; Peralta, Susana; Diaz, Francisca; Moraes, Carlos T.] Univ Miami, Dept Neurol, Miller Sch Med, 1420 NW 9th Ave,Rm 229, Miami, FL 33136 USA.
   [Nissanka, Nadee; Brambilla, Roberta] Univ Miami, Miller Sch Med, Neurosci Grad Program, Miami, FL 33136 USA.
   [Brambilla, Roberta] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA.
   [Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Cell Biol, Miami, FL 33136 USA.
C3 University of Miami; University of Miami; University of Miami; University of Miami
RP Moraes, CT (corresponding author), Univ Miami, Dept Neurol, Miller Sch Med, 1420 NW 9th Ave,Rm 229, Miami, FL 33136 USA.; Moraes, CT (corresponding author), Univ Miami, Miller Sch Med, Dept Cell Biol, Miami, FL 33136 USA.
EM cmoraes@med.miami.edu
FU US National Institutes of Health [5R01EY010804, 1R01AG036871, 1R01NS079965]; Florida Department of Health Ed and Ethel Moore Alzheimer's Disease Research Program [5AZ06]; Miami Center for AIDS Research (CFAR) at the University of Miami Miller School of Medicine; National Institutes of Health (NIH) [P30AI073961]
CR Aviles-Olmos I, 2013, BRAIN, V136, P374, DOI 10.1093/brain/aws009
   Bäckman CM, 2006, GENESIS, V44, P383, DOI 10.1002/dvg.20228
   Banerjee R, 2009, BBA-MOL BASIS DIS, V1792, P651, DOI 10.1016/j.bbadis.2008.11.007
   Barbiero JK, 2014, BEHAV BRAIN RES, V274, P390, DOI 10.1016/j.bbr.2014.08.014
   Bargiotas P, 2013, NEUROPSYCH DIS TREAT, V9, P1605, DOI 10.2147/NDT.S36693
   Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   BENECKE R, 1993, BRAIN, V116, P1451, DOI 10.1093/brain/116.6.1451
   BINDOFF LA, 1991, J NEUROL SCI, V104, P203, DOI 10.1016/0022-510X(91)90311-T
   BLIN O, 1994, J NEUROL SCI, V125, P95, DOI 10.1016/0022-510X(94)90248-8
   Brooks SP, 2009, NAT REV NEUROSCI, V10, P519, DOI 10.1038/nrn2652
   CARDELLACH F, 1993, NEUROLOGY, V43, P2258, DOI 10.1212/WNL.43.11.2258
   Carta AR, 2013, NEUROTOX RES, V23, P112, DOI 10.1007/s12640-012-9342-7
   Cenci MA, 2007, PARKINSONISM RELAT D, V13, PS263, DOI 10.1016/S1353-8020(08)70014-2
   Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3
   Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034
   Diaz F, 2005, HUM MOL GENET, V14, P2737, DOI 10.1093/hmg/ddi307
   Duty S, 2011, BRIT J PHARMACOL, V164, P1357, DOI 10.1111/j.1476-5381.2011.01426.x
   Eiyama A, 2015, CURR OPIN CELL BIOL, V33, P95, DOI 10.1016/j.ceb.2015.01.002
   Ekstrand MI, 2009, PARKINSONISM RELAT D, V15, PS185, DOI 10.1016/S1353-8020(09)70811-9
   Hatami A, 2015, CURR TOP BEHAV NEURO, V22, P303, DOI 10.1007/7854_2014_355
   Heneka MT, 2007, NAT CLIN PRACT NEURO, V3, P496, DOI 10.1038/ncpneuro0586
   Jackson-Lewis V, 2007, NAT PROTOC, V2, P141, DOI 10.1038/nprot.2006.342
   Kim DS, 2000, J NEUROSCI, V20, P4405, DOI 10.1523/JNEUROSCI.20-12-04405.2000
   Kim HW, 2015, NEUROBIOL AGING, V36, P2617, DOI 10.1016/j.neurobiolaging.2015.05.008
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Lee S, 2012, HUM MOL GENET, V21, P4827, DOI 10.1093/hmg/dds352
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   Maeshiba Y, 1997, ARZNEIMITTEL-FORSCH, V47, P29
   Mandrekar-Colucci S, 2012, J NEUROSCI, V32, P10117, DOI 10.1523/JNEUROSCI.5268-11.2012
   MOGI T, 1994, MOL MICROBIOL, V14, P391, DOI 10.1111/j.1365-2958.1994.tb02174.x
   Morató L, 2013, BRAIN, V136, P2432, DOI 10.1093/brain/awt143
   Napolitano M, 2011, BRAIN RES BULL, V85, P231, DOI 10.1016/j.brainresbull.2011.03.011
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Navarro A, 2010, FRONT AGING NEUROSCI, V0, P2
   Noe N, 2013, MITOCHONDRION, V13, P417, DOI 10.1016/j.mito.2012.12.003
   Peralta S, 2015, MITOCHONDRION, V23, P71, DOI 10.1016/j.mito.2015.01.007
   Pickrell AM, 2013, MOL CELL NEUROSCI, V55, P87, DOI 10.1016/j.mcn.2012.08.002
   Pickrell AM, 2011, J NEUROSCI, V31, P17649, DOI 10.1523/JNEUROSCI.4871-11.2011
   Przedborski S, 2001, J NEUROCHEM, V76, P1265, DOI 10.1046/j.1471-4159.2001.00183.x
   Puigserver P, 2005, INT J OBESITY, V29, PS5, DOI 10.1038/sj.ijo.0802905
   Quinn L, 2008, BRIT J PHARMACOL, V154, P226, DOI 10.1038/bjp.2008.78
   Rocha NP, 2015, BIOMED RES INT, V2015, P0, DOI 10.1155/2015/628192
   Schapira AHV, 2014, LANCET, V384, P545, DOI 10.1016/S0140-6736(14)61010-2
   Simuni T, 2015, LANCET NEUROL, V14, P795, DOI 10.1016/S1474-4422(15)00144-1
   Swanson C, 2014, NEUROL RES, V36, P634, DOI 10.1179/1743132813Y.0000000305
   Swanson CR, 2011, J NEUROINFLAMM, V8, P0, DOI 10.1186/1742-2094-8-91
   Ulusoy GK, 2011, BRAIN RES BULL, V85, P380, DOI 10.1016/j.brainresbull.2011.05.001
   Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006
   Yamanaka M, 2012, J NEUROSCI, V32, P17321, DOI 10.1523/JNEUROSCI.1569-12.2012
   Yu Y, 2014, J NEURAL TRANSM, V13, P0
NR 51
TC 57
Z9 61
U1 0
U2 13
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 
EI 1750-1326
J9 MOL NEURODEGENER
JI Mol. Neurodegener.
PD APR 2
PY 2016
VL 11
IS 
BP 
EP 
DI 10.1186/s13024-016-0090-7
PG 15
WC Neurosciences
SC Neurosciences & Neurology
GA DI0OS
UT WOS:000373197200001
PM 27038906
DA 2024-11-01
ER

PT J
AU Baumgart, BR
   Gray, KL
   Woicke, J
   Bunch, RT
   Sanderson, TP
   Van Vleet, TR
AF Baumgart, Bethany R.
   Gray, Katherine L.
   Woicke, Jochen
   Bunch, Roderick T.
   Sanderson, Thomas P.
   Van Vleet, Terry R.
TI MicroRNA as biomarkers of mitochondrial toxicity
SO TOXICOLOGY AND APPLIED PHARMACOLOGY
LA English
DT Article
DE MicroRNA; Mitochondria; Toxicity; Drug safety
ID potential biomarkers; huntingtons-disease; messenger-rnas; rotenone; protein; brain; biogenesis; expression; targets; liver
AB Mitochondrial toxicity can be difficult to detect as most cells can tolerate reduced activity as long as minimal capacity for function is maintained. However, once minimal capacity is lost, apoptosis or necrosis occurs quickly. Identification of more sensitive, early markers of mitochondrial toxicity was the objective of this work. Rotenone, a mitochondrial complex I inhibitor, and 3-nitropropionic acid (3-NP), a mitochondrial complex II inhibitor, were administered daily to male Sprague-Dawley rats at subcutaneous doses of 0.1 or 0.3 mg/kg/day and intraperitoneal doses of 5 or 10 mg/kg/day, respectively, for 1 week. Samples of kidney, skeletal muscle (quadriceps femoris), and serum were collected for analysis of mitochondrial DNA (mtDNA) copy number and microRNA (miRNA) expression patterns. MtDNA was significantly decreased with administration of rotenone at 03 mg/kg/day and 3-NP at 5 and 10 mg/kg/day in the quadriceps femoris and with 3-NP at 10 mg/kg/day in the kidney. Additionally, rotenone and 3-NP treatment produced changes to miRNA expression that were similar in direction (i.e. upregulation, downregulation) to those previously linked to mitochondrial functions, such as mitochondrial damage and biogenesis (miR-122, miR-202-3p); regulation of ATP synthesis, abolished oxidative phosphorylation, and loss of membrane potential due to increased reactive oxygen species (ROS) production (miR-338-5p, miR-546, miR-34c); and mitochondrial DNA damage and depletion (miR-546). These results suggest that miRNAs may be sensitive biomarkers for early detection of mitochondrial toxicity. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Baumgart, Bethany R.; Gray, Katherine L.; Bunch, Roderick T.; Sanderson, Thomas P.] Bristol Myers Squibb, Dept Toxicol, Drug Safety Evaluat, 4401 Highway 62 East, Mt Vernon, IA 47620 USA.
   [Woicke, Jochen] Bristol Myers Squibb, Dept Pathol, Drug Safety Evaluat, 4401 Highway 62 East, Mt Vernon, IA 47620 USA.
   [Van Vleet, Terry R.] Abbvie, Dept Investigat Toxicol & Pathol, 1 N Waukegan Rd, N Chicago, IL 60064 USA.
C3 Bristol-Myers Squibb; Bristol-Myers Squibb; AbbVie
RP Baumgart, BR (corresponding author), Bristol Myers Squibb, Dept Toxicol, Drug Safety Evaluat, 4401 Highway 62 East, Mt Vernon, IA 47620 USA.
EM bethany.baumgart@bms.com
CR Aschrafi A, 2012, LIFE SCI, V0, P0
   Aschrafi A, 2008, J NEUROSCI, V28, P12581, DOI 10.1523/JNEUROSCI.3338-08.2008
   Balasubramaniam S, 2012, JIMD REP, V5, P113, DOI 10.1007/8904_2011_107
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079
   Betel D, 2008, NUCLEIC ACIDS RES, V36, PD149, DOI 10.1093/nar/gkm995
   Binienda ZK, 2013, NEUROSCI LETT, V541, P233, DOI 10.1016/j.neulet.2013.02.047
   Borland MK, 2009, BBA-MOL BASIS DIS, V1792, P68, DOI 10.1016/j.bbadis.2008.09.014
   Brouillet Emmanuel, 2014, CURR PROTOC NEUROSCI, V67, P0, DOI 10.1002/0471142301.ns0948s67
   Brown AM, 2001, J MOL NEUROSCI, V16, P41, DOI 10.1385/JMN:16:1:41
   Brustoloni YM, 2007, MEM I OSWALDO CRUZ, V102, P497, DOI 10.1590/S0074-02762007005000036
   Burchard J, 2010, MOL SYST BIOL, V6, P0, DOI 10.1038/msb.2010.58
   Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242
   Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404
   Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008
   Dykens JA, 2007, DRUG DISCOV TODAY, V12, P777, DOI 10.1016/j.drudis.2007.07.013
   Fan M, 2004, GENE DEV, V18, P278, DOI 10.1101/gad.1152204
   Filipowicz W, 2011, PROG DRUG RES, V67, P221, DOI 10.1007/978-3-7643-8989-5_11
   Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108
   Fukuhara T, 2012, J VIROL, V86, P7918, DOI 10.1128/JVI.00567-12
   Gargalionis AN, 2013, CURR TOP MED CHEM, V13, P1493, DOI 10.2174/15680266113139990098
   Guay C, 2015, CELL COMMUN SIGNAL, V13, P0, DOI 10.1186/s12964-015-0097-7
   Im HI, 2012, TRENDS NEUROSCI, V35, P325, DOI 10.1016/j.tins.2012.01.004
   Iorio MV, 2012, CANCER J, V18, P215, DOI 10.1097/PPO.0b013e318250c001
   Ji KQ, 2015, FREE RADICAL BIO MED, V84, P161, DOI 10.1016/j.freeradbiomed.2015.03.020
   Kumar P, 2011, BRIT J PHARMACOL, V164, P644, DOI 10.1111/j.1476-5381.2011.01418.x
   Lapointe Nicolas, 2004, FASEB J, V18, P717
   Lee WT, 2002, NEUROSCIENCE, V113, P699, DOI 10.1016/S0306-4522(02)00177-X
   Lewis AP, 2010, BIOCHEM SOC T, V38, P1553, DOI 10.1042/BST0381553
   Miñones-Moyano E, 2011, HUM MOL GENET, V20, P3067, DOI 10.1093/hmg/ddr210
   Mirandola SR, 2010, J NEUROSCI RES, V88, P630, DOI 10.1002/jnr.22239
   Mohamed JS, 2014, DIABETES, V63, P1546, DOI 10.2337/db13-1364
   Muniesa A, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0093491
   Ohlenbusch A, 2012, ORPHANET J RARE DIS, V7, P0, DOI 10.1186/1750-1172-7-69
   Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523
   Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001
   Pereira CV, 2009, CURR DRUG SAF, V4, P34, DOI 10.2174/157488609787354440
   Pereira SP, 2009, ATLA-ALTERN LAB ANIM, V37, P355, DOI 10.1177/026119290903700406
   Picard M, 2013, AM J PHYSL REGUL INT, V304, P0
   Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105
   Qiao C, 2011, GENE THER, V18, P403, DOI 10.1038/gt.2010.157
   Seyhan AA, 2015, MOL BIOSYST, V11, P1217, DOI 10.1039/c5mb00064e
   Sherer TB, 2003, J NEUROSCI, V23, P10756, DOI 10.1523/jneurosci.23-34-10756.2003
   Subramaniam SR, 2013, PROG NEUROBIOL, V106, P17, DOI 10.1016/j.pneurobio.2013.04.004
   Suzuki Hiromu, 2013, FRONTIERS IN GENETICS, V4, P258, DOI 10.3389/fgene.2013.00258
   Tariq M, 2005, BRAIN RES BULL, V67, P161, DOI 10.1016/j.brainresbull.2005.06.024
   Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112
   Venegas Victor, 2011, CURR PROTOC HUM GENET, VChapter 19, P0, DOI 10.1002/0471142905.hg1907s68
   Verdejo HE, 2012, CURR HYPERTENS REP, V14, P532, DOI 10.1007/s11906-012-0305-4
   Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106
   Wang QF, 2014, CLIN CANCER RES, V20, P1146, DOI 10.1158/1078-0432.CCR-13-1023
   Watkins J, 2008, J PROTEOME RES, V7, P328, DOI 10.1021/pr070300g
   WEISS J, 1994, J CLIN MICROBIOL, V32, P1663, DOI 10.1128/JCM.32.7.1663-1668.1994
   White NMA, 2011, J UROLOGY, V186, P1077, DOI 10.1016/j.juro.2011.04.110
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Xiong N, 2012, CRIT REV TOXICOL, V42, P613, DOI 10.3109/10408444.2012.680431
   Yan YL, 2015, COMP BIOCHEM PHYS A, V183, P64, DOI 10.1016/j.cbpa.2014.12.011
   Yang Y, 2005, J NEUROSCI RES, V80, P440, DOI 10.1002/jnr.20467
   Yong FL, 2013, BMC CANCER, V13, P0, DOI 10.1186/1471-2407-13-280
   Yu Zuoren, 2012, FRONTIERS IN GENETICS, V3, P191, DOI 10.3389/fgene.2012.00191
   Yuan JS, 2006, BMC BIOINFORMATICS, V7, P0, DOI 10.1186/1471-2105-7-85
   Zaitone SA, 2012, PHARMACOL BIOCHEM BE, V100, P347, DOI 10.1016/j.pbb.2011.09.002
   Zhao Y, 2013, PLOS ONE, V8, P0
NR 63
TC 10
Z9 10
U1 0
U2 18
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0041-008X
EI 1096-0333
J9 TOXICOL APPL PHARM
JI Toxicol. Appl. Pharmacol.
PD DEC 1
PY 2016
VL 312
IS 
BP 26
EP 33
DI 10.1016/j.taap.2015.10.007
PG 8
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA EE8JA
UT WOS:000389870300005
PM 26476301
DA 2024-11-01
ER

PT J
AU El-Hattab, AW
   Scaglia, F
AF El-Hattab, Ayman W.
   Scaglia, Fernando
TI Mitochondrial cytopathies
SO CELL CALCIUM
LA English
DT Review
DE Mitochondrial diseases; Mitochondrial dysfunction; Mitochondrial DNA; Electron transport chain; Diagnosis of mitochondrial diseases; Treatment of mitochondrial diseases
ID dna mutations; disease; melas; replication; biogenesis; deficiency; citrulline; disorders; depletion; coq(10)
AB Mitochondria are found in all nucleated human cells and perform a variety of essential functions, including the generation of cellular energy. Most of mitochondrial proteins are encoded by the nuclear DNA (nDNA) whereas a very small fraction is encoded by the mitochondrial DNA (mtDNA). Mutations in mtDNA or mitochondria-related nDNA genes can result in mitochondrial dysfunction which leads to a wide range of cellular perturbations including aberrant calcium homeostasis, excessive reactive oxygen species production, dysregulated apoptosis, and insufficient energy generation to meet the needs of various organs, particularly those with high energy demand. Impaired mitochondrial function in various tissues and organs results in the multi-organ manifestations of mitochondrial diseases including epilepsy, intellectual disability, skeletal and cardiac myopathies, hepatopathies, endocrinopathies, and nephropathies. Defects in nDNA genes can be inherited in an autosomal or X-linked manners, whereas, mtDNA is maternally inherited. Mitochondrial diseases can result from mutations of nDNA genes encoding subunits of the electron transport chain complexes or their assembly factors, proteins associated with the mitochondrial import or networking, mitochondria translation factors, or proteins involved in mtDNA maintenance. MtDNA defects can be either point mutations or rearrangements. The diagnosis of mitochondrial disorders can be challenging in many cases and is based on clinical recognition, biochemical screening, histopathological studies, functional studies, and molecular genetic testing. Currently, there are no satisfactory therapies available for mitochondrial disorders that significantly alter the course of the disease. Therapeutic options include symptomatic treatment, cofactor supplementation, and exercise. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [El-Hattab, Ayman W.] Tawam Hosp, Dept Pediat, Div Clin Genet & Metab Disorders, Al Ain, U Arab Emirates.
   [Scaglia, Fernando] Baylor Coll Med, Dept Mol & Human Genet, One Baylor Plaza,MS BCM225, Houston, TX 77030 USA.
C3 Baylor College of Medicine
RP Scaglia, F (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, One Baylor Plaza,MS BCM225, Houston, TX 77030 USA.
EM fscaglia@bcm.edu
CR Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Bonnen PE, 2013, AM J HUM GENET, V93, P471, DOI 10.1016/j.ajhg.2013.07.017
   Calvo J, 2009, ARCH NEUROL, V66, P0
   Carrodeguas JA, 2001, MOL CELL, V7, P43, DOI 10.1016/S1097-2765(01)00153-8
   Chinnery PF, 2000, GENEREVIEWS, V0, P1993
   Chinnery PF, 2013, BRIT MED BULL, V106, P135, DOI 10.1093/bmb/ldt017
   CLAYTON DA, 1991, ANNU REV CELL BIOL, V7, P453, DOI 10.1146/annurev.cb.07.110191.002321
   Coenen MJ, 2004, N ENGL J MED, V351, P0
   Di Giovanni S, 2001, NEUROLOGY, V57, P515, DOI 10.1212/WNL.57.3.515
   El-Hattab AW, 2015, INBORN ERRORS METABO, V0, P180
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   El-Hattab AW, 2012, MOL GENET METAB, V107, P247, DOI 10.1016/j.ymgme.2012.06.018
   El-Hattab AW, 2012, MOL GENET METAB, V105, P607, DOI 10.1016/j.ymgme.2012.01.016
   Enns GM, 2012, MOL GENET METAB, V105, P91, DOI 10.1016/j.ymgme.2011.10.009
   Fujita Y, 2015, MITOCHONDRION, V20, P34, DOI 10.1016/j.mito.2014.10.006
   Galluzzi L, 2012, CIRC RES, V111, P1198, DOI 10.1161/CIRCRESAHA.112.268946
   Gold DR, 2001, SEMIN NEUROL, V21, P309, DOI 10.1055/s-2001-17948
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Jacobs HT, 2003, HUM MOL GENET, V12, PR293, DOI 10.1093/hmg/ddg285
   Kang CH, 2012, ANN NY ACAD SCI, V1271, P110, DOI 10.1111/j.1749-6632.2012.06738.x
   Koene S, 2015, JIMD REP, V24, P69, DOI 10.1007/8904_2015_436
   Koga Y, 2007, MITOCHONDRION, V7, P133, DOI 10.1016/j.mito.2006.11.006
   Lang BF, 1999, ANNU REV GENET, V33, P351, DOI 10.1146/annurev.genet.33.1.351
   Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009
   MacKenzie JA, 2007, BBA-MOL BASIS DIS, V1772, P509, DOI 10.1016/j.bbadis.2006.12.002
   MACMILLAN C, 1993, NEUROLOGY, V43, P1586, DOI 10.1212/WNL.43.8.1586
   Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626
   Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282
   Munnich A, 2012, INBORN METABOLIC DIS, V0, P223
   Potgieter M, 2013, NUTR REV, V71, P180, DOI 10.1111/nure.12011
   Rodriguez MC, 2007, MUSCLE NERVE, V35, P235, DOI 10.1002/mus.20688
   Rouault TA, 2012, DIS MODEL MECH, V5, P155, DOI 10.1242/dmm.009019
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755
   Shitara H, 1998, GENETICS, V148, P851
   Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Suomalainen Anu, 2013, EXPERT OPIN MED DIAGN, V7, P313, DOI 10.1517/17530059.2013.812070
   Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050
   Tarnopolsky MA, 2011, AMINO ACIDS, V40, P1397, DOI 10.1007/s00726-011-0876-4
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Thorburn DR, 2003, GENEREVIEWS, V0, P0
   Thorburn DR, 2004, BBA-BIOENERGETICS, V1659, P121, DOI 10.1016/j.bbabio.2004.08.006
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Willems PHGM, 2008, CELL CALCIUM, V44, P123, DOI 10.1016/j.ceca.2008.01.002
   Ylikallio E, 2012, ANN MED, V44, P41, DOI 10.3109/07853890.2011.598547
   Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855
NR 49
TC 65
Z9 69
U1 1
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0143-4160
EI 1532-1991
J9 CELL CALCIUM
JI Cell Calcium
PD SEP 15
PY 2016
VL 60
IS 3
BP 199
EP 206
DI 10.1016/j.ceca.2016.03.003
PG 8
WC Cell Biology
SC Cell Biology
GA DW8YB
UT WOS:000383940300007
PM 26996063
DA 2024-11-01
ER

PT J
AU Béreau, M
   Anheim, M
   Echaniz-Laguna, A
   Magot, A
   Verny, C
   Goideau-Sevrain, M
   Barth, M
   Amati-Bonneau, P
   Allouche, S
   Ayrignac, X
   Bédat-Millet, AL
   Guyant-Maréchal, L
   Kuntzer, T
   Ochsner, F
   Petiot, P
   Vial, C
   Omer, S
   Sole, G
   Taieb, G
   Carvalho, N
   Tio, G
   Kremer, S
   Acquaviva-Bourdain, C
   de Camaret, BM
   Tranchant, C
AF Bereau, M.
   Anheim, M.
   Echaniz-Laguna, A.
   Magot, A.
   Verny, C.
   Goideau-Sevrain, M.
   Barth, M.
   Amati-Bonneau, P.
   Allouche, S.
   Ayrignac, X.
   Bedat-Millet, A. -L.
   Guyant-Marechal, L.
   Kuntzer, T.
   Ochsner, F.
   Petiot, P.
   Vial, C.
   Omer, S.
   Sole, G.
   Taieb, G.
   Carvalho, N.
   Tio, G.
   Kremer, S.
   Acquaviva-Bourdain, C.
   de Camaret, B. Mousson
   Tranchant, C.
TI The wide <i>POLG</i>-related spectrum: An integrated view
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Article
DE POLG-related spectrum; Genotype-phenotype correlations
ID progressive external ophthalmoplegia; ataxic neuropathy; mutations; depletion; a467t
AB The aims of this study were to describe the spectrum of recessively inherited POLG-related disorders, to report new POLG mutations and to discuss genotype-phenotype correlations in order to propose a strategy for diagnosis. Twenty eight patients diagnosed with two POLG mutations at 12 tertiary European centers of adult neurology were studied. Exhaustive phenotypic data, brain MRI, muscle analysis, mitochondrial DNA and POLG analysis findings were collected. Five distinct phenotypes were observed: Sensory Ataxic Neuropathy, Dysarthria and Ophthalmoparesis (SANDO), autosomal recessive Progressive External Ophthalmoplegia (arPEO), Spino Cerebellar Ataxia with Epilepsy (SCAE), Mitochondrial Neuro Gastro Intestinal Encephalopathy (MNGIE)-like phenotype and Sensory Ataxic Neuropathy with Ophthalmoparesis but without dysarthria which we propose to name SANG. An increasing gradient of functional severity was appreciated from PEO with the best prognosis, to SANG, SANDO and finally SCAE respectively. Four new missense mutations were found. Regarding genotype/phenotype correlations, P587L mutation was associated with SANG rather than with SANDO (p < 0.005) and W748S mutation was associated with SANDO or SCAE (with more severe disease progression), rather than with SANG or PEO (p < 0.004). Distinguishing between various phenotypes can have important diagnosis and prognosis implications. POLG mutations should be priority searched for in cases of SANDO or SANG. Mitochondrial respiratory chain and mitochondrial DNA studies should be considered in the case of negative POLG analysis or other phenotypes. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Bereau, M.] Hop Jean Minjoz, Dept Neurol, Besancon, France.
   [Anheim, M.; Echaniz-Laguna, A.; Tranchant, C.] Hop Hautepierre, Serv Neurol, Unite Pathol Mouvement, Strasbourg, France.
   [Anheim, M.; Echaniz-Laguna, A.; Tranchant, C.] Fac Med, Federat Med Translat FMTS, Strasbourg, France.
   [Echaniz-Laguna, A.] Ctr Reference Neuromusculaire Grand Est CERNEST, Paris, France.
   [Magot, A.] Hop Hotel Dieu, CHU Nantes, Ctr Reference Malad Neuromusculaires, Nantes, France.
   [Verny, C.; Goideau-Sevrain, M.] CHU Angers, Ctr Reference Malad Neurogenet, Angers, France.
   [Barth, M.; Amati-Bonneau, P.] CHU Angers, Dept Biochim & Genet, Angers, France.
   [Allouche, S.] CHU Caen, Hop Cote Nacre, Serv Biochim, Caen, France.
   [Ayrignac, X.] CHRU Montpellier, Dept Neurol, Montpellier, France.
   [Bedat-Millet, A. -L.] Hop Charles Nicolle, Dept Neurol, Rouen, France.
   [Guyant-Marechal, L.] Hop Charles Nicolle, Unite Genet Clin, Rouen, France.
   [Kuntzer, T.; Ochsner, F.] Lausanne Univ Hosp CHUV, Dept Clin Neurosci, Lausanne, Switzerland.
   [Petiot, P.] Hop Croix Rousse, Ctr Reference Malad Neuromusculaires Reg Rone Alp, Neurol & Explorat Fonct Neurol, Lyon, France.
   [Vial, C.] Hop Neurol, Serv ENMG & Pathol NeuroMusculaires, Lyon, France.
   [Omer, S.] St George Hosp, Dept Neurol, London, England.
   [Sole, G.] CHU Bordeaux, Dept Neurol, Bordeaux, France.
   [Taieb, G.] Hop Univ Caremeaux, Dept Neurol, Nimes, France.
   [Carvalho, N.] Univ Franche Comte, Neurosci Lab, EA 481, Besancon, France.
   [Tio, G.] CHRU Besancon, INSERM, Ctr Invest Clin & Innovat Technol, Dept Stat,CIT 808, Besancon, France.
   [Kremer, S.] Univ Strasbourg, Hop Hautepierre, CHU Strasbourg, Federat Med Translat Cube 1,Imagerie 2, Strasbourg, France.
   [Acquaviva-Bourdain, C.; de Camaret, B. Mousson] CHU Lyon, Ctr Biol & Pathol Est, Serv Malad Hereditaires Metab, F-69677 Bron, France.
C3 Universite de Franche-Comte; CHU Besancon; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; Nantes Universite; CHU de Nantes; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; CHU de Caen NORMANDIE; Universite de Caen Normandie; Universite de Montpellier; CHU de Montpellier; Universite de Rouen Normandie; CHU de Rouen; Universite de Rouen Normandie; CHU de Rouen; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); CHU Lyon; CHU Lyon; City St Georges, University of London; CHU Bordeaux; Universite de Bordeaux; Universite de Franche-Comte; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Franche-Comte; CHU Besancon; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; CHU Lyon
RP Anheim, M (corresponding author), Hospices Civils Strasbourg, Dept Neurol, 1 Pl Hop BP 426, F-67091 Strasbourg, France.
EM mathieu.anheim@chru-strasbourg.fr
CR Anheim M, 2010, NEUROGENETICS, V11, P1, DOI 10.1007/s10048-009-0196-y
   Anheim M, 1900, V366, V0, P636
   Bindoff LA, 2012, EPILEPSIA, V53, P92, DOI 10.1111/j.1528-1167.2012.03618.x
   Chabi B, 2003, CLIN CHEM, V49, P1309, DOI 10.1373/49.8.1309
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   De Camaret BM, 2007, BIOCHEM J, V402, P377, DOI 10.1042/BJ20060705
   Echaniz-Laguna A, 2010, ARCH NEUROL-CHICAGO, V67, P1140, DOI 10.1001/archneurol.2010.219
   Farnum GA, 1837, BIOCHIM BIOPHYS ACTA, V7, P1113
   Feillet F, 1999, PEDIATR NEUROL, V20, P305, DOI 10.1016/S0887-8994(98)00162-3
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Horga A, 1900, V137, V0, P3200
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   Kinghorn KJ, 2013, J NEUROL, V260, P3, DOI 10.1007/s00415-012-6564-9
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Sidiropoulos C, 2013, NEUROLOGY, V81, P197, DOI 10.1212/WNL.0b013e31829a3438
   Tang S, 2012, J NEUROL, V259, P862, DOI 10.1007/s00415-011-6268-6
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Tchikviladze M, 1900, V86, V0, P646
   Tzoulis C, 1900, V133, V0, P1428
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, HUM MUTAT, V22, P175, DOI 10.1002/humu.10246
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
NR 25
TC 9
Z9 9
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD SEP 15
PY 2016
VL 368
IS 
BP 70
EP 76
DI 10.1016/j.jns.2016.06.062
PG 7
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA DU7SU
UT WOS:000382415700013
PM 27538604
DA 2024-11-01
ER

PT J
AU Altanbyek, V
   Cha, SJ
   Kang, GU
   Im, DS
   Lee, S
   Kim, HJ
   Kim, K
AF Altanbyek, Volodya
   Cha, Sun-Joo
   Kang, Ga-Un
   Im, Dai Sig
   Lee, Seongsoo
   Kim, Hyung-Jun
   Kim, Kiyoung
TI Imbalance of mitochondrial dynamics in <i>Drosophila</i> models of amyotrophic lateral sclerosis
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Mitochondrial dynamics; Mitochondria! dynamics regulatory proteins; Drosophila; DNA/RNA-Binding protein; Amyotrophic lateral sclerosis
ID mutations; fission; disease; fusion; pink1
AB Amyotrophic lateral sclerosis (ALS) is the most common neurodegenerative disease, characterized by progressive and selective loss of motor neurons in the brain and spinal cord. DNA/RNA-binding proteins such as TDP-43, FUS, and TAF15 have been linked with the sporadic and familial forms of ALS. However, the exact pathogenic mechanism of ALS is still unknown. Recently, we found that ALS-causing genes such as TDP-43, FUS, and TAF15 genetically interact with mitochondrial dynamics regulatory genes. In this study, we show that mitochondria! fission was highly enhanced in muscles and motor neurons of TDP-43, FUS, and TAF15-induced fly models of ALS. Furthermore, the mitochondrial fission defects were rescued by co-expression of mitochondrial dynamics regulatory genes such as Marf, Opa1, and the dominant negative mutant form of Drp1. Moreover, we found that the expression level of Marf was decreased in ALS-induced flies. These results indicate that the imbalance of mitochondrial dynamics caused by instability of Marf is linked to the pathogenesis of TDP-43, FUS, and TAF15-associated ALS. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Altanbyek, Volodya; Cha, Sun-Joo] Soonchunhyang Univ, Soochunhyang Inst Medibio Sci, Cheonan 31151, South Korea.
   [Kang, Ga-Un; Kim, Kiyoung] Soonchunhyang Univ, Dept Med Biotechnol, Asan 31538, South Korea.
   [Im, Dai Sig] Soonchunhyang Univ, Dept Chem, Asan 31538, South Korea.
   [Lee, Seongsoo] Korea Basic Res Inst, Gwangju Ctr, Gwangju 61186, South Korea.
   [Kim, Hyung-Jun] Korea Brain Res Inst, Dept Convergence Brain Res, Daegu 41068, South Korea.
C3 Soonchunhyang University; Soonchunhyang University; Soonchunhyang University; Korea Brain Research Institute (KBRI)
RP Kim, K (corresponding author), Soonchunhyang Univ, Dept Med Biotechnol, Asan 31538, South Korea.
EM kiyoung2@sch.ac.kr
FU Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2014R1A1A2058027]; Soonchunhyang University Research Fund
CR Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638
   Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010
   Chen HC, 2009, HUM MOL GENET, V18, PR169, DOI 10.1093/hmg/ddp326
   Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091
   Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565
   Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105
   HIRANO A, 1984, J NEUROPATH EXP NEUR, V43, P461, DOI 10.1097/00005072-198409000-00001
   Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132
   Karbowski M, 2007, J CELL BIOL, V178, P71, DOI 10.1083/jcb.200611064
   Kim HJ, 2015, BIOCHEM BIOPH RES CO, V464, P1235, DOI 10.1016/j.bbrc.2015.07.111
   Kim HJ, 2014, NAT GENET, V46, P152, DOI 10.1038/ng.2853
   Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066
   Leigh P Nigel, 2007, HANDB CLIN NEUROL, V82, P249, DOI 10.1016/S0072-9752(07)80016-9
   Oliveira JMA, 2010, J NEUROCHEM, V114, P1, DOI 10.1111/j.1471-4159.2010.06741.x
   Park YY, 2014, CELL DEATH DIS, V5, P0, DOI 10.1038/cddis.2014.142
   Poole AC, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0010054
   Rothstein JD, 2009, ANN NEUROL, V65, PS3, DOI 10.1002/ana.21543
   Sasaki S, 2007, J NEUROPATH EXP NEUR, V66, P10, DOI 10.1097/nen.0b013e31802c396b
   Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584
   Tan WZ, 2014, BBA-MOL BASIS DIS, V1842, P1295, DOI 10.1016/j.bbadis.2014.02.009
   Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942
   Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018
   Yokoseki A, 2008, ANN NEUROL, V63, P538, DOI 10.1002/ana.21392
   Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107
NR 24
TC 34
Z9 35
U1 0
U2 9
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD DEC 9
PY 2016
VL 481
IS 3-4
BP 259
EP 264
DI 10.1016/j.bbrc.2016.10.134
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA EE4GV
UT WOS:000389561200011
PM 27810362
DA 2024-11-01
ER

PT J
AU Cagnone, G
   Tsai, TS
   Srirattana, K
   Rossello, F
   Powell, DR
   Rohrer, G
   Cree, L
   Trounce, IA
   St John, JC
AF Cagnone, Gael
   Tsai, Te-Sha
   Srirattana, Kanokwan
   Rossello, Fernando
   Powell, David R.
   Rohrer, Gary
   Cree, Lynsey
   Trounce, Ian A.
   St John, Justin C.
TI Segregation of Naturally Occurring Mitochondrial DNA Variants in a Mini-Pig Model
SO GENETICS
LA English
DT Article
DE mitochondrial DNA; segregation; variants; generations; embryo
ID ribosomal-rna gene; copy number; adaptive selection; mtdna heteroplasmy; oocyte maturation; skeletal-muscle; in-vivo; transmission; inheritance; replication
AB The maternally inherited mitochondrial genome (mtDNA) is present in multimeric form within cells and harbors sequence variants (heteroplasmy). While a single mtDNA variant at high load can cause disease, naturally occurring variants likely persist at low levels across generations of healthy populations. To determine how naturally occurring variants are segregated and transmitted, we generated a mini-pig model, which originates from the same maternal ancestor. Following next-generation sequencing, we identified a series of low-level mtDNA variants in blood samples from the female founder and her daughters. Four variants, ranging from 3% to 20%, were selected for validation by high-resolution melting analysis in 12 tissues from 31 animals across three generations. All four variants were maintained in the offspring, but variant load fluctuated significantly across the generations in several tissues, with sex-specific differences in heart and liver. Moreover, variant load was persistently reduced in high-respiratory organs (heart, brain, diaphragm, and muscle), which correlated significantly with higher mtDNA copy number. However, oocytes showed increased heterogeneity in variant load, which correlated with increased mtDNA copy number during in vitro maturation. Altogether, these outcomes show that naturally occurring mtDNA variants segregate and are maintained in a tissue-specific manner across generations. This segregation likely involves the maintenance of selective mtDNA variants during organogenesis, which can be differentially regulated in oocytes and preimplantation embryos during maturation.
C1 [Cagnone, Gael; Tsai, Te-Sha; Srirattana, Kanokwan; St John, Justin C.] Hudson Inst Med Res, Ctr Genet Dis, 31 Wright St, Clayton, Vic 3168, Australia.
   [Cagnone, Gael; Tsai, Te-Sha; Srirattana, Kanokwan; St John, Justin C.] Monash Univ, Dept Mol & Translat Sci, Clayton, Vic 3168, Australia.
   [Rossello, Fernando; Powell, David R.] Monash Univ, Victorian Bioinformat Consortium, Clayton, Vic 3168, Australia.
   [Rossello, Fernando; Powell, David R.] Victorian Life Sci Computat Initiat, Life Sci Computat Ctr, Parkville, Vic 3052, Australia.
   [Rohrer, Gary] ARS, USDA, US Meat Anim Res Ctr, Clay Ctr, NE 68933 USA.
   [Cree, Lynsey] Univ Auckland, Fac Med & Hlth Sci, Dept Obstet & Gynaecol, Auckland 1023, New Zealand.
   [Trounce, Ian A.] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Dept Surg, Ctr Eye Res Australia,Ophthalmol, East Melbourne, Vic 3002, Australia.
C3 Hudson Institute of Medical Research; Monash University; Monash University; University of Melbourne; United States Department of Agriculture (USDA); University of Auckland; Royal Victorian Eye & Ear Hospital; University of Melbourne; Centre for Eye Research Australia
RP St John, JC (corresponding author), Hudson Inst Med Res, Ctr Genet Dis, 31 Wright St, Clayton, Vic 3168, Australia.
EM justin.stjohn@hudson.org.au
FU National Health and Medical Research Council [GNT1041471]; Victorian Government's Operational Infrastructure Support Program; Monash Medical Centre Animal Ethics Committee A (MMCA) [MMCA/2012/84]; ARS [ARS-0426415, 813594] Funding Source: Federal RePORTER
CR Ballana E, 2008, HUM MUTAT, V29, P248, DOI 10.1002/humu.20639
   Battersby BJ, 2003, NAT GENET, V33, P183, DOI 10.1038/ng1073
   Battersby BJ, 2001, HUM MOL GENET, V10, P2469, DOI 10.1093/hmg/10.22.2469
   Birchmeier C, 2000, CURR OPIN CELL BIOL, V12, P725, DOI 10.1016/S0955-0674(00)00159-9
   Bode G, 2010, J PHARMACOL TOX MET, V62, P196, DOI 10.1016/j.vascn.2010.05.009
   Bowles EJ, 2007, GENETICS, V176, P1511, DOI 10.1534/genetics.106.070177
   Burgstaller JP, 2014, CELL REP, V7, P2031, DOI 10.1016/j.celrep.2014.05.020
   Cagnone GLM, 2012, BIOL REPROD, V86, P0, DOI 10.1095/biolreprod.111.094391
   Canter JA, 2005, CANCER RES, V65, P8028, DOI 10.1158/0008-5472.CAN-05-1428
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chinnery PE, 1998, BRAIN, V121, P1889, DOI 10.1093/brain/121.10.1889
   Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X
   Coon KD, 2006, MITOCHONDRION, V6, P194, DOI 10.1016/j.mito.2006.07.002
   Cotterill M, 2013, MOL HUM REPROD, V19, P444, DOI 10.1093/molehr/gat013
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   Crispim D, 2005, DIABETIC MED, V22, P1683, DOI 10.1111/j.1464-5491.2005.01702.x
   De Marinis E, 2008, J ENDOCRINOL, V198, P635, DOI 10.1677/JOE-08-0242
   DUNBAR DR, 1995, P NATL ACAD SCI USA, V92, P6562, DOI 10.1073/pnas.92.14.6562
   Duteil D, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms5093
   El Shourbagy SH, 2006, REPRODUCTION, V131, P233, DOI 10.1530/rep.1.00551
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Federman DD, 2006, NEW ENGL J MED, V354, P1507, DOI 10.1056/NEJMra052529
   Frederiksen AL, 2006, J MED GENET, V43, P0, DOI 10.1136/jmg.2005.039339
   Freyer C, 2012, NAT GENET, V44, P1282, DOI 10.1038/ng.2427
   Goto H, 2011, GENOME BIOL, V12, P0, DOI 10.1186/gb-2011-12-6-r59
   He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802
   Hellebrekers DMEI, 2012, HUM REPROD UPDATE, V18, P341, DOI 10.1093/humupd/dms008
   Hill JH, 2014, NAT GENET, V46, P389, DOI 10.1038/ng.2920
   Hofmann AD, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0035160
   Humpherson PG, 2005, THERIOGENOLOGY, V64, P1852, DOI 10.1016/j.theriogenology.2005.04.019
   Innocenti P, 2011, SCIENCE, V332, P845, DOI 10.1126/science.1201157
   Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93
   Kelly RDW, 2012, NUCLEIC ACIDS RES, V40, P10124, DOI 10.1093/nar/gks770
   Kirches E, 2001, J MED GENET, V38, P312, DOI 10.1136/jmg.38.5.312
   Krisher RL, 2012, MOL REPROD DEV, V79, P311, DOI 10.1002/mrd.22037
   Kucej M, 2007, TRENDS CELL BIOL, V17, P586, DOI 10.1016/j.tcb.2007.08.007
   Lackner LL, 2013, P NATL ACAD SCI USA, V110, PE458, DOI 10.1073/pnas.1215232110
   LAIPIS PJ, 1988, P NATL ACAD SCI USA, V85, P8107, DOI 10.1073/pnas.85.21.8107
   Larsen MO, 2004, ILAR J, V45, P303, DOI 10.1093/ilar.45.3.303
   Leese HJ, 2007, HUM REPROD, V22, P3047, DOI 10.1093/humrep/dem253
   Leese HJ, 2002, BIOESSAYS, V24, P845, DOI 10.1002/bies.10137
   Li MK, 2010, AM J HUM GENET, V87, P237, DOI 10.1016/j.ajhg.2010.07.014
   Lloyd RE, 2006, GENETICS, V172, P2515, DOI 10.1534/genetics.105.055145
   Macháty Z, 2001, MOL REPROD DEV, V58, P39, DOI 10.1002/1098-2795(200101)58:1<39::AID-MRD6>3.0.CO;2-B
   Marchington DR, 1998, AM J HUM GENET, V63, P769, DOI 10.1086/302009
   McFarland R, 2007, CURR TOP DEV BIOL, V77, P113, DOI 10.1016/S0070-2153(06)77005-3
   Monnot S, 2013, HUM MOL GENET, V22, P1867, DOI 10.1093/hmg/ddt040
   OLIVO PD, 1983, NATURE, V306, P400, DOI 10.1038/306400a0
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847
   Ramos A, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0074636
   Rand DM, 2001, GENETICS, V159, P173
   Rebolledo-Jaramillo B, 2014, P NATL ACAD SCI USA, V111, P15474, DOI 10.1073/pnas.1409328111
   Rodell Anders, 2013, FRONT NEUROENERGETICS, V5, P7, DOI 10.3389/fnene.2013.00007
   Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474
   Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434
   Ruiz-Pesini E, 2006, HUM MUTAT, V27, P1072, DOI 10.1002/humu.20378
   Ryu MJ, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003356
   Samuels DC, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003929
   Santos TA, 2006, FERTIL STERIL, V85, P584, DOI 10.1016/j.fertnstert.2005.09.017
   Sato A, 2005, P NATL ACAD SCI USA, V102, P16765, DOI 10.1073/pnas.0506197102
   Sato M, 2013, BBA-MOL CELL RES, V1833, P1979, DOI 10.1016/j.bbamcr.2013.03.010
   Seibel P, 2008, NUCLEIC ACIDS RES, V36, P5872, DOI 10.1093/nar/gkn592
   Sharpley MS, 2012, CELL, V151, P333, DOI 10.1016/j.cell.2012.09.004
   SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299
   Shoubridge EA, 2007, CURR TOP DEV BIOL, V77, P87, DOI 10.1016/S0070-2153(06)77004-1
   Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063
   Sobinoff AP, 2014, HUM REPROD, V29, P2719, DOI 10.1093/humrep/deu235
   Spikings EC, 2006, HUM REPROD UPDATE, V12, P401, DOI 10.1093/humupd/dml011
   Spikings EC, 2007, BIOL REPROD, V76, P327, DOI 10.1095/biolreprod.106.054536
   St John J, 2014, BIOCHIM BIOPHYS ACTA, V1840, P1345
   St John JC, 2010, GENE THER, V17, P147, DOI 10.1038/gt.2009.164
   St John JC, 2010, HUM REPROD UPDATE, V16, P488, DOI 10.1093/humupd/dmq002
   Stewart JB, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004670
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Stigliani S, 2014, MOL HUM REPROD, V20, P1238, DOI 10.1093/molehr/gau086
   Takeda K, 2000, GENETICS, V155, P777
   Ursing BM, 1998, J MOL EVOL, V47, P302, DOI 10.1007/PL00006388
   Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258
   Yao YG, 2013, STEM CELL RES, V10, P361, DOI 10.1016/j.scr.2013.01.006
   Ye KX, 2014, P NATL ACAD SCI USA, V111, P10654, DOI 10.1073/pnas.1403521111
   Yeung KY, 2014, ACTA NEUROPATHOL COM, V2, P0, DOI 10.1186/2051-5960-2-1
   Zsurka G, 2005, NAT GENET, V37, P873, DOI 10.1038/ng1606
NR 84
TC 22
Z9 21
U1 0
U2 6
PU GENETICS SOCIETY AMERICA
PI BETHESDA
PA 9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA
SN 0016-6731
EI 1943-2631
J9 GENETICS
JI Genetics
PD MAR 15
PY 2016
VL 202
IS 3
BP 931
EP +
DI 10.1534/genetics.115.181321
PG 28
WC Genetics & Heredity
SC Genetics & Heredity
GA DF8GT
UT WOS:000371596400010
PM 26819245
DA 2024-11-01
ER

PT J
AU Djordjevic, D
   Brady, L
   Bai, R
   Tarnopolsky, MA
AF Djordjevic, Djurdja
   Brady, Lauren
   Bai, Renkui
   Tarnopolsky, Mark A.
TI Two novel mitochondrial tRNA mutations, A7495G (tRNA<SUP>Ser(UCN)</SUP>) and C5577T (tRNA<SUP>TrP</SUP>), are associated with seizures and cardiac dysfunction
SO MITOCHONDRION
LA English
DT Article
DE Seizures; Cardiomyopathy; tRNA; Mitochondria; De novo; Encephalopathy; Metabolic
ID disease; dna; genome
AB We describe here two novel mitochondrial mutations associated with a complex mitochondrial encephalopathy. An A to G transition at position 7495 (MT-TS1 (MT-tRNSer(UCN))) was identified at 83% heteroplasmy in the muscle of a four year old female with ptosis, hypotonia, seizures, and dilated cardiomyopathy (Case 1). A homoplasmic C to T transition at position 5577 (MT-TW (MT-tRNATrp)) was found in a twenty-four year old woman with exercise intolerance, mild muscle weakness, hearing loss, seizures, and cognitive decline (Case 2). The phenotypic information provided here will assist in phenotype-genotype correlations should additional patients be reported in the future. The mutations can be added to the database of mitochondria( DNA variations in conserved regions which result in clinically diverse phenotypes with the shared markers of mitochondrial disease. (C) 2016 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Djordjevic, Djurdja; Brady, Lauren; Tarnopolsky, Mark A.] McMaster Childrens Hosp, Hamilton, ON, Canada.
   [Bai, Renkui] GeneDx, Gaithersburg, MD USA.
C3 McMaster University
RP Tarnopolsky, MA (corresponding author), McMaster Childrens Hosp, Hamilton, ON, Canada.
EM tamopol@mcmaster.ca
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   [Anonymous], 2007, MAMITTRNA COMPILATIO, V0, P0
   [Anonymous], 2016, MITOMAP HUMAN MITOCH, V0, P0
   Bai RK, 2004, CLIN CHEM, V50, P996, DOI 10.1373/clinchem.2004.031153
   BROWN MD, 1994, J BIOENERG BIOMEMBR, V26, P273, DOI 10.1007/BF00763099
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   MacNeil LG, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0109189
   Poulton J, 2010, PLOS GENET, V6, P0, DOI 10.1371/journal.pgen.1001066
   Retterer K, 2015, GENET. MED, V0, P1
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   Tarnopolsky MA, 2011, MUSCLE NERVE, V43, P717, DOI 10.1002/mus.21945
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258
   Zhang W, 2012, CLIN CHEM, V58, P1322, DOI 10.1373/clinchem.2011.181438
NR 14
TC 5
Z9 5
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD NOV 15
PY 2016
VL 31
IS 
BP 40
EP 44
DI 10.1016/j.mito.2016.09.002
PG 5
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA EC8ZL
UT WOS:000388431500005
PM 27693765
DA 2024-11-01
ER

PT J
AU Finsterer, J
   Wakil, SM
AF Finsterer, Josef
   Wakil, Salma Majid
TI Stroke-like episodes, peri-episodic seizures, and MELAS mutations
SO EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
LA English
DT Review
DE Encephalopathy; Mitochondrial DNA; Cerebrum; Brain; Stroke; Electroencephalography
ID lactic-acidosis; mitochondrial-dna; oxidase deficiency; status epilepticus; l-arginine; encephalopathy; myopathy; patient; encephalomyopathy; epilepsy
AB Purpose: Stroke-like episodes (SLEs) are a hallmark of various mitochondrial disorders, in particular MELAS syndrome. SLEs manifest with vasogenic oedema (DWI and ADC hyperintensity) or partial cytotoxic oedema (DWI hyperintensity, ADC hypointensity) in the acute and subacute stage, and with gyriform T1-hyperintensity (cortical necrosis) in the chronic stage. Principal results: SLEs must be clearly distinguished from ischaemic stroke, since management of these two entities is different. SLEs may go along with or without seizures or epileptiform discharges on EEG. However, in MELAS syndrome seizures may also occur in the absence of SLEs. Focal and generalised seizures have been reported but it is currently unknown if the one or the other prevail. SLEs with and without seizures may respond to NO-precursors 1-arginine, succinate, or citrulline. As a supportive measure a ketogenic diet should be initiated. Seizures prior to or during a SLE or paroxysmal EEG-activity during a SLE should be initially treated with antiepileptic drugs (AEDs) with low mitochondrion toxicity. Only in case these AEDs are ineffective, AEDs with higher mitochondrion-toxicity should be added. Major conclusions: All patients with SLEs need to have an EEG recorded irrespective if they have manifesting seizures or not. There are no mtDNA or nDNA mutations which predispose for SLEs with seizures. (C) 2016 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.
C1 [Finsterer, Josef] Krankenanstalt Rudolfstiftung Wien, Vienna, Austria.
   [Wakil, Salma Majid] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh, Saudi Arabia.
C3 Rudolfstiftung Hospital; King Faisal Specialist Hospital & Research Center
RP Finsterer, J (corresponding author), Krankenanstalt Rudolfstiftung Wien, Vienna, Austria.; Finsterer, J (corresponding author), Postfach 20, A-1180 Vienna, Austria.
EM fifigs1@yahoo.de
CR BARAK Y, 1995, ISRAEL J MED SCI, V31, P224
   Bataillard M, 2001, NEUROLOGY, V56, P405, DOI 10.1212/WNL.56.3.405
   Battisti C, 2014, J NEUROL, V261, P768, DOI 10.1007/s00415-014-7257-3
   Broyer M, 1996, J INHERIT METAB DIS, V19, P65, DOI 10.1007/BF01799350
   CHEN RS, 1993, ACTA NEUROL SCAND, V87, P494
   Chevallier JA, 2014, EPILEPSIA, V55, P707, DOI 10.1111/epi.12570
   Chiyonobu T, 2008, BRAIN DEV-JPN, V30, P430, DOI 10.1016/j.braindev.2007.12.006
   De Greef E, 2012, JIMD REP, V4, P5, DOI 10.1007/8904_2011_29
   Demarest ST, 2014, J CHILD NEUROL, V29, P1249, DOI 10.1177/0883073814538511
   Fassone E, 2012, J MED GENET, V49, P578, DOI 10.1136/jmedgenet-2012-101159
   Finsterer J, 2012, OPEN NEUROL J, V6, P26, DOI 10.2174/1874205X01206010026
   Finsterer J, 2016, HDB EXPT PH IN PRESS, V0, P0
   Furuya H, 1997, RINSHO SHINKEIGAKU, V37, P680
   Goodfellow JA, 2012, POSTGRAD MED J, V88, P326, DOI 10.1136/postgradmedj-2011-130326
   HAMMANS SR, 1993, BRAIN, V116, P617, DOI 10.1093/brain/116.3.617
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Hynynen J, 2014, LIVER TRANSPLANT, V20, P1402, DOI 10.1002/lt.23965
   Iizuka T, 2003, NEUROLOGY, V61, P1238, DOI 10.1212/01.WNL.0000091888.26232.FE
   Iizuka T, 2002, NEUROLOGY, V59, P816, DOI 10.1212/WNL.59.6.816
   Ishikawa N, 2009, BRAIN DEV-JPN, V31, P240, DOI 10.1016/j.braindev.2008.03.012
   JEANFRANCOIS MJB, 1994, AUST NZ J MED, V24, P188, DOI 10.1111/j.1445-5994.1994.tb00556.x
   Kaufman KR, 2010, EPILEPSY BEHAV, V18, P494, DOI 10.1016/j.yebeh.2010.05.020
   Kim JH, 2011, KOREAN J RADIOL, V12, P15, DOI 10.3348/kjr.2011.12.1.15
   Kubota M, 2004, BRAIN DEV-JPN, V26, P481, DOI 10.1016/j.braindev.2004.01.006
   Lam CW, 2015, CLIN CHIM ACTA, V448, P211, DOI 10.1016/j.cca.2015.06.028
   Lamperti C, 2012, NEUROMUSCULAR DISORD, V22, P990, DOI 10.1016/j.nmd.2012.06.003
   Liang WC, 2007, J FORMOS MED ASSOC, V106, PS27, DOI 10.1016/S0929-6646(09)60349-1
   Liu Xiao-li, 2013, ZHONGHUA ER KE ZA ZHI, V51, P130
   Lönnqvist T, 2009, BRAIN, V132, P1553, DOI 10.1093/brain/awp045
   Ma YN, 2010, J NEUROL SCI, V291, P17, DOI 10.1016/j.jns.2010.01.012
   Magner M, 2014, PSYCHIATR POL, V48, P1035, DOI 10.12740/PP/24062
   Mignot C, 2013, ORPHANET J RARE DIS, V8, P0, DOI 10.1186/1750-1172-8-173
   Morin C, 1999, ANN NEUROL, V45, P389, DOI 10.1002/1531-8249(199903)45:3<389::AID-ANA16>3.0.CO;2-B
   Motoda Atsuko, 2013, RINSHO SHINKEIGAKU, V53, P446
   Oguro H, 2004, INTERNAL MED, V43, P427, DOI 10.2169/internalmedicine.43.427
   Pulkes T, 1999, ANN NEUROL, V46, P916, DOI 10.1002/1531-8249(199912)46:6<916::AID-ANA16>3.0.CO;2-R
   Sagnelli A, 2014, J PERIPHER NERV SYST, V19, P183, DOI 10.1111/jns5.12070
   SAITOH S, 1992, BRAIN DEV-JPN, V14, P260, DOI 10.1016/S0387-7604(12)80244-0
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Scholl-Bürgi S, 2009, NEUROPEDIATRICS, V40, P76, DOI 10.1055/s-0029-1231065
   Steriade C, 2014, PEDIATR NEUROL, V50, P498, DOI 10.1016/j.pediatrneurol.2014.01.009
   Toribe Yasuhisa, 2007, NO TO HATTATSU, V39, P38
   Tsujikawa Koyo, 2014, RINSHO SHINKEIGAKU, V54, P882
   Tzoulis C, 2012, BRAIN, V135, P3627, DOI 10.1093/brain/aws223
   VALLEE L, 1994, EUR J PEDIATR, V153, P598, DOI 10.1007/s004310050198
   van Baalen A, 2009, BRAIN DEV-JPN, V31, P183, DOI 10.1016/j.braindev.2008.08.014
   Vastagh I, 2011, IDEGGYOGY SZEMLE, V64, P399
   Wei CY, 2012, CLIN NUCL MED, V37, P876, DOI 10.1097/RLU.0b013e318262ad48
   Wheeler PG, 1998, CLIN DYSMORPHOL, V7, P69
   Whittaker RG, 2015, ANN NEUROL, V0, P0
   Yoshida T, 2013, INTERNAL MED, V52, P1389, DOI 10.2169/internalmedicine.52.0188
NR 51
TC 16
Z9 19
U1 0
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1090-3798
EI 1532-2130
J9 EUR J PAEDIATR NEURO
JI Eur. J. Paediatr. Neurol.
PD NOV 15
PY 2016
VL 20
IS 6
BP 824
EP 829
DI 10.1016/j.ejpn.2016.08.002
PG 6
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA EA1BC
UT WOS:000386322300005
PM 27562097
DA 2024-11-01
ER

PT J
AU Mignarri, A
   Rubegni, A
   Tessa, A
   Stefanucci, S
   Malandrini, A
   Cardaioli, E
   Meschini, MC
   Stromillo, ML
   Doccini, S
   Federico, A
   Santorelli, FM
   Dotti, MT
AF Mignarri, Andrea
   Rubegni, Anna
   Tessa, Alessandra
   Stefanucci, Stefano
   Malandrini, Alessandro
   Cardaioli, Elena
   Meschini, Maria Chiara
   Stromillo, Maria Laura
   Doccini, Stefano
   Federico, Antonio
   Santorelli, Filippo Maria
   Dotti, Maria Teresa
TI Mitochondrial dysfunction in hereditary spastic paraparesis with mutations in <i>DDHD1</i>/SPG28
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Article
DE Hereditary spastic paraplegia; SPG28; DDHD1; Mitochondrial disease
ID form
AB Mutations in DDHD1 cause the SPG28 subtype of hereditary spastic paraplegia (HSP). Recent studies suggested that mitochondrial dysfunction occurs in SPG28. Here we describe two siblings with SPG28, and report evidence of mitochondrial impairment in skeletal muscle and skin fibroblasts. Patient 1 (Pt1) was a 35-year-old man with spastic paraparesis and urinary incontinence, while his 25-year-old brother (Pt2) had gait spasticity and motor axonal neuropathy. In these patients we identified the novel homozygous c.1429C>T/p.R477* mutation in DDHD1, using a next-generation sequencing (NGS) approach. Histochemical analyses in muscle showed mitochondrial alterations, and multiple mitochondrial DNA (mtDNA) deletions were evident. In Pt1, respiratory chain enzyme activities were altered in skeletal muscle, mitochondrial ATP levels reduced, and analysis of skin fibroblasts revealed mitochondrial fragmentation. It seems possible that the novel nonsense mutation identified abolishes DDHD1 protein function thus altering oxidative metabolism. Qualitative alterations of mtDNA could have a pathogenetic significance. We suggest to perform DDHD1 analysis in patients with multiple mtDNA deletions. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Mignarri, Andrea; Malandrini, Alessandro; Cardaioli, Elena; Stromillo, Maria Laura; Federico, Antonio; Dotti, Maria Teresa] Univ Siena, Dept Med Surg & Neurosci, Unit Neurol & Neurometab Disorders, I-53100 Siena, Italy.
   [Rubegni, Anna; Tessa, Alessandra; Meschini, Maria Chiara; Doccini, Stefano; Santorelli, Filippo Maria] IRCCS Stella Maris, Mol Med Unit, Pisa, Italy.
   [Stefanucci, Stefano] Nuovo Osped San Giovanni Battista, Neurol Unit, Foligno, Italy.
C3 University of Siena; IRCCS Fondazione Stella Maris
RP Santorelli, FM (corresponding author), IRCCS Stella Maris, Mol Med Unit, Pisa, Italy.
EM filippo3364@gmail.com
CR Baba T, 2014, J BIOL CHEM, V289, P11497, DOI 10.1074/jbc.M113.531921
   Bouslam N, 2005, ANN NEUROL, V57, P567, DOI 10.1002/ana.20416
   Coutelier M, 2015, BRAIN, V138, P2191, DOI 10.1093/brain/awv143
   Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200
   Goizet C, 2011, HUM MUTAT, V32, P1118, DOI 10.1002/humu.21542
   Gorman GS, 2015, JAMA NEUROL, V72, P106, DOI 10.1001/jamaneurol.2014.1753
   Klebe S, 2015, REV NEUROL-FRANCE, V171, P505, DOI 10.1016/j.neurol.2015.02.017
   Kumar KR, 2013, J NEUROL, V260, P2516, DOI 10.1007/s00415-013-7008-x
   Liguori R, 2014, J NEUROL, V261, P1789, DOI 10.1007/s00415-014-7418-4
   Lo Giudice T, 2014, EXP NEUROL, V261, P518, DOI 10.1016/j.expneurol.2014.06.011
   Nogueira C, 2015, J CHILD NEUROL, V30, P228, DOI 10.1177/0883073814527158
   Pfeffer G, 2014, BRAIN, V137, P1323, DOI 10.1093/brain/awu060
   Santambrogio P, 2015, NEUROBIOL DIS, V81, P144, DOI 10.1016/j.nbd.2015.02.030
   Schüle R, 2006, NEUROLOGY, V67, P430, DOI 10.1212/01.wnl.0000228242.53336.90
   Tesson C, 2012, AM J HUM GENET, V91, P1051, DOI 10.1016/j.ajhg.2012.11.001
   Wedding IM, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0086340
   Zanna C, 2008, BRAIN, V131, P352, DOI 10.1093/brain/awm335
NR 17
TC 19
Z9 20
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD MAR 15
PY 2016
VL 362
IS 
BP 287
EP 291
DI 10.1016/j.jns.2016.02.007
PG 5
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA DH1PW
UT WOS:000372558400057
PM 26944165
DA 2024-11-01
ER

PT J
AU Genin, EC
   Plutino, M
   Bannwarth, S
   Villa, E
   Cisneros-Barroso, E
   Roy, M
   Ortega-Vila, B
   Fragaki, K
   Lespinasse, F
   Pinero-Martos, E
   Augé, G
   Moore, D
   Burté, F
   Lacas-Gervais, S
   Kageyama, Y
   Itoh, K
   Yu-Wai-Man, P
   Sesaki, H
   Ricci, JE
   Vives-Bauza, C
   Paquis-Flucklinger, V
AF Genin, Emmanuelle C.
   Plutino, Morgane
   Bannwarth, Sylvie
   Villa, Elodie
   Cisneros-Barroso, Eugenia
   Roy, Madhuparna
   Ortega-Vila, Bernardo
   Fragaki, Konstantina
   Lespinasse, Francoise
   Pinero-Martos, Estefania
   Auge, Gaelle
   Moore, David
   Burte, Florence
   Lacas-Gervais, Sandra
   Kageyama, Yusuke
   Itoh, Kie
   Yu-Wai-Man, Patrick
   Sesaki, Hiromi
   Ricci, Jean-Ehrland
   Vives-Bauza, Cristofol
   Paquis-Flucklinger, Veronique
TI <i>CHCHD10</i> mutations promote loss of mitochondrial cristae junctions with impaired mitochondrial genome maintenance and inhibition of apoptosis
SO EMBO MOLECULAR MEDICINE
LA English
DT Article
DE CHCHD10; mitochondria; mitochondrial disease; motor neuron disease; mtDNA instability
ID amyotrophic-lateral-sclerosis; motor-neuron death; cell-death; membrane organization; mitofilin complexes; dna nucleoids; contact site; gene; autophagy; reveals
AB CHCHD10-related diseases include mitochondrial DNA instability disorder, frontotemporal dementia-amyotrophic lateral sclerosis (FTD-ALS) clinical spectrum, late-onset spinal motor neuropathy (SMAJ), and Charcot-Marie-Tooth disease type 2 (CMT2). Here, we show that CHCHD10 resides with mitofilin, CHCHD3 and CHCHD6 within the "mitochondrial contact site and cristae organizing system" (MICOS) complex. CHCHD10 mutations lead to MICOS complex disassembly and loss of mitochondrial cristae with a decrease in nucleoid number and nucleoid disorganization. Repair of the mitochondrial genome after oxidative stress is impaired in CHCHD10 mutant fibroblasts and this likely explains the accumulation of deleted mtDNA molecules in patient muscle. CHCHD10 mutant fibroblasts are not defective in the delivery of mitochondria to lysosomes suggesting that impaired mitophagy does not contribute to mtDNA instability. Interestingly, the expression of CHCHD10 mutant alleles inhibits apoptosis by preventing cytochrome c release.
C1 [Genin, Emmanuelle C.; Plutino, Morgane; Bannwarth, Sylvie; Fragaki, Konstantina; Lespinasse, Francoise; Auge, Gaelle; Paquis-Flucklinger, Veronique] Univ Nice Sophia Antipolis, Sch Med, IRCAN, UMR CNRS 7284,INSERM U1081,UNS, F-06189 Nice 2, France.
   [Bannwarth, Sylvie; Fragaki, Konstantina; Auge, Gaelle; Paquis-Flucklinger, Veronique] Nice Teaching Hosp, Dept Med Genet, Natl Ctr Mitochondrial Dis, Nice 2, France.
   [Villa, Elodie; Ricci, Jean-Ehrland] Univ Nice Sophia Antipolis, INSERM, Ctr Mediterraneen Med Mol, Equipe Controle Metab Morts Cellulaires,U1065, F-06189 Nice 2, France.
   [Cisneros-Barroso, Eugenia; Ortega-Vila, Bernardo; Pinero-Martos, Estefania; Vives-Bauza, Cristofol] Son Espases Univ Hosp, Res Unit, Res Hlth Inst Palma IdISPa, Palma De Mallorca, Spain.
   [Roy, Madhuparna; Kageyama, Yusuke; Itoh, Kie; Sesaki, Hiromi] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD USA.
   [Moore, David; Burte, Florence; Yu-Wai-Man, Patrick] Newcastle Univ, Inst Med Genet, Int Ctr Life, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Moore, David; Burte, Florence; Yu-Wai-Man, Patrick] Royal Victoria Infirm, Newcastle Eye Ctr, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.
   [Lacas-Gervais, Sandra] Univ Nice Sophia Antipolis, Joint Ctr Appl Electron Microscopy, F-06189 Nice 2, France.
C3 Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Cote d'Azur; Institut Investigacio Sanitaria Illes Balears (IdISBa); Hospital Universitari Son Espases; Johns Hopkins University; Newcastle University - UK; Newcastle University - UK; Universite Cote d'Azur
RP Paquis-Flucklinger, V (corresponding author), Univ Nice Sophia Antipolis, Sch Med, IRCAN, UMR CNRS 7284,INSERM U1081,UNS, F-06189 Nice 2, France.
EM paquis@hermes.unice.fr
FU Fondation pour la Recherche Medicale (FRM); Association Francaise contre les Myopathies (AFM); National Institutes of Health [GM089853]; Fondation ARC pour la Recherche sur le Cancer; Clinician Scientist Fellowship Award from Medical Research Council (UK) [G1002570]; Fight for Sight (UK); UK National Institute of Health Research (NIHR) as part of the Rare Diseases Translational Research Collaboration; Spanish Instituto de Salud Carlos III [CP11/00046]; FRM fellowship [DEA20130727390]; MRC [G1002570, G0701386] Funding Source: UKRI
CR Agostini M, 2011, BIOCHEM BIOPH RES CO, V414, P451, DOI 10.1016/j.bbrc.2011.09.081
   Alam TI, 2003, NUCLEIC ACIDS RES, V31, P1640, DOI 10.1093/nar/gkg251
   Alkhaja AK, 2012, MOL BIOL CELL, V23, P247, DOI 10.1091/mbc.E11-09-0774
   Auranen M, 2015, NEUROL-GENET, V1, P0, DOI 10.1212/NXG.0000000000000003
   Ballinger SW, 1999, EXP EYE RES, V68, P765, DOI 10.1006/exer.1998.0661
   Ban-Ishihara R, 2013, P NATL ACAD SCI USA, V110, P11863, DOI 10.1073/pnas.1301951110
   Bannwarth S, 2014, BRAIN, V137, P2329, DOI 10.1093/brain/awu138
   Burté F, 2015, NAT REV NEUROL, V11, P11, DOI 10.1038/nrneurol.2014.228
   Chaussenot A, 2014, NEUROBIOL AGING, V35, P0, DOI 10.1016/j.neurobiolaging.2014.07.022
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chiò A, 2015, NEUROBIOL AGING, V36, P0, DOI 10.1016/j.neurobiolaging.2015.01.017
   Copeland WC, 2014, DNA REPAIR, V19, P190, DOI 10.1016/j.dnarep.2014.03.010
   Dadon-Nachum M, 2011, J MOL NEUROSCI, V43, P470, DOI 10.1007/s12031-010-9467-1
   Ferguson CJ, 2009, HUM MOL GENET, V18, P4868, DOI 10.1093/hmg/ddp460
   Friedman JR, 2015, ELIFE, V4, P0, DOI 10.7554/eLife.07739
   Harner M, 2011, EMBO J, V30, P4356, DOI 10.1038/emboj.2011.379
   Hoppins S, 2011, J CELL BIOL, V195, P323, DOI 10.1083/jcb.201107053
   Hori A, 2009, NUCLEIC ACIDS RES, V37, P749, DOI 10.1093/nar/gkn993
   Itoh K, 2013, MOL BIOL CELL, V24, P1842, DOI 10.1091/mbc.E13-03-0125
   Jans DC, 2013, P NATL ACAD SCI USA, V110, P8936, DOI 10.1073/pnas.1301820110
   John GB, 2005, MOL BIOL CELL, V16, P1543, DOI 10.1091/mbc.E04-08-0697
   Johnson JO, 2014, BRAIN, V137, P0, DOI 10.1093/brain/awu265
   Kageyama Y, 2014, EMBO J, V33, P2798, DOI 10.15252/embj.201488658
   Kanki T, 2004, ANN NY ACAD SCI, V1011, P61, DOI 10.1196/annals.1293.007
   Katayama H, 2011, CHEM BIOL, V18, P1042, DOI 10.1016/j.chembiol.2011.05.013
   Kurzwelly D, 2015, BRAIN, V138, P0, DOI 10.1093/brain/awv014
   Lee JA, 2007, CURR BIOL, V17, P1561, DOI 10.1016/j.cub.2007.07.029
   Meyer JN, 2012, AUTOPHAGY, V8, P1822, DOI 10.4161/auto.21741
   Moser JM, 2013, MOL GENET GENOMICS, V288, P207, DOI 10.1007/s00438-013-0741-0
   Müller K, 2014, BRAIN, V137, P0, DOI 10.1093/brain/awu227
   Nassif M, 2010, ANTIOXID REDOX SIGN, V13, P1955, DOI 10.1089/ars.2009.2991
   Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5
   Penttilä S, 2015, ANN NEUROL, V77, P163, DOI 10.1002/ana.24319
   Pfanner N, 2014, J CELL BIOL, V204, P1083, DOI 10.1083/jcb.201401006
   Pirooznia SK, 2014, NEURON, V81, P961, DOI 10.1016/j.neuron.2014.02.024
   Popper P, 1997, EXP NEUROL, V143, P246, DOI 10.1006/exnr.1996.6364
   Rabl R, 2009, J CELL BIOL, V185, P1047, DOI 10.1083/jcb.200811099
   Re DB, 2014, NEURON, V81, P1001, DOI 10.1016/j.neuron.2014.01.011
   Ronchi D, 2015, BRAIN, V138, PE372, DOI 10.1093/brain/awu384
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Santos Janine H, 2006, METHODS MOL BIOL, V314, P183
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351
   Tait SWG, 2010, DEV CELL, V18, P802, DOI 10.1016/j.devcel.2010.03.014
   Tashiro Y, 2012, J BIOL CHEM, V287, P42984, DOI 10.1074/jbc.M112.417600
   von der Malsburg K, 2011, DEV CELL, V21, P694, DOI 10.1016/j.devcel.2011.08.026
   Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200
   Yeo W, 2004, DEV BIOL, V274, P233, DOI 10.1016/j.ydbio.2004.07.026
   Zerbes RM, 2012, BIOL CHEM, V393, P1247, DOI 10.1515/hsz-2012-0239
   Zhang M, 2015, BRAIN, V138, P0, DOI 10.1093/brain/awv082
NR 50
TC 133
Z9 149
U1 1
U2 27
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 1757-4676
EI 1757-4684
J9 EMBO MOL MED
JI EMBO Mol. Med.
PD JAN 15
PY 2016
VL 8
IS 1
BP 58
EP 72
DI 10.15252/emmm.201505496
PG 15
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DA9NI
UT WOS:000368135800006
PM 26666268
DA 2024-11-01
ER

PT J
AU Tranchant, C
   Anheim, M
AF Tranchant, C.
   Anheim, M.
TI Movement disorders in mitochondrial diseases
SO REVUE NEUROLOGIQUE
LA English
DT Article
DE Movement disorders; Mitochondrial diseases; Ataxia; Dystonia; Parkinsonism; Myoclonus
ID onset spinocerebellar ataxia; optic neuropathy; external ophthalmoplegia; familial parkinsonism; polymerase-gamma; spastic ataxia; leigh-syndrome; lebers plus; mutations; neurodegeneration
AB Mitochondrial diseases (MIDs) are a large group of heterogeneous disorders due to mutations in either mitochondrial DNA (mtDNA) or nuclear DNA (nDNA) genes, the latter encoding proteins involved in mitochondrial function. A multisystem clinical picture that involves several organs, including both the peripheral and central nervous systems, is a common presentation of MID. Movement disorders, even isolated ones, are not rare. Cerebellar ataxia is common in myoclonic epilepsy with ragged red fibers (MERFF) due to mutations in the mitochondrial transfer RNA (tRNA) lysine gene, in Kearns-Sayre syndrome due to mtDNA deletions, in sensory ataxic neuropathy with dysarthria and ophthalmoplegia (SANDO) due to nuclear POLG1 gene mutations, and also in ARCA2, Friedreich's ataxia, SPG7, SCA28 and autosomal-recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) due to mutations in nuclear genes involved in mitochondrial morphology or function. Myoclonus is a key feature of MERFF, but may also be encountered in mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS), ARCA2, POLG1 mutations and Leigh syndrome. Dystonia is common in Leigh syndrome (which may be caused by 75 different genes) and in Leber hereditary ocular neuropathy (LHON) plus disease, due to mutations in mtDNA genes that encode subunits of NADH dehydrogenase, as well as in ARCA2, pantothenate kinase-associated neurodegeneration (PECAN), mitochondrial membrane protein associated neurodegeneration (MPAN) and POLG1 mutations. Other movement disorders are rarer (such as parkinsonism, tremor, chorea). Although parkinsonism is more frequent in POLG1 mutations, and myoclonus in MERFF, most movement disorders are found either isolated or combined in numerous MIDs. The presence of associated neurological signs, whether central or peripheral, or of evocative magnetic resonance imaging (MRI) abnormalities (striatal necrosis) should prompt a search for MID. In cases of a particular clinical spectrum (LHON, MERFF, Kearns-Sayre, SANDO, SPG7, ARCA2, ARSACS), a search for the most frequently implicated mutation(s) is recommended. In other cases, muscle biopsies followed by metabolic and genetic studies may be useful for arriving at a diagnosis. (C) 2016 Elsevier Masson SAS. All rights reserved.
C1 [Tranchant, C.; Anheim, M.] Hop Hautepierre, Serv Neurol, 1 Ave Moliere, F-67000 Strasbourg, France.
   [Tranchant, C.; Anheim, M.] Federat Med Translat, F-67000 Strasbourg, France.
C3 Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg
RP Tranchant, C (corresponding author), Hop Hautepierre, Serv Neurol, 1 Ave Moliere, F-67000 Strasbourg, France.
EM christine.tranchant@chru-strasbourg.fr
CR Anheim M, 2012, NEW ENGL J MED, V366, P636, DOI 10.1056/NEJMra1006610
   Auré K, 2007, REV NEUROL-FRANCE, V163, P254, DOI 10.1016/S0035-3787(07)90400-2
   Baertling F, 2014, J NEUROL NEUROSUR PS, V85, P257, DOI 10.1136/jnnp-2012-304426
   Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   BERKOVIC SF, 1989, BRAIN, V112, P1231, DOI 10.1093/brain/112.5.1231
   Bindoff LA, 2012, EPILEPSIA, V53, P92, DOI 10.1111/j.1528-1167.2012.03618.x
   Caer M, 2005, MOVEMENT DISORD, V20, P490, DOI 10.1002/mds.20363
   Chandra SR, 2015, J PEDIATR NEUROSCI, V10, P254, DOI 10.4103/1817-1745.165683
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   De Coo IFM, 1999, ANN NEUROL, V45, P130, DOI 10.1002/1531-8249(199901)45:1<130::AID-ART21>3.0.CO;2-Z
   Dermaut B, 2010, J NEUROL NEUROSUR PS, V81, P90, DOI 10.1136/jnnp.2008.157354
   Di Bella D, 2010, NAT GENET, V42, P313, DOI 10.1038/ng.544
   Dündar H, 2012, PEDIATR NEUROL, V46, P172, DOI 10.1016/j.pediatrneurol.2011.12.006
   Emmanuele V, 2012, ARCH NEUROL-CHICAGO, V69, P978, DOI 10.1001/archneurol.2012.206
   Engert JC, 2000, NAT GENET, V24, P120, DOI 10.1038/72769
   Engl G, 2012, HUM MOL GENET, V21, P287, DOI 10.1093/hmg/ddr458
   Finsterer J, 2002, ACTA NEUROL SCAND, V105, P384, DOI 10.1034/j.1600-0404.2002.01221.x
   Finsterer J, 2011, MOVEMENT DISORD, V26, P784, DOI 10.1002/mds.23651
   Finsterer J, 2009, CAN J NEUROL SCI, V36, P543, DOI 10.1017/S0317167100008027
   Fratter C, 2011, NEUROLOGY, V76, P2032, DOI 10.1212/WNL.0b013e31821e558b
   Garcia-Martin E, 2013, BRIT J OPHTHALMOL, V97, P238, DOI 10.1136/bjophthalmol-2012-302309
   Gautier CA, 2014, REV NEUROL-FRANCE, V170, P339, DOI 10.1016/j.neurol.2013.06.003
   Hartig MB, 2011, AM J HUM GENET, V89, P543, DOI 10.1016/j.ajhg.2011.09.007
   Hayflick SJ, 2003, NEW ENGL J MED, V348, P33, DOI 10.1056/NEJMoa020817
   Hayflick SJ, 2013, BRAIN, V136, P1708, DOI 10.1093/brain/awt095
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   Hörtnagel K, 2003, HUM MOL GENET, V12, P321, DOI 10.1093/hmg/ddg026
   Horvath R, 2007, NEUROLOGY, V68, P56, DOI 10.1212/01.wnl.0000250334.48038.7a
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Hudson G, 2006, HUM MOL GENET, V15, PR244, DOI 10.1093/hmg/ddl233
   Klebe S, 2012, BRAIN, V135, P2980, DOI 10.1093/brain/aws240
   Koppen M, 2007, MOL CELL BIOL, V27, P758, DOI 10.1128/MCB.01470-06
   KOSKINEN T, 1994, MUSCLE NERVE, V17, P509, DOI 10.1002/mus.880170507
   La Morgia C, 2008, NEUROLOGY, V70, P762, DOI 10.1212/01.wnl.0000295505.74234.d0
   Lagier-Tourenne C, 2008, AM J HUM GENET, V82, P661, DOI 10.1016/j.ajhg.2007.12.024
   Lake NJ, 2016, ANN NEUROL, V79, P190, DOI 10.1002/ana.24551
   Lecocq C, 2016, MOVEMENT DISORD, V31, P62, DOI 10.1002/mds.26382
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   Man PYW, 2002, J MED GENET, V39, P162, DOI 10.1136/jmg.39.3.162
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Martin MH, 2007, AM J NEURORADIOL, V28, P1606, DOI 10.3174/ajnr.A0603
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Mignot C, 2013, ORPHANET J RARE DIS, V8, P0, DOI 10.1186/1750-1172-8-173
   NIKOSKELAINEN EK, 1995, J NEUROL NEUROSUR PS, V59, P160, DOI 10.1136/jnnp.59.2.160
   Pfeffer G, 2015, NEUROLOGY, V84, P1174, DOI 10.1212/WNL.0000000000001369
   Pierian TM, 2011, PLOS GENET, V0, P0
   Pilliod J, 2015, ANN NEUROL, V78, P871, DOI 10.1002/ana.24509
   Puccio H, 2014, REV NEUROL-FRANCE, V170, P355, DOI 10.1016/j.neurol.2014.03.008
   Saracchi E, 2013, NEUROL SCI, V34, P407, DOI 10.1007/s10072-012-1013-1
   Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6
   Sidiropoulos C, 2013, NEUROLOGY, V81, P197, DOI 10.1212/WNL.0b013e31829a3438
   Synofzik M, 2013, ORPHANET J RARE DIS, V8, P0, DOI 10.1186/1750-1172-8-41
   Thobois S, 1997, REV NEUROL, V153, P595
   Thomas M, 2004, MOVEMENT DISORD, V19, P36, DOI 10.1002/mds.10650
   THYAGARAJAN D, 1995, ANN NEUROL, V38, P468, DOI 10.1002/ana.410380321
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Vandenberghe W, 2009, MOVEMENT DISORD, V24, P308, DOI 10.1002/mds.22198
   Yang SY, 2007, MOL GENET METAB, V92, P36, DOI 10.1016/j.ymgme.2007.06.001
NR 59
TC 40
Z9 42
U1 1
U2 16
PU MASSON EDITEUR
PI MOULINEAUX CEDEX 9
PA 21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE
SN 0035-3787
EI 2213-0004
J9 REV NEUROL-FRANCE
JI Rev. Neurol.
PD AUG-SEP 15
PY 2016
VL 172
IS 8-9
BP 524
EP 529
DI 10.1016/j.neurol.2016.07.003
PG 6
WC Clinical Neurology
SC Neurosciences & Neurology
GA EA5FY
UT WOS:000386646000014
PM 27476418
DA 2024-11-01
ER

PT J
AU Ostojic, SM
AF Ostojic, Sergej M.
TI Exercise-induced mitochondrial dysfunction: a myth or reality?
SO CLINICAL SCIENCE
LA English
DT Review
DE aging; athletes; DNA deletion; exhaustive exercise; peroxisome proliferator-activated receptor. co-activator 1-alpha (PGC-1 alpha); reactive oxygen species
ID induced oxidative stress; chronic-fatigue-syndrome; exhaustive exercise; strenuous exercise; physical-exercise; skeletal-muscle; endurance exercise; free-radicals; biogenesis; supplementation
AB Beneficial effects of physical activity on mitochondrial health are well substantiated in the scientific literature, with regular exercise improving mitochondrial quality and quantity in normal healthy population, and in cardiometabolic and neurodegenerative disorders and aging. However, several recent studies questioned this paradigm, suggesting that extremely heavy or exhaustive exercise fosters mitochondrial disturbances that could permanently damage its function in health and disease. Exercise-induced mitochondrial dysfunction (EIMD) might be a key proxy for negative outcomes of exhaustive exercise, being a pathophysiological substrate of heart abnormalities, chronic fatigue syndrome (CFS) or muscle degeneration. Here, we overview possible factors that mediate negative effects of exhaustive exercise on mitochondrial function and structure, and put forward alternative solutions for the management of EIMD.
C1 [Ostojic, Sergej M.] Univ Novi Sad, Fac Sport & Phys Educ, Novi Sad 21000, Serbia.
   [Ostojic, Sergej M.] Univ Belgrade, Sch Med, Belgrade 11000, Serbia.
C3 University of Novi Sad; University of Belgrade
RP Ostojic, SM (corresponding author), Univ Novi Sad, Fac Sport & Phys Educ, Novi Sad 21000, Serbia.; Ostojic, SM (corresponding author), Univ Belgrade, Sch Med, Belgrade 11000, Serbia.
EM sergej.ostojic@chess.edu.rs
FU Serbian Ministry of Education, Science and Technological Development [175037]; Faculty of Sport and Physical Education, University of Novi Sad
CR Aguiar AS, 2008, NEUROCHEM RES, V33, P51, DOI 10.1007/s11064-007-9406-x
   ALTMANN R, 1890, ELEMENTARORGANISMEN, V0, P0
   Aon MA, 2013, FRONT PHYSIOL, V4, P0, DOI 10.3389/fphys.2013.00083
   Barbieri E, 2015, OXID MED CELL LONGEV, V2015, P0, DOI 10.1155/2015/917085
   BIELECKI J W, 1988, ACTA PHYSIOLOGICA POLONICA, V39, P421
   Bishop DJ, 2014, BBA-GEN SUBJECTS, V1840, P1266, DOI 10.1016/j.bbagen.2013.10.012
   Booth NE, 2012, INT J CLIN EXP MED, V5, P208
   Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162
   Cao K, 2014, FREE RADICAL BIO MED, V67, P396, DOI 10.1016/j.freeradbiomed.2013.11.029
   Carfagna S, 2015, OXID MED CELL LONGEV, V2015, P0, DOI 10.1155/2015/732090
   Castro-Marrero J, 2013, ANTIOXID REDOX SIGN, V19, P1855, DOI 10.1089/ars.2013.5346
   Catoire M, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0051066
   Chang Y, 2015, INT J SPORTS MED, V36, P1, DOI 10.1055/s-0034-1384545
   Dai YL, 2010, CARDIOVASC TOXICOL, V10, P130, DOI 10.1007/s12012-010-9071-1
   Dumke CL, 2009, EUR J APPL PHYSIOL, V107, P419, DOI 10.1007/s00421-009-1143-1
   Fang YZ, 2002, NUTRITION, V18, P872, DOI 10.1016/S0899-9007(02)00916-4
   Feng ZH, 2011, FREE RADICAL BIO MED, V50, P1437, DOI 10.1016/j.freeradbiomed.2011.03.001
   Fernström M, 2004, J PHYSIOL-LONDON, V554, P755, DOI 10.1113/jphysiol.2003.055202
   Filler K, 2014, BBA CLIN, V1, P12, DOI 10.1016/j.bbacli.2014.04.001
   FRIDEN J, 1988, EUR J APPL PHYSIOL O, V57, P360, DOI 10.1007/BF00635996
   Gao C, 2014, EUR J APPL PHYSIOL, V114, P695, DOI 10.1007/s00421-013-2802-9
   Gibson AS, 1998, CLIN J SPORT MED, V8, P52
   GOHIL K, 1984, BIOSCIENCE REP, V4, P987, DOI 10.1007/BF01116898
   Golinick PD, 1971, MUSCLE METABOLISM EX, V0, P69
   GOLLNICK PD, 1969, INT Z ANGEW PHYSIOL, V27, P257
   GOLLNICK PD, 1969, AM J PHYSIOL, V216, P1502, DOI 10.1152/ajplegacy.1969.216.6.1502
   Gomez-Cabrera MC, 2008, AM J CLIN NUTR, V87, P142, DOI 10.1093/ajcn/87.1.142
   González B, 2000, PFLUG ARCH EUR J PHY, V440, P42, DOI 10.1007/s004240051020
   Gross M, 2015, ANTIOXIDANTS IN SPORT NUTRITION, V0, P111
   Halliwell B, 2012, NUTR REV, V70, P257, DOI 10.1111/j.1753-4887.2012.00476.x
   Hood DA, 2001, J APPL PHYSIOL, V90, P1137, DOI 10.1152/jappl.2001.90.3.1137
   Hsu TG, 2002, MED SCI SPORT EXER, V34, P438, DOI 10.1097/00005768-200203000-00009
   Huang CC, 2009, EUR J APPL PHYSIOL, V107, P697, DOI 10.1007/s00421-009-1177-4
   Huang CC, 2009, CHINESE J PHYSIOL, V52, P306, DOI 10.4077/CJP.2009.AMH068
   Huang JH, 2009, IUBMB LIFE, V61, P201, DOI 10.1002/iub.164
   Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149
   Kalghatgi S, 2013, SCI TRANSL MED, V5, P0, DOI 10.1126/scitranslmed.3006055
   King MA, 2016, AM J PHYSIOL-REG I, V310, PR105, DOI 10.1152/ajpregu.00395.2015
   Koctürk S, 2008, EUR J APPL PHYSIOL, V102, P515, DOI 10.1007/s00421-007-0612-7
   Koenig MK, 2008, PEDIATR NEUROL, V38, P305, DOI 10.1016/j.pediatrneurol.2007.12.001
   La Gerche Andre, 2007, HEART LUNG CIRC, V16 Suppl 3, PS102, DOI 10.1016/j.hlc.2007.03.014
   LAGUENS RP, 1966, EXPERIENTIA, V22, P244, DOI 10.1007/BF01900936
   Lanza IR, 2010, PFLUG ARCH EUR J PHY, V459, P277, DOI 10.1007/s00424-009-0724-5
   Larsen FJ, 2016, FASEB J, V30, P417, DOI 10.1096/fj.15-276857
   Larsen S, 2014, WORLD J DIABETES, V5, P482, DOI 10.4239/wjd.v5.i4.482
   Layec G, 2015, AM J PHYSIOL-REG I, V309, PR378, DOI 10.1152/ajpregu.00522.2014
   Layec G, 2013, NMR BIOMED, V26, P1403, DOI 10.1002/nbm.2966
   Lee S, 2015, BIOCHEM BIOPH RES CO, V461, P354, DOI 10.1016/j.bbrc.2015.04.038
   LI H, 2016, OXID MED CELL LONGEV, V2016, P0
   Li Y, 2012, TOXICOL SCI, V127, P582, DOI 10.1093/toxsci/kfs100
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   Little JP, 2010, J PHYSIOL-LONDON, V588, P1011, DOI 10.1113/jphysiol.2009.181743
   Lumini JA, 2008, SPORTS MED, V38, P735, DOI 10.2165/00007256-200838090-00003
   Manoli I, 2007, TRENDS ENDOCRIN MET, V18, P190, DOI 10.1016/j.tem.2007.04.004
   Marques-Aleixo I, 2012, PROG NEUROBIOL, V99, P149, DOI 10.1016/j.pneurobio.2012.08.002
   McGinley C, 2009, SPORTS MED, V39, P1011, DOI 10.2165/11317890-000000000-00000
   Menshikova EV, 2006, J GERONTOL A-BIOL, V61, P534, DOI 10.1093/gerona/61.6.534
   Mille-Hamard L, 2015, MOL CELL BIOCHEM, V405, P223, DOI 10.1007/s11010-015-2413-3
   Milne KJ, 2002, J APPL PHYSIOL, V93, P561, DOI 10.1152/japplphysiol.00528.2001
   Moslehi J, 2012, CIRC RES, V110, P1226, DOI 10.1161/CIRCRESAHA.111.246868
   Myhill S, 2013, INT J CLIN EXP MED, V6, P1
   Myhill S, 2009, INT J CLIN EXP MED, V2, P1
   Neubauer O, 2008, EXERC IMMUNOL REV, V14, P51
   OKeefe JH, 2012, MAYO CLIN PROC, V87, P587, DOI 10.1016/j.mayocp.2012.04.005
   ORourke B, 2010, FRONT PHYSIOL, V1, P0, DOI 10.3389/fphys.2010.00007
   Oláh A, 2015, INT J CARDIOL, V182, P258, DOI 10.1016/j.ijcard.2014.12.045
   Ostojic SM, 2015, PHARMACOL RES, V94, P51, DOI 10.1016/j.phrs.2015.02.004
   Paillard T, 2015, J CLIN NEUROL, V11, P212
   Pan SS, 2008, SCAND J MED SCI SPOR, V18, P346, DOI 10.1111/j.1600-0838.2007.00684.x
   Paradies G, 2010, FREE RADICAL BIO MED, V48, P1286, DOI 10.1016/j.freeradbiomed.2010.02.020
   Peternelj TT, 2011, SPORTS MED, V41, P1043, DOI 10.2165/11594400-000000000-00000
   Pieczenik SR, 2007, EXP MOL PATHOL, V83, P84, DOI 10.1016/j.yexmp.2006.09.008
   PIERCE GN, 1984, J APPL PHYSIOL, V57, P326, DOI 10.1152/jappl.1984.57.2.326
   Ping Z, 2015, OXID MED CELL LONGEV, V2015, P0, DOI 10.1155/2015/876825
   Ponsot E, 2005, J CELL PHYSIOL, V203, P479, DOI 10.1002/jcp.20245
   Powers SK, 2014, FREE RADICAL RES, V48, P43, DOI 10.3109/10715762.2013.825371
   Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007
   Psilander N, 2014, THESIS, V0, P0
   PUFFER JC, 1992, CLIN SPORT MED, V11, P327
   Radak Z, 2016, FREE RADICAL BIO MED, V98, P187, DOI 10.1016/j.freeradbiomed.2016.01.024
   Rai PK, 2015, BRIT MED BULL, V116, P5, DOI 10.1093/bmb/ldv046
   Rasmussen UF, 2001, PFLUG ARCH EUR J PHY, V443, P180, DOI 10.1007/s004240100689
   Richardson RS, 2007, AM J PHYSIOL-HEART C, V292, PH1516, DOI 10.1152/ajpheart.01045.2006
   Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106
   Ross MF, 2005, BIOCHEMISTRY-MOSCOW+, V70, P222, DOI 10.1007/s10541-005-0104-5
   Sakai Y, 1999, MUSCLE NERVE, V22, P258, DOI 10.1002/(SICI)1097-4598(199902)22:2<258::AID-MUS15>3.0.CO;2-1
   Sharwood K, 2000, INT SPORTMED J, V0, P1
   Smith RAJ, 2012, TRENDS PHARMACOL SCI, V33, P341, DOI 10.1016/j.tips.2012.03.010
   Spina RJ, 1996, J APPL PHYSIOL, V80, P2250, DOI 10.1152/jappl.1996.80.6.2250
   Staud R, 2015, PAIN, V156, P750, DOI 10.1097/j.pain.0000000000000110
   Sun LJ, 2010, LIFE SCI, V86, P39, DOI 10.1016/j.lfs.2009.11.003
   Sun M, 2012, SCAND J MED SCI SPOR, V22, P764, DOI 10.1111/j.1600-0838.2011.01314.x
   Tarnopolsky MA, 2007, AM J PHYSIOL-REG I, V292, PR1271, DOI 10.1152/ajpregu.00472.2006
   Tauler P, 2010, CELL BIO RES PROG, V0, P117
   Taylor SD, 2014, AGING CELL, V13, P29, DOI 10.1111/acel.12146
   Terblanche SE, 2001, COMP BIOCHEM PHYS A, V128, P889, DOI 10.1016/S1095-6433(00)00344-5
   Tuan TC, 2008, BRIT J SPORT MED, V42, P0, DOI 10.1136/bjsm.2006.029314
   Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001
   Wang X, 2014, CELL DEATH DIS, V5, P0, DOI 10.1038/cddis.2014.473
   Wei YH, 1998, P SOC EXP BIOL MED, V217, P53
   Yan Z, 2012, EXERC SPORT SCI REV, V40, P159, DOI 10.1097/JES.0b013e3182575599
   Yang KC, 2014, FREE RADICAL BIO MED, V71, P351, DOI 10.1016/j.freeradbiomed.2014.03.033
NR 102
TC 27
Z9 31
U1 2
U2 26
PU PORTLAND PRESS LTD
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER STREET, LONDON WC1N 2JU, ENGLAND
SN 0143-5221
EI 1470-8736
J9 CLIN SCI
JI Clin. Sci.
PD AUG 1
PY 2016
VL 130
IS 16
BP 1407
EP 1416
DI 10.1042/CS20160200
PG 10
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA EK2MU
UT WOS:000393762200002
PM 27389587
DA 2024-11-01
ER

PT J
AU Spiegel, R
   Saada, A
   Flannery, PJ
   Burté, F
   Soiferman, D
   Khayat, M
   Eisner, V
   Vladovski, E
   Taylor, RW
   Bindoff, LA
   Shaag, A
   Mandel, H
   Schuler-Furman, O
   Shalev, SA
   Elpeleg, O
   Yu-Wai-Man, P
AF Spiegel, Ronen
   Saada, Ann
   Flannery, Padraig J.
   Burte, Florence
   Soiferman, Devorah
   Khayat, Morad
   Eisner, Veronica
   Vladovski, Eugene
   Taylor, Robert W.
   Bindoff, Laurence A.
   Shaag, Avraham
   Mandel, Hanna
   Schuler-Furman, Ora
   Shalev, Stavit A.
   Elpeleg, Orly
   Yu-Wai-Man, Patrick
TI Fatal infantile mitochondrial encephalomyopathy, hypertrophic cardiomyopathy and optic atrophy associated with a homozygous <i>OPA1</i> mutation
SO JOURNAL OF MEDICAL GENETICS
LA English
DT Article
ID skeletal-muscle; dna instability; gene; deficiency; phenotype; disorder; deafness; fusion; mouse
AB Background Infantile-onset encephalopathy and hypertrophic cardiomyopathy caused by mitochondrial oxidative phosphorylation defects are genetically heterogeneous with defects involving both the mitochondrial and nuclear genomes. Objective To identify the causative genetic defect in two sisters presenting with lethal infantile encephalopathy, hypertrophic cardiomyopathy and optic atrophy. Methods We describe a comprehensive clinical, biochemical and molecular genetic investigation of two affected siblings from a consanguineous family. Molecular genetic analysis was done by a combined approach involving genome-wide autozygosity mapping and next-generation exome sequencing. Biochemical analysis was done by enzymatic analysis and Western blot. Evidence for mitochondrial DNA (mtDNA) instability was investigated using long-range and real-time PCR assays. Mitochondrial cristae morphology was assessed with transmission electron microscopy. Results Both affected sisters presented with a similar cluster of neurodevelopmental deficits marked by failure to thrive, generalised neuromuscular weakness and optic atrophy. The disease progression was ultimately fatal with severe encephalopathy and hypertrophic cardiomyopathy. Mitochondrial respiratory chain complex activities were globally decreased in skeletal muscle biopsies. They were found to be homozygous for a novel c. 1601T>G (p. Leu534Arg) mutation in the OPA1 gene, which resulted in a marked loss of steady-state levels of the native OPA1 protein. We observed severe mtDNA depletion in DNA extracted from the patients' muscle biopsies. Mitochondrial morphology was consistent with abnormal mitochondrial membrane fusion. Conclusions We have established, for the first time, a causal link between a pathogenic homozygous OPA1 mutation and human disease. The fatal multisystemic manifestations observed further extend the complex phenotype associated with pathogenic OPA1 mutations, in particular the previously unreported association with hypertrophic cardiomyopathy. Our findings further emphasise the vital role played by OPA1 in mitochondrial biogenesis and mtDNA maintenance.
C1 [Spiegel, Ronen] Emek Med Ctr, Dept Pediat B, Genet Inst, IL-18101 Afula, Israel.
   [Spiegel, Ronen; Khayat, Morad; Shalev, Stavit A.] Technion Israel Inst Technol, Rappaport Sch Med, Emek Med Ctr, Genet Inst, Haifa, Israel.
   [Saada, Ann; Soiferman, Devorah; Shaag, Avraham; Elpeleg, Orly] Hebrew Univ Jerusalem, Hadassah Med Ctr, Mon & Jacques Roboh Dept Genet Res, Jerusalem, Israel.
   [Flannery, Padraig J.; Burte, Florence; Taylor, Robert W.; Yu-Wai-Man, Patrick] Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Eisner, Veronica] Pontificia Univ Catolica Chile, Sch Biol Sci, Dept Cellular & Mol Biol, Santiago, Chile.
   [Vladovski, Eugene] Rambam Med Ctr, Dept Pathol, Haifa, Israel.
   [Bindoff, Laurence A.] Univ Bergen, Dept Clin Med, Bergen, Norway.
   [Mandel, Hanna] Hebrew Univ Jerusalem, Rambam Med Ctr, Metabol Unit, Jerusalem, Israel.
   [Schuler-Furman, Ora] Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Microbiol & Mol Genet, Jerusalem, Israel.
   [Yu-Wai-Man, Patrick] Royal Victoria Infirm, Newcastle Eye Ctr, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.
C3 Emek Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Emek Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Newcastle University - UK; Pontificia Universidad Catolica de Chile; Rambam Health Care Campus; University of Bergen; Hebrew University of Jerusalem; Rambam Health Care Campus; Hebrew University of Jerusalem; Hadassah University Medical Center; Newcastle University - UK
RP Spiegel, R (corresponding author), Emek Med Ctr, Dept Pediat B, IL-18101 Afula, Israel.
EM spiegelr@zahav.net.il
FU Clinician Scientist Fellowship Award from the Medical Research Council (UK) [G1002570]; Fight for Sight (UK); UK National Institute of Health Research (NIHR) as part of the Rare Diseases Translational Research Collaboration; Wellcome Trust Strategic Award [096919Z/11/Z]; Medical Research Council (UK) Centre for Translational Muscle Disease Research [G0601943]; MRC [G1002570, G0701386, G0601943] Funding Source: UKRI
CR Abdulhag UN, 2015, EUR J HUM GENET, V23, P159, DOI 10.1038/ejhg.2014.85
   Alavi MV, 2007, BRAIN, V130, P1029, DOI 10.1093/brain/awm005
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Bonifert T, 2014, BRAIN, V137, P2164, DOI 10.1093/brain/awu165
   Bonneau D, 2014, BRAIN, V137, P0, DOI 10.1093/brain/awu184
   Burté F, 2015, NAT REV NEUROL, V11, P11, DOI 10.1038/nrneurol.2014.228
   Carelli V, 2014, BRAIN, V137, P0
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen L, 2012, J AM HEART ASSOC, V1, P0, DOI 10.1161/JAHA.112.003012
   Davies VJ, 2007, HUM MOL GENET, V16, P1307, DOI 10.1093/hmg/ddm079
   Elachouri G, 2011, GENOME RES, V21, P12, DOI 10.1101/gr.108696.110
   Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Joost K, 2010, PEDIATR NEUROL, V42, P227, DOI 10.1016/j.pediatrneurol.2009.10.004
   Liguori M, 2008, J NEUROL, V255, P127, DOI 10.1007/s00415-008-0571-x
   Liskova P, 2013, ACTA OPHTHALMOL, V91, PE225, DOI 10.1111/aos.12038
   Liu HY, 2011, J BIOMED SCI, V18, P0, DOI 10.1186/1423-0127-18-29
   Lodi R, 2011, ARCH NEUROL-CHICAGO, V68, P67, DOI 10.1001/archneurol.2010.228
   Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Sarzi E, 2012, BRAIN, V135, P3599, DOI 10.1093/brain/aws303
   Schaaf CP, 2011, MOL GENET METAB, V103, P383, DOI 10.1016/j.ymgme.2011.04.018
   Stewart JD, 2008, NEUROLOGY, V71, P1829, DOI 10.1212/01.wnl.0000335931.54095.0a
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
NR 24
TC 87
Z9 92
U1 0
U2 15
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-2593
EI 1468-6244
J9 J MED GENET
JI J. Med. Genet.
PD FEB 15
PY 2016
VL 53
IS 2
BP 127
EP 131
DI 10.1136/jmedgenet-2015-103361
PG 5
WC Genetics & Heredity
SC Genetics & Heredity
GA DB4SF
UT WOS:000368502700007
PM 26561570
DA 2024-11-01
ER

PT J
AU Truong, HT
   Nguyen, VAT
   Nguyen, LV
   Pham, VA
   Phan, TN
AF Hue Thi Truong
   Van-Anh Thi Nguyen
   Lieu Van Nguyen
   Van-Anh Pham
   Tuan-Nghia Phan
TI Screening of common point-mutations and discovery of new T14727C change in mitochondrial genome of Vietnamese encephalomyopathy patients
SO MITOCHONDRIAL DNA PART A
LA English
DT Article
DE Heteroplasmy; homoplasmy; mitochondrial tRNA(Glu); PCR-RFLP
ID hereditary optic neuropathy; dna mutations; muscle; melas; expression; diseases; merrf; gene
AB Vietnamese patients (106) tentatively diagnosed with encephalomyopathy were screened for the presence of 15 common point mutations in mitochondria using PCR-RFLP. The screened mutations include A3243G, T3271C and T3291C for Mitochondrial Encephalopathy, Lactic Acidosis and Stroke-like episodes (MELAS); A8344G and T8356C for Myoclonus Epilepsy and Rag-Red Fibers (MERRF); G11778A, G3460A and T14484C for Leber's Hereditary Optic Neuropathy (LHON); T8993G/C and T9176G for Leigh syndrome; A1555G for deafness syndrome; G4298A, T10010C, T14728C and T14709C for neuromuscular syndrome. As a result, 6 cases of A3243G (5.7%) and 2 cases of T14727C (3.9%) were found. The 6 cases of A3243G mutation were heteroplasmic at different levels (4.23-80.85%). The T14727C change was discovered for the first time in the MTTE gene encoding for tRNA(Glu) and showed homoplasmy. The T14727C change was probably a mutation because it was further confirmed as vertically inherited from the mother and not the result of isolated polymorphism.
C1 [Hue Thi Truong; Van-Anh Thi Nguyen; Tuan-Nghia Phan] VNU Univ Sci, Key Lab Enzyme & Prot Technol, Hanoi, Vietnam.
   [Lieu Van Nguyen] Bach Mai Hosp, Dept Neurol, Hanoi, Vietnam.
   [Van-Anh Pham] Natl Hosp Pediat, Hanoi, Vietnam.
C3 Vietnam National University Hanoi
RP Phan, TN (corresponding author), VNU Univ Sci, Key Lab Enzyme & Prot Technol, 334 Nguyen Trai, Hanoi, Vietnam.
EM phantuannghia@vnu.edu.vn
FU National Foundation for Science and Technology (NAFOSTED) project [106.06.123.09]
CR Akagi M, 2002, NEUROMUSCULAR DISORD, V12, P53, DOI 10.1016/S0960-8966(01)00242-5
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Aniko G, 2010, CENT EUR J MED, V5, P322, DOI 10.2478/s11536-009-0118-2
   Black GCM, 1996, BRIT J OPHTHALMOL, V80, P915, DOI 10.1136/bjo.80.10.915
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Chinnery PF, 2001, BRAIN, V124, P209, DOI 10.1093/brain/124.1.209
   Deschauer M, 1999, NEUROMUSCULAR DISORD, V9, P305, DOI 10.1016/S0960-8966(99)00019-X
   Enns GM, 2006, MOL GENET METAB, V88, P364, DOI 10.1016/j.ymgme.2006.02.001
   Gropman A L, 2001, CURR NEUROL NEUROSCI REP, V1, P185
   Kim DS, 2002, J KOREAN MED SCI, V17, P103, DOI 10.3346/jkms.2002.17.1.103
   Liu VWS, 2001, CANCER RES, V61, P5998
   Lorenzoni PJ, 2009, ARQ NEURO-PSIQUIAT, V67, P668, DOI 10.1590/S0004-282X2009000400018
   Marotta R, 2004, INTERN MED J, V34, P10, DOI 10.1111/j.1444-0903.2004.t01-3-.x
   Mimaki M, 2009, MITOCHONDRION, V9, P115, DOI 10.1016/j.mito.2009.01.005
   Moraes CT, 2003, J MOL DIAGN, V5, P197, DOI 10.1016/S1525-1578(10)60474-6
   Nogueira C, 2007, MITOCHONDRION, V7, P396, DOI 10.1016/j.mito.2007.08.002
   Pereira C, 2007, BIOCHEM BIOPH RES CO, V354, P937, DOI 10.1016/j.bbrc.2007.01.068
   Perucca-Lostanlen D, 2002, BBA-MOL BASIS DIS, V1588, P210, DOI 10.1016/S0925-4439(02)00167-9
   Pulkes T, 2001, ADV DRUG DELIVER REV, V49, P27, DOI 10.1016/S0169-409X(01)00124-7
   Reeve AK, 2008, ANN NY ACAD SCI, V1147, P21, DOI 10.1196/annals.1427.016
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   Solano A, 2001, SALUD PUBLICA MEXICO, V43, P151, DOI 10.1590/S0036-36342001000200010
   Trinh LP, 2009, J GENET APPL, V4, P6
   Wani AA, 2007, PLOS ONE, V2, P0, DOI 10.1371/journal.pone.0000942
   Yu Q, 2007, MITOCHONDRION, V7, P147, DOI 10.1016/j.mito.2006.11.019
NR 25
TC 3
Z9 3
U1 0
U2 10
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2470-1394
EI 2470-1408
J9 MITOCHONDRIAL DNA A
JI Mitochondrial DNA Part A
PD JAN 2
PY 2016
VL 27
IS 1
BP 441
EP 448
DI 10.3109/19401736.2014.900665
PG 8
WC Genetics & Heredity
SC Genetics & Heredity
GA CY4OR
UT WOS:000366388100187
PM 24708131
DA 2024-11-01
ER

PT J
AU Rodrigues, GS
   Godinho, RO
   Kiyomoto, BH
   Gamba, J
   Oliveira, ASB
   Schmidt, B
   Tengan, CH
AF Rodrigues, Gabriela Silva
   Godinho, Rosely Oliveira
   Kiyomoto, Beatriz Hitomi
   Gamba, Juliana
   Bulle Oliveira, Acary Souza
   Schmidt, Beny
   Tengan, Celia Harumi
TI Integrated analysis of the involvement of nitric oxide synthesis in mitochondrial proliferation, mitochondrial deficiency and apoptosis in skeletal muscle fibres
SO SCIENTIFIC REPORTS
LA English
DT Article
ID nadph-diaphorase; dna mutations; synthase; biogenesis; pgc-1-alpha; inhibition; activation
AB Nitric oxide (NO) is an important signaling messenger involved in different mitochondrial processes but only few studies explored the participation of NO in mitochondrial abnormalities found in patients with genetic mitochondrial deficiencies. In this study we verified whether NO synthase (NOS) activity was altered in different types of mitochondrial abnormalities and whether changes in mitochondrial function and NOS activity could be associated with the induction of apoptosis. We performed a quantitative and integrated analysis of NOS activity in individual muscle fibres of patients with mitochondrial diseases, considering mitochondrial function (cytochrome-c-oxidase activity), mitochondrial content, mitochondrial DNA mutation and presence of apoptotic nuclei. Our results indicated that sarcolemmal NOS activity was increased in muscle fibres with mitochondrial proliferation, supporting the relevance of neuronal NOS in the mitochondrial biogenesis process. Sarcoplasmic NOS activity was reduced in cytochrome-c-oxidase deficient fibres, probably as a consequence of the involvement of NO in the regulation of the respiratory chain. Alterations in NOS activity or mitochondrial abnormalities were not predisposing factors to apoptotic nuclei. Taken together, our results show that NO can be considered a potential molecular target for strategies to increase mitochondrial content and indicate that this approach may not be associated with increased apoptotic events.
C1 [Rodrigues, Gabriela Silva; Kiyomoto, Beatriz Hitomi; Gamba, Juliana; Bulle Oliveira, Acary Souza; Tengan, Celia Harumi] Univ Fed Sao Paulo, Escola Paulista Med, Dept Neurol & Neurosurg, Sao Paulo, Brazil.
   [Godinho, Rosely Oliveira] Univ Fed Sao Paulo, Escola Paulista Med, Div Cellular Pharmacol, Sao Paulo, Brazil.
   [Schmidt, Beny] Univ Fed Sao Paulo, Escola Paulista Med, Dept Pathol, Sao Paulo, Brazil.
C3 Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)
RP Tengan, CH (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, Dept Neurol & Neurosurg, Sao Paulo, Brazil.
EM chtengan@unifesp.br
FU Sao Paulo Research Foundation (FAPESP) [2007/03145-9, 2007/00808-7]; Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES); Formas [2007-00808] Funding Source: Formas
CR Auré K, 2006, BRAIN, V129, P1249, DOI 10.1093/brain/awl061
   Baldelli S, 2014, J CELL SCI, V127, P4813, DOI 10.1242/jcs.154229
   Boveris A, 2000, ANN NY ACAD SCI, V899, P121
   BREDT DS, 1991, NEURON, V7, P615, DOI 10.1016/0896-6273(91)90374-9
   Brookes PS, 2000, J BIOL CHEM, V275, P20474, DOI 10.1074/jbc.M001077200
   Brown GC, 1999, BBA-BIOENERGETICS, V1411, P351, DOI 10.1016/S0005-2728(99)00025-0
   Brown GC, 2010, NITRIC OXIDE-BIOL CH, V23, P153, DOI 10.1016/j.niox.2010.06.001
   Colussi C, 2008, P NATL ACAD SCI USA, V105, P19183, DOI 10.1073/pnas.0805514105
   Cordani N, 2014, STEM CELLS, V32, P874, DOI 10.1002/stem.1587
   De Palma C, 2010, CELL DEATH DIFFER, V17, P1684, DOI 10.1038/cdd.2010.48
   Di Giovanni S, 2001, MOL CELL NEUROSCI, V17, P696, DOI 10.1006/mcne.2001.0970
   DiMauro S, 2001, SEMIN CELL DEV BIOL, V12, P397, DOI 10.1006/scdb.2001.0277
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   DiMauro S, 2012, ADV EXP MED BIOL, V748, P341, DOI 10.1007/978-1-4614-3573-0_14
   Dubowitz V, 1973, MUSCLE BIOSPY PRACTI, V0, P0
   Dyakova EY, 2015, FRONT CELL DEV BIOL, V3, P0, DOI 10.3389/fcell.2015.00019
   Fagiolari G, 2002, MUSCLE NERVE, V26, P265, DOI 10.1002/mus.10172
   Fellet AL, 2006, AM J PHYSIOL-HEART C, V291, PH1246, DOI 10.1152/ajpheart.00711.2005
   Frandsen U, 1996, BIOCHEM BIOPH RES CO, V227, P88, DOI 10.1006/bbrc.1996.1472
   Gutsaeva DR, 2008, J NEUROSCI, V28, P2015, DOI 10.1523/JNEUROSCI.5654-07.2008
   HOPE BT, 1991, P NATL ACAD SCI USA, V88, P2811, DOI 10.1073/pnas.88.7.2811
   Ikezoe K, 2002, ACTA NEUROPATHOL, V103, P531, DOI 10.1007/s00401-001-0502-8
   Kirby DM, 2003, ANN NEUROL, V54, P473, DOI 10.1002/ana.10687
   Kiyomoto BH, 2008, J NEUROL SCI, V268, P33, DOI 10.1016/j.jns.2007.10.026
   KOBZIK L, 1995, BIOCHEM BIOPH RES CO, V211, P375, DOI 10.1006/bbrc.1995.1824
   Komen JC, 2014, BRIT J PHARMACOL, V171, P1818, DOI 10.1111/bph.12413
   Lira VA, 2010, J PHYSIOL-LONDON, V588, P3551, DOI 10.1113/jphysiol.2010.194035
   Mannick JA, 2001, J AM COLL SURGEONS, V193, P237, DOI 10.1016/S1072-7515(01)01011-0
   Mannick JB, 2001, J CELL BIOL, V154, P1111, DOI 10.1083/jcb.200104008
   McConell GK, 2010, J APPL PHYSIOL, V108, P589, DOI 10.1152/japplphysiol.00377.2009
   Mirabella M, 2000, BRAIN, V123, P93, DOI 10.1093/brain/123.1.93
   NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6
   Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368
   Nisoli E, 2004, P NATL ACAD SCI USA, V101, P16507, DOI 10.1073/pnas.0405432101
   Nisoli E, 2006, J CELL SCI, V119, P2855, DOI 10.1242/jcs.03062
   Ohkoshi N, 1997, J NEUROL SCI, V149, P151, DOI 10.1016/S0022-510X(97)05385-9
   Planitzer G, 2000, HISTOCHEM J, V32, P303, DOI 10.1023/A:1004041129915
   Rodrigues ADS, 2008, J NEUROL SCI, V264, P182, DOI 10.1016/j.jns.2007.08.002
   Rötig A, 2010, DIABETES METAB, V36, P97, DOI 10.1016/j.diabet.2009.11.002
   Rovere-Querini P, 2014, EUR J PHARMACOL, V730, P181, DOI 10.1016/j.ejphar.2013.11.006
   Scarpulla RC, 2012, BBA-GENE REGUL MECH, V1819, P1088, DOI 10.1016/j.bbagrm.2011.10.011
   Sciacco M, 2001, NEUROLOGY, V56, P1070, DOI 10.1212/WNL.56.8.1070
   Stamler JS, 2001, PHYSIOL REV, V81, P209, DOI 10.1152/physrev.2001.81.1.209
   Tanji K, 2008, METHODS, V46, P274, DOI 10.1016/j.ymeth.2008.09.027
   Tengan CH, 2007, BIOCHEM BIOPH RES CO, V359, P771, DOI 10.1016/j.bbrc.2007.05.184
   Thomas DD, 2008, FREE RADICAL BIO MED, V45, P18, DOI 10.1016/j.freeradbiomed.2008.03.020
   Toledo JC, 2012, CHEM RES TOXICOL, V25, P975, DOI 10.1021/tx300042g
   Umaki Y, 2002, ACTA NEUROPATHOL, V103, P163
   Wadley GD, 2007, J APPL PHYSIOL, V102, P314, DOI 10.1152/japplphysiol.00549.2006
   Wenz T, 2009, IUBMB LIFE, V61, P1051, DOI 10.1002/iub.261
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
NR 51
TC 7
Z9 8
U1 0
U2 4
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
EI 
J9 SCI REP-UK
JI Sci Rep
PD FEB 9
PY 2016
VL 6
IS 
BP 
EP 
DI 10.1038/srep20780
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DD0NY
UT WOS:000369617900001
PM 26856437
DA 2024-11-01
ER

PT J
AU Li, T
   Chen, GL
   Lan, H
   Mao, L
   Zeng, B
AF Li, Tao
   Chen, Gui-Lan
   Lan, Huan
   Mao, Liang
   Zeng, Bo
TI Prevalence of the 4977-bp and 4408-bp mitochondrial DNA deletions in mesenteric arteries from patients with colorectal cancer
SO MITOCHONDRIAL DNA PART A
LA English
DT Article
DE Colorectal cancer; mesenteric artery; mitochondrial DNA deletion
ID bp deletion; atrial-fibrillation; vietnamese patients; oxidative stress; breast-cancer; human-cells; genome; accumulation; muscle
AB Mitochondrial DNA (mtDNA) deletions are found in many diseased tissues and lead to impairment of mitochondrial functions. In this study, we found wide presence of the common 4977-bp and a novel 4408-bp deletion in the mtDNA of mesenteric arteries from patients with colorectal cancer. These two deletions were also detected in samples from healthy individuals. The content of mtDNA with the 4977-bp deletion was significantly lower in healthy controls than cancer-associated samples, and there was no significant difference for the 4408-bp deletion between the two groups. These results suggest that mtDNA in blood vessels around cancer cells may be strongly affected by oxidative stress and tend to accumulate more large-scale variations.
C1 Luzhou Med Coll, Minist Educ, Key Lab Med Elect, Luzhou 646000, Sichuan, Peoples R China.
   [Zeng, Bo] Luzhou Med Coll, Inst Cardiovasc Res, Luzhou 646000, Sichuan, Peoples R China.
C3 Southwest Medical University; Southwest Medical University
RP Zeng, B (corresponding author), Luzhou Med Coll, Inst Cardiovasc Res, Luzhou 646000, Sichuan, Peoples R China.
EM zengbo@lzmc.edu.cn
FU National Natural Science Foundation of China [31300949, 31300965]
CR Chen T, 2011, J HUM GENET, V56, P689, DOI 10.1038/jhg.2011.97
   Chen T, 2011, BMC MED GENET, V12, P0, DOI 10.1186/1471-2350-12-8
   Damas J, 2014, HUM MUTAT, V35, P1, DOI 10.1002/humu.22452
   Dani Maria Angela C, 2004, GENET MOL RES, V3, P395
   Dimberg J, 2015, SPRINGERPLUS, V4, P0, DOI 10.1186/s40064-015-0843-8
   Dimberg J, 2014, ANTICANCER RES, V34, P147
   Goto YI, 1996, BIOCHEM BIOPH RES CO, V222, P215, DOI 10.1006/bbrc.1996.0724
   Lai LP, 2003, CHEST, V123, P539, DOI 10.1378/chest.123.2.539
   LEE HC, 1994, BBA-MOL BASIS DIS, V1226, P37, DOI 10.1016/0925-4439(94)90056-6
   Lin PH, 2003, FREE RADICAL BIO MED, V35, P1310, DOI 10.1016/j.freeradbiomed.2003.07.002
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Nie HR, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0067953
   Nourazarian AR, 2014, ASIAN PAC J CANCER P, V15, P4745, DOI 10.7314/APJCP.2014.15.12.4745
   Singh AK, 2014, MITOCHONDR DNA, V25, P329, DOI 10.3109/19401736.2013.796520
   van Guldener C, 2000, SEMIN THROMB HEMOST, V26, P281, DOI 10.1055/s-2000-8472
   Wei YH, 2001, ANN NY ACAD SCI, V928, P97
   WEI YH, 1992, MUTAT RES, V275, P145, DOI 10.1016/0921-8734(92)90019-L
NR 17
TC 3
Z9 3
U1 0
U2 6
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2470-1394
EI 2470-1408
J9 MITOCHONDRIAL DNA A
JI Mitochondrial DNA Part A
PD JUN 15
PY 2016
VL 27
IS 5
BP 3774
EP 3776
DI 10.3109/19401736.2015.1079900
PG 3
WC Genetics & Heredity
SC Genetics & Heredity
GA DO7IU
UT WOS:000377956700285
PM 26332461
DA 2024-11-01
ER

PT J
AU Rosen, ED
AF Rosen, E. D.
TI Epigenomic and transcriptional control of insulin resistance
SO JOURNAL OF INTERNAL MEDICINE
LA English
DT Article
DE adipocyte; chromatin-modifying enzyme; insulin resistance; transcription factor; transcriptional cofactor; type 2 diabetes
ID activated-receptor-gamma; hepatic glucose output; ppar-gamma; glucocorticoid-receptor; skeletal-muscle; antidiabetic actions; coactivator torc2; promotes obesity; gene-expression; binding
AB Insulin resistance is one of the defining features of type 2 diabetes and the metabolic syndrome and accompanies many other clinical conditions, ranging from obesity to lipodystrophy to glucocorticoid excess. Extraordinary efforts have gone into defining the mechanisms that underlie insulin resistance, with most attention focused on altered signalling as well as mitochondrial and endoplasmic reticulum stress. Here, nuclear mechanisms of insulin resistance, including transcriptional and epigenomic effects, will be discussed. Three levels of control involving transcription factors, transcriptional cofactors, and chromatin-modifying enzymes will be considered. Well-studied examples of the first include PPAR- in adipose tissue and the glucocorticoid receptor and FoxO1 in a variety of insulin-sensitive tissues. These proteins work in concert with cofactors such as PGC-1 and CRTC2, and chromatin-modifying enzymes including DNA methyltransferases and histone acetyltransferases, to regulate key genes that promote insulin-stimulated glucose uptake, gluconeogenesis or other pathways that affect systemic insulin action. Furthermore, genetic variation associated with increased risk of type 2 diabetes is often related to altered transcription factor binding, either by affecting the transcription factor itself, or more commonly by changing the binding affinity of a noncoding regulatory region. Finally, several avenues for therapeutic exploitation in the battle against metabolic disease will be discussed, including small-molecule inhibitors and activators of these factors and their related pathways.
C1 [Rosen, E. D.] Beth Israel Deaconess Med Ctr, Div Endocrinol & Metab, 330 Brookline Ave, Boston, MA 02215 USA.
   [Rosen, E. D.] Harvard Med Sch, 330 Brookline Ave, Boston, MA 02215 USA.
C3 Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School
RP Rosen, ED (corresponding author), Beth Israel Deaconess Med Ctr, Div Endocrinol & Metab, 330 Brookline Ave, Boston, MA 02215 USA.; Rosen, ED (corresponding author), Harvard Med Sch, 330 Brookline Ave, Boston, MA 02215 USA.
EM erosen@bidmc.harvard.edu
FU NIH [R01 DK 085171, R01 DK 102173, R01 DK 102170]
CR Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159
   Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216
   Archer TK, 2008, EXPERT OPIN THER TAR, V12, P1457, DOI 10.1517/14728222.12.11.1457 
   Banks AS, 2015, NATURE, V517, P391, DOI 10.1038/nature13887
   Baranowski M, 2008, J PHYSIOL PHARMACOL, V59, P31
   Barrera LA, 2016, SCIENCE, V351, P1450, DOI 10.1126/science.aad2257
   Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723
   Boucher J, 2014, CSH PERSPECT BIOL, V6, P0, DOI 10.1101/cshperspect.a009191
   Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010
   Britto FA, 2014, AM J PHYSIOL-ENDOC M, V307, PE983, DOI 10.1152/ajpendo.00234.2014
   Calabuig-Navarro V, 2015, J BIOL CHEM, V290, P15581, DOI 10.1074/jbc.M115.650994
   Canettieri G, 2005, CELL METAB, V2, P331, DOI 10.1016/j.cmet.2005.09.008
   Choi JH, 2011, NATURE, V477, P477, DOI 10.1038/nature10383
   Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291
   Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132
   Claussnitzer M, 2014, CELL, V156, P343, DOI 10.1016/j.cell.2013.10.058
   Cleasby ME, 2007, MOL ENDOCRINOL, V21, P215, DOI 10.1210/me.2006-0154
   Coste A, 2008, P NATL ACAD SCI USA, V105, P17187, DOI 10.1073/pnas.0808207105
   Daitoku H, 2011, BBA-MOL CELL RES, V1813, P1954, DOI 10.1016/j.bbamcr.2011.03.001
   Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/s0140-6736(16)30054-x
   Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062
   Eguchi J, 2013, DIABETES, V62, P3394, DOI 10.2337/db12-1327
   Farese RV, 2012, CELL METAB, V15, P570, DOI 10.1016/j.cmet.2012.03.004
   Galmozzi A, 2013, DIABETES, V62, P732, DOI 10.2337/db12-0548
   Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637
   Gaulton KJ, 2008, DIABETES, V57, P3136, DOI 10.2337/db07-1731
   Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200
   Giguère V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017
   Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200
   Haeusler RA, 2010, J BIOL CHEM, V285, P35245, DOI 10.1074/jbc.C110.175851
   Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361
   Heidari N, 2014, GENOME RES, V24, P1905, DOI 10.1101/gr.176586.114
   Herman MA, 2012, NATURE, V484, P333, DOI 10.1038/nature10986
   Hevener AL, 2003, NAT MED, V9, P1491, DOI 10.1038/nm956
   Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561
   Hoehn KL, 2008, CELL METAB, V7, P421, DOI 10.1016/j.cmet.2008.04.005
   Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034
   Housley MP, 2008, J BIOL CHEM, V283, P16283, DOI 10.1074/jbc.M802240200
   Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634
   Huang-Doran Isabel, 2011, PEDIATR ENDOCRINOL REV, V8, P190
   Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101
   Inagaki T, 2009, GENES CELLS, V14, P991, DOI 10.1111/j.1365-2443.2009.01326.x
   Jacobson PB, 2005, J PHARMACOL EXP THER, V314, P191, DOI 10.1124/jpet.104.081257
   James AM, 2012, TRENDS ENDOCRIN MET, V23, P429, DOI 10.1016/j.tem.2012.06.008
   Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842
   Kang S, 2015, NAT CELL BIOL, V17, P44, DOI 10.1038/ncb3080
   Keppler BR, 2008, EXPERT OPIN THER TAR, V12, P1301, DOI 10.1517/14728222.12.10.1301 
   Kim AY, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms8585
   Kim JK, 2000, J CLIN INVEST, V105, P1791, DOI 10.1172/JCI8305
   Kim YB, 1999, J CLIN INVEST, V104, P733, DOI 10.1172/JCI6928
   Kong XX, 2014, CELL, V158, P69, DOI 10.1016/j.cell.2014.04.049
   Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967
   Kung CP, 2016, CELL REP, V14, P2413, DOI 10.1016/j.celrep.2016.02.037
   Kuo TY, 2012, P NATL ACAD SCI USA, V109, P11160, DOI 10.1073/pnas.1111334109
   Kyle UG, 2006, CURR OPIN CLIN NUTR, V9, P388, DOI 10.1097/01.mco.0000232898.74415.42
   Lefterova MI, 2014, TRENDS ENDOCRIN MET, V25, P293, DOI 10.1016/j.tem.2014.04.001
   Lemke U, 2008, CELL METAB, V8, P212, DOI 10.1016/j.cmet.2008.08.001
   Li PP, 2011, CELL, V147, P815, DOI 10.1016/j.cell.2011.09.050
   Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349
   Löwenberg M, 2006, ENDOCRINOLOGY, V147, P3555, DOI 10.1210/en.2005-1602
   Lu M, 2011, NAT MED, V17, P618, DOI 10.1038/nm.2332
   Majithia AR, 2014, P NATL ACAD SCI USA, V111, P13127, DOI 10.1073/pnas.1410428111
   Masuccio F, 2010, J CHILD NEUROL, V25, P941, DOI 10.1177/0883073809349461
   Mathis D, 2013, CELL METAB, V17, P851, DOI 10.1016/j.cmet.2013.05.008
   Menke A, 2015, JAMA-J AM MED ASSOC, V314, P1021, DOI 10.1001/jama.2015.10029
   Mezza T, 2012, ANN NUTR METAB, V61, P337, DOI 10.1159/000342771
   Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098
   Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043
   Morton GJ, 2011, PHYSIOL REV, V91, P389, DOI 10.1152/physrev.00007.2010
   Mouchiroud L, 2014, CELL METAB, V20, P26, DOI 10.1016/j.cmet.2014.03.027
   Nadler ST, 2001, AM J PHYSIOL-ENDOC M, V281, PE1249, DOI 10.1152/ajpendo.2001.281.6.E1249
   Nagai Y, 2009, CELL METAB, V9, P252, DOI 10.1016/j.cmet.2009.01.011
   Nakae J, 2008, DIABETES, V57, P563, DOI 10.2337/db07-0698
   Norris AW, 2003, J CLIN INVEST, V112, P608, DOI 10.1172/JCI200317305
   Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894
   Oh JS, 2015, CELL REP, V10, P1872, DOI 10.1016/j.celrep.2015.02.043
   Ohno H, 2013, NATURE, V504, P163, DOI 10.1038/nature12652
   Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846
   Opherk C, 2004, MOL ENDOCRINOL, V18, P1346, DOI 10.1210/me.2003-0283
   Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988
   Peirce V, 2013, LANCET DIABETES ENDO, V1, P353, DOI 10.1016/S2213-8587(13)70055-X
   Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8
   Puigserver P, 2005, INT J OBESITY, V29, PS5, DOI 10.1038/sj.ijo.0802905
   Vinolo MAR, 2012, AM J PHYSIOL-ENDOC M, V303, PE272, DOI 10.1152/ajpendo.00053.2012
   Rando OJ, 2015, CELL, V161, P93, DOI 10.1016/j.cell.2015.02.021
   Rangwala SM, 2003, DEV CELL, V5, P657, DOI 10.1016/S1534-5807(03)00274-0
   Ren HX, 2012, CELL, V149, P1314, DOI 10.1016/j.cell.2012.04.032
   Roohk DJ, 2013, ENDOCRINOLOGY, V154, P1528, DOI 10.1210/en.2011-1047
   Rosen ED, 2003, MOL CELL BIOL, V23, P7222, DOI 10.1128/MCB.23.20.7222-7229.2003
   Ryan KK, 2011, NAT MED, V17, P623, DOI 10.1038/nm.2349
   Saberi M, 2009, AM J PHYSIOL-ENDOC M, V297, PE1137, DOI 10.1152/ajpendo.00158.2009
   Sacta MA, 2016, ANNU REV PHYSIOL, V78, P155, DOI 10.1146/annurev-physiol-021115-105323
   Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017
   Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406
   Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682
   Shu CJ, 2012, SEMIN IMMUNOL, V24, P436, DOI 10.1016/j.smim.2012.12.001
   Small KS, 2011, NAT GENET, V43, P561, DOI 10.1038/ng.833
   Soccio RE, 2015, CELL, V162, P33, DOI 10.1016/j.cell.2015.06.025
   Soccio RE, 2014, CELL METAB, V20, P573, DOI 10.1016/j.cmet.2014.08.005
   Song Y, 2010, NATURE, V468, P933, DOI 10.1038/nature09564
   Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686
   Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207
   Sun C, 2014, CELL REP, V9, P2250, DOI 10.1016/j.celrep.2014.11.029
   Sun Z, 2013, MOL CELL, V52, P769, DOI 10.1016/j.molcel.2013.10.022
   Sun Z, 2012, NAT MED, V18, P934, DOI 10.1038/nm.2744
   Sung CC, 2012, J BIOMED BIOTECHNOL, V0, P0, DOI DOI 10.1155/2012/634195
   Tateishi K, 2009, NATURE, V458, P757, DOI 10.1038/nature07777
   Wang HM, 2006, J BIOL CHEM, V281, P39128, DOI 10.1074/jbc.M610023200
   Wang YG, 2010, P NATL ACAD SCI USA, V107, P3087, DOI 10.1073/pnas.0914897107
   Wang Y, 2011, MOL ENDOCRINOL, V25, P2041, DOI 10.1210/me.2011-1222
   Whorwood CB, 2002, DIABETES, V51, P1066, DOI 10.2337/diabetes.51.4.1066
   Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8
   Xiao CT, 2011, DIABETES, V60, P918, DOI 10.2337/db10-1433
   Ye JM, 2004, DIABETOLOGIA, V47, P1306, DOI 10.1007/s00125-004-1436-1
   Yi CX, 2012, DIABETES, V61, P339, DOI 10.2337/db11-1239
NR 115
TC 22
Z9 24
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0954-6820
EI 1365-2796
J9 J INTERN MED
JI J. Intern. Med.
PD NOV 15
PY 2016
VL 280
IS 5
BP 443
EP 456
DI 10.1111/joim.12547
PG 14
WC Medicine, General & Internal
SC General & Internal Medicine
GA EA8VL
UT WOS:000386917400003
PM 27739225
DA 2024-11-01
ER

PT J
AU Billing-Ross, P
   Germain, A
   Ye, KX
   Keinan, A
   Gu, ZL
   Hanson, MR
AF Billing-Ross, Paul
   Germain, Arnaud
   Ye, Kaixiong
   Keinan, Alon
   Gu, Zhenglong
   Hanson, Maureen R.
TI Mitochondrial DNA variants correlate with symptoms in myalgic encephalomyelitis/chronic fatigue syndrome
SO JOURNAL OF TRANSLATIONAL MEDICINE
LA English
DT Article
DE Myalgic encephalomyelitis (ME); Chronic fatigue syndrome (CFS); Next-generation sequencing; Mitochondrial DNA; mtDNA; Heteroplasmy; Association; SNPs; Haplogroup; Variants
ID magnetic-resonance-spectroscopy; muscle metabolism; syndrome me/cfs; blood-flow; genome; heteroplasmy; pathogenicity; fibromyalgia; dysfunction; mutations
AB Background: Mitochondrial dysfunction has been hypothesized to occur in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), a disease characterized by fatigue, cognitive difficulties, pain, malaise, and exercise intolerance. We investigated whether haplogroup, single nucleotide polymorphisms (SNPs), or heteroplasmy of mitochondrial DNA (mtDNA) were associated with health status and/or symptoms. Methods: Illumina sequencing of PCR-amplified mtDNA was performed to analyze sequence and extent of heteroplasmy of mtDNAs of 193 cases and 196 age-and gender-matched controls from DNA samples collected by the Chronic Fatigue Initiative. Association testing was carried out to examine possible correlations of mitochondrial sequences with case/control status and symptom constellation and severity as reported by subjects on Short Form-36 and DePaul Symptom Questionnaires. Results: No ME/CFS subject exhibited known disease-causing mtDNA mutations. Extent of heteroplasmy was low in all subjects. Although no association between mtDNA SNPs and ME/CFS vs. healthy status was observed, haplogroups J, U and H as well as eight SNPs in ME/CFS cases were significantly associated with individual symptoms, symptom clusters, or symptom severity. Conclusions: Analysis of mitochondrial genomes in ME/CFS cases indicates that individuals of a certain haplogroup or carrying specific SNPs are more likely to exhibit certain neurological, inflammatory, and/or gastrointestinal symptoms. No increase in susceptibility to ME/CFS of individuals carrying particular mitochondrial genomes or SNPs was observed.
C1 [Billing-Ross, Paul; Gu, Zhenglong] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.
   [Germain, Arnaud; Hanson, Maureen R.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.
   [Ye, Kaixiong; Keinan, Alon] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA.
C3 Cornell University; Cornell University; Cornell University
RP Hanson, MR (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.
EM mrh5@cornell.edu
FU National Science Foundation predoctoral fellowship; NIH [R01 HG006849]
CR Aaron LA, 2000, ARCH INTERN MED, V160, P221, DOI 10.1001/archinte.160.2.221
   Bandelt HJ, 2014, J HUM GENET, V59, P66, DOI 10.1038/jhg.2013.120
   Baudouin SV, 2005, LANCET, V366, P2118, DOI 10.1016/S0140-6736(05)67890-7
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Boles RG, 2015, MITOCHONDRION, V23, P1, DOI 10.1016/j.mito.2015.04.005
   Boles RG, 2015, MITOCHONDRION, V23, P64, DOI 10.1016/j.mito.2015.05.002
   Brown AA, 2014, FATIGUE, V2, P0, DOI 10.1080/21641846.2014.928014
   Carruthers BM, 2011, J INTERN MED, V270, P327, DOI 10.1111/j.1365-2796.2011.02428.x
   Carruthers BM, 2003, J. CHRONIC FATIGUE SYNDR, V11, P7, DOI 10.1300/J092V11N0102
   Castro-Marrero J, 2013, ANTIOXID REDOX SIGN, V19, P1855, DOI 10.1089/ars.2013.5346
   Chinnery PF, 2001, BRAIN, V124, P209, DOI 10.1093/brain/124.1.209
   Dayama G, 2014, NUCLEIC ACIDS RES, V42, P12640, DOI 10.1093/nar/gku1038
   de Laat P, 2012, J INHERIT METAB DIS, V35, P1059, DOI 10.1007/s10545-012-9465-2
   Fuku N, 2007, AM J HUM GENET, V80, P407, DOI 10.1086/512202
   FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009
   Goto H, 2011, GENOME BIOL, V12, P0, DOI 10.1186/gb-2011-12-6-r59
   Hart AB, 2013, AIDS REV, V15, P213
   Hollingsworth KG, 2010, EUR J CLIN INVEST, V40, P608, DOI 10.1111/j.1365-2362.2010.02310.x
   Hornig M, 2015, SCI ADV, V1, P0, DOI 10.1126/sciadv.1400121
   Hutchinson CV, 2014, BRIT J OPHTHALMOL, V98, P144, DOI 10.1136/bjophthalmol-2013-304439
   Jason LA, 2010, AM. J. BIOCHEM. BIOTECHNOL, V6, P120, DOI 10.3844/AJBBSP.2010.120.135
   Jason LA, 2015, FATIGUE, V3, P16, DOI 10.1080/21641846.2014.978110
   Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892
   Klimas NG, 2015, FATIGUE, V3, P75, DOI 10.1080/21641846.2015.1023652
   Kloss-Brandstätter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382
   KOMAROFF AL, 1991, REV INFECT DIS, V13, P0
   Lane RJM, 1998, NEUROMUSCULAR DISORD, V8, P204, DOI 10.1016/S0960-8966(98)00021-2
   Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231
   Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352
   Lyons EA, 2013, BMC GENOMICS, V14, P0, DOI 10.1186/1471-2164-14-881
   Maes M, 2009, NEUROENDOCRINOL LETT, V30, P470
   McCully KK, 2004, J APPL PHYSIOL, V96, P871, DOI 10.1152/japplphysiol.00141.2003
   McCully KK, 2003, CLIN SCI, V104, P641, DOI 10.1042/CS20020279
   Mueller EE, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0052367
   Myhill S, 2013, INT J CLIN EXP MED, V6, P1
   PLIOPLYS AV, 1995, NEUROPSYCHOBIOLOGY, V32, P175, DOI 10.1159/000119233
   Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795
   Smits B, 2011, MITOCHONDRION, V11, P735, DOI 10.1016/j.mito.2011.05.005
   van Oven M, 2009, HUM MUTAT, V30, PE386, DOI 10.1002/humu.20921
   Vermeulen RCW, 2010, J TRANSL MED, V8, P0, DOI 10.1186/1479-5876-8-93
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   WARE JE, 1995, MED CARE, V33, PAS264, DOI 10.1097/00005650-199501001-00005
   WONG R, 1992, CHEST, V102, P1716, DOI 10.1378/chest.102.6.1716
   Ye KX, 2014, P NATL ACAD SCI USA, V111, P10654, DOI 10.1073/pnas.1403521111
NR 45
TC 41
Z9 45
U1 0
U2 23
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1479-5876
EI 
J9 J TRANSL MED
JI J. Transl. Med.
PD JAN 20
PY 2016
VL 14
IS 
BP 
EP 
DI 10.1186/s12967-016-0771-6
PG 12
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DB3FC
UT WOS:000368394500002
PM 26791940
DA 2024-11-01
ER

PT J
AU Vincent, AE
   Rosa, HS
   Alston, CL
   Grady, JP
   Rygiel, KA
   Rocha, MC
   Barresi, R
   Taylor, RW
   Turnbull, DM
AF Vincent, Amy E.
   Rosa, Hannah S.
   Alston, Charlotte L.
   Grady, John P.
   Rygiel, Karolina A.
   Rocha, Mariana C.
   Barresi, Rita
   Taylor, Robert W.
   Turnbull, Doug M.
TI Dysferlin mutations and mitochondrial dysfunction
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Dysferlin; Mitochondria; LGMD2B; Immunofluorescence; Histochemistry; Cytochrome c oxidase deficiency
ID girdle muscular-dystrophy; skeletal-muscle; miyoshi myopathy; membrane repair; 2b; phosphorylation; gene
AB Dysferlinopathies are caused by mutations in the DYSF gene and patients may present with proximal or distal myopathy. Dysferlin is responsible for membrane resealing, and mutations may result in a defect in membrane repair following mechanical or chemical stress, causing an influx of Ca2+. Since mitochondria are involved in Ca2+ buffering, we hypothesised that mitochondrial defects may be present in skeletal muscle biopsies from patients with mutations in this gene. The aim was to characterise mitochondrial defects in muscle from patients with dysferlinopathies. Here, we analysed skeletal muscle biopsies for eight patients by quadruple immunofluorescent assay to assess oxidative phosphorylation protein abundance. Long-range PCR in single muscle fibres was used to look for presence of clonally expanded large-scale mitochondrial DNA rearrangements in patients' skeletal muscle (n = 3). Immunofluorescence demonstrated that the percentage of complex I- and complex IV-deficient fibres was higher in patients with DYSF mutations than in age-matched controls. No clonally expanded mtDNA deletions were detected using long-range PCR in any of the analysed muscle fibres. We conclude that complex I and complex IV deficiency is higher in patients than age matched controls but patients do not have rearrangements of the mtDNA. We hypothesise that respiratory chain deficiency may be the results of an increased cytosolic Ca2+ concentration (due to a membrane resealing defect) causing mitochondrial aberrations. (C) 2016 The Authors. Published by Elsevier B.V.
C1 [Vincent, Amy E.; Rosa, Hannah S.; Alston, Charlotte L.; Grady, John P.; Rygiel, Karolina A.; Rocha, Mariana C.; Taylor, Robert W.; Turnbull, Doug M.] Newcastle Univ, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Barresi, Rita] Newcastle Tyne Hosp NHS Fdn Trust, Rare Dis Advisory Grp, Muscle Immunoanal Unit, Serv Rare Neuromuscular Dis, Newcastle Upon Tyne NE2 4AZ, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust
RP Turnbull, DM (corresponding author), Newcastle Univ, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM doug.turnbull@ncl.ac.uk
FU MRC studentship as part of the MRC Centre for Neuromuscular Disease [MR/K501074/1, MR/K000608/1]; Wellcome Trust Centre for Mitochondrial Research [096919Z/11/Z]; Medical Research Council (UK) Centre for Translational Muscle Disease Research [G0601943]; UK NIHR Biomedical Research Centre in Age and Age Related Diseases award; Lily Foundation; UK NHS Highly Specialised Commissioners; National Institute for Health Research (NIHR) doctoral fellowship [NIHR-HCS-D12-03-04]; MRC [G0700718, MR/K000608/1, MR/L016354/1, G0800674, G0601943, MC_G0802536] Funding Source: UKRI
CR Abdullah N, 2014, BIOPHYS J, V106, P382, DOI 10.1016/j.bpj.2013.11.4492
   Bansal D, 2004, TRENDS CELL BIOL, V14, P206, DOI 10.1016/j.tcb.2004.03.001
   Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573
   Bashir R, 1998, NAT GENET, V20, P37, DOI 10.1038/1689
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Gallardo E, 2001, NEUROLOGY, V57, P2136, DOI 10.1212/WNL.57.11.2136
   Gayathri N, 2011, INDIAN J PATHOL MICR, V54, P350, DOI 10.4103/0377-4929.81636
   Han XJ, 2008, J CELL BIOL, V182, P573, DOI 10.1083/jcb.200802164
   Illarioshkin SN, 2000, NEUROLOGY, V55, P1931, DOI 10.1212/WNL.55.12.1931
   Lek A, 2010, BMC EVOL BIOL, V10, P0, DOI 10.1186/1471-2148-10-231
   Liu FC, 2016, INT J NEUROSCI, V126, P499, DOI 10.3109/00207454.2015.1034801
   Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682
   Pitceathly RDS, 2012, BRAIN, V135, P3392, DOI 10.1093/brain/aws231
   Rocha MC, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep15037
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Weiler T, 1999, HUM MOL GENET, V8, P871, DOI 10.1093/hmg/8.5.871
NR 17
TC 24
Z9 26
U1 0
U2 12
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD NOV 15
PY 2016
VL 26
IS 11
BP 782
EP 788
DI 10.1016/j.nmd.2016.08.008
PG 7
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA EB8FF
UT WOS:000387626200010
PM 27666772
DA 2024-11-01
ER

PT J
AU Asencio, C
   Rodríguez-Hernandez, MA
   Briones, P
   Montoya, J
   Cortés, A
   Emperador, S
   Gavilán, A
   Ruiz-Pesini, E
   Yubero, D
   Montero, R
   Pineda, M
   O'Callaghan, MM
   Alcázar-Fabra, M
   Salviati, L
   Artuch, R
   Navas, P
AF Asencio, Claudio
   Rodriguez-Hernandez, Maria A.
   Briones, Paz
   Montoya, Julio
   Cortes, Ana
   Emperador, Sonia
   Gavilan, Angela
   Ruiz-Pesini, Eduardo
   Yubero, Delia
   Montero, Raquel
   Pineda, Mercedes
   O'Callaghan, Maria M.
   Alcazar-Fabra, Maria
   Salviati, Leonardo
   Artuch, Rafael
   Navas, Placido
TI Severe encephalopathy associated to pyruvate dehydrogenase mutations and unbalanced coenzyme Q<sub>10</sub> content
SO EUROPEAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
ID deficiency; biosynthesis; fibroblasts; tissue; protein; chain; cells
AB Coenzyme Q(10) (CoQ(10)) deficiency is associated to a variety of clinical phenotypes including neuromuscular and nephrotic disorders. We report two unrelated boys presenting encephalopathy, ataxia, and lactic acidosis, who died with necrotic lesions in different areas of brain. Levels of CoQ(10) and complex II+III activity were increased in both skeletal muscle and fibroblasts, but it was a consequence of higher mitochondria mass measured as citrate synthase. In fibroblasts, oxygen consumption was also increased, whereas steady state ATP levels were decreased. Antioxidant enzymes such as NQO1 and MnSOD and mitochondrial marker VDAC were overexpressed. Mitochondria recycling markers Fis1 and mitofusin, and mtDNA regulatory Tfam were reduced. Exome sequencing showed mutations in PDHA1 in the first patient and in PDHB in the second. These genes encode subunits of pyruvate dehydrogenase complex (PDH) that could explain the compensatory increase of CoQ(10) and a defect of mitochondrial homeostasis. These two cases describe, for the first time, a mitochondrial disease caused by PDH defects associated with unbalanced of both CoQ(10) content and mitochondria homeostasis, which severely affects the brain. Both CoQ(10) and mitochondria homeostasis appears as new markers for PDH associated mitochondrial disorders.
C1 [Asencio, Claudio; Rodriguez-Hernandez, Maria A.; Cortes, Ana; Gavilan, Angela; Alcazar-Fabra, Maria; Navas, Placido] Univ Pablo de Olavide, CSIC, Ctr Andaluz Biol Desarrollo, Carretera Utrera Km 1, Seville 41013, Spain.
   [Asencio, Claudio; Rodriguez-Hernandez, Maria A.; Cortes, Ana; Gavilan, Angela; Alcazar-Fabra, Maria; Navas, Placido] Inst Salud Carlos III, CIBERER, Carretera Utrera Km 1, Seville 41013, Spain.
   [Asencio, Claudio; Rodriguez-Hernandez, Maria A.; Briones, Paz; Montoya, Julio; Cortes, Ana; Emperador, Sonia; Gavilan, Angela; Ruiz-Pesini, Eduardo; Yubero, Delia; Montero, Raquel; Pineda, Mercedes; O'Callaghan, Maria M.; Alcazar-Fabra, Maria; Artuch, Rafael; Navas, Placido] ISCIII, Ctr Biomed Res Rare Dis CIBERER, Madrid, Spain.
   [Briones, Paz; Yubero, Delia] Hosp Clin Barcelona, IDIBAPS, Serv Bioquim & Genet Mol, Secc Errores Congenitos Metab IBC U737, Barcelona, Spain.
   [Briones, Paz; Yubero, Delia] CSIC, Barcelona, Spain.
   [Montoya, Julio; Emperador, Sonia; Ruiz-Pesini, Eduardo] Univ Zaragoza, Dept Bioquim Biol Mol & Celular, Zaragoza, Spain.
   [Montero, Raquel; Pineda, Mercedes; O'Callaghan, Maria M.; Artuch, Rafael] Hosp St Joan de Deu, Dept Pathol, Clin Chem, Barcelona, Spain.
   [Montero, Raquel; Pineda, Mercedes; O'Callaghan, Maria M.; Artuch, Rafael] Hosp St Joan de Deu, Dept Neurol, Clin Chem, Barcelona, Spain.
   [Salviati, Leonardo] Univ Padua, Dept Woman & Child Hlth, Clin Genet Unit, Padua, Italy.
   [Salviati, Leonardo] IRP Citta Speranza, Padua, Italy.
C3 Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Consejo Superior de Investigaciones Cientificas (CSIC); University of Zaragoza; University of Barcelona; University of Barcelona; University of Padua; Fondazione Citta della Speranza
RP Navas, P (corresponding author), Univ Pablo de Olavide, CSIC, Ctr Andaluz Biol Desarrollo, Carretera Utrera Km 1, Seville 41013, Spain.; Navas, P (corresponding author), Inst Salud Carlos III, CIBERER, Carretera Utrera Km 1, Seville 41013, Spain.
EM pnavas@upo.es
FU Spanish Ministry of Health (Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III) [PI14/00028, PI10-00662, PI14/01962]; Telethon Italy [GGP13222]; University of Padova [CPDA123573/12]; Fondazione CARIPARO; University Pablo de Olavide (Plan Propio de Investigacion) [APP2D11086]
CR Barros MH, 2005, J BIOL CHEM, V280, P42627, DOI 10.1074/jbc.M510768200
   Bentinger M, 2010, BIOCHEM BIOPH RES CO, V396, P74, DOI 10.1016/j.bbrc.2010.02.147
   Doimo M, 2014, MOL SYNDROMOL, V5, P156, DOI 10.1159/000362826
   Emmanuele V, 2012, ARCH NEUROL-CHICAGO, V69, P978, DOI 10.1001/archneurol.2012.206
   Genova ML, 2014, BBA-BIOENERGETICS, V1837, P427, DOI 10.1016/j.bbabio.2013.11.002
   Glushakova LG, 2011, MOL GENET METAB, V104, P255, DOI 10.1016/j.ymgme.2011.07.023
   Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037
   Imbard A, 2011, MOL GENET METAB, V104, P507, DOI 10.1016/j.ymgme.2011.08.008
   Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381
   Laredj LN, 2014, BIOCHIMIE, V100, P78, DOI 10.1016/j.biochi.2013.12.006
   López-Martín JM, 2007, HUM MOL GENET, V16, P1091, DOI 10.1093/hmg/ddm058
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Montero R, 2008, CLIN BIOCHEM, V41, P697, DOI 10.1016/j.clinbiochem.2008.03.007
   Montero R, 2013, MITOCHONDRION, V13, P337, DOI 10.1016/j.mito.2013.04.001
   Parrado-Fernández C, 2011, FREE RADICAL BIO MED, V50, P1728, DOI 10.1016/j.freeradbiomed.2011.03.024
   Quintana E, 2009, J INHERIT METAB DIS, V32, PS339, DOI 10.1007/s10545-009-1343-1
   Siegel D, 2004, MOL PHARMACOL, V65, P1238, DOI 10.1124/mol.65.5.1238
   Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058
   Winski SL, 2002, CANCER RES, V62, P1420
NR 19
TC 15
Z9 15
U1 0
U2 15
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1018-4813
EI 1476-5438
J9 EUR J HUM GENET
JI Eur. J. Hum. Genet.
PD MAR 15
PY 2016
VL 24
IS 3
BP 367
EP 372
DI 10.1038/ejhg.2015.112
PG 6
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA DE2PP
UT WOS:000370469500014
PM 26014431
DA 2024-11-01
ER

PT J
AU Holmes-Hampton, GP
   Crooks, DR
   Haller, RG
   Guo, S
   Freier, SM
   Monia, BP
   Rouault, TA
AF Holmes-Hampton, Gregory P.
   Crooks, Daniel R.
   Haller, Ronald G.
   Guo, Shuling
   Freier, Susan M.
   Monia, Brett P.
   Rouault, Tracey A.
TI Use of antisense oligonucleotides to correct the splicing error in ISCU myopathy patient cell lines
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID iron-sulfur proteins; succinate-dehydrogenase; muscular-dystrophy; paroxysmal myoglobinuria; lactic-acidosis; intron mutation; skeletal-muscle; dna metabolism; gene; disease
AB ISCU myopathy is an inherited disease that primarily affects individuals of northern Swedish descent who share a single point mutation in the fourth intron of the ISCU gene. The current study shows correction of specific phenotypes associated with disease following treatment with an antisense oligonucleotide (ASO) targeted to the site of the mutation. We have shown that ASO treatment diminished aberrant splicing and increased ISCU protein levels in both patient fibroblasts and patient myotubes in a concentration dependent fashion. Upon ASO treatment, levels of SDHB in patient myotubular cell lines increased to levels observed in control myotubular cell lines. Additionally, we have shown that both patient fibroblast and myotubular cell lines displayed an increase in complex II activity with a concomitant decrease in succinate levels in patient myotubular cell lines after ASO treatment. Mitochondrial and cytosolic aconitase activities increased significantly following ASO treatment in patient myotubes. The current study suggests that ASO treatment may serve as a viable approach to correcting ISCU myopathy in patients.
C1 [Holmes-Hampton, Gregory P.; Rouault, Tracey A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Mol Med Branch, Bethesda, MD 20892 USA.
   [Crooks, Daniel R.] Natl Canc Inst, Ctr Canc Res, Urol Oncol Branch, Bethesda, MD USA.
   [Haller, Ronald G.] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA.
   [Haller, Ronald G.] Texas Hlth Presbyterian Hosp Dallas, Neuromuscular Ctr, Inst Exercise & Environm Med, Dallas, TX 75231 USA.
   [Guo, Shuling; Freier, Susan M.; Monia, Brett P.] Ionis Pharmaceut, Dept Antisense Drug Discovery, Carlsbad, CA USA.
C3 National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Texas System; University of Texas Southwestern Medical Center Dallas; Ionis Pharmaceuticals, Inc.
RP Rouault, TA (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Mol Med Branch, Bethesda, MD 20892 USA.; Rouault, TA (corresponding author), Bldg 35A,Room 2D 908,9000 Rockville Pike, Bethesda, MD 20892 USA.
EM Rouault@mail.nih.gov
FU Intramural program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development
CR Beinert H, 2000, J BIOL INORG CHEM, V5, P2, DOI 10.1007/s007750050002
   BEINERT H, 1993, FASEB J, V7, P1442, DOI 10.1096/fasebj.7.15.8262329
   Bennett CF, 2010, ANNU REV PHARMACOL, V50, P259, DOI 10.1146/annurev.pharmtox.010909.105654
   Braun MM, 2010, NAT REV DRUG DISCOV, V9, P519, DOI 10.1038/nrd3160
   Buratti E, 2006, NUCLEIC ACIDS RES, V34, P3494, DOI 10.1093/nar/gkl498
   Chiriboga CA, 2016, NEUROLOGY, V86, P890, DOI 10.1212/WNL.0000000000002445
   Christie PT, 2001, J CLIN ENDOCR METAB, V86, P3840, DOI 10.1210/jc.86.8.3840
   Corey DR, 2001, GENOME BIOL, V2, P0
   Crooks DR, 2014, HUM MOL GENET, V23, P24, DOI 10.1093/hmg/ddt393
   Crooks DR, 2012, J BIOL CHEM, V287, P40119, DOI 10.1074/jbc.M112.418889
   de Smet MD, 1999, OCUL IMMUNOL INFLAMM, V7, P189, DOI 10.1076/ocii.7.3.189.4007
   Gari K, 2012, SCIENCE, V337, P243, DOI 10.1126/science.1219664
   HALL RE, 1993, J CLIN INVEST, V92, P2660, DOI 10.1172/JCI116882
   HALLER RG, 1991, J CLIN INVEST, V88, P1197, DOI 10.1172/JCI115422
   Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017
   Kakkis ED, 2016, NAT BIOTECHNOL, V34, P380, DOI 10.1038/nbt.3530
   Kastelein JJP, 2006, CIRCULATION, V114, P1729, DOI 10.1161/CIRCULATIONAHA.105.606442
   Kole R, 2015, ADV DRUG DELIVER REV, V87, P104, DOI 10.1016/j.addr.2015.05.008
   Kollberg G, 2009, NEUROMUSCULAR DISORD, V19, P833, DOI 10.1016/j.nmd.2009.09.011
   Kollberg G, 2009, BRAIN, V132, P2170, DOI 10.1093/brain/awp152
   LARSSON LE, 1964, J NEUROL NEUROSUR PS, V27, P361, DOI 10.1136/jnnp.27.5.361
   Liang XH, 2016, NAT BIOTECHNOL, V34, P875, DOI 10.1038/nbt.3589
   LINDERHOLM H, 1990, J INTERN MED, V228, P43, DOI 10.1111/j.1365-2796.1990.tb00191.x
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Maio N, 2016, CELL METAB, V23, P292, DOI 10.1016/j.cmet.2015.12.005
   MITCHELL GA, 1991, P NATL ACAD SCI USA, V88, P815, DOI 10.1073/pnas.88.3.815
   Miyamoto BE, 2011, ORPHANET J RARE DIS, V6, P0, DOI 10.1186/1750-1172-6-49
   Mochel F, 2008, AM J HUM GENET, V82, P652, DOI 10.1016/j.ajhg.2007.12.012
   Morel CF, 2006, J CLIN ENDOCR METAB, V91, P2689, DOI 10.1210/jc.2005-2746
   Muchir A, 2000, HUM MOL GENET, V9, P1453, DOI 10.1093/hmg/9.9.1453
   Noack D, 2001, BBA-MOL BASIS DIS, V1537, P125, DOI 10.1016/S0925-4439(01)00065-5
   Nordin A, 2012, HUM MUTAT, V33, P467, DOI 10.1002/humu.22002
   Nordin A, 2011, HUM GENET, V129, P371, DOI 10.1007/s00439-010-0931-3
   Olsson A, 2008, HUM MOL GENET, V17, P1666, DOI 10.1093/hmg/ddn057
   Pérez B, 2010, J INHERIT METAB DIS, V33, P397, DOI 10.1007/s10545-010-9135-1
   Rouault TA, 2015, NAT REV MOL CELL BIO, V16, P45, DOI 10.1038/nrm3909
   Sanaker PS, 2010, BBA-MOL BASIS DIS, V1802, P539, DOI 10.1016/j.bbadis.2010.02.010
   Saxena N, 2016, JNCI-J NATL CANCER I, V108, P0, DOI 10.1093/jnci/djv287
   Scotti MM, 2016, NAT REV GENET, V17, P19, DOI 10.1038/nrg.2015.3
   Skotte NH, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0107434
   Stehling O, 2012, SCIENCE, V337, P195, DOI 10.1126/science.1219723
   Tong WH, 2000, EMBO J, V19, P5692, DOI 10.1093/emboj/19.21.5692
   Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003
   Touznik A, 2014, EXPERT OPIN BIOL TH, V14, P809, DOI 10.1517/14712598.2014.896335
   Tuffery-Giraud S, 2003, HUM MUTAT, V21, P608, DOI 10.1002/humu.10214
   Vandanmagsar B, 2016, CELL REP, V15, P1686, DOI 10.1016/j.celrep.2016.04.057
   Wang M, 1997, BREAST CANCER RES TR, V44, P145, DOI 10.1023/A:1005753117205
NR 47
TC 10
Z9 11
U1 0
U2 4
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD DEC 1
PY 2016
VL 25
IS 23
BP 5178
EP 5187
DI 10.1093/hmg/ddw338
PG 10
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA EP0FT
UT WOS:000397063300010
PM 28007899
DA 2024-11-01
ER

PT J
AU Janssen, W
   Quaegebeur, A
   Van Goethem, G
   Ann, L
   Smets, K
   Vandenberghe, R
   Van Paesschen, W
AF Janssen, Wouter
   Quaegebeur, Annelies
   Van Goethem, Gert
   Ann, Lofgren
   Smets, Katrien
   Vandenberghe, Rik
   Van Paesschen, Wim
TI The spectrum of epilepsy caused by <i>POLG</i> mutations
SO ACTA NEUROLOGICA BELGICA
LA English
DT Article
DE POLG; Mitochondrial disease; Status epilepticus; Valproate
ID mitochondrial-dna polymerase; w748s mutation; gamma; disease; dysfunction
AB Mutations in POLG are increasingly recognized as a cause of refractory occipital lobe epilepsy (OLE) and status epilepticus (SE). Our aim was to describe the epilepsy syndrome in seven patients with POLG mutations. We retrospectively reviewed the medical records of seven patients with POLG mutations and epilepsy. Mutation analysis was performed by direct sequencing of the coding exons of the POLG gene. Disease onset was at a median age of 18 years (range 12-26). Epilepsy was the presenting problem in six patients. All had focal seizures, with motor (n = 6) and visual (n = 6) phenomena. Six patients had secondarily generalized seizures and two patients had myoclonic seizures. Six patients had one or more episodes of refractory SE, including focal (n = 5), subtle (n = 4), myoclonic (n = 2) and convulsive (n = 3) SE. During or after SE, brain MRI showed lesions affecting the occipital lobe in all patients, probably due to continuous epileptic activity. Five of the six patients with SE died during treatment of SE, one due to valproate-induced hepatotoxicity. Associated clinical symptoms were ataxia (n = 6), polyneuropathy (n = 6), progressive external ophthalmoplegia (PEO) (n = 3) and migraine (n = 3). Epilepsy may be the first and dominant neurological problem caused by POLG mutations. The epilepsy may be severe and the condition of the patient may end in fatal SE. Refractory OLE and SE in a patient with polyneuropathy, ataxia, PEO or migraine warrant screening for POLG mutations. In this clinical setting, valproate should not be given in view of the risk of fatal hepatotoxicity.
C1 [Janssen, Wouter; Quaegebeur, Annelies; Vandenberghe, Rik; Van Paesschen, Wim] Univ Hosp Leuven, Dept Neurol, Herestr 49, B-3000 Louvain, Belgium.
   [Van Goethem, Gert; Smets, Katrien] VIB, Dept Mol Genet, Neurogenet Grp, Antwerp, Belgium.
   [Van Goethem, Gert; Ann, Lofgren; Smets, Katrien] Inst Born Bunge, Neurogenet Lab, Antwerp, Belgium.
   [Van Goethem, Gert; Ann, Lofgren; Smets, Katrien] Univ Antwerp, B-2020 Antwerp, Belgium.
   [Van Goethem, Gert; Smets, Katrien] Univ Antwerp Hosp, Dept Neurol, Antwerp, Belgium.
C3 KU Leuven; University Hospital Leuven; Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Antwerp
RP Van Paesschen, W (corresponding author), Univ Hosp Leuven, Dept Neurol, Herestr 49, B-3000 Louvain, Belgium.
EM wouter.janssen@uzleuven.be; wim.vanpaesschen@uzleuven.be
CR Bindoff LA, 2012, EPILEPSIA, V53, P92, DOI 10.1111/j.1528-1167.2012.03618.x
   Bindoff LA, 2011, EPILEPSIA, V52, P6, DOI 10.1111/j.1528-1167.2011.03223.x
   Blok MJ, 2009, J MED GENET, V46, P776, DOI 10.1136/jmg.2009.067686
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Cohen BH, 2010, METHODS, V51, P364, DOI 10.1016/j.ymeth.2010.05.008
   Engelsen BA, 2008, BRAIN, V131, P818, DOI 10.1093/brain/awn007
   Folbergrová J, 2012, MITOCHONDRION, V12, P35, DOI 10.1016/j.mito.2011.04.004
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Khurana DS, 2013, SEMIN PEDIATR NEUROL, V20, P176, DOI 10.1016/j.spen.2013.10.001
   Milone M, 2010, NEUROLOGIST, V16, P84, DOI 10.1097/NRL.0b013e3181c78a89
   Neeve VCM, 2012, BRAIN, V135, P3614, DOI 10.1093/brain/aws298
   Rahman S, 2012, DEV MED CHILD NEUROL, V54, P397, DOI 10.1111/j.1469-8749.2011.04214.x
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Roshal D, 2011, EPILEPSY BEHAV, V21, P206, DOI 10.1016/j.yebeh.2011.03.003
   Saneto RP, 2013, PEDIATR NEUROL, V48, P167, DOI 10.1016/j.pediatrneurol.2012.09.014
   Smith J, 2013, EMERGING ISSUES MED, V1, P1
   Stewart JD, 2010, HEPATOLOGY, V52, P1791, DOI 10.1002/hep.23891
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Tchikviladze M, 2014, J NEUROL NEUROSURG P, V0, P0
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Tzoulis C, 2014, ANN NEUROL, V76, P66, DOI 10.1002/ana.24185
   Uusimaa J, 2013, EPILEPSIA, V54, P1002, DOI 10.1111/epi.12115
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, NEUROLOGY, V61, P1811, DOI 10.1212/01.WNL.0000098997.23471.65
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Wanrooij S, 2010, BBA-BIOENERGETICS, V1797, P1378, DOI 10.1016/j.bbabio.2010.04.015
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Ylönen S, 2013, J NEUROL, V260, P3144, DOI 10.1007/s00415-013-7132-7
NR 30
TC 13
Z9 15
U1 0
U2 4
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0300-9009
EI 2240-2993
J9 ACTA NEUROL BELG
JI Acta Neurol. Belg.
PD MAR 15
PY 2016
VL 116
IS 1
BP 17
EP 25
DI 10.1007/s13760-015-0499-8
PG 9
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA DE7TX
UT WOS:000370840700004
PM 26104464
DA 2024-11-01
ER

PT J
AU Uittenbogaard, M
   Chiaramello, A
AF Uittenbogaard, Martine
   Chiaramello, Anne
TI Novel subcellular localization of the DNA helicase Twinkle at the kinetochore complex during mitosis in neuronal-like progenitor cells
SO HISTOCHEMISTRY AND CELL BIOLOGY
LA English
DT Article
DE Chromosomal segregation; Hexameric DNA helicases; Kinetochore complex; Mitochondria; Mitosis; Twinkle
ID onset spinocerebellar ataxia; progressive external ophthalmoplegia; pc12 cells; cenp-a; mitochondrial biogenesis; multiple deletions; mutations; aneuploidy; architecture; components
AB During mitosis, the kinetochore, a multi-protein structure located on the centromeric DNA, is responsible for proper segregation of the replicated genome. More specifically, the outer kinetochore complex component Ndc80/Hec1 plays a critical role in regulating microtubule attachment to the spindle for accurate sister chromatid segregation. In addition, DNA helicases play a key contribution for precise and complete disjunction of sister chromatids held together through double-stranded DNA catenations until anaphase. In this study, we focused our attention on the nuclear-encoded DNA helicase Twinkle, which functions as an essential helicase for replication of mitochondrial DNA. It regulates the copy number of the mitochondrial genome, while maintaining its integrity, two processes essential for mitochondrial biogenesis and bioenergetic functions. Although the majority of the Twinkle protein is imported into mitochondria, a small fraction remains cytosolic with an unknown function. In this study, we report a novel expression pattern of Twinkle during chromosomal segregation at distinct mitotic phases. By immunofluorescence microscopy, we found that Twinkle protein colocalizes with the outer kinetochore protein HEC1 as early as prophase until late anaphase in neuronal-like progenitor cells. Thus, our collective results have revealed an unexpected cell cycle-regulated expression pattern of the DNA helicase Twinkle, known for its role in mtDNA replication. Therefore, its recruitment to the kinetochore suggests an evolutionary conserved function for both mitochondrial and nuclear genomic inheritance.
C1 [Uittenbogaard, Martine; Chiaramello, Anne] George Washington Univ, Med Ctr, Dept Anat & Regenerat Biol, 2300 1 St NW, Washington, DC 20037 USA.
C3 George Washington University
RP Chiaramello, A (corresponding author), George Washington Univ, Med Ctr, Dept Anat & Regenerat Biol, 2300 1 St NW, Washington, DC 20037 USA.
EM achiaram@gwu.edu
FU National Institutes of Health, National Institute of Neurological Disorders and Stroke [R21NS085282]; National Center for Research Resources [S10RR025565]; National Institute of Child Health and Human Development [P30HD40677]
CR Aldrup-MacDonald ME, 2014, GENES-BASEL, V5, P33, DOI 10.3390/genes5010033
   Baumann C, 2007, CELL, V128, P101, DOI 10.1016/j.cell.2006.11.041
   Baxter J, 2011, SCIENCE, V331, P1328, DOI 10.1126/science.1201538
   Baxter KK, 2012, EXP CELL RES, V318, P2200, DOI 10.1016/j.yexcr.2012.07.004
   Baxter KK, 2009, ASN NEURO, V1, P0, DOI 10.1042/AN20090036
   Bergeland T, 2001, CURR BIOL, V11, P644, DOI 10.1016/S0960-9822(01)00177-4
   Bergmann JH, 2011, EMBO J, V30, P328, DOI 10.1038/emboj.2010.329
   Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200
   Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310
   Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039
   Ciferri C, 2005, J BIOL CHEM, V280, P29088, DOI 10.1074/jbc.M504070200
   Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6
   Croteau DL, 2012, AGING CELL, V11, P456, DOI 10.1111/j.1474-9726.2012.00803.x
   DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852
   Dierssen M, 2009, PHYSIOL REV, V89, P887, DOI 10.1152/physrev.00032.2007
   Ding L, 2015, INT J MOL SCI, V16, P10870, DOI 10.3390/ijms160510870
   Dunster K, 2002, EUR J CELL BIOL, V81, P117, DOI 10.1078/0171-9335-00232
   Duxin JP, 2009, MOL CELL BIOL, V29, P4274, DOI 10.1128/MCB.01834-08
   Emanuele MJ, 2005, MOL BIOL CELL, V16, P4882, DOI 10.1091/mbc.E05-03-0239
   Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494
   Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   Futami K, 2007, BIOL PHARM BULL, V30, P1685, DOI 10.1248/bpb.30.1685
   Gilkerson R, 2013, COLD SPRING HARB PER, V5, P0
   Gilkerson RW, 2009, INT J BIOCHEM CELL B, V41, P1899, DOI 10.1016/j.biocel.2009.03.016
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Gordon DJ, 2012, NAT REV GENET, V13, P189, DOI 10.1038/nrg3123
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Holmlund T, 2009, BBA-MOL BASIS DIS, V1792, P132, DOI 10.1016/j.bbadis.2008.11.009
   Iourov IY, 2009, NEUROBIOL DIS, V34, P212, DOI 10.1016/j.nbd.2009.01.003
   Izuta H, 2006, GENES CELLS, V11, P673, DOI 10.1111/j.1365-2443.2006.00969.x
   Ke YW, 2011, EMBO J, V30, P3309, DOI 10.1038/emboj.2011.226
   Khidr L, 2008, J BIOL CHEM, V283, P27064, DOI 10.1074/jbc.M802991200
   Kingsbury MA, 2006, CELL MOL LIFE SCI, V63, P2626, DOI 10.1007/s00018-006-6169-5
   Kingsbury MA, 2005, P NATL ACAD SCI USA, V102, P6143, DOI 10.1073/pnas.0408171102
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Lawrence Elizabeth, 2013, COMMUN INTEGR BIOL, V6, Pe27557, DOI 10.4161/cib.27557
   Lawrence EJ, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0072886
   Liu ST, 2006, J CELL BIOL, V175, P41, DOI 10.1083/jcb.200606020
   Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536
   Milenkovic D, 2013, HUM MOL GENET, V22, P1983, DOI 10.1093/hmg/ddt051
   Minczuk M, 2002, NUCLEIC ACIDS RES, V30, P5074, DOI 10.1093/nar/gkf647
   Morino H, 2014, NEUROLOGY, V83, P2054, DOI 10.1212/WNL.0000000000001036
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   ODoherty A, 2005, SCIENCE, V309, P2033, DOI 10.1126/science.1114535
   Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396
   Park MH, 2014, NEUROGENETICS, V15, P171, DOI 10.1007/s10048-014-0405-1
   Peterson SE, 2012, J NEUROSCI, V32, P16213, DOI 10.1523/JNEUROSCI.3706-12.2012
   Rehen SK, 2001, P NATL ACAD SCI USA, V98, P13361, DOI 10.1073/pnas.231487398
   Rehen SK, 2005, J NEUROSCI, V25, P2176, DOI 10.1523/JNEUROSCI.4560-04.2005
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Rouzeau S, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0033905
   Sen D, 2012, J BIOL CHEM, V287, P14545, DOI 10.1074/jbc.M111.309468
   Siegel JJ, 2012, ANNU REV CELL DEV BI, V28, P189, DOI 10.1146/annurev-cellbio-101011-155807
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Stimpson KM, 2011, EMBO J, V30, P233, DOI 10.1038/emboj.2010.339
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Uittenbogaard M, 2005, J NEUROCHEM, V92, P585, DOI 10.1111/j.1471-4159.2004.02886.x
   Uittenbogaard M, 2004, J NEUROCHEM, V91, P1332, DOI 10.1111/j.1471-4159.2004.02814.x
   Uittenbogaard M, 2002, J NEUROSCI RES, V67, P235, DOI 10.1002/jnr.10119
   Uittenbogaard M, 2014, CURR PHARM DESIGN, V20, P5574, DOI 10.2174/1381612820666140305224906
   Uittenbogaard M, 2010, ASN NEURO, V2, P0, DOI 10.1042/AN20100005
   Uittenbogaard M, 2010, J NEUROSCI RES, V88, P33, DOI 10.1002/jnr.22182
   Van Hove JLK, 2009, AM J MED GENET A, V149A, P861, DOI 10.1002/ajmg.a.32731
   Wang DDH, 2009, J BIOL CHEM, V284, P20812, DOI 10.1074/jbc.M109.009605
   Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200
   Wei JH, 2009, J CELL BIOL, V184, P391, DOI 10.1083/jcb.200809090
   Wiseman FK, 2009, HUM MOL GENET, V18, PR75, DOI 10.1093/hmg/ddp010
   Wu GK, 2009, MOL BIOL CELL, V20, P4686, DOI 10.1091/mbc.E08-11-1123
   Wu SX, 2005, P NATL ACAD SCI USA, V102, P17172, DOI 10.1073/pnas.0508560102
   Yang AH, 2003, J NEUROSCI, V23, P10454
   Ylikallio E, 2010, HUM MOL GENET, V19, P2695, DOI 10.1093/hmg/ddq163
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024
   Zierbarth TD, 2007, J MOL BIOL, V367, P1382
NR 77
TC 3
Z9 4
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0948-6143
EI 1432-119X
J9 HISTOCHEM CELL BIOL
JI Histochem. Cell Biol.
PD MAR 15
PY 2016
VL 145
IS 3
BP 275
EP 286
DI 10.1007/s00418-015-1388-1
PG 12
WC Cell Biology; Microscopy
SC Cell Biology; Microscopy
GA DE7LM
UT WOS:000370818200002
PM 26678504
DA 2024-11-01
ER

PT J
AU Bahreini, F
   Houshmand, M
   Modaresi, MH
   Tonekaboni, H
   Nafissi, S
   Nazari, F
   Akrami, SM
AF Bahreini, Fatemeh
   Houshmand, Massoud
   Modaresi, Mohammad Hossein
   Tonekaboni, Hassan
   Nafissi, Shahriar
   Nazari, Ferdoss
   Akrami, Seyed Mohammad
TI Mitochondrial Copy Number and D-Loop Variants in Pompe Patients
SO CELL JOURNAL
LA English
DT Article
DE Pompe; Mitochondrial DNA; D-Loop; Copy Number
ID dna mutations; displacement loop; late-onset; mononucleotide sequence; skeletal-muscle; human-disease; cancer; glycogenosis; pathogenesis; diagnosis
AB Objective: Pompe disease is a rare neuromuscular genetic disorder and is classified into two forms of early and late-onset. Over the past two decades, mitochondrial abnormalities have been recognized as an important contributor to an array of neuromuscular diseases. We therefore aimed to compare mitochondrial copy number and mitochondrial displacement-loop sequence variation in infantile and adult Pompe patients. Materials and Methods: In this retrospective study, the mitochondrial D-loop sequence was analyzed by polymerase chain reaction (PCR) and direct sequencing to detect possible variation in 28 Pompe patients (17 infants and 11 adults). Results were compared with 100 healthy controls and sequences of all individuals were compared with the Cambridge reference sequence. Real-time PCR was used to quantify mitochondrial DNA copy number. Results: Among 59 variants identified, 37(62.71%) were present in the infant group, 14(23.333%) in the adult group and 8(13.333%) in both groups. Mitochondrial copy number in infant patients was lower than adults (P<0.05). A significant frequency difference was seen between the two groups for 12 single nucleotide polymorphism (SNP). A novel insertion (317-318 ins CCC) was observed in patients and six SNPs were identified as neutral variants in controls. There was an inverse association between mitochondrial copy number and D-loop variant number (r=0.54). Conclusion: The 317-318 ins CCC was detected as a new mitochondrial variant in Pompe patients.
C1 [Bahreini, Fatemeh; Modaresi, Mohammad Hossein; Akrami, Seyed Mohammad] Univ Tehran Med Sci, Sch Med, Dept Med Genet, POB 14176-13151,Keshavarz BLV,Poursina St, Tehran, Iran.
   [Houshmand, Massoud] Natl Inst Genet Engn & Biotechnol, Dept Med Genet, Tehran, Iran.
   [Tonekaboni, Hassan] Shahid Beheshti Univ Med Sci, Dept Pediat Neurol, Tehran, Iran.
   [Nafissi, Shahriar; Nazari, Ferdoss] Univ Tehran Med Sci, Iranian Ctr Neurol Res, Tehran, Iran.
C3 Tehran University of Medical Sciences; Shahid Beheshti University Medical Sciences; Tehran University of Medical Sciences
RP Akrami, SM (corresponding author), Univ Tehran Med Sci, Sch Med, Dept Med Genet, POB 14176-13151,Keshavarz BLV,Poursina St, Tehran, Iran.
EM akramism@tums.ac.ir
FU Tehran University of Medical Sciences, Tehran, Iran [23162]
CR Akouchekian M, 2009, DIS COLON RECTUM, V52, P526, DOI 10.1007/DCR.0b013e31819acb99
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Chamkha I, 2012, BIOCHEM BIOPH RES CO, V429, P31, DOI 10.1016/j.bbrc.2012.10.105
   Dato S, 2004, EUR J HUM GENET, V12, P1080, DOI 10.1038/sj.ejhg.5201278
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Dons Sink IJ, 2014, CASE REP ANESTHESIOL, V2014, P0
   ENGEL AG, 1968, MAYO CLIN PROC, V43, P233
   Fernández R, 1999, NEUROMUSCULAR DISORD, V9, P136, DOI 10.1016/S0960-8966(98)00117-5
   Filosto M, 2003, ANN NEUROL, V54, P524, DOI 10.1002/ana.10709
   Ghaffarpour M, 2014, CANCER CELL INT, V14, P0, DOI 10.1186/1475-2867-14-21
   HOUSHMAND M, 1994, BBA-MOL BASIS DIS, V1226, P49, DOI 10.1016/0925-4439(94)90058-2
   Huang HP, 2011, HUM MOL GENET, V20, P4851, DOI 10.1093/hmg/ddr424
   Hudgson P, 1975, RIV ISTOCHIM NORM PATOL, V19, P101
   Khusnutdinova E, 2008, ANN NY ACAD SCI, V1147, P1, DOI 10.1196/annals.1427.001
   Kishnani PS, 2006, GENET MED, V8, P267, DOI 10.1097/01.gim.0000218152.87434.f3
   Kroos M, 2012, HUM MUTAT, V33, P1161, DOI 10.1002/humu.22108
   Kurtz A, 2004, MOL CANCER RES, V2, P433
   Lachmann R, 2013, ORPHANET J RARE DIS, V8, P0, DOI 10.1186/1750-1172-8-160
   Lewandowska E, 2008, FOLIA NEUROPATHOL, V46, P123
   Lim JA, 2014, FRONT AGING NEUROSCI, V6, P0, DOI 10.3389/fnagi.2014.00177
   Mao L, 2002, CLIN CANCER RES, V8, P2021
   Marín-García J, 2002, J CARD FAIL, V8, P93, DOI 10.1054/jcaf.2002.32501
   Mezghani N, 2011, BIOCHEM BIOPH RES CO, V411, P247, DOI 10.1016/j.bbrc.2011.06.106
   Raben N, 2012, AM J MED GENET C, V160C, P13, DOI 10.1002/ajmg.c.31317
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   Schmuczerova J, 2009, MUTAT RES-FUND MOL M, V666, P1, DOI 10.1016/j.mrfmmm.2009.03.002
   Seyedhassani SM, 2010, J ASSIST REPROD GEN, V27, P641, DOI 10.1007/s10815-010-9435-2
   Shakhssalim N, 2013, CANCER CELL INT, V13, P0, DOI 10.1186/1475-2867-13-120
   Suzuki M, 2003, CLIN CANCER RES, V9, P5636
   Tang MY, 2004, CLIN CANCER RES, V10, P1041, DOI 10.1158/1078-0432.CCR-0701-3
   Thorburn DR, 2001, AM J MED GENET, V106, P102, DOI 10.1002/ajmg.1380
   Thurberg BL, 2006, LAB INVEST, V86, P1208, DOI 10.1038/labinvest.3700484
   Thurberg Beth L, 2015, J NEUROMUSCUL DIS, V2, P0
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Udar N, 2009, INVEST OPHTH VIS SCI, V50, P2966, DOI 10.1167/iovs.08-2646
   Van der Beek NAME, 2009, NEUROMUSCULAR DISORD, V19, P113, DOI 10.1016/j.nmd.2008.11.007
   van der Ploeg AT, 2010, NEW ENGL J MED, V362, P1396, DOI 10.1056/NEJMoa0909859
   Van Trappen PO, 2007, GYNECOL ONCOL, V104, P129, DOI 10.1016/j.ygyno.2006.07.010
   VERITY MA, 1991, MUSCLE NERVE, V14, P435, DOI 10.1002/mus.880140509
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a021220
   Yanovitch TL, 2010, J PEDIAT OPHTH STRAB, V47, P34, DOI 10.3928/01913913-20100106-08
NR 41
TC 5
Z9 5
U1 0
U2 1
PU ROYAN INST
PI TEHRAN
PA PO BOX 19395-4644, TEHRAN, 00000, IRAN
SN 2228-5806
EI 2228-5814
J9 CELL J
JI Cell J.
PD FAL 15
PY 2016
VL 18
IS 3
BP 405
EP 415
DI 
PG 11
WC Cell Biology
SC Cell Biology
GA DW7YN
UT WOS:000383869800014
PM 27602323
DA 2024-11-01
ER

PT J
AU Shoar, Z
   Goldenthal, MJ
   De Luca, F
   Suarez, E
AF Shoar, Zohreh
   Goldenthal, Michael J.
   De Luca, Francesco
   Suarez, Elizabeth
TI Mitochondrial DNA content and function, childhood obesity, and insulin resistance
SO ENDOCRINE RESEARCH
LA English
DT Article
DE Childhood obesity; mitochondrial content; mitochondrial function; mitochondrial respiratory complexes
ID oxidative stress; protein-synthesis; adipose-tissue; copy number; muscle; inflammation; dysfunction; increase; disease; glucose
AB Objectives: The objectives of our study were to compare the mitochondrial enzyme activity between obese and non-obese children and to assess the association between mitochondrial DNA content and function and markers of metabolic syndrome. Methods: Clinical and anthropometric data of obese and normal-weight children ages 2-18 years were collected. We collected buccal swabs for mitochondrial respiratory enzymes (complex I, IV, and Citrate Synthase). In obese children only, serum levels of metabolic parameters and mitochondrial DNA from mononuclear cells were quantitated. Results: We recruited 75 obese and 65 normal-weight children. There was no difference in respiratory complex enzyme activity levels between obese and normal-weight subjects. In obese subjects, mitochondrial to nuclear DNA (mt/nDNA) ratio was significantly correlated with BMI Z-score and BMI percentile (p<0.05, and p<0.01, respectively), and the strength of this correlation was proportionate to the degree of obesity. We did not find any association between mt/nDNA ratio and metabolic parameters. We observed a significant positive association between complex IV activity and fasting insulin level (p<0.05). Finally, fasting insulin explained 45% of the variation in the complex IV activity level (p<0.05). Conclusion: Our findings indicate that mitochondrial DNA content is directly related to obesity, but not to the markers of metabolic syndrome/insulin resistance in children. Longitudinal studies involving larger samples are needed to confirm our findings and help elucidate the relationship between mitochondrial function, adiposity, and insulin resistance.
C1 [Shoar, Zohreh; De Luca, Francesco; Suarez, Elizabeth] Drexel Univ, Sect Endocrinol & Diabet, Coll Med, St Christophers Hosp, Philadelphia, PA 19104 USA.
   [Goldenthal, Michael J.] Drexel Univ, Sect Child Neurol, Coll Med, St Christophers Hosp, Philadelphia, PA 19104 USA.
C3 Drexel University; Drexel University
RP Shoar, Z (corresponding author), St Christophers Hosp Children, Sect Endocrinol & Diabet, 3601 A St, Philadelphia, PA 19134 USA.
EM zshoar@gmail.com
CR Mieldazis SFA, 2010, J PEDIAT-BRAZIL, V86, P245, DOI 10.1590/S0021-75572010000300014
   Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340
   Barrientos A, 1997, BIOCHEM MOL MED, V62, P165, DOI 10.1006/bmme.1997.2647
   Boirie Y, 2001, DIABETES, V50, P2652, DOI 10.2337/diabetes.50.12.2652
   Bondia-Pons I, 2012, J PHYSIOL BIOCHEM, V68, P701, DOI 10.1007/s13105-012-0154-2
   Bournat Juan C, 2010, CURR OPIN ENDOCRINOL DIABETES OBES, V17, P446, DOI 10.1097/MED.0b013e32833c3026
   Capková M, 2002, INT J OBESITY, V26, P1110, DOI 10.1038/sj.ijo.0802055
   Cormio A, 2009, BBA-BIOENERGETICS, V1787, P547, DOI 10.1016/j.bbabio.2009.01.008
   Danadian K, 1999, DIABETES CARE, V22, P1325, DOI 10.2337/diacare.22.8.1325
   De Naeyer H, 2011, OBESITY FACTS, V4, P407, DOI 10.1159/000333445
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Franks PW, 2010, NEW ENGL J MED, V362, P485, DOI 10.1056/NEJMoa0904130
   Goldenthal MJ, 2012, MOL GENET METAB, V105, P457, DOI 10.1016/j.ymgme.2011.11.193
   Han DH, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0019739
   Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105
   Hoeks J, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0027274
   Holmström MH, 2012, AM J PHYSIOL-ENDOC M, V302, PE731, DOI 10.1152/ajpendo.00159.2011
   Igosheva N, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0010074
   Kaaman M, 2007, DIABETOLOGIA, V50, P2526, DOI 10.1007/s00125-007-0818-6
   Kim JA, 2008, CIRC RES, V102, P401, DOI 10.1161/CIRCRESAHA.107.165472
   Larsen S, 2011, DIABETOLOGIA, V54, P1427, DOI 10.1007/s00125-011-2098-4
   Lee HC, 2000, BIOCHEM J, V348, P425, DOI 10.1042/0264-6021:3480425
   Lee HC, 1999, ARCH BIOCHEM BIOPHYS, V362, P309, DOI 10.1006/abbi.1998.1036
   Lee HK, 2005, ANN NY ACAD SCI, V1042, P1, DOI 10.1196/annals.1338.001
   Lee HK, 1998, DIABETES RES CLIN PR, V42, P161, DOI 10.1016/S0168-8227(98)00110-7
   Lindinger A, 2010, OBES SURG, V20, P84, DOI 10.1007/s11695-009-9987-3
   Liu CS, 2003, FREE RADICAL RES, V37, P1307, DOI 10.1080/10715760310001621342
   Malik AN, 2013, MITOCHONDRION, V13, P481, DOI 10.1016/j.mito.2012.10.011
   Malik Afshan N, 2009, DIABETES RES CLIN PRACT, V86, Pe22, DOI 10.1016/j.diabres.2009.07.002
   Martínez JA, 2006, J PHYSIOL BIOCHEM, V62, P303, DOI 10.1007/BF03165759
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Morino K, 2006, DIABETES, V55, PS9, DOI 10.2337/db06-S002
   Morrison JA, 2011, METABOLISM, V60, P24, DOI 10.1016/j.metabol.2009.12.013
   Morrison JA, 2010, ARCH PEDIAT ADOL MED, V164, P53, DOI 10.1001/archpediatrics.2009.228
   Nadal-Casellas A, 2013, MOL CELL BIOCHEM, V373, P125, DOI 10.1007/s11010-012-1481-x
   Nisoli E, 2007, CIRC RES, V100, P795, DOI 10.1161/01.RES.0000259591.97107.6c
   Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992
   Ren J, 2010, J MOL MED, V88, P993, DOI 10.1007/s00109-010-0663-9
   Sleigh A, 2011, J CLIN INVEST, V121, P2457, DOI 10.1172/JCI46405
   Stump CS, 2003, P NATL ACAD SCI USA, V100, P7996, DOI 10.1073/pnas.1332551100
   Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093
   Weiss R, 2008, DIABETES CARE, V31, PS310, DOI 10.2337/dc08-s273
   Weng SW, 2009, DIABETES RES CLIN PR, V83, P94, DOI 10.1016/j.diabres.2008.10.002
   Willis JH, 2009, BBA-BIOENERGETICS, V1787, P533, DOI 10.1016/j.bbabio.2008.10.009
   Wilms L, 2009, ACTA PAEDIAT, V0, P0
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Yeckel CW, 2004, J CLIN ENDOCR METAB, V89, P1096, DOI 10.1210/jc.2003-031503
   Zhang YQ, 2010, J IMMUNOL, V184, P5645, DOI 10.4049/jimmunol.0901814
NR 49
TC 14
Z9 16
U1 0
U2 7
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0743-5800
EI 1532-4206
J9 ENDOCR RES
JI Endocr. Res.
PD JAN 2
PY 2016
VL 41
IS 1
BP 49
EP 56
DI 10.3109/07435800.2015.1068797
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DG4AT
UT WOS:000372013000008
PM 26513277
DA 2024-11-01
ER

PT J
AU Catalán-García, M
   Garrabou, G
   Morén, C
   Guitart-Mampel, M
   Hernando, A
   Díaz-Ramos, A
   González-Casacuberta, I
   Juárez, DL
   Bañó, M
   Enrich-Bengoa, J
   Emperador, S
   Milisenda, JC
   Moreno, P
   Tobías, E
   Zorzano, A
   Montoya, J
   Cardellach, F
   Grau, JM
AF Catalan-Garcia, Marc
   Garrabou, Gloria
   Moren, Constanza
   Guitart-Mampel, Mariona
   Hernando, Adriana
   Diaz-Ramos, Angels
   Gonzalez-Casacuberta, Ingrid
   Juarez, Diana-Luz
   Bano, Maria
   Enrich-Bengoa, Jennifer
   Emperador, Sonia
   Cesar Milisenda, Jose
   Moreno, Pedro
   Tobias, Ester
   Zorzano, Antonio
   Montoya, Julio
   Cardellach, Francesc
   Maria Grau, Josep
TI Mitochondrial DNA disturbances and deregulated expression of oxidative phosphorylation and mitochondrial fusion proteins in sporadic inclusion body myositis
SO CLINICAL SCIENCE
LA English
DT Article
DE deletions; depletion; mitochondria; mitofusin-2; OPA1; sporadic inclusion body myositis
ID innate immune-responses; kearns-sayre-syndrome; mitofusin 2 mfn2; skeletal-muscle; quality-control; dynamics; disease; mutations; deletions; fibers
AB Sporadic inclusion body myositis (sIBM) is one of the most common myopathies in elderly people. Mitochondrial abnormalities at the histological level are present in these patients. We hypothesize that mitochondrial dysfunction may play a role in disease aetiology. We took the following measurements of muscle and peripheral blood mononuclear cells (PBMCs) from 30 sIBM patients and 38 age-and gender-paired controls: mitochondrial DNA (mtDNA) deletions, amount of mtDNA and mtRNA, mitochondrial protein synthesis, mitochondrial respiratory chain (MRC) complex I and IV enzymatic activity, mitochondrial mass, oxidative stress and mitochondrial dynamics (mitofusin 2 and optic atrophy 1 levels). Depletion of mtDNA was present in muscle from sIBM patients and PBMCs showed deregulated expression of mitochondrial proteins in oxidative phosphorylation. MRC complex IV/citrate synthase activity was significantly decreased in both tissues and mitochondrial dynamics were affected in muscle. Depletion of mtDNA was significantly more severe in patients with mtDNA deletions, which also presented deregulation of mitochondrial fusion proteins. Imbalance in mitochondrial dynamics in muscle was associated with increased mitochondrial genetic disturbances (both depletion and deletions), demonstrating that proper mitochondrial turnover is essential for mitochondrial homoeostasis and muscle function in these patients.
C1 [Catalan-Garcia, Marc; Garrabou, Gloria; Moren, Constanza; Guitart-Mampel, Mariona; Hernando, Adriana; Gonzalez-Casacuberta, Ingrid; Juarez, Diana-Luz; Bano, Maria; Enrich-Bengoa, Jennifer; Cesar Milisenda, Jose; Moreno, Pedro; Tobias, Ester; Cardellach, Francesc; Maria Grau, Josep] Univ Barcelona, Fac Med, CELLEX IDIBAPS, Muscle Res & Mitochondrial Funct Lab, Barcelona, Spain.
   [Catalan-Garcia, Marc; Garrabou, Gloria; Moren, Constanza; Guitart-Mampel, Mariona; Hernando, Adriana; Gonzalez-Casacuberta, Ingrid; Juarez, Diana-Luz; Bano, Maria; Enrich-Bengoa, Jennifer; Cesar Milisenda, Jose; Moreno, Pedro; Tobias, Ester; Cardellach, Francesc; Maria Grau, Josep] Hosp Clin Barcelona, Dept Internal Med, CIBERER U722, Barcelona, Spain.
   [Diaz-Ramos, Angels; Zorzano, Antonio] Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Barcelona, Spain.
   [Diaz-Ramos, Angels; Zorzano, Antonio] Univ Barcelona, Fac Biol, Dept Bioquim & Biomed Mol, E-08028 Barcelona, Spain.
   [Diaz-Ramos, Angels; Zorzano, Antonio] Inst Salud Carlos III, CIBER Diabet Enfermedades Metab Asociadas CIBERDE, Madrid, Spain.
   [Emperador, Sonia; Montoya, Julio] Univ Zaragoza, Dept Bioquim Biol Mol & Celular, Inst Invest Sanitarias Aragon, CIBERER U727, Zaragoza, Spain.
C3 University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of Zaragoza; CIBER - Centro de Investigacion Biomedica en Red; CIBERER
RP Garrabou, G (corresponding author), Univ Barcelona, Fac Med, CELLEX IDIBAPS, Muscle Res & Mitochondrial Funct Lab, Barcelona, Spain.; Garrabou, G (corresponding author), Hosp Clin Barcelona, Dept Internal Med, CIBERER U722, Barcelona, Spain.
EM garrabou@clinic.ub.es
FU Instituto de Salud Carlos III (ISCIII) [PI14/00005, PI15/00903, PI15/00817, PIE1400061]; Fondo Europeo de Desarrollo Regional (FEDER) [SGR 2014/376]; La Marato [87/C/2015]; Fundacio CELLEX and CIBER of Rare Diseases (CIBERER, an initiative of ISCIII)
CR Ascaso FJ, 2010, CLIN EXP OPHTHALMOL, V38, P812, DOI 10.1111/j.1442-9071.2010.02335.x
   Burté F, 2015, NAT REV NEUROL, V11, P11, DOI 10.1038/nrneurol.2014.228
   Carod-Artal FJ, 2006, NEUROLOGIA, V21, P357
   Catalán M, 2014, AUTOIMMUN REV, V13, P363, DOI 10.1016/j.autrev.2014.01.016
   Challa S, 2004, NEUROL INDIA, V52, P353
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen KH, 2014, FASEB J, V28, P382, DOI 10.1096/fj.13-230037
   Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275
   Dorn GW, 2015, GENE DEV, V29, P1981, DOI 10.1101/gad.269894.115
   Gang Q, 2014, ORPHANET J RARE DIS, V9, P0, DOI 10.1186/1750-1172-9-88
   Garrabou G, 2016, ADDICT BIOL, V21, P159, DOI 10.1111/adb.12183
   Garrabou G, 2012, J INFECT DIS, V205, P392, DOI 10.1093/infdis/jir764
   Gomez L, 2006, AM J TRANSPLANT, V6, P487, DOI 10.1111/j.1600-6143.2005.01219.x
   Guedes-Dias P, 2016, NEUROBIOL DIS, V90, P51, DOI 10.1016/j.nbd.2015.09.008
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Houston MJ, 2007, MUSCLE BIOPSY PRACTI, V1, P0
   Hu Jing, 2007, ZHONGHUA NEI KE ZA ZHI, V46, P658
   Hernández-Alvarez MI, 2010, DIABETES CARE, V33, P645, DOI 10.2337/dc09-1305
   Joshi PR, 2014, J CLIN NEUROSCI, V21, P1959, DOI 10.1016/j.jocn.2014.05.051
   Lartigue L, 2013, INT J BIOCHEM CELL B, V45, P2052, DOI 10.1016/j.biocel.2013.06.014
   Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008
   Liu K, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0057223
   Mastaglia F L, 2009, ACTA MYOL, V28, P66
   Mishra P, 2014, NAT REV MOL CELL BIO, V15, P634, DOI 10.1038/nrm3877
   Montero R, 2013, MITOCHONDRION, V13, P337, DOI 10.1016/j.mito.2013.04.001
   Morén C, 2015, AIDS, V29, P5, DOI 10.1097/QAD.0000000000000486
   Morén C, 2013, DRUG CHEM TOXICOL, V36, P496, DOI 10.3109/01480545.2013.776578
   Morén C, 2012, JAIDS-J ACQ IMM DEF, V60, P111, DOI 10.1097/QAI.0b013e318250455e
   Moslemi AR, 1997, HUM MUTAT, V10, P381, DOI 10.1002/(SICI)1098-1004(1997)10:5<381::AID-HUMU8>3.0.CO;2-I
   Muller FL, 2007, AM J PHYSIOL-REG I, V293, PR1159, DOI 10.1152/ajpregu.00767.2006
   Needham M, 2008, J CLIN NEUROSCI, V15, P1350, DOI 10.1016/j.jocn.2008.01.011
   Ni HM, 2015, REDOX BIOL, V4, P6, DOI 10.1016/j.redox.2014.11.006
   Nogalska A, 2015, J NEUROPATH EXP NEUR, V74, P538, DOI 10.1097/NEN.0000000000000196
   Nogalska A, 2010, AM J PATHOL, V177, P1377, DOI 10.2353/ajpath.2010.100050
   Oldfors A, 2006, NEUROLOGY, V66, PS49, DOI 10.1212/01.wnl.0000192127.63013.8d
   Rose MR, 2013, NEUROMUSCULAR DISORD, V23, P1044, DOI 10.1016/j.nmd.2013.08.007
   Rygiel KA, 2015, NEUROPATH APPL NEURO, V41, P288, DOI 10.1111/nan.12149
   Santel A, 2006, BBA-MOL CELL RES, V1763, P490, DOI 10.1016/j.bbamcr.2006.02.004
   Sebastián D, 2012, P NATL ACAD SCI USA, V109, P5523, DOI 10.1073/pnas.1108220109
   Sivakumar K, 1996, NEUROLOGY, V46, P1337, DOI 10.1212/WNL.46.5.1337
   Solano A, 2004, PEDIATR NEPHROL, V19, P790, DOI 10.1007/s00467-004-1473-5
   Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058
   Sunitha B, 2016, J NEUROCHEM, V138, P174, DOI 10.1111/jnc.13626
   Tezel G, 2009, INVEST OPHTH VIS SCI, V50, P1001, DOI 10.1167/iovs.08-2717
   Vattemi G, 2014, AUTOIMMUN HIGHLIGHTS, V5, P77, DOI 10.1007/s13317-014-0062-2
   Vielhaber S, 2013, ACTA NEUROPATHOL, V125, P245, DOI 10.1007/s00401-012-1036-y
   Walker MA, 2014, J IMMUNOL RES, V2014, P0, DOI 10.1155/2014/164309
   West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975
NR 48
TC 33
Z9 34
U1 0
U2 14
PU PORTLAND PRESS LTD
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER STREET, LONDON WC1N 2JU, ENGLAND
SN 0143-5221
EI 1470-8736
J9 CLIN SCI
JI Clin. Sci.
PD OCT 1
PY 2016
VL 130
IS 19
BP 1741
EP 1751
DI 10.1042/CS20160080
PG 11
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA EK2NQ
UT WOS:000393764400005
PM 27413019
DA 2024-11-01
ER

PT J
AU Dewulf, JP
   Barrea, C
   Vincent, MF
   De Laet, C
   Van Coster, R
   Seneca, S
   Marie, S
   Nassogne, MC
AF Dewulf, Joseph P.
   Barrea, Catherine
   Vincent, Marie-Francoise
   De Laet, Corinne
   Van Coster, Rudy
   Seneca, Sara
   Marie, Sandrine
   Nassogne, Marie-Cecile
TI Evidence of a wide spectrum of cardiac involvement due to <i>ACAD9</i> mutations: Report on nine patients
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Article
DE ACAD9; Acyl-COA dehydrogenase 9; Cardiomyopathy; Complex I deficiency
ID complex-i deficiency; acyl-coa dehydrogenase; oxidation; disease; gene
AB Acyl-CoA dehydrogenase 9 (ACAD9) is a mitochondrial protein involved in oxidative phosphorylation complex I biogenesis. This protein also exhibits acyl-CoA dehydrogenase (ACAD) activity. ACAD9-mutated patients have been reported to suffer from primarily heart, muscle, liver, and nervous system disorders. ACAD9 mutation is suspected in cases of elevated lactic acid levels combined with complex I deficiency, and confirmed by ACAD9 gene analysis. At least 18 ACAD9-mutated patients have previously been reported, usually displaying severe cardiac involvement. We retrospectively studied nine additional patients from three unrelated families with a wide spectrum of cardiac involvement between the families as well as the patients from the same families. All patients exhibited elevated lactate levels. Deleterious ACAD9 mutations were identified in all patients except one for whom it was not possible to recover DNA. To our knowledge, this is one of the first reports on isolated mild ventricular hypertrophy due to ACAD9 mutation in a family with moderate symptoms during adolescence. This report also confirms that dilated cardiomyopathy may occur in conjunction with ACAD9 mutation and that some patients may respond clinically to riboflavin treatment. Of note, several patients suffered from patent ductus arteriosus (PDA), with one exhibiting a complex congenital heart defect. It is yet unknown whether these cardiac manifestations were related to ACAD9 mutation. In conclusion, this disorder should be suspected in the presence of lactic acidosis, complex I deficiency, and any cardiac involvement, even mild. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Dewulf, Joseph P.; Vincent, Marie-Francoise; Marie, Sandrine] Catholic Univ Louvain, Clin Univ St Luc, Serv Biochim Genet, B-1200 Brussels, Belgium.
   [Barrea, Catherine] Catholic Univ Louvain, Clin Univ St Luc, Serv Cardiol Pediat, B-1200 Brussels, Belgium.
   [De Laet, Corinne] Univ Libre Bruxelles, Hop Univ Enfants Reine Fabiola, Nutr & Metab Unit, Brussels, Belgium.
   [Van Coster, Rudy] Univ Hosp, Pediat Neurol, De Pintelaan 185, B-9000 Ghent, Belgium.
   [Seneca, Sara] Res Grp Reprod & Genet VUB, UZ Brussel, Ctr Med Genet, Laarbeeklaan 101, B-1090 Brussels, Belgium.
   [Nassogne, Marie-Cecile] Catholic Univ Louvain, Clin Univ St Luc, Serv Neurol Pediat, Ave Hippocrate 10-1062, B-1200 Brussels, Belgium.
C3 Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Ghent University; Ghent University Hospital; University Hospital Brussels; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc
RP Nassogne, MC (corresponding author), Catholic Univ Louvain, Clin Univ St Luc, Serv Neurol Pediat, Ave Hippocrate 10-1062, B-1200 Brussels, Belgium.
EM Marie-cecile.nassogne@uclouvain.be
CR Collet M, 2015, EUR J HUM GENET, V0, P0
   Distelmaier F, 2009, BRAIN, V132, P833, DOI 10.1093/brain/awp058
   Garone C, 2013, JAMA NEUROL, V70, P1177, DOI 10.1001/jamaneurol.2013.3197
   Gerards M, 2011, BRAIN, V134, P210, DOI 10.1093/brain/awq273
   Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846
   Haack TB, 2012, J MED GENET, V49, P83, DOI 10.1136/jmedgenet-2011-100577
   Haack TB, 2010, NAT GENET, V42, P1131, DOI 10.1038/ng.706
   He M, 2007, AM J HUM GENET, V81, P87, DOI 10.1086/519219
   Koene S, 2012, J INHERIT METAB DIS, V35, P737, DOI 10.1007/s10545-012-9492-z
   Lagoutte-Renosi J, 2015, JIMD REP, V0, P0
   Leslie N, 2016, HUM PATHOL, V49, P27, DOI 10.1016/j.humpath.2015.09.039
   Nouws J, 2014, JIMD REP, V12, P37, DOI 10.1007/8904_2013_242
   Nouws J, 2014, HUM MOL GENET, V23, P1311, DOI 10.1093/hmg/ddt521
   Nouws J, 2010, CELL METAB, V12, P283, DOI 10.1016/j.cmet.2010.08.002
   Oey NA, 2006, BIOCHEM BIOPH RES CO, V346, P33, DOI 10.1016/j.bbrc.2006.05.088
   Schiff M, 2015, HUM MOL GENET, V24, P3238, DOI 10.1093/hmg/ddv074
   SCHOLTE HR, 1995, BBA-MOL BASIS DIS, V1271, P75, DOI 10.1016/0925-4439(95)00013-T
   Zhang J, 2002, BIOCHEM BIOPH RES CO, V297, P1033, DOI 10.1016/S0006-291X(02)02336-7
NR 18
TC 18
Z9 21
U1 0
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
EI 1096-7206
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD JUL 15
PY 2016
VL 118
IS 3
BP 185
EP 189
DI 10.1016/j.ymgme.2016.05.005
PG 5
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine
GA DQ1SX
UT WOS:000378981800009
PM 27233227
DA 2024-11-01
ER

PT J
AU Rygiel, KA
   Tuppen, HA
   Grady, JP
   Vincent, A
   Blakely, EL
   Reeve, AK
   Taylor, RW
   Picard, M
   Miller, J
   Turnbull, DM
AF Rygiel, Karolina A.
   Tuppen, Helen A.
   Grady, John P.
   Vincent, Amy
   Blakely, Emma L.
   Reeve, Amy K.
   Taylor, Robert W.
   Picard, Martin
   Miller, James
   Turnbull, Doug M.
TI Complex mitochondrial DNA rearrangements in individual cells from patients with sporadic inclusion body myositis
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID real-time pcr; muscle-fibers; mtdna rearrangements; autosomal-dominant; deletion mutations; multiple deletions; duplicated mtdna; single; quantification; abnormality
AB Mitochondrial DNA (mtDNA) rearrangements are an important cause of mitochondrial disease and age related mitochondrial dysfunction in tissues including brain and skeletal muscle. It is known that different mtDNA deletions accumulate in single cells, but the detailed nature of these rearrangements is still unknown. To evaluate this we used a complementary set of sensitive assays to explore the mtDNA rearrangements in individual cells from patients with sporadic inclusion body myositis, a late-onset inflammatory myopathy with prominent mitochondrial changes. We identified large-scale mtDNA deletions in individual muscle fibres with 20% of cytochrome c oxidase-deficient myofibres accumulating two or more mtDNA deletions. The majority of deletions removed only the major arc but similar to 10% of all deletions extended into the minor arc removing the origin of light strand replication (O-L) and a variable number of genes. Some mtDNA molecules contained two deletion sites. Additionally, we found evidence of mitochondrial genome duplications allowing replication and clonal expansion of these complex rearranged molecules. The extended spectrum of mtDNA rearrangements in single cells provides insight into the process of clonal expansion which is fundamental to our understanding of the role of mtDNA mutations in ageing and disease.
C1 [Rygiel, Karolina A.; Tuppen, Helen A.; Grady, John P.; Vincent, Amy; Blakely, Emma L.; Reeve, Amy K.; Taylor, Robert W.; Turnbull, Doug M.] Newcastle Univ, Sch Med, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Rygiel, Karolina A.; Vincent, Amy; Reeve, Amy K.; Turnbull, Doug M.] Newcastle Univ, Sch Med, Inst Neurosci, Newcastle Univ Ctr Ageing & Vital, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Picard, Martin] Columbia Univ, Dept Neurol, Dept Psychiat, Coll Phys & Surg,Div Behav Med,Med Ctr, New York, NY 10032 USA.
   [Picard, Martin] Columbia Univ, Med Ctr, CTNI, Coll Phys & Surg, New York, NY 10032 USA.
   [Miller, James] Newcastle Upon Tyne Hosp NHS Fdn Trust, Royal Victoria Infirm, Dept Neurol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle University - UK; Columbia University; Columbia University; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust
RP Rygiel, KA; Turnbull, DM (corresponding author), Newcastle Univ, Sch Med, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.; Rygiel, KA; Turnbull, DM (corresponding author), Newcastle Univ, Sch Med, Inst Neurosci, Newcastle Univ Ctr Ageing & Vital, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM karolina.rygiel@ncl.ac.uk; doug.turnbull@newcastle.ac.uk
FU Newcastle University Centre for Brain Ageing and Vitality (Biotechnology and Biological Sciences Research Council) [G0700718]; Newcastle University Centre for Brain Ageing and Vitality (Engineering and Physical Sciences Research Council) [G0700718]; Newcastle University Centre for Brain Ageing and Vitality (Economic and Social Research Council) [G0700718]; Newcastle University Centre for Brain Ageing and Vitality (Medical Research Council) [G0700718]; UK NIHR Biomedical Research Centre in Age and Age Related Diseases; MRC Centre for Neuromuscular Disease [G000608-1]; Wellcome Trust Centre for Mitochondrial Research [096919/Z/11/Z]; Lily Foundation; UK NHS Specialist Commissioners 'Rare Mitochondrial Disorders of Adults and Children' Service; MRC [G0700718, MR/L016354/1] Funding Source: UKRI
CR [Anonymous], 2015, SCI REP-UK, V0, P0
   [Anonymous], 2013, 13033997QBIOGN ARXIV, V0, P0
   Bank C, 2000, BIOCHEM BIOPH RES CO, V279, P595, DOI 10.1006/bbrc.2000.3951
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Blakely EL, 2004, J MED GENET, V41, P0, DOI 10.1136/jmg.2003.011296
   Bodyak ND, 2001, HUM MOL GENET, V10, P17, DOI 10.1093/hmg/10.1.17
   Campbell GR, 2011, ANN NEUROL, V69, P481, DOI 10.1002/ana.22109
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   Damas J, 2014, HUM MUTAT, V35, P1, DOI 10.1002/humu.22452
   DUNBAR DR, 1993, HUM MOL GENET, V2, P1619, DOI 10.1093/hmg/2.10.1619
   Fratter C, 2011, NEUROLOGY, V76, P2032, DOI 10.1212/WNL.0b013e31821e558b
   Gokey NG, 2004, AGING CELL, V3, P319, DOI 10.1111/j.1474-9728.2004.00122.x
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   Hilton-Jones D, 2010, NEUROMUSCULAR DISORD, V20, P622, DOI 10.1016/j.nmd.2010.07.087
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   Huber W, 2015, NAT METHODS, V12, P115, DOI 10.1038/NMETH.3252
   Jansson M, 2000, ACTA NEUROPATHOL, V100, P23, DOI 10.1007/s004010051188
   Kajander OA, 2000, HUM MOL GENET, V9, P2821, DOI 10.1093/hmg/9.19.2821
   Khrapko K, 1999, NUCLEIC ACIDS RES, V27, P2434, DOI 10.1093/nar/27.11.2434
   Kraytsberg Y, 2005, EXPERT REV MOL DIAGN, V5, P809, DOI 10.1586/14737159.5.5.809
   Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lee CM, 1998, FREE RADICAL BIO MED, V25, P964, DOI 10.1016/S0891-5849(98)00185-3
   Lindgren U, 2015, NEUROMUSCULAR DISORD, V25, P281, DOI 10.1016/j.nmd.2014.12.010
   Manfredi G, 1997, ANN NEUROL, V42, P180, DOI 10.1002/ana.410420208
   Moslemi AR, 1996, ANN NEUROL, V40, P707, DOI 10.1002/ana.410400506
   Moslemi AR, 1997, HUM MUTAT, V10, P381, DOI 10.1002/(SICI)1098-1004(1997)10:5<381::AID-HUMU8>3.0.CO;2-I
   Muraki K, 2001, AM J MED GENET, V98, P205, DOI 10.1002/1096-8628(20010122)98:3<205::AID-AJMG1077>3.0.CO;2-P
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Needham M, 2007, MUSCLE NERVE, V35, P549, DOI 10.1002/mus.20766
   Nicholls TJ, 2014, HUM MOL GENET, V23, P6147, DOI 10.1093/hmg/ddu336
   Odoardi F, 2003, AM J MED GENET A, V118A, P247, DOI 10.1002/ajmg.a.20006
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Oldfors A, 2006, NEUROLOGY, V66, PS49, DOI 10.1212/01.wnl.0000192127.63013.8d
   OLDFORS A, 1993, BRAIN, V116, P325, DOI 10.1093/brain/116.2.325
   POULTON J, 1994, HUM MOL GENET, V3, P947, DOI 10.1093/hmg/3.6.947
   POULTON J, 1993, HUM MOL GENET, V2, P23, DOI 10.1093/hmg/2.1.23
   R Development Core Team, 2016, R: A LANGUAGE AND ENVIRONMENT FOR STATISTICAL COMPUTING, V0, P0
   Rygiel KA, 2015, NEUROPATH APPL NEURO, V41, P288, DOI 10.1111/nan.12149
   Santorelli FM, 1996, ANN NEUROL, V39, P789, DOI 10.1002/ana.410390615
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   Tawil R, 2002, CURR OPIN RHEUMATOL, V14, P653, DOI 10.1097/00002281-200211000-00004
   Tengan CH, 1998, BBA-MOL BASIS DIS, V1406, P73, DOI 10.1016/S0925-4439(97)00087-2
   Tuppen HAL, 2010, BRAIN, V133, P2952, DOI 10.1093/brain/awq232
   Wanrooij S, 2012, EMBO REP, V13, P1130, DOI 10.1038/embor.2012.161
NR 45
TC 34
Z9 36
U1 1
U2 6
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD JUN 20
PY 2016
VL 44
IS 11
BP 5313
EP 5329
DI 10.1093/nar/gkw382
PG 17
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA DR2SB
UT WOS:000379753100037
PM 27131788
DA 2024-11-01
ER

PT J
AU Granatiero, V
   Giorgio, V
   Cali, T
   Patron, M
   Brini, M
   Bernardi, P
   Tiranti, V
   Zeviani, M
   Pallafacchina, G
   De Stefani, D
   Rizzuto, R
AF Granatiero, V.
   Giorgio, V.
   Cali, T.
   Patron, M.
   Brini, M.
   Bernardi, P.
   Tiranti, V.
   Zeviani, M.
   Pallafacchina, G.
   De Stefani, D.
   Rizzuto, R.
TI Reduced mitochondrial Ca<SUP>2+</SUP> transients stimulate autophagy in human fibroblasts carrying the 13514A > G mutation of the ND5 subunit of NADH dehydrogenase
SO CELL DEATH AND DIFFERENTIATION
LA English
DT Article
ID complex-i; permeability transition; endoplasmic-reticulum; calcium uniporter; mtdna mutation; protein; parkin; micu1; mcu; pathogenesis
AB Mitochondrial disorders are a group of pathologies characterized by impairment of mitochondrial function mainly due to defects of the respiratory chain and consequent organellar energetics. This affects organs and tissues that require an efficient energy supply, such as brain and skeletal muscle. They are caused by mutations in both nuclear-and mitochondrial DNA (mtDNA)-encoded genes and their clinical manifestations show a great heterogeneity in terms of age of onset and severity, suggesting that patient-specific features are key determinants of the pathogenic process. In order to correlate the genetic defect to the clinical phenotype, we used a cell culture model consisting of fibroblasts derived from patients with different mutations in the mtDNA-encoded ND5 complex I subunit and with different severities of the illness. Interestingly, we found that cells from patients with the 13514A>G mutation, who manifested a relatively late onset and slower progression of the disease, display an increased autophagic flux when compared with fibroblasts from other patients or healthy donors. We characterized their mitochondrial phenotype by investigating organelle turnover, morphology, membrane potential and Ca2+ homeostasis, demonstrating that mitochondrial quality control through mitophagy is upregulated in 13514A>G cells. This is due to a specific downregulation of mitochondrial Ca2+ uptake that causes the stimulation of the autophagic machinery through the AMPK signaling axis. Genetic and pharmacological manipulation of mitochondrial Ca2+ homeostasis can revert this phenotype, but concurrently decreases cell viability. This indicates that the higher mitochondrial turnover in complex I deficient cells with this specific mutation is a pro-survival compensatory mechanism that could contribute to the mild clinical phenotype of this patient.
C1 [Granatiero, V.; Giorgio, V.; Patron, M.; Bernardi, P.; Pallafacchina, G.; De Stefani, D.; Rizzuto, R.] Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy.
   [Granatiero, V.; Giorgio, V.; Patron, M.; Bernardi, P.; Pallafacchina, G.; De Stefani, D.; Rizzuto, R.] CNR Neurosci Inst, Padua, Italy.
   [Cali, T.; Brini, M.] Univ Padua, Dept Biol, I-35121 Padua, Italy.
   [Tiranti, V.] Fdn IRCCS Inst Neurol Besta, Dept Expt Res & Diagnost, Unit Mol Neurogenet, Milan, Italy.
   [Zeviani, M.] MRC, Mitochondrial Biol Unit, Cambridge, England.
C3 University of Padua; Consiglio Nazionale delle Ricerche (CNR); University of Padua
RP Rizzuto, R (corresponding author), Univ Padua, Dept Biomed Sci, Via Colombo 3, I-35121 Padua, Italy.
EM rosario.rizzuto@unipd.it
FU Telethon-Italy [GPP10005A]; Italian Ministry of Health; Italian Ministry of Education, University and Research; European Union (ERC mitoCalcium) [294777]; National Institutes of Health [1P01AG025532-01A1]; Cariparo Foundation (Padua); Cariplo Foundation (Padua); Italian Association for Cancer Research (AIRC); University of Padova [GRIC128SP0]; MRC [MC_UP_1002/1] Funding Source: UKRI
CR Andersen Martin N, 2012, COMMUN INTEGR BIOL, V5, P480, DOI 10.4161/cib.21200
   Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234
   Bernardi P, 2013, FRONT PHYSIOL, V4, P0, DOI 10.3389/fphys.2013.00095
   Brini M, 1999, NAT MED, V5, P951, DOI 10.1038/11396
   BRINI M, 1995, J BIOL CHEM, V270, P9896, DOI 10.1074/jbc.270.17.9896
   Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   Calì T, 2013, BBA-MOL BASIS DIS, V1832, P495, DOI 10.1016/j.bbadis.2013.01.004
   Cárdenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007
   Celsi F, 2009, BBA-BIOENERGETICS, V1787, P335, DOI 10.1016/j.bbabio.2009.02.021
   Chinnery PF, 2012, INT J EPIDEMIOL, V41, P177, DOI 10.1093/ije/dyr232
   Corona P, 2001, ANN NEUROL, V49, P106, DOI 10.1002/1531-8249(200101)49:1<106::AID-ANA16>3.0.CO;2-T
   Csordás G, 2013, CELL METAB, V17, P976, DOI 10.1016/j.cmet.2013.04.020
   de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534
   De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230
   Denton RM, 2009, BBA-BIOENERGETICS, V1787, P1309, DOI 10.1016/j.bbabio.2009.01.005
   Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012
   Granatiero V, 2014, COLD SPRING HARB PRO, V2014, P1
   Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249
   Hoffman NE, 2014, MOL BIOL CELL, V25, P936, DOI 10.1091/mbc.E13-08-0502
   Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807
   Katayama H, 2011, CHEM BIOL, V18, P1042, DOI 10.1016/j.chembiol.2011.05.013
   Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496
   Koopman WJH, 2007, AM J PHYSIOL-CELL PH, V293, PC22, DOI 10.1152/ajpcell.00194.2006
   Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023
   Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018
   Malfatti E, 2007, BRAIN, V130, P1894, DOI 10.1093/brain/awm114
   Mallilankaraman K, 2012, CELL, V151, P630, DOI 10.1016/j.cell.2012.10.011
   Montero M, 2004, BIOCHEM J, V384, P19, DOI 10.1042/BJ20040990
   Montero M, 2002, FASEB J, V16, P1955, DOI 10.1096/fj.02-0553fje
   MONTERO M, 1995, EMBO J, V14, P5467, DOI 10.1002/j.1460-2075.1995.tb00233.x
   Narendra D, 2012, CSH PERSPECT BIOL, V4, P0, DOI 10.1101/cshperspect.a011338
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Patron M, 2014, MOL CELL, V53, P726, DOI 10.1016/j.molcel.2014.01.013
   Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002
   Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358
   Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308
   Raffaello A, 2013, EMBO J, V32, P2362, DOI 10.1038/emboj.2013.157
   Rasola A, 2011, CELL CALCIUM, V50, P222, DOI 10.1016/j.ceca.2011.04.007
   RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0
   Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412
   Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014
   Rozwodowska M, 2000, MED SCI MONIT, V6, P817
   Sancak Y, 2013, SCIENCE, V342, P1379, DOI 10.1126/science.1242993
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107
   Willems PHGM, 2008, CELL CALCIUM, V44, P123, DOI 10.1016/j.ceca.2008.01.002
   Winklhofer KF, 2014, TRENDS CELL BIOL, V24, P332, DOI 10.1016/j.tcb.2014.01.001
   Wong LJC, 2010, DEV DISABIL RES REV, V16, P154, DOI 10.1002/ddrr.104
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   Zhang Y, 2007, AUTOPHAGY, V3, P337, DOI 10.4161/auto.4127
NR 52
TC 51
Z9 51
U1 0
U2 19
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 1350-9047
EI 1476-5403
J9 CELL DEATH DIFFER
JI Cell Death Differ.
PD FEB 15
PY 2016
VL 23
IS 2
BP 231
EP 241
DI 10.1038/cdd.2015.84
PG 11
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA DA8NN
UT WOS:000368062200005
PM 26206091
DA 2024-11-01
ER

PT J
AU Calderwood, L
   Holm, IA
   Teot, LA
   Anselm, I
AF Calderwood, Laurel
   Holm, Ingrid A.
   Teot, Lisa A.
   Anselm, Irina
TI Adrenal Insufficiency in Mitochondrial Disease: A Rare Case of GFER-Related Mitochondrial Encephalomyopathy and Review of the Literature
SO JOURNAL OF CHILD NEUROLOGY
LA English
DT Review
DE mitochondrial DNA (mtDNA) deletion; congenital cataracts; lactic acidosis; next generation panel
ID kearns-sayre-syndrome; dna deletion; liver-regeneration; pearson syndrome; addison-disease; child; augmentor; myopathy; mutation; acid
AB GFER-related mitochondrial encephalomyopathy has been previously described only in 3 siblings of a consanguineous Moroccan family. Their phenotype included congenital cataracts, hypotonia, developmental delay, and sensorineural hearing loss. Multiple mitochondrial respiratory chain complex deficiencies were identified on muscle biopsy. We describe a now-19-year-old woman with adrenal insufficiency, lactic acidosis, congenital cataracts, and respiratory insufficiency secondary to mitochondrial disorder, who was reported by North et al (1996) as a toddler. Compound heterozygous GFER mutations c.373C>T (Q125X) and c.581G>A (R194 H) were recently discovered in this patient. The purpose of this report is (1) to expand the phenotype this ultra-rare disorder and (2) to provide a review of the literature describing the unique finding of adrenal insufficiency in patients with molecularly confirmed disorders of mitochondrial metabolism.
C1 [Calderwood, Laurel] Boston Univ, Sch Med, Dept Obstet & Gynecol, Boston, MA 02118 USA.
   [Holm, Ingrid A.] Boston Childrens Hosp, Div Genet & Genom, Div Endocrinol, Dept Med,Manton Ctr Orphan Dis Res, Boston, MA 02115 USA.
   [Holm, Ingrid A.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA.
   [Teot, Lisa A.] Boston Childrens Hosp, Dept Pathol, Boston, MA 02115 USA.
   [Teot, Lisa A.; Anselm, Irina] Harvard Univ, Sch Med, Boston, MA USA.
   [Anselm, Irina] Boston Childrens Hosp, Dept Neurol, 300 Longwood Ave, Boston, MA 02115 USA.
C3 Boston University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital
RP Anselm, I (corresponding author), Boston Childrens Hosp, Dept Neurol, 300 Longwood Ave, Boston, MA 02115 USA.
EM irina.anselm@childrens.harvard.edu
CR Afroze B, 2014, BRAIN DEV-JPN, V36, P924, DOI 10.1016/j.braindev.2013.12.009
   Artuch R, 1998, HORM RES, V50, P99, DOI 10.1159/000023243
   Boles RG, 1998, EUR J PEDIATR, V157, P643, DOI 10.1007/s004310050902
   Bruno C, 1998, J INHERIT METAB DIS, V21, P155, DOI 10.1023/A:1005347826664
   Daithankar VN, 2010, BIOCHEMISTRY-US, V49, P6737, DOI 10.1021/bi100912m
   Di Fonzo A, 2009, AM J HUM GENET, V84, P594, DOI 10.1016/j.ajhg.2009.04.004
   Duran GP, 2012, JIMD REP, V3, P5, DOI 10.1007/8904_2011_33
   Gatzidou E, 2006, WORLD J GASTROENTERO, V12, P4951, DOI 10.3748/wjg.v12.i31.4951
   Hopkins SE, 2010, J CHILD NEUROL, V25, P752, DOI 10.1177/0883073809343313
   Nicolino M, 1997, J CLIN ENDOCR METAB, V82, P3063, DOI 10.1210/jc.82.9.3063
   North K, 1996, J PEDIATR-US, V128, P688, DOI 10.1016/S0022-3476(96)80136-3
   RIBES A, 1993, J INHERIT METAB DIS, V16, P537, DOI 10.1007/BF00711675
   Sanaker PS, 2007, ACTA NEUROL SCAND, V115, P64, DOI 10.1111/j.1600-0404.2007.00850.x
   Schaefer AM, 2013, MOL CELL ENDOCRINOL, V379, P2, DOI 10.1016/j.mce.2013.06.004
   Tzoufi M, 2013, EUR J PEDIATR, V172, P557, DOI 10.1007/s00431-012-1798-1
   Williams TB, 2012, MOL GENET METAB, V106, P104, DOI 10.1016/j.ymgme.2012.01.018
NR 17
TC 18
Z9 19
U1 0
U2 5
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0883-0738
EI 1708-8283
J9 J CHILD NEUROL
JI J. Child Neurol.
PD FEB 15
PY 2016
VL 31
IS 2
BP 190
EP 194
DI 10.1177/0883073815587327
PG 5
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA DC0VB
UT WOS:000368934800011
PM 26018198
DA 2024-11-01
ER

PT J
AU Tafakhori, A
   Ng, AYJ
   Tohari, S
   Venkatesh, B
   Lee, H
   Eskin, A
   Nelson, SF
   Bonnard, C
   Reversade, B
   Kariminejad, A
AF Tafakhori, Abbas
   Ng, Alvin Yu Jin
   Tohari, Sumanty
   Venkatesh, Byrappa
   Lee, Hane
   Eskin, Ascia
   Nelson, Stanley F.
   Bonnard, Carine
   Reversade, Bruno
   Kariminejad, Ariana
TI Mutation in <i>TWINKLE</i> in a Large Iranian Family with Progressive External Ophthalmoplegia, Myopathy, Dysphagia and Dysphonia, and Behavior Change
SO ARCHIVES OF IRANIAN MEDICINE
LA English
DT Article
DE Dysphonia; myopathy; ptosis; progressive external ophthalmoplegia; TWINKLE
ID oculopharyngeal muscular-dystrophy; peo1 gene mutation; mitochondrial-dna; distal myopathy; cell-death; depletion; aggregation; inclusions; expansion; deletions
AB BACKGROUND: TWINKLE (c10orf2) gene is responsible for autosomal dominant progressive external ophthalmoplegia (PEO). In rare cases, additional features such as muscle weakness, peripheral neuropathy, ataxia, cardiomyopathy, dysphagia, dysphonia, cataracts, depression, dementia, parkinsonism, and hearing loss have been reported in association with heterozygous mutations of the TWINKLE gene. METHODS: We have studied a large Iranian family with myopathy, dysphonia, dysphagia, and behavior change in addition to PEO in affected members. RESULTS: We identified a missense mutation c.1121G > A in the c10orf2 gene in all affected members. Early death is a novel feature seen in affected members of this family that has not been reported to date. CONCLUSION: The association of PEO, myopathy, dysphonia, dysphagia, behavior change and early death has not been previously reported in the literature or other patients with this mutation.
C1 [Tafakhori, Abbas] Univ Tehran Med Sci, Iranian Ctr Neurol Research, Dept Neurol, Tehran, Iran.
   [Ng, Alvin Yu Jin; Tohari, Sumanty; Venkatesh, Byrappa; Reversade, Bruno] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore.
   [Lee, Hane; Eskin, Ascia; Nelson, Stanley F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.
   [Bonnard, Carine; Reversade, Bruno] ASTAR, Inst Med Biol, Singapore, Singapore.
   [Kariminejad, Ariana] Kariminejad Najmabadi Pathol & Genet Ctr, 2,4th St Hasan Seyf St Sanat Sq, Tehran, Iran.
C3 Tehran University of Medical Sciences; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB)
RP Kariminejad, A (corresponding author), Kariminejad Najmabadi Pathol & Genet Ctr, 2,4th St Hasan Seyf St Sanat Sq, Tehran, Iran.
EM arianakariminejad@Yahoo.com
CR Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   AMATO AA, 1995, MUSCLE NERVE, V18, P842, DOI 10.1002/mus.880180807
   Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   BRAIS B, 1995, HUM MOL GENET, V4, P429, DOI 10.1093/hmg/4.3.429
   Caburet S, 2004, J MED GENET, V41, P932, DOI 10.1136/jmg.2004.024356
   Cunningham V, 2009, AM J MED GENET A, V149A, P981
   Durmus H, 2011, NEUROLOGY, V76, P227, DOI 10.1212/WNL.0b013e318207b043
   Echaniz-Laguna A, 2010, NEUROGENETICS, V11, P21, DOI 10.1007/s10048-009-0202-4
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   Jeppesen TD, 2008, NEUROMUSCULAR DISORD, V18, P306, DOI 10.1016/j.nmd.2007.10.007
   Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86
   Liu ZR, 2008, MOL VIS, V14, P1995
   Lönnqvist T, 2009, BRAIN, V132, P1553, DOI 10.1093/brain/awp045
   Martin-Negrier ML, 2011, EUR J NEUROL, V18, P436, DOI 10.1111/j.1468-1331.2010.03171.x
   Messaed C, 2007, NEUROBIOL DIS, V26, P546, DOI 10.1016/j.nbd.2007.02.004
   Naïmi M, 2006, EUR J HUM GENET, V14, P917, DOI 10.1038/sj.ejhg.5201627
   Nasrallah IM, 2004, J CELL BIOL, V167, P411, DOI 10.1083/jcb.200408091
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   SATOYOSHI E, 1977, ARCH NEUROL-CHICAGO, V34, P89, DOI 10.1001/archneur.1977.00500140043007
   SCRIMGEOUR EM, 1984, AM J MED GENET, V17, P763, DOI 10.1002/ajmg.1320170407
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   TOME FMS, 1980, ACTA NEUROPATHOL, V49, P85, DOI 10.1007/BF00692226
   Uyama E, 1998, NEUROMUSCULAR DISORD, V8, P119, DOI 10.1016/S0960-8966(98)00002-9
   van der Sluijs BM, 2004, J NEUROL NEUROSUR PS, V75, P1499, DOI 10.1136/jnnp.2003.025072
   Virgilio R, 2008, J NEUROL, V255, P1384, DOI 10.1007/s00415-008-0926-3
   Zoghbi HY, 1999, CURR OPIN NEUROBIOL, V9, P566, DOI 10.1016/S0959-4388(99)00013-6
NR 31
TC 5
Z9 5
U1 0
U2 2
PU ACAD MEDICAL SCIENCES I R IRAN
PI TEHRAN
PA PO BOX 19395-5655, TEHRAN, 00000, IRAN
SN 1029-2977
EI 1735-3947
J9 ARCH IRAN MED
JI Arch. Iran. Med.
PD FEB 15
PY 2016
VL 19
IS 2
BP 87
EP 91
DI 
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA DC9LX
UT WOS:000369544200002
PM 26838077
DA 2024-11-01
ER

PT J
AU Onesto, E
   Colombrita, C
   Gumina, V
   Borghi, MO
   Dusi, S
   Doretti, A
   Fagiolari, G
   Invernizzi, F
   Moggio, M
   Tiranti, V
   Silani, V
   Ratti, A
AF Onesto, Elisa
   Colombrita, Claudia
   Gumina, Valentina
   Borghi, Maria Orietta
   Dusi, Sabrina
   Doretti, Alberto
   Fagiolari, Gigliola
   Invernizzi, Federica
   Moggio, Maurizio
   Tiranti, Valeria
   Silani, Vincenzo
   Ratti, Antonia
TI Gene-specific mitochondria dysfunctions in human <i>TARDBP</i> and <i>C9ORF72</i> fibroblasts
SO ACTA NEUROPATHOLOGICA COMMUNICATIONS
LA English
DT Article
DE ALS; FTD; TDP-43; C9ORF72; Fibroblast; Mitochondria dysfunction
ID amyotrophic-lateral-sclerosis; hexanucleotide repeat; skin fibroblasts; tdp-43; mutations; model; phosphorylation; ultrastructure; expansions; muscle
AB Dysregulation of RNA metabolism represents an important pathogenetic mechanism in both amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) due to the involvement of the DNA/RNA-binding proteins TDP-43 and FUS and, more recently, of C9ORF72. A potential link between dysregulation of RNA metabolism and mitochondrial dysfunction is recently emerged in TDP-43 disease models. To further investigate the possible relationship between these two pathogenetic mechanisms in ALS/FTD, we studied mitochondria functionality in human mutant TARDBP(p.A382T) and C9ORF72 fibroblasts grown in galactose medium to induce a switch from a glycolytic to an oxidative metabolism. In this condition we observed significant changes in mitochondria morphology and ultrastructure in both mutant cells with a fragmented mitochondria network particularly evident in TARDBP(p.A382T) fibroblasts. From analysis of the mitochondrial functionality, a decrease of mitochondria membrane potential with no alterations in oxygen consumption rate emerged in TARDBP fibroblasts. Conversely, an increased oxygen consumption and mitochondria hyperpolarization were observed in C9ORF72 fibroblasts in association to increased ROS and ATP content. We found evidence of autophagy/mitophagy in dynamic equilibrium with the biogenesis of novel mitochondria, particularly in mutant C9ORF72 fibroblasts where an increase of mitochondrial DNA content and mass, and of PGC1-alpha protein was observed. Our imaging and biochemical data show that wild-type and mutant TDP-43 proteins do not localize at mitochondria so that the molecular mechanisms responsible for such mitochondria impairment remain to be further elucidated. For the first time our findings assess a link between C9ORF72 and mitochondria dysfunction and indicate that mitochondria functionality is affected in TARDBP and C9ORF72 fibroblasts with gene-specific features in oxidative conditions. As in neuronal metabolism mitochondria are actively used for ATP production, we speculate that TARDBP and C9ORF72 mutations might trigger cell death by impairing not only RNA metabolism, but also mitochondria activity in ALS/FTD neurons.
C1 [Onesto, Elisa; Colombrita, Claudia; Gumina, Valentina; Doretti, Alberto; Silani, Vincenzo; Ratti, Antonia] IRCCS Ist Auxol Italiano, Dept Neurol & Lab Neurosci, Via Zucchi 18, I-20095 Milanino, MI, Italy.
   [Colombrita, Claudia; Gumina, Valentina; Doretti, Alberto; Silani, Vincenzo; Ratti, Antonia] Univ Milan, Dino Ferrari Ctr, Dept Pathophysiol & Transplantat, Milan, Italy.
   [Borghi, Maria Orietta] IRCCS Ist Auxol Italiano, Lab Immunorheumatol, Milan, Italy.
   [Borghi, Maria Orietta] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy.
   [Dusi, Sabrina; Invernizzi, Federica; Tiranti, Valeria] Fdn IRCCS Neurol Inst Carlo Besta, Mol Neurogenet Unit, Milan, Italy.
   [Fagiolari, Gigliola; Moggio, Maurizio] Univ Milan, Dept Neurosci, Neuromuscular & Rare Dis Unit, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy.
C3 IRCCS Istituto Auxologico Italiano; University of Milan; IRCCS Istituto Auxologico Italiano; University of Milan; Fondazione IRCCS Istituto Neurologico Carlo Besta; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan
RP Ratti, A (corresponding author), IRCCS Ist Auxol Italiano, Dept Neurol & Lab Neurosci, Via Zucchi 18, I-20095 Milanino, MI, Italy.; Ratti, A (corresponding author), Univ Milan, Dino Ferrari Ctr, Dept Pathophysiol & Transplantat, Milan, Italy.
EM antonia.ratti@unimi.it
FU Telethon Network of Genetic Biobanks [GTB07001, GTB12001]
CR AFIFI AK, 1966, NEUROLOGY, V16, P475, DOI 10.1212/WNL.16.5.475
   Aguirre T, 1998, ANN NEUROL, V43, P452, DOI 10.1002/ana.410430407
   Akimoto C, 2014, J MED GENET, V51, P419, DOI 10.1136/jmedgenet-2014-102360
   Allen SP, 2015, NEUROBIOL AGING, V36, P2893, DOI 10.1016/j.neurobiolaging.2015.07.013
   Allen SP, 2014, NEUROBIOL AGING, V35, P1499, DOI 10.1016/j.neurobiolaging.2013.11.025
   ATSUMI T, 1981, ACTA NEUROPATHOL, V55, P193, DOI 10.1007/BF00691318
   Auburger G, 2012, MOL NEUROBIOL, V46, P20, DOI 10.1007/s12035-012-8245-1
   Bartolome F, 2013, NEURON, V78, P57, DOI 10.1016/j.neuron.2013.02.028
   Brömme HJ, 2008, EXP GERONTOL, V43, P638, DOI 10.1016/j.exger.2008.01.010
   Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048
   Corrado L, 2009, HUM MUTAT, V30, P688, DOI 10.1002/humu.20950
   Crugnola V, 2010, ARCH NEUROL-CHICAGO, V67, P849, DOI 10.1001/archneurol.2010.128
   DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011
   Gendron TF, 2014, ACTA NEUROPATHOL, V127, P359, DOI 10.1007/s00401-013-1237-z
   Hong K, 2012, NEUROSCI LETT, V530, P144, DOI 10.1016/j.neulet.2012.10.003
   Invernizzi F, 2012, MITOCHONDRION, V12, P328, DOI 10.1016/j.mito.2012.01.001
   Kirk K, 2014, ANN NEUROL, V76, P620, DOI 10.1002/ana.24244
   Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Lu JS, 2012, BRAIN RES BULL, V89, P185, DOI 10.1016/j.brainresbull.2012.09.005
   Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2
   Mead RJ, 2013, FREE RADICAL BIO MED, V61, P438, DOI 10.1016/j.freeradbiomed.2013.04.018
   Ramamoorthy M, 2012, FREE RADICAL BIO MED, V53, P1371, DOI 10.1016/j.freeradbiomed.2012.07.018
   Raman R, 2015, NEUROPATH APPL NEURO, V41, P201, DOI 10.1111/nan.12147
   Ratti A, 2016, J NEUROCHEM, V138, P95, DOI 10.1111/jnc.13625
   Ratti A, 2012, NEUROBIOL AGING, V33, P0, DOI 10.1016/j.neurobiolaging.2012.06.008
   Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010
   Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430
   ROBINSON BH, 1992, BIOCHEM MED METAB B, V48, P122, DOI 10.1016/0885-4505(92)90056-5
   Rohrer JD, 2015, LANCET NEUROL, V14, P291, DOI 10.1016/S1474-4422(14)70233-9
   Sasaki S, 2007, ACTA NEUROPATHOL, V114, P633, DOI 10.1007/s00401-007-0299-1
   Sasaki S, 2007, J NEUROPATH EXP NEUR, V66, P10, DOI 10.1097/nen.0b013e31802c396b
   Shan X, 2010, P NATL ACAD SCI USA, V107, P16325, DOI 10.1073/pnas.1003459107
   Stribl C, 2014, J BIOL CHEM, V289, P10769, DOI 10.1074/jbc.M113.515940
   Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942
   Wang K, 2011, AUTOPHAGY, V7, P297, DOI 10.4161/auto.7.3.14502
   Wang WZ, 2013, HUM MOL GENET, V22, P4706, DOI 10.1093/hmg/ddt319
   Xu YF, 2011, MOL NEURODEGENER, V6, P0, DOI 10.1186/1750-1326-6-73
   Xu YF, 2010, J NEUROSCI, V30, P10851, DOI 10.1523/JNEUROSCI.1630-10.2010
NR 40
TC 133
Z9 147
U1 6
U2 32
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2051-5960
EI 
J9 ACTA NEUROPATHOL COM
JI Acta Neuropathol. Commun.
PD MAY 5
PY 2016
VL 4
IS 
BP 
EP 
DI 10.1186/s40478-016-0316-5
PG 14
WC Neurosciences
SC Neurosciences & Neurology
GA DL2RN
UT WOS:000375482900001
PM 27151080
DA 2024-11-01
ER

PT J
AU Rafiq, J
   Duno, M
   Ostergaard, E
   Ravn, K
   Vissing, CR
   Wibrand, F
   Vissing, J
AF Rafiq, Jabin
   Duno, Morten
   Ostergaard, Elsebet
   Ravn, Kirstine
   Vissing, Christoffer R.
   Wibrand, Flemming
   Vissing, John
TI Exercise Intolerance and Myoglobinuria Associated with a Novel Maternally Inherited <i>MT</i>-<i>ND1</i> Mutation
SO JIMD REPORTS, VOL 25
LA English
DT Article; Book Chapter
ID mitochondrial-dna mutations; disease; gene
AB The most common clinical phenotype caused by a mtDNA mutation in complex I of the mitochondrial respiratory chain is Leber hereditary optic neuropathy. We report a family with a novel maternally inherited homoplasmic mtDNA m.4087A>G mutation in the ND1 gene (MT-ND1) associated with isolated myopathy, recurrent episodes of myoglobinuria, and rhabdomyolysis. DNA from blood in seven family members and muscle from four family members were PCR amplified and sequenced directly and assessed for the m.4087A>G variation in MT-ND1. Mitochondrial enzyme activity in all muscle biopsies was measured. PCR and direct sequencing of the MT-ND1 genes from blood showed that all seven family members were homoplasmic for the m.4087A>G mutation (NC_012920.1:c.781A>G). The mutation predicts a threonine to alanine substitution at position 261 (p.T261A). The same mutation was found in muscle of all four family members available for muscle biopsy, and biochemical analyses revealed an isolated complex I defect in muscle of all family members (range 22-52% of normal). Muscle morphology showed severe myopathic changes with internal nuclei in multiple fibers of all family members. Monosymptomatic myopathy with recurrent myoglobinuria is a rare phenotype of mitochondrial myopathies. We report this phenotype in a family affected by a novel homoplasmic mutation in MT-ND1. It is the first time such a phenotype has been associated with complex I gene mutations and a homoplasmic mutation of mtDNA.
C1 [Rafiq, Jabin; Vissing, Christoffer R.; Vissing, John] Copenhagen Neuromuscular Ctr, Dept Neurol, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.
   [Duno, Morten; Ostergaard, Elsebet; Ravn, Kirstine; Wibrand, Flemming] Univ Copenhagen, Dept Clin Genet, Rigshosp, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.
C3 University of Copenhagen; Rigshospitalet
RP Vissing, J (corresponding author), Copenhagen Neuromuscular Ctr, Dept Neurol, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.
EM vissing@rh.dk
CR ALLEN RC, 1992, AM J HUM GENET, V51, P1229
   ASTRAND I, 1960, ACTA PHYSIOL SCAND SUPPL, V49, P1
   Jeppesen TD, 2003, J NEUROL, V250, P293, DOI 10.1007/s00415-003-0993-4
   Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185
   Ostergaard E, 2007, BRAIN, V130, P853, DOI 10.1093/brain/awl383
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   SWAIN DP, 1994, MED SCI SPORT EXER, V26, P112
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Vissing CR, 2013, NEUROLOGY, V80, P1908, DOI 10.1212/WNL.0b013e3182929fb2
   Wong LJC, 2007, MUSCLE NERVE, V36, P279, DOI 10.1002/mus.20807
   Yu-Wai-Man P, 2011, PROG RETIN EYE RES, V30, P81, DOI 10.1016/j.preteyeres.2010.11.002
NR 11
TC 4
Z9 4
U1 0
U2 0
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 2192-8304
EI 
J9 JIMD REP
PD JUN 15
PY 2016
VL 25
IS 
BP 65
EP 70
DI 10.1007/8904_2015_459
PG 6
WC Endocrinology & Metabolism; Genetics & Heredity
SC Endocrinology & Metabolism; Genetics & Heredity
GA BI0RD
UT WOS:000405113700010
PM 26108648
DA 2024-11-01
ER

PT J
AU Lamperti, C
   Zeviani, M
AF Lamperti, Costanza
   Zeviani, Massimo
TI Myoclonus epilepsy in mitochondrial disorders
SO EPILEPTIC DISORDERS
LA English
DT Review
DE MERRF; MELAS; Alpers-Huttenlocher syndrome; hepatopathic poliodystrophy; mitochondrial DNA; oxidative phosphorylation; mitochondrial respiratory chain; progressive myoclonus epilepsies
ID ragged-red fibers; progressive external ophthalmoplegia; dna-polymerase-gamma; merrf/melas overlap syndrome; respiratory-chain defects; mtdna merrf mutation; polg mutations; ekboms syndrome; rnalys gene; disease
AB Mitochondrial disorders is a group of clinical entities associated with abnormalities of the mitochondrial respiratory chain (MRC), which carries out the oxidative phosphorylation (OXPHOS) of ADP into ATP. As the MRC is the result of genetic complementation between two separate genomes, nuclear and mitochondrial, OXPHOS failure can derive from mutations in either nuclear-encoded, or mitochondrial-encoded, genes. Epilepsy is a relatively common feature of mitochondrial disease, especially in early-onset encephalopathies of infants and children. However, the two most common entities associated with epilepsy include MERRF, for Myoclonic Epilepsy with Ragged Red Fibers, and AHS, or Alpers-Huttenlocher syndrome, also known as hepatopathic poliodystrophy. Whilst MERRF is a maternally inherited condition caused by mtDNA mutations, particularly the 8344A>G substitution in the gene encoding mt-tRNA(Iys), AHS is typically caused by recessive mutations in POLG, encoding the catalytic subunit of polymerase gamma, the only mtDNA polymerase in humans. AHS is the most severe, early-onset, invariably fatal syndrome within a disease spectrum, which also include other epileptogenic entities, all due to POLG mutations and including Spino-cerebellar Ataxia and Epilepsy (SCAE). This review reports the main clinical, neuroimaging, biochemical, and molecular features of epilepsy-related mitochondrial syndrome, particularly MERRF and AHS.
C1 [Lamperti, Costanza] Carlo Besta Inst Neurol, Unit Mol Neurogenet, Milan, Italy.
   [Zeviani, Massimo] MRC Mitochondrial Biol Unit, Cambridge, England.
C3 Fondazione IRCCS Istituto Neurologico Carlo Besta
RP Zeviani, M (corresponding author), MRC Mitochondrial Biol Unit, Cambridge, England.
EM mdz21@mrc-mbu.cam.ac.uk
FU Medical Research Council [MC_UP_1002/1] Funding Source: Medline
CR Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Austin SA, 1998, NEUROLOGY, V51, P1447, DOI 10.1212/WNL.51.5.1447
   BERKOVIC SF, 1991, LANCET, V338, P457, DOI 10.1016/0140-6736(91)91090-H
   CALABRESI PA, 1994, MUSCLE NERVE, V17, P943, DOI 10.1002/mus.880170815
   Canafoglia L, 2001, NEUROLOGY, V56, P1340, DOI 10.1212/WNL.56.10.1340
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   DiMauro S, 2000, NEUROL SCI, V21, P0
   DIMAURO S, 1985, ANN NEUROL, V17, P521, DOI 10.1002/ana.410170602
   EKBOM K, 1975, ACTA NEUROL SCAND, V51, P393
   El Sabbagh S, 2010, EPILEPSIA, V51, P1225, DOI 10.1111/j.1528-1167.2009.02504.x
   Farge G, 2007, NUCLEIC ACIDS RES, V35, P902, DOI 10.1093/nar/gkl1116
   HAMMANS SR, 1993, BRAIN, V116, P617, DOI 10.1093/brain/116.3.617
   HARDING BN, 1990, J CHILD NEUROL, V5, P273, DOI 10.1177/088307389000500402
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   HOLME E, 1993, AM J HUM GENET, V52, P551
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Howell N, 1996, NEUROLOGY, V46, P219, DOI 10.1212/WNL.46.1.219
   Hunt JR, 1921, BRAIN, V44, P490
   Khurana DS, 2008, NEUROPEDIATRICS, V39, P8, DOI 10.1055/s-2008-1076737
   Lagrue E, 2007, PEDIATR RES, V62, P14, DOI 10.1203/PDR.0b013e31806790d7
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055
   LARSSON NG, 1992, AM J HUM GENET, V51, P1201
   Lee YM, 2008, EPILEPSIA, V49, P685, DOI 10.1111/j.1528-1167.2007.01522.x
   Liu KM, 2014, METAB BRAIN DIS, V29, P139, DOI 10.1007/s11011-013-9464-5
   LOMBES A, 1989, ANN NEUROL, V26, P20, DOI 10.1002/ana.410260104
   Lönnqvist T, 2009, BRAIN, V132, P1553, DOI 10.1093/brain/awp045
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Minassian Berge A, 2016, EPILEPTIC DISORD, V18, P1
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561
   Mokranjac D, 2005, BIOCHEM SOC T, V33, P1019, DOI 10.1042/BST0331019
   MORAES CT, 1992, NAT GENET, V1, P359, DOI 10.1038/ng0892-359
   NASS MMK, 1966, P NATL ACAD SCI USA, V56, P1215, DOI 10.1073/pnas.56.4.1215
   NAUMANN M, 1995, ACTA NEUROPATHOL, V89, P152
   Ozawa M, 1997, MUSCLE NERVE, V20, P271, DOI 10.1002/(SICI)1097-4598(199703)20:3<271::AID-MUS2>3.0.CO;2-8
   Parikh S, 2008, PEDIATR NEUROL, V38, P191, DOI 10.1016/j.pediatrneurol.2007.10.011
   Rahman S, 2012, DEV MED CHILD NEUROL, V54, P397, DOI 10.1111/j.1469-8749.2011.04214.x
   ROSING HS, 1985, ANN NEUROL, V17, P228, DOI 10.1002/ana.410170303
   Saneto RP, 2010, DEV DISABIL RES REV, V16, P163, DOI 10.1002/ddrr.105
   Sano M, 1996, J NEUROL, V243, P441, DOI 10.1007/BF00900496
   Santorelli FM, 1996, AM J HUM GENET, V58, P933
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   SHOUBRIDGE EA, 1994, J BIOENERG BIOMEMBR, V26, P301, DOI 10.1007/BF00763101
   SILVESTRI G, 1993, NEUROLOGY, V43, P1200, DOI 10.1212/WNL.43.6.1200
   SILVESTRI G, 1992, AM J HUM GENET, V51, P1213
   Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   TEIN I, 1993, PEDIATR RES, V34, P281, DOI 10.1203/00006450-199309000-00008
   TRAFF J, 1995, ACTA NEUROL SCAND, V92, P394
   TSAIRIS P, 1973, NEUROLOGY, V23, P408
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Wolf NI, 2009, EPILEPSIA, V50, P1596, DOI 10.1111/j.1528-1167.2008.01877.x
   Zeviani Massimo, 1993, EUROPEAN JOURNAL OF HUMAN GENETICS, V1, P80
NR 56
TC 19
Z9 22
U1 0
U2 3
PU JOHN LIBBEY EUROTEXT LTD
PI MONTROUGE
PA 127 AVE DE LA REPUBLIQUE, 92120 MONTROUGE, FRANCE
SN 1294-9361
EI 1950-6945
J9 EPILEPTIC DISORD
JI Epileptic Disord.
PD SEP 15
PY 2016
VL 18
IS 
BP S94
EP S102
DI 
PG 9
WC Clinical Neurology
SC Neurosciences & Neurology
GA FA7NB
UT WOS:000405632300009
PM 27618766
DA 2024-11-01
ER

PT J
AU Sen, D
   Patel, G
   Patel, SS
AF Sen, Doyel
   Patel, Gayatri
   Patel, Smita S.
TI Homologous DNA strand exchange activity of the human mitochondrial DNA helicase TWINKLE
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID progressive external ophthalmoplegia; bacteriophage t7; crystal-structure; branch migration; binding-protein; replication forks; in-vitro; recombination; deletions; primase
AB A crucial component of the human mitochondrial DNA replisome is the ring-shaped helicase TWINKLE-a phage T7-gene 4-like protein expressed in the nucleus and localized in the human mitochondria. Our previous studies showed that despite being a helicase, TWINKLE has unique DNA annealing activity. At the time, the implications of DNA annealing by TWINKLE were unclear. Herein, we report that TWINKLE uses DNA annealing function to actively catalyze strand-exchange reaction between the unwinding substrate and a homologous single-stranded DNA. Using various biochemical experiments, we demonstrate that the mechanism of strand-exchange involves active coupling of unwinding and annealing reactions by the TWINKLE. Unlike strand-annealing, the strand-exchange reaction requires nucleotide hydrolysis and greatly stimulated by short region of homology between the recombining DNA strands that promote joint molecule formation to initiate strand-exchange. Furthermore, we show that TWINKLE catalyzes branch migration by resolving homologous four-way junction DNA. These four DNA modifying activities of TWINKLE: strand-separation, strand-annealing, strand-exchange and branch migration suggest a dual role of TWINKLE in mitochondrial DNA maintenance. In addition to playing a major role in fork progression during leading strand DNA synthesis, we propose that TWINKLE is involved in recombinational repair of the human mitochondrial DNA.
C1 [Sen, Doyel; Patel, Gayatri; Patel, Smita S.] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA.
C3 Rutgers University System; Rutgers University New Brunswick; Rutgers University Biomedical & Health Sciences
RP Patel, SS (corresponding author), Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA.
EM patelss@rutgers.edu
FU National Institutes of Health [GM55310]
CR Ahnert P, 1997, J BIOL CHEM, V272, P32267, DOI 10.1074/jbc.272.51.32267
   Akhmedov AT, 2015, MOL CELL BIOCHEM, V409, P283, DOI 10.1007/s11010-015-2532-x
   Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8
   Chen XJ, 2013, MICROBIOL MOL BIOL R, V77, P476, DOI 10.1128/MMBR.00007-13
   Clayton DA, 2003, IUBMB LIFE, V55, P213, DOI 10.1080/1521654031000134824
   Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763
   Cox MM, 2001, ANNU REV GENET, V35, P53, DOI 10.1146/annurev.genet.35.102401.090016
   Cymerman IA, 2008, NUCLEIC ACIDS RES, V36, P1369, DOI 10.1093/nar/gkm1169
   Farge G, 2008, NUCLEIC ACIDS RES, V36, P393, DOI 10.1093/nar/gkm1025
   Fernández-Millán P, 2015, NUCLEIC ACIDS RES, V43, P4284, DOI 10.1093/nar/gkv189
   Fusté JM, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004832
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Holt IJ, 2012, CSH PERSPECT BIOL, V4, P0, DOI 10.1101/cshperspect.a012971
   Jeong YJ, 2013, NUCLEIC ACIDS RES, V41, P4219, DOI 10.1093/nar/gkt133
   Kaplan DL, 2002, MOL CELL, V10, P647, DOI 10.1016/S1097-2765(02)00642-1
   Kong DC, 1996, EMBO J, V15, P2010, DOI 10.1002/j.1460-2075.1996.tb00552.x
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Liu J, 2010, VIROL J, V7, P0, DOI 10.1186/1743-422X-7-357
   McKinney EA, 2013, GENET MOL BIOL, V36, P308, DOI 10.1590/s1415-47572013000300002
   Michel B, 2000, TRENDS BIOCHEM SCI, V25, P173, DOI 10.1016/S0968-0004(00)01560-7
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561
   Morris PD, 2001, METHODS, V23, P149, DOI 10.1006/meth.2000.1116
   Nimonkar AV, 2002, J BIOL CHEM, V277, P15182, DOI 10.1074/jbc.M109988200
   Patel G, 2011, J BIOL CHEM, V286, P20490, DOI 10.1074/jbc.M110.201657
   Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651
   Pohjoismäki JLO, 2011, MITOCHONDRION, V11, P630, DOI 10.1016/j.mito.2011.04.002
   Pohjoismäki JLO, 2009, J BIOL CHEM, V284, P21446, DOI 10.1074/jbc.M109.016600
   Rasnik I, 2008, EMBO J, V27, P1727, DOI 10.1038/emboj.2008.106
   Rosenberg AH, 1996, J BIOL CHEM, V271, P26819, DOI 10.1074/jbc.271.43.26819
   Sage JM, 2013, MITOCHONDRION, V13, P350, DOI 10.1016/j.mito.2013.04.004
   Sage JM, 2010, J BIOL CHEM, V285, P18984, DOI 10.1074/jbc.M109.099846
   SALINAS F, 1995, CELL, V82, P111, DOI 10.1016/0092-8674(95)90057-8
   Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7
   Sen D, 2012, J BIOL CHEM, V287, P14545, DOI 10.1074/jbc.M111.309468
   Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Sykora P, 2012, MECH AGEING DEV, V133, P169, DOI 10.1016/j.mad.2011.11.003
   Szymanski MR, 2015, EMBO J, V34, P1959, DOI 10.15252/embj.201591520
   Tann AW, 2011, J BIOL CHEM, V286, P31975, DOI 10.1074/jbc.M110.215715
   Torregrosa-Muñumer R, 2015, MOL BIOL CELL, V26, P4197, DOI 10.1091/mbc.E15-06-0390
   Toth EA, 2003, MOL CELL, V12, P1113, DOI 10.1016/S1097-2765(03)00442-8
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Vandenberghe W, 2009, MOVEMENT DISORD, V24, P308, DOI 10.1002/mds.22198
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Wanrooij S, 2010, BBA-BIOENERGETICS, V1797, P1378, DOI 10.1016/j.bbabio.2010.04.015
   Washington MT, 1996, J BIOL CHEM, V271, P26825, DOI 10.1074/jbc.271.43.26825
   Yardimci H, 2012, NATURE, V492, P205, DOI 10.1038/nature11730
   Ziebarth TD, 2007, J MOL BIOL, V367, P1382, DOI 10.1016/j.jmb.2007.01.079
NR 51
TC 18
Z9 24
U1 1
U2 12
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD MAY 19
PY 2016
VL 44
IS 9
BP 4200
EP 4210
DI 10.1093/nar/gkw098
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA DO0MD
UT WOS:000377472100028
PM 26887820
DA 2024-11-01
ER

PT J
AU Librado, P
   Fages, A
   Gaunitz, C
   Leonardi, M
   Wagner, S
   Khan, N
   Hanghoj, K
   Alquraishi, SA
   Alfarhan, AH
   Al-Rasheid, KA
   Sarkissian, CD
   Schubert, M
   Orlando, L
AF Librado, Pablo
   Fages, Antoine
   Gaunitz, Charleen
   Leonardi, Michela
   Wagner, Stefanie
   Khan, Naveed
   Hanghoj, Kristian
   Alquraishi, Saleh A.
   Alfarhan, Ahmed H.
   Al-Rasheid, Khaled A.
   Sarkissian, Clio Der
   Schubert, Mikkel
   Orlando, Ludovic
TI The Evolutionary Origin and Genetic Makeup of Domestic Horses
SO GENETICS
LA English
DT Review
ID stationary night blindness; polysaccharide storage myopathy; optimum racing distance; synthase gys1 mutation; gait keeper mutation; ancient dna; genome sequence; mitochondrial genm; deleterious mutations; positive selection
AB The horse was domesticated only 5.5 KYA, thousands of years after dogs, cattle, pigs, sheep, and goats. The horse nonetheless represents the domestic animal that most impacted human history; providing us with rapid transportation, which has considerably changed the speed and magnitude of the circulation of goods and people, as well as their cultures and diseases. By revolutionizing warfare and agriculture, horses also deeply influenced the politico-economic trajectory of human societies. Reciprocally, human activities have circled back on the recent evolution of the horse, by creating hundreds of domestic breeds through selective programs, while leading all wild populations to near extinction. Despite being tightly associated with humans, several aspects in the evolution of the domestic horse remain controversial. Here, we review recent advances in comparative genomics and paleogenomics that helped advance our understanding of the genetic foundation of domestic horses.
C1 [Librado, Pablo; Fages, Antoine; Gaunitz, Charleen; Leonardi, Michela; Wagner, Stefanie; Khan, Naveed; Hanghoj, Kristian; Sarkissian, Clio Der; Schubert, Mikkel; Orlando, Ludovic] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Oster Voldgade 5-7, DK-1350 Copenhagen K, Denmark.
   [Fages, Antoine; Hanghoj, Kristian; Orlando, Ludovic] Univ Toulouse 3, CNRS, UMR 5288, Lab Anthropobiol Mol & Imagerie Synth, F-31000 Toulouse, France.
   [Wagner, Stefanie] Univ Bordeaux, INRA, Biodiversite Genes & Communautes UMR1202, F-33610 Cestas, France.
   [Wagner, Stefanie] Univ Bordeaux, Biodiversite Genes & Communautes UMR1202, F-33170 Talence, France.
   [Khan, Naveed] Abdul Wali Khan Univ, Dept Biotechnol, Mardan 23200, Pakistan.
   [Alquraishi, Saleh A.; Alfarhan, Ahmed H.; Al-Rasheid, Khaled A.] King Saud Univ, Dept Zool, Coll Sci, Riyadh 11451, Saudi Arabia.
C3 University of Copenhagen; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; INRAE; Universite de Bordeaux; Universite de Bordeaux; Abdul Wali Khan University; King Saud University
RP Orlando, L (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Oster Voldgade 5-7, DK-1350 Copenhagen K, Denmark.
EM Lorlando@snm.ku.dk
FU Danish Council for Independent Research, Natural Sciences [4002-00152B]; Danish National Research Foundation [DNRF94]; Initiative d'Excellence Chaires d'attractivite, Universite de Toulouse (OURASI); International Research Group Program [IRG14-08]; Deanship of Scientific Research, King Saud University; Marie-Curie Individual Fellowship [MSCA-IF-657852]; Villum Fonden Blokstipendier grant; Villum Fonden research project grant (miGENEPI)
CR Achilli A, 2012, P NATL ACAD SCI USA, V109, P2449, DOI 10.1073/pnas.1111637109
   Adler CJ, 2013, NAT GENET, V45, P450, DOI 10.1038/ng.2536
   Alroy J, 2001, SCIENCE, V292, P1893, DOI 10.1126/science.1059342
   Andersson L, 2015, GENOME BIOL, V16, P0, DOI 10.1186/s13059-015-0622-4
   Andersson LS, 2012, NATURE, V488, P642, DOI 10.1038/nature11399
   [Anonymous], 2015, 2 REP STAT WORLD AN, V0, P0
   [Anonymous], 2010, HORSE WHEEL LANGUAGE, V0, P0
   [Anonymous], 2009, HORSE HUMAN HIST, V0, P0
   Baird JD, 2010, VET REC, V167, P781, DOI 10.1136/vr.c3447
   Beaumont MA, 2002, GENETICS, V162, P2025
   Bellone RR, 2008, GENETICS, V179, P1861, DOI 10.1534/genetics.108.088807
   Bellone RR, 2010, BRIEF FUNCT GENOMICS, V9, P193, DOI 10.1093/bfgp/elq002
   Bendrey R, 2012, WORLD ARCHAEOL, V44, P135, DOI 10.1080/00438243.2012.647571
   Binns MM, 2010, ANIM GENET, V41, P154, DOI 10.1111/j.1365-2052.2010.02126.x
   Bollongino R, 2008, PLOS ONE, V3, P0, DOI 10.1371/journal.pone.0003418
   Boyle KV, 2006, P10, V0, P0
   Brandariz-Fontes C, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0064985
   Brooks SA, 2010, ANIM GENET, V41, P159, DOI 10.1111/j.1365-2052.2010.02127.x
   Bruford MW, 2003, NAT REV GENET, V4, P900, DOI 10.1038/nrg1203
   Burney DA, 2005, TRENDS ECOL EVOL, V20, P395, DOI 10.1016/j.tree.2005.04.022
   Cardona A, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0098076
   Carpenter ML, 2013, AM J HUM GENET, V93, P852, DOI 10.1016/j.ajhg.2013.10.002
   Charlesworth B, 2009, NAT REV GENET, V10, P195, DOI 10.1038/nrg2526
   Cieslak M, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0015311
   Crubézy E, 2010, BMC EVOL BIOL, V10, P0, DOI 10.1186/1471-2148-10-25
   Cruz F, 2008, MOL BIOL EVOL, V25, P2331, DOI 10.1093/molbev/msn177
   Csilléry K, 2010, TRENDS ECOL EVOL, V25, P410, DOI 10.1016/j.tree.2010.04.001
   Dabney J, 2013, P NATL ACAD SCI USA, V110, P15758, DOI 10.1073/pnas.1314445110
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Edwards CJ, 2007, P ROY SOC B-BIOL SCI, V274, P1377, DOI 10.1098/rspb.2007.0020
   Faith JT, 2009, P NATL ACAD SCI USA, V106, P20641, DOI 10.1073/pnas.0908153106
   Fegraeus KJ, 2015, J HERED, V106, P734, DOI 10.1093/jhered/esv062
   Firestone RB, 2007, P NATL ACAD SCI USA, V104, P16016, DOI 10.1073/pnas.0706977104
   Flink LG, 2014, P NATL ACAD SCI USA, V111, P6184, DOI 10.1073/pnas.1308939110
   Frantz LAF, 2015, NAT GENET, V47, P1141, DOI 10.1038/ng.3394
   Fu QM, 2016, NATURE, V534, P200, DOI 10.1038/nature17993
   Fu QM, 2013, P NATL ACAD SCI USA, V110, P2223, DOI 10.1073/pnas.1221359110
   Gallimore R, 2005, CLIM DYNAM, V25, P755, DOI 10.1007/s00382-005-0054-z
   Gamba C, 2016, MOL ECOL RESOUR, V16, P459, DOI 10.1111/1755-0998.12470
   Gansauge MT, 2014, GENOME RES, V24, P1543, DOI 10.1101/gr.174201.114
   Gansauge MT, 2013, NAT PROTOC, V8, P737, DOI 10.1038/nprot.2013.038
   Gokhman D, 2016, TRENDS ECOL EVOL, V31, P290, DOI 10.1016/j.tree.2016.01.010
   Gokhman D, 2014, SCIENCE, V344, P523, DOI 10.1126/science.1250368
   Götherström A, 2005, P ROY SOC B-BIOL SCI, V272, P2345, DOI 10.1098/rspb.2005.3243
   Groeneveld LF, 2010, ANIM GENET, V41, P6, DOI 10.1111/j.1365-2052.2010.02038.x
   Guthrie RD, 2006, NATURE, V441, P207, DOI 10.1038/nature04604
   Haile J, 2009, P NATL ACAD SCI USA, V106, P22352, DOI 10.1073/pnas.0912510106
   Han HY, 2015, ASIAN AUSTRAL J ANIM, V28, P1066, DOI 10.5713/ajas.14.0784
   Heller R, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0062992
   HIGUCHI R, 1984, NATURE, V312, P282, DOI 10.1038/312282a0
   Hill EW, 2010, BMC GENOMICS, V11, P0, DOI 10.1186/1471-2164-11-552
   Hill EW, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0008645
   Ho SYW, 2011, MOL ECOL RESOUR, V11, P423, DOI 10.1111/j.1755-0998.2011.02988.x
   Huntley B, 1988, VEGETATION HISTORY, V0, P0
   Imsland F, 2016, NAT GENET, V48, P152, DOI 10.1038/ng.3475
   Jansen T, 2002, P NATL ACAD SCI USA, V99, P10905, DOI 10.1073/pnas.152330099
   Jónsson H, 2014, P NATL ACAD SCI USA, V111, P18655, DOI 10.1073/pnas.1412627111
   Kimura B, 2011, P ROY SOC B-BIOL SCI, V278, P50, DOI 10.1098/rspb.2010.0708
   King SRB, 2015, IUCN RED LIST THREAT, V2015, P0
   Koch PL, 2006, ANNU REV ECOL EVOL S, V37, P215, DOI 10.1146/annurev.ecolsys.34.011802.132415
   Koenig D, 2013, P NATL ACAD SCI USA, V110, PE2655, DOI 10.1073/pnas.1309606110
   Kreutzmann N, 2014, ANIM GENET, V45, P460, DOI 10.1111/age.12149
   Kristjansson T, 2014, J ANIM BREED GENET, V131, P415, DOI 10.1111/jbg.12112
   Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231
   Librado P, 2015, P NATL ACAD SCI USA, V112, PE6889, DOI 10.1073/pnas.1513696112
   Lindgren G, 2004, NAT GENET, V36, P335, DOI 10.1038/ng1326
   Lippold S, 2011, BMC EVOL BIOL, V11, P0, DOI 10.1186/1471-2148-11-328
   Lira J, 2010, MOL ECOL, V19, P64, DOI 10.1111/j.1365-294X.2009.04430.x
   Lister AM, 1998, ANCIENT BIOMOLECULES, V2, P267
   Lorenzen ED, 2011, NATURE, V479, P359, DOI 10.1038/nature10574
   Lu J, 2006, TRENDS GENET, V22, P126, DOI 10.1016/j.tig.2006.01.004
   Ludwig A, 2015, PHILOS T R SOC B, V370, P0, DOI 10.1098/rstb.2013.0386
   Ludwig A, 2009, SCIENCE, V324, P485, DOI 10.1126/science.1172750
   Lynch VJ, 2015, CELL REP, V12, P217, DOI 10.1016/j.celrep.2015.06.027
   MacFadden BJ, 2005, SCIENCE, V307, P1728, DOI 10.1126/science.1105458
   Makvandi-Nejad S, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0039929
   Malaspinas AS, 2012, GENETICS, V192, P599, DOI 10.1534/genetics.112.140939
   Marsden CD, 2016, P NATL ACAD SCI USA, V113, P152, DOI 10.1073/pnas.1512501113
   McCoy AM, 2014, J HERED, V105, P163, DOI 10.1093/jhered/est075
   McCue ME, 2010, ANIM GENET, V41, P145, DOI 10.1111/j.1365-2052.2010.02124.x
   Mccue ME, 2008, GENOMICS, V91, P458, DOI 10.1016/j.ygeno.2008.01.011
   McCue ME, 2012, PLOS GENET, V8, P0, DOI 10.1371/journal.pgen.1002451
   McGivney BA, 2012, ANIM GENET, V43, P810, DOI 10.1111/j.1365-2052.2012.02329.x
   Meadows JRS, 2004, ANIM GENET, V35, P379, DOI 10.1111/j.1365-2052.2004.01180.x
   Meiri M, 2013, SCI REP-UK, V3, P0, DOI 10.1038/srep03035
   Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344
   Natanaelsson C, 2006, BMC GENET, V7, P0, DOI 10.1186/1471-2156-7-45
   Ollivier M, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0075110
   Orlando L, 2006, MOL ECOL, V15, P2083, DOI 10.1111/j.1365-294X.2006.02922.x
   Orlando L, 2015, GENOME BIOL, V16, P0, DOI 10.1186/s13059-015-0793-z
   Orlando L, 2015, NAT REV GENET, V16, P395, DOI 10.1038/nrg3935
   Orlando L, 2014, SCIENCE, V345, P511, DOI 10.1126/science.1256515
   Orlando L, 2013, NATURE, V499, P74, DOI 10.1038/nature12323
   Orlando L, 2009, P NATL ACAD SCI USA, V106, P21754, DOI 10.1073/pnas.0903672106
   Ottoni C, 2013, MOL BIOL EVOL, V30, P824, DOI 10.1093/molbev/mss261
   Outram AK, 2009, SCIENCE, V323, P1332, DOI 10.1126/science.1168594
   OWENSMITH N, 1987, PALEOBIOLOGY, V13, P351
   Pakendorf B, 2006, HUM GENET, V120, P334, DOI 10.1007/s00439-006-0213-2
   Park SDE, 2015, GENOME BIOL, V16, P0, DOI 10.1186/s13059-015-0790-2
   Pedersen JS, 2014, GENOME RES, V24, P454, DOI 10.1101/gr.163592.113
   Petersen JL, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0054997
   Petersen JL, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003211
   Promerová M, 2014, ANIM GENET, V45, P274, DOI 10.1111/age.12120
   Pruvost M, 2011, P NATL ACAD SCI USA, V108, P18626, DOI 10.1073/pnas.1108982108
   Ramírez O, 2015, HEREDITY, V114, P175, DOI 10.1038/hdy.2014.81
   Rasmussen M, 2014, NATURE, V506, P225, DOI 10.1038/nature13025
   Römpler H, 2006, NAT PROTOC, V1, P720, DOI 10.1038/nprot.2006.84
   Sandmeyer LS, 2012, VET OPHTHALMOL, V15, P18, DOI 10.1111/j.1463-5224.2011.00903.x
   Sarkissian CD, 2015, CURR BIOL, V25, P2577, DOI 10.1016/j.cub.2015.08.032
   Sarkissian CD, 2015, BIOL LETTERS, V11, P0, DOI 10.1098/rsbl.2014.1058
   Scheu A, 2015, BMC GENET, V16, P0, DOI 10.1186/s12863-015-0203-2
   Schraiber JG, 2016, GENETICS, V203, P493, DOI 10.1534/genetics.116.187278
   Schubert M, 2014, P NATL ACAD SCI USA, V111, PE5661, DOI 10.1073/pnas.1416991111
   Sommer RS, 2011, J QUATERNARY SCI, V26, P805, DOI 10.1002/jqs.1509
   Sundqvist AK, 2006, GENETICS, V172, P1121, DOI 10.1534/genetics.105.042358
   Thalmann O, 2013, SCIENCE, V342, P871, DOI 10.1126/science.1243650
   Tozaki T, 2010, ANIM GENET, V41, P28, DOI 10.1111/j.1365-2052.2010.02095.x
   Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285
   van den Hoven R, 2015, BMC VET RES, V11, P0, DOI 10.1186/s12917-015-0428-3
   Vilà C, 2001, SCIENCE, V291, P474, DOI 10.1126/science.291.5503.474
   Vilstrup JT, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0055950
   Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158
   Wallner B, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0060015
   Warinner C, 2014, SCI REP-UK, V4, P0, DOI 10.1038/srep07104
   Warmuth V, 2012, P NATL ACAD SCI USA, V109, P8202, DOI 10.1073/pnas.1111122109
   Warmuth V, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0018194
   Warmuth VM, 2013, MOL ECOL, V22, P5340, DOI 10.1111/mec.12491
   Weinstock J, 2005, PLOS BIOL, V3, P1373, DOI 10.1371/journal.pbio.0030241
   Zeder MA, 2006, TRENDS GENET, V22, P139, DOI 10.1016/j.tig.2006.01.007
   Zeng K, 2006, GENETICS, V174, P1431, DOI 10.1534/genetics.106.061432
NR 130
TC 51
Z9 59
U1 5
U2 126
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0016-6731
EI 1943-2631
J9 GENETICS
JI Genetics
PD OCT 15
PY 2016
VL 204
IS 2
BP 423
EP 434
DI 10.1534/genetics.116.194860
PG 12
WC Genetics & Heredity
SC Genetics & Heredity
GA DZ4ZP
UT WOS:000385871400006
PM 27729493
DA 2024-11-01
ER

PT J
AU McKiernan, P
   Ball, S
   Santra, S
   Foster, K
   Fratter, C
   Poulton, J
   Craig, K
   McFarland, R
   Rahman, S
   Hargreaves, I
   Gupte, G
   Sharif, K
   Taylor, RW
AF McKiernan, Patrick
   Ball, Sarah
   Santra, Saikat
   Foster, Katherine
   Fratter, Carl
   Poulton, Joanna
   Craig, Kate
   McFarland, Robert
   Rahman, Shamima
   Hargreaves, Iain
   Gupte, Girish
   Sharif, Khalid
   Taylor, Robert W.
TI Incidence of Primary Mitochondrial Disease in Children Younger Than 2 Years Presenting With Acute Liver Failure
SO JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
LA English
DT Article
DE acute liver failure; liver transplantation; mitochondrial disease; mitochondrial DNA depletion syndrome; respiratory chain deficiency
ID dna depletion syndrome; mutations; onset; transplantation; disorders
AB Background:Mitochondrial liver disease (MLD), and in particular mitochondrial DNA (mtDNA) depletion syndrome (MDS) is an important cause of acute liver failure (ALF) in infancy. Early and accurate diagnosis is important because liver transplantation (LT) is often contraindicated. It is unclear which methods are the best to diagnose MLD in the setting of ALF.Objective:The aim of the study was to determine the incidence of MLD in children younger than 2 years with ALF and the utility of routine investigations to detect MLD.Methods:Thirty-nine consecutive infants with ALF were admitted to a single unit from 2009 to 2011. All were extensively investigated using an established protocol. Genes implicated in mitochondrial DNA depletion syndrome were sequenced in all cases and tissue mtDNA copy number measured where available.Results:Five infants (17%) had genetically proven MLD: DGUOK (n=2), POLG (n=2), and MPV17 (1). Four of these died, whereas 1 recovered. Two had normal muscle mtDNA copy number and 3 had normal muscle respiratory chain enzymes. An additional 8 children had low hepatic mtDNA copy number but pathogenic mutations were not detected. One of these developed fatal multisystemic disease after LT, whereas 5 who survived remain well without evidence of multisystemic disease up to 6 years later. Magnetic resonance spectroscopy did not distinguish between those with and without MLD.Conclusions:Low liver mtDNA copy number may be a secondary phenomenon in ALF.Screening for mtDNA maintenance gene mutations may be the most efficient way to confirm MLD in ALF in the first 2 years of life.
C1 [McKiernan, Patrick; Gupte, Girish; Sharif, Khalid] Birmingham Childrens Hosp, Liver Unit, Birmingham, W Midlands, England.
   [McKiernan, Patrick; Gupte, Girish] Univ Birmingham, Birmingham, W Midlands, England.
   [Ball, Sarah; Santra, Saikat] Birmingham Childrens Hosp, Dept Clin IMD, Birmingham, W Midlands, England.
   [Foster, Katherine] Birmingham Childrens Hosp, Dept Radiol, Birmingham, W Midlands, England.
   [Fratter, Carl] Oxford Univ Hosp NHS Fdn Trust, Oxford Med Genet Labs, London, England.
   [Poulton, Joanna] Univ Oxford, Nuffield Dept Obstet & Gynaecol, London, England.
   [Craig, Kate; McFarland, Robert; Taylor, Robert W.] Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res & Highly Spe, London, England.
   [Rahman, Shamima; Hargreaves, Iain] UCL Inst Child Hlth, Genet & Genom Med, London, England.
C3 University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham; Oxford University Hospitals NHS Foundation Trust; University of Oxford; Newcastle University - UK; University of London; University College London
RP McKiernan, P (corresponding author), UPMC, Childrens Hosp Pittsburgh, Div Gastroenterol Hepatol Nutr, 4401 Penn Ave, Pittsburgh, PA 15224 USA.
EM patrick.mckiernan@chp.edu
FU UK NHS Highly Specialized "Rare Mitochondrial Disorders of Adults and Children" Service; Wellcome Trust [096919Z/11/Z]; Great Ormond Street Hospital Children's Charity; MRC [G0800674] Funding Source: UKRI
CR Al-Hussaini A, 2014, J PEDIATR-US, V164, P553, DOI 10.1016/j.jpeds.2013.10.082
   Calvo SE, 2012, SCI TRANSL MED, V4, P0, DOI 10.1126/scitranslmed.3003310
   CormierDaire V, 1997, J PEDIATR-US, V130, P817, DOI 10.1016/S0022-3476(97)80027-3
   Davit-Spraul A, 2014, JIMD REP, V14, P17, DOI 10.1007/8904_2013_278
   deBruyn JC, 2007, J PEDIATR GASTR NUTR, V45, P252, DOI 10.1097/MPG.0b013e318048838f
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   Fitzpatrick E, 2014, ARCH DIS CHILD, V99, P354, DOI 10.1136/archdischild-2013-304426
   Freisinger P, 2006, ARCH NEUROL-CHICAGO, V63, P1129, DOI 10.1001/archneur.63.8.1129
   Haack TB, 2015, AM J HUM GENET, V97, P163, DOI 10.1016/j.ajhg.2015.05.009
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Helbling D, 2013, J PEDIATR GASTR NUTR, V57, P438, DOI 10.1097/MPG.0b013e31829ef4b4
   Lane M, 2016, J INHERIT METAB DIS, V39, P427, DOI 10.1007/s10545-016-9927-z
   Lee WS, 2013, J PEDIATR-US, V163, P942, DOI 10.1016/j.jpeds.2013.05.036
   Lee WS, 2005, J PEDIATR GASTR NUTR, V40, P575, DOI 10.1097/01.MPG.0000158524.30294.E2
   McFarland R, 2008, ARCH DIS CHILD, V93, P151, DOI 10.1136/adc.2007.122911
   Molleston JP, 2013, J PEDIATR GASTR NUTR, V57, P269, DOI 10.1097/MPG.0b013e31829ef67a
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   Rahman S, 2013, J INHERIT METAB DIS, V36, P659, DOI 10.1007/s10545-013-9614-2
   Schara U, 2011, J INHERIT METAB DIS, V34, P197, DOI 10.1007/s10545-010-9250-z
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Stewart JD, 2010, HEPATOLOGY, V52, P1791, DOI 10.1002/hep.23891
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Uusimaa J, 2013, EUR J HUM GENET, V22, P553
   Zeharia A, 2009, AM J HUM GENET, V85, P401, DOI 10.1016/j.ajhg.2009.08.004
NR 24
TC 35
Z9 36
U1 0
U2 14
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0277-2116
EI 1536-4801
J9 J PEDIATR GASTR NUTR
JI J. Pediatr. Gastroenterol. Nutr.
PD DEC 15
PY 2016
VL 63
IS 6
BP 592
EP 597
DI 10.1097/MPG.0000000000001345
PG 6
WC Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics
SC Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics
GA ED3EW
UT WOS:000388733200026
PM 27482763
DA 2024-11-01
ER

PT J
AU Longo, N
   Frigeni, M
   Pasquali, M
AF Longo, Nicola
   Frigeni, Marta
   Pasquali, Marzia
TI Carnitine transport and fatty acid oxidation
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
LA English
DT Article
DE Carnitine; Arrhythmia; SLC22A5; OCTN2; Newborn screening; Autism
ID acyl-coa synthetase; organic cation/carnitine transporter; binding protein gene; genotype-phenotype correlations; lipid-metabolism; vectorial acylation; insulin-resistance; skeletal-muscle; faroe-islands; octn2 gene
AB Carnitine is essential for the transfer of long-chain fatty acids across the inner mitochondrial membrane for subsequent Is-oxidation. It can be synthesized by the body or assumed with the diet from meat and dairy products. Defects in carnitine biosynthesis do not routinely result in low plasma carnitine levels. Carnitine is accumulated by the cells and retained by kidneys using OCTN2, a high affinity organic cation transporter specific for carnitine. Defects in the OCTN2 carnitine transporter results in autosomal recessive primary carnitine deficiency characterized by decreased intracellular carnitine accumulation, increased losses of carnitine in the urine, and low serum carnitine levels. Patients can present early in life with hypoketotic hypoglycemia and hepatic encephalopathy, or later in life with skeletal and cardiac myopathy or sudden death from cardiac arrhythmia, usually triggered by fasting or catabolic state. This disease responds to oral carnitine that, in pharmacological doses, enters cells using the amino acid transporter B-0,B-+. Primary carnitine deficiency can be suspected from the clinical presentation or identified by low levels of free carnitine (CO) in the newborn screening. Some adult patients have been diagnosed following the birth of an unaffected child with very low carnitine levels in the newborn screening. The diagnosis is confirmed by measuring low carnitine uptake in the patients' fibroblasts or by DNA sequencing of the SLC22A5 gene encoding the OCTN2 carnitine transporter. Some mutations are specific for certain ethnic backgrounds, but the majority are private and identified only in individual families. Although the genotype usually does not correlate with metabolic or cardiac involvement in primary carnitine deficiency, patients presenting as adults tend to have at least one missense mutation retaining residual activity. This article is part of a Special Issue entitled: Mitochondrial Channels edited by Pierre Sonveaux, Pierre Maechler and Jean-Claude Martinou. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Longo, Nicola; Frigeni, Marta] Univ Utah, Dept Pediat, Div Med Genet, 500 Chipeta Way, Salt Lake City, UT USA.
   [Longo, Nicola; Pasquali, Marzia] Univ Utah, Dept Pathol, 500 Chipeta Way, Salt Lake City, UT USA.
   [Longo, Nicola; Pasquali, Marzia] ARUP Labs, 500 Chipeta Way, Salt Lake City, UT USA.
C3 Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; ARUP Laboratories
RP Longo, N (corresponding author), Univ UT, Dept Pediat, Div Med Genet, 695 Chipeta Way, Salt Lake City, UT 84108 USA.
EM Nicola.Longo@hsc.utah.edu
FU National Institutes of Health [R01 DK 53824]
CR Aitman TJ, 2000, NATURE, V405, P1015, DOI 10.1038/35016636
   Akpinar B, 2010, CLIN GENET, V78, P89
   Anderson CM, 2013, MOL ASPECTS MED, V34, P516, DOI 10.1016/j.mam.2012.07.010
   Anichini A, 2011, NEUROL RES, V33, P24, DOI 10.1179/016164110X12767786356390
   Arias-Barrau E, 2009, METHODS MOL BIOL, V580, P233, DOI 10.1007/978-1-60761-325-1_13
   Auinger A, 2012, BRIT J NUTR, V107, P1422, DOI 10.1017/S0007114511004727
   Berlanga A, 2014, CLIN EXP GASTROENTER, V7, P221, DOI 10.2147/CEG.S62831
   BIEBER LL, 1988, ANNU REV BIOCHEM, V57, P261, DOI 10.1146/annurev.bi.57.070188.001401
   Binnert C, 2000, AM J PHYSIOL-ENDOC M, V279, PE1072, DOI 10.1152/ajpendo.2000.279.5.E1072
   Black Paul N, 2007, NOVARTIS FOUND SYMP, V286, P127
   Black PN, 2007, BBA-MOL CELL BIOL L, V1771, P286, DOI 10.1016/j.bbalip.2006.05.003
   BLACK PN, 2007, NOVART FDN SYMP, V286, P138
   BLACK PN, 2007, NOVART FDN SYMP, V286, P162
   BLACK PN, 2007, NOVART FDN SYMP, V286, P196
   Boord JB, 2002, ARTERIOSCL THROM VAS, V22, P1686, DOI 10.1161/01.ATV.0000033090.81345.E6
   Borum P R, 1995, J CHILD NEUROL, V10 Suppl 2, P0
   Burckhardt G, 2000, AM J PHYSIOL-RENAL, V278, PF853, DOI 10.1152/ajprenal.2000.278.6.F853
   Burwinkel B, 1999, BIOCHEM BIOPH RES CO, V261, P484, DOI 10.1006/bbrc.1999.1060
   Carter A L, 1995, J CHILD NEUROL, V10 Suppl 2, P0
   Cederbaum SD, 2002, MOL GENET METAB, V77, P195, DOI 10.1016/S1096-7192(02)00169-5
   Celestino-Soper PBS, 2012, P NATL ACAD SCI USA, V109, P7974, DOI 10.1073/pnas.1120210109
   Celestino-Soper PBS, 2011, HUM MOL GENET, V20, P4360, DOI 10.1093/hmg/ddr363
   Cooper DE, 2015, J BIOL CHEM, V290, P20023, DOI 10.1074/jbc.R115.663260
   Crombez EA, 2008, MOL GENET METAB, V94, P132, DOI 10.1016/j.ymgme.2008.01.005
   De Biase I, 2012, JIMD REP, V2, P87, DOI 10.1007/8904_2011_52
   de Sain-van der Velden MGM, 2013, MOL GENET METAB, V110, P116, DOI 10.1016/j.ymgme.2013.04.008
   di San Filippo CA, 2004, J BIOL CHEM, V279, P7247, DOI 10.1074/jbc.M309171200
   di San Filippo CA, 2003, J BIOL CHEM, V278, P47776, DOI 10.1074/jbc.M307911200
   Dobrowolski SE, 2005, HUM MUTAT, V25, P306, DOI 10.1002/humu.20137
   Doege H, 2006, PHYSIOLOGY, V21, P259, DOI 10.1152/physiol.00014.2006
   Drosatos Konstantinos, 2013, CURR HEART FAIL REP, V10, P109, DOI 10.1007/s11897-013-0133-0
   El-Hattab AW, 2015, MOL GENET METAB, V0, P0
   El-Hattab AW, 2010, GENET MED, V12, P19, DOI 10.1097/GIM.0b013e3181c5e6f7
   Filipek PA, 2004, J AUTISM DEV DISORD, V34, P615, DOI 10.1007/s10803-004-5283-1
   Filippo CADS, 2008, MOL GENET METAB, V94, P162, DOI 10.1016/j.ymgme.2008.02.002
   Filippo CAD, 2006, HUM MUTAT, V27, P513, DOI 10.1002/humu.20314
   Filippo CADS, 2011, BBA-MOL BASIS DIS, V1812, P312, DOI 10.1016/j.bbadis.2010.11.007
   Frigeni M, 2015, J INHERIT METAB D S1, V38, P0
   Fu Li-jun, 2012, ZHONGHUA ER KE ZA ZHI, V50, P929
   Fu LJ, 2013, KOREAN CIRC J, V43, P785, DOI 10.4070/kcj.2013.43.12.785
   Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589
   Gazzerro E, 2010, EUR J HUM GENET, V18, P137, DOI 10.1038/ejhg.2009.103
   Glatz JFC, 2006, CARDIOVASC DRUG THER, V20, P471, DOI 10.1007/s10557-006-0582-8
   Grevengoed TJ, 2014, ANNU REV NUTR, V34, P1, DOI 10.1146/annurev-nutr-071813-105541
   Han LS, 2014, EUR J MED GENET, V57, P571, DOI 10.1016/j.ejmg.2014.08.001
   Hardwick JP, 2008, BIOCHEM PHARMACOL, V75, P2263, DOI 10.1016/j.bcp.2008.03.004
   Herrmann T, 2003, J CELL BIOL, V161, P1105, DOI 10.1083/jcb.200207080
   Herrmann T, 2001, GENE, V270, P31, DOI 10.1016/S0378-1119(01)00489-9
   Hirano T, 2006, BBA-BIOMEMBRANES, V1758, P1743, DOI 10.1016/j.bbamem.2006.07.002
   Hisanaga Y, 2004, J BIOL CHEM, V279, P31717, DOI 10.1074/jbc.M400100200
   Hoffmann L, 2014, LIPIDS, V49, P25, DOI 10.1007/s11745-013-3865-4
   Hotamisligil GS, 2015, NAT REV ENDOCRINOL, V11, P592, DOI 10.1038/nrendo.2015.122
   Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377
   Houten SM, 2010, J INHERIT METAB DIS, V33, P469, DOI 10.1007/s10545-010-9061-2
   Hu CX, 2012, MOL CANCER THER, V11, P921, DOI 10.1158/1535-7163.MCT-11-0980
   Hubbard B, 2006, GASTROENTEROLOGY, V130, P1259, DOI 10.1053/j.gastro.2006.02.012
   Kiens B, 2006, PHYSIOL REV, V86, P205, DOI 10.1152/physrev.00023.2004
   Kilic M, 2012, JIMD REP, V3, P17, DOI 10.1007/8904_2011_36
   Kim CA, 2008, J CLIN ENDOCR METAB, V93, P1129, DOI 10.1210/jc.2007-1328
   Klar J, 2009, AM J HUM GENET, V85, P248, DOI 10.1016/j.ajhg.2009.06.021
   Koizumi A, 1999, HUM MOL GENET, V8, P2247, DOI 10.1093/hmg/8.12.2247
   Komlósi K, 2009, J INHERIT METAB DIS, V32, PS15, DOI 10.1007/s10545-009-0926-1
   Kör D, 2015, J PEDIATR ENDOCR MET, V28, P669, DOI 10.1515/jpem-2014-0302
   Krammer J, 2011, INT J MED SCI, V8, P599, DOI 10.7150/ijms.8.599
   Lamhonwah AM, 2002, AM J MED GENET, V111, P271, DOI 10.1002/ajmg.10585
   Le Borgne F, 2011, BIOCHEM BIOPH RES CO, V409, P699, DOI 10.1016/j.bbrc.2011.05.068
   Lee J, 2012, J TURBUL, V13, P1, DOI 10.1080/14685248.2012.684387
   Lee NC, 2010, MOL GENET METAB, V100, P46, DOI 10.1016/j.ymgme.2009.12.015
   Leydiker KB, 2011, MOL GENET METAB, V103, P92, DOI 10.1016/j.ymgme.2011.01.011
   Li FY, 2010, HUM MUTAT, V31, PE1632, DOI 10.1002/humu.21311
   LOMBARD KA, 1989, AM J CLIN NUTR, V50, P301, DOI 10.1093/ajcn/50.2.301
   Longo N, 2006, AM J MED GENET C, V142C, P77, DOI 10.1002/ajmg.c.30087
   Longo N, 2001, AM J PHYSIOL-CELL PH, V280, PC912, DOI 10.1152/ajpcell.2001.280.4.C912
   Lousa CD, 2013, P NATL ACAD SCI USA, V110, P1279, DOI 10.1073/pnas.1218034110
   Lund AM, 2007, J INHERIT METAB DIS, V30, P341, DOI 10.1007/s10545-007-0527-9
   Maeda K, 2003, DIABETES, V52, P300, DOI 10.2337/diabetes.52.2.300
   Makhseed N, 2004, J INHERIT METAB DIS, V27, P778, DOI 10.1023/B:BOLI.0000045837.23328.f4
   Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076
   Martin GG, 2006, AM J PHYSIOL-GASTR L, V290, PG36, DOI 10.1152/ajpgi.00510.2004
   Martin GG, 2003, J BIOL CHEM, V278, P21429, DOI 10.1074/jbc.M300287200
   Masuda D, 2009, J LIPID RES, V50, P999, DOI 10.1194/jlr.P700032-JLR200
   Mayatepek E, 2000, HUM MUTAT, V15, P118, DOI 10.1002/(SICI)1098-1004(200001)15:1<118::AID-HUMU28>3.0.CO;2-8
   Mazzini M, 2011, CARDIOLOGY, V120, P52, DOI 10.1159/000333127
   Melton EM, 2011, J BIOL CHEM, V286, P30670, DOI 10.1074/jbc.M111.226316
   Méndez-Giménez L, 2014, MOL CELL ENDOCRINOL, V397, P78, DOI 10.1016/j.mce.2014.06.017
   Mitsuyoshi H, 2009, HEPATOL RES, V39, P366, DOI 10.1111/j.1872-034X.2008.00464.x
   Mutlu-Albayrak H, 2015, CASE REP GENET, V2015, P0
   Nakanishi T, 2001, J PHYSIOL-LONDON, V532, P297, DOI 10.1111/j.1469-7793.2001.0297f.x
   Nava C, 2012, TRANSL PSYCHIAT, V2, P0, DOI 10.1038/tp.2012.102
   Neess D, 2015, PROG LIPID RES, V59, P1, DOI 10.1016/j.plipres.2015.04.001
   Newberry EP, 2003, J BIOL CHEM, V278, P51664, DOI 10.1074/jbc.M309377200
   Nezu JI, 1999, NAT GENET, V21, P91, DOI 10.1038/5030
   OLSON AL, 1987, J NUTR, V117, P1024, DOI 10.1093/jn/117.6.1024
   OQUENDO P, 1989, CELL, V58, P95, DOI 10.1016/0092-8674(89)90406-6
   PAIK WK, 1971, SCIENCE, V174, P114, DOI 10.1126/science.174.4005.114
   Pasquali M, 2006, AM J MED GENET C, V142C, P64, DOI 10.1002/ajmg.c.30086
   Pochini L, 2013, J BIOMOL SCREEN, V18, P851, DOI 10.1177/1087057113493006
   Pochini L, 2009, CHEM-BIOL INTERACT, V179, P394, DOI 10.1016/j.cbi.2008.10.052
   Rahbeeni Z, 2002, J INHERIT METAB DIS, V25, P363, DOI 10.1023/A:1020143632011
   Rashidi-Nezhad A, 2014, BMC MED GENET, V15, P0, DOI 10.1186/1471-2350-15-75
   Rasmussen J, 2015, JIMD REP, V20, P103, DOI 10.1007/8904_2014_398
   Rasmussen J, 2014, MOLEC GENET METAB RE, V1, P241, DOI 10.1016/j.ymgmr.2014.04.008
   Rasmussen J, 2014, J INHERIT METAB DIS, V37, P215, DOI 10.1007/s10545-013-9606-2
   Rasmussen J, 2014, J INHERIT METAB DIS, V37, P223, DOI 10.1007/s10545-013-9640-0
   Rasmussen J, 2013, J INHERIT METAB DIS, V36, P35, DOI 10.1007/s10545-012-9488-8
   Razani B, 2002, MOL CELL BIOL, V22, P2329, DOI 10.1128/MCB.22.7.2329-2344.2002
   Razani B, 2002, J BIOL CHEM, V277, P8635, DOI 10.1074/jbc.M110970200
   REBOUCHE CJ, 1984, J CLIN INVEST, V73, P857, DOI 10.1172/JCI111281
   Rebouche CJ, 2004, ANN NY ACAD SCI, V1033, P30, DOI 10.1196/annals.1320.003
   REBOUCHE CJ, 1980, BIOCHIM BIOPHYS ACTA, V630, P22, DOI 10.1016/0304-4165(80)90133-6
   Rigault C, 2006, BBA-MOL CELL BIOL L, V1761, P1469, DOI 10.1016/j.bbalip.2006.09.014
   Rijlaarsdam RS, 2004, PACE, V27, P675, DOI 10.1111/j.1540-8159.2004.00507.x
   Roe CR, 2001, METABOLIC MOL BASES, V0, P2297
   Rose EC, 2012, HUM MUTAT, V33, P118, DOI 10.1002/humu.21607
   Saheki T, 2000, MOL GENET METAB, V71, P545, DOI 10.1006/mgme.2000.3093
   Saini-Chohan HK, 2012, J LIPID RES, V53, P4, DOI 10.1194/jlr.R012120
   Sanders RJ, 2008, FASEB J, V22, P2064, DOI 10.1096/fj.07-099150
   Sarafoglou K, 2010, CLIN GENET, V78, P191, DOI 10.1111/j.1399-0004.2009.01368.x
   Scaglia F, 1998, GENET MED, V1, P34
   Scaglia F, 1999, ARCH BIOCHEM BIOPHYS, V364, P99, DOI 10.1006/abbi.1999.1118
   Scaglia F, 1999, SEMIN PERINATOL, V23, P152, DOI 10.1016/S0146-0005(99)80047-0
   Scherer PE, 1996, P NATL ACAD SCI USA, V93, P131, DOI 10.1073/pnas.93.1.131
   Schimmenti LA, 2007, MOL GENET METAB, V90, P441, DOI 10.1016/j.ymgme.2006.10.003
   SCHMIDTSOMMERFELD E, 1990, BIOL NEONATE, V58, P81, DOI 10.1159/000243302
   Schrader M, 2015, J INHERIT METAB DIS, V38, P681, DOI 10.1007/s10545-015-9819-7
   Shibbani K, 2014, CLIN GENET, V85, P127, DOI 10.1111/cge.12112
   SLONIM AE, 1981, J PEDIATR-US, V99, P551, DOI 10.1016/S0022-3476(81)80252-1
   Sobol PT, 2011, MOL THER, V19, P335, DOI 10.1038/mt.2010.264
   Spiekerkoetter U, 2003, J INHERIT METAB DIS, V26, P613, DOI 10.1023/A:1025968502527
   Stanley C A, 1995, ADV PEDIATR, V42, P209
   Stanley CA, 2004, ANN NY ACAD SCI, V1033, P42, DOI 10.1196/annals.1320.004
   Tamai I, 1998, J BIOL CHEM, V273, P20378, DOI 10.1074/jbc.273.32.20378
   Tang NLS, 2002, HUM MUTAT, V20, P0, DOI 10.1002/humu.9053
   Tang NLS, 1999, HUM MOL GENET, V8, P655, DOI 10.1093/hmg/8.4.655
   Tang ZL, 1996, J BIOL CHEM, V271, P2255, DOI 10.1074/jbc.271.4.2255
   Therrell BL, 2014, MOL GENET METAB, V113, P14, DOI 10.1016/j.ymgme.2014.07.009
   Tong FM, 2006, ARCH BIOCHEM BIOPHYS, V447, P46, DOI 10.1016/j.abb.2006.01.005
   Urban TJ, 2006, MOL PHARMACOL, V70, P1602, DOI 10.1124/mol.106.028126
   Uysal KT, 2000, ENDOCRINOLOGY, V141, P3388, DOI 10.1210/en.141.9.3388
   van Roermund CWT, 2014, BBA-MOL CELL BIOL L, V1841, P563, DOI 10.1016/j.bbalip.2013.12.001
   van Roermund CWT, 2011, BBA-MOL CELL BIOL L, V1811, P148, DOI 10.1016/j.bbalip.2010.11.010
   van Roermund CWT, 2008, FASEB J, V22, P4201, DOI 10.1096/fj.08-110866
   Vaz FM, 1999, HUM GENET, V105, P157, DOI 10.1007/s004390051079
   Vaz FM, 2002, BIOCHEM J, V361, P417, DOI 10.1042/0264-6021:3610417
   Vijay S, 2006, J INHERIT METAB DIS, V29, P627, DOI 10.1007/s10545-006-0376-y
   Violante S, 2013, BBA-MOL CELL BIOL L, V1831, P1467, DOI 10.1016/j.bbalip.2013.06.007
   Wakahara T, 2007, DEV BIOL, V303, P527, DOI 10.1016/j.ydbio.2006.11.041
   Wanders RJA, 2010, BBA-MOL CELL BIOL L, V1801, P272, DOI 10.1016/j.bbalip.2010.01.001
   Wanders RJA, 2014, BIOCHIMIE, V98, P36, DOI 10.1016/j.biochi.2013.08.022
   Wanders Ronald J A, 2013, SUBCELL BIOCHEM, V69, P23, DOI 10.1007/978-94-007-6889-5_2
   Wanders RJA, 2011, BBA-MOL CELL BIOL L, V1811, P498, DOI 10.1016/j.bbalip.2011.06.006
   Wanders RJA, 2011, FEBS J, V278, P182, DOI 10.1111/j.1742-4658.2010.07947.x
   Wang YH, 2000, HUM MUTAT, V16, P401, DOI 10.1002/1098-1004(200011)16:5<401::AID-HUMU4>3.0.CO;2-J
   Wang YH, 2000, HUM MUTAT, V15, P238, DOI 10.1002/(SICI)1098-1004(200003)15:3<238::AID-HUMU4>3.0.CO;2-3
   Wang YH, 2000, J BIOL CHEM, V275, P20782, DOI 10.1074/jbc.M000194200
   Wang YH, 1999, P NATL ACAD SCI USA, V96, P2356, DOI 10.1073/pnas.96.5.2356
   Wang YH, 2001, GENET MED, V3, P387, DOI 10.1097/00125817-200111000-00002
   Watkins PA, 2007, J LIPID RES, V48, P2736, DOI 10.1194/jlr.M700378-JLR200
   Wilcken B, 2001, J PEDIATR-US, V138, P581, DOI 10.1067/mpd.2001.111813
   Wong GK, 2011, ANESTHESIOLOGY, V114, P1417, DOI 10.1097/ALN.0b013e31821a8d46
   Wu X, 1998, BIOCHEM BIOPH RES CO, V246, P589, DOI 10.1006/bbrc.1998.8669
   Wu X, 1999, J PHARMACOL EXP THER, V290, P1482
   Wu Zheng-Mu, 2012, ZHONGHUA NAN KE XUE, V18, P253
   Yeung DCY, 2008, EUR HEART J, V29, P2156, DOI 10.1093/eurheartj/ehn295
   Ziats MN, 2015, AM J MED GENET A, V167, P2496, DOI 10.1002/ajmg.a.37192
   Ziats MN, 2015, AM J MED GENET A, V167, P2162, DOI 10.1002/ajmg.a.37144
   Zou ZY, 2003, J BIOL CHEM, V278, P16414, DOI 10.1074/jbc.M210557200
NR 167
TC 541
Z9 596
U1 5
U2 84
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-4889
EI 0006-3002
J9 BBA-MOL CELL RES
JI Biochim. Biophys. Acta-Mol. Cell Res.
PD OCT 15
PY 2016
VL 1863
IS 10
BP 2422
EP 2435
DI 10.1016/j.bbamcr.2016.01.023
PG 14
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA DU6TR
UT WOS:000382348000006
PM 26828774
DA 2024-11-01
ER

PT J
AU Liu, FC
   Lou, JW
   Zhao, DD
   Li, W
   Zhao, YY
   Sun, XL
   Yan, CZ
AF Liu, Fuchen
   Lou, Jianwei
   Zhao, Dandan
   Li, Wei
   Zhao, Yuying
   Sun, Xiulian
   Yan, Chuanzhu
TI Dysferlinopathy: mitochondrial abnormalities in human skeletal muscle
SO INTERNATIONAL JOURNAL OF NEUROSCIENCE
LA English
DT Article
ID girdle muscular-dystrophy; dna copy number; oxidative stress; miyoshi myopathy; membrane repair; dysfunction; reticulum; mutations; tissue; gene
C1 [Liu, Fuchen; Lou, Jianwei; Zhao, Dandan; Li, Wei; Zhao, Yuying; Yan, Chuanzhu] Shandong Univ, Qilu Hosp, Dept Neurol, Jinan 250012, Peoples R China.
   [Liu, Fuchen] Yale Univ, Sch Med, Kavli Inst Neurosci, Dept Neurobiol, New Haven, CT USA.
   [Sun, Xiulian] Shandong Univ, Qilu Hosp, Otolaryngol Lab, Jinan 250012, Peoples R China.
   [Yan, Chuanzhu] Shandong Univ, Sch Med, Minist Educ, Key Lab Expt Teratol, Jinan 250012, Peoples R China.
   [Yan, Chuanzhu] Shandong Univ, Brain Sci Res Inst, Jinan 250012, Peoples R China.
C3 Shandong University; Yale University; Shandong University; Shandong University; Shandong University
RP Yan, CZ (corresponding author), Shandong Univ, Key Lab Expt Teratol, Brain Sci Res Inst, Dept Neurol,Qilu Hosp,Minist Educ, 107 West Wenhua Rd, Jinan 250012, Peoples R China.
EM chuanzhuyan@163.com
CR Ankala A, 2014, MUSCLE NERVE, V50, P333, DOI 10.1002/mus.24195
   Aoki M, 2001, NEUROLOGY, V57, P271, DOI 10.1212/WNL.57.2.271
   Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573
   Bernardi P, 2008, ANN NY ACAD SCI, V1147, P303, DOI 10.1196/annals.1427.009
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Covian-Nares JF, 2010, J CELL SCI, V123, P1884, DOI 10.1242/jcs.066084
   de Morrée A, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0013854
   Deconinck N, 2007, PEDIATR NEUROL, V36, P1, DOI 10.1016/j.pediatrneurol.2006.09.016
   Flix B, 2013, INT J BIOCHEM CELL B, V45, P1927, DOI 10.1016/j.biocel.2013.06.007
   Franzini-Armstrong C, 2007, PHYSIOLOGY, V22, P261, DOI 10.1152/physiol.00017.2007
   Fujita E, 2007, HUM MOL GENET, V16, P618, DOI 10.1093/hmg/ddm002
   Gal A, 2008, CLIN NEUROPATHOL, V27, P289
   Gayathri N, 2011, INDIAN J PATHOL MICR, V54, P350, DOI 10.4103/0377-4929.81636
   Gu F, 2013, TRANSL PSYCHIAT, V3, P0, DOI 10.1038/tp.2013.68
   Ho MF, 2002, ANN NEUROL, V51, P129, DOI 10.1002/ana.10080
   Ide T, 2001, CIRC RES, V88, P529, DOI 10.1161/01.RES.88.5.529
   Illa I, 2001, ANN NEUROL, V49, P130, DOI 10.1002/1531-8249(200101)49:1<130::AID-ANA22>3.3.CO;2-S
   Katsetos CD, 2013, SEMIN PEDIATR NEUROL, V20, P202, DOI 10.1016/j.spen.2013.10.010
   Kerr JP, 2014, FRONT PHYSIOL, V5, P0, DOI 10.3389/fphys.2014.00089
   Kerr JP, 2013, P NATL ACAD SCI USA, V110, P20831, DOI 10.1073/pnas.1307960110
   Khrapko K, 1999, NUCLEIC ACIDS RES, V27, P2434, DOI 10.1093/nar/27.11.2434
   Liu CS, 2003, FREE RADICAL RES, V37, P1307, DOI 10.1080/10715760310001621342
   Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682
   McNeil PL, 2005, NAT REV MOL CELL BIO, V6, P499, DOI 10.1038/nrm1665
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Mueller AL, 2014, MUSCLE NERVE, V50, P286, DOI 10.1002/mus.24220
   Ramadasan-Nair R, 2014, J BIOL CHEM, V289, P485, DOI 10.1074/jbc.M113.493270
   SHAY JW, 1990, J BIOL CHEM, V265, P14802
NR 28
TC 22
Z9 22
U1 0
U2 12
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0020-7454
EI 1563-5279
J9 INT J NEUROSCI
JI Int. J. Neurosci.
PD JUN 2
PY 2016
VL 126
IS 6
BP 499
EP 509
DI 
PG 11
WC Neurosciences
SC Neurosciences & Neurology
GA DG4AI
UT WOS:000372011900003
PM 26000923
DA 2024-11-01
ER

PT J
AU Rajakulendran, S
   Pitceathly, RDS
   Taanman, JW
   Costello, H
   Sweeney, MG
   Woodward, CE
   Jaunmuktane, Z
   Holton, JL
   Jacques, TS
   Harding, BN
   Fratter, C
   Hanna, MG
   Rahman, S
AF Rajakulendran, Sanjeev
   Pitceathly, Robert D. S.
   Taanman, Jan-Willem
   Costello, Harry
   Sweeney, Mary G.
   Woodward, Cathy E.
   Jaunmuktane, Zane
   Holton, Janice L.
   Jacques, Thomas S.
   Harding, Brian N.
   Fratter, Carl
   Hanna, Michael G.
   Rahman, Shamima
TI A Clinical, Neuropathological and Genetic Study of Homozygous A467T <i>POLG</i>-Related Mitochondrial Disease
SO PLOS ONE
LA English
DT Article
ID dna-polymerase-gamma; progressive external ophthalmoplegia; mutations; phenotype; spectrum; features; encephalomyopathy; dominant; epilepsy; myopathy
AB Mutations in the nuclear gene POLG (encoding the catalytic subunit of DNA polymerase gamma) are an important cause of mitochondrial disease. The most common POLG mutation, A467T, appears to exhibit considerable phenotypic heterogeneity. The mechanism by which this single genetic defect results in such clinical diversity remains unclear. In this study we evaluate the clinical, neuropathological and mitochondrial genetic features of four unrelated patients with homozygous A467T mutations. One patient presented with the severe and lethal Alpers-Huttenlocher syndrome, which was confirmed on neuropathology, and was found to have a depletion of mitochondrial DNA (mtDNA). Of the remaining three patients, one presented with mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS), one with a phenotype in the Myoclonic Epilepsy, Myopathy and Sensory Ataxia (MEMSA) spectrum and one with Sensory Ataxic Neuropathy, Dysarthria and Ophthalmoplegia (SANDO). All three had secondary accumulation of multiple mtDNA deletions. Complete sequence analysis of muscle mtDNA using the MitoChip resequencing chip in all four cases demonstrated significant variation in mtDNA, including a pathogenic MT-ND5 mutation in one patient. These data highlight the variable and overlapping clinical and neuropathological phenotypes and downstream molecular defects caused by the A467T mutation, which may result from factors such as the mtDNA genetic background, nuclear genetic modifiers and environmental stressors.
C1 [Rajakulendran, Sanjeev; Pitceathly, Robert D. S.; Hanna, Michael G.] UCL Inst Neurol, London WC1N 3BG, England.
   [Rajakulendran, Sanjeev; Pitceathly, Robert D. S.; Hanna, Michael G.] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England.
   [Rajakulendran, Sanjeev; Hanna, Michael G.] MRC Ctr Neuromuscular Dis, London WC1N 3BG, England.
   [Pitceathly, Robert D. S.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Basic & Clin Neuroscince, London SE5 8AF, England.
   [Taanman, Jan-Willem] UCL Inst Neurol, Dept Clin Neurosci, London NW3 2PF, England.
   [Costello, Harry; Rahman, Shamima] UCL Inst Child Hlth, Mitochondrial Res Grp, Genet & Genom Med, London WC1N 1EH, England.
   [Sweeney, Mary G.; Woodward, Cathy E.] UCL Inst Neurol, Dept Neurogenet, London WC1N 3BG, England.
   [Sweeney, Mary G.; Woodward, Cathy E.; Jaunmuktane, Zane; Holton, Janice L.] Natl Hosp Neurol, London WC1N 3BG, England.
   [Jaunmuktane, Zane; Holton, Janice L.] UCL Inst Neurol, Div Neuropathol, London WC1N 3BG, England.
   [Jacques, Thomas S.] UCL Inst Child Hlth, Dev Biol & Canc Programme, London WC1N 1EH, England.
   [Jacques, Thomas S.] Great Ormond St Hosp Children Fdn Trust, Dept Histopathol, London WC1N 1EH, England.
   [Harding, Brian N.] Childrens Hosp Philadelphia, Div Neuropathol, Philadelphia, PA 19104 USA.
   [Fratter, Carl] Churchill Hosp, Oxford Univ Hosp NHS Trust, Oxford Med Genet Labs, Oxford OX3 7LE, England.
   [Rahman, Shamima] Great Ormond St Hosp Sick Children, Metab Unit, London WC1N 3JH, England.
C3 University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; King's College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust
RP Rahman, S (corresponding author), UCL Inst Child Hlth, Mitochondrial Res Grp, Genet & Genom Med, London WC1N 1EH, England.
EM shamima.rahman@ucl.ac.uk
FU Wellcome Trust Clinical Research Training Fellowship; Myositis UK; National Institute for Health Research Biomedical Research Centres at Great Ormond Street Hospital; University College London Hospitals, an MRC Centre for Neuromuscular Diseases grant [G0601943]; UK NHS Specialised Service for Rare Mitochondrial Diseases of Adults and Children; MRC [MR/K000608/1, G0200335, G0601943] Funding Source: UKRI
CR Blok MJ, 2009, J MED GENET, V46, P776, DOI 10.1136/jmg.2009.067686
   Blümcke I, 2013, EPILEPSIA, V54, P1315, DOI 10.1111/epi.12220
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Engelsen BA, 2008, BRAIN, V131, P818, DOI 10.1093/brain/awn007
   Euro L, 2011, NUCLEIC ACIDS RES, V39, P9072, DOI 10.1093/nar/gkr618
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Hargreaves IP, 2002, J INHERIT METAB DIS, V25, P673, DOI 10.1023/A:1022881231253
   Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   McHugh JC, 2010, MUSCLE NERVE, V41, P265, DOI 10.1002/mus.21494
   McKenzie M, 2007, J BIOL CHEM, V282, P36845, DOI 10.1074/jbc.M704158200
   Neeve VCM, 2012, BRAIN, V135, P3614, DOI 10.1093/brain/aws298
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076
   Pitceathly RDS, 2013, J NEUROL NEUROSUR PS, V84, P107, DOI 10.1136/jnnp-2012-303232
   Rahman S, 2012, BMJ OPEN, V2, P0, DOI 10.1136/bmjopen-2011-000411
   Rovio AT, 2001, NAT GENET, V29, P261, DOI 10.1038/ng759
   Schulte C, 2009, NEUROLOGY, V73, P898, DOI 10.1212/WNL.0b013e3181b78488
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Stumpf JD, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a011395
   Tang S, 2012, J NEUROL, V259, P862, DOI 10.1007/s00415-011-6268-6
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, NEUROLOGY, V61, P1811, DOI 10.1212/01.WNL.0000098997.23471.65
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Xie HBM, 2011, BMC BIOINFORMATICS, V12, P0, DOI 10.1186/1471-2105-12-402
   Zhadanov SI, 2005, BIOCHEM BIOPH RES CO, V332, P1115, DOI 10.1016/j.bbrc.2005.05.059
NR 32
TC 33
Z9 34
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
EI 
J9 PLOS ONE
JI PLoS One
PD JAN 6
PY 2016
VL 11
IS 1
BP 
EP 
DI 10.1371/journal.pone.0145500
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DA4XE
UT WOS:000367805100027
PM 26735972
DA 2024-11-01
ER

PT J
AU Filosto, M
   Lanzi, G
   Nesti, C
   Vielmi, V
   Marchina, E
   Galvagni, A
   Giliani, S
   Santorelli, FM
   Padovani, A
AF Filosto, Massimiliano
   Lanzi, Gaetana
   Nesti, Claudia
   Vielmi, Valentina
   Marchina, Eleonora
   Galvagni, Anna
   Giliani, Silvia
   Santorelli, Filippo M.
   Padovani, Alessandro
TI A novel mitochondrial tRNA<SUP>Ala</SUP> gene variant causes chronic progressive external ophthalmoplegia in a patient with Huntington disease
SO MOLECULAR GENETICS AND METABOLISM REPORTS
LA English
DT Article
DE Mitochondrial diseases; CPEO; Huntington disease; mtDNA; tRNA
ID defective axonal-transport; synaptic degeneration; mutant huntingtin; mutation; dna; dynamics; myopathy
AB Chronic progressive external ophthalmoplegia is a mitochondrial disorder usually caused by single or multiple mitochondrial DNA (mtDNA) deletions and, more rarely, by maternally inherited mtDNA point mutations, most frequently in tRNA genes (MTT). We report on a patient presenting with a progressive eyelid ptosis with bilateral ophthalmoparesis, dysphagia, dysphonia and mild proximal limb weakness associate with a mild movement disorder characterized by abnormal involuntary movements involving head and limbs, imbalance and gait instability. Muscle biopsy demonstrated the presence of ragged red fibers and several cytochrome-C-oxidase negative fibers. Molecular analysis showed the novel m.5613T > C heteroplasmic mutation in the mitochondrial tRNA(Ala) gene (MTTA) which disrupts a conserved site and fulfills the accepted criteria of pathogenicity. Moreover, a 38 CAG trinucleotide repeat expansion was found on the huntingtin gene, thus configuring a singular CPEO/"reduced penetrance" Huntington disease "double trouble". With this novel MTTA point mutation, we extend the spectrum of provisional pathogenic changes in this gene, which is a very rare site of pathogenic mutation, and confirm that clinical expression of these mutations is hardly ever heterogeneous, including myopathy and CPEO. Mitochondrial involvement is an emerging key determinant in the pathogenesis of Huntington disease and it is well known that mutant huntingtin influences the mitochondrial respiratory complexes II and III. A synergist effect of the HTT and MTTA mutations on respiratory chain function may be hypothesized in our patient and should be regarded as a spur for further studies on the mtDNA/HTT reciprocal interactions. (C) 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
C1 [Filosto, Massimiliano; Vielmi, Valentina; Galvagni, Anna; Padovani, Alessandro] Univ Hosp Spedali Civili, Sect Neuromuscular Dis & Neuropathies, Neurol Clin, Brescia, Italy.
   [Lanzi, Gaetana; Giliani, Silvia] Univ Hosp Spedali Civili, Inst Mol Med A Nocivelli, Brescia, Italy.
   [Nesti, Claudia; Santorelli, Filippo M.] IRCCS Stella Maris, Mol Med Unit, Pisa, Italy.
   [Marchina, Eleonora] Univ Brescia, Dept Biomed Sci & Biotechnol, Div Biol & Genet, I-25121 Brescia, Italy.
C3 Hospital Spedali Civili Brescia; Hospital Spedali Civili Brescia; IRCCS Fondazione Stella Maris; University of Brescia
RP Filosto, M (corresponding author), Univ Hosp Spedali Civili, Neurol Clin, Pzle Spedali Civili 1, I-25100 Brescia, Italy.
EM massimiliano.filosto@unibs.it
CR Acevedo-Torres K, 2009, DNA REPAIR, V8, P126, DOI 10.1016/j.dnarep.2008.09.004
   ANDREU AL, 2002, METHODS MOL BIOL NEU, V217, P185
   Bancroft JD, 1984, MANUAL HISTOLOGICAL, V0, P0
   Chinnery PF, 1997, NEUROLOGY, V49, P1166, DOI 10.1212/WNL.49.4.1166
   Correia SC, 2012, ADV EXP MED BIOL, V724, P205, DOI 10.1007/978-1-4614-0653-2_16
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   Ha AD, 2012, CURR OPIN NEUROL, V25, P491, DOI 10.1097/WCO.0b013e3283550c97
   Han DY, 2007, BIOCHEM BIOPH RES CO, V357, P554, DOI 10.1016/j.bbrc.2007.03.199
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kosinski CM, 2007, MOVEMENT DISORD, V22, P1637, DOI 10.1002/mds.21550
   Lehmann D, 2015, EUR J HUM GENET, V23, P1735, DOI 10.1038/ejhg.2015.73
   Li XM, 2004, NUCLEIC ACIDS RES, V32, P867, DOI 10.1093/nar/gkh226
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E
   Mancuso Michelangelo, 2008, HUMAN GENOMICS, V3, P71
   McFarland R, 2008, NEUROMUSCULAR DISORD, V18, P63, DOI 10.1016/j.nmd.2007.07.007
   Pinós T, 2011, MITOCHONDRION, V11, P228, DOI 10.1016/j.mito.2010.08.008
   Reddy PH, 2012, BBA-MOL BASIS DIS, V1822, P101, DOI 10.1016/j.bbadis.2011.10.016
   Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0
   Shirendeb U, 2011, HUM MOL GENET, V20, P1438, DOI 10.1093/hmg/ddr024
   Shirendeb UP, 2012, HUM MOL GENET, V21, P406, DOI 10.1093/hmg/ddr475
   Spagnolo M, 2001, NEUROMUSCULAR DISORD, V11, P481, DOI 10.1016/S0960-8966(01)00195-X
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058
   Swalwell H, 2006, NEUROLOGY, V66, P447, DOI 10.1212/01.wnl.0000196490.36349.83
   Tang XW, 2010, MOL GENET METAB, V100, P57, DOI 10.1016/j.ymgme.2010.01.008
   Turner C, 2007, MOVEMENT DISORD, V22, P1715, DOI 10.1002/mds.21540
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   Zielonka D, 2014, FRONT PHYSIOL, V5, P0, DOI 10.3389/fphys.2014.00380
NR 32
TC 5
Z9 8
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 
EI 2214-4269
J9 MOL GENET METAB REP
JI Molec. Genet. Metab. Rep.
PD MAR 15
PY 2016
VL 6
IS 
BP 70
EP 73
DI 10.1016/j.ymgmr.2016.02.001
PG 4
WC Genetics & Heredity
SC Genetics & Heredity
GA DZ7CY
UT WOS:000386022900014
PM 27014581
DA 2024-11-01
ER

PT J
AU Konokhova, Y
   Spendiff, S
   Jagoe, RT
   Aare, S
   Kapchinsky, S
   MacMillan, NJ
   Rozakis, P
   Picard, M
   Aubertin-Leheudre, M
   Pion, CH
   Bourbeau, J
   Hepple, RT
   Taivassalo, T
AF Konokhova, Yana
   Spendiff, Sally
   Jagoe, R. Thomas
   Aare, Sudhakar
   Kapchinsky, Sophia
   MacMillan, Norah J.
   Rozakis, Paul
   Picard, Martin
   Aubertin-Leheudre, Mylene
   Pion, Charlotte H.
   Bourbeau, Jean
   Hepple, Russell T.
   Taivassalo, Tanja
TI Failed upregulation of TFAM protein and mitochondrial DNA in oxidatively deficient fibers of chronic obstructive pulmonary disease locomotor muscle
SO SKELETAL MUSCLE
LA English
DT Article
DE Chronic obstructive pulmonary disease; Mitochondrial biogenesis; Mitochondrial DNA; mtDNA copy number; Muscle oxidative impairment; Oxidative stress; COX deficiency; TFAM; Laser capture microscopy
ID vastus lateralis muscle; maximal oxygen-uptake; skeletal-muscle; peripheral muscle; physical-activity; succinate-dehydrogenase; oxidase activity; wild-type; quadriceps; copd
AB Background: Low mitochondrial content and oxidative capacity are well-established features of locomotor muscle dysfunction, a prevalent and debilitating systemic occurrence in patients with chronic obstructive pulmonary disease (COPD). Although the exact cause is not firmly established, physical inactivity and oxidative stress are among the proposed underlying mechanisms. Here, we assess the impact of COPD pathophysiology on mitochondrial DNA (mtDNA) integrity, biogenesis, and cellular oxidative capacity in locomotor muscle of COPD patients and healthy controls. We hypothesized that the high oxidative stress environment of COPD muscle would yield a higher presence of deletion-containing mtDNA and oxidative-deficient fibers and impaired capacity for mitochondrial biogenesis. Methods: Vastus lateralis biopsies were analyzed from 29 COPD patients and 19 healthy age-matched controls for the presence of mtDNA deletions, levels of oxidatively damaged DNA, mtDNA copy number, and regulators of mitochondrial biogenesis as well the proportion of oxidative-deficient fibers (detected histologically as cytochrome c oxidase-deficient, succinate dehydrogenase positive (COX-/SDH+)). Additionally, mtDNA copy number and mitochondrial transcription factor A (TFAM) content were measured in laser captured COX-SDH+ and normal single fibers of both COPD and controls. Results: Compared to controls, COPD muscle exhibited significantly higher levels of oxidatively damaged DNA (8-hydroxy-2-deoxyguanosine (8-OHdG) levels = 387 +/- 41 vs. 258 +/- 21 pg/mL) and higher prevalence of mtDNA deletions (74 vs. 15 % of subjects in each group), which was accompanied by a higher abundance of oxidative-deficient fibers (8.0 +/- 2.1 vs. 1.5 +/- 0.4 %). Interestingly, COPD patients with mtDNA deletions had higher levels of 8-OHdG (457 +/- 46 pg/mL) and longer smoking history (66.3 +/- 7.5 years) than patients without deletions (197 +/- 29 pg/mL; 38.0 +/- 7.3 years). Transcript levels of regulators of mitochondrial biogenesis and oxidative metabolism were upregulated in COPD compared to controls. However, single fiber analyses of COX -/SDH+ and normal fibers exposed an impairment in mitochondrial biogenesis in COPD; in healthy controls, we detected a marked upregulation of mtDNA copy number and TFAM protein in COX-/SDH+ compared to normal fibers, reflecting the expected compensatory attempt by the oxidative-deficient cells to increase energy levels; in contrast, they were similar between COX-/SDH+ and normal fibers in COPD patients. Taken together, these findings suggest that although the signaling factors regulating mitochondrial biogenesis are increased in COPD muscle, impairment in the translation of these signals prevents the restoration of normal oxidative capacity. Conclusions: Single fiber analyses provide the first substantive evidence that low muscle oxidative capacity in COPD cannot be explained by physical inactivity alone and is likely driven by the disease pathophysiology.
C1 [Konokhova, Yana; Spendiff, Sally; Kapchinsky, Sophia; MacMillan, Norah J.; Rozakis, Paul; Hepple, Russell T.; Taivassalo, Tanja] McGill Univ, Dept Kinesiol, 475 Pine Ave West,Room 222, Montreal, PQ H2W 1S4, Canada.
   [Konokhova, Yana; Spendiff, Sally; Aare, Sudhakar; Hepple, Russell T.] McGill Univ, Ctr Hlth, Dept Crit Care Med, Montreal, PQ H2W 1S4, Canada.
   [Jagoe, R. Thomas] McGill Univ, Dept Oncol, Montreal, PQ H2W 1S4, Canada.
   [Jagoe, R. Thomas] McGill Univ, Dept Med, Montreal, PQ H2W 1S4, Canada.
   [Picard, Martin] Columbia Univ Coll Phys & Surg, Columbia Univ, Med Ctr, Div Behav Med,Dept Psychiat,Dept Neurol, 630 W 168th St, New York, NY 10032 USA.
   [Picard, Martin] Columbia Univ Coll Phys & Surg, Columbia Univ, Med Ctr, Columbia Translat Neurosci Initiat, 630 W 168th St, New York, NY 10032 USA.
   [Aubertin-Leheudre, Mylene; Pion, Charlotte H.] Univ Quebec, Dept Kinanthropol, Montreal, PQ H3C 3P8, Canada.
   [Bourbeau, Jean; Taivassalo, Tanja] McGill Univ, Ctr Hlth, Ctr Innovat Med CIM, Resp Epidemiol & Clin Res Unit, Montreal, PQ H2W 1S4, Canada.
   [Hepple, Russell T.] McGill Univ, Meakins Christie Labs, Montreal, PQ H2W 1S4, Canada.
C3 McGill University; McGill University; McGill University; McGill University; Columbia University; Columbia University; University of Quebec; University of Quebec Montreal; McGill University; McGill University
RP Taivassalo, T (corresponding author), McGill Univ, Dept Kinesiol, 475 Pine Ave West,Room 222, Montreal, PQ H2W 1S4, Canada.; Taivassalo, T (corresponding author), McGill Univ, Ctr Hlth, Ctr Innovat Med CIM, Resp Epidemiol & Clin Res Unit, Montreal, PQ H2W 1S4, Canada.
EM tanja.taivassalo@mcgill.ca
FU Canadian Institutes of Health Research Operating Grant [162111]; Natural Sciences and Engineering Research Council (NSERC) [303606]
CR Adhihetty PJ, 2007, AM J PHYSIOL-ENDOC M, V293, PE672, DOI 10.1152/ajpendo.00043.2007
   Allaire J, 2004, THORAX, V59, P673, DOI 10.1136/thx.2003.020636
   Apabhai S, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0022294
   ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211
   Barreiro E, 2003, AM J RESP CELL MOL, V29, P771, DOI 10.1165/rcmb.2003-0138OC
   Barreiro E, 2014, MASS SPECTROM REV, V33, P219, DOI 10.1002/mas.21394
   Barreiro E, 2010, AM J RESP CRIT CARE, V182, P477, DOI 10.1164/rccm.200908-1220OC
   BLACKIE SP, 1989, AM REV RESPIR DIS, V139, P1424, DOI 10.1164/ajrccm/139.6.1424
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Campbell GR, 2013, NEUROPATH APPL NEURO, V39, P377, DOI 10.1111/j.1365-2990.2012.01290.x
   Couillard A, 2005, EUR RESPIR J, V26, P703, DOI 10.1183/09031936.05.00139904
   Couillard A, 2003, AM J RESP CRIT CARE, V167, P1664, DOI 10.1164/rccm.200209-1028OC
   Debigare R, 2008, J APPL PHYSL BETHESD, V105, P5, DOI 10.1152/ japplphysiol. 90336.2008a
   Debigaré R, 2008, J APPL PHYSIOL, V105, P751, DOI 10.1152/japplphysiol.90336.2008a
   DIZDAROGLU M, 1986, ANAL BIOCHEM, V156, P182, DOI 10.1016/0003-2697(86)90171-5
   Fermoselle C, 2012, EUR RESPIR J, V40, P851, DOI 10.1183/09031936.00137211
   FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533
   Gosker HR, 2007, EUR RESPIR J, V30, P73, DOI 10.1183/09031936.00146906
   Gosker HR, 2003, EUR RESPIR J, V22, P280, DOI 10.1183/09031936.03.00012803
   Gosker HR, 2002, EUR RESPIR J, V19, P617, DOI 10.1183/09031936.02.00762001
   Gouzi F, 2013, J APPL PHYSIOL, V115, P346, DOI 10.1152/japplphysiol.01352.2012
   Greaves LC, 2010, INVEST OPHTH VIS SCI, V51, P3340, DOI 10.1167/iovs.09-4659
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   HENRIKSSON J, 1977, ACTA PHYSIOL SCAND, V99, P91, DOI 10.1111/j.1748-1716.1977.tb10356.x
   Hood DA, 2011, COMPR PHYSIOL, V1, P1119, DOI 10.1002/cphy.c100074
   Karamanlidis G, 2010, CIRC RES, V106, P1541, DOI 10.1161/CIRCRESAHA.109.212753
   KASAI H, 1984, NUCLEIC ACIDS RES, V12, P2137, DOI 10.1093/nar/12.4.2137
   Larsen RG, 2012, APPL PHYSIOL NUTR ME, V37, P88, DOI 10.1139/h11-135
   LARSSON NG, 1994, BIOCHEM BIOPH RES CO, V200, P1374, DOI 10.1006/bbrc.1994.1603
   Lezza Angela M S, 2012, FRONTIERS IN BIOLOGY 生物学前沿, V7, P30
   LOFT S, 1992, CARCINOGENESIS, V13, P2241, DOI 10.1093/carcin/13.12.2241
   Maltais F, 2000, THORAX, V55, P848, DOI 10.1136/thorax.55.10.848
   Maltais Francois, 2014, AM J RESPIR CRIT CARE MED, V189, Pe15, DOI 10.1164/rccm.201402-0373ST
   Marquis K, 2002, AM J RESP CRIT CARE, V166, P809, DOI 10.1164/rccm.2107031
   Meyer A, 2013, EXP PHYSIOL, V98, P1063, DOI 10.1113/expphysiol.2012.069468
   MITA S, 1989, P NATL ACAD SCI USA, V86, P9509, DOI 10.1073/pnas.86.23.9509
   Murphy JL, 2012, NEUROMUSCULAR DISORD, V22, P690, DOI 10.1016/j.nmd.2012.04.003
   Natanek SA, 2013, EUR RESPIR J, V41, P1275, DOI 10.1183/09031936.00098412
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Picard M, 2008, AM J RESP CRIT CARE, V178, P1040, DOI 10.1164/rccm.200807-1005OC
   Picca A, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0074644
   Pitta F, 2005, ARCH PHYS MED REHAB, V86, P1979, DOI 10.1016/j.apmr.2005.04.016
   Puente-Maestu L, 2009, EUR RESPIR J, V33, P1045, DOI 10.1183/09031936.00112408
   Puente-Maestu L, 2011, THORAX, V66, P121, DOI 10.1136/thx.2010.153031
   Quinlivan EP, 2008, ANAL BIOCHEM, V373, P383, DOI 10.1016/j.ab.2007.09.031
   Rabe Klaus F, 2006, PROC AM THORAC SOC, V3, P641, DOI 10.1513/pats.200604-099SS
   Remels AH, 2007, EUR RESPIR J, V30, P245, DOI 10.1183/09031936.00144106
   Rocha MC, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep15037
   Rygiel KA, 2015, NEUROPATH APPL NEURO, V41, P288, DOI 10.1111/nan.12149
   Sciacco M, 1996, METHODS ENZYMOL, V264, P509, DOI 10.1016/S0076-6879(96)64045-2
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   Shanely RA, 2014, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/51812
   Slot IGM, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0090150
   Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050
   Taivassalo T, 2003, BRAIN, V126, P413, DOI 10.1093/brain/awg028
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   van den Borst B, 2013, J APPL PHYSIOL, V114, P1319, DOI 10.1152/japplphysiol.00508.2012
   Wagner PD, 2006, RESPIROLOGY, V11, P681, DOI 10.1111/j.1440-1843.2006.00939.x
   Watz H, 2009, EUR RESPIR J, V33, P262, DOI 10.1183/09031936.00024608
   Yana K, 2013, COPD SKELETAL MUSCLE, V0, P0
   Yana KS, 2014, J FRALITY AGING, V3, P67
   Yu-Wai-Man P, 2010, HUM MOL GENET, V19, P3043, DOI 10.1093/hmg/ddq209
NR 63
TC 36
Z9 41
U1 0
U2 11
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2044-5040
EI 
J9 SKELET MUSCLE
JI Skeletal Muscle
PD FEB 18
PY 2016
VL 6
IS 
BP 
EP 
DI 10.1186/s13395-016-0083-9
PG 16
WC Cell Biology
SC Cell Biology
GA DE1UC
UT WOS:000370411000001
PM 26893822
DA 2024-11-01
ER

PT J
AU Morel, G
   Bannwarth, S
   Chaussenot, A
   Cano, A
   Fragaki, K
   Ait-El-Mkadem, S
   Rouzier, C
   De Paula, AM
   Chabrol, B
   Paquis-Flucklinger, V
AF Morel, Godelieve
   Bannwarth, Sylvie
   Chaussenot, Annabelle
   Cano, Aline
   Fragaki, Konstantina
   Ait-El-Mkadem, Samira
   Rouzier, Cecile
   De Paula, Andre Maues
   Chabrol, Brigitte
   Paquis-Flucklinger, Veronique
TI A new mutation in the mitochondrial tRNA<SUP>Pro</SUP> gene associated with early-onset neuromuscular phenotype and ragged-red fibers
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Mitochondrial myopathy; mtDNA; MTTP gene; Neuromuscular disease; New mutation; NGS
ID transfer-rnas; dna
AB An 11-year-old boy with psychomotor delay, exercise intolerance, ptosis and growth delay had a muscle biopsy showing typical mitochondrial alterations (60% of ragged-red fibers and 90% of cytochrome-c oxidase-deficient fibers). Next-generation sequencing revealed a novel heteroplasmic mutation (m.15958A>T) in the MTTP gene that encodes tRNA(Pro). The mutation was not present in the accessible non-muscle tissues of the patient's asymptomatic mother. Mutations in the rarely affected MTTP gene are responsible for different clinical presentations. We report the third early-onset case associated with a mutation in this gene. The severity of myopathy is likely related to the high mutation rate (96%) found in the patient's muscle. The clinical heterogeneity associated with MTTP mutations illustrates the value of the next-generation sequencing in routine diagnosis of mitochondrial diseases. (C) 2016 Published by Elsevier B.V.
C1 [Morel, Godelieve; Bannwarth, Sylvie; Chaussenot, Annabelle; Fragaki, Konstantina; Ait-El-Mkadem, Samira; Rouzier, Cecile; Paquis-Flucklinger, Veronique] Nice Teaching Hosp, Dept Med Genet, Natl Ctr Mitochondrial Dis, Nice, France.
   [Bannwarth, Sylvie; Chaussenot, Annabelle; Fragaki, Konstantina; Ait-El-Mkadem, Samira; Rouzier, Cecile; Paquis-Flucklinger, Veronique] Univ Nice Sophia Antipolis, CNRS, IRCAN, INSERM,UMR 7284, F-06107 Nice, France.
   [Bannwarth, Sylvie; Chaussenot, Annabelle; Fragaki, Konstantina; Ait-El-Mkadem, Samira; Rouzier, Cecile; Paquis-Flucklinger, Veronique] Univ Nice Sophia Antipolis, U1081, F-06107 Nice, France.
   [Cano, Aline; Chabrol, Brigitte] Marseille Teaching Hosp, Timone Hosp, Dept Neuropediat, Marseille, France.
   [De Paula, Andre Maues] Marseille Teaching Hosp, Timone Hosp, Dept Neuropathol, Marseille, France.
C3 CHU Nice; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Nice; Universite Cote d'Azur; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille
RP Paquis-Flucklinger, V (corresponding author), Univ Nice Sophia Antipolis, Sch Med, IRCAN, UMR 7284,INSERM,CNRS,U1081,UNS, 28 Ave Valombrose, F-06107 Nice 2, France.
EM paquis@hermes.unice.fr
CR Blakely EL, 2009, ARCH NEUROL-CHICAGO, V66, P399, DOI 10.1001/archneurol.2008.576
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Da Pozzo P, 2009, EUR J HUM GENET, V17, P1092, DOI 10.1038/ejhg.2009.12
   Grasbon-Frodl EM, 1999, NEUROGENETICS, V2, P121, DOI 10.1007/s100480050063
   IONASESCU VV, 1994, NEUROLOGY, V44, P975, DOI 10.1212/WNL.44.5.975
   MORAES CT, 1993, NAT GENET, V4, P284, DOI 10.1038/ng0793-284
   Paul R, 1996, TRENDS GENET, V12, P131
   Rouzier C, 2010, J MED GENET, V47, P670, DOI 10.1136/jmg.2009.073445
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Scaglia F, 2008, MUSCLE NERVE, V37, P150, DOI 10.1002/mus.20917
   Seneca S, 2000, J INHERIT METAB DIS, V23, P853, DOI 10.1023/A:1026729223050
   Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531
   Wong LJC, 2002, AM J MED GENET, V113, P59, DOI 10.1002/ajmg.10767
NR 13
TC 5
Z9 5
U1 0
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD DEC 15
PY 2016
VL 26
IS 12
BP 885
EP 889
DI 10.1016/j.nmd.2016.09.012
PG 5
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA EG5HD
UT WOS:000391074000011
PM 27816331
DA 2024-11-01
ER

PT J
AU Nascimento, A
   Ortez, C
   Jou, C
   O'Callaghan, M
   Ramos, F
   Garcia-Cazorla, A
AF Nascimento, Andres
   Ortez, Carlos
   Jou, Cristina
   O'Callaghan, Mar
   Ramos, Federico
   Garcia-Cazorla, Angels
TI Neuromuscular Manifestations in Mitochondria! Diseases in Children
SO SEMINARS IN PEDIATRIC NEUROLOGY
LA English
DT Review
ID marie-tooth-disease; progressive external ophthalmoplegia; multiple mtdna deletions; dna-polymerase-gamma; neurogastrointestinal encephalomyopathy mngie; cerebral folate-deficiency; transfer rnaleu(uur) gene; mitofusin 2 mutations; complex i deficiency; c-oxidase deficiency
AB Mitochondrial diseases exhibit significant clinical and genetic heterogeneity. Mitochondria are highly dynamic organelles that are the major contributor of adenosine triphosphate, through oxidative phosphorylation. These disorders may be developed at any age, with isolated or multiple system involvement, and in any pattern of inheritance. Defects in the mitochondria! respiratory chain impair energy production and almost invariably involve skeletal muscle and peripheral nerves, causing exercise intolerance, cramps, recurrent myoglobinuria, or fixed weakness, which often affects extraocular muscles and results in droopy eyelids (ptosis), progressive external ophthalmoplegia, peripheral ataxia, and peripheral polyneuropathy. This review describes the main neuromuscular symptomatology through different syndromes reported in the literature and from our experience. We want to highlight the importance of searching for the "clue clinical signs" associated with inheritance pattern as key elements to guide the complex diagnosis process and genetic studies in mitochondrial diseases. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Nascimento, Andres; Ortez, Carlos; Jou, Cristina] Inst Salud Carlos III, Hosp Sant Joan de Deu, Dept Neurol, Neuromuscular Units, Barcelona, Spain.
   [Nascimento, Andres; Jou, Cristina; O'Callaghan, Mar; Ramos, Federico; Garcia-Cazorla, Angels] Inst Pediat Res Sant Joan de Deu, Ctr Biomed Res Rare Dis CIBERER, Madrid, Spain.
   [O'Callaghan, Mar; Ramos, Federico; Garcia-Cazorla, Angels] Inst Salud Carlos III, Hosp Sant Joan de Deu, Dept Neurol, Neurometab Units, Barcelona, Spain.
C3 Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III
RP Nascimento, A (corresponding author), Univ Barcelona, Dept Neurol, Hosp Sant Joan de Deu, Passeig Sant Joan de Deu 2, Barcelona 08950, Spain.
EM anascimento@hsjdbcn.org
CR Ackerley S, 2006, HUM MOL GENET, V15, P347, DOI 10.1093/hmg/ddi452
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Antonelli FM, 1993, ANN NEUROL, V34, P827
   APPENZELLER O, 1976, ARCH NEUROL-CHICAGO, V33, P733, DOI 10.1001/archneur.1976.00500110001001
   Auré K, 2004, NEUROLOGY, V63, P727, DOI 10.1212/01.WNL.0000134607.76780.B2
   Baloh RH, 2007, J NEUROSCI, V27, P422, DOI 10.1523/JNEUROSCI.4798-06.2007
   Bannwarth S, 2013, J MED GENET, V50, P704, DOI 10.1136/jmedgenet-2013-101604
   Barca E, 2015, CURR NEUROL NEUROSCI, V15, P0, DOI 10.1007/s11910-015-0590-9
   Béhin A, 2012, NEUROLOGY, V78, P644, DOI 10.1212/WNL.0b013e318248df2b
   Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Buchaklian AH, 2012, MOL GENET METAB, V107, P92, DOI 10.1016/j.ymgme.2012.04.019
   Cámara Y, 2015, NEUROLOGY, V84, P2286, DOI 10.1212/WNL.0000000000001644
   Cámara Y, 2014, HUM MOL GENET, V23, P2459, DOI 10.1093/hmg/ddt641
   Cartoni R, 2010, BRAIN, V133, P1460, DOI 10.1093/brain/awq082
   Casas KA, 2004, AM J MED GENET A, V125A, P201, DOI 10.1002/ajmg.a.20368
   Cassereau J, 2014, REV NEUROL-FRANCE, V170, P366, DOI 10.1016/j.neurol.2013.11.005
   Cassereau J, 2011, EXP NEUROL, V227, P31, DOI 10.1016/j.expneurol.2010.09.006
   Cassereau J, 2009, NEUROGENETICS, V10, P145, DOI 10.1007/s10048-008-0166-9
   Caviston JP, 2006, TRENDS CELL BIOL, V16, P530, DOI 10.1016/j.tcb.2006.08.002
   Chalmers RM, 1996, J NEUROL SCI, V143, P41, DOI 10.1016/S0022-510X(96)00032-9
   Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638
   Chaussenot A, 2014, REV NEUROL-FRANCE, V170, P323, DOI 10.1016/j.neurol.2014.03.007
   Chen XJ, 2007, J NEUROSCI, V27, P14515, DOI 10.1523/JNEUROSCI.4338-07.2007
   Chung KW, 2006, BRAIN, V129, P2103, DOI 10.1093/brain/awl174
   Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101
   Courchesne Stephanie L, 2011, PLOS ONE, V6, Pe16753, DOI 10.1371/journal.pone.0016753
   Craig K, 2012, MITOCHONDRION, V12, P313, DOI 10.1016/j.mito.2011.11.006
   dYdewalle C, 2011, NAT MED, V17, P968, DOI 10.1038/nm.2396
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534
   Deschauer M, 2005, NEUROMUSCULAR DISORD, V15, P311, DOI 10.1016/j.nmd.2004.12.004
   Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275
   Di Fonzo A, 2003, HUM MUTAT, V22, P0, DOI 10.1002/humu.9203
   Di Fonzo A, 2009, AM J HUM GENET, V84, P594, DOI 10.1016/j.ajhg.2009.04.004
   Diaz F, 2005, HUM MOL GENET, V14, P2737, DOI 10.1093/hmg/ddi307
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   DiMauro S, 2006, CURR OPIN RHEUMATOL, V18, P636, DOI 10.1097/01.bor.0000245729.17759.f2
   Echaniz-Laguna A, 2013, NEUROLOGY, V81, P1523, DOI 10.1212/WNL.0b013e3182a4a518
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Estela A, 2011, J BIOL CHEM, V286, P36777, DOI 10.1074/jbc.M111.260042
   Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354
   Fratter C, 2011, NEUROLOGY, V76, P2032, DOI 10.1212/WNL.0b013e31821e558b
   FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3
   Garone C, 2014, EMBO MOL MED, V6, P1016, DOI 10.15252/emmm.201404092
   Garone C, 2012, ARCH NEUROL-CHICAGO, V69, P1648, DOI 10.1001/archneurol.2012.405
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   Gelfand JM, 2011, J NEUROL, V258, P440, DOI 10.1007/s00415-010-5775-1
   Gerards M, 2011, BRAIN, V134, P210, DOI 10.1093/brain/awq273
   Giordano C, 2009, NEUROLOGY, V72, P1103, DOI 10.1212/01.wnl.0000345002.47396.e1
   Gómez-Zaera M, 2001, MOL GENET METAB, V72, P72, DOI 10.1006/mgme.2000.3107
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   Kalko SG, 2014, BMC GENOMICS, V15, P0, DOI 10.1186/1471-2164-15-91
   Guillet V, 2011, FASEB J, V25, P1618, DOI 10.1096/fj.10-173609
   Hays AP, 2006, MITOCHONDRIAL MEDICINE, V0, P45
   Hirano M, 2004, NEUROLOGIST, V10, P8, DOI 10.1097/01.nrl.0000106919.06469.04
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   Hirano M, 2006, MITOCHONDRIAL MEDICINE, V0, P27
   Hirokawa N, 2004, CURR OPIN NEUROBIOL, V14, P564, DOI 10.1016/j.conb.2004.08.011
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Holve S, 1999, J PEDIATR-US, V135, P482, DOI 10.1016/S0022-3476(99)70172-1
   Horváth R, 2005, NEUROMUSCULAR DISORD, V15, P851, DOI 10.1016/j.nmd.2005.09.005
   Horváth R, 2002, J MED GENET, V39, P812, DOI 10.1136/jmg.39.11.812
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Horvath R, 2009, BRAIN, V132, P3165, DOI 10.1093/brain/awp221
   Horvath R, 2009, J NEUROL, V256, P810, DOI 10.1007/s00415-009-5023-8
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Hudson G, 2006, HUM MOL GENET, V15, PR244, DOI 10.1093/hmg/ddl233
   Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078
   Irobi J, 2004, NAT GENET, V36, P597, DOI 10.1038/ng1328
   Ishihara N, 2004, J CELL SCI, V117, P6535, DOI 10.1242/jcs.01565
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   Kärppä M, 2005, BRAIN, V128, P1861, DOI 10.1093/brain/awh515
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kawamata H, 2011, HUM MOL GENET, V20, P2964, DOI 10.1093/hmg/ddr200
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Kennerson ML, 2013, HUM MOL GENET, V22, P1404, DOI 10.1093/hmg/dds557
   Kiferle L, 2013, NEUROSCI LETT, V556, P1, DOI 10.1016/j.neulet.2013.09.034
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   Kollberg G, 2005, J NEUROPATH EXP NEUR, V64, P123, DOI 10.1093/jnen/64.2.123
   Kollberg G, 2009, NEUROMUSCULAR DISORD, V19, P147, DOI 10.1016/j.nmd.2008.11.014
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Lalani SR, 2005, ARCH NEUROL-CHICAGO, V62, P317, DOI 10.1001/archneur.62.2.317
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Logan CV, 2014, NAT GENET, V46, P188, DOI 10.1038/ng.2851
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Mancuso M, 2003, ARCH NEUROL-CHICAGO, V60, P1007, DOI 10.1001/archneur.60.7.1007
   Maniura-Weber K, 2004, EUR J HUM GENET, V12, P509, DOI 10.1038/sj.ejhg.5201185
   Martí R, 2010, PEDIATR RES, V68, P151, DOI 10.1203/00006450-201011001-00294
   McFarland R, 2004, NEUROMUSCULAR DISORD, V14, P162, DOI 10.1016/j.nmd.2003.10.011
   McPherson E, 2006, AM J MED GENET A, V140A, P184, DOI 10.1002/ajmg.a.31041
   Misko A, 2010, J NEUROSCI, V30, P4232, DOI 10.1523/JNEUROSCI.6248-09.2010
   Mochel F, 2008, AM J HUM GENET, V82, P652, DOI 10.1016/j.ajhg.2007.12.012
   Montero R, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0148709
   Nicholson GA, 2008, NEUROLOGY, V70, P1678, DOI 10.1212/01.wnl.0000311275.89032.22
   Niemann A, 2005, J CELL BIOL, V170, P1067, DOI 10.1083/jcb.200507087
   Niemann A, 2009, NEUROBIOL DIS, V36, P509, DOI 10.1016/j.nbd.2009.09.011
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Noack R, 2012, HUM MOL GENET, V21, P150, DOI 10.1093/hmg/ddr450
   OGASAHARA S, 1989, P NATL ACAD SCI USA, V86, P2379, DOI 10.1073/pnas.86.7.2379
   Ogilvie I, 2005, J CLIN INVEST, V115, P2784, DOI 10.1172/JCI26020
   Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Pineda M, 2006, ANN NEUROL, V59, P394, DOI 10.1002/ana.20746
   Pitceathly RDS, 2014, CURR OPIN NEUROL, V27, P576, DOI 10.1097/WCO.0000000000000126
   Pitceathly RDS, 2013, J NEUROL NEUROSUR PS, V84, P107, DOI 10.1136/jnnp-2012-303232
   Pitceathly RDS, 2012, BRAIN, V135, P3392, DOI 10.1093/brain/aws231
   Pitceathly RDS, 2012, NEUROLOGY, V79, P1145, DOI 10.1212/WNL.0b013e3182698d8d
   Pitceathly RDS, 2011, J MED GENET, V48, P610, DOI 10.1136/jmg.2010.088328
   Polke JM, 2011, NEUROLOGY, V77, P168, DOI 10.1212/WNL.0b013e3182242d4d
   Pulkes T, 2005, NEUROMUSCULAR DISORD, V15, P364, DOI 10.1016/j.nmd.2005.01.006
   Pulkes T, 2005, NEUROLOGY, V64, P1091, DOI 10.1212/01.WNL.0000154471.33156.55
   Quijada-Fraile P, 2014, ORPHANET J RARE DIS, V9, P0, DOI 10.1186/s13023-014-0217-2
   Quinzii CM, 2008, BIOFACTORS, V32, P113, DOI 10.1002/biof.5520320113
   Riley LG, 2013, ORPHANET J RARE DIS, V8, P0, DOI 10.1186/1750-1172-8-193
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   Rinaldi C, 2012, AM J HUM GENET, V91, P1095, DOI 10.1016/j.ajhg.2012.10.008
   Rojo M, 2002, J CELL SCI, V115, P1663
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Ronchi D, 2012, BRAIN, V135, P3404, DOI 10.1093/brain/aws258
   Rouzier C, 2014, EUR J HUM GENET, V22, P542, DOI 10.1038/ejhg.2013.171
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   RUSANEN H, 1995, NEUROLOGY, V45, P1188, DOI 10.1212/WNL.45.6.1188
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Spiegel R, 2014, EUR J HUM GENET, V22, P902, DOI 10.1038/ejhg.2013.269
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Vallat JM, 2008, J NEUROPATH EXP NEUR, V67, P1097, DOI 10.1097/NEN.0b013e31818b6cbc
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Van Hove JLK, 2009, AM J MED GENET A, V149A, P861, DOI 10.1002/ajmg.a.32731
   Verhoeven K, 2006, BRAIN, V129, P2093, DOI 10.1093/brain/awl126
   Vilá MR, 2008, J NEUROL SCI, V267, P137, DOI 10.1016/j.jns.2007.10.019
   Vilà MR, 2003, NEUROLOGY, V60, P1203, DOI 10.1212/01.WNL.0000055928.58122.47
   Vucic S, 2003, NEUROLOGY, V60, P696, DOI 10.1212/01.WNL.0000048561.61921.71
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Walter MC, 2010, J NEUROL, V257, P1517, DOI 10.1007/s00415-010-5565-9
   Weedon MN, 2011, AM J HUM GENET, V89, P308, DOI 10.1016/j.ajhg.2011.07.002
   WILLIAMS LL, 1979, NEUROLOGY, V29, P1492, DOI 10.1212/WNL.29.11.1492
   Young MJ, 2011, HUM MOL GENET, V20, P3052, DOI 10.1093/hmg/ddr209
   Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
   Züchner S, 2006, ANN NEUROL, V59, P276, DOI 10.1002/ana.20797
NR 154
TC 6
Z9 6
U1 0
U2 3
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 1071-9091
EI 1558-0776
J9 SEMIN PEDIATR NEUROL
JI Semin. Pediatr. Neurol.
PD NOV 15
PY 2016
VL 23
IS 4
BP 290
EP 305
DI 10.1016/j.spen.2016.11.004
PG 16
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA EP7IL
UT WOS:000397551400005
PM 28284391
DA 2024-11-01
ER

PT J
AU Mayorga, L
   Laurito, SR
   Loos, MA
   Eiroa, HD
   de Pinho, S
   Lubieniecki, F
   Arroyo, HA
   Pereyra, MF
   Kauffman, MA
   Roqué, M
AF Mayorga, Lia
   Laurito, Sergio R.
   Loos, Mariana A.
   Eiroa, Hernan D.
   de Pinho, Silvina
   Lubieniecki, Fabiana
   Arroyo, Hugo A.
   Pereyra, Marcela F.
   Kauffman, Marcelo A.
   Roque, Maria
TI Mitochondrial DNA deletions detected by Multiplex Ligation-dependent Probe Amplification
SO MITOCHONDRIAL DNA PART A
LA English
DT Article
DE Chronic progressive external ophthalmoplegia; copy number changes; diagnosis; Kearns Sayre Syndrome; mitochondrial disease; NUMTs
ID quantification; disease
AB The genetic diagnosis algorithm for mitochondrial (mt) diseases starts looking for deletions and common mutations in mtDNA. MtDNA's special features, such as large and variable genome copies, heteroplasmy, polymorphisms, and its duplication in the nuclear genome as pseudogenes (NUMTs), make it vulnerable to diagnostic misleading interpretations. Multiplex Ligation-dependent Probe Amplification (MLPA) is used to detect copy number variations in nuclear genes and its application on mtDNA has not been widely spread. We report three Kearns Sayre Syndrome patients and one Chronic Progressive External Ophthalmoplegia adult, whose diagnostic mtDNA deletions were detected by MLPA using a very low amount of DNA. This managed to "dilute'' the NUMT interference as well as enhance MLPA's efficiency. By this report, we conclude that when MLPA is performed upon a reduced amount of DNA, it can detect effectively mtDNA deletions. We propose MLPA as a possible first step method in the diagnosis of mt diseases.
C1 [Mayorga, Lia; Laurito, Sergio R.; Roque, Maria] IHEM CCT CONICET, Mendoza, Argentina.
   [Mayorga, Lia; Laurito, Sergio R.; Roque, Maria] Natl Univ Cuyo, Mendoza, Argentina.
   [Loos, Mariana A.; Eiroa, Hernan D.; de Pinho, Silvina; Lubieniecki, Fabiana; Arroyo, Hugo A.] Garrahan Childrens Hosp, Buenos Aires, DF, Argentina.
   [Pereyra, Marcela F.] Notti Childrens Hosp, Mendoza, Argentina.
   [Kauffman, Marcelo A.] JM Ramos Meji Gen Hosp, Buenos Aires, DF, Argentina.
C3 Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza; Hospital de Pediatria Doctor Juan Garrahan; Hospital Ramos Mejia
RP Mayorga, L (corresponding author), IHEM CCT CONICET, Mendoza, Argentina.; Mayorga, L (corresponding author), Natl Univ Cuyo, Mendoza, Argentina.
EM liamayorga@fcm.uncu.edu.ar
CR Chi CS, 2015, PEDIATR NEONATOL, V56, P7, DOI 10.1016/j.pedneo.2014.03.009
   Cui H, 2013, GENET MED, V15, P388, DOI 10.1038/gim.2012.144
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   Kwon MJ, 2011, ANN CLIN LAB SCI, V41, P385
   Malik AN, 2011, BIOCHEM BIOPH RES CO, V412, P1, DOI 10.1016/j.bbrc.2011.06.067
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Schouten JP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf056
   Tonska K, 2012, GENE, V506, P161, DOI 10.1016/j.gene.2012.06.081
   ZEVIANI M, 1990, ANN NEUROL, V28, P94, DOI 10.1002/ana.410280118
NR 9
TC 7
Z9 8
U1 0
U2 4
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2470-1394
EI 2470-1408
J9 MITOCHONDRIAL DNA A
JI Mitochondrial DNA Part A
PD JUN 15
PY 2016
VL 27
IS 4
BP 2864
EP 2867
DI 10.3109/19401736.2015.1053132
PG 4
WC Genetics & Heredity
SC Genetics & Heredity
GA DO7IQ
UT WOS:000377956300212
PM 26114318
DA 2024-11-01
ER

PT J
AU Baykara, O
   Sahin, SK
   Akbas, F
   Guven, M
   Onaran, I
AF Baykara, O.
   Sahin, S. K.
   Akbas, F.
   Guven, M.
   Onaran, I.
TI The effects of mitochondrial DNA deletion and copy number variations on different exercise intensities in highly trained swimmers
SO CELLULAR AND MOLECULAR BIOLOGY
LA English
DT Article
DE mtDNA4977 deletion; oxidative stress; mtDNA content
ID 4977 bp deletion; blood oxidative stress; antioxidant status; common deletion; human-disease; cells; mutations; muscle; lymphocytes; metabolism
AB It has been suggested that heavy exercise might increase oxidative stress, causing mitochondrial DNA (mtDNA) mutations as well as DNA mutations and changes in the mtDNA copy number in cells. mtDNA(4977) deletion is one of the most common deletions seen on mitochondria. We hypothesize association between exercise induced oxidative stress and mtDNA damage in peripheral blood lymphocytes (PBLs) of highly trained swimmers. Therefore we studied the mtDNA(4977) deletion level, mtDNA copy number and their relationship with cellular ATP and oxidative stress status in PBLs of swimmers. 8 highly trained and 8 normal trained swimmers and 8 non-athlete subjects were included in the study. The mtDNA(4977) deletion and amount of mtDNA were measured using RT-PCR method whereas dichlorohydrofluoroscein (DCF) assay method was used to assess cellular oxidative stress and ATP levels were measured using bioluminescence method. Even though an increase in mtDNA(4977) deletion was found in all study groups, the difference was not statistically significant (p=0.98). The mtDNA copy numbers were found to be surprisingly high in highly trained swimmers compared to normal trained swimmers and non-athlete subjects by 4.03 fold (p= 0.0002) and 5.58 fold (p= 0.0003), respectively. No significant differences were found between groups by means of intracellular ATP levels (p= 0.406) and oxidative stress (p= 0.430). No correlation was found between mtDNA copy number and intracellular ATP content of the PBLs (p= 0.703). Our results suggest that heavy training does not have a specific effect on mtDNA(4977) deletion but it may be affecting mitochondrial copy numbers which may act as a compensatory mechanism related to ATP levels in blood.
C1 [Baykara, O.; Guven, M.; Onaran, I.] Istanbul Univ, Cerrahpasa Med Fac, Dept Med Biol, Istanbul, Turkey.
   [Sahin, S. K.] Uludag Univ, Fac Educ, Dept Phys Educ, Bursa, Turkey.
   [Akbas, F.] Bezmialem Vakif Univ, Fac Med, Dept Med Biol, Istanbul, Turkey.
C3 Istanbul University - Cerrahpasa; Istanbul University; Uludag University; Bezmialem Vakif University
RP Baykara, O (corresponding author), Istanbul Univ, Cerrahpasa Tip Fak, Tibbi Biyol & Genet ABD, Kat 6, TR-34098 Istanbul, Turkey.
EM obaykara@istanbul.edu.tr
FU Research Fund of Istanbul University (Istanbul Universitesi Bilimsel Arastirma Projeleri Birimi) [46470]
CR Alessio HM, 1997, INT J SPORT NUTR, V7, P1
   [Anonymous], 2015, HUMAN MITOCHONDRIAL, V0, P0
   Awobajo F O, 2013, NIG Q J HOSP MED, V23, P117
   Balakrishnan SD, 1998, CELL BIOCHEM FUNCT, V16, P269, DOI 10.1002/(SICI)1099-0844(1998120)16:4<269::AID-CBF797>3.3.CO;2-2
   Chen B, 2011, MOL BIOL REP, V38, P3635, DOI 10.1007/s11033-010-0476-5
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   De Lucas RD, 2014, J SPORT SCI, V32, P22, DOI 10.1080/02640414.2013.797098
   Dimberg J, 2014, ANTICANCER RES, V34, P147
   Drew B, 2004, ACTA PHYSIOL SCAND, V182, P333, DOI 10.1111/j.1365-201X.2004.01371.x
   Dumont P, 2000, FREE RADICAL BIO MED, V28, P361, DOI 10.1016/S0891-5849(99)00249-X
   Finaud J, 2006, SPORTS MED, V36, P327, DOI 10.2165/00007256-200636040-00004
   Finaud J, 2006, INT J SPORTS MED, V27, P87, DOI 10.1055/s-2005-837489
   GATTERMANN N, 1995, LEUKEMIA, V9, P1704
   Gougoura S, 2007, EUR J APPL PHYSIOL, V100, P235, DOI 10.1007/s00421-007-0423-x
   Hou JH, 1998, MUTAT RES, V403, P5
   Howell N, 1996, AM J HUM GENET, V59, P501
   Indo HP, 2007, MITOCHONDRION, V7, P106, DOI 10.1016/j.mito.2006.11.026
   Jafari A, 2005, BRIT J SPORT MED, V39, P517, DOI 10.1136/bjsm.2004.014068
   Jou MJ, 2007, J PINEAL RES, V43, P389, DOI 10.1111/j.1600-079X.2007.00490.x
   Kara M, 2012, BALK J MED GENET, V15, P25, DOI 10.2478/v10034-012-0004-0
   Lanza IR, 2009, AM J CLIN NUTR, V89, P467S, DOI 10.3945/ajcn.2008.26717D
   LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012
   Lee HC, 2002, J BIOMED SCI, V9, P517, DOI 10.1007/BF02254978
   Lee HC, 2000, BIOCHEM J, V348, P425, DOI 10.1042/0264-6021:3480425
   Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010
   LEE HC, 1994, BBA-MOL BASIS DIS, V1226, P37, DOI 10.1016/0925-4439(94)90056-6
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Lobachev AN, 1978, DEPOSITED DOC, V0, P2172
   Lobachev AN, 1985, DEPOSITED DOC, V6756-B85, P28
   Malik Afshan N, 2009, DIABETES RES CLIN PRACT, V86, Pe22, DOI 10.1016/j.diabres.2009.07.002
   Marin DP, 2013, INT IMMUNOPHARMACOL, V17, P462, DOI 10.1016/j.intimp.2013.07.009
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   Mohamed SA, 2004, EXP GERONTOL, V39, P181, DOI 10.1016/j.exger.2003.10.011
   Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5
   Navarro F, 2013, EUR J APPL PHYSIOL, V113, P1343, DOI 10.1007/s00421-012-2554-y
   Nie HR, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0067953
   Nielsen HB, 2003, SPORTS MED, V33, P853, DOI 10.2165/00007256-200333110-00005
   Nikolaidis MG, 2007, APPL PHYSIOL NUTR ME, V32, P197, DOI 10.1139/H06-097
   Porteous WK, 1998, EUR J BIOCHEM, V257, P192, DOI 10.1046/j.1432-1327.1998.2570192.x
   Ramond A, 2013, FUND CLIN PHARMACOL, V27, P252, DOI 10.1111/j.1472-8206.2011.01015.x
   SAHIN SK, 2013, EUR J EXP BIOL, V3, P211
   Schneider CD, 2005, CAN J APPL PHYSIOL, V30, P723, DOI 10.1139/h05-151
   Schon EA, 2000, TRENDS BIOCHEM SCI, V25, P555, DOI 10.1016/S0968-0004(00)01688-1
   Siems WG, 1999, QJM-INT J MED, V92, P193, DOI 10.1093/qjmed/92.4.193
   SINGH N, 1995, MOL CELL BIOCHEM, V147, P77, DOI 10.1007/BF00944786
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001
   von Wurmb N, 1998, MUTAT RES-FUND MOL M, V422, P247, DOI 10.1016/S0027-5107(98)00205-X
   von Wurmb-Schwark N, 2010, MECH AGEING DEV, V131, P179, DOI 10.1016/j.mad.2010.01.005
   WALLACE DC, 1990, PEDIATR RES, V28, P525, DOI 10.1203/00006450-199011000-00023
   Wei YH, 1998, P SOC EXP BIOL MED, V217, P53
   Wen Q, 2011, RADIAT ONCOL, V6, P0, DOI 10.1186/1748-717X-6-133
   Wong J, 2009, DIABETOLOGIA, V52, P1953, DOI 10.1007/s00125-009-1424-6
   Xia P, 2009, BMC CANCER, V9, P0, DOI 10.1186/1471-2407-9-454
   Ye CZ, 2002, CLIN CHIM ACTA, V318, P33, DOI 10.1016/S0009-8981(01)00799-9
NR 56
TC 9
Z9 11
U1 1
U2 10
PU C M B  ASSOC
PI POITIERS
PA 34 BOULEVARD SOLFERINO, 86000 POITIERS, FRANCE
SN 0145-5680
EI 1165-158X
J9 CELL MOL BIOL
JI Cell. Mol. Biol.
PD JUN 15
PY 2016
VL 62
IS 12
BP 109
EP 115
DI 10.14715/cmb/2016.62.12.19
PG 7
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA EN6NX
UT WOS:000396121800019
PM 27894409
DA 2024-11-01
ER

PT J
AU Min-Wen, JC
   Jun-Hao, ET
   Shyh-Chang, N
AF Min-Wen, Jason Chua
   Jun-Hao, Elwin Tan
   Shyh-Chang, Ng
TI Stem cell mitochondria during aging
SO SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
LA English
DT Review
DE Stem cells; Mitochondria; mtDNA; Regeneration; Degeneration; Aging
ID human polynucleotide phosphorylase; human skeletal-muscle; insulin-resistance; oxidative stress; dna mutations; self-renewal; hematopoietic progenitors; replicative senescence; dopaminergic-neurons; calorie restriction
AB Mitochondria are the central hubs of cellular metabolism, equipped with their own mitochondrial DNA (mtDNA) blueprints to direct part of the programming of mitochondrial oxidative metabolism and thus reactive oxygen species (ROS) levels. In stem cells, many stem cell factors governing the intricate balance between self -renewal and differentiation have been found to directly regulate mitochondrial processes to control stem cell behaviors during tissue regeneration and aging. Moreover, numerous nutrient -sensitive signaling pathways controlling organismal longevity in an evolutionarily conserved fashion also influence stem cell -mediated tissue homeostasis during aging via regulation of stem cell mitochondria. At the genomic level, it has been demonstrated that heritable mtDNA mutations and variants affect mammalian stem cell homeostasis and influence the risk for human degenerative diseases during aging. Because such a multitude of stem cell factors and signaling pathways ultimately converge on the mitochondria as the primary mechanism to modulate cellular and organismal longevity, it would be most efficacious to develop technologies to therapeutically target and direct mitochondrial repair in stem cells, as a unified strategy to combat aging -related degenerative diseases in the future. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Min-Wen, Jason Chua; Jun-Hao, Elwin Tan; Shyh-Chang, Ng] Genome Inst Singapore, Stem Cell & Regenerat Biol, 60 Biopolis St, Singapore S138672, Singapore.
C3 Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)
RP Shyh-Chang, N (corresponding author), Genome Inst Singapore, Stem Cell & Regenerat Biol, 60 Biopolis St, Singapore S138672, Singapore.
EM shyhng@gmail.com
FU JCO grant from the Agency for Science Technology and Research [1431AFG128]; Genome Institute of Singapore
CR Achilli A, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0021029
   Aguirre A, 2014, CELL STEM CELL, V15, P589, DOI 10.1016/j.stem.2014.10.003
   Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Akita Y, 2000, HUM MUTAT, V15, P382, DOI 10.1002/(SICI)1098-1004(200004)15:4<382::AID-HUMU15>3.0.CO;2-B
   Alila OF, 2015, MITOCONDRIAL DNA, V10, P1
   [Anonymous], 2009, CELL COMMUN SIGNAL, V0, P0, DOI DOI 10.1186/1478-811X-7-S1-A57
   Baines HL, 2014, MECH AGEING DEV, V139, P22, DOI 10.1016/j.mad.2014.06.003
   Barger JL, 2003, EXP GERONTOL, V38, P1343, DOI 10.1016/j.exger.2003.10.017
   Benhamed M, 2012, NAT CELL BIOL, V14, P266, DOI 10.1038/ncb2443
   Bonen A, 2009, APPL PHYSIOL NUTR ME, V34, P307, DOI 10.1139/H09-008
   Brisca G, 2015, BIOCHEM BIOPH RES CO, V458, P601, DOI 10.1016/j.bbrc.2015.01.157
   Cantó C, 2011, PHYSIOLOGY, V26, P214, DOI 10.1152/physiol.00010.2011
   Cantó C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813
   Carrieri G, 2001, HUM GENET, V108, P194, DOI 10.1007/s004390100463
   Castilho RM, 2009, CELL STEM CELL, V5, P279, DOI 10.1016/j.stem.2009.06.017
   Cerletti M, 2012, CELL STEM CELL, V10, P515, DOI 10.1016/j.stem.2012.04.002
   Cha MY, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0034929
   Chagnon P, 1999, AM J MED GENET, V85, P20, DOI 10.1002/(SICI)1096-8628(19990702)85:1<20::AID-AJMG6>3.0.CO;2-K
   Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297
   Chen C, 2009, SCI SIGNAL, V2, P0, DOI 10.1126/scisignal.2000559
   Chen JC, 2003, EXP HEMATOL, V31, P1097, DOI 10.1016/S0301-472X(03)00238-8
   Chen ML, 2009, BLOOD, V114, P4045, DOI 10.1182/blood-2008-08-169474
   Chinnery PF, 2013, BRIT MED BULL, V106, P135, DOI 10.1093/bmb/ldt017
   Copley MR, 2013, NAT CELL BIOL, V15, P916, DOI 10.1038/ncb2783
   Coto E, 2011, NEUROGENETICS, V12, P345, DOI 10.1007/s10048-011-0295-4
   Crispim D, 2006, ANN HUM GENET, V70, P488, DOI 10.1111/j.1469-1809.2005.00249.x
   Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322
   Dai DF, 2010, AGING CELL, V9, P536, DOI 10.1111/j.1474-9726.2010.00581.x
   Dasgupta B, 2009, DEV CELL, V16, P256, DOI 10.1016/j.devcel.2009.01.005
   Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822
   Dillon LM, 2012, HUM MOL GENET, V21, P2288, DOI 10.1093/hmg/dds049
   Dimas AS, 2014, DIABETES, V63, P2158, DOI 10.2337/db13-0949
   Drummond MJ, 2011, PHYSIOL GENOMICS, V43, P595, DOI 10.1152/physiolgenomics.00148.2010
   Drummond-Barbosa D, 2001, DEV BIOL, V231, P265, DOI 10.1006/dbio.2000.0135
   Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371
   Estrada JC, 2013, CELL DEATH DIS, V4, P0, DOI 10.1038/cddis.2013.211
   Fesahat F, 2007, CELL MOL NEUROBIOL, V27, P329, DOI 10.1007/s10571-006-9126-9
   Fox RG, 2012, AM J PHYSIOL-GASTR L, V302, PG914, DOI 10.1152/ajpgi.00402.2011
   French SW, 2007, CANCER LETT, V248, P198, DOI 10.1016/j.canlet.2006.07.006
   Fuku N, 2007, AM J HUM GENET, V80, P407, DOI 10.1086/512202
   Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0
   Gan BY, 2010, NATURE, V468, P701, DOI 10.1038/nature09595
   Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633
   Goh LH, 2013, DEV BIOL, V381, P353, DOI 10.1016/j.ydbio.2013.06.031
   Gurumurthy S, 2010, NATURE, V468, P659, DOI 10.1038/nature09572
   Hämäläinen RH, 2015, CELL REP, V11, P1614, DOI 10.1016/j.celrep.2015.05.009
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   Ho JH, 2011, CELL TRANSPLANT, V20, P1209, DOI 10.3727/096368910X546562
   Hochmuth CE, 2011, CELL STEM CELL, V8, P188, DOI 10.1016/j.stem.2010.12.006
   Hsu HJ, 2008, DEV BIOL, V313, P700, DOI 10.1016/j.ydbio.2007.11.006
   Hwang S, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0022116
   Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989
   Jin H, 2014, BIOCHIM BIOPHYS ACTA, V1842, P1282
   Jun-Hao ET, 2016, TRENDS ENDOCRINOL ME, V0, P0
   Kaplon J, 2013, NATURE, V498, P109, DOI 10.1038/nature12154
   Katajisto P, 2015, SCIENCE, V348, P340, DOI 10.1126/science.1260384
   Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944
   Khaw SL, 2015, CELL REP, V12, P1080, DOI 10.1016/j.celrep.2015.07.032
   Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942
   Kofler B, 2009, BMC MED GENET, V10, P0, DOI 10.1186/1471-2350-10-35
   Kovalenko OA, 2010, AGING CELL, V9, P203, DOI 10.1111/j.1474-9726.2010.00551.x
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishnan KJ, 2012, NEUROBIOL AGING, V33, P2210, DOI 10.1016/j.neurobiolaging.2011.08.009
   Kuhn HG, 1996, J NEUROSCI, V16, P2027
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kukreja L, 2014, MOL NEURODEGENER, V9, P0, DOI 10.1186/1750-1326-9-16
   Kulawiec Mariola, 2009, J CARCINOG, V8, P8, DOI 10.4103/1477-3163.50893
   LaFever L, 2005, SCIENCE, V309, P1071, DOI 10.1126/science.1111410
   Lakatos A, 2010, NEUROBIOL AGING, V31, P1355, DOI 10.1016/j.neurobiolaging.2010.04.031
   Leszczyniecka M, 2003, GENE, V316, P143, DOI 10.1016/S0378-1119(03)00752-2
   Leszczyniecka M, 2002, P NATL ACAD SCI USA, V99, P16636, DOI 10.1073/pnas.252643699
   Liang H, 2009, AM J PHYSIOL-ENDOC M, V296, PE945, DOI 10.1152/ajpendo.90292.2008
   Liou CW, 2012, DIABETES, V61, P2642, DOI 10.2337/db11-1369
   Liu WC, 2011, P NATL ACAD SCI USA, V108, P12920, DOI 10.1073/pnas.1107332108
   Logan A, 2014, AGING CELL, V13, P765, DOI 10.1111/acel.12212
   Sosa-Ortiz AL, 2012, ARCH MED RES, V43, P600, DOI 10.1016/j.arcmed.2012.11.003
   Machida S, 2004, EXP GERONTOL, V39, P1521, DOI 10.1016/j.exger.2004.08.009
   Maruszak A, 2009, NEUROBIOL AGING, V30, P1749, DOI 10.1016/j.neurobiolaging.2008.01.004
   Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001
   Mohlke KL, 2005, HUM GENET, V118, P245, DOI 10.1007/s00439-005-0046-4
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571
   Narbonne P, 2006, DEVELOPMENT, V133, P611, DOI 10.1242/dev.02232
   Shyh-Chang N, 2013, SCIENCE, V339, P222, DOI 10.1126/science.1226603
   Norddahl GL, 2011, CELL STEM CELL, V8, P499, DOI 10.1016/j.stem.2011.03.009
   OBrien LC, 2015, STEM CELLS DEV, V24, P1984, DOI 10.1089/scd.2015.0076
   Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100
   Petersen KF, 2005, PLOS MED, V2, P879, DOI 10.1371/journal.pmed.0020233
   Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   Pickrell AM, 2011, J NEUROSCI, V31, P17649, DOI 10.1523/JNEUROSCI.4871-11.2011
   Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708
   Rai P, 2011, ONCOGENE, V30, P1489, DOI 10.1038/onc.2010.520
   Ramanathan A, 2009, P NATL ACAD SCI USA, V106, P22229, DOI 10.1073/pnas.0912074106
   Reddy PH, 2009, EXP NEUROL, V218, P286, DOI 10.1016/j.expneurol.2009.03.042
   Rera M, 2011, CELL METAB, V14, P623, DOI 10.1016/j.cmet.2011.09.013
   Rimmelé P, 2015, EMBO REP, V16, P1164, DOI 10.15252/embr.201439704
   Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8
   Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354
   Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036
   Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862
   Ryall JG, 2015, CELL STEM CELL, V16, P171, DOI 10.1016/j.stem.2014.12.004
   Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982
   Santoro A, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0012037
   Sarkar D, 2003, J BIOL CHEM, V278, P24542, DOI 10.1074/jbc.M302421200
   Schell JC, 2014, MOL CELL, V56, P400, DOI 10.1016/j.molcel.2014.09.026
   Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200
   Shaltouki A, 2015, STEM CELL REP, V4, P847, DOI 10.1016/j.stemcr.2015.02.019
   Shim J, 2012, NAT CELL BIOL, V14, P394, DOI 10.1038/ncb2453
   Shyh-Chang N, 2015, CELL METAB, V21, P349, DOI 10.1016/j.cmet.2015.02.011
   Shyh-Chang N, 2013, CELL, V155, P778, DOI 10.1016/j.cell.2013.09.059
   Shyh-Chang N, 2013, DEVELOPMENT, V140, P2535, DOI 10.1242/dev.091777
   Shyh-Chang N, 2011, EMBO J, V30, P4851, DOI 10.1038/emboj.2011.436
   Simoneau JA, 1997, J APPL PHYSIOL, V83, P166, DOI 10.1152/jappl.1997.83.1.166
   Stevens DA, 2015, P NATL ACAD SCI USA, V112, P11696, DOI 10.1073/pnas.1500624112
   Strauss KA, 2013, P NATL ACAD SCI USA, V110, P3453, DOI 10.1073/pnas.1300690110
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Toledano H, 2012, NATURE, V485, P605, DOI 10.1038/nature11061
   Tolonen, 2014, PHARMACOL RES PERSPE, V2, P0
   Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tufi R, 2014, NAT CELL BIOL, V16, P157, DOI 10.1038/ncb2901
   Ueishi S, 2009, CELL STRUCT FUNCT, V34, P61, DOI 10.1247/csf.08042
   Urbach A, 2014, GENE DEV, V28, P971, DOI 10.1101/gad.237149.113
   van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051
   van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Vedrenne V, 2012, AM J HUM GENET, V91, P912, DOI 10.1016/j.ajhg.2012.09.001
   von Ameln S, 2012, AM J HUM GENET, V91, P919, DOI 10.1016/j.ajhg.2012.09.002
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wallace DC, 2010, GENE DEV, V24, P1571, DOI 10.1101/gad.1960210
   Wang G, 2010, CELL, V142, P456, DOI 10.1016/j.cell.2010.06.035
   Wang ZA, 2012, NAT COMMUN, V3, P0, DOI 10.1038/ncomms1765
   Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895
   Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106
   Wilson FH, 2004, SCIENCE, V306, P1190, DOI 10.1126/science.1102521
   Winklhofer KF, 2010, BBA-MOL BASIS DIS, V1802, P29, DOI 10.1016/j.bbadis.2009.08.013
   Wu LW, 2015, ELIFE, V4, P0, DOI 10.7554/eLife.09431
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Wulfert M, 2008, EXP HEMATOL, V36, P577, DOI 10.1016/j.exphem.2008.01.004
   Xavier JM, 2014, ANTIOXID REDOX SIGN, V21, P1009, DOI 10.1089/ars.2013.5417
   Yalcin S, 2008, J BIOL CEM, V283, P2705
   Yalcin S, 2010, EMBO J, V29, P4118, DOI 10.1038/emboj.2010.292
   Yan MH, 2013, FREE RADICAL BIO MED, V62, P90, DOI 10.1016/j.freeradbiomed.2012.11.014
   Yao YG, 2013, STEM CELL RES, V10, P361, DOI 10.1016/j.scr.2013.01.006
   Yilmaz ÖH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163
   YOSHIDA R, 1995, INTERNAL MED, V34, P953, DOI 10.2169/internalmedicine.34.953
   Yuan J, 2012, SCIENCE, V335, P1195, DOI 10.1126/science.1216557
   Zhang, 2014, PLOS ONE, V9, P0
   Zhang MM, 2015, J CELL MOL MED, V19, P1174, DOI 10.1111/jcmm.12369
   Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033
NR 152
TC 19
Z9 19
U1 0
U2 47
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1084-9521
EI 
J9 SEMIN CELL DEV BIOL
JI Semin. Cell Dev. Biol.
PD APR 15
PY 2016
VL 52
IS 
BP 110
EP 118
DI 10.1016/j.semcdb.2016.02.005
PG 9
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA DG8JO
UT WOS:000372330300016
PM 26851627
DA 2024-11-01
ER

PT J
AU Chen, XH
   An, XB
   Chen, DR
   Ye, MQ
   Shen, WL
   Han, WQ
   Zhang, YY
   Gao, PJ
AF Chen, Xiaohui
   An, Xiangbo
   Chen, Dongrui
   Ye, Maoqing
   Shen, Weili
   Han, Weiqing
   Zhang, Youyi
   Gao, Pingjin
TI Chronic Exercise Training Improved Aortic Endothelial and Mitochondrial Function via an AMPKα2-Dependent Manner
SO FRONTIERS IN PHYSIOLOGY
LA English
DT Article
DE AMPK; exercise; vascular; endothelial function; mitochondrial function
ID activated protein-kinase; coronary-artery-disease; regular physical-activity; nitric-oxide synthase; skeletal-muscle; cell-proliferation; oxidative stress; nad(p)h oxidase; blood-pressure; dysfunction
AB Chronic exercise training is known to protect the vasculature; however, the underlying mechanisms remain obscure. The present study hypothesized that exercise may improve aortic endothelial and mitochondrial function through an adenosine monophosphate-activated protein kinase alpha 2 (AMPK alpha 2)-dependent manner. Ten-week-old AMPK alpha 2 knockout (AMPK alpha 2(-/-)) mice and age-matched wild-type (WT) mice were subjected to daily treadmill running for 6 weeks, and the thoracic aorta from these mice were used for further examination. Our results showed that exercise significantly promoted vasodilatation and increased expression and phosphorylation of endothelial nitric oxide synthase (eNOS), concomitant with increased AMPK alpha 2 expression in WT mice. These effects were not observed in AMPK alpha 2(-/-) mice. Furthermore, exercise training increased thoracic aortic mitochondria' content as indicated by increased Complex I and mitochondria' DNA (mtDNA) in WT mice but not in AMPK alpha 2(-/-) mice. This may be caused by decreased mitochondria' autophagy since the expression of BH3 domain-containing BCL2 family members BNIP3-like (BNIP3L) and LC3B were decreased in WT mice with exercise. And these changes were absent with AMPK alpha 2 deletion in mice. Importantly, exercise increased the expression of manganous superoxide dismutase (MnSOD) and catalase, suggesting that mitochondria' antioxidative capacity was increased. Notably, the improved antioxidative capacity was lost in AMPK alpha 2(-/-) mice with exercise. In conclusion, this study illustrated that AMPK alpha 2 plays a critical role in exercise-related vascular protection via increasing endothelial and mitochondria' function in the artery.
C1 [Chen, Xiaohui; Gao, Pingjin] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biol Sci, Lab Vasc Biol,Inst Hlth Sci, Shanghai, Peoples R China.
   [Chen, Xiaohui; Gao, Pingjin] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Stem Cell Biol,Inst Hlth Sci, Shanghai, Peoples R China.
   [An, Xiangbo; Zhang, Youyi] Peking Univ, Hosp 3, Inst Vasc Med, Beijing, Peoples R China.
   [Chen, Dongrui; Ye, Maoqing; Shen, Weili; Han, Weiqing; Gao, Pingjin] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Shanghai Key Lab Hypertens, Shanghai, Peoples R China.
   [Chen, Dongrui; Ye, Maoqing; Shen, Weili; Han, Weiqing; Gao, Pingjin] Shanghai Res Inst Hypertens, Shanghai, Peoples R China.
C3 Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Peking University; Shanghai Jiao Tong University
RP Gao, PJ (corresponding author), Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biol Sci, Lab Vasc Biol,Inst Hlth Sci, Shanghai, Peoples R China.; Gao, PJ (corresponding author), Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Stem Cell Biol,Inst Hlth Sci, Shanghai, Peoples R China.; Zhang, YY (corresponding author), Peking Univ, Hosp 3, Inst Vasc Med, Beijing, Peoples R China.; Gao, PJ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Shanghai Key Lab Hypertens, Shanghai, Peoples R China.; Gao, PJ (corresponding author), Shanghai Res Inst Hypertens, Shanghai, Peoples R China.
EM zhangyy@bjmu.edu.cn; gaopingjin@sibs.ac.cn
FU National Natural Science Foundation of China [81100184, 81230071, 81300089, 81200203, 91539202, 81570221]; Scientific Fund of Shanghai Jiao Tong University School of Medicine [14XJ10042]; Pujiang Program of the Shanghai Science and Technology Committee [14PJ1406400]; Scientific Research Foundation for the Returned Overseas Chinese Scholars of the State Education Ministry; Shanghai Medical Bureau Fund [201540037]
CR Adams V, 2005, CIRCULATION, V111, P555, DOI 10.1161/01.CIR.0000154560.88933.7E
   Cacicedo JM, 2011, AM J PHYSIOL-HEART C, V301, PH1255, DOI 10.1152/ajpheart.01279.2010
   Chen L, 2012, EURASIP J WIREL COMM, V0, P0, DOI DOI 10.1186/1687-1499-2012-230
   Dikalova AE, 2010, CIRC RES, V107, P106, DOI 10.1161/CIRCRESAHA.109.214601
   Ding Hu, 2013, ZHONGGUO YING YONG SHENG LI XUE ZA ZHI, V29, P543
   Dromparis P, 2013, ANNU REV PHYSIOL, V75, P95, DOI 10.1146/annurev-physiol-030212-183804
   FERNANDO P, 1993, CAN J PHYSIOL PHARM, V71, P854, DOI 10.1139/y93-128
   Goirand F, 2007, J PHYSIOL-LONDON, V581, P1163, DOI 10.1113/jphysiol.2007.132589
   Gonçalves IO, 2016, APPL PHYSIOL NUTR ME, V41, P298, DOI 10.1139/apnm-2015-0470
   Gu Q, 2014, EXP GERONTOL, V56, P37, DOI 10.1016/j.exger.2014.02.014
   Hambrecht R, 2003, CIRCULATION, V107, P3152, DOI 10.1161/01.CIR.0000074229.93804.5C
   Hambrecht R, 2000, NEW ENGL J MED, V342, P454, DOI 10.1056/NEJM200002173420702
   Hamidie RDR, 2015, METABOLISM, V64, P1334, DOI 10.1016/j.metabol.2015.07.010
   Hattori Y, 2006, HYPERTENSION, V47, P1183, DOI 10.1161/01.HYP.0000221429.94591.72
   Jin HS, 2011, AM J HYPERTENS, V24, P1127, DOI 10.1038/ajh.2011.131
   Jorgensen SB, 2006, J PHYSIOL-LONDON, V574, P17, DOI 10.1113/jphysiol.2006.109942
   Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003
   Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152
   Kim YA, 2012, J PHYSIOL BIOCHEM, V68, P229, DOI 10.1007/s13105-011-0135-x
   Kojda G, 2001, CIRCULATION, V103, P2839
   Kroeller-Schoen S, 2013, ARTERIOSCL THROM VAS, V33, P1928, DOI 10.1161/ATVBAHA.113.301717
   Kröller-Schön S, 2012, ARTERIOSCL THROM VAS, V32, P1632, DOI 10.1161/ATVBAHA.111.243980
   Kukidome D, 2006, DIABETES, V55, P120, DOI 10.2337/diabetes.55.1.120
   Kumral ZNO, 2016, J PHYSIOL PHARMACOL, V67, P45
   Li XN, 2009, DIABETES, V58, P2246, DOI 10.2337/db08-1512
   Ma XW, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0129971
   Magnoni LJ, 2014, J EXP BIOL, V217, P1649, DOI 10.1242/jeb.099192
   Marcelino TB, 2013, NEUROSCIENCE, V246, P28, DOI 10.1016/j.neuroscience.2013.04.043
   Marosi K, 2012, NEUROSCIENCE, V226, P21, DOI 10.1016/j.neuroscience.2012.09.001
   McGee SL, 2003, DIABETES, V52, P926, DOI 10.2337/diabetes.52.4.926
   Morrow VA, 2003, J BIOL CHEM, V278, P31629, DOI 10.1074/jbc.M212831200
   Musi N, 2005, FEBS LETT, V579, P2045, DOI 10.1016/j.febslet.2005.02.052
   Nagata D, 2004, CIRCULATION, V110, P444, DOI 10.1161/01.CIR.0000136025.96811.76
   Pangare Meenal, 2012, JOURNAL OF SMOOTH MUSCLE RESEARCH, V48, P1
   Reznick RM, 2006, J PHYSIOL-LONDON, V574, P33, DOI 10.1113/jphysiol.2006.109512
   Richter EA, 2009, BIOCHEM J, V418, P261, DOI 10.1042/BJ20082055
   Russell AP, 2014, BBA-GEN SUBJECTS, V1840, P1276, DOI 10.1016/j.bbagen.2013.11.016
   Salabei JK, 2013, REDOX BIOL, V1, P542, DOI 10.1016/j.redox.2013.10.011
   Schulz E, 2008, CIRCULATION, V118, P1347, DOI 10.1161/CIRCULATIONAHA.108.784298
   Steinberg GR, 2007, MINI-REV MED CHEM, V7, P519
   Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008
   Stewart KJ, 2002, JAMA-J AM MED ASSOC, V288, P1622, DOI 10.1001/jama.288.13.1622
   Sun GQ, 2015, CLIN EXP HYPERTENS, V37, P616, DOI 10.3109/10641963.2015.1036060
   Szewczyk A, 2015, PHARMACOL REP, V67, P704, DOI 10.1016/j.pharep.2015.04.009
   Tang XQ, 2014, FRONT PHYSIOL, V5, P0, DOI 10.3389/fphys.2014.00175
   Wang SX, 2010, CIRC RES, V106, P1117, DOI 10.1161/CIRCRESAHA.109.212530
   Wang SX, 2009, DIABETES, V58, P1893, DOI 10.2337/db09-0267
   Wenzel P, 2008, CARDIOVASC RES, V80, P280, DOI 10.1093/cvr/cvn182
   Yan Z, 2012, EXERC SPORT SCI REV, V40, P159, DOI 10.1097/JES.0b013e3182575599
   Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028
   Zhou WG, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0088722
   Zhu YY, 2013, J BIOL CHEM, V288, P1099, DOI 10.1074/jbc.M112.399345
NR 52
TC 20
Z9 22
U1 0
U2 11
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-042X
EI 
J9 FRONT PHYSIOL
JI Front. Physiol.
PD DEC 21
PY 2016
VL 7
IS 
BP 
EP 
DI 10.3389/fphys.2016.00631
PG 10
WC Physiology
SC Physiology
GA EF2NJ
UT WOS:000390161100001
PM 28066264
DA 2024-11-01
ER

PT J
AU DeBrosse, C
   Nanga, RPR
   Wilson, N
   D'Aquilla, K
   Elliott, M
   Hariharan, H
   Yan, F
   Wade, K
   Nguyen, S
   Worsley, D
   Parris-Skeete, C
   McCormick, E
   Xiao, R
   Cunningham, ZZ
   Fishbein, L
   Nathanson, KL
   Lynch, DR
   Stallings, VA
   Yudkoff, M
   Falk, MJ
   Reddy, R
   McCormack, SE
AF DeBrosse, Catherine
   Nanga, Ravi Prakash Reddy
   Wilson, Neil
   D'Aquilla, Kevin
   Elliott, Mark
   Hariharan, Hari
   Yan, Felicia
   Wade, Kristin
   Sara Nguyen
   Worsley, Diana
   Parris-Skeete, Chevonne
   McCormick, Elizabeth
   Xiao, Rui
   Cunningham, Zuela Zolkipli
   Fishbein, Lauren
   Nathanson, Katherine L.
   Lynch, David R.
   Stallings, Virginia A.
   Yudkoff, Marc
   Falk, Marni J.
   Reddy, Ravinder
   McCormack, Shana E.
TI Muscle oxidative phosphorylation quantitation using creatine chemical exchange saturation transfer (CrCEST) MRI in mitochondrial disorders
SO JCI INSIGHT
LA English
DT Article
ID magnetic-resonance-spectroscopy; complex ii deficiency; skeletal-muscle; friedreichs-ataxia; point mutation; dna deletions; fiber types; disease; myopathy; capacity
AB Systemic mitochondrial energy deficiency is implicated in the pathophysiology of many age-related human diseases. Currently available tools to estimate mitochondrial oxidative phosphorylation (OXPHOS) capacity in skeletal muscle in vivo lack high anatomic resolution. Muscle groups vary with respect to their contractile and metabolic properties. Therefore, muscle group-specific estimates of OXPHOS would be advantageous. To address this need, a noninvasive creatine chemical exchange saturation transfer (CrCEST) MRI technique has recently been developed, which provides a measure of free creatine. After exercise, skeletal muscle can be imaged with CrCEST in order to make muscle group-specific measurements of OXPHOS capacity, reflected in the recovery rate (tCr) of free Cr. In this study, we found that individuals with genetic mitochondrial diseases had significantly (P = 0.026) prolonged postexercise tCr in the medial gastrocnemius muscle, suggestive of less OXPHOS capacity. Additionally, we observed that lower resting CrCEST was associated with prolonged tau PCr, with a Pearson's correlation coefficient of -0.42 (P = 0.046), consistent with previous hypotheses predicting that resting creatine levels may correlate with P-31 magnetic resonance spectroscopy-based estimates of OXPHOS capacity. We conclude that CrCEST can noninvasively detect changes in muscle creatine content and OXPHOS capacity, with high anatomic resolution, in individuals with mitochondrial disorders.
C1 [DeBrosse, Catherine; Nanga, Ravi Prakash Reddy; Wilson, Neil; D'Aquilla, Kevin; Elliott, Mark; Hariharan, Hari; Reddy, Ravinder] Univ Penn, Dept Radiol, Ctr Magnet Resonance & Opt Imaging, Philadelphia, PA 19104 USA.
   [Yan, Felicia; Wade, Kristin; Sara Nguyen; Worsley, Diana; Parris-Skeete, Chevonne; McCormack, Shana E.] Childrens Hosp Philadelphia, Div Endocrinol & Diabet, Philadelphia, PA 19104 USA.
   [McCormick, Elizabeth; Yudkoff, Marc; Falk, Marni J.] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA.
   [Xiao, Rui] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA.
   [Cunningham, Zuela Zolkipli; Lynch, David R.] Childrens Hosp Philadelphia, Dept Neurol, Philadelphia, PA 19104 USA.
   [Fishbein, Lauren] Univ Colorado, Sch Med, Div Endocrinol Diabet & Metab, Aurora, CO USA.
   [Nathanson, Katherine L.] Univ Penn, Dept Med, Div Translat Med & Human Genet, Perelman Sch Med, Philadelphia, PA 19104 USA.
   [Nathanson, Katherine L.] Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA.
   [Stallings, Virginia A.] Childrens Hosp Philadelphia, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA.
   [Stallings, Virginia A.; Yudkoff, Marc; Falk, Marni J.; McCormack, Shana E.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA.
C3 University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania
RP McCormack, SE (corresponding author), Div Endocrinol & Diabet, 3401 Civ Ctr Blvd,Suite 11NW, Philadelphia, PA 19104 USA.
EM mccormacks1@email.chop.edu
FU NCATS NIH HHS [UL1 TR000003, UL1 TR001878] Funding Source: Medline; NIBIB NIH HHS [T32 EB020087, P41 EB015893] Funding Source: Medline; NICHD NIH HHS [U54 HD086984] Funding Source: Medline; NIDDK NIH HHS [K12 DK094723, P30 DK019525, K23 DK102659] Funding Source: Medline
CR Alston C, 2015, HUM GENET, V134, P869, DOI 10.1007/s00439-015-1568-z
   Alston CL, 2012, J MED GENET, V49, P569, DOI 10.1136/jmedgenet-2012-101146
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   ARNOLD DL, 1985, ANN NEUROL, V18, P189, DOI 10.1002/ana.410180205
   Barile JP, 2013, QUAL LIFE RES, V22, P1201, DOI 10.1007/s11136-012-0246-z
   Bates MGD, 2013, EUR HEART J-CARD IMG, V14, P650, DOI 10.1093/ehjci/jes226
   Bayot A, 2011, BMC MED, V9, P0, DOI 10.1186/1741-7015-9-112
   CHANCE B, 1995, BBA-MOL BASIS DIS, V1271, P7, DOI 10.1016/0925-4439(95)00003-M
   Cochran AJR, 2014, EXP PHYSIOL, V99, P782, DOI 10.1113/expphysiol.2013.077453
   Cree-Green M, 2014, MED SCI SPORT EXER, V46, P2030, DOI 10.1249/MSS.0000000000000316
   DIMAURO S, 1985, ANN NEUROL, V17, P521, DOI 10.1002/ana.410170602
   Feldman HI, 2003, J AM SOC NEPHROL, V14, PS148, DOI 10.1097/01.ASN.0000070149.78399.CE
   Glatz C, 2011, MITOCHONDRION, V11, P615, DOI 10.1016/j.mito.2011.04.003
   Haris M, 2014, NAT MED, V20, P209, DOI 10.1038/nm.3436
   Haris M, 2012, NMR BIOMED, V25, P1305, DOI 10.1002/nbm.2792
   Horiuchi M, 2014, EXP PHYSIOL, V99, P348, DOI 10.1113/expphysiol.2013.075846
   Jackson CB, 2014, J MED GENET, V51, P170, DOI 10.1136/jmedgenet-2013-101932
   Jeppesen TD, 2009, EUR J NEUROL, V16, P1336, DOI 10.1111/j.1468-1331.2009.02660.x
   JOHNSON MA, 1973, J NEUROL SCI, V18, P111, DOI 10.1016/0022-510X(73)90023-3
   Kaplan J, 1999, P NATL ACAD SCI USA, V96, P10948, DOI 10.1073/pnas.96.20.10948
   KENTBRAUN JA, 1990, J APPL PHYSIOL, V69, P1165, DOI 10.1152/jappl.1990.69.3.1165
   Kim M, 2009, MAGN RESON MED, V61, P1441, DOI 10.1002/mrm.21873
   Kogan F, 2014, J MAGN RESON IMAGING, V40, P596, DOI 10.1002/jmri.24412
   Kogan Feliks, 2013, CURR RADIOL REP, V1, P102
   Kogan F, 2014, MAGN RESON MED, V71, P164, DOI 10.1002/mrm.24641
   Larsen RG, 2012, APPL PHYSIOL NUTR ME, V37, P88, DOI 10.1139/h11-135
   Little JP, 2011, J APPL PHYSIOL, V111, P1554, DOI 10.1152/japplphysiol.00921.2011
   Little JP, 2011, AM J PHYSIOL-REG I, V300, PR1303, DOI 10.1152/ajpregu.00538.2010
   Lodi R, 1999, P NATL ACAD SCI USA, V96, P11492, DOI 10.1073/pnas.96.20.11492
   MATTHEWS PM, 1991, NEUROLOGY, V41, P114, DOI 10.1212/WNL.41.1.114
   Milone M, 2013, JAMA NEUROL, V70, P1429, DOI 10.1001/jamaneurol.2013.3521
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Parasoglou P, 2013, NMR BIOMED, V26, P348, DOI 10.1002/nbm.2866
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Parikh S, 2009, CURR TREAT OPTION N, V11, P414, DOI 10.1007/s11940-009-0046-0
   PENN AMW, 1992, NEUROLOGY, V42, P2147, DOI 10.1212/WNL.42.11.2147
   PROCTOR DN, 1995, J APPL PHYSIOL, V78, P2033, DOI 10.1152/jappl.1995.78.6.2033
   Ricardo AC, 2015, AM J KIDNEY DIS, V65, P412, DOI 10.1053/j.ajkd.2014.09.016
   Scheuermann-Freestone M, 2003, CIRCULATION, V107, P3040, DOI 10.1161/01.CIR.0000072789.89096.10
   SHOFFNER JM, 1991, REV NEUROL-FRANCE, V147, P431
   SIMONEAU JA, 1995, FASEB J, V9, P273, DOI 10.1096/fasebj.9.2.7781930
   Simoneau JA, 1997, J APPL PHYSIOL, V83, P166, DOI 10.1152/jappl.1997.83.1.166
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Stacpoole PW, 2012, MITOCHONDRION, V12, P623, DOI 10.1016/j.mito.2012.09.005
   Tarnopolsky MA, 1999, MUSCLE NERVE, V22, P1228, DOI 10.1002/(SICI)1097-4598(199909)22:9<1228::AID-MUS9>3.3.CO;2-Y
   Tarnopolsky MA, 2001, MUSCLE NERVE, V24, P682, DOI 10.1002/mus.1055
   Tarnopolsky MA, 2014, J CHILD NEUROL, V29, P1225, DOI 10.1177/0883073814538512
   Trappe SW, 2001, INT J SPORTS MED, V22, P186, DOI 10.1055/s-2001-16385
   Wallace DC, 2013, J CLIN INVEST, V123, P1405, DOI 10.1172/JCI61398
   Wilson NE, 2016, EXERCISECEST, V0, P0
   Zierath JR, 2004, PLOS BIOL, V2, P1523, DOI 10.1371/journal.pbio.0020348
   Zierz CM, 2015, NEUROPATHOLOGY, V35, P130, DOI 10.1111/neup.12173
NR 52
TC 35
Z9 37
U1 0
U2 6
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
SN 2379-3708
EI 
J9 JCI INSIGHT
JI JCI Insight
PD NOV 3
PY 2016
VL 1
IS 18
BP 
EP 
DI 10.1172/jci.insight.88207
PG 15
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA EB1PK
UT WOS:000387125700005
PM 27812541
DA 2024-11-01
ER

PT J
AU Anagnostou, ME
   Ng, YS
   Taylor, RW
   McFarland, R
AF Anagnostou, Maria-Eleni
   Ng, Yi Shiau
   Taylor, Robert W.
   McFarland, Robert
TI Epilepsy due to mutations in the mitochondrial polymerase gamma (<i>POLG</i>) gene: A clinical and molecular genetic review
SO EPILEPSIA
LA English
DT Review
DE Mitochondrial disease; Status epilepticus; Stroke-like lesion; mtDNA copy number; Treatment
ID alpers-huttenlocher syndrome; refractory status epilepticus; dna-polymerase; myocerebrohepatopathy spectrum; hepatocerebral syndrm; mtdna deletions; disease; depletion; childhood; encephalopathy
AB We performed a systematic review of the clinical, molecular, and biochemical features of polymerase gamma (POLG)-related epilepsy and current evidence on seizure management. Patients were identified from a combined electronic search of articles using Ovid Medline and Scopus databases, published from January 2000 to January 2015. Only patients with a confirmed genetic diagnosis of POLG mutations were considered. Seventy-two articles were included for analysis. We identified 128 pathogenic variants in 372 patients who had POLG-related epilepsy. Among these, 84% of the cases harbored at least one of these pathogenic variants: p.Ala467Thr, p.Trp748Ser, and p.Gly848Ser. A bimodal distribution of disease onset was present in early childhood (<5 years) and adolescence; female patients had a later presentation than male patients (median age 4.00 vs. 1.83 years, p-value = 0.041). Focal-onset seizure including convulsive, myoclonus, and occipital seizures was common at the outset and was refractory to pharmacotherapy. We confirmed that homozygous pathogenic variants located in the linker region of POLG were associated with later age of onset and longer survival compared to compound heterozygous variants. In addition, biochemical and molecular heterogeneities in different tissues were frequently observed. POLG-related epilepsy is clinically heterogeneous, and the prognosis is, in part, influenced by the location of the variants in the gene and the presence of hepatic involvement. Normal muscle and fibroblast studies do no exclude the diagnosis of POLG-related mitochondrial disease and direct sequencing of the POLG gene should be the gold standard when investigating suspected cases.
C1 [Anagnostou, Maria-Eleni; Ng, Yi Shiau; Taylor, Robert W.; McFarland, Robert] Newcastle Univ, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK
RP McFarland, R (corresponding author), Newcastle Univ, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM robert.mcfarland@newcastle.ac.uk
FU Wellcome Trust [096919Z/11/Z]; Medical Research Council [G0601943, G0800674]; Lily Foundation; UK NHS Specialized Services and Newcastle upon Tyne Hospitals NHS Foundation Trust; MRC [G0601943, G0200373, G0800674] Funding Source: UKRI
CR Allen NM, 2014, SEIZURE-EUR J EPILEP, V23, P237, DOI 10.1016/j.seizure.2013.07.005
   Ashley N, 2008, HUM MOL GENET, V17, P2496, DOI 10.1093/hmg/ddn150
   Bao XH, 2008, BRAIN DEV-JPN, V30, P295, DOI 10.1016/j.braindev.2007.08.009
   Blok MJ, 2009, J MED GENET, V46, P776, DOI 10.1136/jmg.2009.067686
   Boes M, 2009, SEIZURE-EUR J EPILEP, V18, P232, DOI 10.1016/j.seizure.2008.08.003
   Brinjikji W, 2011, JIMD REP, V1, P89, DOI 10.1007/8904_2011_22
   Cardenas JF, 2010, SEMIN PEDIATR NEUROL, V17, P62, DOI 10.1016/j.spen.2010.02.012
   Cheldi A, 2013, BMC NEUROL, V13, P0, DOI 10.1186/1471-2377-13-8
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   de Camaret BM, 2011, MITOCHONDRION, V11, P223, DOI 10.1016/j.mito.2010.07.011
   de Vries MC, 2008, J INHERIT METAB DIS, V31, PS299, DOI 10.1007/s10545-008-0871-4
   de Vries MC, 2007, EUR J PEDIATR, V166, P229, DOI 10.1007/s00431-006-0234-9
   Engelsen BA, 2008, BRAIN, V131, P818, DOI 10.1093/brain/awn007
   Farnum GA, 2014, BBA-BIOENERGETICS, V1837, P1113, DOI 10.1016/j.bbabio.2014.01.021
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Ferreira M, 2011, NEUROMUSCULAR DISORD, V21, P483, DOI 10.1016/j.nmd.2011.03.011
   Hakonen AH, 2007, EUR J HUM GENET, V15, P779, DOI 10.1038/sj.ejhg.5201831
   Hansen N, 2012, NEUROL SCI, V33, P209, DOI 10.1007/s10072-011-0631-3
   HARDING BN, 1986, BRAIN, V109, P181, DOI 10.1093/brain/109.1.181
   Hasselmann O, 2010, MOL GENET METAB, V99, P58, DOI 10.1016/j.ymgme.2009.08.005
   Horst DM, 2014, PEDIATR NEUROL, V51, P734, DOI 10.1016/j.pediatrneurol.2014.06.015
   Hunter MF, 2011, PEDIATR NEUROL, V45, P311, DOI 10.1016/j.pediatrneurol.2011.07.008
   Isohanni P, 2011, NEUROLOGY, V76, P811, DOI 10.1212/WNL.0b013e31820e7b25
   Janssen W, 2016, ACTA NEUROL BELG, V116, P17, DOI 10.1007/s13760-015-0499-8
   Joshi CN, 2009, PEDIATR NEUROL, V40, P314, DOI 10.1016/j.pediatrneurol.2008.10.023
   Khan A, 2012, J CHILD NEUROL, V27, P636, DOI 10.1177/0883073811423973
   Kollberg G, 2006, J NEUROPATH EXP NEUR, V65, P758, DOI 10.1097/01.jnen.0000229987.17548.6e
   Kurt B, 2010, ARCH NEUROL-CHICAGO, V67, P239, DOI 10.1001/archneurol.2009.332
   Lax NZ, 2016, NEUROPATH APPL NEURO, V42, P180, DOI 10.1111/nan.12238
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Li SB, 2015, HEPATOLOGY, V61, P1730, DOI 10.1002/hep.27712
   Lupashko S, 2011, CHILD NERV SYST, V27, P1321, DOI 10.1007/s00381-011-1495-9
   Lutz RE, 2009, J PEDIATR GASTR NUTR, V49, P126, DOI 10.1097/MPG.0b013e31817d9cad
   Mangalat N, 2012, ULTRASTRUCT PATHOL, V36, P219, DOI 10.3109/01913123.2012.666334
   Martikainen MH, 2012, EPILEPTIC DISORD, V14, P438, DOI 10.1684/epd.2012.0543
   Mccoy B, 2011, EUR J PAEDIATR NEURO, V15, P558, DOI 10.1016/j.ejpn.2011.05.012
   McFarland R, 2008, ARCH DIS CHILD, V93, P151, DOI 10.1136/adc.2007.122911
   Mohamed K, 2011, J INHERIT METAB DIS, V34, P439, DOI 10.1007/s10545-011-9278-8
   Montassir H, 2015, BRAIN DEV-JPN, V37, P719, DOI 10.1016/j.braindev.2014.10.013
   Naess K, 2012, JIMD REP, V4, P67, DOI 10.1007/8904_2011_73
   Naïmi M, 2006, EUR J HUM GENET, V14, P917, DOI 10.1038/sj.ejhg.5201627
   Navarro-Sastre A, 2012, MOL GENET METAB, V107, P409, DOI 10.1016/j.ymgme.2012.08.018
   Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   Nolte KW, 2013, NEUROPATHOLOGY, V33, P59, DOI 10.1111/j.1440-1789.2012.01317.x
   Prasun P, 2014, J NEUROL, V261, P2218, DOI 10.1007/s00415-014-7493-6
   Prüss H, 2008, EPILEPSY RES, V82, P219, DOI 10.1016/j.eplepsyres.2008.08.005
   Roels F, 2009, BMC CLIN PATHOL, V9, P0, DOI 10.1186/1472-6890-9-4
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Roshal D, 2011, EPILEPSY BEHAV, V21, P206, DOI 10.1016/j.yebeh.2011.03.003
   Rouzier C, 2014, EUR J HUM GENET, V22, P542, DOI 10.1038/ejhg.2013.171
   Saneto RP, 2013, PEDIATR NEUROL, V48, P167, DOI 10.1016/j.pediatrneurol.2012.09.014
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Scalais E, 2012, EUR J PAEDIATR NEURO, V16, P542, DOI 10.1016/j.ejpn.2012.01.013
   Schaller A, 2011, BMC NEUROL, V11, P0, DOI 10.1186/1471-2377-11-4
   Simon M, 2014, JIMD REP, V14, P29, DOI 10.1007/8904_2013_280
   Sofou K, 2012, EUR J PAEDIATR NEURO, V16, P379, DOI 10.1016/j.ejpn.2011.12.006
   Stewart JD, 2009, J MED GENET, V46, P209, DOI 10.1136/jmg.2008.058180
   Stewart JD, 2010, HEPATOLOGY, V52, P1791, DOI 10.1002/hep.23891
   Stricker S, 2009, J NEUROL NEUROSUR PS, V80, P1181, DOI 10.1136/jnnp.2008.166066
   Taanman JW, 2009, HUM MUTAT, V30, P248, DOI 10.1002/humu.20852
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tuladhar AM, 2013, J NEUROL, V260, P903, DOI 10.1007/s00415-012-6776-z
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Tzoulis C, 2014, ANN NEUROL, V76, P66, DOI 10.1002/ana.24185
   Uusimaa J, 2008, EPILEPSIA, V49, P1038, DOI 10.1111/j.1528-1167.2008.01544.x
   Uusimaa J, 2013, EPILEPSIA, V54, P1002, DOI 10.1111/epi.12115
   van den Heuvel LP, 2004, MITOCHONDRION, V4, P395, DOI 10.1016/j.mito.2004.07.005
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Visser NA, 2011, J NEUROL, V258, P218, DOI 10.1007/s00415-010-5721-2
   Vu TH, 1998, NEUROLOGY, V50, P1783, DOI 10.1212/WNL.50.6.1783
   Wiltshire E, 2008, ARCH NEUROL-CHICAGO, V65, P121, DOI 10.1001/archneurol.2007.14
   Witters P, 2010, J INHERIT METAB DIS, V33, P451, DOI 10.1007/s10545-010-9108-4
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
   Woodbridge P, 2013, INTERN MED J, V43, P150, DOI 10.1111/j.1445-5994.2012.02847.x
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Zsurka G, 2015, LANCET NEUROL, V14, P956, DOI 10.1016/S1474-4422(15)00148-9
NR 80
TC 54
Z9 63
U1 0
U2 11
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0013-9580
EI 1528-1167
J9 EPILEPSIA
JI Epilepsia
PD OCT 15
PY 2016
VL 57
IS 10
BP 1531
EP 1545
DI 10.1111/epi.13508
PG 15
WC Clinical Neurology
SC Neurosciences & Neurology
GA EB8QV
UT WOS:000387656800003
PM 27554452
DA 2024-11-01
ER

PT J
AU Xia, CY
   Liu, Y
   Liu, H
   Zhang, YC
   Ma, YN
   Qi, Y
AF Xia, Chang-Yu
   Liu, Yu
   Liu, Hui
   Zhang, Yan-Chun
   Ma, Yi-Nan
   Qi, Yu
TI Clinical and Molecular Characteristics in 100 Chinese Pediatric Patients with m.3243A&gt;G Mutation in Mitochondrial DNA
SO CHINESE MEDICAL JOURNAL
LA English
DT Article
DE Clinical Symptom; Heteroplasmy; Mitochondrial A3243G Mutation; Mitochondrial Disease
ID transfer rnaleu(uur) gene; greater-than g; lactic-acidosis; a3243g mutation; melas mutation; point mutation; transfer-rna; prevalence; features; encephalopathy
AB Background: Mitochondrial diseases are a group of energy metabolic disorders with multisystem involvements. Variable clinical features present a major challenge in pediatric diagnoses. We summarized the clinical spectrum of m.3243A>G mutation in Chinese pediatric patients, to define the common clinical manifestations and study the correlation between heteroplasmic degree of the mutation and clinical severity of the disease. Methods: Clinical data of one-hundred pediatric patients with symptomatic mitochondrial disease harboring m.3243A>G mutation from 2007 to 2013 were retrospectively reviewed. Detection of m.3243A>G mutation ratio was performed by polymerase chain reaction (PCR)-restriction fragment length polymorphism. Correlation between m.3243A>G mutation ratio and age was evaluated. The differences in clinical symptom frequency of patients with low, middle, and high levels of mutation ratio were analyzed by Chi-square test. Results: Sixty-six patients (66%) had suffered a delayed diagnosis for an average of 2 years. The most frequent symptoms were seizures (76%), short stature (73%), elevated plasma lactate (70%), abnormal magnetic resonance imaging/computed tomography (MRI/CT) changes (68%), vomiting (55%), decreased vision (52%), headache (50%), and muscle weakness (48%). The mutation ratio was correlated negatively with onset age (r = -0.470, P < 0.001). Myopathy was more frequent in patients with a high level of mutation ratio. However, patients with a low or middle level of m.3243A>G mutation ratio were more likely to suffer hearing loss, decreased vision, and gastrointestinal disturbance than patients with a high level of mutation ratio. Conclusions: Our study showed that half of Chinese pediatric patients with m.3243A>G mutation presented seizures, short stature, abnormal MRI/CT changes, elevated plasma lactate, vomiting, and headache. Pediatric patients with these recurrent symptoms should be considered for screening m.3243A>G mutation. Clinical manifestations and laboratory abnormalities should be carefully monitored in patients with this point mutation.
C1 [Xia, Chang-Yu; Liu, Yu; Liu, Hui; Zhang, Yan-Chun; Ma, Yi-Nan; Qi, Yu] Peking Univ, Dept Cent Lab, Hosp 1, Beijing 100034, Peoples R China.
C3 Peking University
RP Ma, YN (corresponding author), Peking Univ, Dept Cent Lab, Hosp 1, Beijing 100034, Peoples R China.
EM mayinan1014@163.com
FU National Natural Science Foundation of China [81271256, 81471153]; Capital Characteristic Clinical Application Research Projects [Z131107002213062]
CR Bosbach S, 2003, BRAIN, V126, P1231, DOI 10.1093/brain/awg101
   Chae JH, 2004, BRAIN DEV-JPN, V26, P459, DOI 10.1016/j.braindev.2004.01.002
   Chi CS, 2010, PEDIATR NEUROL, V43, P183, DOI 10.1016/j.pediatrneurol.2010.04.015
   Chin J, 2014, MITOCHONDRION, V17, P34, DOI 10.1016/j.mito.2014.05.005
   de Laat P, 2012, J INHERIT METAB DIS, V35, P1059, DOI 10.1007/s10545-012-9465-2
   Deschauer M, 2004, J NEUROL NEUROSUR PS, V75, P1204, DOI 10.1136/jnnp.2003.026278
   Fabrizi GM, 1996, J NEUROL NEUROSUR PS, V61, P47, DOI 10.1136/jnnp.61.1.47
   Finsterer J, 2007, ACTA NEUROL SCAND, V116, P1, DOI 10.1111/j.1600-0404.2007.00836.x
   Frederiksen AL, 2006, J MED GENET, V43, P0, DOI 10.1136/jmg.2005.039339
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Holmgren D, 2003, EUR HEART J, V24, P280, DOI 10.1016/S0195-668X(02)00387-1
   Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   Koga Y, 2000, ARCH DIS CHILD, V82, P407, DOI 10.1136/adc.82.5.407
   Ma YN, 2010, J NEUROL SCI, V291, P17, DOI 10.1016/j.jns.2010.01.012
   Ma YN, 2009, MITOCHONDRION, V9, P139, DOI 10.1016/j.mito.2009.01.004
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Majamaa K, 1997, NEUROLOGY, V49, P1331, DOI 10.1212/WNL.49.5.1331
   Majamaa-Voltti Kirsi, 2002, BMC CARDIOVASC DISORD, V2, P12
   MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
   MORAES CT, 1993, NEUROMUSCULAR DISORD, V3, P43, DOI 10.1016/0960-8966(93)90040-Q
   Park H, 2003, BIOCHEMISTRY-US, V42, P958, DOI 10.1021/bi026882r
   Rahman S, 2015, EPILEPSY BEHAV, V49, P71, DOI 10.1016/j.yebeh.2015.05.003
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001
   Sue CM, 1998, J NEUROL NEUROSUR PS, V65, P233, DOI 10.1136/jnnp.65.2.233
   Torroni A, 2003, AM J HUM GENET, V72, P1005, DOI 10.1086/373936
   Uusimaa J, 2007, ANN NEUROL, V62, P278, DOI 10.1002/ana.21196
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Wang YX, 2015, CHINESE MED J-PEKING, V128, P1820, DOI 10.4103/0366-6999.159360
NR 31
TC 18
Z9 21
U1 1
U2 7
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0366-6999
EI 2542-5641
J9 CHINESE MED J-PEKING
JI Chin. Med. J.
PD AUG 20
PY 2016
VL 129
IS 16
BP 1945
EP 1949
DI 10.4103/0366-6999.187845
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA DV9DG
UT WOS:000383239400010
PM 27503020
DA 2024-11-01
ER

PT J
AU Fayzullina, S
   Martin, LJ
AF Fayzullina, Saniya
   Martin, Lee J.
TI DNA Damage Response and DNA Repair in Skeletal Myocytes From a Mouse Model of Spinal Muscular Atrophy
SO JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
LA English
DT Article
DE DNA damage; DNA repair; p53; Motor neuron disease; Satellite cell; Skeletal muscle; Spinal muscular atrophy
ID differentiated muscle-cells; motor-neuron gene; satellite cells; myogenic differentiation; increased susceptibility; strain differences; in-vitro; apoptosis; protein; mitochondrial
AB We studied DNA damage response (DDR) and DNA repair capacities of skeletal muscle cells from a mouse model of infantile spinal muscular atrophy (SMA) caused by loss-of-function mutation of survival of motor neuron (Smn). Primary myocyte cultures derived from skeletal muscle satellite cells of neonatal control and mutant SMN mice had similar myotube length, myonuclei, satellite cell marker Pax7 and differentiated myotube marker myosin, and acetylcholine receptor clustering. DNA damage was induced in differentiated skeletal myotubes by gamma-irradiation, etoposide, and methyl methanesulfonate (MMS). Unexposed control and SMA myotubes had stable genome integrity. After gamma-irradiation and etoposide, myotubes repaired most DNA damage equally. Control and mutant myotubes exposed to MMS exhibited equivalent DNA damage without repair. Control and SMA myotube nuclei contained DDR proteins phospho-p53 and phospho-H2AX foci that, with DNA damage, dispersed and then re-formed similarly after recovery. We conclude that mouse primary satellite cell-derived myotubes effectively respond to and repair DNA strand-breaks, while DNA alkylation repair is underrepresented. Morphological differentiation, genome stability, genome sensor, and DNA strand-break repair potential are preserved in mouse SMA myocytes; thus, reduced SMN does not interfere with myocyte differentiation, genome integrity, and DNA repair, and faulty DNA repair is unlikely pathogenic in SMA.
C1 [Fayzullina, Saniya; Martin, Lee J.] Johns Hopkins Sch Med, Dept Pathol, Div Neuropathol, Baltimore, MD USA.
   [Fayzullina, Saniya; Martin, Lee J.] Johns Hopkins Sch Med, Pathobiol Grad Training Program, Baltimore, MD USA.
C3 Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine
RP Martin, LJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, 558 Ross Bldg,720 Rutland Ave, Baltimore, MD 21205 USA.
EM martinl@jhmi.edu
CR Bois PRJ, 2003, EMBO J, V22, P1147, DOI 10.1093/emboj/cdg116
   Boyer JG, 2014, HUM MOL GENET, V23, P4249, DOI 10.1093/hmg/ddu142
   Briese M, 2006, J COMP NEUROL, V497, P808, DOI 10.1002/cne.21010
   Brouillette J, 2005, CARDIOVASC RES, V65, P148, DOI 10.1016/j.cardiores.2004.09.012
   Burlet P, 1998, HUM MOL GENET, V7, P1927, DOI 10.1093/hmg/7.12.1927
   Chia R, 2005, NAT GENET, V37, P1181, DOI 10.1038/ng1665
   Collins AR, 2004, MOL BIOTECHNOL, V26, P249, DOI 10.1385/MB:26:3:249
   Cousin W, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0063528
   Crawford TO, 1996, NEUROBIOL DIS, V3, P97, DOI 10.1006/nbdi.1996.0010
   Dogra C, 2006, J BIOL CHEM, V281, P10327, DOI 10.1074/jbc.M511131200
   DUBOWITZ V, 1964, BRAIN, V87, P707, DOI 10.1093/brain/87.4.707
   FALLON JR, 1994, TRENDS NEUROSCI, V17, P469, DOI 10.1016/0166-2236(94)90135-X
   Falsone SF, 2012, CELL REP, V2, P358, DOI 10.1016/j.celrep.2012.06.012
   Fayzullina S, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0093329
   Festing MFW, 2010, TOXICOL PATHOL, V38, P681, DOI 10.1177/0192623310373776
   Fortini P, 2012, CELL DEATH DIFFER, V19, P1741, DOI 10.1038/cdd.2012.53
   Fortini P, 2010, MUTAT RES-FUND MOL M, V685, P38, DOI 10.1016/j.mrfmmm.2009.11.003
   Fortini P, 2013, MUTAT RES-FUND MOL M, V743, P160, DOI 10.1016/j.mrfmmm.2013.03.004
   GARDNERMEDWIN D, 1967, J NEUROL SCI, V5, P121, DOI 10.1016/0022-510X(67)90013-5
   Gilder AS, 2011, MOL BIOL CELL, V22, P1070, DOI 10.1091/mbc.E10-08-0731
   Gogliotti RG, 2010, BIOCHEM BIOPH RES CO, V391, P517, DOI 10.1016/j.bbrc.2009.11.090
   Hammond SM, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0015887
   Harford TJ, 2010, APOPTOSIS, V15, P71, DOI 10.1007/s10495-009-0428-5
   Hayhurst M, 2012, DEV BIOL, V368, P323, DOI 10.1016/j.ydbio.2012.05.037
   Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709
   Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794
   Jedrzejowska M, 2009, ACTA BIOCHIM POL, V56, P103
   Khanna A, 2015, CANCER RES, V75, P2133, DOI 10.1158/0008-5472.CAN-14-3247
   Kohn KW, 2005, BIOCHEM BIOPH RES CO, V331, P816, DOI 10.1016/j.bbrc.2005.03.186
   Komarova EA, 2000, ONCOGENE, V19, P3791, DOI 10.1038/sj.onc.1203717
   Latella L, 2004, MOL CELL BIOL, V24, P6350, DOI 10.1128/MCB.24.14.6350-6361.2004
   LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3
   Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0
   Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760
   MacFarlane M, 1996, MOL PHARMACOL, V50, P900
   MacLeod M J, 1999, EUR J PAEDIATR NEUROL, V3, P65, DOI 10.1016/S1090-3798(99)80015-4
   Mahmoudi M, 2008, CIRC RES, V103, P717, DOI 10.1161/CIRCRESAHA.108.182899
   Martin LJ, 2008, J NEUROPATH EXP NEUR, V67, P377, DOI 10.1097/NEN.0b013e31816ff780
   Martin LJ, 2010, PHARMACEUTICALS, V3, P839, DOI 10.3390/ph3040839
   Martin LJ, 2009, EXP NEUROL, V218, P333, DOI 10.1016/j.expneurol.2009.02.015
   Martin LJ, 2009, CEREB CORTEX, V19, P1273, DOI 10.1093/cercor/bhn167
   Martin LJ, 2002, NEUROCHEM RES, V27, P1093, DOI 10.1023/A:1020961006216
   Martindale JJ, 2005, J BIOL CHEM, V280, P669, DOI 10.1074/jbc.M406690200
   MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407
   Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333
   Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758
   Narciso L, 2007, P NATL ACAD SCI USA, V104, P17010, DOI 10.1073/pnas.0701743104
   Nicole S, 2003, J CELL BIOL, V161, P571, DOI 10.1083/jcb.200210117
   Nicole S, 2002, MUSCLE NERVE, V26, P4, DOI 10.1002/mus.10110
   Okuno H, 2012, CELL BIOL INT, V36, P441, DOI 10.1042/CBI20100782
   OSTLING O, 1984, BIOCHEM BIOPH RES CO, V123, P291, DOI 10.1016/0006-291X(84)90411-X
   Pavlath G K, 1996, METHODS MOL MED, V2, P307, DOI 10.1385/0-89603-335-X:307
   PEARN J, 1980, LANCET, V1, P919
   Puri PL, 2002, NAT GENET, V32, P585, DOI 10.1038/ng1023
   Raats MM, 1992, FOOD QUALITY AND PREFERENCE, V3, P89, DOI 10.1016/0950-3293(91)90028-D
   RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275
   Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858
   Roos WP, 2013, CANCER LETT, V332, P237, DOI 10.1016/j.canlet.2012.01.007
   Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723
   Scharf JM, 1998, NAT GENET, V20, P83, DOI 10.1038/1753
   Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920
   Schuster-Gossler K, 2007, P NATL ACAD SCI USA, V104, P537, DOI 10.1073/pnas.0608281104
   Shefer G, 2004, J CELL SCI, V117, P5393, DOI 10.1242/jcs.01419
   SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0
   Takaku M, 2011, BIOCHEMISTRY-US, V50, P6797, DOI 10.1021/bi200828g
   Takizawa Y, 2010, NUCLEIC ACIDS RES, V38, P5059, DOI 10.1093/nar/gkq271
   THIEME A, 1994, HUM GENET, V93, P344, DOI 10.1007/BF00212036
   THOMAS NH, 1994, NEUROMUSCULAR DISORD, V4, P497, DOI 10.1016/0960-8966(94)90090-6
   Vasconsuelo A, 2008, J ENDOCRINOL, V196, P385, DOI 10.1677/JOE-07-0250
   Velma V, 2010, FEBS LETT, V584, P4735, DOI 10.1016/j.febslet.2010.11.004
   Vincent SD, 2014, HUM MOL GENET, V23, P5087, DOI 10.1093/hmg/ddu232
   Vitte J, 2009, ADV EXP MED BIOL, V652, P237, DOI 10.1007/978-90-481-2813-6_16
   Vos MJ, 2010, HUM MOL GENET, V19, P4677, DOI 10.1093/hmg/ddq398
   Wang L, 2012, EXP CELL RES, V318, P2324, DOI 10.1016/j.yexcr.2012.06.018
   Wang WL, 2005, MOL GENET METAB, V85, P38, DOI 10.1016/j.ymgme.2004.12.015
   Wang Y, 2011, MOL NEURODEGENER, V6, P0, DOI 10.1186/1750-1326-6-75
   Wiklund SJ, 2003, MUTAGENESIS, V18, P167, DOI 10.1093/mutage/18.2.167
   Wu CY, 2009, BMC CELL BIOL, V10, P0, DOI 10.1186/1471-2121-10-40
   Wyatt MD, 2006, CHEM RES TOXICOL, V19, P1580, DOI 10.1021/tx060164e
   ZHAN QM, 1993, MOL CELL BIOL, V13, P4242, DOI 10.1128/MCB.13.7.4242
   Zhou BBS, 2004, NATURE REV, V4, P1
   Zwemer CF, 2007, J APPL PHYSIOL, V102, P286, DOI 10.1152/japplphysiol.00536.2006
NR 83
TC 9
Z9 9
U1 0
U2 8
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-3069
EI 1554-6578
J9 J NEUROPATH EXP NEUR
JI J. Neuropathol. Exp. Neurol.
PD SEP 15
PY 2016
VL 75
IS 9
BP 889
EP 902
DI 10.1093/jnen/nlw064
PG 14
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA DX8WJ
UT WOS:000384671300007
PM 27452406
DA 2024-11-01
ER

PT J
AU Pham, TD
   Wallace, DC
   Burke, PJ
AF Pham, Ted D.
   Wallace, Douglas C.
   Burke, Peter J.
TI Microchambers with Solid-State Phosphorescent Sensor for Measuring Single Mitochondrial Respiration
SO SENSORS
LA English
DT Article
DE respiration; mitochondria; oxygen consumption rate; phosphorescent probes; PtTFPP
ID oxygen sensors; heteroplasmy; tissue; probes; cells; selection; lifetime; muscle; mtdna; dna
AB It is now well established that, even within a single cell, multiple copies of the mitochondrial genome may be present (genetic heteroplasmy). It would be interesting to develop techniques to determine if and to what extent this genetic variation results in functional variation from one mitochondrion to the next (functional heteroplasmy). Measuring mitochondrial respiration can reveal the organelles' functional capacity for Adenosine triphosphate (ATP) production and determine mitochondrial damage that may arise from genetic or age related defects. However, available technologies require significant quantities of mitochondria. Here, we develop a technology to assay the respiration of a single mitochondrion. Our "micro-respirometer" consists of micron sized chambers etched out of borofloat glass substrates and coated with an oxygen sensitive phosphorescent dye Pt(II) meso-tetra(pentafluorophenyl) porphine (PtTFPP) mixed with polystyrene. The chambers are sealed with a polydimethylsiloxane layer coated with oxygen impermeable Viton rubber to prevent diffusion of oxygen from the environment. As the mitochondria consume oxygen in the chamber, the phosphorescence signal increases, allowing direct determination of the respiration rate. Experiments with coupled vs. uncoupled mitochondria showed a substantial difference in respiration, confirming the validity of the microchambers as single mitochondrial respirometers. This demonstration could enable future high-throughput assays of mitochondrial respiration and benefit the study of mitochondrial functional heterogeneity, and its role in health and disease.
C1 [Pham, Ted D.; Burke, Peter J.] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA.
   [Wallace, Douglas C.] Univ Penn, Ctr Mitochondrial & Epigen Med, Philadelphia, PA 19104 USA.
   [Burke, Peter J.] Univ Calif Irvine, Dept Elect Engn, Irvine, CA 92697 USA.
C3 University of California System; University of California Irvine; University of Pennsylvania; University of California System; University of California Irvine
RP Burke, PJ (corresponding author), Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA.; Burke, PJ (corresponding author), Univ Calif Irvine, Dept Elect Engn, Irvine, CA 92697 USA.
EM tedp@uci.edu; wallaced1@email.chop.edu; pburke@uci.edu
FU NIH National Cancer Institute [1R21CA143351-01]
CR [Anonymous], 2013, BIOENERGETICS 4, V0, P0
   Celina M, 2005, MACROMOLECULES, V38, P2754, DOI 10.1021/ma0487913
   Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025
   CLARK LC, 1953, J APPL PHYSIOL, V6, P189, DOI 10.1152/jappl.1953.6.3.189
   Collins TJ, 2002, EMBO J, V21, P1616, DOI 10.1093/emboj/21.7.1616
   Deegan RD, 1997, NATURE, V389, P827, DOI 10.1038/39827
   Dmitriev RI, 2014, BIOMATER SCI-UK, V2, P853, DOI 10.1039/c3bm60272a
   Dmitriev RI, 2012, CELL MOL LIFE SCI, V69, P2025, DOI 10.1007/s00018-011-0914-0
   Dragavon J, 2008, J R SOC INTERFACE, V5, PS151, DOI 10.1098/rsif.2008.0106.focus
   Drioli E, 2010, COMPREHENSIVE MEMBRANE SCIENCE AND ENGINEERING, V1st, P0
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478
   GEAR ARL, 1972, J CELL BIOL, V54, P325, DOI 10.1083/jcb.54.2.325
   Grad LI, 2005, P NATL ACAD SCI USA, V102, P18367, DOI 10.1073/pnas.0506939102
   Grist SM, 2015, SENSORS-BASEL, V15, P20030, DOI 10.3390/s150820030
   Hütter E, 2006, EXP GERONTOL, V41, P457, DOI 10.1016/j.exger.2006.02.004
   Hüser J, 1999, BIOCHEM J, V343, P311, DOI 10.1042/0264-6021:3430311
   Kurokawa H, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep10657
   Lascaratos G, 2007, VISION RES, V47, P1191, DOI 10.1016/j.visres.2006.12.014
   Li MK, 2010, AM J HUM GENET, V87, P237, DOI 10.1016/j.ajhg.2010.07.014
   Liu H, 2013, SMALL, V9, P2639, DOI 10.1002/smll.201203127
   Ma Q, 2011, J BIOL CHEM, V286, P27573, DOI 10.1074/jbc.M111.241794
   Molter TW, 2008, IEEE T AUTOM SCI ENG, V5, P32, DOI 10.1109/TASE.2007.909441
   Molter TW, 2009, SENSOR ACTUAT B-CHEM, V135, P678, DOI 10.1016/j.snb.2008.10.036
   Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385
   Nock V, 2008, LAB CHIP, V8, P1300, DOI 10.1039/b801879k
   Nock V, 2010, MICROELECTRON ENG, V87, P814, DOI 10.1016/j.mee.2009.11.076
   ORiordan TC, 2000, ANAL BIOCHEM, V278, P221, DOI 10.1006/abio.1999.4431
   Papkovsky DB, 2004, METHOD ENZYMOL, V381, P715
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   PEACOCK RN, 1980, J VAC SCI TECHNOL, V17, P330, DOI 10.1116/1.570380
   Picard M, 2013, J APPL PHYSIOL, V114, P161, DOI 10.1152/japplphysiol.01096.2012
   Quaranta Michela, 2012, BIOANAL REV, V4, P115
   Rogers GW, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0021746
   RUMSEY WL, 1988, SCIENCE, V241, P1649, DOI 10.1126/science.3420417
   Sharpley MS, 2012, CELL, V151, P333, DOI 10.1016/j.cell.2012.09.004
   Skolimowski M, 2010, LAB CHIP, V10, P2162, DOI 10.1039/c003558k
   SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671
   Van Dam M, 2006, THESIS, V0, P0
   Vollmer AP, 2005, LAB CHIP, V5, P1059, DOI 10.1039/b508097e
   Wallace DC, 2011, COLD SH Q B, V76, P1, DOI 10.1101/sqb.2011.76.010462
   Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365
   Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314
   Will Y, 2006, NAT PROTOC, V1, P2563, DOI 10.1038/nprot.2006.351
   Wu CF, 2009, ANGEW CHEM INT EDIT, V48, P2741, DOI 10.1002/anie.200805894
   Wu CC, 2010, TALANTA, V81, P228, DOI 10.1016/j.talanta.2009.11.062
   Wu RR, 2015, BIOCHEM BIOPH RES CO, V460, P572, DOI 10.1016/j.bbrc.2015.03.071
NR 48
TC 3
Z9 6
U1 1
U2 15
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 1424-8220
J9 SENSORS-BASEL
JI Sensors
PD JUL 15
PY 2016
VL 16
IS 7
BP 
EP 
DI 10.3390/s16071065
PG 14
WC Chemistry, Analytical; Engineering, Electrical & Electronic; Instruments & Instrumentation
SC Chemistry; Engineering; Instruments & Instrumentation
GA DS7MG
UT WOS:000380967000122
PM 27409618
DA 2024-11-01
ER

PT J
AU Nikkanen, J
   Forsström, S
   Euro, L
   Paetau, I
   Kohnz, RA
   Wang, LY
   Chilov, D
   Viinamäki, J
   Roivainen, A
   Marjamäki, P
   Liljenbäck, H
   Ahola, S
   Buzkova, J
   Terzioglu, M
   Khan, NA
   Pirnes-Karhu, S
   Paetau, A
   Lönnqvist, T
   Sajantila, A
   Isohanni, P
   Tyynismaa, H
   Nomura, DK
   Battersby, BJ
   Velagapudi, V
   Carroll, CJ
   Suomalainen, A
AF Nikkanen, Joni
   Forsstrom, Saara
   Euro, Liliya
   Paetau, Ilse
   Kohnz, Rebecca A.
   Wang, Liya
   Chilov, Dmitri
   Viinamaki, Jenni
   Roivainen, Anne
   Marjamaki, Paivi
   Liljenback, Heidi
   Ahola, Sofia
   Buzkova, Jana
   Terzioglu, Mugen
   Khan, Nahid A.
   Pirnes-Karhu, Sini
   Paetau, Anders
   Lonnqvist, Tuula
   Sajantila, Antti
   Isohanni, Pirjo
   Tyynismaa, Henna
   Nomura, Daniel K.
   Battersby, Brendan J.
   Velagapudi, Vidya
   Carroll, Christopher J.
   Suomalainen, Anu
TI Mitochondrial DNA Replication Defects Disturb Cellular dNTP Pools and Remodel One-Carbon Metabolism
SO CELL METABOLISM
LA English
DT Article
ID progressive external ophthalmoplegia; onset spinocerebellar ataxia; multiple deletions; crystal-structure; recessive ataxia; bacteriophage t7; mtdna depletion; helicase; mutations; twinkle
AB Mitochondrial dysfunction affects cellular energy metabolism, but less is known about the consequences for cytoplasmic biosynthetic reactions. We report that mtDNA replication disorders caused by TWINKLE mutations-mitochondrial myopathy (MM) and infantile onset spinocerebellar ataxia (IOSCA)-remodel cellular dNTP pools in mice. MM muscle shows tissue-specific induction of the mitochondrial folate cycle, purine metabolism, and imbalanced and increased dNTP pools, consistent with progressive mtDNA mutagenesis. IOSCA-TWINKLE is predicted to hydrolyze dNTPs, consistent with low dNTP pools and mtDNA depletion in the disease. MM muscle also modifies the cytoplasmic one-carbon cycle, transsulfuration, and methylation, as well as increases glucose uptake and its utilization for de novo serine and glutathione biosynthesis. Our evidence indicates that the mitochondrial replication machinery communicates with cytoplasmic dNTP pools and that upregulation of glutathione synthesis through glucose-driven de novo serine biosynthesis contributes to the metabolic stress response. These results are important for disorders with primary or secondary mtDNA instability and offer targets for metabolic therapy.
C1 [Nikkanen, Joni; Forsstrom, Saara; Euro, Liliya; Paetau, Ilse; Chilov, Dmitri; Ahola, Sofia; Buzkova, Jana; Terzioglu, Mugen; Khan, Nahid A.; Pirnes-Karhu, Sini; Isohanni, Pirjo; Tyynismaa, Henna; Battersby, Brendan J.; Carroll, Christopher J.; Suomalainen, Anu] Univ Helsinki, Res Programs Unit, Mol Neurol, FIN-00290 Helsinki, Finland.
   [Kohnz, Rebecca A.; Nomura, Daniel K.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.
   [Kohnz, Rebecca A.; Nomura, Daniel K.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA.
   [Wang, Liya] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, S-75007 Uppsala, Sweden.
   [Viinamaki, Jenni; Sajantila, Antti] Univ Helsinki, Dept Forens Med, Kytosuontie 11, SF-00300 Helsinki, Finland.
   [Roivainen, Anne; Marjamaki, Paivi; Liljenback, Heidi] Univ Turku, Turku PET Ctr, FIN-20520 Turku, Finland.
   [Roivainen, Anne; Liljenback, Heidi] Univ Turku, Inst Biomed, Turku Ctr Dis Modeling, FIN-20520 Turku, Finland.
   [Paetau, Anders] Univ Helsinki, Helsinki Univ Hosp, HUSLAB, FIN-00290 Helsinki, Finland.
   [Paetau, Anders] Univ Helsinki, Helsinki Univ Hosp, Dept Pathol, FIN-00290 Helsinki, Finland.
   [Lonnqvist, Tuula; Isohanni, Pirjo] Univ Helsinki, Helsinki Univ Hosp, Childrens Hosp, Dept Child Neurol, FIN-00290 Helsinki, Finland.
   [Suomalainen, Anu] Univ Helsinki, Helsinki Univ Hosp, Dept Neurol, FIN-00290 Helsinki, Finland.
   [Tyynismaa, Henna] Univ Helsinki, Dept Med & Clin Genet, FIN-00290 Helsinki, Finland.
   [Velagapudi, Vidya] Univ Helsinki, Inst Mol Med Finland, Metabol Unit, FIN-00290 Helsinki, Finland.
   [Suomalainen, Anu] Univ Helsinki, Ctr Neurosci, Helsinki 00790, Finland.
C3 University of Helsinki; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Swedish University of Agricultural Sciences; University of Helsinki; University of Turku; University of Turku; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; University of Helsinki
RP Carroll, CJ; Suomalainen, A (corresponding author), Univ Helsinki, Res Programs Unit, Mol Neurol, FIN-00290 Helsinki, Finland.; Suomalainen, A (corresponding author), Univ Helsinki, Helsinki Univ Hosp, Dept Neurol, FIN-00290 Helsinki, Finland.; Suomalainen, A (corresponding author), Univ Helsinki, Ctr Neurosci, Helsinki 00790, Finland.
EM christopher.carroll@helsinki.fi; anu.wartiovaara@helsinki.fi
FU European Research Council; Academy of Finland; Sigrid Juselius Foundation; Jane and Aatos Erkko Foundation; University of Helsinki; Helsinki University Central Hospital; Helsinki Biomedical Graduate School; NIH [R01CA172667]; University of Turku; Turku University Hospital; Abo Akademi University
CR Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770
   BALSOM PD, 1994, SPORTS MED, V18, P268, DOI 10.2165/00007256-199418040-00005
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Christensen KE, 2006, BIOESSAYS, V28, P595, DOI 10.1002/bies.20420
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Crampton DJ, 2006, MOL CELL, V21, P165, DOI 10.1016/j.molcel.2005.11.027
   DeNicola GM, 2015, NAT GENET, V47, P1475, DOI 10.1038/ng.3421
   Di Pietro E, 2004, BBA-GEN SUBJECTS, V1674, P78, DOI 10.1016/j.bbagen.2004.06.014
   Field MS, 2006, J BIOL CHEM, V281, P4215, DOI 10.1074/jbc.M510624200
   Garcia-Diaz B, 2014, BRAIN, V137, P1337, DOI 10.1093/brain/awu068
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Hingorani MM, 1996, BIOCHEMISTRY-US, V35, P2218, DOI 10.1021/bi9521497
   Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595
   Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Li Y, 2014, CELL, V158, P213, DOI 10.1016/j.cell.2014.05.034
   Liao JC, 2005, J MOL BIOL, V350, P452, DOI 10.1016/j.jmb.2005.04.051
   Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890
   Lönnqvist T, 1998, J NEUROL SCI, V161, P57, DOI 10.1016/S0022-510X(98)00249-4
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Martí R, 2012, METHODS MOL BIOL, V837, P135, DOI 10.1007/978-1-61779-504-6_9
   Mehrmohamadi M, 2014, CELL REP, V9, P1507, DOI 10.1016/j.celrep.2014.10.026
   Mudd SH, 2007, AM J CLIN NUTR, V85, P19, DOI 10.1093/ajcn/85.1.19
   Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Nilsson R, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms4128
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Pagliarini DJ, 2013, GENE DEV, V27, P2615, DOI 10.1101/gad.229724.113
   Pike ST, 2010, J BIOL CHEM, V285, P4612, DOI 10.1074/jbc.M109.079855
   Poli J, 2012, EMBO J, V31, P883, DOI 10.1038/emboj.2011.470
   Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7
   SCHIRCH V, 1989, ARCH BIOCHEM BIOPHYS, V269, P371, DOI 10.1016/0003-9861(89)90120-3
   SCOTT JM, 1981, LANCET, V2, P337
   Sengupta Rajib, 2014, WORLD J BIOL CHEM, V5, P68, DOI 10.4331/wjbc.v5.i1.68
   Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Stockler S, 1996, AM J HUM GENET, V58, P914
   STRONG WB, 1990, J BIOL CHEM, V265, P12149
   Suh JR, 2001, ANNU REV NUTR, V21, P255, DOI 10.1146/annurev.nutr.21.1.255
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856
   Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810
   Tufi R, 2014, NAT CELL BIOL, V16, P157, DOI 10.1038/ncb2901
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
NR 52
TC 201
Z9 213
U1 0
U2 21
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1550-4131
EI 1932-7420
J9 CELL METAB
JI Cell Metab.
PD APR 12
PY 2016
VL 23
IS 4
BP 635
EP 648
DI 10.1016/j.cmet.2016.01.019
PG 14
WC Cell Biology; Endocrinology & Metabolism
SC Cell Biology; Endocrinology & Metabolism
GA DJ3RL
UT WOS:000374123200012
PM 26924217
DA 2024-11-01
ER

PT J
AU Mkaouar-Rebai, E
   Felhi, R
   Tabebi, M
   Alila-Fersi, O
   Chamkha, I
   Maalej, M
   Ammar, M
   Kammoun, F
   Keskes, L
   Hachicha, M
   Fakhfakh, F
AF Mkaouar-Rebai, Emna
   Felhi, Rahma
   Tabebi, Mouna
   Alila-Fersi, Olfa
   Chamkha, Imen
   Maalej, Marwa
   Ammar, Marwa
   Kammoun, Fatma
   Keskes, Leila
   Hachicha, Mongia
   Fakhfakh, Faiza
TI Mitochondrial DNA triplication and punctual mutations in patients with mitochondrial neuromuscular disorders
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Mitochondrial mutations; mtDNA; Mitochondrial duplication; m.9157G > A; m.14924T > C; MT-ATP6
ID 9-bp deletion; d-loop; duplication; sequence; genome
AB Mitochondrial diseases are a heterogeneous group of disorders caused by the impairment of the mitochondrial oxidative phosphorylation system which have been associated with various mutations of the mitochondrial DNA (mtDNA) and nuclear gene mutations. The clinical phenotypes are very diverse and the spectrum is still expanding. As brain and muscle are highly dependent on OXPHOS, consequently, neurological disorders and myopathy are common features of mtDNA mutations. Mutations in mtDNA can be classified into three categories: large-scale rearrangements, point mutations in tRNA or rRNA genes and point mutations in protein coding genes. In the present report, we screened mitochondrial genes of complex I, III, IV and V in 2 patients with mitochondrial neuromuscular disorders. The results showed the presence the pathogenic heteroplasmic m.9157G>A variation (A211T) in the MT-ATP6 gene in the first patient. We also reported the first case of triplication of 9 bp in the mitochondrial NC7 region in Africa and Tunisia, in association with the novel m.14924T>C in the MT-CYB gene in the second patient with mitochondrial neuromuscular disorder. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Mkaouar-Rebai, Emna; Alila-Fersi, Olfa; Chamkha, Imen; Fakhfakh, Faiza] Univ Sfax, Fac Sci Sfax, Dept Sci Vie, Sfax, Tunisia.
   [Felhi, Rahma; Tabebi, Mouna; Maalej, Marwa; Ammar, Marwa; Keskes, Leila] Univ Sfax, Fac Med Sfax, Lab Genet Mol Humaine, Sfax, Tunisia.
   [Kammoun, Fatma; Hachicha, Mongia] CHU Hedi Chaker Sfax, Serv Pediat, Sfax, Tunisia.
C3 Universite de Sfax; Faculty of Sciences Sfax; Universite de Sfax; Universite de Sfax; Hopital Hedi Chaker
RP Mkaouar-Rebai, E; Fakhfakh, F (corresponding author), Fac Sci Sfax, Dept Sci Vie, Route Soukra,Km 3, Sfax, Tunisia.
EM emna.mkaouar@gmail.com; faiza.fakhfakh02@gmail.com
FU Ministry of the Higher Education and the Scientific Research in Tunisia
CR Amanchy R, 2007, NAT BIOTECHNOL, V25, P285, DOI 10.1038/nbt0307-285
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Attimonelli M, 2005, BMC BIOINFORMATICS, V6, P0, DOI 10.1186/1471-2105-6-S4-S4
   Blum A, 2009, ISR MED ASSOC J, V11, P105
   Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607
   BROCKINGTON M, 1993, NAT GENET, V4, P67, DOI 10.1038/ng0593-67
   Carling PJ, 2011, MITOCHONDRION, V11, P686, DOI 10.1016/j.mito.2011.05.004
   Chiaratti MR, 2011, MITOCHONDRION, V11, P820, DOI 10.1016/j.mito.2010.11.004
   Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195
   Cree LM, 2009, BBA-MOL BASIS DIS, V1792, P1097, DOI 10.1016/j.bbadis.2009.03.002
   Cwerman-Thibault H, 2011, J INHERIT METAB DIS, V34, P327, DOI 10.1007/s10545-010-9131-5
   El-Hattab AW, 2016, CELL CALCIUM, V0, P0
   Elango S, 2011, MITOCHONDRION, V11, P878, DOI 10.1016/j.mito.2011.07.002
   Montiel-Sosa JF, 2013, MITOCHONDR DNA, V24, P420, DOI 10.3109/19401736.2012.760550
   Hung WY, 2008, MUTAGENESIS, V23, P137, DOI 10.1093/mutage/gen002
   LEWIN HA, 1992, BIOTECHNIQUES, V13, P522
   LI S, 2000, EUR J HUM GENET, V22, P1040
   Mancuso M, 2004, J MED GENET, V41, P0, DOI 10.1136/jmg.2003.012278
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   PASSARINO G, 1993, AM J HUM GENET, V53, P609
   POULTON J, 1993, DEV MED CHILD NEUROL, V35, P833
   POULTON J, 1989, LANCET, V1, P236
   POULTON J, 1992, BIOESSAYS, V14, P763, DOI 10.1002/bies.950141108
   Prasad BV, 2001, HUM BIOL, V0, P715
   Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493
   Rubino F, 2012, NUCLEIC ACIDS RES, V40, PD1150, DOI 10.1093/nar/gkr1086
   Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755
   SHIELDS GF, 1992, AM J HUM GENET, V50, P758
   Cardena MMSG, 2013, MITOCHONDR DNA, V24, P46, DOI 10.3109/19401736.2012.717933
   Soodyall H, 1996, AM J HUM GENET, V58, P595
   Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591
   Tang S, 2013, HUM MUTAT, V34, P882, DOI 10.1002/humu.22307
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Thangaraj K, 2005, HUM GENET, V116, P507, DOI 10.1007/s00439-005-1271-6
   Thangaraj K, 2008, HUM HERED, V66, P1, DOI 10.1159/000114160
   Tucker EJ, 2011, IUBMB LIFE, V63, P669, DOI 10.1002/iub.495
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
NR 37
TC 5
Z9 5
U1 0
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD APR 29
PY 2016
VL 473
IS 2
BP 578
EP 585
DI 10.1016/j.bbrc.2016.03.126
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA DK3IG
UT WOS:000374809700033
PM 27033601
DA 2024-11-01
ER

PT J
AU Murakami, T
   Ueba, Y
   Shinoto, Y
   Koga, Y
   Kaneda, D
   Hatoko, T
   Kato, T
   Yonemitsu, S
   Murol, S
   Okil, S
AF Murakami, Takaaki
   Ueba, Yoko
   Shinoto, Yuya
   Koga, Yasutoshi
   Kaneda, Daita
   Hatoko, Tomonobu
   Kato, Tomoko
   Yonemitsu, Shin
   Murol, Seiji
   Okil, Shogo
TI Successful Glycemic Control Decreases the Elevated Serum FGF21 Level without Affecting Normal Serum GDF15 Levels in a Patient with Mitochondrial Diabetes
SO TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
DE biomarker; FGF21; GDF15; GLP-1 receptor agonist; mitochondrial diabetes mellitus
ID growth-factor 21; pancreatic beta-cells; disease; resistance; biomarker; mellitus; mutation; japanese; damage
AB Mitochondrial diabetes mellitus is a subtype of diabetes linked to mutations in mitochondrial DNA. In patients with mitochondrial diabetes mellitus, the effect of glycemic control on the serum concentrations of fibroblast growth factor 21 (FGF21) and growth differentiation factor 15 (GDF15) has not been evaluated. FGF21 and GDF15 have been reported to be useful biomarkers for the diagnosis and severity assessment of mitochondrial diseases like mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). Recent studies have shown FGF21 acts in an endocrine fashion to regulate glucose and lipid metabolism in type 2 diabetes mellitus, while the exact biological functions of GDF15 remain unknown. Although mitochondrial diabetes mellitus is commonly found in cases with mitochondrial diseases, the comparison of FGF21 and GDF15 levels between those with and without diabetes has not been performed. Here, we report a 24-year-old woman with mitochondrial diabetes mellitus, who showed a high level of serum FGF21, but not serum GDF15, at diagnosis. In our case, liraglutide, a glucagon-like peptide-1 receptor agonist, added to insulin glargine was effective for her glycemic control and showed no adverse effects, including gastrointestinal symptoms and hypoglycemia, during a 14-week observation. The successful glycemic control caused a decrease in the FGF21 level, without affecting the GDF15 level. Thus, we should consider patients' glycemic control levels in using FGF21 values for the diagnosis of mitochondrial diseases. In addition, sustained GDF15 levels during glycemic treatment in our case suggest the usefulness of GDF15 as a marker for clinical severity of muscle-manifested mitochondrial diseases.
C1 [Murakami, Takaaki; Ueba, Yoko; Hatoko, Tomonobu; Kato, Tomoko; Yonemitsu, Shin; Murol, Seiji; Okil, Shogo] Osaka Red Cross Hosp, Dept Endocrinol & Diabet, Osaka, Osaka 5430027, Japan.
   [Shinoto, Yuya] Osaka Red Cross Hosp, Dept Neurol, Osaka, Osaka 5430027, Japan.
   [Koga, Yasutoshi] Kurume Univ, Sch Med, Dept Pediat & Child Hlth, Kurume, Fukuoka 830, Japan.
   [Kaneda, Daita] Tokyo Metropolitan Geriatr Hosp, Dept Neurol, Tokyo 173, Japan.
   [Kaneda, Daita] Inst Gerontol, Tokyo, Japan.
C3 Osaka Red Cross Hospital; Osaka Red Cross Hospital; Kurume University; Tokyo Metropolitan Institute of Gerontology
RP Murakami, T (corresponding author), Osaka Red Cross Hosp, Dept Endocrinol & Diabet, Tennoji Ku, 5-30 Fudegasaki Cho, Osaka, Osaka 5430027, Japan.
EM t.murakami@osaka-med.jrc.or.jp
CR Chavez AO, 2009, DIABETES CARE, V32, P1542, DOI 10.2337/dc09-0684
   Chen C, 2011, DIABETES CARE, V34, P2113, DOI 10.2337/dc11-0294
   Ciregia F, 2015, MOL BIOSYST, V11, P1696, DOI 10.1039/c5mb00022j
   Fan R, 2010, DIABETES OBES METAB, V12, P815, DOI 10.1111/j.1463-1326.2010.01238.x
   Fujita Y, 2015, MITOCHONDRION, V20, P34, DOI 10.1016/j.mito.2014.10.006
   Iglesias P, 2012, EUR J ENDOCRINOL, V167, P301, DOI 10.1530/EJE-12-0357
   Koene S, 2014, NEUROLOGY, V83, P125, DOI 10.1212/WNL.0000000000000578
   Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200
   Liang C, 2014, BBA-GEN SUBJECTS, V1840, P1360, DOI 10.1016/j.bbagen.2013.10.040
   McDonnell MT, 2004, EUR J HUM GENET, V12, P778, DOI 10.1038/sj.ejhg.5201216
   Mukai E, 2011, DIABETES, V60, P218, DOI 10.2337/db10-0021
   Murakami T, 2016, TOHOKU J EXP MED, V238, P311, DOI 10.1620/tjem.238.311
   Ogata M, 2014, BIOCHEM BIOPH RES CO, V447, P133, DOI 10.1016/j.bbrc.2014.03.143
   Samson SL, 2011, DIABETOLOGIA, V54, P3093, DOI 10.1007/s00125-011-2317-z
   Schaefer AM, 2006, NEUROLOGY, V66, P1932, DOI 10.1212/01.wnl.0000219759.72195.41
   Sun F, 2012, EXP DIABETES RES, V2012, P0, DOI 10.1155/2012/230624
   Suzuki S, 2003, DIABETES RES CLIN PR, V59, P207, DOI 10.1016/S0168-8227(02)00246-2
   Xiao Y, 2012, J CLIN ENDOCR METAB, V97, PE54, DOI 10.1210/jc.2011-1930
   Yang ML, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0026359
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
NR 21
TC 13
Z9 15
U1 0
U2 10
PU TOHOKU UNIV MEDICAL PRESS
PI SENDAI
PA 2-1, SEIRYO-MACHI, AOBA-KU, SENDAI, MIYAGI 980-8575, JAPAN
SN 0040-8727
EI 1349-3329
J9 TOHOKU J EXP MED
JI Tohoku J. Exp. Med.
PD JUN 15
PY 2016
VL 239
IS 2
BP 89
EP 94
DI 10.1620/tjem.239.89
PG 6
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA DO9IW
UT WOS:000378100900001
PM 27212224
DA 2024-11-01
ER

PT J
AU Safdar, A
   Annis, S
   Kraytsberg, Y
   Laverack, C
   Saleem, A
   Popadin, K
   Woods, DC
   Tilly, JL
   Khrapko, K
AF Safdar, Adeel
   Annis, Sofia
   Kraytsberg, Yevgenya
   Laverack, Chloe
   Saleem, Ayesha
   Popadin, Konstantin
   Woods, Dori C.
   Tilly, Jonathan L.
   Khrapko, Konstantin
TI Amelioration of premature aging in mtDNA mutator mouse by exercise: the interplay of oxidative stress, PGC-1α, p53, and DNA damage. A hypothesis
SO CURRENT OPINION IN GENETICS & DEVELOPMENT
LA English
DT Article
ID skeletal-muscle; mutations; mice; mitochondria; disease; protein; mutagenesis; bypass; cardiomyopathy; suppression
AB The mtDNA mutator mouse lacks the proofreading capacity of the sole mtDNA polymerase, leading to accumulation of somatic mtDNA mutations, and a profound premature aging phenotype including elevated oxidative stress and apoptosis, and reduced mitochondrial function. We have previously reported that endurance exercise alleviates the aging phenotype in the mutator mice, reduces oxidative stress, and enhances mitochondrial biogenesis. Here we summarize our findings, with the emphasis on the central role of p53 in these adaptations. We demonstrate that mtDNA in sedentary and exercised PoIG mice carry similar amounts of mutations in muscle, but in addition to that sedentary mice have more non-mutational damage, which is mitigated by exercise. It follows therefore that the profound alleviation of the mtDNA mutator phenotype in muscle by exercise may not require a reduction in mtDNA mutational load, but rather a decrease of mtDNA damage and/or oxidative stress. We further hypothesize that the observed 'alleviation without a reduction of mutational load' implies that the oxidative stress in PoIG muscle is maintained, at least in part, by the 'malicious cycle', a hypothetical positive feedback potentially driven by the 'transcriptional mutagenesis', that is the conversion of chemically modified nucleotides into mutant RNA bases by the mitochondrial RNA polymerase.
C1 [Safdar, Adeel; Saleem, Ayesha] McMaster Univ, Dept Pediat, Hamilton, ON L8N 3Z5, Canada.
   [Annis, Sofia; Laverack, Chloe; Woods, Dori C.; Tilly, Jonathan L.; Khrapko, Konstantin] Northeastern Univ, Dept Biol, Boston, MA 02215 USA.
   [Kraytsberg, Yevgenya] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.
   [Kraytsberg, Yevgenya] Harvard Med Sch, Boston, MA 02215 USA.
   [Popadin, Konstantin] Univ Lausanne, Lausanne, Switzerland.
C3 McMaster University; Northeastern University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Lausanne
RP Khrapko, K (corresponding author), Northeastern Univ, Dept Biol, Boston, MA 02215 USA.
EM kkhrapko@gmail.com
FU Canadian Institutes of Health Research Banting Fellowship; American Federation for Aging Research Fellowship; Natural Sciences and Engineering Research Council of Canada; NIH [R37-AG012279]; Ellison Medical Foundation Senior Scholar Award
CR Achanta G, 2005, EMBO J, V24, P3482, DOI 10.1038/sj.emboj.7600819
   Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Bakhanashvili M, 2008, CELL DEATH DIFFER, V15, P1865, DOI 10.1038/cdd.2008.122
   Bakhanashvili M, 2009, AIDS, V23, P779, DOI 10.1097/QAD.0b013e328329c74e
   Bandy B, 1990, FREE RADIC BIOL MED, V5, P3
   Dai DF, 2010, AGING CELL, V9, P536, DOI 10.1111/j.1474-9726.2010.00581.x
   de Souza-Pinto NC, 2004, ONCOGENE, V23, P6559, DOI 10.1038/sj.onc.1207874
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Granata C, 2016, FASEB J, V30, P959, DOI 10.1096/fj.15-276907
   Greaves LC, 2009, AGING CELL, V8, P566, DOI 10.1111/j.1474-9726.2009.00505.x
   Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206
   Hiona A, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0011468
   Khrapko K, 2006, AGING CELL, V5, P279, DOI 10.1111/j.1474-9726.2006.00209.x
   Khrapko K, 2014, PROG MOL BIOL TRANSL, V127, P29, DOI 10.1016/B978-0-12-394625-6.00002-7
   Kolesar JE, 2014, FREE RADICAL BIO MED, V75, P241, DOI 10.1016/j.freeradbiomed.2014.07.038
   Kraytsberg Y, 2008, METHODS, V46, P269, DOI 10.1016/j.ymeth.2008.10.005
   Kraytsberg Y, 2009, AGING CELL, V8, P502, DOI 10.1111/j.1474-9726.2009.00484.x
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lin MT, 2012, ANN NEUROL, V71, P850, DOI 10.1002/ana.23568
   Maslov AY, 2013, AGING CELL, V0, P0
   Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716
   Nakanishi N, 2013, MUTAGENESIS, V28, P117, DOI 10.1093/mutage/ges060
   Park JH, 2016, FEBS LETT, V590, P924, DOI 10.1002/1873-3468.12061
   Safdar A, 2016, SKELETAL MUSCLE, V6, P520
   Safdar A, 2011, J BIOL CHEM, V286, P10605, DOI 10.1074/jbc.M110.211466
   Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108
   Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787
   Saleem A, 2013, J PHYSIOL-LONDON, V591, P3625, DOI 10.1113/jphysiol.2013.252791
   Saxowsky TT, 2008, P NATL ACAD SCI USA, V105, P18877, DOI 10.1073/pnas.0806464105
   St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Vaseva AV, 2009, BBA-BIOENERGETICS, V1787, P414, DOI 10.1016/j.bbabio.2008.10.005
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms9065
   Viswanathan A, 1999, SCIENCE, V284, P159, DOI 10.1126/science.284.5411.159
   Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106
   Zhang D, 2003, CARDIOVASC RES, V57, P147, DOI 10.1016/S0008-6363(02)00695-8
   Zhang DK, 2000, GENOMICS, V69, P151, DOI 10.1006/geno.2000.6333
NR 39
TC 32
Z9 34
U1 0
U2 11
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0959-437X
EI 1879-0380
J9 CURR OPIN GENET DEV
JI Curr. Opin. Genet. Dev.
PD JUN 15
PY 2016
VL 38
IS 
BP 127
EP 132
DI 10.1016/j.gde.2016.06.011
PG 6
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA EA6LH
UT WOS:000386740200019
PM 27497229
DA 2024-11-01
ER

PT J
AU Murakami, T
   Shinoto, Y
   Yonemitsu, S
   Muro, S
   Oki, S
   Koga, Y
   Goto, Y
   Kaneda, D
AF Murakami, Takaaki
   Shinoto, Yuya
   Yonemitsu, Shin
   Muro, Seiji
   Oki, Shogo
   Koga, Yasutoshi
   Goto, Yu-ichi
   Kaneda, Daita
TI Early Onset of Diabetes Mellitus Accelerates Cognitive Decline in Japanese Patients with Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-Like Episodes
SO TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
DE cognitive decline; hypoglycemia; MELAS; mitochondrial diabetes mellitus; A3243G mutation
ID clinical-features; dna mutation; melas; dementia; disease; risk
AB Approximately 80% of patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke like episodes (MELAS) carry the A3243G mutation in the mitochondrial tRNALeu (UUR) gene. Conversely, this mutation has also been identified as one of the most prevalent genetic abnormalities in patients with diabetes mellitus. Mitochondrial diabetes mellitus complicated with MELAS is relatively common, and 12.5% of patients with the A3243G mutation develop MELAS after being diagnosed with diabetes mellitus. However, the clinical impact of diabetes mellitus in MELAS patients remains unclear. Therefore, we retrospectively studied 14 Japanese MELAS patients with the A3243G mutation: three men and eleven women, with the mean age of 48.0 (+/- 15.4) years. Eight patients had been diagnosed with diabetes mellitus prior to the diagnosis of mitochondrial disease, and all of them were treated with insulin. The other six included four patients with concurrent diagnosis of diabetes and mitochondrial disease, one patient diagnosed with diabetes after the diagnosis of mitochondrial disease, and one patient without developing diabetes currently. We thus compared the patients' characteristics between those with and without early onset of diabetes mellitus. Cognitive decline (75.0% vs. 0%; p = 0.03) and poor glycemic control with severe hypoglycemic events (75.0% vs. 16.7%; p = 0.05) were more common in MELAS patients with a prior diagnosis of diabetes than in those without the prior diagnosis of diabetes. Our data suggest that the latent progress of cognitive decline is accelerated because of early onset of diabetes mellitus in MELAS patients.
C1 [Murakami, Takaaki; Yonemitsu, Shin; Muro, Seiji; Oki, Shogo] Osaka Red Cross Hosp, Dept Endocrinol & Diabet, Osaka, Japan.
   [Shinoto, Yuya] Osaka Red Cross Hosp, Dept Neurol, Osaka, Japan.
   [Koga, Yasutoshi] Kurume Univ, Sch Med, Dept Pediat & Child Hlth, Kurume, Fukuoka 830, Japan.
   [Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, Kodaira, Tokyo 1870031, Japan.
   [Kaneda, Daita] Tokyo Metropolitan Geriatr Hosp & Inst Gerontol, Dept Neurol, Tokyo, Japan.
C3 Osaka Red Cross Hospital; Osaka Red Cross Hospital; Kurume University; National Center for Neurology & Psychiatry - Japan; Tokyo Metropolitan Institute of Gerontology
RP Murakami, T (corresponding author), Osaka Red Cross Hosp, Dept Endocrinol & Diabet, Tennoji Ku, 5-30 Fudegasaki Cho, Osaka 5430027, Japan.
EM t.murakami@osaka-med.jrc.or.jp
FU Ministry of Health, Labour and Welfare, Japan
CR El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Finsterer J, 2009, J NEUROL SCI, V283, P143, DOI 10.1016/j.jns.2009.02.347
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   Gudala K, 2013, J DIABETES INVEST, V4, P640, DOI 10.1111/jdi.12087
   McDonnell MT, 2004, EUR J HUM GENET, V12, P778, DOI 10.1038/sj.ejhg.5201216
   Schaefer AM, 2006, NEUROLOGY, V66, P1932, DOI 10.1212/01.wnl.0000219759.72195.41
   Seaquist ER, 2013, DIABETES CARE, V36, P1384, DOI 10.2337/dc12-2480
   Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x
   Simoncini C, 2015, OXID MED CELL LONGEV, V2015, P0, DOI 10.1155/2015/803942
   Suzuki S, 2003, DIABETES RES CLIN PR, V59, P207, DOI 10.1016/S0168-8227(02)00246-2
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   VANDENOUWELAND JMW, 1995, MUSCLE NERVE, V0, PS124
   Whitmer RA, 2009, JAMA-J AM MED ASSOC, V301, P1565, DOI 10.1001/jama.2009.460
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
NR 14
TC 5
Z9 6
U1 0
U2 2
PU TOHOKU UNIV MEDICAL PRESS
PI SENDAI
PA 2-1, SEIRYO-MACHI, AOBA-KU, SENDAI, MIYAGI 980-8575, JAPAN
SN 0040-8727
EI 1349-3329
J9 TOHOKU J EXP MED
JI Tohoku J. Exp. Med.
PD APR 15
PY 2016
VL 238
IS 4
BP 311
EP 316
DI 10.1620/tjem.238.311
PG 6
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA DK4WH
UT WOS:000374920500007
PM 27063563
DA 2024-11-01
ER

PT J
AU Riley, LG
   Rudinger-Thirion, J
   Schmitz-Abe, K
   Thorburn, DR
   Davis, RL
   Teo, J
   Arbuckle, S
   Cooper, ST
   Campagna, DR
   Frugier, M
   Markianos, K
   Sue, CM
   Fleming, MD
   Christodoulou, J
AF Riley, Lisa G.
   Rudinger-Thirion, Joelle
   Schmitz-Abe, Klaus
   Thorburn, David R.
   Davis, Ryan L.
   Teo, Juliana
   Arbuckle, Susan
   Cooper, Sandra T.
   Campagna, Dean R.
   Frugier, Magali
   Markianos, Kyriacos
   Sue, Carolyn M.
   Fleming, Mark D.
   Christodoulou, John
TI LARS2 Variants Associated with Hydrops, Lactic Acidosis, Sideroblastic Anemia, and Multisystem Failure
SO JIMD REPORTS, VOL 28
LA English
DT Article; Book Chapter
ID transfer-rna synthetase; premature ovarian failure; escherichia-coli; mitochondrial myopathy; perrault syndrome; yars2 mutations; hearing-loss; aminoacylation; management; diagnosis
AB Pathogenic variants in mitochondrial aminoacyl-tRNA synthetases result in a broad range of mitochondrial respiratory chain disorders despite their shared role in mitochondrial protein synthesis. LARS2 encodes the mitochondrial leucyl-tRNA synthetase, which attaches leucine to its cognate tRNA. Sequence variants in LARS2 have previously been associated with Perrault syndrome, characterized by premature ovarian failure and hearing loss (OMIM #615300). In this study, we report variants in LARS2 that are associated with a severe multisystem metabolic disorder. The proband was born prematurely with severe lactic acidosis, hydrops, and sideroblastic anemia. She had multisystem complications with hyaline membrane disease, impaired cardiac function, a coagulopathy, pulmonary hypertension, and progressive renal disease and succumbed at 5 days of age. Whole exome sequencing of patient DNA revealed compound heterozygous variants in LARS2 (c.1289C>T; p.Ala430Val and c.1565C>A; p.Thr522Asn). The c.1565C>A (p.Thr522Asn) LARS2 variant has previously been associated with Perrault syndrome and both identified variants are predicted to be damaging (SIFT, PolyPhen). Muscle and liver samples from the proband did not display marked mitochondrial respiratory chain enzyme deficiency. Immunoblotting of patient muscle and liver showed LARS2 levels were reduced in liver and complex I protein levels were reduced in patient muscle and liver. Aminoacylation assays revealed p.Ala430Val LARS2 had an 18-fold loss of catalytic efficiency and p.Thr522Asn a 9-fold loss compared to wild-type LARS2. We suggest that the identified LARS2 variants are responsible for the severe multisystem clinical phenotype seen in this baby and that mutations in LARS2 can result in variable phenotypes.
C1 [Riley, Lisa G.; Christodoulou, John] Childrens Hosp Westmead, Kids Res Inst, Genet Metab Disorders Res Unit, Locked Bag 4001, Westmead, NSW 2145, Australia.
   [Riley, Lisa G.; Cooper, Sandra T.; Christodoulou, John] Univ Sydney, Sydney Med Sch, Discipline Paediat & Child Hlth, Sydney, NSW, Australia.
   [Rudinger-Thirion, Joelle; Frugier, Magali] Univ Strasbourg, Architecture & Reactivite ARN, CNRS, IBMC, Strasbourg, France.
   [Schmitz-Abe, Klaus; Markianos, Kyriacos] Harvard Med Sch, Boston Childrens Hosp, Dept Med, Div Genet & Genom, Boston, MA USA.
   [Schmitz-Abe, Klaus; Markianos, Kyriacos] Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA USA.
   [Schmitz-Abe, Klaus] Broad Inst, Cambridge, MA USA.
   [Thorburn, David R.] Univ Melbourne, Dept Paediat, Murdoch Childrens Res Inst, Melbourne, Vic, Australia.
   [Thorburn, David R.] Univ Melbourne, Royal Childrens Hosp, Victorian Clin Genet Serv, Melbourne, Vic, Australia.
   [Davis, Ryan L.; Sue, Carolyn M.] Univ Sydney, Dept Neurogenet, Kolling Inst Med Res, Sydney, NSW, Australia.
   [Davis, Ryan L.; Sue, Carolyn M.] Royal North Shore Hosp, Sydney, NSW, Australia.
   [Teo, Juliana] Childrens Hosp Westmead, Dept Haematol, Sydney, NSW, Australia.
   [Arbuckle, Susan] Childrens Hosp Westmead, Dept Pathol, Sydney, NSW, Australia.
   [Cooper, Sandra T.] Childrens Hosp Westmead, Kids Res Inst, Inst Neurosci & Muscle Res, Sydney, NSW, Australia.
   [Campagna, Dean R.; Fleming, Mark D.] Harvard Med Sch, Boston Childrens Hosp, Dept Pathol, Boston, MA USA.
   [Christodoulou, John] Univ Sydney, Sydney Med Sch, Discipline Genet Med, Sydney, NSW, Australia.
C3 NSW Health; The Children's Hospital at Westmead; University of Sydney; Sydney Childrens Hospitals Network; University of Sydney; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Murdoch Children's Research Institute; University of Melbourne; Murdoch Children's Research Institute; Victorian Clinical Genetics Services; University of Melbourne; Royal Children's Hospital Melbourne; University of Sydney; Kolling Institute of Medical Research; Royal North Shore Hospital; University of Sydney; NSW Health; The Children's Hospital at Westmead; University of Sydney; NSW Health; The Children's Hospital at Westmead; NSW Health; The Children's Hospital at Westmead; University of Sydney; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Sydney
RP Riley, LG (corresponding author), Childrens Hosp Westmead, Kids Res Inst, Genet Metab Disorders Res Unit, Locked Bag 4001, Westmead, NSW 2145, Australia.
EM lisa.riley@health.nsw.gov.au
FU NIDDK NIH HHS [R01 DK087992] Funding Source: Medline
CR Belostotsky R, 2011, AM J HUM GENET, V88, P193, DOI 10.1016/j.ajhg.2010.12.010
   Bottomley SS, 2014, HEMATOL ONCOL CLIN N, V28, P653, DOI 10.1016/j.hoc.2014.04.008
   Chakraborty PK, 2014, BLOOD, V124, P2867, DOI 10.1182/blood-2014-08-591370
   Dallabona C, 2014, NEUROLOGY, V82, P2063, DOI 10.1212/WNL.0000000000000497
   Diodato Daria, 2014, INT J CELL BIOL, V2014, P787956, DOI 10.1155/2014/787956
   Du X, 2003, J PROTEIN CHEM, V22, P71, DOI 10.1023/A:1023071928587
   Frazier AE, 2012, METHODS MOL BIOL, V837, P49, DOI 10.1007/978-1-61779-504-6_4
   Götz A, 2011, AM J HUM GENET, V88, P635, DOI 10.1016/j.ajhg.2011.04.006
   Konovalova S, 2013, MOL GENET METAB, V108, P206, DOI 10.1016/j.ymgme.2013.01.010
   Lue SW, 2005, BIOCHEMISTRY-US, V44, P3010, DOI 10.1021/bi047901v
   McKenzie M, 2009, METHOD ENZYMOL, V456, P321, DOI 10.1016/S0076-6879(08)04418-2
   Menezes MJ, 2014, BBA-GEN SUBJECTS, V1840, P1368, DOI 10.1016/j.bbagen.2013.12.025
   Mursinna RS, 2001, BIOCHEMISTRY-US, V40, P5376, DOI 10.1021/bi002915w
   Nakajima J, 2014, J HUM GENET, V59, P229, DOI 10.1038/jhg.2013.143
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076
   Palencia A, 2012, NAT STRUCT MOL BIOL, V19, P677, DOI 10.1038/nsmb.2317
   PERRET V, 1990, NATURE, V344, P787, DOI 10.1038/344787a0
   Pierce SB, 2013, AM J HUM GENET, V92, P614, DOI 10.1016/j.ajhg.2013.03.007
   Pierce SB, 2011, P NATL ACAD SCI USA, V108, P6543, DOI 10.1073/pnas.1103471108
   Riley LG, 2013, ORPHANET J RARE DIS, V8, P0, DOI 10.1186/1750-1172-8-193
   Sarkar J, 2012, J BIOL CHEM, V287, P14772, DOI 10.1074/jbc.M111.322412
   SCHIMMEL P, 1993, P NATL ACAD SCI USA, V90, P8763, DOI 10.1073/pnas.90.19.8763
   Shahni R, 2013, AM J MED GENET A, V161, P2334, DOI 10.1002/ajmg.a.36065
   Sohm B, 2003, J MOL BIOL, V328, P995, DOI 10.1016/S0022-2836(03)00373-5
   STARZYK RM, 1987, SCIENCE, V237, P1614, DOI 10.1126/science.3306924
   Steenweg ME, 2012, BRAIN, V135, P1387, DOI 10.1093/brain/aws070
   Talim B, 2013, BRAIN, V136, P0, DOI 10.1093/brain/aws197
   Yao YN, 2003, PROTEIN EXPRES PURIF, V30, P112, DOI 10.1016/S1046-5928(03)00097-4
NR 29
TC 48
Z9 52
U1 0
U2 3
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 2192-8304
EI 
J9 JIMD REP
PD JUN 15
PY 2016
VL 28
IS 
BP 49
EP 57
DI 10.1007/8904_2015_515
PG 9
WC Endocrinology & Metabolism; Genetics & Heredity
SC Endocrinology & Metabolism; Genetics & Heredity
GA BI0QY
UT WOS:000405111900006
PM 26537577
DA 2024-11-01
ER

PT J
AU Malena, A
   Pantic, B
   Borgia, D
   Sgarbi, G
   Solaini, G
   Holt, IJ
   Spinazzola, A
   Perissinotto, E
   Sandri, M
   Baracca, A
   Vergani, L
AF Malena, Adriana
   Pantic, Boris
   Borgia, Doriana
   Sgarbi, Gianluca
   Solaini, Giancarlo
   Holt, Ian J.
   Spinazzola, Antonella
   Perissinotto, Egle
   Sandri, Marco
   Baracca, Alessandra
   Vergani, Lodovica
TI Mitochondrial quality control: Cell-type-dependent responses to pathological mutant mitochondrial DNA
SO AUTOPHAGY
LA English
DT Article
DE A549; B2 adenocarcinoma cells; autophagy; mitochondria; mitochondrial dynamics; mitochondrial quality control; mitophagy; mutation-m3243G; pathological mtDNA; RD; Myo rhabdomyosarcoma cells
ID parkin-mediated mitophagy; skeletal-muscle; mtdna mutations; pathogenic mechanism; membrane fusion; atp synthesis; cybrid cells; autophagy; dynamics; tissue
AB Pathological mutations in the mitochondrial DNA (mtDNA) produce a diverse range of tissue-specific diseases and the proportion of mutant mitochondrial DNA can increase or decrease with time via segregation, dependent on the cell or tissue type. Previously we found that adenocarcinoma (A549.B2) cells favored wild-type (WT) mtDNA, whereas rhabdomyosarcoma (RD.Myo) cells favored mutant (m3243G) mtDNA. Mitochondrial quality control (mtQC) can purge the cells of dysfunctional mitochondria via mitochondrial dynamics and mitophagy and appears to offer the perfect solution to the human diseases caused by mutant mtDNA. In A549.B2 and RD.Myo cybrids, with various mutant mtDNA levels, mtQC was explored together with macroautophagy/autophagy and bioenergetic profile. The 2 types of tumor-derived cell lines differed in bioenergetic profile and mitophagy, but not in autophagy. A549.B2 cybrids displayed upregulation of mitophagy, increased mtDNA removal, mitochondrial fragmentation and mitochondrial depolarization on incubation with oligomycin, parameters that correlated with mutant load. Conversely, heteroplasmic RD.Myo lines had lower mitophagic markers that negatively correlated with mutant load, combined with a fully polarized and highly fused mitochondrial network. These findings indicate that pathological mutant mitochondrial DNA can modulate mitochondrial dynamics and mitophagy in a cell-type dependent manner and thereby offer an explanation for the persistence and accumulation of deleterious variants.
C1 [Malena, Adriana; Pantic, Boris; Borgia, Doriana; Vergani, Lodovica] Univ Padua, Dept Neurosci, I-35100 Padua, Italy.
   [Sgarbi, Gianluca; Solaini, Giancarlo; Baracca, Alessandra] Univ Bologna, Dept Biomed & Neuromotor Sci, I-40126 Bologna, Italy.
   [Holt, Ian J.; Spinazzola, Antonella] Mill Hill Lab, MRC, London, England.
   [Perissinotto, Egle] Univ Padua, Dept Cardiac Thorac & Vasc Sci, Biostat Epidemiol & Publ Hlth Unit, Padua, Italy.
   [Sandri, Marco] Univ Padua, Dept Biomed Sci, I-35100 Padua, Italy.
   [Sandri, Marco] Venetian Inst Mol Med, Via Orus 2, I-35129 Padua, Italy.
C3 University of Padua; University of Bologna; University of Padua; University of Padua; Veneto Institute Molecular Medicine
RP Sandri, M (corresponding author), Venetian Inst Mol Med, Via Orus 2, I-35129 Padua, Italy.; Baracca, A (corresponding author), Dipartimento Sci Biomed & Neuromotorie, Via Irnerio 48, I-40126 Bologna, Italy.; Vergani, L (corresponding author), Ctr Biomed Pietro DAbano, Dipartimento Neurosci, Via Orus 2B, I-35129 Padua, Italy.
EM marco.sandri@unipd.it; alessandra.baracca@unibo.it; lodovica.vergani@unipd.it
FU Associazione Neuromuscolare Angela Maria Nieddu (ARNAN); AFM [14631]; Telethon Grant [GGP10145]; Medical Research Council Senior Non-Clinical Fellowship [MC_PC_13029]; MRC [MC_PC_13029/2, MC_U105663140, MC_PC_13029/1] Funding Source: UKRI
CR ATTARDI G, 1995, BBA-MOL BASIS DIS, V1271, P241, DOI 10.1016/0925-4439(95)00034-2
   Baker BM, 2011, TRENDS BIOCHEM SCI, V36, P254, DOI 10.1016/j.tibs.2011.01.004
   Baracca A, 2003, BBA-BIOENERGETICS, V1606, P137, DOI 10.1016/S0005-2728(03)00110-5
   Baracca A, 2013, INT J BIOCHEM CELL B, V45, P1356, DOI 10.1016/j.biocel.2013.03.013
   Becker D, 2012, J BIOL CHEM, V287, P22969, DOI 10.1074/jbc.M112.365700
   Benard G, 2009, SEMIN CELL DEV BIOL, V20, P365, DOI 10.1016/j.semcdb.2008.12.012
   Campesi I, 2013, LIFE SCI, V93, P145, DOI 10.1016/j.lfs.2013.06.001
   Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105
   Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048
   Charan RA, 2015, MOL CELL NEUROSCI, V66, P62, DOI 10.1016/j.mcn.2015.02.008
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chinnery PF, 1999, AM J MED GENET, V85, P498
   Chinnery PF, 2002, TRENDS GENET, V18, P173, DOI 10.1016/S0168-9525(01)02636-1
   DErchia AM, 2015, MITOCHONDRION, V20, P13, DOI 10.1016/j.mito.2014.10.005
   Dai Y, 2014, HUM MOL GENET, V23, P637, DOI 10.1093/hmg/ddt450
   de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534
   DESJARDINS P, 1985, MOL CELL BIOL, V5, P1163, DOI 10.1128/MCB.5.5.1163
   Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   DUNBAR DR, 1995, P NATL ACAD SCI USA, V92, P6562, DOI 10.1073/pnas.92.14.6562
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Fan TWM, 2008, MOL CANCER, V7, P0, DOI 10.1186/1476-4598-7-79
   Fernández-Vizarra E, 2010, MITOCHONDRION, V10, P253, DOI 10.1016/j.mito.2009.12.148
   Frederiksen AL, 2006, J MED GENET, V43, P0, DOI 10.1136/jmg.2005.039339
   Galloway CA, 2012, FREE RADICAL BIO MED, V53, P2218, DOI 10.1016/j.freeradbiomed.2012.09.035
   Gilkerson RW, 2012, HUM MOL GENET, V21, P978, DOI 10.1093/hmg/ddr529
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Guha M, 2007, J BIOL CHEM, V282, P14536, DOI 10.1074/jbc.M611693200
   Hämäläinen RH, 2013, P NATL ACAD SCI USA, V110, PE3622, DOI 10.1073/pnas.1311660110
   Hill BG, 2012, BIOL CHEM, V393, P1485, DOI 10.1515/hsz-2012-0198
   Holt IJ, 1997, HUM MOL GENET, V6, P1251, DOI 10.1093/hmg/6.8.1251
   Hyvärinen AK, 2007, NUCLEIC ACIDS RES, V35, P6458, DOI 10.1093/nar/gkm676
   Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270
   Jeppesen TD, 2003, ANN NEUROL, V54, P86, DOI 10.1002/ana.10594
   Jin SM, 2012, J CELL SCI, V125, P795, DOI 10.1242/jcs.093849
   Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084
   Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487
   Kageyama Y, 2014, EMBO J, V33, P2798, DOI 10.15252/embj.201488658
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356
   Komatsu M, 2010, GENES CELLS, V15, P923, DOI 10.1111/j.1365-2443.2010.01433.x
   Kuznetsov AV, 2009, INT J BIOCHEM CELL B, V41, P1928, DOI 10.1016/j.biocel.2009.03.007
   LIEBER M, 1976, INT J CANCER, V17, P62, DOI 10.1002/ijc.2910170110
   Losón OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721
   Mai S, 2010, J CELL SCI, V123, P917, DOI 10.1242/jcs.059246
   Mailloux RJ, 2014, REDOX BIOL, V2, P123, DOI 10.1016/j.redox.2013.12.011
   Malena A, 2009, HUM MOL GENET, V18, P3407, DOI 10.1093/hmg/ddp281
   Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001
   Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008
   Mathupala SP, 2009, SEMIN CANCER BIOL, V19, P17, DOI 10.1016/j.semcancer.2008.11.006
   Meeusen S, 2006, CELL, V127, P383, DOI 10.1016/j.cell.2006.09.021
   Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026
   Morán M, 2014, BBA-MOL BASIS DIS, V1842, P1059, DOI 10.1016/j.bbadis.2014.03.013
   Moreno-Sánchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x
   Mouli PK, 2009, BIOPHYS J, V96, P3509, DOI 10.1016/j.bpj.2008.12.3959
   Murakawa T, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms8527
   Nakada K, 2009, INT J BIOCHEM CELL B, V41, P1907, DOI 10.1016/j.biocel.2009.05.010
   Narendra DP, 2010, PLOS BIOL, V8, P0, DOI 10.1371/journal.pbio.1000298
   Naue J, 2015, MITOCHONDRION, V20, P82, DOI 10.1016/j.mito.2014.12.002
   Ni HM, 2015, REDOX BIOL, V4, P6, DOI 10.1016/j.redox.2014.11.006
   Nicholls DG, 2000, TRENDS NEUROSCI, V23, P166, DOI 10.1016/S0166-2236(99)01534-9
   Norton M, 2014, SCI SIGNAL, V7, P0, DOI 10.1126/scisignal.2004374
   Novak I, 2012, ANTIOXID REDOX SIGN, V17, P794, DOI 10.1089/ars.2011.4407
   ORiordan TC, 2007, ANAL CHEM, V79, P9414, DOI 10.1021/ac701770b
   Okatsu K, 2010, GENES CELLS, V15, P887, DOI 10.1111/j.1365-2443.2010.01426.x
   Oliván S, 2014, BIOMED RES INT, V2014, P0, DOI 10.1155/2014/652817
   Palmer CS, 2011, CELL SIGNAL, V23, P1534, DOI 10.1016/j.cellsig.2011.05.021
   Pantic B, 2013, CELL DEATH DIS, V4, P0, DOI 10.1038/cddis.2013.385
   Pontarin G, 2012, P NATL ACAD SCI USA, V109, P13302, DOI 10.1073/pnas.1211289109
   Samuels DC, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003929
   Sauvanet C, 2010, SEMIN CELL DEV BIOL, V21, P558, DOI 10.1016/j.semcdb.2009.12.006
   Sgarbi G, 2006, BIOCHEM J, V395, P493, DOI 10.1042/BJ20051748
   Sgarbi G, 2014, AGING-US, V6, P296, DOI 10.18632/aging.100654
   Shutt T, 2012, EMBO REP, V13, P909, DOI 10.1038/embor.2012.128
   Skulachev VP, 2001, TRENDS BIOCHEM SCI, V26, P23, DOI 10.1016/S0968-0004(00)01735-7
   Solaini G, 2008, BBA-BIOENERGETICS, V1777, P941, DOI 10.1016/j.bbabio.2008.04.034
   Solaini G, 2007, BIOSCIENCE REP, V27, P11, DOI 10.1007/s10540-007-9033-4
   Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252
   Springer W, 2011, AUTOPHAGY, V7, P266, DOI 10.4161/auto.7.3.14348
   Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107
   Sunada Y, 1998, NEUROSCI LETT, V254, P180, DOI 10.1016/S0304-3940(98)00697-1
   TONIN PN, 1991, CANCER RES, V51, P5100
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Valenci I, 2015, MITOCHONDRION, V20, P64, DOI 10.1016/j.mito.2014.11.001
   Vergani L, 2004, EUR J BIOCHEM, V271, P3646, DOI 10.1111/j.1432-1033.2004.04298.x
   VERGANI L, 1995, BIOCHEM BIOPH RES CO, V210, P880, DOI 10.1006/bbrc.1995.1740
   Vergani L, 2000, NEUROMUSCULAR DISORD, V10, P454, DOI 10.1016/S0960-8966(00)00096-1
   Vergani L, 2007, BRAIN, V130, P2715, DOI 10.1093/brain/awm151
   Wang K, 2011, AUTOPHAGY, V7, P297, DOI 10.4161/auto.7.3.14502
   Wani WY, 2015, LAB INVEST, V95, P14, DOI 10.1038/labinvest.2014.131
   Wei HF, 2015, BBA-MOL CELL RES, V1853, P2784, DOI 10.1016/j.bbamcr.2015.03.013
   Westermann B, 2012, BBA-BIOENERGETICS, V1817, P1833, DOI 10.1016/j.bbabio.2012.02.033
   Willems PHGM, 2015, CELL METAB, V22, P207, DOI 10.1016/j.cmet.2015.06.006
   Wong YC, 2014, P NATL ACAD SCI USA, V111, PE4439, DOI 10.1073/pnas.1405752111
   Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028
   Zu XL, 2004, BIOCHEM BIOPH RES CO, V313, P459, DOI 10.1016/j.bbrc.2003.11.136
NR 96
TC 21
Z9 23
U1 0
U2 4
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1554-8627
EI 1554-8635
J9 AUTOPHAGY
JI Autophagy
PD JUN 15
PY 2016
VL 12
IS 11
BP 2098
EP 2112
DI 10.1080/15548627.2016.1226734
PG 15
WC Cell Biology
SC Cell Biology
GA EB8TW
UT WOS:000387665000011
PM 27627835
DA 2024-11-01
ER

PT J
AU Kelland, E
   Rupar, CA
   Prasad, AN
   Tay, KY
   Downie, A
   Prasad, C
AF Kelland, E.
   Rupar, C. A.
   Prasad, Asuri N.
   Tay, K. Y.
   Downie, A.
   Prasad, C.
TI The expanding phenotype of MELAS caused by the m.3291T&gt;C mutation in the <i>MT</i>-<i>TL1</i> gene
SO MOLECULAR GENETICS AND METABOLISM REPORTS
LA English
DT Article
DE MELAS; MELAS 3291T > C; tRNA(leu) ((UUR)) mutation; Phenotypic features; Mitochondrial
ID mitochondrial myopathy; lactic-acidosis; encephalopathy; episodes; disease; dna
AB m.3291T>C mutation in the MT-TL1 gene has been infrequently encountered in association with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS), however remains poorly characterized from a clinical perspective. In the following report we describe in detail the phenotypic features, long term follow up (>7 years) and management in a Caucasian family with MELAS due to the m.3291T>C mutation and review the literature on m.3291T>C mutation. The clinical phenotype in the proposita included overlapping features of MELAS, MERRF (Myoclonic epilepsy and ragged-red fiber syndrome), MNGIE (Mitochondrial neurogastrointestinal encephalopathy), KSS (Kearns-Sayre Syndrome) and CPEO (Chronic progressive external ophthalmoplegia). Crown Copyright (C) 2016 Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
C1 [Kelland, E.; Rupar, C. A.; Prasad, Asuri N.; Prasad, C.] Childrens Hosp London Hlth Sci Ctr, Dept Pediat, London, ON, Canada.
   [Rupar, C. A.] Childrens Hosp London Hlth Sci Ctr, Dept Biochem, London, ON, Canada.
   [Rupar, C. A.] Childrens Hosp London Hlth Sci Ctr, Dept Pathol & Lab Med, London, ON, Canada.
   [Prasad, Asuri N.] Childrens Hosp London Hlth Sci Ctr, Dept Neurol, London, ON, Canada.
   [Rupar, C. A.; Prasad, Asuri N.; Prasad, C.] Childrens Hosp London Hlth Sci Ctr, Childrens Hlth Res Inst, London, ON, Canada.
   [Tay, K. Y.] Childrens Hosp London Hlth Sci Ctr, Med Imaging, London, ON, Canada.
   [Rupar, C. A.; Prasad, Asuri N.; Tay, K. Y.; Downie, A.; Prasad, C.] Western Univ, Childrens Hosp London Hlth Sci Ctr, London, ON, Canada.
   [Downie, A.] Childrens Hosp London Hlth Sci Ctr, Paediat Psychol, London, ON, Canada.
C3 London Health Sciences Centre; London Health Sciences Centre; London Health Sciences Centre; London Health Sciences Centre; London Health Sciences Centre; London Health Sciences Centre; Western University (University of Western Ontario); London Health Sciences Centre; London Health Sciences Centre
RP Prasad, C (corresponding author), Childrens Hosp, London Hlth Sci Ctr, 800 Commissioners Rd East, London, ON N6C 2V5, Canada.
EM Chitra.Prasad@lhsc.on.ca
CR Ding Y, 2012, MITOCHONDR DNA, V23, P323, DOI 10.3109/19401736.2012.674119
   Emmanuele V, 2011, MUSCLE NERVE, V44, P448, DOI 10.1002/mus.22149
   Finsterer J, 2007, ACTA NEUROL SCAND, V116, P1, DOI 10.1111/j.1600-0404.2007.00836.x
   GOTO YI, 1994, BIOCHEM BIOPH RES CO, V202, P1624, DOI 10.1006/bbrc.1994.2119
   Kirino Y, 2005, P NATL ACAD SCI USA, V102, P7127, DOI 10.1073/pnas.0500563102
   Koga Y, 2012, BBA-GEN SUBJECTS, V1820, P608, DOI 10.1016/j.bbagen.2011.09.005
   Liu KM, 2014, METAB BRAIN DIS, V29, P139, DOI 10.1007/s11011-013-9464-5
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Salsano E, 2011, J NEUROL SCI, V300, P165, DOI 10.1016/j.jns.2010.09.022
   Sunami Y, 2011, NEUROL SCI, V32, P861, DOI 10.1007/s10072-011-0719-9
   Uziel G, 2000, NEUROMUSCULAR DISORD, V10, P415, DOI 10.1016/S0960-8966(99)00115-7
   Yarham JW, 2013, J NEUROL SCI, V325, P165, DOI 10.1016/j.jns.2012.12.003
NR 12
TC 13
Z9 14
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2214-4269
EI 
J9 MOL GENET METAB REP
JI Molec. Genet. Metab. Rep.
PD MAR 15
PY 2016
VL 6
IS 
BP 64
EP 69
DI 10.1016/j.ymgmr.2016.02.003
PG 6
WC Genetics & Heredity
SC Genetics & Heredity
GA DZ7CY
UT WOS:000386022900013
PM 27014580
DA 2024-11-01
ER

PT J
AU McClelland, C
   Manousakis, G
   Lee, MS
AF McClelland, Collin
   Manousakis, Georgios
   Lee, Michael S.
TI Progressive External Ophthalmoplegia
SO CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS
LA English
DT Review
DE Mitochondrial myopathy; Progressive external ophthalmoplegia
ID kearns-sayre-syndrome; mitochondrial-dna deletions; sensorineural hearing-loss; impair mtdna replication; extraocular-muscles; optic atrophy; clinical-features; opa1 mutations; diagnosis; disease
AB Progressive external ophthalmoplegia (PEO), marked by progressive bilateral ptosis and diffuse reduction in ocular motility, represents a finding of mitochondrial myopathy rather than a true diagnosis. PEO often occurs with other systemic features of mitochondrial dysfunction that can cause significant morbidity and mortality. Accurate and early recognition of PEO is paramount for the optimal care of these patients. We present an evidence-based review of the presenting neuroophthalmic features, differential diagnosis, diagnostic tools, systemic implications, and treatment options for isolated PEO and other PEO-associated mitochondrial syndromes.
C1 [McClelland, Collin; Lee, Michael S.] Univ Minnesota, Dept Ophthalmol, 420 Delaware St SE MMC 493, Minneapolis, MN 55455 USA.
   [McClelland, Collin; Lee, Michael S.] Univ Minnesota, Dept Visual Neurosci, 420 Delaware St SE MMC 493, Minneapolis, MN 55455 USA.
   [Manousakis, Georgios; Lee, Michael S.] Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA.
   [Lee, Michael S.] Univ Minnesota, Dept Neurosurg, Minneapolis, MN 55455 USA.
C3 University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities
RP Lee, MS (corresponding author), Univ Minnesota, Dept Ophthalmol, 420 Delaware St SE MMC 493, Minneapolis, MN 55455 USA.; Lee, MS (corresponding author), Univ Minnesota, Dept Visual Neurosci, 420 Delaware St SE MMC 493, Minneapolis, MN 55455 USA.; Lee, MS (corresponding author), Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA.; Lee, MS (corresponding author), Univ Minnesota, Dept Neurosurg, Minneapolis, MN 55455 USA.
EM cmc@umn.edu; gmanousa@umn.edu; mikelee@umn.edu
FU Research to Prevent Blindness (New York, NY)
CR Ahn J, 2008, BRIT J OPHTHALMOL, V92, P1685, DOI 10.1136/bjo.2008.144816
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   [Anonymous], 2010, NEUROOPHTHALMOLOGY D, V0, P0
   Assaf AA, 2011, EYE, V25, P1251, DOI 10.1038/eye.2011.38
   de Castro FAA, 2010, OPHTHAL PLAST RECONS, V26, P416, DOI 10.1097/IOP.0b013e3181cb57a7
   Behbehani R, 2007, J NEURO-OPHTHALMOL, V27, P41, DOI 10.1097/WNO.0b013e31803312fa
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Chaudhuri Z, 2013, JAMA OPHTHALMOL, V131, P619, DOI 10.1001/jamaophthalmol.2013.783
   Chu BC, 1999, NEURORADIOLOGY, V41, P759, DOI 10.1007/s002340050838
   Domenis DR, 2011, DIGEST DIS SCI, V56, P2343, DOI 10.1007/s10620-011-1631-0
   DRACHMAN DA, 1968, ARCH NEUROL-CHICAGO, V18, P654, DOI 10.1001/archneur.1968.00470360076008
   Draeger A, 2006, J PATHOL, V210, P94, DOI 10.1002/path.2018
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Fraunfelder FW, 2008, OPHTHALMOLOGY, V115, P2282, DOI 10.1016/j.ophtha.2008.08.006
   Gonzalez-Moron D, 2013, BMJ CASE REP, V0, P20
   González-Vioque E, 2006, ARCH NEUROL-CHICAGO, V63, P107, DOI 10.1001/archneur.63.1.107
   Gregoratos Gabriel, 2002, CIRCULATION, V106, P2145, DOI 10.1161/01.CIR.0000035996.46455.09
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   Hanisch F, 2005, NERVENARZT, V76, P395, DOI 10.1007/s00115-004-1742-3
   Hanisch F, 2015, J NEUROL NEUROSUR PS, V86, P630, DOI 10.1136/jnnp-2013-306748
   Hansen N, 2012, NEUROL SCI, V33, P209, DOI 10.1007/s10072-011-0631-3
   Hirano M, 2001, NEUROLOGY, V57, P2163, DOI 10.1212/WNL.57.12.2163
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   Horga A, 2014, BRAIN, V137, P3200, DOI 10.1093/brain/awu279
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Kornblum C, 2005, J NEUROL, V252, P1101, DOI 10.1007/s00415-005-0827-7
   Kornblum C, 2001, NEUROLOGY, V56, P1409, DOI 10.1212/WNL.56.10.1409
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   KRENDEL DA, 1987, MUSCLE NERVE, V10, P299, DOI 10.1002/mus.880100404
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lapid O, 2000, PLAST RECONSTR SURG, V106, P1213, DOI 10.1097/00006534-200010000-00046
   Lee Andrew G, 2002, CURR NEUROL NEUROSCI REP, V2, P413, DOI 10.1007/s11910-002-0067-5
   Liskova P, 2013, ACTA OPHTHALMOL, V91, PE225, DOI 10.1111/aos.12038
   López-Gallardo E, 2009, MITOCHONDRION, V9, P314, DOI 10.1016/j.mito.2009.04.005
   Man CYW, 2006, EYE, V20, P564, DOI 10.1038/sj.eye.6701924
   Mancuso M, 2015, J NEUROL, V262, P1301, DOI 10.1007/s00415-015-7710-y
   MEIRE F, 1985, OPHTHALMIC PAED GEN, V5, P91, DOI 10.3109/13816818509007861
   Miller NR, 2005, WALSH HOYTS CLIN NEU, V1, P237
   Milone M, 2013, MOL GENET METAB, V110, P35, DOI 10.1016/j.ymgme.2013.07.007
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MULLIE MA, 1985, ARCH OPHTHALMOL-CHIC, V103, P1825, DOI 10.1001/archopht.1985.01050120059020
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Okamoto K, 1996, J NEURO-OPHTHALMOL, V16, P286
   OLSON W, 1972, ARCH NEUROL-CHICAGO, V26, P193, DOI 10.1001/archneur.1972.00490090019001
   Ortube MC, 2006, J AAPOS, V10, P414, DOI 10.1016/j.jaapos.2006.04.012
   OTA I, 1989, NIPPON GANKA GAKKAI ZASSHI, V93, P329
   OTA Y, 1994, RETINA-J RET VIT DIS, V14, P270, DOI 10.1097/00006982-199414030-00015
   Peragallo JH, 2015, J NEURO-OPHTHALMOL, V35, P185, DOI 10.1097/WNO.0000000000000228
   PETTY RKH, 1986, BRAIN, V109, P915, DOI 10.1093/brain/109.5.915
   Pfeffer G, 2009, NEUROLOGY, V73, P71, DOI 10.1212/WNL.0b013e3181aae814
   Pfeffer G, 2013, ANN MED, V45, P4, DOI 10.3109/07853890.2011.605389
   Pfeffer G, 2012, MUSCLE NERVE, V46, P593, DOI 10.1002/mus.23538
   Pfeffer G, 2012, CAN J NEUROL SCI, V39, P520, DOI 10.1017/S0317167100014062
   Pfeffer G, 2011, CAN J NEUROL SCI, V38, P119, DOI 10.1017/S031716710001115X
   Pineles SL, 2012, J AAPOS, V16, P529, DOI 10.1016/j.jaapos.2012.08.005
   Pitceathly RD, 2015, EUR RADIOL, V0, P0
   POLAK PE, 1989, EUR HEART J, V10, P281, DOI 10.1093/oxfordjournals.eurheartj.a059477
   REICHMANN H, 1991, EUR NEUROL, V31, P108, DOI 10.1159/000116656
   RESKENIELSEN E, 1976, ACTA OPHTHALMOL, V54, P553
   Reyes A, 2015, AM J HUM GENET, V97, P186, DOI 10.1016/j.ajhg.2015.05.013
   Richardson C, 2005, EYE, V19, P258, DOI 10.1038/sj.eye.6701488
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Schaefer AM, 2005, MUSCLE NERVE, V32, P104, DOI 10.1002/mus.20319
   Shorr N, 1987, OPHTHALMIC PLAST RECONSTR SURG, V3, P141, DOI 10.1097/00002341-198703030-00005
   Sinnathuray AR, 2003, OTOL NEUROTOL, V24, P418, DOI 10.1097/00129492-200305000-00012
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   St Guily J L, 1994, EAR NOSE THROAT J, V73, P34
   Sundaram C, 2011, J CLIN NEUROSCI, V18, P535, DOI 10.1016/j.jocn.2010.06.014
   SUOMALAINEN A, 1995, NAT GENET, V9, P146, DOI 10.1038/ng0295-146
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   Tinley C, 2010, STRABISMUS, V18, P41, DOI 10.3109/09273971003758388
   TRANCHANT C, 1993, NEUROMUSCULAR DISORD, V3, P561, DOI 10.1016/0960-8966(93)90116-2
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Van Goethem G, 2003, NEUROMOL MED, V3, P129, DOI 10.1385/NMM:3:3:129
   Wabbels B, 2008, OPHTHALMOLOGE, V105, P550, DOI 10.1007/s00347-007-1643-5
   Wallace DK, 1997, OPHTHALMOLOGY, V104, P695, DOI 10.1016/S0161-6420(97)30250-4
   Walsh FB, 1969, CLIN NEURO OPHTH, V0, P567
   Wong LJC, 2013, MITOCHONDRION, V13, P379, DOI 10.1016/j.mito.2013.02.001
   Young TJ, 2005, PACE, V28, P454, DOI 10.1111/j.1540-8159.2005.40049.x
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
NR 82
TC 51
Z9 58
U1 0
U2 12
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1528-4042
EI 1534-6293
J9 CURR NEUROL NEUROSCI
JI Curr. Neurol. Neurosci. Rep.
PD JUN 15
PY 2016
VL 16
IS 6
BP 
EP 
DI 10.1007/s11910-016-0652-7
PG 10
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA DM3YL
UT WOS:000376282500002
PM 27072953
DA 2024-11-01
ER

PT J
AU Wen, SZ
   Niedzwiecka, K
   Zhao, WW
   Xu, ST
   Liang, SS
   Zhu, XD
   Xie, HL
   Tribouillard-Tanvier, D
   Giraud, MF
   Zeng, CH
   Dautant, A
   Kucharczyk, R
   Liu, ZH
   di Rago, JP
   Chen, HM
AF Wen, Shuzhen
   Niedzwiecka, Katarzyna
   Zhao, Weiwei
   Xu, Shutian
   Liang, Shaoshan
   Zhu, Xiaodong
   Xie, Honglang
   Tribouillard-Tanvier, Deborah
   Giraud, Marie-France
   Zeng, Caihong
   Dautant, Alain
   Kucharczyk, Roza
   Liu, Zhihong
   di Rago, Jean-Paul
   Chen, Huimei
TI Identification of G8969>A in mitochondrial <i>ATP6</i> gene that severely compromises ATP synthase function in a patient with IgA nephropathy
SO SCIENTIFIC REPORTS
LA English
DT Article
ID yeast model; mutation; dna; disease; pathogenesis; disorders; defects; deficiency; mechanisms; proteins
AB Here we elucidated the pathogenesis of a 14-year-old Chinese female who initially developed an isolated nephropathy followed by a complex clinical presentation with brain and muscle problems, which indicated that the disease process was possibly due to a mitochondrial dysfunction. Careful evaluation of renal biopsy samples revealed a decreased staining of cells induced by COX and NADH dehydrogenase activities, and a strong fragmentation of the mitochondrial network. These anomalies were due to the presence of a mutation in the mitochondrial ATP6 gene, G8969>A. This mutation leads to replacement of a highly conserved serine residue at position 148 of the a-subunit of ATP synthase. Increasing the mutation load in cybrid cell lines was paralleled by the appearance of abnormal mitochondrial morphologies, diminished respiration and enhanced production of reactive oxygen species. An equivalent of the G8969>A mutation in yeast had dramatic consequences on ATP synthase, with a block in proton translocation. The mutation was particularly abundant (89%) in the kidney compared to blood and urine, which is likely the reason why this organ was affected first. Based on these findings, we suggest that nephrologists should pay more attention to the possibility of a mitochondrial dysfunction when evaluating patients suffering from kidney problems.
C1 [Wen, Shuzhen; Zhao, Weiwei; Xu, Shutian; Liang, Shaoshan; Zhu, Xiaodong; Xie, Honglang; Zeng, Caihong; Liu, Zhihong; Chen, Huimei] Nanjing Univ, Jinling Hosp, Natl Clin Res Ctr Kidney Dis, Sch Med, Nanjing, Jiangsu, Peoples R China.
   [Niedzwiecka, Katarzyna; Kucharczyk, Roza] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland.
   [Tribouillard-Tanvier, Deborah; Giraud, Marie-France; Dautant, Alain; di Rago, Jean-Paul] Inst Biochimie & Genet Cellulaires, CNRS, UMR 5095, F-33077 Bordeaux, France.
   [Tribouillard-Tanvier, Deborah; Giraud, Marie-France; Dautant, Alain; di Rago, Jean-Paul] Univ Bordeaux, IBGC, UMR 5095, F-33077 Bordeaux, France.
   [Tribouillard-Tanvier, Deborah] Inst Biochimie & Genet Cellulaires, INSERM, F-33077 Bordeaux, France.
C3 Nanjing University; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm)
RP Liu, ZH; Chen, HM (corresponding author), Nanjing Univ, Jinling Hosp, Natl Clin Res Ctr Kidney Dis, Sch Med, Nanjing, Jiangsu, Peoples R China.; di Rago, JP (corresponding author), Inst Biochimie & Genet Cellulaires, CNRS, UMR 5095, F-33077 Bordeaux, France.; di Rago, JP (corresponding author), Univ Bordeaux, IBGC, UMR 5095, F-33077 Bordeaux, France.
EM liuzhihong@nju.edu.cn; jp.dirago@ibgc.cnrs.fr; chenhuimei@nju.edu.cn
FU National Basic Research Program of China 973 Program [2012CB517600, 2012CB517606]; National Natural Science Foundation (NSF) Grant [81370788, 8151101098]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, SEM; FRM (Fondation pour la Recherche Medicale); AFM (Association Francaise contre les Myopathies); Agence Nationale de la Recherche [ANR-12-BSV8-024]; National Science Center of Poland [UMO-2013/11/B/NZ1/02102]
CR ACKERMAN SH, 1990, J BIOL CHEM, V265, P9952
   Allegretti M, 2015, NATURE, V521, P237, DOI 10.1038/nature14185
   Bietenhader M, 2012, PLOS GENET, V8, P0, DOI 10.1371/journal.pgen.1002876
   Bonnefoy N, 2001, METHOD CELL BIOL, V65, P381, DOI 10.1016/S0091-679X(01)65022-2
   Burrage LC, 2014, MOL GENET METAB, V113, P207, DOI 10.1016/j.ymgme.2014.06.004
   DEMEIRLEIR L, 1995, PEDIATR NEUROL, V13, P242, DOI 10.1016/0887-8994(95)00184-H
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Donadio JV, 2002, NEW ENGL J MED, V347, P738, DOI 10.1056/NEJMra020109
   EMAUS RK, 1986, BIOCHIM BIOPHYS ACTA, V850, P436, DOI 10.1016/0005-2728(86)90112-X
   Fillingame RH, 2003, FEBS LETT, V555, P29, DOI 10.1016/S0014-5793(03)01101-3
   Finsterer J, 2004, EUR J NEUROL, V11, P163, DOI 10.1046/j.1351-5101.2003.00728.x
   Guerin B, 1979, METHODS ENZYMOL, V55, P149
   Houstek J, 2006, BBA-BIOENERGETICS, V1757, P1400, DOI 10.1016/j.bbabio.2006.04.006
   Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850
   Jia ZD, 2013, HUM MOL GENET, V22, P4064, DOI 10.1093/hmg/ddt256
   Jin B, 2014, NEPHROL DIAL TRANSPL, V29, P2251, DOI 10.1093/ndt/gfu239
   Koopman WJH, 2013, EMBO J, V32, P9, DOI 10.1038/emboj.2012.300
   Kucharczyk R, 2013, INT J BIOCHEM CELL B, V45, P130, DOI 10.1016/j.biocel.2012.07.001
   Kucharczyk R, 2009, HUM MOL GENET, V18, P2889, DOI 10.1093/hmg/ddp226
   Kucharczyk R, 2009, BBA-MOL CELL RES, V1793, P817, DOI 10.1016/j.bbamcr.2009.02.011
   Kucharczyk R, 2009, BBA-MOL CELL RES, V1793, P186, DOI 10.1016/j.bbamcr.2008.06.012
   Lefebvre-Legendre L, 2001, J BIOL CHEM, V276, P6789, DOI 10.1074/jbc.M009557200
   Lightowlers RN, 2014, FEBS LETT, V588, P2496, DOI 10.1016/j.febslet.2014.05.054
   Magistroni R, 2015, KIDNEY INT, V88, P974, DOI 10.1038/ki.2015.252
   Mayr JA, 2004, PEDIATR RES, V55, P988, DOI 10.1203/01.pdr.0000127016.67809.6b
   Morales-Rios E, 2015, P NATL ACAD SCI USA, V112, P13231, DOI 10.1073/pnas.1517542112
   Morava E, 2006, AM J MED GENET A, V140A, P863, DOI 10.1002/ajmg.a.31194
   Nijtmans LGJ, 2001, J BIOL CHEM, V276, P6755, DOI 10.1074/jbc.M008114200
   Okamoto K, 1998, J CELL BIOL, V142, P613, DOI 10.1083/jcb.142.3.613
   Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221
   Rak M, 2007, J BIOL CHEM, V282, P34039, DOI 10.1074/jbc.M703053200
   Rak M, 2007, J BIOL CHEM, V282, P10853, DOI 10.1074/jbc.M608692200
   RIGOULET M, 1979, FEBS LETT, V102, P18, DOI 10.1016/0014-5793(79)80919-9
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Rötig A, 2003, J NEPHROL, V16, P286
   Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488
   Sauvanet C, 2010, SEMIN CELL DEV BIOL, V21, P558, DOI 10.1016/j.semcdb.2009.12.006
   Schon EA, 2001, SEMIN CELL DEV BIOL, V12, P441, DOI 10.1006/scdb.2001.0281
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   SOMLO M, 1968, EUR J BIOCHEM, V5, P276, DOI 10.1111/j.1432-1033.1968.tb00368.x
   Sperl W, 2006, NEUROMUSCULAR DISORD, V16, P821, DOI 10.1016/j.nmd.2006.08.008
   SZABOLCS MJ, 1994, KIDNEY INT, V45, P1388, DOI 10.1038/ki.1994.181
   Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707
   Venard R, 2003, BIOCHEMISTRY-US, V42, P7626, DOI 10.1021/bi034394t
   VIK SB, 1988, J BIOL CHEM, V263, P6599
   Walker JE, 2013, BIOCHEM SOC T, V41, P1, DOI 10.1042/BST20110773
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107
   White KE, 2012, MICRON, V43, P1001, DOI 10.1016/j.micron.2012.04.013
   Zeviani M, 2007, CURR OPIN NEUROL, V20, P564, DOI 10.1097/WCO.0b013e3282ef58cd
   Zhou AN, 2015, ELIFE, V4, P0, DOI 10.7554/eLife.10180
NR 51
TC 25
Z9 27
U1 0
U2 11
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
EI 
J9 SCI REP-UK
JI Sci Rep
PD NOV 4
PY 2016
VL 6
IS 
BP 
EP 
DI 10.1038/srep36313
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EB0FD
UT WOS:000387017900001
PM 27812026
DA 2024-11-01
ER

PT J
AU Dvorakova, V
   Kolarova, H
   Magner, M
   Tesarova, M
   Hansikova, H
   Zeman, J
   Honzik, T
AF Dvorakova, V.
   Kolarova, H.
   Magner, M.
   Tesarova, M.
   Hansikova, H.
   Zeman, J.
   Honzik, T.
TI The phenotypic spectrum of fifty Czech m.3243A&gt;G carriers
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Article
DE MELAS; m.3243A > G; Heteroplasmy; Natural course; Fully expressed phenotype; Oligosymptomatic patients
ID mitochondrial-dna mutation; greater-than-g; severe lactic-acidosis; clinical phenotypes; a3243g mutation; melas syndrome; mtdna mutation; rhabdomyolysis; prevalence; features
AB Background: Mitochondrial myopathy, Encephalopathy, Lactic Acidosis and Stroke-like episodes syndrome (MELAS) is a common mitochondrial disorder with varying multisystemic clinical manifestation. We present a comprehensive clinical picture of 50 Czech m.3243A>G carriers with emphasis on the sequence of symptoms in symptomatic patients. Results: Symptoms developed in 33 patients (66%) and 17 carriers remained unaffected (34%). The age of onset varied from 1 month to 47 years of age, with juvenile presentation occurring in 53% of patients. Myopathy was the most common presenting symptom (18%), followed by CPEO/ptosis and hearing loss, with the latter also being the most common second symptom. Stroke-like episodes (SLE) occurred in fourteen patients, although never as a first symptom, and were frequently preceded by migraines (58%). Rhabdomyolysis developed in two patients. The second symptom appeared 5.0 +/- 8.3 years (range 0-28 years) after the first, and the interval between the second and third symptom was 2.0 +/- 6.0 years (range 0-21 years). Four of our patients remained monosymptomatic up to 12 years of follow-up. The sequence of symptoms according to their time of manifestation was migraines, myopathy, seizures, CPEO/ptosis, SLE, hearing loss, and diabetes mellitus. The average age at death was 32.4 +/- 17.7 years (range 9-60 years) in the juvenile form and 44.0 +/- 12.7 years (range 35-53 years) in the adult form. Some patients with SLE harboured very low heteroplasmy levels in various tissues. No threshold for any organ dysfunction could be determined based on these levels. Conclusions: Sufficient knowledge of the timeline of the natural course of MELAS syndrome may improve the prediction and management of symptoms in patients with this mitochondrial disease. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Dvorakova, V.; Kolarova, H.; Magner, M.; Tesarova, M.; Hansikova, H.; Zeman, J.; Honzik, T.] Charles Univ Prague, Gen Univ Hosp Prague, Fac Med 1, Dept Paediat & Adolescent Med, Ke Karlovu 2, Prague 12101 2, Czech Republic.
C3 Charles University Prague; General University Hospital Prague
RP Honzik, T (corresponding author), Charles Univ Prague, Gen Univ Hosp Prague, Fac Med 1, Dept Paediat & Adolescent Med, Ke Karlovu 2, Prague 12101 2, Czech Republic.
EM tomas.honzik@vfn.cz
FU Ministry of Health of the Czech Republic [MZ CR AZV 16-32341A, RVO-VFN 64165]; Grant Agency of the Czech Republic [14-36804G]; Charles University in Prague [GAUK 38515/2015, PRVOUK P24/LF1/3, UNCE 204011/2012, SW 260256/2016]
CR Blum S, 2011, INTERN MED J, V41, P200, DOI 10.1111/j.1445-5994.2010.02379.x
   Cevoli S, 2010, CEPHALALGIA, V30, P919, DOI 10.1177/0333102409354654
   Chae JH, 2004, BRAIN DEV-JPN, V26, P459, DOI 10.1016/j.braindev.2004.01.002
   Chin J, 2014, MITOCHONDRION, V17, P34, DOI 10.1016/j.mito.2014.05.005
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   Corman V, 2001, REV MED LIEGE, V56, P681
   de Laat P, 2012, J INHERIT METAB DIS, V35, P1059, DOI 10.1007/s10545-012-9465-2
   Di Gennaro G, 2000, HEADACHE, V40, P568, DOI 10.1046/j.1526-4610.2000.00088.x
   DiMauro S, 1993, MELAS GENEREVIEWS R, V0, P0
   El-Hattab AW, 2014, MITOCHONDRION, V18, P63, DOI 10.1016/j.mito.2014.07.008
   Fayssoil Abdallah, 2009, CONGEST HEART FAIL, V15, P284, DOI 10.1111/j.1751-7133.2009.00108.x
   Frederiksen AL, 2009, J CLIN ENDOCR METAB, V94, P2872, DOI 10.1210/jc.2009-0235
   GABOW PA, 1982, MEDICINE, V61, P141, DOI 10.1097/00005792-198205000-00002
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HARA H, 1994, J NEUROL NEUROSUR PS, V57, P1545, DOI 10.1136/jnnp.57.12.1545-a
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   HIROSE Y, 1993, INTERNAL MED, V32, P798, DOI 10.2169/internalmedicine.32.798
   Höschl C, 2012, INT REV PSYCHIATR, V24, P278, DOI 10.3109/09540261.2012.688730
   Honzik T, 2012, J INHERIT METAB DIS, V35, P749, DOI 10.1007/s10545-011-9440-3
   Inczedy-Farkas G, 2012, BEHAV BRAIN FUNCT, V8, P0, DOI 10.1186/1744-9081-8-9
   Inoue Shigeaki, 2007, J INTENSIVE CARE MED, V22, P240, DOI 10.1177/0885066607301343
   Jung I, 2015, J CLIN NEUROL, V11, P104, DOI 10.3988/jcn.2015.11.1.104
   Kanaumi T, 2006, PEDIATR NEUROL, V34, P235, DOI 10.1016/j.pediatrneurol.2005.08.024
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Kaufmann P, 2009, ARCH NEUROL-CHICAGO, V66, P85, DOI 10.1001/archneurol.2008.526
   Klopstock T, 1996, NEUROLOGY, V46, P1735, DOI 10.1212/WNL.46.6.1735
   Kwon JH, 2003, EUR NEUROL, V50, P123, DOI 10.1159/000072517
   Lofberg M, 1998, ACTA NEUROL SCAND, V98, P268, DOI 10.1111/j.1600-0404.1998.tb07307.x
   Ma YN, 2010, J NEUROL SCI, V291, P17, DOI 10.1016/j.jns.2010.01.012
   Maassen JA, 2004, DIABETES, V53, PS103, DOI 10.2337/diabetes.53.2007.S103
   Malfatti E, 2013, NEUROLOGY, V80, P100, DOI 10.1212/WNL.0b013e31827b1a2f
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   Mancuso M, 2013, NEUROL SCI, V34, P71, DOI 10.1007/s10072-011-0901-0
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Ohkubo K, 2001, CLIN CHEM, V47, P1641
   Okajima Y, 1998, HEART, V80, P292, DOI 10.1136/hrt.80.3.292
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Tan TMM, 2009, CLIN ENDOCRINOL, V70, P340, DOI 10.1111/j.1365-2265.2008.03341.x
   Uusimaa J, 2007, ANN NEUROL, V62, P278, DOI 10.1002/ana.21196
   VANDENOUWELAND JMW, 1994, DIABETES, V43, P746, DOI 10.2337/diabetes.43.6.746
   Vanniarajan A, 2006, AM J MED GENET B, V141B, P440, DOI 10.1002/ajmg.b.30302
   Wortmann SB, 2007, ACTA PAEDIATR, V96, P450, DOI 10.1111/j.1651-2227.2006.00158.x
   YANG CY, 1995, CLIN ENDOCRINOL, V43, P235, DOI 10.1111/j.1365-2265.1995.tb01922.x
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
NR 48
TC 27
Z9 28
U1 0
U2 8
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
EI 1096-7206
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD AUG 15
PY 2016
VL 118
IS 4
BP 288
EP 295
DI 10.1016/j.ymgme.2016.06.003
PG 8
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine
GA DT2RL
UT WOS:000381328000010
PM 27296531
DA 2024-11-01
ER

PT J
AU Cao, M
   Donà, M
   Valentino, L
   Semplicini, C
   Maresca, A
   Cassina, M
   Torraco, A
   Galletta, E
   Manfioli, V
   Sorarù, G
   Carelli, V
   Stramare, R
   Bertini, E
   Carozzo, R
   Salviati, L
   Pegoraro, E
AF Cao, Michelangelo
   Dona, Marta
   Valentino, Lucia
   Semplicini, Claudio
   Maresca, Alessandra
   Cassina, Matteo
   Torraco, Alessandra
   Galletta, Eva
   Manfioli, Valeria
   Soraru, Gianni
   Carelli, Valerio
   Stramare, Roberto
   Bertini, Enrico
   Carozzo, Rosalba
   Salviati, Leonardo
   Pegoraro, Elena
TI Clinical and molecular study in a long-surviving patient with MLASA syndrome due to novel <i>PUS1</i> mutations
SO NEUROGENETICS
LA English
DT Article
DE Mitochondrial biogenesis; MLASA; mtDNA copy number; PUS1
ID sideroblastic anemia-mlasa; mitochondrial myopathy; lactic-acidosis; transfer-rna; missense mutation; gene; yars2; deficiency
AB Myopathy-lactic acidosis-sideroblastic anemia (MLASA) syndrome is a rare autosomal recessive disease. We studied a 43-year-old female presenting since childhood with mild cognitive impairment and sideroblastic anemia. She later developed hepatopathy, cardiomyopathy, and insulin-dependent diabetes. Muscle weakness appeared in adolescence and, at age 43, she was unable to walk. Two novel different mutations in the PUS1 gene were identified: c.487delA (p.I163Lfs*4) and c.884 G > A (p.R295Q). Quantitative analysis of DNA from skeletal muscle biopsies showed a significant increase in mitochondrial DNA (mtDNA) content in the patient compared to controls. Clinical and molecular findings of this patient widen the genotype-phenotype spectrum in MLASA syndrome.
C1 [Cao, Michelangelo; Semplicini, Claudio; Galletta, Eva; Manfioli, Valeria; Soraru, Gianni; Pegoraro, Elena] Univ Padua, Dept Neurosci, Padua, Italy.
   [Dona, Marta; Cassina, Matteo; Salviati, Leonardo] Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy.
   [Valentino, Lucia; Carelli, Valerio] Univ Bologna, Neurol Unit, Dept Biomed & NeuroMotor Sci DIBINEM, Bologna, Italy.
   [Valentino, Lucia; Maresca, Alessandra; Carelli, Valerio] Bellaria Hosp, IRCCS Inst Neurol Sci, Bologna, Italy.
   [Torraco, Alessandra; Bertini, Enrico; Carozzo, Rosalba] IRCCS, Childrens Res Hosp Bambino Gesu, Unit Neuromuscular & Neurodegenerat Disorders, Mol Med Lab, Rome, Italy.
   [Stramare, Roberto] Univ Padua, Dept Med, Sect Radiol, Padua, Italy.
   [Pegoraro, Elena] Univ Padua, Dept Neurosci, I-35128 Padua, Italy.
C3 University of Padua; University of Padua; University of Bologna; AUSL di Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); IRCCS Bambino Gesu; University of Padua; University of Padua
RP Pegoraro, E (corresponding author), Univ Padua, Dept Neurosci, Padua, Italy.
EM elena.pegoraro@unipd.it
FU Telethon Italy [GGP13222]; University of Padova [CPDA123573/12]; Fondazione CARIPARO; Telethon Network of Genetic BioBank [GTB12001D]; Eurobiobank network
CR Ardissone A, 2015, JIMD REP, V20, P95, DOI 10.1007/8904_2014_397
   Burrage LC, 2014, MOL GENET METAB, V113, P207, DOI 10.1016/j.ymgme.2014.06.004
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   Bykhovskaya Y, 2007, MOL GENET METAB, V91, P148, DOI 10.1016/j.ymgme.2007.02.006
   Carelli V, 2015, ANN NEUROL, V78, P21, DOI 10.1002/ana.24410
   Casas K, 2004, AM J MED GENET A, V127A, P44, DOI 10.1002/ajmg.a.20652
   Casas KA, 2004, AM J MED GENET A, V125A, P201, DOI 10.1002/ajmg.a.20368
   Czudnochowski N, 2013, J MOL BIOL, V425, P3875, DOI 10.1016/j.jmb.2013.05.014
   Desbats MA, 2015, EUR J HUM GENET, V23, P1254, DOI 10.1038/ejhg.2014.277
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Fernandez-Vizarra E, 2007, J MED GENET, V44, P173, DOI 10.1136/jmg.2006.045252
   Giordano C, 2014, BRAIN, V137, P335, DOI 10.1093/brain/awt343
   INBAL A, 1995, AM J MED GENET, V55, P372, DOI 10.1002/ajmg.1320550325
   Malena A, 2013, ACTA NEUROPATHOL, V126, P109, DOI 10.1007/s00401-013-1122-9
   Metodiev MD, 2015, EUR J HUM GENET, V23, P880, DOI 10.1038/ejhg.2014.192
   Nakajima J, 2014, J HUM GENET, V59, P229, DOI 10.1038/jhg.2013.143
   Patton JR, 2005, J BIOL CHEM, V280, P19823, DOI 10.1074/jbc.M500216200
   RAWLES JM, 1974, AM J MED, V56, P891, DOI 10.1016/0002-9343(74)90820-1
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   Sasarman F, 2012, HUM MUTAT, V33, P1201, DOI 10.1002/humu.22098
   Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058
   Trevisson E, 2007, HUM MUTAT, V28, P694, DOI 10.1002/humu.20498
   Zeharia A, 2005, J CHILD NEUROL, V20, P449, DOI 10.1177/08830738050200051301
NR 23
TC 27
Z9 28
U1 0
U2 7
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1364-6745
EI 1364-6753
J9 NEUROGENETICS
JI Neurogenetics
PD JAN 15
PY 2016
VL 17
IS 1
BP 65
EP 70
DI 10.1007/s10048-015-0465-x
PG 6
WC Genetics & Heredity; Clinical Neurology
SC Genetics & Heredity; Neurosciences & Neurology
GA DA3KJ
UT WOS:000367695300009
PM 26556812
DA 2024-11-01
ER

PT J
AU Wang, ZX
   Hong, DJ
   Zhang, W
   Li, WR
   Shi, X
   Zhao, DH
   Yang, X
   Lv, H
   Yuan, Y
AF Wang, Zhaoxia
   Hong, Daojun
   Zhang, Wei
   Li, Wurong
   Shi, Xin
   Zhao, Danhua
   Yang, Xu
   Lv, He
   Yuan, Yull
TI Severe sensory neuropathy In patients with adult-onset multiple acyl-CoA dehydrogenase deficiency
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Multiple Acyl-CoA dehydrogenase deficiency; Sensory neuropathy; ETFDH; Phenotype
ID lipid storage myopathy; coenzyme-q10 deficiency; oxidative stress; chinese patients; mutations; metabolism; defects
AB Multiple Acyl-CoA dehydrogenase deficiency (MADD) is an autosomal recessive disorder of fatty acid oxidation. Most patients with late-onset MADD are clinically characterized by lipid storage myopathy with dramatic responsiveness to riboflavin treatment. Abnormalities of peripheral neuropathy have rarely been reported in patients with late-onset MADD. We describe six patients who presented with proximal limb weakness and loss of sensation in the distal limbs. Muscle biopsy revealed typical myopathological patterns of lipid storage myopathy and blood acylcarnitine profiles showed a combined elevation of multiple acylcarnitines supporting the diagnosis of MADD. However, nerve conduction investigations and rural nerve biopsies in these patients indicated severe axonal sensory neuropathy. Causative ETFDH gene mutations were found in all six cases. No other causative gene mutations were identified in mitochondrial DNA and genes associated with hereditary neuropathies through next generation-sequencing panel. Late-onset patients with ETFDH mutations can present with proximal muscle weakness and distal sensory neuropathy, which might be a new phenotypic variation, but the precise underlying pathogenesis remains to be elucidated. (C) 2015 Published by Elsevier B.V.
C1 [Wang, Zhaoxia; Zhang, Wei; Shi, Xin; Zhao, Danhua; Lv, He; Yuan, Yull] Peking Univ, Hosp 1, Dept Neurol, Xishiku St 8, Beijing 100034, Peoples R China.
   [Hong, Daojun] Nanchang Univ, Affiliated Hosp 1, Dept Neurol, Nanchang, Peoples R China.
   [Li, Wurong] Capital Med Univ, Beijing Ditan Hosp, Dept Neurol, Beijing, Peoples R China.
   [Yang, Xu] China Aerosp Corp, Cent Hosp, Dept Neurol, Beijing, Peoples R China.
C3 Peking University; Nanchang University; Capital Medical University
RP Yuan, Y (corresponding author), Peking Univ, Hosp 1, Dept Neurol, Xishiku St 8, Beijing 100034, Peoples R China.
EM yuanyun2002@sohu.com
FU National Natural Science Foundation of China [30870864, 81260194, 81460199]; Ministry of Science and Technology of the People's Republic of China [2011ZX09307-001-07]
CR Bruno C, 2008, CURR OPIN NEUROL, V21, P601, DOI 10.1097/WCO.0b013e32830dd5a6
   Cornelius N, 2013, HUM MOL GENET, V22, P3819, DOI 10.1093/hmg/ddt232
   Cotelli MS, 2012, NEUROL SCI, V33, P1383, DOI 10.1007/s10072-011-0900-1
   Frerman FE, 2001, METABOLIC MOL BASIS, V0, P2357
   Gempel K, 2007, BRAIN, V130, P2037, DOI 10.1093/brain/awm054
   Gianazza E, 2006, ELECTROPHORESIS, V27, P1182, DOI 10.1002/elps.200500687
   Grünert SC, 2014, ORPHANET J RARE DIS, V9, P0, DOI 10.1186/s13023-014-0117-5
   Kim SH, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003563
   [李务荣 Li Wurong], 2012, 中风与神经疾病杂志 JOURNAL OF APOPLEXY AND NERVOUS DISEASES, V29, P200
   Liang W C, 2010, ACTA MYOL, V29, P351
   Meyerson C, 2015, CLIN OPHTHALMOL, V9, P1165, DOI 10.2147/OPTH.S62021
   Ohkuma A, 2009, MUSCLE NERVE, V39, P333, DOI 10.1002/mus.21167
   Olsen RKJ, 2007, BRAIN, V130, P2045, DOI 10.1093/brain/awm135
   Olsen RKJ, 2013, MOL GENET METAB, V110, PS31, DOI 10.1016/j.ymgme.2013.10.007
   Olsen RKJ, 2003, HUM MUTAT, V22, P12, DOI 10.1002/humu.10226
   Palmieri F, 2014, J INHERIT METAB DIS, V37, P565, DOI 10.1007/s10545-014-9708-5
   Peng YF, 2015, BMC NEUROL, V15, P0, DOI 10.1186/s12883-015-0380-7
   Poorabbas A, 2007, EUR J CLIN NUTR, V61, P892, DOI 10.1038/sj.ejcn.1602594
   Quistad GB, 2002, TOXICOL APPL PHARM, V179, P57, DOI 10.1006/taap.2001.9342
   Simkovic M, 2002, BIOCHEM J, V364, P659, DOI 10.1042/BJ20020042
   Song YQ, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0008329
   Viader A, 2013, NEURON, V77, P886, DOI 10.1016/j.neuron.2013.01.012
   Weiss MD, 2010, MUSCLE NERVE, V41, P882, DOI 10.1002/mus.21636
   Wen B, 2010, J NEUROL NEUROSUR PS, V81, P231, DOI 10.1136/jnnp.2009.176404
   Zhang W, 2010, NEUROL SCI, V31, P61, DOI 10.1007/s10072-009-0128-5
   Zhao D, 2011, J HUM GENET, V56, P759, DOI 10.1038/jhg.2011.96
   Zhu M, 2014, J HUM GENET, V59, P256, DOI 10.1038/jhg.2014.10
NR 27
TC 32
Z9 33
U1 0
U2 15
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD FEB 15
PY 2016
VL 26
IS 2
BP 170
EP 175
DI 10.1016/j.nmd.2015.12.002
PG 6
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA DF9AH
UT WOS:000371652100009
PM 26821934
DA 2024-11-01
ER

PT J
AU Maeda, K
   Kawai, H
   Sanada, M
   Terashima, T
   Ogawa, N
   Idehara, R
   Makiishi, T
   Yasuda, H
   Sato, S
   Hoshi, K
   Yahikozawa, H
   Nishi, K
   Itoh, Y
   Ogasawara, K
   Tomita, K
   Indo, HP
   Majima, HJ
AF Maeda, Kengo
   Kawai, Hiromichi
   Sanada, Mitsuru
   Terashima, Tomoya
   Ogawa, Nobuhiro
   Idehara, Ryo
   Makiishi, Tetsuya
   Yasuda, Hitoshi
   Sato, Shun-ichi
   Hoshi, Ken-ichi
   Yahikozawa, Hiroyuki
   Nishi, Katsuji
   Itoh, Yasushi
   Ogasawara, Kazumasa
   Tomita, Kazuo
   Indo, Hiroko P.
   Majima, Hideyuki J.
TI Clinical Phenotype and Segregation of Mitochondrial 3243A&gt;G Mutation in 2 Pairs of Monozygotic Twins
SO JAMA NEUROLOGY
LA English
DT Article
ID tissue distribution; dna deletions; disease; mtdna; transmission; myopathy
AB IMPORTANCE The regulatory factors explaining the wide spectrum of clinical phenotypes for mitochondrial 3243A>G mutation are not known. Crosstalk between nuclear genes and mitochondrial DNA might be one factor. OBSERVATIONS In this case series, we compared 2 pairs of male twins with the mitochondrial 3243 A>G mutation and mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes syndrome with a female control patient. One pair of monozygotic twins presented with diabetes and deafness in their 30s, stroke-like episodes in their 40s, and cardiac events and death in their 50s. Another pair of twins presented with deafness and stroke-like episodes in their 20s. The degree of heteroplasmy of 3243A>G mutation in the various tissues and organs was similar in the first pair of twins compared with the control patient. CONCLUSIONS AND RELEVANCE The clinical phenotype and segregation of mitochondrial 3243A>G mutation was similar in monozygotic twins. The onset age and distribution of the symptoms might be regulated by nuclear genes. Our findings might help to predict the clinical course of the surviving twins and afford an opportunity for therapy before the onset of mitochondrial disease, especially for monozygotic twins caused by nuclear transfer with a small amount of nuclear-donor mitochondrial DNA.
C1 [Maeda, Kengo; Ogawa, Nobuhiro; Idehara, Ryo] Natl Hosp Org Higashi Ohmi Gen Med Ctr, Dept Neurol, 255 Gochi, Higashi Ohmi, Shiga 5278505, Japan.
   [Maeda, Kengo; Kawai, Hiromichi; Sanada, Mitsuru; Terashima, Tomoya; Ogawa, Nobuhiro; Yasuda, Hitoshi] Shiga Univ Med Sci, Dept Internal Med, Div Neurol, Otsu, Shiga, Japan.
   [Makiishi, Tetsuya] Yabase Chuo Hosp, Dept Internal Med, Kusatsu, Shiga, Japan.
   [Sato, Shun-ichi; Hoshi, Ken-ichi; Yahikozawa, Hiroyuki] Nagano Red Cross Hosp, Dept Neurol, Nagano, Japan.
   [Nishi, Katsuji] Shiga Univ Med Sci, Dept Legal Med, Otsu, Shiga, Japan.
   [Itoh, Yasushi; Ogasawara, Kazumasa] Shiga Univ Med Sci, Div Pathol & Dis Regulat, Dept Pathol, Otsu, Shiga, Japan.
   [Tomita, Kazuo; Indo, Hiroko P.; Majima, Hideyuki J.] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Oncol, Kagoshima, Kagoshima, Japan.
   [Tomita, Kazuo; Indo, Hiroko P.; Majima, Hideyuki J.] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Space Environm Med, Kagoshima, Kagoshima, Japan.
C3 Shiga University of Medical Science; Nagano Red Cross Hospital; Shiga University of Medical Science; Shiga University of Medical Science; Kagoshima University; Kagoshima University
RP Maeda, K (corresponding author), Natl Hosp Org Higashi Ohmi Gen Med Ctr, Dept Neurol, 255 Gochi, Higashi Ohmi, Shiga 5278505, Japan.
EM maeda-kengo@shiga-hosp.jp
FU Grants-in-Aid for Scientific Research [16K11513, 26460876] Funding Source: KAKEN
CR Blakely EL, 2004, J MED GENET, V41, P0, DOI 10.1136/jmg.2003.011296
   Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958
   DEGOUL F, 1994, ANN NEUROL, V35, P365, DOI 10.1002/ana.410350321
   DUNBAR DR, 1995, P NATL ACAD SCI USA, V92, P6562, DOI 10.1073/pnas.92.14.6562
   Feigenbaum A, 1996, AM J MED GENET, V62, P404, DOI 10.1002/(SICI)1096-8628(19960424)62:4<404::AID-AJMG14>3.0.CO;2-S
   Hankins GVD, 2005, PAEDIATR PERINAT EP, V19, P8, DOI 10.1111/j.1365-3016.2005.00609.x
   Hao HL, 1999, HUM MOL GENET, V8, P1117, DOI 10.1093/hmg/8.6.1117
   HARDING AE, 1992, AM J HUM GENET, V50, P629
   MATTHEWS PM, 1994, J MED GENET, V31, P41, DOI 10.1136/jmg.31.1.41
   MATTHEWS PM, 1995, HUM GENET, V96, P261
   MORGANHUGHES JA, 1995, BBA-MOL BASIS DIS, V1271, P135, DOI 10.1016/0925-4439(95)00020-5
   Nakashima-Kamimura N, 2005, J CELL SCI, V118, P5357, DOI 10.1242/jcs.02645
   Paull D, 2013, NATURE, V493, P632, DOI 10.1038/nature11800
   Rose MR, 1998, ARCH NEUROL-CHICAGO, V55, P17, DOI 10.1001/archneur.55.1.17
   Scott Lynette, 2002, REPROD BIOMED ONLINE, V5, P276
   SHANSKE S, 1990, NEUROLOGY, V40, P24, DOI 10.1212/WNL.40.1.24
   Spyropoulos A, 2013, JAMA NEUROL, V70, P1552, DOI 10.1001/jamaneurol.2013.4111
   ZEVIANI M, 1990, ANN NEUROL, V28, P94, DOI 10.1002/ana.410280118
NR 18
TC 28
Z9 29
U1 1
U2 5
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6149
EI 2168-6157
J9 JAMA NEUROL
JI JAMA Neurol.
PD AUG 15
PY 2016
VL 73
IS 8
BP 990
EP 993
DI 10.1001/jamaneurol.2016.0886
PG 4
WC Clinical Neurology
SC Neurosciences & Neurology
GA DX2MS
UT WOS:000384204900021
PM 27323007
DA 2024-11-01
ER

PT J
AU Cordero, MD
   Alcocer-Gómez, E
   Marín-Aguilar, F
   Rybkina, T
   Cotán, D
   Pérez-Pulido, A
   Alvarez-Suarez, JM
   Battino, M
   Sánchez-Alcazar, JA
   Carrión, AM
   Culic, O
   Navarro-Pando, JM
   Bullón, P
AF Cordero, Mario D.
   Alcocer-Gomez, Elisabet
   Marin-Aguilar, Fabiola
   Rybkina, Tatyana
   Cotan, David
   Perez-Pulido, Antonio
   Miguel Alvarez-Suarez, Jose
   Battino, Maurizio
   Antonio Sanchez-Alcazar, Jose
   Carrion, Angel M.
   Culic, Ognjen
   Navarro-Pando, Jose M.
   Bullon, Pedro
TI Mutation in cytochrome b gene of mitochondrial DNA in a family with fibromyalgia is associated with NLRP3-inflammasome activation
SO JOURNAL OF MEDICAL GENETICS
LA English
DT Article
ID blood mononuclear-cells; nlrp3 inflammasome; coenzyme q(10); oxidative stress; disease; muscle; supplementation; dysfunction; fibroblasts; deficiency
AB Background Fibromyalgia (FM) is a worldwide diffuse musculoskeletal chronic pain condition that affects up to 5% of the general population. Many symptoms associated with mitochondrial diseases are reported in patients with FM such as exercise intolerance, fatigue, myopathy and mitochondrial dysfunction. In this study, we report a mutation in cytochrome b gene of mitochondrial DNA (mtDNA) in a family with FM with inflammasome complex activation. Methods mtDNA from blood cells of five patients with FM were sequenced. We clinically and genetically characterised a patient with FM and family with a new mutation in mtCYB. Mitochondrial mutation phenotypes were determined in skin fibroblasts and transmitochondrial cybrids. Results After mtDNA sequence in patients with FM, we found a mitochondrial homoplasmic mutation m. 15804T>C in the mtCYB gene in a patient and family, which was maternally transmitted. Mutation was observed in several tissues and skin fibroblasts showed a very significant mitochondrial dysfunction and oxidative stress. Increased NLRP3-inflammasome complex activation was observed in blood cells from patient and family. Conclusions We propose further studies on mtDNA sequence analysis in patients with FM with evidences for maternal inheritance. The presence of similar symptoms in mitochondrial myopathies could unmask mitochondrial diseases among patients with FM. On the other hand, the inflammasome complex activation by mitochondrial dysfunction could be implicated in the pathophysiology of mitochondrial diseases.
C1 [Cordero, Mario D.; Marin-Aguilar, Fabiola; Bullon, Pedro] Univ Seville, Univ Hosp Virgen Rocio CSIC, IBiS Inst Biomed Seville, Seville, Spain.
   [Cordero, Mario D.; Bullon, Pedro] Univ Seville, Dept Oral Med, Res Lab, Seville, Spain.
   [Alcocer-Gomez, Elisabet; Cotan, David; Perez-Pulido, Antonio; Antonio Sanchez-Alcazar, Jose] Univ Pablo Olavide CSIC Junta Andalucia, CABD, Seville, Spain.
   [Alcocer-Gomez, Elisabet; Cotan, David; Antonio Sanchez-Alcazar, Jose] ISCIII, CIBERER, Seville, Spain.
   [Rybkina, Tatyana; Carrion, Angel M.] Univ Pablo Olavide Sevilla, Div Neurociencias, Seville, Spain.
   [Miguel Alvarez-Suarez, Jose] Univ Las Amer, Fac Ciencias Salud, Escuela Med Vet & Zootecnia, Quito, Ecuador.
   [Battino, Maurizio] Univ Politecn Marche, Dipartimento Sci Clin Specialist & Odontostomatol, Ancona, Italy.
   [Culic, Ognjen] Univ Zagreb, Fac Pharm & Biochem, Zagreb 41000, Croatia.
   [Navarro-Pando, Jose M.] Inst Estudio Biol Reprod Humana INEBIR, Unidad Reprod Humana & Cirugia Endoscopia, Seville, Spain.
C3 Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); University of Sevilla; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universidad Pablo de Olavide; Universidad de Las Americas - Ecuador; Marche Polytechnic University; University of Zagreb
RP Cordero, MD (corresponding author), Univ Seville, Univ Hosp Virgen Rocio CSIC, IBiS Inst Biomed Seville, Seville, Spain.; Cordero, MD (corresponding author), Univ Seville, Dept Oral Med, Res Lab, Seville, Spain.; Cordero, MD (corresponding author), Univ Seville, Inst Biomed Seville, C Calle Antonio Maura Montaner S-N, Seville 41013, Spain.
EM mdcormor@us.es
FU Federacion Andaluza de Fibromialgia y Fatiga Cronica (ALBA Andalucia); Federacion Onubense de Fibromialgia y Fatiga Cronica; Fundacion Ramon Areces; DGICYT (Departamento Gubernamental de Investigaciones Cientificas y Tecnologicas) [BFU2011-27207]; Grupo de Investigacion Junta de Andalucia [CTS113]; Consejeria de Salud of the Junta de Andalucia [PI-0036-2014]
CR Alcocer-Gómez E, 2015, BBA-MOL BASIS DIS, V1852, P1257, DOI 10.1016/j.bbadis.2015.03.005
   [Anonymous], 2013, MEDIAT INFLAMM, V0, P0, DOI DOI 10.1155/2013/678627
   Arnold LM, 2004, ARTHRITIS RHEUM-US, V50, P944, DOI 10.1002/art.20042
   Arpa J, 2003, MUSCLE NERVE, V28, P690, DOI 10.1002/mus.10507
   Bagis S, 2005, RHEUMATOL INT, V25, P188, DOI 10.1007/s00296-003-0427-8
   Bazzichi L, 2007, CLIN EXP RHEUMATOL, V25, P225
   Bazzichi L, 2008, CLIN BIOCHEM, V41, P1084, DOI 10.1016/j.clinbiochem.2008.06.012
   Biasini M, 2014, NUCLEIC ACIDS RES, V42, PW252, DOI 10.1093/nar/gku340
   Bonfield JK, 1998, NUCLEIC ACIDS RES, V26, P3404, DOI 10.1093/nar/26.14.3404
   BOYLE JS, 1995, TRENDS GENET, V11, P8, DOI 10.1016/S0168-9525(00)88977-5
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Buskila D, 1996, SEMIN ARTHRITIS RHEU, V26, P605, DOI 10.1016/S0049-0172(96)80011-4
   Chen ZT, 2015, MOL MED REP, V11, P1956, DOI 10.3892/mmr.2014.2911
   Cordero MD, 2014, ANTIOXID REDOX SIGN, V20, P1169, DOI 10.1089/ars.2013.5198
   Cordero MD, 2013, ANTIOXID REDOX SIGN, V19, P1356, DOI 10.1089/ars.2013.5260
   Cordero MD, 2013, ANTIOXID REDOX SIGN, V18, P800, DOI 10.1089/ars.2012.4892
   Cordero MD, 2012, NUTRITION, V28, P1200, DOI 10.1016/j.nut.2012.03.018
   Cordero MD, 2010, ARTHRITIS RES THER, V12, P0, DOI 10.1186/ar2918
   Cotán D, 2011, FASEB J, V25, P2669, DOI 10.1096/fj.10-165340
   Dashdorj A, 2013, BMC MED, V11, P0, DOI 10.1186/1741-7015-11-178
   De la Mata M, 2012, NEUROTHERAPEUTICS, V9, P446, DOI 10.1007/s13311-012-0103-3
   Ding ZF, 2014, BIOCHEM BIOPH RES CO, V451, P637, DOI 10.1016/j.bbrc.2014.08.034
   Gerdle B, 2013, EUR J PAIN, V17, P1205, DOI 10.1002/j.1532-2149.2013.00284.x
   Gómez-Durán A, 2010, HUM MOL GENET, V19, P3343, DOI 10.1093/hmg/ddq246
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   Hargreaves I P, 2014, INT J BIOCHEM CELL BIOL, V49, P105, DOI 10.1016/j.biocel.2014.01.020
   Harijith A, 2014, FRONT PHYSIOL, V5, P0, DOI 10.3389/fphys.2014.00352
   KALYANRAMAN UP, 1984, J RHEUMATOL, V11, P808
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Lanciano P, 2013, BBA-BIOENERGETICS, V1827, P1332, DOI 10.1016/j.bbabio.2013.03.009
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Mancuso M, 2013, NEUROMUSCULAR DISORD, V23, P907, DOI 10.1016/j.nmd.2013.07.011
   Marchetti C, 2014, J CARDIOVASC PHARM, V63, P316, DOI 10.1097/FJC.0000000000000053
   Menu P, 2011, CLIN EXP IMMUNOL, V166, P1, DOI 10.1111/j.1365-2249.2011.04440.x
   MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
   Miyamae T, 2013, REDOX REP, V18, P12, DOI 10.1179/1351000212Y.0000000036
   Mkaouar-Rebai E, 2011, J CHILD NEUROL, V26, P12, DOI 10.1177/0883073810371227
   Montini G, 2008, NEW ENGL J MED, V358, P2849, DOI 10.1056/NEJMc0800582
   Ozgocmen S, 2006, RHEUMATOL INT, V26, P585, DOI 10.1007/s00296-005-0078-z
   Pongratz DE, 1998, Z RHEUMATOL, V57, P47
   Quinzii CM, 2010, DEV DISABIL RES REV, V16, P183, DOI 10.1002/ddrr.108
   Roos S, 2014, NEUROMUSCULAR DISORD, V24, P713, DOI 10.1016/j.nmd.2014.05.009
   Ross Rebecca L, 2010, OPEN IMMUNOL J, V3, P9
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Scarpelli Mauro, 2010, RECENT PAT CNS DRUG DISCOV, V5, P203, DOI 10.2174/157488910793362412
   Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009
   Takahashi M, 2014, INT HEART J, V55, P101, DOI 10.1536/ihj.13-388
   Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478
   van de Glind G, 2007, EUR J PAEDIATR NEURO, V11, P243, DOI 10.1016/j.ejpn.2007.01.004
   Vattemi G, 2013, FREE RADICAL BIO MED, V63, P108, DOI 10.1016/j.freeradbiomed.2013.04.025
   Villanova M, 1999, MUSCLE NERVE, V22, P289, DOI 10.1002/(SICI)1097-4598(199902)22:2<289::AID-MUS26>3.0.CO;2-O
   Watson NF, 2009, ARTHRITIS RHEUM-US, V60, P2839, DOI 10.1002/art.24772
   Wheeler TJ, 2014, BMC BIOINFORMATICS, V15, P0, DOI 10.1186/1471-2105-15-7
   YUNUS MB, 1986, AM J MED, V81, P38, DOI 10.1016/0002-9343(86)90872-7
   Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663
NR 56
TC 24
Z9 27
U1 0
U2 19
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-2593
EI 1468-6244
J9 J MED GENET
JI J. Med. Genet.
PD FEB 15
PY 2016
VL 53
IS 2
BP 113
EP 122
DI 10.1136/jmedgenet-2015-103392
PG 10
WC Genetics & Heredity
SC Genetics & Heredity
GA DB4SF
UT WOS:000368502700005
PM 26566881
DA 2024-11-01
ER

PT J
AU Rodenburg, RJ
AF Rodenburg, Richard J.
TI Mitochondrial complex I-linked disease
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
LA English
DT Article
DE Mitochondrial disease; Complex I; mtDNA; Whole exome sequencing; Enzyme measurement
ID hereditary optic neuropathy; respiratory-chain; leigh-syndrome; superoxide-production; clinical-features; calcium uniporter; atp production; deficiency; mutation; exome
AB Complex I deficiency is the most frequently encountered single mitochondrial single enzyme deficiency in patients with a mitochondrial disorder. Although specific genotype-phenotype correlations are very difficult to identify, the majority of patients present with symptoms caused by leukodystrophy. The poor genotype-phenotype correlations can make establishing a diagnosis a challenge. The classical way to establish a complex I deficiency in patients is by performing spectrophotometric measurements of the enzyme in a muscle biopsy or other patient-derived material (liver or heart biopsy, cultured skin fibroblasts). Complex I is encoded by both the mtDNA and nuclear DNA and pathogenic mutations have been identified in the majority of the 44 genes encoding the structural subunits of complex I. In recent years, the increasing possibilities for diagnostic molecular genetic tests of large gene panels, exomes, and even entire genomes has led to the identification of many novel genetic defects causing complex I deficiency. Complex I mutations not only result in a reduced enzyme activity but also induce secondary effects at the cellular level, such as elevated reactive oxygen species production, altered membrane potential and mitochondrial morphology. At this moment there is no cure for complex I deficiency and the treatment options for complex I patients are restricted to symptomatic treatment. Recent developments, amongst others based on the treatment of the secondary effects of complex I deficiency, have shown to be promising as new therapeutic strategies in vitro and have entered clinical trials. This article is part of a Special Issue entitled Respiratory complex I, edited by Volker Zickermann and Ulrich Brandt. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Rodenburg, Richard J.] Radboud Univ Nijmegen, Med Ctr, RCMM, Translat Metab Lab 774,Dept Pediat, POB 9101, NL-6500 HB Nijmegen, Netherlands.
C3 Radboud University Nijmegen
RP Rodenburg, RJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, RCMM, Translat Metab Lab 774,Dept Pediat, POB 9101, NL-6500 HB Nijmegen, Netherlands.
EM richard.rodenburg@radboudumc.nl
CR Angebault C, 2015, HUM MOL GENET, V24, P3948, DOI 10.1093/hmg/ddv133
   Balsa E, 2012, CELL METAB, V16, P378, DOI 10.1016/j.cmet.2012.07.015
   Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234
   Blanchet L, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep08035
   Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003
   Brookes AJ, 2015, NAT REV GENET, V0, P0
   Calvo SE, 2012, SCI TRANSL MED, V4, P0, DOI 10.1126/scitranslmed.3003310
   Carelli V, 2011, BRAIN, V134, P0, DOI 10.1093/brain/awr180
   Danhauser K, 2011, MOL GENET METAB, V103, P161, DOI 10.1016/j.ymgme.2011.03.004
   De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230
   Deschauer M, 2003, NEUROLOGY, V60, P1357, DOI 10.1212/01.WNL.0000055869.99975.4B
   DiMauro S, 1993, GENE REV R, V0, P0
   Distelmaier F, 2009, J MOL MED, V87, P515, DOI 10.1007/s00109-009-0452-5
   Distelmaier F, 2009, BRAIN, V132, P833, DOI 10.1093/brain/awp058
   Fassone E, 2012, J MED GENET, V49, P578, DOI 10.1136/jmedgenet-2012-101159
   Finkel T, 2015, CIRC RES, V116, P1810, DOI 10.1161/CIRCRESAHA.116.305484
   Gilissen C, 2014, NATURE, V0, P0
   Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846
   Hadzsiev K, 2010, NEUROMOL MED, V12, P277, DOI 10.1007/s12017-010-8115-9
   Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176
   Iannetti EF, 2015, INT J BIOCHEM CELL B, V63, P66, DOI 10.1016/j.biocel.2015.01.020
   Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873
   Johnson KR, 2001, NAT GENET, V27, P191, DOI 10.1038/84831
   Kevelam SH, 2013, NEUROLOGY, V80, P1577, DOI 10.1212/WNL.0b013e31828f1914
   Klopstock T, 2011, BRAIN, V134, P2677, DOI 10.1093/brain/awr170
   Koene S, 2012, J INHERIT METAB DIS, V35, P737, DOI 10.1007/s10545-012-9492-z
   KUONEN DR, 1986, ANAL BIOCHEM, V153, P221, DOI 10.1016/0003-2697(86)90084-9
   Lake NJ, 2015, ANN NEUROL, V0, P0
   Lake NJ, 2015, J NEUROPATH EXP NEUR, V74, P482, DOI 10.1097/NEN.0000000000000195
   Lelieveld SH, 2015, HUM MUTAT, V36, P815, DOI 10.1002/humu.22813
   Loeffen J, 1998, AM J HUM GENET, V63, P1598, DOI 10.1086/302154
   Luo XP, 1997, J CLIN INVEST, V99, P2877, DOI 10.1172/JCI119481
   McFarland R, 2007, NEUROLOGY, V69, P911, DOI 10.1212/01.wnl.0000267843.10977.4a
   Mimaki M, 2012, BBA-BIOENERGETICS, V1817, P851, DOI 10.1016/j.bbabio.2011.08.010
   Mitchell AL, 2006, J MED GENET, V43, P175, DOI 10.1136/jmg.2005.032474
   Ngu LH, 2012, BBA-MOL BASIS DIS, V1822, P168, DOI 10.1016/j.bbadis.2011.10.012
   NIKOSKELAINEN EK, 1995, J NEUROL NEUROSUR PS, V59, P160, DOI 10.1136/jnnp.59.2.160
   Nouws J, 2012, BRAIN, V135, P12, DOI 10.1093/brain/awr261
   Ohtake A, 2014, BBA-GEN SUBJECTS, V1840, P1355, DOI 10.1016/j.bbagen.2014.01.025
   Ortega-Recalde O, 2013, MITOCHONDRION, V13, P749, DOI 10.1016/j.mito.2013.03.010
   Pagniez-Mammeri H, 2012, MOL GENET METAB, V105, P163, DOI 10.1016/j.ymgme.2011.11.188
   Pagniez-Mammeri H, 2012, MOL GENET METAB, V105, P173, DOI 10.1016/j.ymgme.2011.10.001
   Pfeffer G, 2013, NAT REV NEUROL, V9, P474, DOI 10.1038/nrneurol.2013.129
   Pitceathly RDS, 2013, CELL REP, V3, P1795, DOI 10.1016/j.celrep.2013.05.005
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595
   Rodenburg RJT, 2011, J INHERIT METAB DIS, V34, P283, DOI 10.1007/s10545-010-9081-y
   Saada A, 2014, INT J BIOCHEM CELL B, V48, P60, DOI 10.1016/j.biocel.2013.12.010
   Sancak Y, 2013, SCIENCE, V342, P1379, DOI 10.1126/science.1242993
   SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A
   Shehata BM, 2015, AM J MED GENET A, V167, P2114, DOI 10.1002/ajmg.a.37138
   Tahara EB, 2009, FREE RADICAL BIO MED, V46, P1283, DOI 10.1016/j.freeradbiomed.2009.02.008
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Tucker EJ, 2011, IUBMB LIFE, V63, P669, DOI 10.1002/iub.495
   Valsecchi F, 2009, BBA-MOL BASIS DIS, V1792, P1130, DOI 10.1016/j.bbadis.2009.01.001
   Van Coster R, 2001, PEDIATR RES, V50, P658, DOI 10.1203/00006450-200111000-00020
   van den Heuvel LP, 2004, MITOCHONDRION, V4, P395, DOI 10.1016/j.mito.2004.07.005
   Verkaart S, 2007, BBA-MOL BASIS DIS, V1772, P373, DOI 10.1016/j.bbadis.2006.12.009
   Vinothkumar KR, 2014, NATURE, V515, P80, DOI 10.1038/nature13686
   Visch HJ, 2004, J BIOL CHEM, V279, P40328, DOI 10.1074/jbc.M408068200
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Willis JH, 2009, BBA-BIOENERGETICS, V1787, P533, DOI 10.1016/j.bbabio.2008.10.009
   Wortmann SB, 2015, J INHERIT METAB DIS, V38, P437, DOI 10.1007/s10545-015-9823-y
   Yu-Wai-Man P, 2011, PROG RETIN EYE RES, V30, P81, DOI 10.1016/j.preteyeres.2010.11.002
   Zhu JP, 2015, P NATL ACAD SCI USA, V112, P12087, DOI 10.1073/pnas.1510577112
   Zickermann V, 2015, SCIENCE, V347, P44, DOI 10.1126/science.1259859
NR 66
TC 136
Z9 145
U1 0
U2 19
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0005-2728
EI 0006-3002
J9 BBA-BIOENERGETICS
JI Biochim. Biophys. Acta-Bioenerg.
PD JUL 15
PY 2016
VL 1857
IS 7
BP 938
EP 945
DI 10.1016/j.bbabio.2016.02.012
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA DO4BT
UT WOS:000377727500010
PM 26906428
DA 2024-11-01
ER

PT J
AU Li, G
   Duan, YX
   Zhang, XB
   Wu, F
AF Li, G.
   Duan, Y. X.
   Zhang, X. B.
   Wu, F.
TI Mitochondrial tRNA mutations may be infrequent in hepatocellular carcinoma patients
SO GENETICS AND MOLECULAR RESEARCH
LA English
DT Article
DE Hepatocellular carcinoma; mt-tRNA; Mutations; Polymorphisms
ID dna; gene; polymorphism; haplogroups; myopathy; deletion; cancer; liver; risk
AB Mitochondrial DNA mutations have been shown to play important roles in the pathogenesis of hepatocellular carcinoma (HCC). In particular, genes encoding mitochondrial tRNA (mt-tRNA) are hotspots for pathogenic mutations associated with HCC. Recently, an increasing number of studies have reported the involvement of such mutations in this disease. As a result, several mt-tRNA mutations associated with HCC have been described. Some of these are neutral polymorphisms and may not cause mitochondrial dysfunction. Moreover, the molecular mechanisms by which these pathogenic mutations result in HCC remain unclear. To address this problem, we evaluated five mt-tRNA variants (tRNAVal T1659C, tRNA(Ala) G5650A, tRNA(Arg) T10463C, tRNA(Glu) A14679G, and tRNA(Pro) C15975T) implicated in the clinical manifestation of HCC in humans. We performed evolutionary conservation analysis and used a bioinformatic tool to predict the secondary structure of the mt-tRNAs carrying these mutations. Using an established pathogenicity scoring system, we classified T10463C and A14679G as neutral polymorphisms, and determined that the T1659C, G5650A, and C15975T variants should be regarded as pathogenic mutations. To the best of our knowledge, this is the first report to establish the pathogenicity of HCC-associated mt-tRNA mutations.
C1 [Li, G.; Zhang, X. B.] Wenzhou Med Univ, Dept Chemoradiat Oncol, Affiliated Hosp 1, Wenzhou, Peoples R China.
   [Duan, Y. X.] Wenzhou Med Univ, Radiat Dept, Affiliated Hosp 1, Wenzhou, Peoples R China.
   [Wu, F.] Wenzhou Med Univ, Dept Gastroenterol, Affiliated Hosp 1, Wenzhou, Peoples R China.
C3 Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University
RP Wu, F (corresponding author), Wenzhou Med Univ, Dept Gastroenterol, Affiliated Hosp 1, Wenzhou, Peoples R China.
EM wufangwzmc@sina.com
FU Natural Science Foundation of Zhejiang Province [LY15H030015]; Wenzhou Bureau of Science and Technology [Y20140281]
CR Abbott JA, 2014, FRONT GENET, V5, P0, DOI 10.3389/fgene.2014.00158
   Blakely EL, 2004, J NEUROL SCI, V225, P99, DOI 10.1016/j.jns.2004.07.007
   Da Pozzo P, 2009, EUR J HUM GENET, V17, P1092, DOI 10.1038/ejhg.2009.12
   Ding Y, 2012, MITOCHONDR DNA, V23, P323, DOI 10.3109/19401736.2012.674119
   Fang HZ, 2010, BMC CANCER, V10, P0, DOI 10.1186/1471-2407-10-421
   Fang Y, 2015, GENET MOL RES, V14, P5031, DOI 10.4238/2015.May.12.6
   Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516
   Finnilä S, 2001, J MOL MED, V79, P641, DOI 10.1007/s001090100268
   Marku E, 2015, GENET MOL RES, V14, P5221, DOI 10.4238/2015.May.18.13
   Mathews DH, 2006, CURR OPIN STRUC BIOL, V16, P270, DOI 10.1016/j.sbi.2006.05.010
   McFarland R, 2008, NEUROMUSCULAR DISORD, V18, P63, DOI 10.1016/j.nmd.2007.07.007
   PARK SJ, 1988, J BIOL CHEM, V263, P16527
   Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755
   Schütte K, 2009, DIGEST DIS, V27, P80, DOI 10.1159/000218339
   Servidei Serenella, 2003, NEUROMUSCUL DISORD, V13, P848
   van Oven M, 2009, HUM MUTAT, V30, PE386, DOI 10.1002/humu.20921
   Vivekanandan P, 2010, MODERN PATHOL, V23, P790, DOI 10.1038/modpathol.2010.51
   Wan YY, 2014, GENET MOL RES, V13, P6820, DOI 10.4238/2014.August.29.3
   Wheelhouse NM, 2005, BRIT J CANCER, V92, P1268, DOI 10.1038/sj.bjc.6602496
   Wong LJC, 2004, J MED GENET, V41, P0, DOI 10.1136/jmg.2003.013532
   Yang Y, 2015, CHINESE J CANCER RES, V27, P497, DOI 10.3978/j.issn.1000-9604.2015.10.05
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
   Yin PH, 2010, MITOCHONDRION, V10, P174, DOI 10.1016/j.mito.2009.12.147
   Yin PH, 2004, BRIT J CANCER, V90, P2390, DOI 10.1038/sj.bjc.6601838
NR 24
TC 1
Z9 1
U1 0
U2 1
PU FUNPEC-EDITORA
PI RIBEIRAO PRETO
PA RUA FLORIANO PEIXOTO 2444, ALTO DA BOA VISTA, RIBEIRAO PRETO, SP 00000, BRAZIL
SN 1676-5680
EI 
J9 GENET MOL RES
JI Genet. Mol. Res.
PD JUN 15
PY 2016
VL 15
IS 2
BP 
EP 
DI 10.4238/gmr.15027665
PG 7
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA DY1UH
UT WOS:000384879400144
PM 27420959
DA 2024-11-01
ER

PT J
AU Vodopivec, I
   Cho, TA
   Rizzo, JF
   Frosch, MP
   Sims, KB
AF Vodopivec, Ivana
   Cho, Tracey A.
   Rizzo, Joseph F., III
   Frosch, Matthew P.
   Sims, Katherine B.
TI Mitochondrial Encephalopathy and Optic Neuropathy Due to m.10158 <i>MT</i>-<i>ND3</i> Complex I Mutation Presenting in an Adult Patient <i>Case Report and Review of the Literature</i>
SO NEUROLOGIST
LA English
DT Review
DE mitochondrial disease; MT-ND3; optic neuropathy; headache; stroke-like episodes; epilepsy
ID nd3 gene; leigh-syndrome; dna mutation; missense mutation; deficiency; disease; prevalence; disorders; children; lesions
AB Introduction: Establishing a diagnosis of mitochondrial disease in adults remains a clinician's challenge. We report a case of syndrome reminiscent of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) in an adult patient who carries m.10158T>C mutation in complex I respiratory chain gene MT-ND3 (mitochondrially encoded NADH dehydrogenase 3). Case Report: This 26-year-old man from Thailand presented with new-onset headaches, seizures, stroke-like episodes, and poor vision due to optic neuropathy and cortical blindness. Instead of expected mutations in the mitochondrial tRNA gene that are frequently associated with MELAS, the mutation in MT-ND3 with variable tissue heteroplasmy (blood 5.3%, muscle 89.5%) was demonstrated. The patient's clinical features, blood biomarkers, neuroimaging findings, muscle biopsy with histochemical and functional in vitro analysis, and genetic studies were analyzed and compared with all previously reported ND3 disease cases. Conclusions: ND3 disease due to m.10158T>C mutation was previously described only in patients with Leigh or Leigh-like syndrome. Our findings thus indicate that ND3 disease can manifest with atypical phenotype in adults. The diagnosis of mitochondrial disease caused by other than typical MELAS-associated mutations in adults with stroke-like episodes, headaches, and seizures should be considered. An analysis of tissue other than blood, which is more likely to harbor a tissue-specific mitochondrial DNA mutation at a measurable level, may be necessary for diagnosis.
C1 [Vodopivec, Ivana; Cho, Tracey A.; Rizzo, Joseph F., III; Frosch, Matthew P.; Sims, Katherine B.] Harvard Med Sch, Boston, MA USA.
   [Vodopivec, Ivana; Cho, Tracey A.; Sims, Katherine B.] Massachusetts Gen Hosp, Dept Neurol, 55 Fruit St, Boston, MA 02114 USA.
   [Vodopivec, Ivana; Rizzo, Joseph F., III] Massachusetts Eye & Ear Infirm, Neuroophthalmol Serv, Boston, MA 02114 USA.
   [Frosch, Matthew P.] Massachusetts Gen Hosp, Neuropathol Serv, Boston, MA 02114 USA.
C3 Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Massachusetts General Hospital
RP Vodopivec, I (corresponding author), Massachusetts Gen Hosp, Dept Neurol, 55 Fruit St, Boston, MA 02114 USA.
EM ivodopivec@partners.org
CR ANTOZZI C, 1995, J NEUROL SCI, V129, P152, DOI 10.1016/0022-510X(94)00267-R
   Bannwarth S, 2013, J MED GENET, V50, P704, DOI 10.1136/jmedgenet-2013-101604
   Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659
   Chae JH, 2007, PEDIATR RES, V61, P622, DOI 10.1203/pdr.0b013e3180459f2d
   Cohen BH, 2013, NEUROTHERAPEUTICS, V10, P227, DOI 10.1007/s13311-013-0188-3
   Crimi M, 2004, PEDIATR RES, V55, P842, DOI 10.1203/01.PDR.0000117844.73436.68
   Esteitie N, 2005, ANN NEUROL, V58, P544, DOI 10.1002/ana.20570
   Fassone E, 2012, J MED GENET, V49, P578, DOI 10.1136/jmedgenet-2012-101159
   Finsterer J, 2001, J INHERIT METAB DIS, V24, P560, DOI 10.1023/A:1012415810881
   Iizuka T, 2003, NEUROLOGY, V61, P1238, DOI 10.1212/01.WNL.0000091888.26232.FE
   Kirby DM, 2004, J CLIN INVEST, V114, P837, DOI 10.1172/JCI200420683
   Lebon S, 2003, J MED GENET, V40, P896, DOI 10.1136/jmg.40.12.896
   Lebre AS, 2011, J MED GENET, V48, P16, DOI 10.1136/jmg.2010.079624
   Leshinsky-Silver E, 2005, BIOCHEM BIOPH RES CO, V334, P582, DOI 10.1016/j.bbrc.2005.06.134
   Lim BC, 2009, J CHILD NEUROL, V24, P828, DOI 10.1177/0883073808331085
   Malfatti E, 2007, BRAIN, V130, P1894, DOI 10.1093/brain/awm114
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   Miller DK, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0104879
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Sarzi E, 2007, AM J MED GENET A, V143A, P33, DOI 10.1002/ajmg.a.31565
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Taylor RW, 2001, ANN NEUROL, V50, P104, DOI 10.1002/ana.1084
   Thorburn DR, 2004, MITOCHONDRION, V4, P363, DOI 10.1016/j.mito.2004.07.003
   Valente L, 2009, BBA-BIOENERGETICS, V1787, P491, DOI 10.1016/j.bbabio.2008.10.001
   Wang K, 2009, NEUROGENETICS, V10, P337, DOI 10.1007/s10048-009-0194-0
NR 26
TC 9
Z9 12
U1 1
U2 7
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1074-7931
EI 
J9 NEUROLOGIST
JI Neurologist
PD JUL 15
PY 2016
VL 21
IS 4
BP 61
EP 65
DI 10.1097/NRL.0000000000000084
PG 5
WC Clinical Neurology
SC Neurosciences & Neurology
GA DQ2LE
UT WOS:000379033000004
PM 27348141
DA 2024-11-01
ER

PT J
AU Roh, J
   Rhee, J
   Chaudhari, V
   Rosenzweig, A
AF Roh, Jason
   Rhee, James
   Chaudhari, Vinita
   Rosenzweig, Anthony
TI The Role of Exercise in Cardiac Aging From Physiology to Molecular Mechanisms
SO CIRCULATION RESEARCH
LA English
DT Review
DE aging; cardiovascular diseases; exercise; heart; phenotype
ID mitochondrial-dna mutations; oxidative stress-response; adenoviral gene-transfer; age-associated changes; left-ventricular mass; chronic heart-failure; sarcoplasmic-reticulum; skeletal-muscle; endurance exercise; cardiovascular-responses
AB Aging induces structural and functional changes in the heart that are associated with increased risk of cardiovascular disease and impaired functional capacity in the elderly. Exercise is a diagnostic and therapeutic tool, with the potential to provide insights into clinical diagnosis and prognosis, as well as the molecular mechanisms by which aging influences cardiac physiology and function. In this review, we first provide an overview of how aging impacts the cardiac response to exercise, and the implications this has for functional capacity in older adults. We then review the underlying molecular mechanisms by which cardiac aging contributes to exercise intolerance, and conversely how exercise training can potentially modulate aging phenotypes in the heart. Finally, we highlight the potential use of these exercise models to complement models of disease in efforts to uncover new therapeutic targets to prevent or treat heart disease in the aging population.
C1 [Roh, Jason; Rhee, James; Chaudhari, Vinita; Rosenzweig, Anthony] Massachusetts Gen Hosp, Div Cardiovasc, Boston, MA 02114 USA.
   [Roh, Jason] Massachusetts Gen Hosp, Dept Anesthesiol Crit Care & Pain Med, Boston, MA 02114 USA.
   [Rhee, James] Harvard Univ, Sch Med, Boston, MA USA.
C3 Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School
RP Rosenzweig, A (corresponding author), Massachusetts Gen Hosp, Div Cardiol, 55 Fruit St,Bigelow 800,Mailstop 817, Boston, MA 02114 USA.
EM arosenzweig@partners.org
FU National Institutes of Health [R01HL110733, R01HL122987, T32HL073734, T32GM007592]; LaDue Fellowship Award from Harvard Medical School
CR Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a
   Anderson R, 2009, BBA-GEN SUBJECTS, V1790, P1059, DOI 10.1016/j.bbagen.2009.04.005
   ANVERSA P, 1986, J AM COLL CARDIOL, V8, P1441, DOI 10.1016/S0735-1097(86)80321-7
   Aquilano K, 2013, ANTIOXID REDOX SIGN, V18, P386, DOI 10.1089/ars.2012.4615
   Arbab-Zadeh A, 2004, CIRCULATION, V110, P1799, DOI 10.1161/01.CIR.0000142863.71285.74
   Backs J, 2011, J CELL BIOL, V195, P403, DOI 10.1083/jcb.201105063
   Baris OR, 2015, CELL METAB, V21, P667, DOI 10.1016/j.cmet.2015.04.005
   Bayod S, 2012, EXP GERONTOL, V47, P925, DOI 10.1016/j.exger.2012.08.004
   Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680
   Bhella PS, 2014, J AM COLL CARDIOL, V64, P1257, DOI 10.1016/j.jacc.2014.03.062
   Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842
   Blair SN, 1996, JAMA-J AM MED ASSOC, V276, P205, DOI 10.1001/jama.276.3.205
   Bodyak N, 2002, NUCLEIC ACIDS RES, V30, P3788, DOI 10.1093/nar/gkf497
   BOHM M, 1993, AM J PHYSIOL, V264, PH805, DOI 10.1152/ajpheart.1993.264.3.H805
   Borlaug BA, 2010, J AM COLL CARDIOL, V56, P845, DOI 10.1016/j.jacc.2010.03.077
   Boström P, 2010, CELL, V143, P1072, DOI 10.1016/j.cell.2010.11.036
   Boyle AJ, 2011, EXP GERONTOL, V46, P549, DOI 10.1016/j.exger.2011.02.010
   Brenner DA, 2001, CIRCULATION, V104, P221, DOI 10.1161/01.CIR.104.2.221
   Brodde OE, 1999, PHARMACOL REV, V51, P651
   Brodde OE, 1998, J CLIN INVEST, V101, P471, DOI 10.1172/JCI1113
   Brubaker PH, 2011, CIRCULATION, V123, P1010, DOI 10.1161/CIRCULATIONAHA.110.940577
   Bye A, 2008, PHYSIOL GENOMICS, V33, P100, DOI 10.1152/physiolgenomics.00269.2007
   Cain BS, 1998, J AM COLL CARDIOL, V32, P458, DOI 10.1016/S0735-1097(98)00233-2
   Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582
   Ceylan-Isik AF, 2013, BASIC RES CARDIOL, V108, P0, DOI 10.1007/s00395-013-0335-3
   Cherry AD, 2014, J BIOL CHEM, V289, P41, DOI 10.1074/jbc.M113.512483
   Chinsomboon J, 2009, P NATL ACAD SCI USA, V106, P21401, DOI 10.1073/pnas.0909131106
   Choi SY, 2009, J KOREAN MED SCI, V24, P32, DOI 10.3346/jkms.2009.24.1.32
   Chung E, 2013, CARDIOVASC RES, V100, P402, DOI 10.1093/cvr/cvt208
   Dai DF, 2010, AGING CELL, V9, P536, DOI 10.1111/j.1474-9726.2010.00581.x
   Dai DF, 2009, TRENDS CARDIOVAS MED, V19, P213, DOI 10.1016/j.tcm.2009.12.004
   Dai DF, 2009, CIRCULATION, V119, P2789, DOI 10.1161/CIRCULATIONAHA.108.822403
   Davies CH, 1996, CARDIOVASC RES, V31, P152, DOI 10.1016/S0008-6363(95)00187-5
   de Simone G, 2008, EUR HEART J, V29, P741, DOI 10.1093/eurheartj/ehm605
   DeBosch B, 2006, CIRCULATION, V113, P2097, DOI 10.1161/CIRCULATIONAHA.105.595231
   DEMARIA AN, 1978, CIRCULATION, V57, P237, DOI 10.1161/01.CIR.57.2.237
   Demirel HA, 1998, MED SCI SPORT EXER, V30, P1211, DOI 10.1097/00005768-199808000-00005
   Derumeaux G, 2008, CIRC-CARDIOVASC IMAG, V1, P227, DOI 10.1161/CIRCIMAGING.107.745919
   Dillon LM, 2012, HUM MOL GENET, V21, P2288, DOI 10.1093/hmg/dds049
   Dillon LM, 2012, IUBMB LIFE, V64, P231, DOI 10.1002/iub.608
   Domenighetti AA, 2005, HYPERTENSION, V46, P426, DOI 10.1161/01.HYP.0000173069.53699.d9
   Edelmann F, 2011, J AM COLL CARDIOL, V58, P1780, DOI 10.1016/j.jacc.2011.06.054
   Egerman MA, 2015, CELL METAB, V22, P164, DOI 10.1016/j.cmet.2015.05.010
   Eisele JC, 2008, BASIC RES CARDIOL, V103, P12, DOI 10.1007/s00395-007-0684-x
   Ellison GM, 2012, HEART, V98, P5, DOI 10.1136/heartjnl-2011-300639
   Engelhardt S, 1999, P NATL ACAD SCI USA, V96, P7059, DOI 10.1073/pnas.96.12.7059
   ESLER M, 1981, CLIN SCI, V60, P217, DOI 10.1042/cs0600217
   ESLER MD, 1995, AM J PHYSIOL-REG I, V268, PR278, DOI 10.1152/ajpregu.1995.268.1.R278
   Fang J, 2008, J AM COLL CARDIOL, V52, P428, DOI 10.1016/j.jacc.2008.03.061
   Fares E, 2010, CLIN EXP PHARMACOL P, V37, P1, DOI 10.1111/j.1440-1681.2009.05276.x
   FERRARA N, 1995, J MOL CELL CARDIOL, V27, P1141, DOI 10.1016/0022-2828(95)90050-0
   Ferrara N, 1997, J MOL CELL CARDIOL, V29, P439, DOI 10.1006/jmcc.1996.0397
   Ferrara N, 2008, REJUV RES, V11, P139, DOI 10.1089/rej.2007.0576
   Fleg JL, 2005, CIRCULATION, V112, P674, DOI 10.1161/CIRCULATIONAHA.105.545459
   FLEG JL, 1994, CIRCULATION, V90, P2333, DOI 10.1161/01.CIR.90.5.2333
   FLEG JL, 1988, J APPL PHYSIOL, V65, P1147, DOI 10.1152/jappl.1988.65.3.1147
   FLEG JL, 1995, J APPL PHYSIOL, V78, P890, DOI 10.1152/jappl.1995.78.3.890
   Flynn JM, 2013, AGING CELL, V12, P851, DOI 10.1111/acel.12109
   FORMAN DE, 1992, J GERONTOL, V47, PM56, DOI 10.1093/geronj/47.2.M56
   FOWLER MB, 1986, CIRCULATION, V74, P1290, DOI 10.1161/01.CIR.74.6.1290
   Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB
   Fujimoto N, 2010, CIRCULATION, V122, P1797, DOI 10.1161/CIRCULATIONAHA.110.973784
   Fukazawa R, 2003, J MOL CELL CARDIOL, V35, P1473, DOI 10.1016/j.yjmcc.2003.09.012
   GERSTENBLITH G, 1977, CIRCULATION, V56, P273, DOI 10.1161/01.CIR.56.2.273
   Go AS, 2013, CIRCULATION, V127, PE6, DOI 10.1161/CIR.0b013e31828124ad
   Gomez-Cabrera MC, 2008, AM J CLIN NUTR, V87, P142, DOI 10.1093/ajcn/87.1.142
   Gounder SS, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0045697
   Gratton JP, 2001, J BIOL CHEM, V276, P30359, DOI 10.1074/jbc.M009698200
   Gulati M, 2010, CIRCULATION, V122, P130, DOI 10.1161/CIRCULATIONAHA.110.939249
   Hafner AV, 2010, AGING-US, V2, P914, DOI 10.18632/aging.100252
   Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Haykowsky MJ, 2012, J AM COLL CARDIOL, V60, P120, DOI 10.1016/j.jacc.2012.02.055
   He XQ, 2012, MOL PHARMACOL, V82, P887, DOI 10.1124/mol.112.081133
   Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983
   Heineke J, 2010, CIRCULATION, V121, P419, DOI 10.1161/CIRCULATIONAHA.109.882068
   HIGGINBOTHAM MB, 1986, AM J CARDIOL, V57, P1374, DOI 10.1016/0002-9149(86)90221-3
   Hiona A, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0011468
   Hsu CP, 2008, BIOL CHEM, V389, P221, DOI 10.1515/BC.2008.032
   Huang CY, 2012, J APPL PHYSIOL, V112, P883, DOI 10.1152/japplphysiol.00605.2011
   Iemitsu M, 2004, AM J PHYSIOL-HEART C, V286, PH1696, DOI 10.1152/ajpheart.00761.2003
   Iemitsu M, 2006, AM J PHYSIOL-HEART C, V291, PH1290, DOI 10.1152/ajpheart.00820.2005
   Inuzuka Y, 2009, CIRCULATION, V120, P1695, DOI 10.1161/CIRCULATIONAHA.109.871137
   Isenberg G, 2003, CELL CALCIUM, V34, P271, DOI 10.1016/S0143-4160(03)00121-0
   Jackson MF, 2012, J ENDOCRINOL, V213, P263, DOI 10.1530/JOE-11-0455
   Janczewski AM, 2010, HEART FAIL REV, V15, P431, DOI 10.1007/s10741-010-9167-5
   JIANG MT, 1993, CIRC RES, V72, P102, DOI 10.1161/01.RES.72.1.102
   Kang KW, 2005, ANTIOXID REDOX SIGN, V7, P1664, DOI 10.1089/ars.2005.7.1664
   KANTER MM, 1985, J APPL PHYSIOL, V59, P1298, DOI 10.1152/jappl.1985.59.4.1298
   Kappagoda T, 2012, HEART FAIL REV, V17, P635, DOI 10.1007/s10741-011-9297-4
   Kavazis AN, 2014, J APPL PHYSIOL, V117, P223, DOI 10.1152/japplphysiol.00210.2014
   Kaye DM, 2008, NEUROMOL MED, V10, P179, DOI 10.1007/s12017-008-8034-1
   Kemi OJ, 2005, CARDIOVASC RES, V67, P161, DOI 10.1016/j.cardiores.2005.03.010
   Kemi OJ, 2008, FRONT BIOSCI-LANDMRK, V13, P356, DOI 10.2741/2685
   Kemi OJ, 2007, J MOL CELL CARDIOL, V43, P354, DOI 10.1016/j.yjmcc.2007.06.013
   Kemi OJ, 2008, EUR J CARDIOV PREV R, V15, P145, DOI 10.1097/HJR.0b013e3282efd4e0
   Khrapko K, 1999, NUCLEIC ACIDS RES, V27, P2434, DOI 10.1093/nar/27.11.2434
   Kim J, 2008, MOL ENDOCRINOL, V22, P2531, DOI 10.1210/me.2008-0265
   KITZMAN DW, 1991, J AM COLL CARDIOL, V17, P1065, DOI 10.1016/0735-1097(91)90832-T
   Koch LG, 2012, TRENDS CARDIOVAS MED, V22, P29, DOI 10.1016/j.tcm.2012.06.007
   Koch LG, 2011, CIRC RES, V109, P1162, DOI 10.1161/CIRCRESAHA.111.253807
   Kong SW, 2005, PHYSIOL GENOMICS, V21, P34, DOI 10.1152/physiolgenomics.00226.2004
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kwak HB, 2006, FASEB J, V20, P791, DOI 10.1096/fj.05-5116fje
   Lai CH, 2014, AGE, V36, P0, DOI 10.1007/s11357-014-9706-4
   Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58
   Lakatta EG, 2002, COMP BIOCHEM PHYS A, V132, P699, DOI 10.1016/S1095-6433(02)00124-1
   Lanza IR, 2008, DIABETES, V57, P2933, DOI 10.2337/db08-0349
   Lauer MS, 1999, JAMA-J AM MED ASSOC, V281, P524, DOI 10.1001/jama.281.6.524
   Laughlin MH, 1999, ADV PHYSIOL EDUC, V22, PS244, DOI 10.1152/advances.1999.277.6.S244
   Lebrasseur NK, 2003, AM J PHYSIOL-CELL PH, V284, PC1149, DOI 10.1152/ajpcell.00487.2002
   Lee CK, 2002, P NATL ACAD SCI USA, V99, P14988, DOI 10.1073/pnas.232308999
   Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268
   Lenk K, 2012, EUR J PREV CARDIOL, V19, P404, DOI 10.1177/1741826711402735
   Lenk K, 2009, EUR J HEART FAIL, V11, P342, DOI 10.1093/eurjhf/hfp020
   Leosco D, 2007, AM J PHYSIOL-HEART C, V293, PH1596, DOI 10.1152/ajpheart.00308.2007
   Leosco D, 2013, FRONT PHYSIOL, V4, P0, DOI 10.3389/fphys.2013.00348
   LEVY D, 1990, NEW ENGL J MED, V0322, P0
   LEVY D, 1988, ANN INTERN MED, V108, P7, DOI 10.7326/0003-4819-108-1-7
   Liao PH, 2015, ONCOTARGET, V6, P35383, DOI 10.18632/oncotarget.6168
   Lim CC, 2000, J MOL CELL CARDIOL, V32, P2075, DOI 10.1006/jmcc.2000.1239
   Lim CC, 1999, AM J PHYSIOL-HEART C, V277, PH2083, DOI 10.1152/ajpheart.1999.277.5.H2083
   Lin CH, 2014, AGE, V36, P0, DOI 10.1007/s11357-014-9705-5
   Ling C, 2004, J CLIN INVEST, V114, P1518, DOI 10.1172/JCI200421889
   Linke A, 2005, CIRCULATION, V111, P1763, DOI 10.1161/01.CIR.0000165503.08661.E5
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Little JP, 2010, AM J PHYSIOL-REG I, V298, PR912, DOI 10.1152/ajpregu.00409.2009
   Liu XJ, 2015, CELL METAB, V21, P584, DOI 10.1016/j.cmet.2015.02.014
   Loffredo FS, 2014, CIRC RES, V115, P97, DOI 10.1161/CIRCRESAHA.115.302929
   Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015
   LOMPRE AM, 1991, CIRC RES, V69, P1380, DOI 10.1161/01.RES.69.5.1380
   Lujan HL, 2013, AM J PHYSIOL-REG I, V304, PR286, DOI 10.1152/ajpregu.00517.2012
   MANNE ND, 2014, J CLIN EXP CARDIOLOG, V5, P1
   Matsui T, 2001, CIRCULATION, V104, P330
   Matsui T, 1999, CIRCULATION, V100, P2373, DOI 10.1161/01.CIR.100.23.2373
   McGuire DK, 2001, CIRCULATION, V104, P1358, DOI 10.1161/hc3701.096099
   McMullen JR, 2004, J BIOL CHEM, V279, P4782, DOI 10.1074/jbc.M310405200
   McMullen JR, 2003, P NATL ACAD SCI USA, V100, P12355, DOI 10.1073/pnas.1934654100
   Menshikova EV, 2006, J GERONTOL A-BIOL, V61, P534, DOI 10.1093/gerona/61.6.534
   Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311
   Molkentin JD, 2013, CIRC RES, V113, P16, DOI 10.1161/CIRCRESAHA.113.301667
   Morissette MR, 2006, CIRC RES, V99, P15, DOI 10.1161/01.RES.0000231290.45676.d4
   Morissette MR, 2009, AGING CELL, V8, P573, DOI 10.1111/j.1474-9726.2009.00508.x
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   Muthusamy VR, 2012, FREE RADICAL BIO MED, V52, P366, DOI 10.1016/j.freeradbiomed.2011.10.440
   Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858
   OGAWA T, 1992, CIRCULATION, V86, P494, DOI 10.1161/01.CIR.86.2.494
   Olfert IM, 2004, J GERONTOL A-BIOL, V59, P801
   OLIVETTI G, 1991, CIRC RES, V68, P1560, DOI 10.1161/01.RES.68.6.1560
   ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730
   Palacios OM, 2009, AGING-US, V1, P771, DOI 10.18632/aging.100075
   Pillai VB, 2014, CIRC RES, V114, P368, DOI 10.1161/CIRCRESAHA.113.300536
   Pillai VB, 2010, CARDIOVASC RES, V88, P250, DOI 10.1093/cvr/cvq250
   Planavila A, 2011, CARDIOVASC RES, V90, P276, DOI 10.1093/cvr/cvq376
   Platt C, 2015, CELL METAB, V21, P227, DOI 10.1016/j.cmet.2015.01.014
   Poller U, 1997, J AM COLL CARDIOL, V29, P187, DOI 10.1016/S0735-1097(96)00437-8
   POWERS SK, 1993, AM J PHYSIOL, V265, PH2094, DOI 10.1152/ajpheart.1993.265.6.H2094
   Prasad A, 2007, AM J CARDIOL, V99, P1629, DOI 10.1016/j.amjcard.2007.01.050
   Proctor DN, 1997, J APPL PHYSIOL, V82, P1411, DOI 10.1152/jappl.1997.82.5.1411
   Putinski C, 2013, P NATL ACAD SCI USA, V110, PE4079, DOI 10.1073/pnas.1315587110
   Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106
   Ritchie RH, 2013, AM J PHYSIOL-HEART C, V304, PH729, DOI 10.1152/ajpheart.00638.2012
   RODEHEFFER RJ, 1984, CIRCULATION, V69, P203, DOI 10.1161/01.CIR.69.2.203
   Rodgers BD, 2009, J PHYSIOL-LONDON, V587, P4873, DOI 10.1113/jphysiol.2009.172544
   Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034
   Rommel C, 1999, SCIENCE, V286, P1738, DOI 10.1126/science.286.5445.1738
   Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Rossoni LV, 2011, J HYPERTENS, V29, P2349, DOI 10.1097/HJH.0b013e32834d2532
   Safdar A, 2011, J BIOL CHEM, V286, P10605, DOI 10.1074/jbc.M110.211466
   Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108
   SCARPACE PJ, 1994, J APPL PHYSIOL, V77, P737, DOI 10.1152/jappl.1994.77.2.737
   Schefer V, 1996, EXP GERONTOL, V31, P387, DOI 10.1016/0531-5565(95)02032-2
   Schmidt U, 2000, CIRCULATION, V101, P790, DOI 10.1161/01.CIR.101.7.790
   Serneri GGN, 2001, CIRC RES, V89, P977, DOI 10.1161/hh2301.100982
   Shefer G, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0013307
   Smith SC, 2015, CIRC RES, V117, P926, DOI 10.1161/CIRCRESAHA.115.307527
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   SOMANI SM, 1995, PHARMACOL BIOCHEM BE, V51, P627, DOI 10.1016/0091-3057(94)00427-K
   Spina RJ, 1998, AM J PHYSIOL-HEART C, V274, PH397, DOI 10.1152/ajpheart.1998.274.2.H397
   St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024
   Stratton JR, 2003, J AM COLL CARDIOL, V41, P2077, DOI 10.1016/S0735-1097(03)00418-2
   STRATTON JR, 1992, CIRCULATION, V86, P504, DOI 10.1161/01.CIR.86.2.504
   STRATTON JR, 1994, CIRCULATION, V89, P1648, DOI 10.1161/01.CIR.89.4.1648
   Sugden MC, 2010, J ENDOCRINOL, V204, P93, DOI 10.1677/JOE-09-0359
   Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162
   TAFFET GE, 1993, AM J PHYSIOL, V264, PH1609, DOI 10.1152/ajpheart.1993.264.5.H1609
   TATE CA, 1990, AM J PHYSIOL, V258, PH431, DOI 10.1152/ajpheart.1990.258.2.H431
   Tate CA, 1996, AM J PHYSIOL-HEART C, V271, PH68, DOI 10.1152/ajpheart.1996.271.1.H68
   Terman A, 2005, CARDIOVASC RES, V68, P355, DOI 10.1016/j.cardiores.2005.08.014
   Thomas MM, 2011, EXP GERONTOL, V46, P803, DOI 10.1016/j.exger.2011.06.005
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Turturro A, 1999, J GERONTOL A-BIOL, V54, PB492, DOI 10.1093/gerona/54.11.B492
   Ungvari Z, 2010, J GERONTOL A-BIOL, V65, P1028, DOI 10.1093/gerona/glq113
   van Empel VPM, 2004, CARDIOVASC RES, V63, P487, DOI 10.1016/j.cardiores.2004.02.013
   Vella CA, 2005, BRIT J SPORT MED, V39, P190, DOI 10.1136/bjsm.2004.013037
   Viña J, 2009, ADV DRUG DELIVER REV, V61, P1369, DOI 10.1016/j.addr.2009.06.006
   Walton RD, 2016, J GERONTOL A-BIOL, V71, P1005, DOI 10.1093/gerona/glv093
   Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089
   Wang W, 2004, CIRC RES, V95, P798, DOI 10.1161/01.RES.0000145361.50017.aa
   Wang WW, 2014, OXID MED CELL LONGEV, V2014, P0, DOI 10.1155/2014/457429
   Wang Y, 2010, PHYSIOL RES, V59, P633, DOI 10.33549/physiolres.931928
   Weeks KL, 2012, CIRC-HEART FAIL, V5, P523, DOI 10.1161/CIRCHEARTFAILURE.112.966622
   Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106
   WHITE M, 1994, CIRCULATION, V90, P1225, DOI 10.1161/01.CIR.90.3.1225
   Wisloff U, 2009, EXERC SPORT SCI REV, V37, P139, DOI 10.1097/JES.0b013e3181aa65fc
   Wright KJ, 2014, EXP GERONTOL, V50, P9, DOI 10.1016/j.exger.2013.11.006
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   XIAO RP, 1994, J CLIN INVEST, V94, P2051, DOI 10.1172/JCI117559
   Xiao RP, 1998, J CLIN INVEST, V101, P1273, DOI 10.1172/JCI1335
   Xu A, 1998, AM J PHYSIOL-HEART C, V275, PH2087, DOI 10.1152/ajpheart.1998.275.6.H2087
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Yamashita K, 2001, CIRC RES, V88, P609, DOI 10.1161/01.RES.88.6.609
   Yamashita N, 1999, J EXP MED, V189, P1699, DOI 10.1084/jem.189.11.1699
   Yazdanyar A, 2009, CLIN GERIATR MED, V25, P563, DOI 10.1016/j.cger.2009.07.007
   Yuan R, 2009, AGING CELL, V8, P277, DOI 10.1111/j.1474-9726.2009.00478.x
   Zhu WZ, 2003, J CLIN INVEST, V111, P617, DOI 10.1172/JCI200316326
   Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741
NR 220
TC 99
Z9 104
U1 2
U2 30
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0009-7330
EI 1524-4571
J9 CIRC RES
JI Circ.Res.
PD JAN 22
PY 2016
VL 118
IS 2
BP 279
EP 295
DI 10.1161/CIRCRESAHA.115.305250
PG 17
WC Cardiac & Cardiovascular Systems; Hematology; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology; Hematology
GA DB7WZ
UT WOS:000368729100014
PM 26838314
DA 2024-11-01
ER

PT J
AU Rosa, ID
   Cámara, Y
   Durigon, R
   Moss, CF
   Vidoni, S
   Akman, G
   Hunt, L
   Johnson, MA
   Grocott, S
   Wang, LY
   Thorburn, DR
   Hirano, M
   Poulton, J
   Taylor, RW
   Elgar, G
   Martí, R
   Voshol, P
   Holt, IJ
   Spinazzola, A
AF Rosa, Ilaria Dalla
   Camara, Yolanda
   Durigon, Romina
   Moss, Chloe F.
   Vidoni, Sara
   Akman, Gokhan
   Hunt, Lilian
   Johnson, Mark A.
   Grocott, Sarah
   Wang, Liya
   Thorburn, David R.
   Hirano, Michio
   Poulton, Joanna
   Taylor, Robert W.
   Elgar, Greg
   Marti, Ramon
   Voshol, Peter
   Holt, Ian J.
   Spinazzola, Antonella
TI MPV17 Loss Causes Deoxynucleotide Insufficiency and Slow DNA Replication in Mitochondria
SO PLOS GENETICS
LA English
DT Article
ID progressive external ophthalmoplegia; ribonucleotide reductase; thymidine kinase; human-equilibrative-nucleoside-transporter-1 hent1; dguok mutations; human-cells; gene; protein; depletion; identification
AB MPV17 is a mitochondrial inner membrane protein whose dysfunction causes mitochondrial DNA abnormalities and disease by an unknown mechanism. Perturbations of deoxynucleoside triphosphate (dNTP) pools are a recognized cause of mitochondrial genomic instability; therefore, we determined DNA copy number and dNTP levels in mitochondria of two models of MPV17 deficiency. In Mpv17 ablated mice, liver mitochondria showed substantial decreases in the levels of dGTP and dTTP and severe mitochondrial DNA depletion, whereas the dNTP pool was not significantly altered in kidney and brain mitochondria that had near normal levels of DNA. The shortage of mitochondrial dNTPs in Mpv17(-/-) liver slows the DNA replication in the organelle, as evidenced by the elevated level of replication intermediates. Quiescent fibroblasts of MPV17-mutant patients recapitulate key features of the primary affected tissue of the Mpv17(-/-) mice, displaying virtual absence of the protein, decreased dNTP levels and mitochondrial DNA depletion. Notably, the mitochondrial DNA loss in the patients' quiescent fibroblasts was prevented and rescued by deoxynucleoside supplementation. Thus, our study establishes dNTP insufficiency in the mitochondria as the cause of mitochondrial DNA depletion in MPV17 deficiency, and identifies deoxynucleoside supplementation as a potential therapeutic strategy for MPV17-related disease. Moreover, changes in the expression of factors involved in mitochondrial deoxynucleotide homeostasis indicate a remodeling of nucleotide metabolism in MPV17 disease models, which suggests mitochondria lacking functional MPV17 have a restricted purine mitochondrial salvage pathway.
C1 [Rosa, Ilaria Dalla; Durigon, Romina; Moss, Chloe F.; Akman, Gokhan; Hunt, Lilian; Elgar, Greg; Holt, Ian J.; Spinazzola, Antonella] MRC Mill Hill Lab, London, England.
   [Camara, Yolanda; Marti, Ramon] Univ Autonoma Barcelona, Vall Hebron Inst Recerca, Lab Mitochondrial Disorders, E-08193 Barcelona, Catalonia, Spain.
   [Camara, Yolanda; Marti, Ramon] Inst Salud Carlos III, Biomed Network, Res Ctr Rare Dis, Madrid, Spain.
   [Vidoni, Sara; Johnson, Mark A.] MRC, Mitochondrial Biol Unit, Wellcome Trust MRC Bldg, Cambridge, England.
   [Grocott, Sarah; Poulton, Joanna] John Radcliffe Hosp, Womens Ctr, Nuffield Dept Obstet & Gynaecol, Mitochondrial Genet Grp, Oxford OX3 9DU, England.
   [Wang, Liya] Swedish Univ Agr Sci, Biomed Ctr, Dept Anat Physiol & Biochem, Uppsala, Sweden.
   [Thorburn, David R.] Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic, Australia.
   [Thorburn, David R.] Univ Melbourne, Dept Paediat, Royal Childrens Hosp, Flemington Rd, Parkville, Vic 3052, Australia.
   [Hirano, Michio] Columbia Univ, Med Ctr, Dept Neurol, New York, NY USA.
   [Taylor, Robert W.] Newcastle Univ, Sch Med, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Voshol, Peter] Univ Cambridge, Inst Metab Sci, Cambridge, England.
C3 Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Instituto de Salud Carlos III; University of Oxford; Swedish University of Agricultural Sciences; Murdoch Children's Research Institute; University of Melbourne; Royal Children's Hospital Melbourne; Columbia University; Newcastle University - UK; University of Cambridge
RP Spinazzola, A (corresponding author), MRC Mill Hill Lab, London, England.
EM antonella.spinazzola@crick.ac.uk
FU Medical Research Council [MC_PC_13029]; European Union Marie Curie Fellowship [PIEF-GA-2009-255578]; Wellcome Trust [096919/Z/11/Z]; UK NHS Highly Specialized Rare Mitochondrial Disorders of Adults and Children Service; Australian National Health and Medical Research Council; Spanish Instituto de Salud Carlos III [PI12/00322]; Muscular Dystrophy Association-Telethon (AFM Telethon); MRC [MC_PC_13029/2, MC_U105663140, MC_PC_13029/1, MR/K000608/1] Funding Source: UKRI
CR Alston CL, 2013, NEUROLOGY, V81, P2051, DOI 10.1212/01.wnl.0000436931.94291.e6
   Anderson DD, 2011, P NATL ACAD SCI USA, V108, P15163, DOI 10.1073/pnas.1103623108
   Antonenkov VD, 2015, J BIOL CHEM, V290, P13840, DOI 10.1074/jbc.M114.608083
   Ashley N, 2007, HUM MOL GENET, V16, P1400, DOI 10.1093/hmg/ddm090
   Besse A, 2015, CELL METAB, V21, P417, DOI 10.1016/j.cmet.2015.02.008
   Blakely EL, 2012, NEUROMUSCULAR DISORD, V22, P587, DOI 10.1016/j.nmd.2012.03.006
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Carrozzo R, 2006, ANN NEUROL, V59, P265, DOI 10.1002/ana.20729
   Chimploy K, 2013, J BIOL CHEM, V288, P13145, DOI 10.1074/jbc.M113.461111
   Da-Rè C, 2014, J BIOL CHEM, V289, P7448, DOI 10.1074/jbc.M113.543926
   Dalla Rosa I, 2014, NUCLEIC ACIDS RES, V42, P8500, DOI 10.1093/nar/gku513
   Dallabona C, 2010, HUM MOL GENET, V19, P1098, DOI 10.1093/hmg/ddp581
   Di Noia MA, 2014, J BIOL CHEM, V289, P33137, DOI 10.1074/jbc.M114.610808
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Eriksson S, 2008, NUCLEOS NUCLEOT NUCL, V27, P800, DOI 10.1080/15257770802146197
   Ferraro P, 2005, J BIOL CHEM, V280, P24472, DOI 10.1074/jbc.M502869200
   Friedman KL, 1995, METHOD ENZYMOL, V262, P613
   Gandhi VV, 2011, PLOS COMPUT BIOL, V7, P0, DOI 10.1371/journal.pcbi.1002078
   Garone C, 2014, EMBO MOL MED, V6, P1016, DOI 10.15252/emmm.201404092
   Garone C, 2012, ARCH NEUROL-CHICAGO, V69, P1648, DOI 10.1001/archneurol.2012.405
   González-Vioque E, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002035
   Håkansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200
   HAN ZY, 1994, CHROMOSOMA, V103, P162, DOI 10.1007/BF00368008
   Kazak L, 2012, NAT REV MOL CELL BIO, V13, P659, DOI 10.1038/nrm3439
   Krauss J, 2013, BIOL OPEN, V2, P703, DOI 10.1242/bio.20135132
   Lai YR, 2004, J BIOL CHEM, V279, P4490, DOI 10.1074/jbc.M307938200
   Lee EW, 2006, J BIOL CHEM, V281, P16700, DOI 10.1074/jbc.M513825200
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Li Heng, 2013, PREPRINT, V0, P0, DOI DOI 10.48550/ARXIV.1303.3997
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Marcelino LA, 1999, MUTAT RES-DNA REPAIR, V434, P177, DOI 10.1016/S0921-8777(99)00028-2
   Marobbio CMT, 2006, BIOCHEM J, V393, P441, DOI 10.1042/BJ20051284
   Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Nishigaki Y, 2003, J CLIN INVEST, V111, P1913, DOI 10.1172/JCI200317828
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Ostergaard E, 2008, J INHERIT METAB DIS, V31, P226, DOI 10.1007/s10545-008-0828-7
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Pontarin G, 2007, J BIOL CHEM, V282, P16820, DOI 10.1074/jbc.M701310200
   Pontarin G, 2012, P NATL ACAD SCI USA, V109, P13302, DOI 10.1073/pnas.1211289109
   Pontarin G, 2011, J BIOL CHEM, V286, P11132, DOI 10.1074/jbc.M110.202283
   Reinhold R, 2012, MOL CELL BIOL, V32, P5009, DOI 10.1128/MCB.00843-12
   Reyes A, 2013, NUCLEIC ACIDS RES, V41, P5837, DOI 10.1093/nar/gkt196
   Reyes Aurelio, 2007, METHODS MOL BIOL, V372, P219, DOI 10.1007/978-1-59745-365-3_16
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   Ronchi D, 2012, BRAIN, V135, P3404, DOI 10.1093/brain/aws258
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Saada A, 2008, MOL GENET METAB, V95, P169, DOI 10.1016/j.ymgme.2008.07.007
   Saada Ann, 2009, BIOCHEM J, V422, Pe3, DOI 10.1042/BJ20091194
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Song SW, 2005, P NATL ACAD SCI USA, V102, P4990, DOI 10.1073/pnas.0500253102
   Song SW, 2003, J BIOL CHEM, V278, P43893, DOI 10.1074/jbc.C300401200
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2009, J INTERN MED, V265, P174, DOI 10.1111/j.1365-2796.2008.02059.x
   Spinazzola A, 2002, J BIOL CHEM, V277, P4128, DOI 10.1074/jbc.M111028200
   Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Uusimaa J, 2014, EUR J HUM GENET, V22, P184, DOI 10.1038/ejhg.2013.112
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   VANDYCK E, 1995, MOL GEN GENET, V246, P426, DOI 10.1007/BF00290446
   Villarroya J, 2009, EXP CELL RES, V315, P1429, DOI 10.1016/j.yexcr.2009.02.018
   Viscomi C, 2009, HUM MOL GENET, V18, P12, DOI 10.1093/hmg/ddn309
   WEIHER H, 1990, CELL, V62, P425, DOI 10.1016/0092-8674(90)90008-3
   WISEMAN A, 1978, MOL GEN GENET, V167, P51, DOI 10.1007/BF00270321
   Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392
   YOUNG P, 1994, BIOCHEM BIOPH RES CO, V203, P46, DOI 10.1006/bbrc.1994.2146
NR 70
TC 61
Z9 63
U1 0
U2 20
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7404
EI 
J9 PLOS GENET
JI PLoS Genet.
PD JAN 15
PY 2016
VL 12
IS 1
BP 
EP 
DI 10.1371/journal.pgen.1005779
PG 23
WC Genetics & Heredity
SC Genetics & Heredity
GA DC6ZN
UT WOS:000369368200023
PM 26760297
DA 2024-11-01
ER

PT J
AU Malhotra, K
   Liebeskind, DS
AF Malhotra, Konark
   Liebeskind, David S.
TI Imaging of MELAS
SO CURRENT PAIN AND HEADACHE REPORTS
LA English
DT Review
DE MELAS; Mitochondrial myopathy; MRI; Stroke-like episodes
ID stroke-like episodes; mitochondrial-dna mutation; magnetic-resonance-spectroscopy; cerebral-blood-flow; lactic-acidosis; transfer-rna; encephalopathy; myopathy; mr; diffusion
AB Mitochondrial diseases are multisystem disorders that frequently involve the central nervous system. The clinical presentation of these disorders may be challenging to differentiate from cerebrovascular disorders. Various imaging techniques are now available that provide a wide range of imaging modalities during initial clinical evaluation and throughout the disease course. Recent technological advancements have introduced advanced neuroimaging modalities that provide detailed information of metabolic disorders at the tissue level. Imaging findings, though diverse, usually have characteristic features that support differentiating these disorders from vascular syndromes. This article provides an overview of various neuroimaging modalities available along with the advent of new imaging techniques being utilized in these disorders.
C1 [Malhotra, Konark] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA.
   [Liebeskind, David S.] Neurovasc Imaging Res Core, Neurosci Res Bldg,635 Charles E Young Dr South, Los Angeles, CA 90095 USA.
C3 University of California System; University of California Los Angeles
RP Liebeskind, DS (corresponding author), Neurovasc Imaging Res Core, Neurosci Res Bldg,635 Charles E Young Dr South, Los Angeles, CA 90095 USA.
EM konark.malhotra@yahoo.com; davidliebeskind@yahoo.com
FU NIH-NINDS
CR Abe K, 2004, NEURORADIOLOGY, V46, P113, DOI 10.1007/s00234-003-1138-2
   ALLARD JC, 1988, AM J NEURORADIOL, V9, P1234
   Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x
   Carolei Antonio, 2010, HANDB CLIN NEUROL, V97, P529, DOI 10.1016/S0072-9752(10)97048-6
   Chinnery PF, 1993, GENEREVIEWS, V0, P0
   Chung SH, 2005, NEUROLOGY, V65, PE19, DOI 10.1212/01.wnl.0000184112.34211.d1
   DAVIS PC, 1987, AM J NEURORADIOL, V8, P71
   DEVOLDER A, 1988, J COMPUT ASSIST TOMO, V12, P854
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   Dindyal S, 2014, ANN R COLL SURG ENGL, V96, P101, DOI 10.1308/003588414
   Finsterer J, 2010, EPILEPTIC DISORD, V12, P330, DOI 10.1684/epd.2010.0338
   Ganslandt O, 1997, NEUROSURGERY, V41, P621, DOI 10.1097/00006123-199709000-00023
   Gire C, 2002, CHILD NERV SYST, V18, P621, DOI 10.1007/s00381-002-0621-0
   Goodfellow JA, 2012, POSTGRAD MED J, V88, P326, DOI 10.1136/postgradmedj-2011-130326
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   Haas R, 2004, MITOCHONDRION, V4, P471, DOI 10.1016/j.mito.2004.07.008
   Hirano M, 1994, CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   Huppi P S, 2001, SEMIN NEONATOL, V6, P195, DOI 10.1053/siny.2001.0039
   Iizuka T, 2005, CURR NEUROVASC RES, V2, P29, DOI 10.2174/1567202052773544
   Iizuka T, 2003, NEUROLOGY, V61, P1238, DOI 10.1212/01.WNL.0000091888.26232.FE
   Iizuka T, 2009, J NEUROL SCI, V278, P35, DOI 10.1016/j.jns.2008.11.016
   Ikawa M, 2013, MITOCHONDRION, V13, P676, DOI 10.1016/j.mito.2013.09.007
   Ikawa M, 2009, MITOCHONDRION, V9, P144, DOI 10.1016/j.mito.2009.01.011
   Ito H, 2008, BRAIN DEV-JPN, V30, P483, DOI 10.1016/j.braindev.2008.01.003
   Ito H, 2011, BRAIN DEV-JPN, V33, P283, DOI 10.1016/j.braindev.2010.06.010
   Jamieson DG, 2014, CURR PAIN HEADACHE R, V18, P0, DOI 10.1007/s11916-014-0444-1
   Johnson ECB, 2011, NEUROHOSPITALIST, V1, P48, DOI 10.1177/1941875210385948
   Kamada K, 2001, J NEUROL NEUROSUR PS, V70, P675, DOI 10.1136/jnnp.70.5.675
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Kim IO, 1996, AM J ROENTGENOL, V166, P641, DOI 10.2214/ajr.166.3.8623642
   Kim JH, 2011, KOREAN J RADIOL, V12, P15, DOI 10.3348/kjr.2011.12.1.15
   Kodaka R, 1996, STROKE, V27, P1350, DOI 10.1161/01.STR.27.8.1350
   Koga Y, 2006, NEUROLOGY, V66, P1766, DOI 10.1212/01.wnl.0000220197.36849.1e
   Koga Y, 2010, ANN NY ACAD SCI, V1201, P104, DOI 10.1111/j.1749-6632.2010.05624.x
   Lax NZ, 2012, BRAIN, V135, P1736, DOI 10.1093/brain/aws110
   Lazzaro MA, 2010, SEMIN NEUROL, V30, P492, DOI 10.1055/s-0030-1268860
   Liu JR, 2005, NEUROL INDIA, V53, P323, DOI 10.4103/0028-3886.16932
   Majoie CB, 2002, AM J NEURORADIOL, V23, P813
   Malhotra K, 2015, J NEUROIMAGING, V25, P517, DOI 10.1111/jon.12272
   Malhotra K, 2014, J STROKE CEREBROVASC, V23, P31, DOI 10.1016/j.jstrokecerebrovasdis.2012.08.004
   Möller HE, 2005, J NEUROL SCI, V229, P131, DOI 10.1016/j.jns.2004.11.014
   Molnár MJ, 2000, NEUROLOGY, V55, P544, DOI 10.1212/WNL.55.4.544
   Moroni I, 2002, NEUROPEDIATRICS, V33, P79, DOI 10.1055/s-2002-32372
   Nishioka J, 2008, BRAIN DEV-JPN, V30, P100, DOI 10.1016/j.braindev.2007.06.008
   Noguchi A, 2005, PEDIATR NEUROL, V33, P70, DOI 10.1016/j.pediatrneurol.2005.01.013
   OOIWA Y, 1993, STROKE, V24, P304, DOI 10.1161/01.STR.24.2.304
   Osborn AG, 2015, DIAGNOSTIC IMAGING: BRAIN, V3rd, P0
   Pauli W, 2013, POL J RADIOL, V78, P61, DOI 10.12659/PJR.884010
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Ramanathan RS, 2013, NEUROLOGY, V81, PE46, DOI 10.1212/WNL.0b013e3182a08d47
   Renard D, 2014, J NEUROL NEUROSUR PS, V85, P1055, DOI 10.1136/jnnp-2013-306933
   Rossini PM, 1998, BRAIN RES, V782, P153, DOI 10.1016/S0006-8993(97)01274-2
   Saneto RP, 2008, MITOCHONDRION, V8, P396, DOI 10.1016/j.mito.2008.05.003
   Thajeb P, 2005, ANN NY ACAD SCI, V1042, P48, DOI 10.1196/annals.1338.005
   Tschampa HJ, 2013, J NEUROL, V260, P1071, DOI 10.1007/s00415-012-6763-4
   Tsujikawa T, 2010, BRAIN DEV-JPN, V32, P143, DOI 10.1016/j.braindev.2008.12.003
   Tzoulis C, 2009, STROKE, V40, PE15, DOI 10.1161/STROKEAHA.108.523118
   Virtanen SM, 2011, AM J NEURORADIOL, V32, P522, DOI 10.3174/ajnr.A2309
   Wang XY, 2003, NEURORADIOLOGY, V45, P640, DOI 10.1007/s00234-003-1029-6
   Wang YX, 2015, CHINESE MED J-PEKING, V128, P1820, DOI 10.4103/0366-6999.159360
   Weiduschat N, 2014, NEUROLOGY, V82, P798, DOI 10.1212/WNL.0000000000000169
   Wilichowski E, 1999, NEUROPEDIATRICS, V30, P256, DOI 10.1055/s-2007-973500
   Xie S, 2014, METHOD ENZYMOL, V547, P433, DOI 10.1016/B978-0-12-801415-8.00021-7
   Yeh HL, 2013, BRAIN DEV-JPN, V35, P158, DOI 10.1016/j.braindev.2012.03.017
   Yoneda M, 1999, NEUROLOGY, V53, P2182, DOI 10.1212/WNL.53.9.2182
   Yonemura K, 2001, AM J NEURORADIOL, V22, P269
   Yoshida T, 2013, INTERNAL MED, V52, P1389, DOI 10.2169/internalmedicine.52.0188
   Yu L, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0079859
NR 69
TC 35
Z9 37
U1 0
U2 15
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1531-3433
EI 1534-3081
J9 CURR PAIN HEADACHE R
JI Curr. Pain Headache Rep.
PD SEP 15
PY 2016
VL 20
IS 9
BP 
EP 
DI 10.1007/s11916-016-0583-7
PG 8
WC Clinical Neurology
SC Neurosciences & Neurology
GA DV1NX
UT WOS:000382689000003
PM 27477183
DA 2024-11-01
ER

PT J
AU Stoll, EA
   Karapavlovic, N
   Rosa, H
   Woodmass, M
   Rygiel, K
   White, K
   Turnbull, DM
   Faulkes, CG
AF Stoll, Elizabeth A.
   Karapavlovic, Nevena
   Rosa, Hannah
   Woodmass, Michael
   Rygiel, Karolina
   White, Kathryn
   Turnbull, Douglass M.
   Faulkes, Chris G.
TI Naked mole-rats maintain healthy skeletal muscle and Complex IV mitochondrial enzyme function into old age
SO AGING-US
LA English
DT Article
DE naked mole-rat; mitochondria; oxidative stress; animal models of aging; sarcopenia
ID longest-living rodent; dna deletions; oxidative damage; single cells; mice; genome; mechanisms; mutations; disease; accumulation
AB The naked mole-rat (NMR) Heterocephalus glaber is an exceptionally long-lived rodent, living up to 32 years in captivity. This extended lifespan is accompanied by a phenotype of negligible senescence, a phenomenon of very slow changes in the expected physiological characteristics with age. One of the many consequences of normal aging in mammals is the devastating and progressive loss of skeletal muscle, termed sarcopenia, caused in part by respiratory enzyme dysfunction within the mitochondria of skeletal muscle fibers. Here we report that NMRs avoid sarcopenia for decades. Muscle fiber integrity and mitochondrial ultrastructure are largely maintained in aged animals. While mitochondrial Complex IV expression and activity remains stable, Complex I expression is significantly decreased. We show that aged naked mole-rat skeletal muscle tissue contains some mitochondrial DNA rearrangements, although the common mitochondrial DNA deletions associated with aging in human and other rodent skeletal muscles are not present. Interestingly, NMR skeletal muscle fibers demonstrate a significant increase in mitochondrial DNA copy number. These results have intriguing implications for the role of mitochondria in aging, suggesting Complex IV, but not Complex I, function is maintained in the long-lived naked mole rat, where sarcopenia is avoided and healthy muscle function is maintained for decades.
C1 [Stoll, Elizabeth A.; Rosa, Hannah; Rygiel, Karolina; Turnbull, Douglass M.] Newcastle Univ, LLHW Ctr Ageing & Vital, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Stoll, Elizabeth A.; Rosa, Hannah; Rygiel, Karolina; Turnbull, Douglass M.] Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Inst Ageing & Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Stoll, Elizabeth A.; Rygiel, Karolina; Turnbull, Douglass M.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Karapavlovic, Nevena; Woodmass, Michael] Newcastle Univ, Undergrad Programme Biomed Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [White, Kathryn] Newcastle Univ, Sch Med, Electron Microscopy Res Serv, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Faulkes, Chris G.] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England.
C3 Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; University of London; Queen Mary University London
RP Stoll, EA (corresponding author), Newcastle Univ, LLHW Ctr Ageing & Vital, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.; Stoll, EA (corresponding author), Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Inst Ageing & Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.; Stoll, EA (corresponding author), Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM elizabeth.stoll@ncl.ac.uk
FU Newcastle University Centre for Brain Ageing and Vitality (Biotechnology and Biological Sciences Research Council); Newcastle University Centre for Brain Ageing and Vitality (Engineering and Physical Sciences Research Council); Newcastle University Centre for Brain Ageing and Vitality (Economic and Social Research Council); Newcastle University Centre for Brain Ageing and Vitality (Medical Research Council) [G0700718]; UK NIHR Biomedical Research Centre in Age; MRC Centre for Neuromuscular Disease [G000608-1]; Wellcome Trust Centre for Mitochondrial Research [096919/Z/11/Z]; MRC [G0700718, MR/L016354/1, MR/K000608/1, G0800674, MC_G0802536] Funding Source: UKRI
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andziak B, 2005, MECH AGEING DEV, V126, P1206, DOI 10.1016/j.mad.2005.06.009
   Andziak B, 2006, AGING CELL, V5, P525, DOI 10.1111/j.1474-9726.2006.00246.x
   Andziak B, 2006, AGING CELL, V5, P463, DOI 10.1111/j.1474-9726.2006.00237.x
   Aspnes LE, 1997, FASEB J, V11, P573, DOI 10.1096/fasebj.11.7.9212081
   Barja G, 2000, FASEB J, V14, P312, DOI 10.1096/fasebj.14.2.312
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bodyak ND, 2001, HUM MOL GENET, V10, P17, DOI 10.1093/hmg/10.1.17
   Brandon MC, 2005, NUCLEIC ACIDS RES, V33, P0
   Brierley EJ, 1996, QJM-MON J ASSOC PHYS, V89, P251
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Buffenstein R, 2007, FASEB J, V0, P21
   Buffenstein R, 2008, J COMP PHYSIOL B, V178, P439, DOI 10.1007/s00360-007-0237-5
   Cree LM, 2008, DIABETOLOGIA, V51, P1440, DOI 10.1007/s00125-008-1054-4
   Csiszar A, 2007, AM J PHYSIOL-HEART C, V293, PH919, DOI 10.1152/ajpheart.01287.2006
   de Souza-Pinto NC, 2008, DNA REPAIR, V7, P1098, DOI 10.1016/j.dnarep.2008.03.011
   Edrey YH, 2011, ILAR J, V52, P41, DOI 10.1093/ilar.52.1.41
   Eimon PM, 1996, DEV GENET, V18, P107, DOI 10.1002/(SICI)1520-6408(1996)18:2<107::AID-DVG3>3.0.CO;2-D
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   Greaves LC, 2011, MECH AGEING DEV, V132, P588, DOI 10.1016/j.mad.2011.10.004
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   Hiona A, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0011468
   JARVIS JUM, 1981, SCIENCE, V212, P571, DOI 10.1126/science.7209555
   Khrapko K, 1997, P NATL ACAD SCI USA, V94, P13798, DOI 10.1073/pnas.94.25.13798
   Kim EB, 2011, NATURE, V479, P223, DOI 10.1038/nature10533
   Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024
   Kruse SE, 2016, AGING CELL, V15, P89, DOI 10.1111/acel.12412
   Liang ST, 2010, AGING CELL, V9, P626, DOI 10.1111/j.1474-9726.2010.00588.x
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510x(90)90006-9
   Murase T, 2000, MODERN PATHOL, V13, P147, DOI 10.1038/modpathol.3880028
   Perier C, 2013, BRAIN, V136, P2369, DOI 10.1093/brain/awt196
   Pesce V, 2001, FREE RADICAL BIO MED, V30, P1223, DOI 10.1016/S0891-5849(01)00517-2
   Proctor DN, 1998, J NUTR, V128, P351S, DOI 10.1093/jn/128.2.351S
   Rahman S, 2000, BRAIN, V123, P591, DOI 10.1093/brain/123.3.591
   Rocha MC, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep15037
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Tarry-Adkins JL, 2016, DIS MODEL MECH, V9, P1221, DOI 10.1242/dmm.026591
   Taylor RW, 2001, NUCLEIC ACIDS RES, V29, Part. no., DOI 10.1093/nar/29.15.e74
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   van der Giezen M, 2005, EMBO REP, V6, P525, DOI 10.1038/sj.embor.7400440
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Yu CF, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0026729
NR 42
TC 24
Z9 24
U1 0
U2 20
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
EI 
J9 AGING-US
JI Aging-US
PD DEC 15
PY 2016
VL 8
IS 12
BP 3468
EP +
DI 10.18632/aging.101140
PG 18
WC Cell Biology; Geriatrics & Gerontology
SC Cell Biology; Geriatrics & Gerontology
GA EI5IP
UT WOS:000392527800025
PM 27997359
DA 2024-11-01
ER

PT J
AU Korzeniewski, B
AF Korzeniewski, Bernard
TI Faster and stronger manifestation of mitochondrial diseases in skeletal muscle than in heart related to cytosolic inorganic phosphate (P<sub>i</sub>) accumulation
SO JOURNAL OF APPLIED PHYSIOLOGY
LA English
DT Article
DE mitochondrial disease; OXPHOS deficiency; tissue specificity; skeletal muscle; heart; inorganic phosphate
ID oxygen-uptake kinetics; oxidative-phosphorylation; tissue-specificity; dna mutations; force production; mammalian heart; redox state; consumption; work; myopathy
AB A model of the cell bioenergetic system was used to compare the effect of oxidative phosphorylation (OXPHOS) deficiencies in a broad range of moderate ATP demand in skeletal muscle and heart. Computer simulations revealed that kinetic properties of the system are similar in both cases despite the much higher mitochondria content and "basic" OXPHOS activity in heart than in skeletal muscle, because of a much higher each-step activation (ESA) of OXPHOS in skeletal muscle than in heart. Large OXPHOS deficiencies lead in both tissues to a significant decrease in oxygen consumption (Vo(2)) and phosphocreatine (PCr) and increase in cytosolic ADP, P-i, and H+. The main difference between skeletal muscle and heart is a much higher cytosolic Pi concentration in healthy tissue and much higher cytosolic P-i accumulation (level) at low OXPHOS activities in the former, caused by a higher PCr level in healthy tissue (and higher total phosphate pool) and smaller P-i redistribution between cytosol and mitochondria at OXPHOS deficiency. This difference does not depend on ATP demand in a broad range. A much greater P-i increase and PCr decrease during rest-to-moderate work transition in skeletal muscle at OXPHOS deficiencies than at normal OXPHOS activity significantly slows down the Vo(2) on-kinetics. Because high cytosolic P-i concentrations cause fatigue in skeletal muscle and can compromise force generation in skeletal muscle and heart, this system property can contribute to the faster and stronger manifestation of mitochondrial diseases in skeletal muscle than in heart. Shortly, skeletal muscle with large OXPHOS deficiencies becomes fatigued already during low/moderate exercise.
C1 [Korzeniewski, Bernard] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Ul Gronostajowa 7, PL-30387 Krakow, Poland.
C3 Jagiellonian University
RP Korzeniewski, B (corresponding author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Ul Gronostajowa 7, PL-30387 Krakow, Poland.
EM bernard.korzeniewski@gmail.com
CR Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007
   BALABAN RS, 1986, SCIENCE, V232, P1121, DOI 10.1126/science.3704638
   Benard G, 2006, AM J PHYSIOL-CELL PH, V291, PC1172, DOI 10.1152/ajpcell.00195.2006
   BESSMAN SP, 1981, SCIENCE, V211, P448, DOI 10.1126/science.6450446
   Brandes R, 1997, CIRC RES, V80, P82, DOI 10.1161/01.RES.80.1.82
   Brookes PS, 2005, FREE RADICAL BIO MED, V38, P12, DOI 10.1016/j.freeradbiomed.2004.10.016
   BROWN GC, 1990, EUR J BIOCHEM, V192, P355, DOI 10.1111/j.1432-1033.1990.tb19234.x
   Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720
   Chomyn A, 1998, AM J HUM GENET, V62, P745, DOI 10.1086/301813
   Cieslar JH, 2000, J BIOL CHEM, V275, P6129, DOI 10.1074/jbc.275.9.6129
   Crooks DR, 2012, J BIOL CHEM, V287, P40119, DOI 10.1074/jbc.M112.418889
   Dahlstedt AJ, 2001, J PHYSIOL-LONDON, V533, P379, DOI 10.1111/j.1469-7793.2001.0379a.x
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   FELL DA, 1995, BIOCHEM J, V311, P35, DOI 10.1042/bj3110035
   Giannesini B, 2001, FEBS LETT, V507, P25, DOI 10.1016/S0014-5793(01)02942-8
   Glancy B, 2013, BIOCHEMISTRY-US, V52, P2793, DOI 10.1021/bi3015983
   Grassi B, 1996, J APPL PHYSIOL, V80, P988, DOI 10.1152/jappl.1996.80.3.988
   Grassi B, 2015, EXERC SPORT SCI REV, V43, P75, DOI 10.1249/JES.0000000000000043
   Grassi B, 2009, MED SCI SPORT EXER, V41, P2120, DOI 10.1249/MSS.0b013e3181aae96b
   Haller RG, 2000, EXERCISE CIRCULATION, V0, P0
   HEINEMAN FW, 1993, AM J PHYSIOL, V264, PH433, DOI 10.1152/ajpheart.1993.264.2.H433
   Hochachka P, 1994, MUSCLES METABOLIC MA, V0, P0
   KATZ LA, 1989, AM J PHYSIOL, V256, PH265, DOI 10.1152/ajpheart.1989.256.1.H265
   KAUPPINEN R, 1983, BIOCHIM BIOPHYS ACTA, V725, P131, DOI 10.1016/0005-2728(83)90232-3
   Kay L, 1997, J MOL CELL CARDIOL, V29, P3399, DOI 10.1006/jmcc.1997.0564
   Korzeniewski B, 2005, BIOPHYS CHEM, V116, P145, DOI 10.1016/j.bpc.2005.04.001
   Korzeniewski B, 2003, BIOCHEM J, V375, P799, DOI 10.1042/BJ20030882
   Korzeniewski B, 1998, BIOCHEM J, V330, P1189, DOI 10.1042/bj3301189
   Korzeniewski B, 2001, BIOPHYS CHEM, V92, P17, DOI 10.1016/S0301-4622(01)00184-3
   Korzeniewski B, 2004, BIOPHYS CHEM, V110, P147, DOI 10.1016/j.bpc.2004.01.011
   Korzeniewski B, 1996, BIOCHEM J, V319, P143, DOI 10.1042/bj3190143
   Korzeniewski B, 2007, BIOPHYS CHEM, V129, P93, DOI 10.1016/j.bpc.2007.05.013
   Korzeniewski B, 2006, AM J PHYSIOL-HEART C, V291, PH1466, DOI 10.1152/ajpheart.00004.2006
   Korzeniewski B, 2015, J PHYSIOL-LONDON, V593, P5255, DOI 10.1113/JP271299
   Korzeniewski B, 2015, BBA-BIOENERGETICS, V1847, P1310, DOI 10.1016/j.bbabio.2015.07.007
   Korzeniewski B, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0117145
   Korzeniewski B, 2014, J APPL PHYSIOL, V116, P83, DOI 10.1152/japplphysiol.00759.2013
   LETELLIER T, 1993, BIOCHIM BIOPHYS ACTA, V1141, P58, DOI 10.1016/0005-2728(93)90189-M
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   Liguzinski P, 2006, AM J PHYSIOL-CELL PH, V291, PC1213, DOI 10.1152/ajpcell.00078.2006
   Lombès A, 2014, BIOCHIMIE, V100, P171, DOI 10.1016/j.biochi.2013.08.012
   Pathare N, 2005, J APPL PHYSIOL, V98, P307, DOI 10.1152/japplphysiol.00612.2004
   Peluffo RD, 2004, BIOPHYS J, V87, P883, DOI 10.1529/biophysj.103.030643
   Pfeffer G, 2013, ANN MED, V45, P4, DOI 10.3109/07853890.2011.605389
   PORTMAN MA, 1989, J CLIN INVEST, V83, P456, DOI 10.1172/JCI113904
   Rao R, 2010, J NEUROCHEM, V114, P728, DOI 10.1111/j.1471-4159.2010.06797.x
   Rohwer JM, 2010, J PHYS CHEM B, V114, P16280, DOI 10.1021/jp108412s
   Rossignol R, 1999, J BIOL CHEM, V274, P33426, DOI 10.1074/jbc.274.47.33426
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Saada A, 2003, MOL GENET METAB, V79, P1, DOI 10.1016/S1096-7192(03)00063-5
   Sahlin K, 1998, ACTA PHYSIOL SCAND, V162, P261, DOI 10.1046/j.1365-201X.1998.0298f.x
   SAHLIN K, 1987, BIOCHEM J, V245, P551, DOI 10.1042/bj2450551
   Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755
   Sequeira V, 2015, J PHYSIOL-LONDON, V593, P3899, DOI 10.1113/JP270354
   Sharma N, 2005, J PHYSIOL-LONDON, V562, P593, DOI 10.1113/jphysiol.2004.075713
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   van Beek JHGM, 1998, MOL CELL BIOCHEM, V184, P321, DOI 10.1023/A:1006817215408
   van der Velden J, 2001, CIRCULATION, V104, P1140, DOI 10.1161/hc3501.095485
   WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   WALLACE DC, 1993, TRENDS GENET, V9, P128, DOI 10.1016/0168-9525(93)90207-X
   Westerblad H, 2002, NEWS PHYSIOL SCI, V17, P17
   Whipp BJ, 2002, BIOCHEM SOC T, V30, P237, DOI 10.1042/BST0300237
   Wüst RCI, 2013, J PHYSIOL-LONDON, V591, P731, DOI 10.1113/jphysiol.2012.241992
   Wüst RCI, 2011, J PHYSIOL-LONDON, V589, P3995, DOI 10.1113/jphysiol.2010.203422
NR 67
TC 7
Z9 7
U1 0
U2 1
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 8750-7587
EI 1522-1601
J9 J APPL PHYSIOL
JI J. Appl. Physiol.
PD AUG 1
PY 2016
VL 121
IS 2
BP 424
EP 437
DI 10.1152/japplphysiol.00358.2016
PG 14
WC Physiology; Sport Sciences
SC Physiology; Sport Sciences
GA EE5LP
UT WOS:000389649400007
PM 27283913
DA 2024-11-01
ER

PT J
AU Belmonte, FR
   Martin, JL
   Frescura, K
   Damas, J
   Pereira, F
   Tarnopolsky, MA
   Kaufman, BA
AF Belmonte, Frances R.
   Martin, James L.
   Frescura, Kristin
   Damas, Joana
   Pereira, Filipe
   Tarnopolsky, Mark A.
   Kaufman, Brett A.
TI Digital PCR methods improve detection sensitivity and measurement precision of low abundance mtDNA deletions
SO SCIENTIFIC REPORTS
LA English
DT Article
ID mitochondrial-dna deletions; real-time pcr; muscle-fibers; copy number; substantia-nigra; disease; mutations; accumulation; mechanisms; neurons
AB Mitochondrial DNA (mtDNA) mutations are a common cause of primary mitochondrial disorders, and have also been implicated in a broad collection of conditions, including aging, neurodegeneration, and cancer. Prevalent among these pathogenic variants are mtDNA deletions, which show a strong bias for the loss of sequence in the major arc between, but not including, the heavy and light strand origins of replication. Because individual mtDNA deletions can accumulate focally, occur with multiple mixed breakpoints, and in the presence of normal mtDNA sequences, methods that detect broad-spectrum mutations with enhanced sensitivity and limited costs have both research and clinical applications. In this study, we evaluated semi-quantitative and digital PCR-based methods of mtDNA deletion detection using double-stranded reference templates or biological samples. Our aim was to describe key experimental assay parameters that will enable the analysis of low levels or small differences in mtDNA deletion load during disease progression, with limited false-positive detection. We determined that the digital PCR method significantly improved mtDNA deletion detection sensitivity through absolute quantitation, improved precision and reduced assay standard error.
C1 [Belmonte, Frances R.; Martin, James L.; Kaufman, Brett A.] Univ Pittsburgh, Sch Med, Div Cardiol, Ctr Metab & Mitochondrial Med, Pittsburgh, PA 15261 USA.
   [Belmonte, Frances R.; Martin, James L.; Kaufman, Brett A.] Vasc Med Inst, Pittsburgh, PA 15261 USA.
   [Frescura, Kristin; Tarnopolsky, Mark A.] McMaster Univ, Med Ctr, Dept Pediat, Hamilton, ON L8N 3Z5, Canada.
   [Frescura, Kristin; Tarnopolsky, Mark A.] McMaster Univ, Med Ctr, Dept Med, Hamilton, ON L8N 3Z5, Canada.
   [Damas, Joana] Univ London Royal Vet Coll, Dept Comparat Biomed Sci, London, England.
   [Pereira, Filipe] Univ Porto, Interdisciplinary Ctr Marine & Environm Res CIIMA, Rua Campo Alegre 823, P-4100 Oporto, Portugal.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; McMaster University; McMaster University; University of London; University of London Royal Veterinary College; Universidade do Porto
RP Kaufman, BA (corresponding author), Univ Pittsburgh, Sch Med, Div Cardiol, Ctr Metab & Mitochondrial Med, Pittsburgh, PA 15261 USA.; Kaufman, BA (corresponding author), Vasc Med Inst, Pittsburgh, PA 15261 USA.
EM bkauf@pitt.edu
FU NIGMS [R01GM110424]; Foundation for Science and Technology [VIH/SAU/0011/2011]; Fundação para a Ciência e a Tecnologia [VIH/SAU/0011/2011] Funding Source: FCT
CR Barthélémy C, 2001, ANN NEUROL, V49, P607, DOI 10.1002/ana.1002.abs
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   Campbell G, 2014, HUM MOL GENET, V23, P4612, DOI 10.1093/hmg/ddu176
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   CARIELLO NF, 1991, GENE, V99, P105, DOI 10.1016/0378-1119(91)90040-I
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Chinnery PF, 2002, LANCET, V360, P1323, DOI 10.1016/S0140-6736(02)11310-9
   Damas J, 2014, NUCL ACIDS RES, V42, P0
   Damas J, 2014, HUM MUTAT, V35, P1, DOI 10.1002/humu.22452
   Damas J, 2012, NUCLEIC ACIDS RES, V40, P7606, DOI 10.1093/nar/gks500
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Dong DW, 2014, BMC GENOMICS, V15, P0, DOI 10.1186/1471-2164-15-677
   Elstner M, 2011, MOL BRAIN, V4, P0, DOI 10.1186/1756-6606-4-43
   Gokey NG, 2004, AGING CELL, V3, P319, DOI 10.1111/j.1474-9728.2004.00122.x
   Grady JP, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0114462
   Greaves LC, 2010, INVEST OPHTH VIS SCI, V51, P3340, DOI 10.1167/iovs.09-4659
   Guo XH, 2010, BBA-BIOENERGETICS, V1797, P1159, DOI 10.1016/j.bbabio.2010.04.005
   He LP, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/gnf067
   Khrapko K, 1999, NUCLEIC ACIDS RES, V27, P2434, DOI 10.1093/nar/27.11.2434
   Kolesar JE, 2013, NUCLEIC ACIDS RES, V41, P0, DOI 10.1093/nar/gks1324
   Kraytsberg Y, 2005, EXPERT REV MOL DIAGN, V5, P809, DOI 10.1586/14737159.5.5.809
   Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024
   Lax NZ, 2012, J NEUROPATH EXP NEUR, V71, P148, DOI 10.1097/NEN.0b013e318244477d
   Maniura-Weber K, 2004, NUCLEIC ACIDS RES, V32, P6015, DOI 10.1093/nar/gkh921
   Manoj P, 2014, MITOCHONDRIAL DNA, V1736, P1
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Moraes CT, 2003, J MOL DIAGN, V5, P197, DOI 10.1016/S1525-1578(10)60474-6
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Phillips NR, 2014, SCI REP-UK, V4, P0, DOI 10.1038/srep03887
   Ross JM, 2011, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/3266
   Sadikovic B, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0015687
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Tang YY, 2000, MOL BIOL CELL, V11, P1471, DOI 10.1091/mbc.11.4.1471
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Taylor SD, 2014, AGING CELL, V13, P29, DOI 10.1111/acel.12146
   Van Haute L, 2013, NAT BIOTECHNOL, V31, P20, DOI 10.1038/nbt.2473
   Villarroya J, 2011, BIOCHEM BIOPH RES CO, V407, P333, DOI 10.1016/j.bbrc.2011.03.018
   Wallace DC, 2009, GENE DEV, V23, P1714, DOI 10.1101/gad.1784909
   Wanagat J, 2015, EXP GERONTOL, V61, P15, DOI 10.1016/j.exger.2014.11.012
   Wong LJC, 2013, NEUROTHERAPEUTICS, V10, P262, DOI 10.1007/s13311-012-0170-5
NR 43
TC 55
Z9 59
U1 0
U2 19
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
EI 
J9 SCI REP-UK
JI Sci Rep
PD APR 28
PY 2016
VL 6
IS 
BP 
EP 
DI 10.1038/srep25186
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DK5FB
UT WOS:000374944100001
PM 27122135
DA 2024-11-01
ER

PT J
AU Joyce, PI
   Fratta, P
   Landman, AS
   Mcgoldrick, P
   Wackerhage, H
   Groves, M
   Busam, BS
   Galino, J
   Corrochano, S
   Beskina, OA
   Esapa, C
   Ryder, E
   Carter, S
   Stewart, M
   Codner, G
   Hilton, H
   Teboul, L
   Tucker, J
   Lionikas, A
   Estabel, J
   Ramirez-Solis, R
   White, JK
   Brandner, S
   Plagnol, V
   Bennet, DLH
   Abramov, AY
   Reensmith, L
   Fisher, EMC
   Acevedo-Arozena, A
AF Joyce, Peter I.
   Fratta, Pietro
   Landman, Allison S.
   Mcgoldrick, Philip
   Wackerhage, Henning
   Groves, Michael
   Busam, Bharani Shiva
   Galino, Jorge
   Corrochano, Silvia
   Beskina, Olga A.
   Esapa, Christopher
   Ryder, Edward
   Carter, Sarah
   Stewart, Michelle
   Codner, Gemma
   Hilton, Helen
   Teboul, Lydia
   Tucker, Jennifer
   Lionikas, Arimantas
   Estabel, Jeanne
   Ramirez-Solis, Ramiro
   White, Jacqueline K.
   Brandner, Sebastian
   Plagnol, Vincent
   Bennet, David L. H.
   Abramov, Andrey Y.
   Greensmith, Linda
   Fisher, Elizabeth M. C.
   Acevedo-Arozena, Abraham
TI Deficiency of the zinc finger protein ZFP106 causes motor and sensory neurodegeneration
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID differentiation-associated protein-1; amyotrophic-lateral-sclerosis; mitochondrial dysfunction; mouse; disease; neuropathy; mutations; gene; sod1(g93a); expression
AB Zinc finger motifs are distributed amongst manyeukaryotic protein families, directing nucleic acid-protein and protein-protein interactions. Zinc finger protein 106 (ZFP106) has previously been associated with roles in immune response, muscle differentiation, testes development and DNA damage, although little is known about its specific function. To further investigate the function of ZFP106, we performed an in-depth characterization of Zfp106 deficient mice (Zfp106(-/-)), and we report a novel role for ZFP106 in motor and sensory neuronal maintenance and survival. Zfp106(-/-) mice develop severe motor abnormalities, major deficits in muscle strength and histopathological changes in muscle. Intriguingly, despite being highly expressed throughout the central nervous system, Zfp106(-/-) mice undergo selective motor and sensory neuronal and axonal degeneration specific to the spinal cord and peripheral nervous system. Neurodegeneration does not occur during development of Zfp106-/mice, suggesting that ZFP106 is likely required for the maintenance of mature peripheral motor and sensory neurons. Analysis of embryonic Zfp106(-/-) motor neurons revealed deficits in mitochondrial function, with an inhibition of Complex I within the mitochondrial electron transport chain. Our results highlight a vital role for ZFP106 in sensory and motor neuron maintenance and reveal a novel player in mitochondrial dysfunction and neurodegeneration.
C1 [Joyce, Peter I.; Landman, Allison S.; Corrochano, Silvia; Esapa, Christopher; Carter, Sarah; Stewart, Michelle; Codner, Gemma; Hilton, Helen; Teboul, Lydia; Tucker, Jennifer; Acevedo-Arozena, Abraham] MRC, Mammalian Genet Unit, Harwell OX11 0RD, Oxon, England.
   [Fratta, Pietro; Mcgoldrick, Philip; Groves, Michael; Beskina, Olga A.; Brandner, Sebastian; Abramov, Andrey Y.; Greensmith, Linda; Fisher, Elizabeth M. C.] UCL Inst Neurol, Queen Sq, London WC1N 3BG, England.
   [Fratta, Pietro; Mcgoldrick, Philip; Groves, Michael; Beskina, Olga A.; Brandner, Sebastian; Abramov, Andrey Y.; Greensmith, Linda; Fisher, Elizabeth M. C.] MRC, Ctr Neuromuscular Dis, Queen Sq, London WC1N 3BG, England.
   [Wackerhage, Henning; Busam, Bharani Shiva; Lionikas, Arimantas] Univ Aberdeen, Hlth Sci, Aberdeen AB25 2ZD, Scotland.
   [Galino, Jorge; Ryder, Edward; Bennet, David L. H.] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England.
   [Estabel, Jeanne; Ramirez-Solis, Ramiro; White, Jacqueline K.] Sanger Inst, Wellcome Trust Genome Campus, Hinxton CB10 1SA, Cambs, England.
   [Plagnol, Vincent] UCL, Genet Inst, Mortimer St, London WC1E 6BT, England.
C3 University of London; University College London; University of London; University College London; University of Aberdeen; University of Oxford; Wellcome Trust Sanger Institute; University of London; University College London
RP Acevedo-Arozena, A (corresponding author), MRC, Mammalian Genet Unit, Harwell OX11 0RD, Oxon, England.; Reensmith, L; Fisher, EMC (corresponding author), UCL Inst Neurol, Queen Sq, London WC1N 3BG, England.; Reensmith, L; Fisher, EMC (corresponding author), MRC, Ctr Neuromuscular Dis, Queen Sq, London WC1N 3BG, England.
EM l.greensmith@ucl.ac.uk; e.fisher@prion.ucl.ac.uk; a.acevedo@har.mrc.ac.uk
FU UK Medical Research Council (MRC); Motor Neurone Disease Association (MNDA); MRC [MC_UP_A390_1106]; MRC [G1000287, MR/K000608/1, MR/K018523/1, MR/M008606/1, G0801110, G0500288, MC_UP_1502/1, MC_UP_A390_1106] Funding Source: UKRI
CR Abramov AY, 2010, BRAIN, V133, P797, DOI 10.1093/brain/awq015
   Abramov AY, 2010, BBA-GEN SUBJECTS, V1800, P297, DOI 10.1016/j.bbagen.2009.08.002
   Acevedo-Arozena A, 2011, DIS MODEL MECH, V4, P686, DOI 10.1242/dmm.007237
   Acsadi G, 2009, J NEUROSCI RES, V87, P2748, DOI 10.1002/jnr.22106
   Anders S, 2010, GENOME BIOL, V11, P0, DOI 10.1186/gb-2010-11-10-r106
   Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111
   Baets J, 2011, BRAIN, V134, P2664, DOI 10.1093/brain/awr184
   Bartlett BJ, 2011, AUTOPHAGY, V7, P572, DOI 10.4161/auto.7.6.14943
   Baxter RV, 2002, NAT GENET, V30, P21, DOI 10.1038/ng796
   Bilsland LG, 2008, J NEUROCHEM, V107, P1271, DOI 10.1111/j.1471-4159.2008.05699.x
   Biswas M, 2010, TOXICOL APPL PHARM, V244, P16, DOI 10.1016/j.taap.2009.07.034
   BROOKE MH, 1970, ARCH NEUROL-CHICAGO, V23, P369, DOI 10.1001/archneur.1970.00480280083010
   Burchell VS, 2010, EXPERT OPIN THER TAR, V14, P497, DOI 10.1517/14728221003730434
   Campanella M, 2008, CELL METAB, V8, P13, DOI 10.1016/j.cmet.2008.06.001
   Chang WT, 2005, BIOCHEM BIOPH RES CO, V334, P199, DOI 10.1016/j.bbrc.2005.06.079
   Corrochano S, 2014, BRAIN, V137, P3171, DOI 10.1093/brain/awu292
   Cuesta A, 2002, NAT GENET, V30, P22, DOI 10.1038/ng798
   Daoud H, 2012, NEUROBIOL AGING, V33, P0
   Duchen MR, 2003, METHOD ENZYMOL, V361, P353
   Faes L, 2011, J BIOENERG BIOMEMBR, V43, P587, DOI 10.1007/s10863-011-9393-0
   GABREELSFESTEN AAWM, 1991, BRAIN, V114, P1855, DOI 10.1093/brain/114.4.1855
   Grasberger H, 2005, GENE, V344, P143, DOI 10.1016/j.gene.2004.09.035
   Grasberger H, 2005, INT J BIOCHEM CELL B, V37, P1421, DOI 10.1016/j.biocel.2005.01.013
   Haeusler AR, 2014, NATURE, V507, P195, DOI 10.1038/nature13124
   Hatayama M, 2010, BMC EVOL BIOL, V10, P0, DOI 10.1186/1471-2148-10-53
   Hentati A, 1998, NEUROGENETICS, V2, P55, DOI 10.1007/s100480050052
   Ide S, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms7674
   Joyce PI, 2015, HUM MOL GENET, V24, P1883, DOI 10.1093/hmg/ddu605
   Joyce PI, 2011, MAMM GENOME, V22, P420, DOI 10.1007/s00335-011-9339-1
   Kalmar B, 2008, J NEUROCHEM, V107, P339, DOI 10.1111/j.1471-4159.2008.05595.x
   KELLETT B S, 1963, J MED LAB TECHNOL, V20, P196
   Kieran D, 2004, NEUROSCIENCE, V125, P427, DOI 10.1016/j.neuroscience.2004.01.046
   Kobayashi A, 2011, GENES CELLS, V16, P692, DOI 10.1111/j.1365-2443.2011.01522.x
   Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103
   Lee CS, 2011, P NATL ACAD SCI USA, V108, P8408, DOI 10.1073/pnas.1019209108
   Lee I, 2001, BIOL CHEM, V382, P1629, DOI 10.1515/BC.2001.198
   Lezi E, 2012, ADV EXP MED BIOL, V942, P269, DOI 10.1007/978-94-007-2869-1_12
   Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lloyd KCK, 2011, ANN NY ACAD SCI, V1245, P24, DOI 10.1111/j.1749-6632.2011.06311.x
   Loiseau D, 2007, ANN NEUROL, V61, P315, DOI 10.1002/ana.21086
   Mackay JP, 1998, TRENDS BIOCHEM SCI, V23, P1, DOI 10.1016/S0968-0004(97)01168-7
   Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321
   Orlacchio A, 2010, BRAIN, V133, P591, DOI 10.1093/brain/awp325
   OUVRIER RA, 1981, J NEUROL SCI, V51, P181, DOI 10.1016/0022-510X(81)90097-6
   Ouvrier R, 2010, DEV MED CHILD NEUROL, V52, P328, DOI 10.1111/j.1469-8749.2010.03613.x
   Pitceathly RDS, 2012, NEUROLOGY, V79, P1145, DOI 10.1212/WNL.0b013e3182698d8d
   Ricketts T, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0085962
   Rogers DC, 2001, NEUROSCI LETT, V306, P89, DOI 10.1016/S0304-3940(01)01885-7
   Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551
   Shimazaki H, 2012, J MED GENET, V49, P777, DOI 10.1136/jmedgenet-2012-101212
   Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120
   Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001
   Wang LC, 2001, J ANAT, V198, P295, DOI 10.1046/j.1469-7580.2001.19830295.x
   Yaffe MB, 2001, CURR OPIN CELL BIOL, V13, P131, DOI 10.1016/S0955-0674(00)00189-7
   Yao Z, 2011, J CELL SCI, V124, P4194, DOI 10.1242/jcs.088260
   Zuberi AR, 1998, IMMUNITY, V9, P687, DOI 10.1016/S1074-7613(00)80666-4
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
NR 58
TC 13
Z9 14
U1 0
U2 8
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD JAN 15
PY 2016
VL 25
IS 2
BP 291
EP 307
DI 10.1093/hmg/ddv471
PG 17
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA DG5VU
UT WOS:000372148200008
PM 26604141
DA 2024-11-01
ER

PT J
AU Leopold, JA
   Maron, BA
AF Leopold, Jane A.
   Maron, Bradley A.
TI Molecular Mechanisms of Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE pulmonary arterial hypertension; DNA damage; microRNA; metabolism; mitochondria; endothelial-to-mesenchymal transition
ID smooth-muscle-cells; chronic hypoxia; mesenchymal transition; dna-damage; receptor; gene; contributes; expression; proliferation; epidemiology
AB Pulmonary arterial hypertension (PAH) is a devastating disease that is precipitated by hypertrophic pulmonary vascular remodeling of distal arterioles to increase pulmonary artery pressure and pulmonary vascular resistance in the absence of left heart, lung parenchymal, or thromboembolic disease. Despite available medical therapy, pulmonary artery remodeling and its attendant hemodynamic consequences result in right ventricular dysfunction, failure, and early death. To limit morbidity and mortality, attention has focused on identifying the cellular and molecular mechanisms underlying aberrant pulmonary artery remodeling to identify pathways for intervention. While there is a well-recognized heritable genetic component to PAH, there is also evidence of other genetic perturbations, including pulmonary vascular cell DNA damage, activation of the DNA damage response, and variations in microRNA expression. These findings likely contribute, in part, to dysregulation of proliferation and apoptosis signaling pathways akin to what is observed in cancer; changes in cellular metabolism, metabolic flux, and mitochondrial function; and endothelial-to-mesenchymal transition as key signaling pathways that promote pulmonary vascular remodeling. This review will highlight recent advances in the field with an emphasis on the aforementioned molecular mechanisms as contributors to the pulmonary vascular disease pathophenotype.
C1 [Leopold, Jane A.; Maron, Bradley A.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA.
   [Maron, Bradley A.] Vet Affairs Boston Healthcare Syst, Div Cardiol, Boston, MA 02132 USA.
C3 Harvard University; Harvard Medical School; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System
RP Leopold, JA (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA.
EM jleopold@partners.org; bmaron@partners.org
FU NIH/NHLBI [U01HL125215, K08HL11207-01A1]; Thomas W. Smith, MD Foundation; American Heart Association; Pulmonary Hypertension Association; Cardiovascular Medical Research and Education Fund (CMREF); Klarman Foundation at Brigham and Women's Hospital; Gilead Young Scholars Foundation
CR Aguero J, 2016, J AM COLL CARDIOL, V67, P2032, DOI 10.1016/j.jacc.2016.02.049
   Aguero J, 2014, AM J PHYSIOL-HEART C, V307, PH1204, DOI 10.1152/ajpheart.00246.2014
   Aldred MA, 2010, AM J RESP CRIT CARE, V182, P1153, DOI 10.1164/rccm.201003-0491OC
   Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X
   Archer SL, 2008, AM J PHYSIOL-HEART C, V294, PH570, DOI 10.1152/ajpheart.01324.2007
   Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233
   Archer SL, 2010, CIRCULATION, V121, P2661, DOI 10.1161/CIRCULATIONAHA.109.916098
   Austin ED, 2012, CIRC-CARDIOVASC GENE, V5, P336, DOI 10.1161/CIRCGENETICS.111.961888
   Bertero T, 2015, J BIOL CHEM, V290, P2069, DOI 10.1074/jbc.M114.617845
   Bertero T, 2014, J CLIN INVEST, V124, P3514, DOI 10.1172/JCI74773
   Bockmeyer CL, 2012, J HEART LUNG TRANSPL, V31, P764, DOI 10.1016/j.healun.2012.03.010
   Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864
   Bonnet S, 2007, P NATL ACAD SCI USA, V104, P11418, DOI 10.1073/pnas.0610467104
   Bonnet S, 2006, CIRCULATION, V113, P2630, DOI 10.1161/CIRCULATIONAHA.105.609008
   Brock M, 2009, CIRC RES, V104, P1184, DOI 10.1161/CIRCRESAHA.109.197491
   Caruso P, 2012, CIRC RES, V111, P290, DOI 10.1161/CIRCRESAHA.112.267591
   Caruso P, 2010, ARTERIOSCL THROM VAS, V30, P716, DOI 10.1161/ATVBAHA.109.202028
   Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195
   Cotroneo E, 2015, CIRC RES, V116, P1680, DOI 10.1161/CIRCRESAHA.116.305265
   Courboulin Audrey, 2011, RESPIR RES, V12, P128, DOI 10.1186/1465-9921-12-128
   Courboulin A, 2011, J EXP MED, V208, P535, DOI 10.1084/jem.20101812
   Deng ZM, 2000, AM J RESP CRIT CARE, V161, P1055, DOI 10.1164/ajrccm.161.3.9906051
   Eyries M, 2014, NAT GENET, V46, P65, DOI 10.1038/ng.2844
   Federici C, 2015, AM J RESP CRIT CARE, V192, P219, DOI 10.1164/rccm.201411-2128OC
   Fernandez RA, 2015, AM J PHYSIOL-CELL PH, V308, PC581, DOI 10.1152/ajpcell.00202.2014
   Frid MG, 2002, CIRC RES, V90, P1189, DOI 10.1161/01.RES.0000021432.70309.28
   Germain M, 2013, NAT GENET, V45, P518, DOI 10.1038/ng.2581
   Gilbert G, 2014, CARDIOVASC RES, V103, P313, DOI 10.1093/cvr/cvu069
   Good RB, 2015, AM J PATHOL, V185, P1850, DOI 10.1016/j.ajpath.2015.03.019
   Guignabert C, 2009, FASEB J, V23, P4135, DOI 10.1096/fj.09-131664
   Hadri L, 2013, CIRCULATION, V128, P512, DOI 10.1161/CIRCULATIONAHA.113.001585
   Hoeper MM, 2013, J AM COLL CARDIOL, V62, PD42, DOI 10.1016/j.jacc.2013.10.032
   KENNEDY EP, 1949, J BIOL CHEM, V179, P957
   Krenning G, 2016, STEM CELLS INT, V2016, P0, DOI 10.1155/2016/9762959
   Kuga T, 1996, CIRC RES, V79, P14, DOI 10.1161/01.RES.79.1.14
   Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226
   Lee C, 2012, CIRCULATION, V126, P2601, DOI 10.1161/CIRCULATIONAHA.112.114173
   Lee SD, 1998, J CLIN INVEST, V101, P927, DOI 10.1172/JCI1910
   Li ML, 2014, AM J RESP CELL MOL, V50, P1118, DOI 10.1165/rcmb.2013-0349OC
   Ling Y, 2012, AM J RESP CRIT CARE, V186, P790, DOI 10.1164/rccm.201203-0383OC
   Ma L, 2013, NEW ENGL J MED, V369, P351, DOI 10.1056/NEJMoa1211097
   Machado RD, 2015, HUM MUTAT, V36, P1113, DOI 10.1002/humu.22904
   Marsboom G, 2012, CIRC RES, V110, P1484, DOI 10.1161/CIRCRESAHA.111.263848
   McGoon MD, 2013, J AM COLL CARDIOL, V62, PD51, DOI 10.1016/j.jacc.2013.10.023
   McMurtry MS, 2004, CIRC RES, V95, P830, DOI 10.1161/01.RES.0000145360.16770.9f
   Meloche J, 2014, CIRCULATION, V129, P786, DOI 10.1161/CIRCULATIONAHA.113.006167
   Parikh VN, 2012, CIRCULATION, V125, P1520, DOI 10.1161/CIRCULATIONAHA.111.060269
   Paulin R, 2014, CIRC RES, V115, P148, DOI 10.1161/CIRCRESAHA.115.301130
   Peng GY, 2015, CIRC J, V79, P2058, DOI 10.1253/circj.CJ-15-0067
   Perez VADJ, 2014, AM J RESP CRIT CARE, V189, P1260, DOI 10.1164/rccm.201310-17490C
   Piao L, 2013, J MOL MED, V91, P333, DOI 10.1007/s00109-012-0982-0
   Potus F, 2015, CIRCULATION, V132, P932, DOI 10.1161/CIRCULATIONAHA.115.016382
   Pullamsetti SS, 2012, AM J RESP CRIT CARE, V185, P409, DOI 10.1164/rccm.201106-1093OC
   Qiao LN, 2014, CIRCULATION, V129, P692, DOI 10.1161/CIRCULATIONAHA.113.003734
   Ranchoux B, 2015, CIRCULATION, V131, P1006, DOI 10.1161/CIRCULATIONAHA.114.008750
   RANDLE PJ, 1963, LANCET, V1, P785
   Rhodes CJ, 2013, AM J RESP CRIT CARE, V187, P294, DOI 10.1164/rccm.201205-0839OC
   Ruiter G, 2015, PULM CIRC, V5, P466, DOI 10.1086/682217
   Sheikh AQ, 2015, SCI TRANSL MED, V7, P0, DOI 10.1126/scitranslmed.aaa9712
   Sheikh AQ, 2014, CELL REP, V6, P809, DOI 10.1016/j.celrep.2014.01.042
   Stevens HC, 2016, PULM CIRC, V6, P109, DOI 10.1086/685079
   Thomson J, 2001, JOURNAL OF HEART AND LUNG TRANSPLANTATION, V20, P149, DOI 10.1016/S1053-2498(01)00259-5
   Tuder RM, 1998, CHEST, V114, P1S, DOI 10.1378/chest.114.1_Supplement.1S-a
   Tuder RM, 2013, J AM COLL CARDIOL, V62, PD4, DOI 10.1016/j.jacc.2013.10.025
   Wang GL, 2014, INT J CARDIOL, V177, PE167, DOI 10.1016/j.ijcard.2014.08.124
   Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519
   White K, 2015, EMBO MOL MED, V7, P695, DOI 10.15252/emmm.201404511
   Xu WL, 2007, P NATL ACAD SCI USA, V104, P1342, DOI 10.1073/pnas.0605080104
   Yeager ME, 2001, CIRC RES, V88, P0
   Yu AY, 1999, J CLIN INVEST, V103, P691, DOI 10.1172/JCI5912
   Zhao L, 2015, NATURE, V524, P356, DOI 10.1038/nature14620
   Zhou GF, 2015, AM J RESP CELL MOL, V52, P139, DOI 10.1165/rcmb.2014-0166TR
NR 72
TC 114
Z9 128
U1 0
U2 35
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD MAY 15
PY 2016
VL 17
IS 5
BP 
EP 
DI 10.3390/ijms17050761
PG 14
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA DP9BJ
UT WOS:000378791400150
PM 27213345
DA 2024-11-01
ER

PT J
AU Montecchiani, C
   Pedace, L
   Lo Giudice, T
   Casella, A
   Mearini, M
   Gaudiello, F
   Pedroso, JL
   Terracciano, C
   Caltagirone, C
   Massa, R
   St George-Hyslop, PH
   Barsottini, OGP
   Kawarai, T
   Orlacchio, A
AF Montecchiani, Celeste
   Pedace, Lucia
   Lo Giudice, Temistocle
   Casella, Antonella
   Mearini, Marzia
   Gaudiello, Fabrizio
   Pedroso, Jose L.
   Terracciano, Chiara
   Caltagirone, Carlo
   Massa, Roberto
   St George-Hyslop, Peter H.
   Barsottini, Orlando G. P.
   Kawarai, Toshitaka
   Orlacchio, Antonio
TI ALS5/SPG11/<i>KIAA1840</i> mutations cause autosomal recessive axonal Charcot-Marie-Tooth disease
SO BRAIN
LA English
DT Article
DE ALS5/SPG11/KIAA1840 mutations; axonal degeneration; Charcot-Marie-Tooth disease; spatacsin
ID hereditary spastic paraplegia; motor neuropathy; spg11 gene; spatacsin; phenotype; form; family; heterogeneity; reliability; variability
AB Charcot-Marie-Tooth disease is a group of hereditary peripheral neuropathies that share clinical characteristics of progressive distal muscle weakness and atrophy, foot deformities, distal sensory loss, as well as diminished tendon reflexes. Hundreds of causative DNA changes have been found, but much of the genetic basis of the disease is still unexplained. Mutations in the ALS5/SPG11/KIAA1840 gene are a frequent cause of autosomal recessive hereditary spastic paraplegia with thin corpus callosum and peripheral axonal neuropathy, and account for similar to 40% of autosomal recessive juvenile amyotrophic lateral sclerosis. The overlap of axonal Charcot-Marie-Tooth disease with both diseases, as well as the common autosomal recessive inheritance pattern of thin corpus callosum and axonal Charcot-Marie-Tooth disease in three related patients, prompted us to analyse the ALS5/SPG11/KIAA1840 gene in affected individuals with autosomal recessive axonal Charcot-Marie-Tooth disease. We investigated 28 unrelated families with autosomal recessive axonal Charcot-Marie-Tooth disease defined by clinical, electrophysiological, as well as pathological evaluation. Besides, we screened for all the known genes related to axonal autosomal recessive Charcot-Marie-Tooth disease (CMT2A2/HMSN2A2/MFN2, CMT2B1/LMNA, CMT2B2/MED25, CMT2B5/NEFL, ARCMT2F/dHMN2B/HSPB1, CMT2K/GDAP1, CMT2P/LRSAM1, CMT2R/TRIM2, CMT2S/IGHMBP2, CMT2T/HSJ1, CMTRID/COX6A1, ARAN-NM/HINT and GAN/GAN), for the genes related to autosomal recessive hereditary spastic paraplegia with thin corpus callosum and axonal peripheral neuropathy (SPG7/PGN, SPG15/ZFYVE26, SPG21/ACP33, SPG35/FA2H, SPG46/GBA2, SPG55/C12orf65 and SPG56/CYP2U1), as well as for the causative gene of peripheral neuropathy with or without agenesis of the corpus callosum (SLC12A6). Mitochondrial disorders related to Charcot-Marie-Tooth disease type 2 were also excluded by sequencing POLG and TYMP genes. An additional locus for autosomal recessive Charcot-Marie-Tooth disease type 2H on chromosome 8q13-21.1 was excluded by linkage analysis. Pedigrees originated in Italy, Brazil, Canada, England, Iran, and Japan. Interestingly, we identified 15 ALS5/SPG11/KIAA1840 mutations in 12 families (two sequence variants were never reported before, p.Gln198* and p.Pro2212fs*5). No large deletions/duplications were detected in these patients. The novel mutations seemed to be pathogenic since they co-segregated with the disease in all pedigrees and were absent in 300 unrelated controls. Furthermore, in silico analysis predicted their pathogenic effect. Our results indicate that ALS5/SPG11/KIAA1840 is the causative gene of a wide spectrum of clinical features, including autosomal recessive axonal Charcot-Marie-Tooth disease.
C1 [Montecchiani, Celeste; Pedace, Lucia; Lo Giudice, Temistocle; Casella, Antonella; Mearini, Marzia; Gaudiello, Fabrizio; Orlacchio, Antonio] CERC IRCCS Santa Lucia, Lab Neurogenet, Rome, Italy.
   [Lo Giudice, Temistocle; Terracciano, Chiara; Caltagirone, Carlo; Massa, Roberto; Orlacchio, Antonio] Univ Roma Tor Vergata, Dipartimento Med Sistemi, Rome, Italy.
   [Pedroso, Jose L.; Barsottini, Orlando G. P.] Univ Fed Sao Paulo, Dept Neurol, Sao Paulo, Brazil.
   [Caltagirone, Carlo] IRCCS Santa Lucia, Lab Neurol Clin & Comportamentale, Rome, Italy.
   [St George-Hyslop, Peter H.] Univ Toronto, Ctr Res Neurodegenerat Dis, Toronto, ON, Canada.
   [St George-Hyslop, Peter H.] Univ Toronto, Dept Med, Toronto, ON, Canada.
   [St George-Hyslop, Peter H.] Univ Cambridge, Dept Clin Neurosci, Cambridge, England.
   [Kawarai, Toshitaka] Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Clin Neurosci, Tokushima 770, Japan.
C3 IRCCS Santa Lucia; University of Rome Tor Vergata; Universidade Federal de Sao Paulo (UNIFESP); IRCCS Santa Lucia; University of Toronto; University of Toronto; University of Cambridge; Tokushima University
RP Orlacchio, A (corresponding author), Ist Ricovero & Cura Carattere Sci IRCCS Santa Luc, CERC, Lab Neurogenet, 64 Via Fosso Fiorano, I-00143 Rome, Italy.
EM a.orlacchio@hsantalucia.it
FU Italian Ministero della Salute [GR09.109]; Comitato Telethon Fondazione Onlus, Italy [GGP10121]; Universita di Roma "Tor Vergata", Rome, Italy [E82I15000190005]; Rotary Club Sanluri Medio Campidano, Sanluri (VS), Italy (Grant Noi per Voi); Japan Society for the Promotion of Science (JSPS KAKENHI) [26461294]; Ministry of Health, Labour, and Welfare of Japan; Brain Science Foundation, Japan; MRC [MR/N012453/1, MC_G1000734] Funding Source: UKRI
CR American Psychiatric Association, 2013, DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS, V0, P0
   Barhoumi C, 2001, NEUROMUSCULAR DISORD, V11, P27, DOI 10.1016/S0960-8966(00)00162-0
   Bettencourt C, 2014, CLIN GENET, V85, P154, DOI 10.1111/cge.12133
   Bienfait HME, 2007, AXONAL PHENOTYPES CH, V0, P0
   Bird DT, 1993, CHARCOT MARIE TOOTH, V0, P0
   Birouk N, 1997, BRAIN, V120, P813, DOI 10.1093/brain/120.5.813
   Bomont P, 2000, NAT GENET, V26, P370, DOI 10.1038/81701
   Byrnes LJ, 2011, P NATL ACAD SCI USA, V108, P2216, DOI 10.1073/pnas.1012792108
   Carlesimo GA, 1996, EUR NEUROL, V36, P378, DOI 10.1159/000117297
   Carosi L, 2015, J NEUROL NEUROSUR PS, V86, P702, DOI 10.1136/jnnp-2014-308625
   Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9
   Cassereau J, 2014, REV NEUROL-FRANCE, V170, P366, DOI 10.1016/j.neurol.2013.11.005
   Chiurchiù V, 2014, NEUROMOL MED, V16, P3, DOI 10.1007/s12017-013-8271-9
   Claramunt R, 2005, J MED GENET, V42, P358, DOI 10.1136/jmg.2004.022178
   Cottenie E, 2014, AM J HUM GENET, V95, P590, DOI 10.1016/j.ajhg.2014.10.002
   Crimella C, 2012, CLIN GENET, V82, P157, DOI 10.1111/j.1399-0004.2011.01717.x
   Daoud H, 2012, NEUROBIOL AGING, V33, P0, DOI 10.1016/j.neurobiolaging.2011.11.012
   De Sandre-Giovannoli A, 2002, AM J HUM GENET, V70, P726, DOI 10.1086/339274
   Del Bo R, 2007, NEUROGENETICS, V8, P301, DOI 10.1007/s10048-007-0095-z
   Denora PS, 2009, HUM MUTAT, V30, PE500, DOI 10.1002/humu.20945
   DYCK PJ, 1968, MAYO CLIN PROC, V43, P81
   Dyck PJ, 2005, PERIPHEAL NEUROPATHY, V0, P0
   Feely SME, 2011, NEUROLOGY, V76, P1690, DOI 10.1212/WNL.0b013e31821a441e
   Fridman V, 2014, NEUROLOGY, V83, P580, DOI 10.1212/WNL.0000000000000700
   Fusco C, 2010, BRAIN DEV-JPN, V32, P592, DOI 10.1016/j.braindev.2009.08.003
   Genari AB, 2011, NEUROMUSCULAR DISORD, V21, P428, DOI 10.1016/j.nmd.2011.03.008
   Gess B, 2014, NEUROLOGY, V83, P1726, DOI 10.1212/WNL.0000000000000966
   Goizet C, 2009, HUM MUTAT, V30, PE376, DOI 10.1002/humu.20920
   Guelly C, 2011, AM J HUM GENET, V88, P99, DOI 10.1016/j.ajhg.2010.12.003
   Guernsey DL, 2010, PLOS GENET, V6, P0, DOI 10.1371/journal.pgen.1001081
   Hammer MB, 2013, AM J HUM GENET, V92, P245, DOI 10.1016/j.ajhg.2012.12.012
   Hanein S, 2008, AM J HUM GENET, V82, P992, DOI 10.1016/j.ajhg.2008.03.004
   Hegele RA, 2005, CLIN GENET, V68, P31, DOI 10.1111/j.1399-0004.2005.00447.x
   Hehr U, 2007, ANN NEUROL, V62, P656, DOI 10.1002/ana.21310
   Hirst J, 2013, MOL BIOL CELL, V24, P2558, DOI 10.1091/mbc.E13-03-0170
   Houlden H, 2008, NEUROLOGY, V71, P1660, DOI 10.1212/01.wnl.0000319696.14225.67
   Howard HC, 2002, NAT GENET, V32, P384, DOI 10.1038/ng1002
   Ito D, 2009, BRAIN, V132, P8, DOI 10.1093/brain/awn216
   Jerath NU, 2015, BBA-MOL BASIS DIS, V1852, P667, DOI 10.1016/j.bbadis.2014.07.031
   Landouré G, 2013, HUM MUTAT, V34, P1357, DOI 10.1002/humu.22378
   Leal A, 2009, NEUROGENETICS, V10, P275, DOI 10.1007/s10048-009-0183-3
   Lee MJ, 2008, J NEUROL NEUROSUR PS, V79, P607, DOI 10.1136/jnnp.2007.136390
   Leonardis L, 2012, EUR J NEUROL, V19, P992, DOI 10.1111/j.1468-1331.2012.03665.x
   Lo Giudice T, 2014, EXP NEUROL, V261, P518, DOI 10.1016/j.expneurol.2014.06.011
   Martin E, 2013, AM J HUM GENET, V92, P238, DOI 10.1016/j.ajhg.2012.11.021
   Martin E, 2012, NEUROBIOL DIS, V48, P299, DOI 10.1016/j.nbd.2012.07.003
   Medical Research Council, 1981, 45 MED RES COUNC, V0, P0
   Murphy SM, 2011, J PERIPHER NERV SYST, V16, P191, DOI 10.1111/j.1529-8027.2011.00350.x
   Nicholson GA, 2008, NEUROLOGY, V70, P1678, DOI 10.1212/01.wnl.0000311275.89032.22
   Nishino I, 2000, ANN NEUROL, V47, P792
   Orlacchio A, 2008, NEUROLOGY, V70, P1959, DOI 10.1212/01.wnl.0000294330.27058.61
   Orlacchio A, 2010, BRAIN, V133, P591, DOI 10.1093/brain/awp325
   OTT J, 1983, ANN HUM GENET, V47, P311, DOI 10.1111/j.1469-1809.1983.tb01001.x
   Paisan-Ruiz C, 2008, EUR J NEUROL, V15, P1065, DOI 10.1111/j.1468-1331.2008.02247.x
   Palumbo C, 2002, ACTA NEUROPATHOL, V104, P287, DOI 10.1007/s00401-002-0558-0
   Pehlivan D, 2015, HUM GENET, V134, P671, DOI 10.1007/s00439-015-1548-3
   Pensato V, 2014, BRAIN, V137, P1907, DOI 10.1093/brain/awu121
   Pérez-Branguli F, 2014, HUM MOL GENET, V23, P4859, DOI 10.1093/hmg/ddu200
   Pierson TM, 2012, EUR J HUM GENET, V20, P476, DOI 10.1038/ejhg.2011.222
   Pippucci T, 2009, EUR J NEUROL, V16, P121, DOI 10.1111/j.1468-1331.2008.02367.x
   Querin G, 2014, EUR J NEUROL, V21, PE85, DOI 10.1111/ene.12481
   Reyes-Marin K, 2011, CLIN NEUROL NEUROSUR, V113, P243, DOI 10.1016/j.clineuro.2010.10.015
   Sagnelli A, 2014, J PERIPHER NERV SYST, V19, P183, DOI 10.1111/jns5.12070
   Simpson MA, 2003, AM J HUM GENET, V73, P1147, DOI 10.1086/379522
   Spiegel R, 2014, EUR J HUM GENET, V22, P0, DOI 10.1038/ejhg.2013.284
   Stevanin G, 2008, BRAIN, V131, P772, DOI 10.1093/brain/awm293
   Stevanin G, 2007, NAT GENET, V39, P366, DOI 10.1038/ng1980
   Tamiya G, 2014, AM J HUM GENET, V95, P294, DOI 10.1016/j.ajhg.2014.07.013
   Tazir M, 2014, J NEUROL SCI, V347, P14, DOI 10.1016/j.jns.2014.10.013
   Tazir M, 2013, J PERIPHER NERV SYST, V18, P113, DOI 10.1111/jns5.12026
   Tessa A, 2014, CURR MOL MED, V14, P1034, DOI 10.2174/1566524014666141010154526
   Tesson C, 2012, AM J HUM GENET, V91, P1051, DOI 10.1016/j.ajhg.2012.11.001
   Timmerman V, 2013, EXP NEUROL, V246, P14, DOI 10.1016/j.expneurol.2012.01.010
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Windpassinger C, 2004, NAT GENET, V36, P271, DOI 10.1038/ng1313
   Yum SW, 2009, ANN NEUROL, V66, P759, DOI 10.1002/ana.21728
   Zimon M, 2012, NAT GENET, V44, P1080, DOI 10.1038/ng.2406
NR 77
TC 73
Z9 79
U1 0
U2 7
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
EI 1460-2156
J9 BRAIN
JI Brain
PD JAN 1
PY 2016
VL 139
IS 
BP 73
EP 85
DI 10.1093/brain/awv320
PG 13
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA DD8VM
UT WOS:000370205000020
PM 26556829
DA 2024-11-01
ER

PT J
AU Machiela, E
   Dues, DJ
   Senchuk, MM
   Van Raamsdonk, JM
AF Machiela, Emily
   Dues, Dylan J.
   Senchuk, Megan M.
   Van Raamsdonk, Jeremy M.
TI Oxidative stress is increased in <i>C</i>. <i>elegans</i> models of Huntington's disease but does not contribute to polyglutamine toxicity phenotypes
SO NEUROBIOLOGY OF DISEASE
LA English
DT Article
DE Huntington's disease; polyglutamine toxicity disorder; aggregation; oxidative stress; superoxide dismutase; reactive oxygen species (ROS); C. elegans; animal model; genetics
ID yac128 mouse model; unfolded protein response; superoxide-dismutase gene; caenorhabditis-elegans; life-span; mutant huntingtin; neurological phenotype; mitochondrial-dna; cellular toxicity; motor dysfunction
AB Huntington's disease (HD) is an adult onset neurodegenerative disorder for which there is currently no cure. While HD patients and animal models of the disease exhibit increased oxidative damage, it is currently uncertain to what extent oxidative stress contributes to disease pathogenesis. In this work, we use a genetic approach to define the role of oxidative stress in HD. We find that a C. elegans model of HD expressing a disease-length polyglutamine tract in the body wall muscle is hypersensitive to oxidative stress and shows an upregulation of antioxidant defense genes, indicating that the HD worm model has increased levels of oxidative stress. To determine whether this increase in oxidative stress contributes to the development of polyglutamine-toxicity phenotypes in this HD model, we examined the effect of deleting individual superoxide dismutase (sod) genes in the HD worm model. As predicted, we found that deletion of sod genes in the HD worm model resulted in a clear increase in sensitivity to oxidative stress. However, we found that increasing oxidative stress in the HD worm model did not exacerbate deficits caused by polyglutamine toxicity. We confirmed these observations in two worm models expressing disease-length polyglutamine tracts in neurons. Furthermore, we found that treatment with antioxidants failed to rescue movement deficits or decrease aggregation in HD worm models. Combined, this suggests that the increase in oxidative stress in worm models of HD does not contribute to the phenotypic deficits observed in these worms, and provides a possible explanation for the failure of antioxidants in HD clinical trials. (C) 2016 Elsevier Inc All rights reserved.
C1 [Machiela, Emily; Dues, Dylan J.; Senchuk, Megan M.; Van Raamsdonk, Jeremy M.] Van Andel Res Inst, Ctr Neurodegenerat Sci, Lab Aging & Neurodegenerat Dis, Grand Rapids, MI USA.
   [Van Raamsdonk, Jeremy M.] Michigan State Univ, Dept Translat Sci & Mol Med, Grand Rapids, MI USA.
   [Van Raamsdonk, Jeremy M.] Michigan State Univ, Dept Genet, E Lansing, MI 48824 USA.
C3 Van Andel Institute; Michigan State University; Michigan State University
RP Van Raamsdonk, JM (corresponding author), Van Andel Res Inst, 333 Bostwick Ave NE, Grand Rapids, MI 49503 USA.
EM jeremy.vanraamsdonk@vai.org
FU Hereditary Disease Foundation; Canadian Institutes of Health Research; Van Andel Research Institute; Van Andel Institute Graduate School
CR Ajayi A, 2012, BMC NEUROSCI, V13, P0, DOI 10.1186/1471-2202-13-86
   Alam ZI, 2000, J NEUROCHEM, V75, P840, DOI 10.1046/j.1471-4159.2000.0750840.x
   Andre R, 2016, CURR OPIN PHARMACOL, V26, P33, DOI 10.1016/j.coph.2015.09.008
   Andreassen OA, 2001, NEUROREPORT, V12, P3371, DOI 10.1097/00001756-200110290-00044
   Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998
   Blackwell TK, 2015, FREE RADIC BIOL MED, V0, P0
   Bogdanov MB, 2001, J NEUROCHEM, V79, P1246, DOI 10.1046/j.1471-4159.2001.00689.x
   Bonanomi M, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0129727
   Brignull HR, 2006, J NEUROSCI, V26, P7597, DOI 10.1523/JNEUROSCI.0990-06.2006
   Browne SE, 1997, ANN NEUROL, V41, P646, DOI 10.1002/ana.410410514
   Browne SE, 1999, BRAIN PATHOL, V9, P147
   Browne SE, 2006, ANTIOXID REDOX SIGN, V8, P2061, DOI 10.1089/ars.2006.8.2061
   Cooper JF, 2015, NPJ PARKINSONS DIS, V1, P0, DOI 10.1038/npjparkd.2015.22
   Cotto JJ, 1999, BIOCHEM SOC SYMP, V0, P105
   Doonan R, 2008, GENE DEV, V22, P3236, DOI 10.1101/gad.504808
   Dues DJ, 2016, AGING-US, V8, P777, DOI 10.18632/aging.100939
   Faber PW, 1999, P NATL ACAD SCI USA, V96, P179, DOI 10.1073/pnas.96.1.179
   Ferrante RJ, 2000, J NEUROSCI, V20, P4389, DOI 10.1523/JNEUROSCI.20-12-04389.2000
   Ferrante RJ, 1997, J NEUROCHEM, V69, P2064
   Ferrante RJ, 2002, J NEUROSCI, V22, P1592, DOI 10.1523/JNEUROSCI.22-05-01592.2002
   Fujii M, 1998, DNA RES, V5, P25, DOI 10.1093/dnares/5.1.25
   GIGLIO AM, 1994, BIOCHEM MOL BIOL INT, V33, P41
   GIGLIO MP, 1994, BIOCHEM MOL BIOL INT, V33, P37
   Gil JM, 2008, EUR J NEUROSCI, V27, P2803, DOI 10.1111/j.1460-9568.2008.06310.x
   Gil-Mohapel J, 2014, CURR DRUG TARGETS, V15, P454, DOI 10.2174/1389450115666140115113734
   Haynes CM, 2010, J CELL SCI, V123, P3849, DOI 10.1242/jcs.075119
   Hekimi S, 2011, TRENDS CELL BIOL, V21, P569, DOI 10.1016/j.tcb.2011.06.008
   Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2
   Hersch SM, 2006, NEUROLOGY, V66, P250, DOI 10.1212/01.wnl.0000194318.74946.b6
   Hunter T, 1997, J BIOL CHEM, V272, P28652, DOI 10.1074/jbc.272.45.28652
   Jensen LT, 2005, J BIOL CHEM, V280, P41373, DOI 10.1074/jbc.M509142200
   Jovaisaite V, 2014, J EXP BIOL, V217, P137, DOI 10.1242/jeb.090738
   Kim SJ, 2003, BIOCHEM BIOPH RES CO, V307, P660, DOI 10.1016/S0006-291X(03)01241-5
   Klepac N, 2007, J NEUROL, V254, P1676, DOI 10.1007/s00415-007-0611-y
   Leavitt BR, 2001, AM J HUM GENET, V68, P313, DOI 10.1086/318207
   Lee SJ, 2010, CURR BIOL, V20, P2131, DOI 10.1016/j.cub.2010.10.057
   MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E
   Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0
   Mielcarek M, 2013, PLOS BIOL, V11, P0, DOI 10.1371/journal.pbio.1001717
   Miyata R, 2008, J NEUROL SCI, V264, P133, DOI 10.1016/j.jns.2007.08.025
   Morcos M, 2008, AGING CELL, V7, P260, DOI 10.1111/j.1474-9726.2008.00371.x
   Mori K, 2009, J BIOCHEM, V146, P743, DOI 10.1093/jb/mvp166
   Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099
   Parker JA, 2001, P NATL ACAD SCI USA, V98, P13318, DOI 10.1073/pnas.231476398
   Pérez VI, 2009, BBA-GEN SUBJECTS, V1790, P1005, DOI 10.1016/j.bbagen.2009.06.003
   Pérez-Severiano F, 2000, BRAIN RES, V862, P234, DOI 10.1016/S0006-8993(00)02082-5
   Polidori MC, 1999, NEUROSCI LETT, V272, P53, DOI 10.1016/S0304-3940(99)00578-9
   Powell-Coffman JA, 2010, TRENDS ENDOCRIN MET, V21, P435, DOI 10.1016/j.tem.2010.02.006
   Praticò D, 2008, ANN NY ACAD SCI, V1147, P70, DOI 10.1196/annals.1427.010
   Ramzan F, 2015, J NEUROSCI, V35, P6444, DOI 10.1523/JNEUROSCI.3599-14.2015
   Rebec GV, 2003, NEUROREPORT, V14, P1263, DOI 10.1097/00001756-200307010-00015
   Satyal SH, 2000, P NATL ACAD SCI USA, V97, P5750, DOI 10.1073/pnas.100107297
   Schäkel C, 2015, 8TH ACM INTERNATIONAL CONFERENCE ON PERVASIVE TECHNOLOGIES RELATED TO ASSISTIVE ENVIRONMENTS (PETRA 2015), V0, P0, DOI DOI 10.1145/2769493.2769499
   Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169
   Snijder PM, 2015, MOL MED, V0, P0
   Sorolla MA, 2008, FREE RADICAL BIO MED, V45, P667, DOI 10.1016/j.freeradbiomed.2008.05.014
   Sorolla MA, 2012, BIOFACTORS, V38, P173, DOI 10.1002/biof.1013
   Stack EC, 2008, ANN NY ACAD SCI, V1147, P79, DOI 10.1196/annals.1427.008
   Stoy N, 2005, J NEUROCHEM, V93, P611, DOI 10.1111/j.1471-4159.2005.03070.x
   Suzuki N, 1996, DNA RES, V3, P171, DOI 10.1093/dnares/3.3.171
   Vabulas RM, 2010, CSH PERSPECT BIOL, V2, P0, DOI 10.1101/cshperspect.a004390
   Van Raamsdonk JM, 2006, BMC NEUROSCI, V7, P0, DOI 10.1186/1471-2202-7-80
   Van Raamsdonk JM, 2007, NEUROBIOL DIS, V26, P512, DOI 10.1016/j.nbd.2007.01.006
   Van Raamsdonk JM, 2009, PLOS GENET, V5, P0, DOI 10.1371/journal.pgen.1000361
   Van Raamsdonk Jeremy Michael, 2015, WORM, V4, Pe1094607, DOI 10.1080/21624054.2015.1094607
   Van Raamsdonk JM, 2012, P NATL ACAD SCI USA, V109, P5785, DOI 10.1073/pnas.1116158109
   Van Raamsdonk JM, 2010, ANTIOXID REDOX SIGN, V13, P1911, DOI 10.1089/ars.2010.3215
   Van Raamsdonk JM, 2010, GENETICS, V185, P559, DOI 10.1534/genetics.110.115378
   Van Raamsdonk JM, 2005, HUM MOL GENET, V14, P1379, DOI 10.1093/hmg/ddi147
   Van Raamsdonk JM, 2005, EXP NEUROL, V196, P266, DOI 10.1016/j.expneurol.2005.07.021
   Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038
   Wei YH, 2016, P NATL ACAD SCI USA, V113, PE2832, DOI 10.1073/pnas.1524727113
   Yanase S, 2009, J GERONTOL A-BIOL, V64, P530, DOI 10.1093/gerona/glp020
   Yang W, 2007, GENETICS, V177, P2063, DOI 10.1534/genetics.107.080788
   Yang W, 2010, PLOS BIOL, V8, P0, DOI 10.1371/journal.pbio.1000556
   Yu YC, 2009, J NEUROSCI RES, V87, P1884, DOI 10.1002/jnr.22011
   Zhang Y, 2006, EMBO J, V25, P5896, DOI 10.1038/sj.emboj.7601445
   Zhou C, 2008, ANN NY ACAD SCI, V1147, P93, DOI 10.1196/annals.1427.023
   Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217
   Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009
NR 80
TC 33
Z9 39
U1 0
U2 20
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0969-9961
EI 1095-953X
J9 NEUROBIOL DIS
JI Neurobiol. Dis.
PD DEC 15
PY 2016
VL 96
IS 
BP 1
EP 11
DI 10.1016/j.nbd.2016.08.008
PG 11
WC Neurosciences
SC Neurosciences & Neurology
GA EC3WX
UT WOS:000388058900001
PM 27544481
DA 2024-11-01
ER

PT J
AU Luigetti, M
   Sauchelli, D
   Primiano, G
   Cuccagna, C
   Bernardo, D
   Lo Monaco, M
   Servidei, S
AF Luigetti, M.
   Sauchelli, D.
   Primiano, G.
   Cuccagna, C.
   Bernardo, D.
   Lo Monaco, M.
   Servidei, S.
TI Peripheral neuropathy is a common manifestation of mitochondrial diseases: a single-centre experience
SO EUROPEAN JOURNAL OF NEUROLOGY
LA English
DT Article
DE MELAS; MERRF; mitochondrial diseases; MNGIE; nerve; PEO; peripheral neuropathy
ID nerve-conduction; merrf mutation; dna; disorders; gene
AB Background and purpose: Peripheral neuropathy in mitochondrial diseases (MDs) may vary from a subclinical finding in a multisystem syndrome to a severe, even isolated, manifestation in some patients. Methods: To investigate the involvement of the peripheral nervous system in MDs extensive electrophysiological studies were performed in 109 patients with morphological, biochemical and genetic diagnosis of MD [12 A3243G progressive external ophthalmoplegia (PEO)/mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS), 16 myoclonic epilepsy with ragged-red fibres (MERRF), four mitochondrial neurogastrointestinal encephalomyopathy (MNGIE), 67 PEO with single or multiple deletions of mitochondrial DNA, 10 others]. Results: A neuropathy was found in 49 patients (45%). The incidence was very high in MNGIE (100%), MELAS (92%) and MERRF (69%), whilst 28% of PEO patients had evidence of peripheral involvement. The most frequent abnormality was a sensory axonal neuropathy found in 32/49 patients (65%). A sensory-motor axonal neuropathy was instead detected in 16% of the patients and sensory-motor axonal demyelinating neuropathy in 16%. Finally one Leigh patient had a motor axonal neuropathy. It is interesting to note that the great majority had preserved tendon reflexes and no sensory disturbances. Conclusions: In conclusion, peripheral involvement in MD is frequent even if often mild or asymptomatic. The correct identification and characterization of peripheral neuropathy through electrophysiological studies represents another tile in the challenge of MD diagnosis.
C1 [Luigetti, M.; Sauchelli, D.; Primiano, G.; Cuccagna, C.; Bernardo, D.; Lo Monaco, M.; Servidei, S.] Univ Cattolica Sacro Cuore, Inst Neurol, Dept Geriatr Neurosci & Orthoped, I-00168 Rome, Italy.
C3 Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli
RP Luigetti, M (corresponding author), Inst Neurol, Largo Francesco Vito 1, I-00168 Rome, Italy.
EM mluigetti@gmail.com
CR [Anonymous], 1989, ELECTRODIAGNOSIS DIS, V0, P0
   Bouillot S, 2002, J PERIPHER NERV SYST, V7, P213, DOI 10.1046/j.1529-8027.2002.02027.x
   Catteruccia M, 2015, J NEUROL, V262, P701, DOI 10.1007/s00415-014-7632-0
   Finsterer J, 2011, J NEUROL SCI, V304, P9, DOI 10.1016/j.jns.2011.02.012
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Horga A, 2014, BRAIN, V137, P3200, DOI 10.1093/brain/awu279
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   Kärppä M, 2003, J NEUROL, V250, P216, DOI 10.1007/s00415-003-0981-8
   Kaufmann P, 2006, ARCH NEUROL-CHICAGO, V63, P746, DOI 10.1001/archneur.63.5.746
   Lax NZ, 2012, BRAIN, V135, P62, DOI 10.1093/brain/awr326
   Luigetti M, 2013, CLIN NEUROPHYSIOL, V124, P1899, DOI 10.1016/j.clinph.2013.02.116
   Luigetti M, 2012, CLIN NEUROPHYSIOL, V123, P1891, DOI 10.1016/j.clinph.2012.02.075
   Mancuso M, 2015, J NEUROL, V262, P1301, DOI 10.1007/s00415-015-7710-y
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Menezes MP, 2012, DEV MED CHILD NEUROL, V54, P407, DOI 10.1111/j.1469-8749.2012.04271.x
   Merolli A, 2013, J RECONSTR MICROSURG, V29, P0, DOI 10.1055/s-0033-1348038
   Milone M, 2010, NEUROLOGIST, V16, P84, DOI 10.1097/NRL.0b013e3181c78a89
   Mnatsakanyan L, 2011, J NEURO-OPHTHALMOL, V31, P6, DOI 10.1097/WNO.0b013e3181fab1b4
   Pareyson D, 2013, LANCET NEUROL, V12, P1011, DOI 10.1016/S1474-4422(13)70158-3
   Rahman S, 2009, J NEUROL NEUROSUR PS, V80, P943, DOI 10.1136/jnnp.2008.158279
   Van den Bergh PYK, 2010, EUR J NEUROL, V17, P356, DOI 10.1111/j.1468-1331.2009.02930.x
   Zochodne DW, 2007, MUSCLE NERVE, V36, P144, DOI 10.1002/mus.20785
NR 24
TC 36
Z9 39
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1351-5101
EI 1468-1331
J9 EUR J NEUROL
JI Eur. J. Neurol.
PD JUN 15
PY 2016
VL 23
IS 6
BP 1020
EP 1027
DI 10.1111/ene.12954
PG 8
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA DL6QZ
UT WOS:000375765000007
PM 26822221
DA 2024-11-01
ER

PT J
AU Barends, M
   Verschuren, L
   Morava, E
   Nesbitt, V
   Turnbull, D
   McFarland, R
AF Barends, Marlieke
   Verschuren, Lotte
   Morava, Eva
   Nesbitt, Victoria
   Turnbull, Doug
   McFarland, Robert
TI Causes of Death in Adults with Mitochondrial Disease
SO JIMD REPORTS, VOL 26
LA English
DT Article; Book Chapter
ID kearns-sayre-syndrome; progressive external ophthalmoplegia; atrioventricular-block; cardiac involvement; lactic-acidosis; mutation; dna; prevalence; disorders; children
AB Introduction: Mitochondrial diseases are a clinically, biochemically and genetically heterogeneous group of disorders with a variable age of onset and rate of disease progression. It might therefore be expected that this variation be reflected in the age and cause of death. However, to date, little has been reported regarding the 'end-of-life' period and causes of death in mitochondrial disease patients. For some specific syndromes, the associated clinical problems might predict the cause of death, but for many patients, it remains difficult to provide an accurate prognosis. Aims: To describe a retrospective cohort of adult mitochondrial disease patients who had attended the NHS Highly Specialised Services for Rare Mitochondrial Diseases in Newcastle upon Tyne (UK), evaluate life expectancy and causes of death and assess the consequences for daily patient care. Methods: All deceased adult patients cared for at this centre over a period of 10 years were included in the study. Patient history, data on laboratory findings, biochemical investigations and genetic studies were analysed retrospectively. Results: A total of 30 adult mitochondrial patients died within the time period of the study. The main mitochondrial disease-related causes of death in this patient cohort were respiratory failure, cardiac failure and acute cerebral incidents such as seizures and strokes. In almost half of the patients, the cause of death remained unknown. Based on our study, we present recommendations regarding the care of patients with mitochondrial disease.
C1 [Barends, Marlieke; Verschuren, Lotte] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mitochondrial Disorders, Nijmegen, Netherlands.
   [Barends, Marlieke; Verschuren, Lotte] Radboud Univ Nijmegen, Med Ctr, Dept Pediat, Nijmegen, Netherlands.
   [Barends, Marlieke; Verschuren, Lotte; Nesbitt, Victoria; Turnbull, Doug; McFarland, Robert] Newcastle Univ, Inst Ageing & Hlth, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [Morava, Eva] Tulane Univ, Sch Med, Hayward Genet Ctr SL 31, 1430 Tulane Ave, New Orleans, LA 70112 USA.
C3 Radboud University Nijmegen; Radboud University Nijmegen; Newcastle University - UK; Tulane University
RP McFarland, R (corresponding author), Newcastle Univ, Inst Ageing & Hlth, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
EM Robert.mcfarland@ncl.ac.uk
FU MRC [G1100540, G0800674, G0900652, G0502157, MR/L016451/1, G0400074] Funding Source: UKRI; Medical Research Council [G0400074, G0502157, G0900652, G0800674, G1100540, MR/L016451/1] Funding Source: Medline
CR Arpa J, 2003, MUSCLE NERVE, V28, P690, DOI 10.1002/mus.10507
   Ashizawa T, 2001, ARCH NEUROL-CHICAGO, V58, P1053, DOI 10.1001/archneur.58.7.1053
   Bates MGD, 2013, EUR HEART J-CARD IMG, V14, P650, DOI 10.1093/ehjci/jes226
   Benditt JO, 2013, AM J RESP CRIT CARE, V187, P1046, DOI 10.1164/rccm.201210-1804CI
   BERENBERG RA, 1977, ANN NEUROL, V1, P37, DOI 10.1002/ana.410010104
   Chawla S, 2008, PEDIATR CARDIOL, V29, P659, DOI 10.1007/s00246-007-9040-z
   Coenen MJH, 1999, BIOCHEM BIOPH RES CO, V265, P339, DOI 10.1006/bbrc.1999.1662
   de Vries MC, 2007, EUR J PEDIATR, V166, P229, DOI 10.1007/s00431-006-0234-9
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Herrero-Martín MD, 2010, J NEUROL NEUROSUR PS, V81, P471, DOI 10.1136/jnnp.2009.173831
   Finsterer J, 2014, INT J CARDIOL, V177, P754, DOI 10.1016/j.ijcard.2014.11.014
   Greden JF, 2001, J CLIN PSYCHIAT, V62, P0
   Huang CC, 2002, J BIOMED SCI, V9, P527, DOI 10.1007/BF02254979
   Hudson G, 2007, ARCH NEUROL-CHICAGO, V64, P553, DOI 10.1001/archneur.64.4.553
   Caballero PEJ, 2007, NEUROLOGIST, V13, P33, DOI 10.1097/01.nrl.0000252953.49721.f5
   Kato H, 2006, J NEUROL, V253, P529, DOI 10.1007/s00415-005-0010-1
   Katsanos KH, 2002, INT J CARDIOL, V83, P179, DOI 10.1016/S0167-5273(02)00040-2
   Klopstock T, 1999, NEUROLOGY, V53, P855, DOI 10.1212/WNL.53.4.855
   Limongelli G, 2010, EUR J HEART FAIL, V12, P114, DOI 10.1093/eurjhf/hfp186
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Majamaa-Voltti K, 2008, J NEUROL NEUROSUR PS, V79, P0, DOI 10.1136/jnnp.2007.122648
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Mancuso M, 2013, NEUROL SCI, V34, P71, DOI 10.1007/s10072-011-0901-0
   Marcus KA, 2011, MITOCHONDRION, V11, P405, DOI 10.1016/j.mito.2010.12.005
   McFarland R, 2009, J INTERN MED, V265, P210, DOI 10.1111/j.1365-2796.2008.02066.x
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Morava E, 2006, NEUROLOGY, V67, P1823, DOI 10.1212/01.wnl.0000244435.27645.54
   Morava E, 2006, AM J MED GENET A, V140A, P863, DOI 10.1002/ajmg.a.31194
   Morava E, 2010, MITOCHONDRION, V10, P528, DOI 10.1016/j.mito.2010.05.011
   Palmio J, 2014, J NEUROL NEUROSUR PS, V85, P345, DOI 10.1136/jnnp-2013-304965
   Pfeiffer RF, 2011, PARKINSONISM RELAT D, V17, P10, DOI 10.1016/j.parkreldis.2010.08.003
   Sanger TD, 1996, PEDIATR NEUROL, V14, P57, DOI 10.1016/0887-8994(95)00226-X
   Schaefer AM, 2006, NEUROLOGY, V66, P1932, DOI 10.1212/01.wnl.0000219759.72195.41
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001
   Smits BW, 2011, J NEUROL, V258, P2020, DOI 10.1007/s00415-011-6060-7
   Sweet D, 2011, SOCIAL TRENDS 41 HLT, V0, P0
   Wahbi K, 2010, NEUROLOGY, V74, P674, DOI 10.1212/WNL.0b013e3181d0ccf4
   Welzing L, 2009, EUR J PEDIATR, V168, P757, DOI 10.1007/s00431-008-0831-x
   Wortmann SB, 2007, ACTA PAEDIATR, V96, P450, DOI 10.1111/j.1651-2227.2006.00158.x
   Yilmaz A, 2012, CLIN RES CARDIOL, V101, P255, DOI 10.1007/s00392-011-0387-z
NR 42
TC 29
Z9 29
U1 0
U2 1
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 2192-8304
EI 
J9 JIMD REP
PD JUN 15
PY 2016
VL 26
IS 
BP 103
EP 113
DI 10.1007/8904_2015_449
PG 11
WC Endocrinology & Metabolism; Genetics & Heredity
SC Endocrinology & Metabolism; Genetics & Heredity
GA BI0RB
UT WOS:000405113200015
PM 26354038
DA 2024-11-01
ER

PT J
AU Bouchereau, J
   Barrot, SV
   Dupré, T
   Moore, SEH
   Cardas, R
   Capri, Y
   Gaignard, P
   Slama, A
   Delanoë, C
   de Baulny, HO
   Seta, N
   Schiff, M
   Servais, L
AF Bouchereau, Juliette
   Barrot, Sandrine Vuillaumier
   Dupre, Thierry
   Moore, Stuart E. H.
   Cardas, Ruxandra
   Capri, Yline
   Gaignard, Pauline
   Slama, Abdelhamid
   Delanoe, Catherine
   de Baulny, Helene Ogier
   Seta, Nathalie
   Schiff, Manuel
   Servais, Laurent
TI Abnormal Glycosylation Profile and High Alpha-Fetoprotein in a Patient with <i>Twinkle</i> Variants
SO JIMD REPORTS, VOL 29
LA English
DT Article; Book Chapter
ID onset spinocerebellar ataxia; sensory neuropathy; mitochondria; mutations; depletion; disease
AB The C10orf2 gene encodes Twinkle, a protein involved in mitochondrial DNA (mtDNA) replication. Twinkle mutations cause mtDNA deletion or depletion and are associated with a large spectrum of clinical symptoms including dominant progressive external ophthalmoplegia (adPEO), infantile-onset spinocerebellar ataxia (IOSCA), and early-onset encephalopathy. The diagnosis remains difficult because of the wide range of symptoms and lack of association with specific metabolic changes. We report herein a child with early-onset encephalopathy, unusual abnormal movements, deafness, and axonal neuropathy. All laboratory investigations were normal with the exceptions of high alpha-fetoprotein levels and an abnormal glycosylation profile. These abnormal parameters resulted in misdiagnosis as a previously unidentified congenital disorder of glycosylation (CDG) type I syndrome. Whole exome sequencing revealed two point mutations in C10orf2 that were confirmed by Sanger sequencing; neither had been previously reported. This report enlarges the clinical phenotype of Twinkle mutations and suggests that an abnormal glycosylation profile suggestive of CDG type I associated with high blood alpha-fetoprotein levels without obvious cause should prompt Twinkle sequencing.
C1 [Bouchereau, Juliette; de Baulny, Helene Ogier; Schiff, Manuel] Hop Robert Debre, AP HP, Reference Ctr Inborn Errors Metab Dis, Paris, France.
   [Barrot, Sandrine Vuillaumier; Dupre, Thierry; Seta, Nathalie] Hop Bichat Claude Bernard, AP HP, Biochim Metab & Cellulaire, Paris, France.
   [Barrot, Sandrine Vuillaumier; Dupre, Thierry; Moore, Stuart E. H.] Univ Paris Diderot, INSERM, Ctr Rech Bichat Beaujon CRB3, U773, Paris, France.
   [Cardas, Ruxandra; Servais, Laurent] Hop La Pitie Salpetriere, Inst Myol, Paris, France.
   [Capri, Yline] Hop Robert Debre, AP HP, Genet Clin, Paris, France.
   [Gaignard, Pauline; Slama, Abdelhamid] Hop Bicetre, AP HP, Biochim, Le Kremlin Bicetre, France.
   [Delanoe, Catherine] Hop Robert Debre, Serv Explorat Fonct, Paris, France.
   [Schiff, Manuel] Univ Paris Diderot, Sorbonne Paris Cite, Hop Robert Debre, Inserm,U1141, Paris, France.
C3 Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Hopital Universitaire Bicetre - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Robert-Debre - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)
RP Servais, L (corresponding author), Hop La Pitie Salpetriere, Inst Myol, Paris, France.
EM l.servais@institut-myologie.org
CR Alpers BJ, 1931, ARCH NEURO PSYCHIATR, V25, P469, DOI 10.1001/archneurpsyc.1931.02230030027002
   Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   GASNIER F, 1991, CLIN CHIM ACTA, V199, P69, DOI 10.1016/0009-8981(91)90010-A
   GASNIER F, 1991, J BIOCHEM, V110, P702, DOI 10.1093/oxfordjournals.jbchem.a123644
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Helander A, 2001, CLIN CHEM, V47, P1225
   Jaeken J, 2011, J INHERIT METAB DIS, V34, P853, DOI 10.1007/s10545-011-9299-3
   KOSKINEN T, 1994, J NEUROL SCI, V121, P50, DOI 10.1016/0022-510X(94)90156-2
   Lönnqvist T, 1998, J NEUROL SCI, V161, P57, DOI 10.1016/S0022-510X(98)00249-4
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Seta N, 1996, CLIN CHIM ACTA, V254, P131, DOI 10.1016/0009-8981(96)06379-6
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Tan EP, 2014, J BIOL CHEM, V289, P14719, DOI 10.1074/jbc.M113.525790
NR 14
TC 4
Z9 8
U1 0
U2 3
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 2192-8304
EI 
J9 JIMD REP
PD JUN 15
PY 2016
VL 29
IS 
BP 109
EP 113
DI 10.1007/8904_2016_526
PG 5
WC Endocrinology & Metabolism; Genetics & Heredity
SC Endocrinology & Metabolism; Genetics & Heredity
GA BI0RO
UT WOS:000405118700015
PM 26920903
DA 2024-11-01
ER

PT J
AU Bannwarth, S
   Berg-Alonso, L
   Augé, G
   Fragaki, K
   Kolesar, JE
   Lespinasse, F
   Lacas-Gervais, S
   Burel-Vandenbos, F
   Villa, E
   Belmonte, F
   Michiels, JF
   Ricci, JE
   Gherardi, R
   Harrington, L
   Kaufman, BA
   Paquis-Flucklinger, V
AF Bannwarth, Sylvie
   Berg-Alonso, Laetitia
   Auge, Gaelle
   Fragaki, Konstantina
   Kolesar, Jill E.
   Lespinasse, Francoise
   Lacas-Gervais, Sandra
   Burel-Vandenbos, Fanny
   Villa, Elodie
   Belmonte, Frances
   Michiels, Jean-Francois
   Ricci, Jean-Ehrland
   Gherardi, Romain
   Harrington, Lea
   Kaufman, Brett A.
   Paquis-Flucklinger, Veronique
TI Inactivation of Pill helicase causes a mitochondrial myopathy in mice
SO MITOCHONDRION
LA English
DT Article
DE PIA helicase; mtDNA instability; Mitochondrial myopathy; Mitochondrial disease
ID human pif1 helicase; mtdna mutator mice; complex i defect; dna-replication; saccharomyces-cerevisiae; oxidative damage; telomerase; protein; instability; nuclear
AB Mutations in genes coding for mitochondrial helicases such as TWINKLE and DNA2 are involved in mitochondrial myopathies with mtDNA instability in both human and mouse. We show that inactivation of Pti1, a third member of the mitochondrial helicase family, causes a similar phenotype in mouse. pif1 -/- animals develop a mitochondria] myopathy with respiratory chain deficiency. Pif1 inactivation is responsible for a deficiency to repair oxidative stress-induced mtDNA damage in mouse embryonic fibroblasts that is improved by complementation with mitochondrial isoform mPif1(67). These results open new perspectives for the exploration of patients with mtDNA instability disorders. (C) 2016 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Bannwarth, Sylvie; Berg-Alonso, Laetitia; Auge, Gaelle; Fragaki, Konstantina; Lespinasse, Francoise; Paquis-Flucklinger, Veronique] UNS, IRCAN, CNRS, UMR 7284,INSERM,U1081,Fac Med, Nice, France.
   [Bannwarth, Sylvie; Auge, Gaelle; Fragaki, Konstantina; Paquis-Flucklinger, Veronique] CHU Nice, Serv Genet Med, Hop Archet 2, Nice, France.
   [Kolesar, Jill E.; Belmonte, Frances; Kaufman, Brett A.] Univ Pittsburgh, Dept Med, Ctr Metab & Mitochondrial Med, Pittsburgh, PA USA.
   [Lacas-Gervais, Sandra] Univ Nice Sophia Antipolis, Ctr Commun Microscopie Elect Appl, Fac Sci, Nice, France.
   [Burel-Vandenbos, Fanny; Michiels, Jean-Francois] CHU Nice, Serv Neuropathol, Hop Pasteur, F-06202 Nice, France.
   [Villa, Elodie; Ricci, Jean-Ehrland] Univ Nice Sophia Antipolis, INSERM, U1065, C3M,Equipe Controle Metabol Morts Cellulaires, Nice, France.
   [Gherardi, Romain] Univ Paris Est, INSERM, U955, E10, Creteil, France.
   [Harrington, Lea] Univ Montreal, Inst Rech Immunol & Cancerol, 2950 Chemin Polytech, Montreal, PQ H3T 1J4, Canada.
C3 Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Cote d'Azur; CHU Nice; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Universite Cote d'Azur; CHU Nice; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite de Montreal
RP Paquis-Flucklinger, V (corresponding author), UNS, IRCAN, UMR7284, Sch Med,INSERM, 28 Ave Valombrose, F-06107 Nice, France.
EM paquis@hermes.unice.fr
FU Fondation pour la Recherche Medicale (FRM) [DPM20121125552]; Association Francaise contre les Myopathies [AFM-16248];  [R01GM110424]
CR Arenas J, 1998, ANN NEUROL, V43, P397, DOI 10.1002/ana.410430321
   Bannwarth S, 2005, HUM MUTAT, V25, P575, DOI 10.1002/humu.20177
   Bannwarth S, 2012, MITOCHONDRION, V12, P654, DOI 10.1016/j.mito.2012.07.111
   Bochman ML, 2010, DNA REPAIR, V9, P237, DOI 10.1016/j.dnarep.2010.01.008
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Budd ME, 2006, MOL CELL BIOL, V26, P2490, DOI 10.1128/MCB.26.7.2490-2500.2006
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   De Bono JP, 2006, AM J PHYSIOL-REG I, V290, PR926, DOI 10.1152/ajpregu.00694.2005
   de Souza-Pinto NC, 2010, MECH AGEING DEV, V131, P503, DOI 10.1016/j.mad.2010.04.009
   Ding L, 2015, INT J MOL SCI, V16, P10870, DOI 10.3390/ijms160510870
   Doudican NA, 2005, MOL CELL BIOL, V25, P5196, DOI 10.1128/MCB.25.12.5196-5204.2005
   Duxin JP, 2009, MOL CELL BIOL, V29, P4274, DOI 10.1128/MCB.01834-08
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   FOURY F, 1983, P NATL ACAD SCI-BIOL, V80, P5345, DOI 10.1073/pnas.80.17.5345
   Furda AM, 2012, DNA REPAIR, V11, P684, DOI 10.1016/j.dnarep.2012.06.002
   Futami K, 2007, BIOL PHARM BULL, V30, P1685, DOI 10.1248/bpb.30.1685
   George T, 2009, NUCLEIC ACIDS RES, V37, P6491, DOI 10.1093/nar/gkp671
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Kazak L, 2013, NUCLEIC ACIDS RES, V41, P2354, DOI 10.1093/nar/gks1347
   Kolesar JE, 2014, FREE RADICAL BIO MED, V75, P241, DOI 10.1016/j.freeradbiomed.2014.07.038
   Kolesar JE, 2013, NUCLEIC ACIDS RES, V41, P0, DOI 10.1093/nar/gks1324
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   LAHAYE A, 1993, J BIOL CHEM, V268, P26155
   LeDoux SP, 1999, MUTAT RES-DNA REPAIR, V434, P149, DOI 10.1016/S0921-8777(99)00026-9
   Li JR, 2014, NUCLEIC ACIDS RES, V42, P8527, DOI 10.1093/nar/gku541
   Morales CP, 1999, NAT GENET, V21, P115, DOI 10.1038/5063
   Neyton S, 2004, MOL HUM REPROD, V10, P917, DOI 10.1093/molehr/gah123
   Paeschke K, 2013, NATURE, V497, P458, DOI 10.1038/nature12149
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Rothfuss O, 2010, NUCLEIC ACIDS RES, V38, P0, DOI 10.1093/nar/gkp1082
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787
   Sanders CM, 2010, BIOCHEM J, V430, P119, DOI 10.1042/BJ20100612
   Sawyer DE, 1999, MUTAT RES-DNA REPAIR, V434, P161, DOI 10.1016/S0921-8777(99)00027-0
   SCHULZ VP, 1994, CELL, V76, P145, DOI 10.1016/0092-8674(94)90179-1
   SHULL S, 1991, J BIOL CHEM, V266, P24398
   Snow BE, 2007, MOL CELL BIOL, V27, P1017, DOI 10.1128/MCB.01866-06
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Wilson MA, 2013, NATURE, V502, P393, DOI 10.1038/nature12585
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Zhang DH, 2006, NUCLEIC ACIDS RES, V34, P1393, DOI 10.1093/nar/gkl029
   Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024
   Zhou JQ, 2000, SCIENCE, V289, P771, DOI 10.1126/science.289.5480.771
NR 46
TC 27
Z9 31
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD SEP 15
PY 2016
VL 30
IS 
BP 126
EP 137
DI 10.1016/j.mito.2016.02.005
PG 12
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA DX0FN
UT WOS:000384037300014
PM 26923168
DA 2024-11-01
ER

PT J
AU Lehtonen, JM
   Forsström, S
   Bottani, E
   Viscomi, C
   Baris, OR
   Isoniemi, H
   Höckerstedt, K
   Österlund, P
   Hurme, M
   Jylhävä, J
   Leppä, S
   Markkula, R
   Heliö, T
   Mombelli, G
   Uusimaa, J
   Laaksonen, R
   Laaksovirta, H
   Auranen, M
   Zeviani, M
   Smeitink, J
   Wiesner, RJ
   Nakada, K
   Isohanni, P
   Suomalainen, A
AF Lehtonen, Jenni M.
   Forsstrom, Saara
   Bottani, Emanuela
   Viscomi, Carlo
   Baris, Olivier R.
   Isoniemi, Helena
   Hockerstedt, Krister
   Osterlund, Pia
   Hurme, Mikko
   Jylhava, Juulia
   Leppa, Sirpa
   Markkula, Ritva
   Helio, Tiina
   Mombelli, Giuliana
   Uusimaa, Johanna
   Laaksonen, Reijo
   Laaksovirta, Hannu
   Auranen, Mari
   Zeviani, Massimo
   Smeitink, Jan
   Wiesner, Rudolf J.
   Nakada, Kazuto
   Isohanni, Pirjo
   Suomalainen, Anu
TI FGF21 is a biomarker for mitochondrial translation and mtDNA maintenance disorders
SO NEUROLOGY
LA English
DT Article
ID growth; mice; disease; deficiency; activation; mutations; deletions; myopathy; twinkle; obesity
AB Objective: To validate new mitochondrial myopathy serum biomarkers for diagnostic use. Methods: We analyzed serum FGF21 (S-FGF21) and GDF15 from patients with (1) mitochondrial diseases and (2) nonmitochondrial disorders partially overlapping with mitochondrial disorder phenotypes. We (3) did a meta-analysis of S-FGF21 in mitochondrial disease and (4) analyzed S-Fgf21 and skeletal muscle Fgf21 expression in 6 mouse models with different muscle-manifesting mitochondrial dysfunctions. Results: We report that S-FGF21 consistently increases in primary mitochondrial myopathy, especially in patients with mitochondrial translation defects or mitochondrial DNA (mtDNA) deletions (675 and 347 pg/mL, respectively; controls: 66 pg/mL, p<0.0001 for both). This is corroborated in mice (mtDNA deletions 1,163 vs 379 pg/mL, p<0.0001). However, patients and mice with structural respiratory chain subunit or assembly factor defects showed low induction (human 335 pg/mL, p<0.05; mice 335 pg/mL, not significant). Overall specificities of FGF21 and GDF15 to find patients with mitochondrial myopathy were 89.3% vs 86.4%, and sensitivities 67.3% and 76.0%, respectively. However, GDF15 was increased also in a wide range of nonmitochondrial conditions. Conclusions: S-FGF21 is a specific biomarker for muscle-manifesting defects of mitochondrial translation, including mitochondrial transfer-RNA mutations and primary and secondary mtDNA deletions, the most common causes of mitochondrial disease. However, normal S-FGF21 does not exclude structural respiratory chain complex or assembly factor defects, important to acknowledge in diagnostics. Classification of evidence: This study provides Class III evidence that elevated S-FGF21 accurately distinguishes patients with mitochondrial myopathies from patients with other conditions, and FGF21 and GDF15 mitochondrial myopathy from other myopathies.
C1 [Lehtonen, Jenni M.; Forsstrom, Saara; Isoniemi, Helena; Auranen, Mari; Isohanni, Pirjo] Univ Helsinki, Res Programs Unit, Mol Neurol, Helsinki, Finland.
   [Osterlund, Pia] Univ Helsinki, Fac Med Clinicum, Oncol, Helsinki, Finland.
   [Leppa, Sirpa] Univ Helsinki, Finland Genome Scale Biol Program, Helsinki, Finland.
   [Bottani, Emanuela; Viscomi, Carlo; Zeviani, Massimo] MRC, Mitochondrial Biol Unit, Mitochondrial Med Grp, Cambridge, England.
   [Baris, Olivier R.; Wiesner, Rudolf J.] Univ Cologne, Inst Vegetat Physiol, Ctr Physiol & Pathophysiol, Cologne, Germany.
   [Isoniemi, Helena; Hockerstedt, Krister] Helsinki Univ Hosp, Transplantat & Liver Surg Clin, Helsinki, Finland.
   [Osterlund, Pia; Leppa, Sirpa] Helsinki Univ Hosp, Dept Oncol, Helsinki, Finland.
   [Helio, Tiina] Helsinki Univ Hosp, Dept Cardiol, Heart & Lung Ctr, Helsinki, Finland.
   [Hurme, Mikko; Jylhava, Juulia; Laaksonen, Reijo] Univ Tampere, Sch Med, Tampere, Finland.
   [Markkula, Ritva] Univ Helsinki, Anaesthesiol Intens Care & Pain Med, Helsinki, Finland.
   [Laaksovirta, Hannu; Auranen, Mari; Suomalainen, Anu] Univ Helsinki, Neurol, Clin Neurosci, Helsinki, Finland.
   [Isohanni, Pirjo] Univ Helsinki, Childrens Hosp, Child Neurol, Helsinki, Finland.
   Helsinki Univ Hosp, Helsinki, Finland.
   [Mombelli, Giuliana] Osped Niguarda Ca Granda, Cardiotoracovasc Dept, Dyslipidemia Ctr, Milan, Italy.
   [Uusimaa, Johanna] Univ Oulu, PEDEGO Res Unit, Oulu, Finland.
   [Uusimaa, Johanna] Univ Oulu, Bioctr Oulu, Oulu, Finland.
   [Laaksonen, Reijo] Tampere Univ Hosp, Finnish Clin Biobank Tampere, Tampere, Finland.
   [Smeitink, Jan] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mitochondrial Disorders, Nijmegen, Netherlands.
   [Wiesner, Rudolf J.] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany.
   [Wiesner, Rudolf J.] Univ Cologne, Ctr Mol Med, CMMC, Cologne, Germany.
   [Nakada, Kazuto] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan.
   [Uusimaa, Johanna] Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland.
   [Uusimaa, Johanna] Univ Oulu, Oulu, Finland.
C3 University of Helsinki; University of Helsinki; University of Helsinki; University of Cologne; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; Tampere University; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Ospedale Niguarda Ca' Granda; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Oulu; University of Oulu; Tampere University; Tampere University Hospital; Radboud University Nijmegen; University of Cologne; University of Cologne; University of Tsukuba; University of Oulu; University of Oulu
RP Suomalainen, A (corresponding author), Univ Helsinki, Neurol, Clin Neurosci, Helsinki, Finland.
EM anu.wartiovaara@helsinki.fi
FU MRC [MC_UP_1002/1] Funding Source: UKRI; Grants-in-Aid for Scientific Research [16H04678, 16K14719] Funding Source: KAKEN; Medical Research Council [MC_UP_1002/1] Funding Source: Medline
CR Al Payne B, 2013, AIDS RES THER, V10, P0, DOI 10.1186/1742-6405-10-27
   Baris OR, 2015, CELL METAB, V21, P667, DOI 10.1016/j.cmet.2015.04.005
   Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125
   Davis RL, 2016, NEUROLOGY, V86, P2010, DOI 10.1212/WNL.0000000000002705
   Davis RL, 2013, NEUROLOGY, V81, P1819, DOI 10.1212/01.wnl.0000436068.43384.ef
   DellAgnello C, 2007, HUM MOL GENET, V16, P431, DOI 10.1093/hmg/ddl477
   Dogan SA, 2014, CELL METAB, V19, P458, DOI 10.1016/j.cmet.2014.02.004
   Fried LP, 2001, J GERONTOL A-BIOL, V56, PM146, DOI 10.1093/gerona/56.3.M146
   Fujita Y, 2015, MITOCHONDRION, V20, P34, DOI 10.1016/j.mito.2014.10.006
   Gälman C, 2008, CELL METAB, V8, P169, DOI 10.1016/j.cmet.2008.06.014
   Kalko SG, 2014, BMC GENOMICS, V15, P0, DOI 10.1186/1471-2164-15-91
   Han SH, 2010, METABOLISM, V59, P1656, DOI 10.1016/j.metabol.2010.03.018
   Hudson G, 2006, HUM MOL GENET, V15, PR244, DOI 10.1093/hmg/ddl233
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Koene S, 2014, NEUROLOGY, V83, P125, DOI 10.1212/WNL.0000000000000578
   Kramer F, 2011, BIOMARKERS, V16, PS31, DOI 10.3109/1354750X.2011.561498
   Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004
   LAYFIELD LJ, 1995, ACTA CYTOL, V39, P11
   Lin ZF, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0018398
   Lin ZF, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0015534
   Montero R, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0148709
   Mraz M, 2009, CLIN ENDOCRINOL, V71, P369, DOI 10.1111/j.1365-2265.2008.03502.x
   Nawarskas James J, 2005, CARDIOL REV, V13, P76, DOI 10.1097/01.crd.0000154790.42283.a1
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Rhodes CJ, 2013, HANDB EXP PHARMACOL, V218, P77, DOI 10.1007/978-3-642-38664-0_4
   Salehi MH, 2013, MOL BIOL REP, V40, P6495, DOI 10.1007/s11033-013-2767-0
   Schirris TJJ, 2015, CELL METAB, V22, P399, DOI 10.1016/j.cmet.2015.08.002
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2011, J CLIN ENDOCR METAB, V96, PE351, DOI 10.1210/jc.2010-1326
   Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310
   Viscomi C, 2009, HUM MOL GENET, V18, P12, DOI 10.1093/hmg/ddn309
   Wong LJC, 2010, DEV DISABIL RES REV, V16, P154, DOI 10.1002/ddrr.104
   Yang CF, 2013, BMC GASTROENTEROL, V13, P0, DOI 10.1186/1471-230X-13-67
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
   Yilmaz Y, 2010, EUR J CLIN INVEST, V40, P887, DOI 10.1111/j.1365-2362.2010.02338.x
   Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476
NR 38
TC 157
Z9 167
U1 0
U2 20
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD NOV 29
PY 2016
VL 87
IS 22
BP 2290
EP 2299
DI 10.1212/WNL.0000000000003374
PG 10
WC Clinical Neurology
SC Neurosciences & Neurology
GA EI1MA
UT WOS:000392240300010
PM 27794108
DA 2024-11-01
ER

PT J
AU Altmann, J
   Buchner, B
   Nadaj-Pakleza, A
   Schäfer, J
   Jackson, S
   Lehmann, D
   Deschauer, M
   Kopajtich, R
   Lautenschläger, R
   Kuhn, KA
   Karle, K
   Schöls, L
   Schulz, J
   Weis, J
   Prokisch, H
   Kornblum, C
   Claeys, KG
   Klopstock, T
AF Altmann, Judith
   Buchner, Boriana
   Nadaj-Pakleza, Aleksandra
   Schaefer, Jochen
   Jackson, Sandra
   Lehmann, Diana
   Deschauer, Marcus
   Kopajtich, Robert
   Lautenschlaeger, Ronald
   Kuhn, Klaus A.
   Karle, Kathrin
   Schoels, Ludger
   Schulz, Joerg B.
   Weis, Joachim
   Prokisch, Holger
   Kornblum, Cornelia
   Claeys, Kristl G.
   Klopstock, Thomas
TI Expanded phenotypic spectrum of the m.8344A&gt;G "MERRF" mutation: data from the German mitoNET registry
SO JOURNAL OF NEUROLOGY
LA English
DT Article
DE Myoclonus; Ataxia; Epilepsy; Ragged-red fibres; Psychiatric; Hearing impairment
ID stroke-like episodes; a8344g mutation; myoclonic epilepsy; clinical-features; leigh-syndrome; mitochondrial; heterogeneity; lipomatosis; myopathy; melas
AB The m.8344A > G mutation in the MTTK gene, which encodes the mitochondrial transfer RNA for lysine, is traditionally associated with myoclonic epilepsy and ragged-red fibres (MERRF), a multisystemic mitochondrial disease that is characterised by myoclonus, seizures, cerebellar ataxia, and mitochondrial myopathy with ragged-red fibres. We studied the clinical and paraclinical phenotype of 34 patients with the m.8344A > G mutation, mainly derived from the nationwide mitoREGISTER, the multicentric registry of the German network for mitochondrial disorders (mitoNET). Mean age at symptom onset was 24.5 years +/- 10.9 (6-48 years) with adult onset in 75 % of the patients. In our cohort, the canonical features seizures, myoclonus, cerebellar ataxia and ragged-red fibres that are traditionally associated with MERRF, occurred in only 61, 59, 70, and 63 % of the patients, respectively. In contrast, other features such as hearing impairment were even more frequently present (72 %). Other common features in our cohort were migraine (52 %), psychiatric disorders (54 %), respiratory dysfunction (45 %), gastrointestinal symptoms (38 %), dysarthria (36 %), and dysphagia (35 %). Brain MRI revealed cerebral and/or cerebellar atrophy in 43 % of our patients. There was no correlation between the heteroplasmy level in blood and age at onset or clinical phenotype. Our findings further broaden the clinical spectrum of the m.8344A > G mutation, document the large clinical variability between carriers of the same mutation, even within families and indicate an overlap of the phenotype with other mitochondrial DNA-associated syndromes.
C1 [Altmann, Judith; Schulz, Joerg B.; Claeys, Kristl G.] Rhein Westfal TH Aachen, Dept Neurol, Aachen, Germany.
   [Altmann, Judith; Weis, Joachim; Claeys, Kristl G.] Rhein Westfal TH Aachen, Inst Neuropathol, Aachen, Germany.
   [Buchner, Boriana; Klopstock, Thomas] Univ Munich, Dept Neurol, Friedrich Baur Inst, D-80539 Munich, Germany.
   [Nadaj-Pakleza, Aleksandra] Univ Hosp Angers, Dept Neurol, Angers, France.
   [Schaefer, Jochen; Jackson, Sandra] Univ Hosp Carl Gustav Carus, Dept Neurol, Dresden, Germany.
   [Lehmann, Diana; Deschauer, Marcus] Univ Halle Wittenberg, Dept Neurol, D-06108 Halle, Germany.
   [Deschauer, Marcus] Univ Technol Munchen, Dept Neurol, Munich, Germany.
   [Kopajtich, Robert; Prokisch, Holger] Helmholtz Ctr Munchen, Inst Human Genet, Munich, Germany.
   [Kopajtich, Robert; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-80290 Munich, Germany.
   [Lautenschlaeger, Ronald; Kuhn, Klaus A.] Univ Technol Munchen, Inst Med Stat & Epidemiol, Munich, Germany.
   [Karle, Kathrin; Schoels, Ludger] Inst Clin Neurogenet, Dept Neurol, Tubingen, Germany.
   [Karle, Kathrin; Schoels, Ludger] Hertie Inst Clin Brain Res, Tubingen, Germany.
   [Schulz, Joerg B.] JARA Translat Brain Med, Aachen, Germany.
   [Kornblum, Cornelia] Univ Hosp Bonn, Dept Neurol, Bonn, Germany.
   [Kornblum, Cornelia] Univ Hosp Bonn, Ctr Rare Dis Bonn ZSEB, Bonn, Germany.
   [Claeys, Kristl G.] Univ Hosp Leuven, Dept Neurol, Leuven, Belgium.
   [Claeys, Kristl G.] Univ Leuven KU Leuven, Leuven, Belgium.
   [Klopstock, Thomas] German Ctr Neurodegenerat Dis DZNE, Munich, Germany.
   [Klopstock, Thomas] Munich Cluster Syst Neurol SyNergy, Munich, Germany.
C3 RWTH Aachen University; RWTH Aachen University; University of Munich; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Martin Luther University Halle Wittenberg; Technical University of Munich; Technical University of Munich; Technical University of Munich; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Bonn; University of Bonn; KU Leuven; University Hospital Leuven; KU Leuven; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich
RP Claeys, KG (corresponding author), Rhein Westfal TH Aachen, Dept Neurol, Aachen, Germany.; Claeys, KG (corresponding author), Rhein Westfal TH Aachen, Inst Neuropathol, Aachen, Germany.; Claeys, KG (corresponding author), Univ Hosp Leuven, Dept Neurol, Leuven, Belgium.; Claeys, KG (corresponding author), Univ Leuven KU Leuven, Leuven, Belgium.
EM Kristl.Claeys@uzleuven.be
FU German Bundesministerium fur Bildung und Forschung (BMBF) through German Network for mitochondrial disorders (mitoNET) [01GM1113A, 01GM1113C]; Deutsche Gesellschaft fur Muskelkranke e.V. (DGM)
CR Blakely EL, 2014, NEUROMUSCULAR DISORD, V24, P533, DOI 10.1016/j.nmd.2014.03.011
   Catteruccia M, 2015, J NEUROL, V262, P701, DOI 10.1007/s00415-014-7632-0
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236
   DiMauro S, 2002, J CHILD NEUROL, V17, P0
   DiMauro S, 2003, GENE REV, V0, P0
   FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3
   Gámez J, 1998, NEUROLOGY, V51, P258, DOI 10.1212/WNL.51.1.258
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   GRAF WD, 1993, ANN NEUROL, V33, P640, DOI 10.1002/ana.410330613
   Han JY, 2014, J CLIN NEUROSCI, V21, P2009, DOI 10.1016/j.jocn.2014.03.020
   Howell N, 1996, NEUROLOGY, V46, P219, DOI 10.1212/WNL.46.1.219
   Iizuka T, 2002, NEUROLOGY, V59, P816, DOI 10.1212/WNL.59.6.816
   Mancuso M, 2013, NEUROLOGY, V80, P2049, DOI 10.1212/WNL.0b013e318294b44c
   Molnar MJ, 2009, J NEUROL, V256, P264, DOI 10.1007/s00415-009-0841-2
   Muñoz-Málaga A, 2000, MUSCLE NERVE, V23, P538, DOI 10.1002/(SICI)1097-4598(200004)23:4<538::AID-MUS12>3.3.CO;2-K
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Schaefer AM, 2006, NEUROLOGY, V66, P1932, DOI 10.1212/01.wnl.0000219759.72195.41
   Schmitz-Hübsch T, 2006, NEUROLOGY, V66, P1717, DOI 10.1212/01.wnl.0000219042.60538.92
   SHOFFNER JM, 1992, AM J HUM GENET, V51, P1179
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   SILVESTRI G, 1993, NEUROLOGY, V43, P1200, DOI 10.1212/WNL.43.6.1200
   Tanji K, 2003, ACTA NEUROPATHOL, V105, P69, DOI 10.1007/s00401-002-0604-y
   WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8
   Weyer A, 2007, MOVEMENT DISORD, V22, P1633, DOI 10.1002/mds.21544
NR 25
TC 64
Z9 69
U1 0
U2 13
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5354
EI 1432-1459
J9 J NEUROL
JI J. Neurol.
PD MAY 15
PY 2016
VL 263
IS 5
BP 961
EP 972
DI 10.1007/s00415-016-8086-3
PG 12
WC Clinical Neurology
SC Neurosciences & Neurology
GA DM1XU
UT WOS:000376141000014
PM 26995359
DA 2024-11-01
ER

PT J
AU Safdar, A
   Khrapko, K
   Flynn, JM
   Saleem, A
   De Lisio, M
   Johnston, APW
   Kratysberg, Y
   Samjoo, IA
   Kitaoka, Y
   Ogborn, DI
   Little, JP
   Raha, S
   Parise, G
   Akhtar, M
   Hettinga, BP
   Rowe, GC
   Arany, Z
   Prolla, TA
   Tarnopolsky, MA
AF Safdar, Adeel
   Khrapko, Konstantin
   Flynn, James M.
   Saleem, Ayesha
   De Lisio, Michael
   Johnston, Adam P. W.
   Kratysberg, Yevgenya
   Samjoo, Imtiaz A.
   Kitaoka, Yu
   Ogborn, Daniel I.
   Little, Jonathan P.
   Raha, Sandeep
   Parise, Gianni
   Akhtar, Mahmood
   Hettinga, Bart P.
   Rowe, Glenn C.
   Arany, Zoltan
   Prolla, Tomas A.
   Tarnopolsky, Mark A.
TI RETRACTED: Exercise-induced mitochondrial p53 repairs mtDNA mutations in mutator mice (Retracted Article)
SO SKELETAL MUSCLE
LA English
DT Article; Retracted Publication
DE Skeletal muscle; Satellite cells; Endurance exercise; p53; Mitochondrial DNA mutations; Mutator mouse; Oxidative stress; Telomere; Apoptosis; Senescence
ID endurance exercise; telomere length; physical-activity; oxidative stress; skeletal-muscle; dna mutations; pcr; association; mortality; catalase
AB Background: Human genetic disorders and transgenic mouse models have shown that mitochondrial DNA (mtDNA) mutations and telomere dysfunction instigate the aging process. Epidemiologically, exercise is associated with greater life expectancy and reduced risk of chronic diseases. While the beneficial effects of exercise are well established, the molecular mechanisms instigating these observations remain unclear. Results: Endurance exercise reduces mtDNA mutation burden, alleviates multisystem pathology, and increases lifespan of the mutator mice, with proofreading deficient mitochondrial polymerase gamma (POLG1). We report evidence for a POLG1-independent mtDNA repair pathway mediated by exercise, a surprising notion as POLG1 is canonically considered to be the sole mtDNA repair enzyme. Here, we show that the tumor suppressor protein p53 translocates to mitochondria and facilitates mtDNA mutation repair and mitochondrial biogenesis in response to endurance exercise. Indeed, in mutator mice with muscle-specific deletion of p53, exercise failed to prevent mtDNA mutations, induce mitochondrial biogenesis, preserve mitochondrial morphology, reverse sarcopenia, or mitigate premature mortality. Conclusions: Our data establish a new role for p53 in exercise-mediated maintenance of the mtDNA genome and present mitochondrially targeted p53 as a novel therapeutic modality for diseases of mitochondrial etiology.
C1 [Safdar, Adeel; Saleem, Ayesha; Kitaoka, Yu; Raha, Sandeep; Hettinga, Bart P.; Tarnopolsky, Mark A.] McMaster Univ, Dept Pediat, Hamilton, ON L8N 3Z5, Canada.
   [Safdar, Adeel; Tarnopolsky, Mark A.] McMaster Univ, Dept Med, Hamilton, ON L8N 3Z5, Canada.
   [Safdar, Adeel; De Lisio, Michael; Johnston, Adam P. W.; Parise, Gianni] McMaster Univ, Dept Kinesiol, Hamilton, ON L8N 3Z5, Canada.
   [Samjoo, Imtiaz A.] McMaster Univ, Dept Med Sci, Hamilton, ON L8N 3Z5, Canada.
   [Parise, Gianni] McMaster Univ, Dept Med Phys & Appl Radiat Sci, Hamilton, ON L8N 3Z5, Canada.
   [Khrapko, Konstantin; Kratysberg, Yevgenya] Northeastern Univ, Boston, MA 02115 USA.
   [Flynn, James M.] Buck Inst Res Aging, Novato, CA 94945 USA.
   [Little, Jonathan P.] Univ British Columbia Okanagan, Sch Hlth & Exercise Sci, Kelowna, BC V1V 1V7, Canada.
   [Rowe, Glenn C.] Univ Alabama Birmingham, Div Cardiovasc Dis, Birmingham, AL 35294 USA.
   [Arany, Zoltan] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.
   [Prolla, Tomas A.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA.
   [Prolla, Tomas A.] Univ Wisconsin, Dept Med Genet, Madison, WI 53706 USA.
C3 McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; Northeastern University; Buck Institute for Research on Aging; University of British Columbia; University of British Columbia Okanagan; University of Alabama System; University of Alabama Birmingham; University of Pennsylvania; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison
RP Tarnopolsky, MA (corresponding author), McMaster Univ, Dept Pediat, Hamilton, ON L8N 3Z5, Canada.; Tarnopolsky, MA (corresponding author), McMaster Univ, Dept Med, Hamilton, ON L8N 3Z5, Canada.
EM tarnopol@mcmaster.ca
FU Canadian Institutes of Health Research (CIHR); CIHR; American Federation for Aging Research; Ellison Medical Foundation (EMF); Natural Sciences and Engineering Research Council of Canada; United Mitochondrial Disease Foundation; NIH [AG019787]; EMF
CR Achanta G, 2005, EMBO J, V24, P3482, DOI 10.1038/sj.emboj.7600819
   Arany Z, 2006, P NATL ACAD SCI USA, V103, P10086, DOI 10.1073/pnas.0603615103
   Atzmon G, 2010, P NATL ACAD SCI USA, V107, P1710, DOI 10.1073/pnas.0906191106
   Bakhanashvili M, 2008, CELL DEATH DIFFER, V15, P1865, DOI 10.1038/cdd.2008.122
   Buchner DM, 2009, CLIN GERIATR MED, V25, P661, DOI 10.1016/j.cger.2009.08.002
   Callicott RJ, 2006, COMPARATIVE MED, V56, P17
   Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7
   Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, P0, DOI 10.1093/nar/30.10.e47
   Chakravarty EF, 2008, ARCH INTERN MED, V168, P1638, DOI 10.1001/archinte.168.15.1638
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Dai DF, 2010, AGING CELL, V9, P536, DOI 10.1111/j.1474-9726.2010.00581.x
   Elly L, 2009, METHOD ENZYMOL, V456, P169, DOI 10.1016/S0076-6879(08)04409-1
   Ema H, 2005, CURR PROTOC IMMUNOL, V0, P0
   HIGUCHI M, 1985, J GERONTOL, V40, P281, DOI 10.1093/geronj/40.3.281
   HOLLOSZY JO, 1976, ANNU REV PHYSIOL, V38, P273, DOI 10.1146/annurev.ph.38.030176.001421
   JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6
   Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873
   Kraytsberg Y, 2005, EXPERT REV MOL DIAGN, V5, P809, DOI 10.1586/14737159.5.5.809
   Kucej M, 2008, J CELL SCI, V121, P1861, DOI 10.1242/jcs.028605
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Logan A, 2014, AGING CELL, V13, P765, DOI 10.1111/acel.12212
   Parise G, 2005, FREE RADICAL BIO MED, V39, P289, DOI 10.1016/j.freeradbiomed.2005.03.024
   Parise G, 2005, EXP GERONTOL, V40, P173, DOI 10.1016/j.exger.2004.09.002
   RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275
   Safdar A, 2011, J BIOL CHEM, V286, P10605, DOI 10.1074/jbc.M110.211466
   Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108
   Safdar A, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0010778
   Safdar A, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0005610
   Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787
   Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982
   Saleem A, 2013, J PHYSIOL-LONDON, V591, P3625, DOI 10.1113/jphysiol.2013.252791
   Salpea KD, 2010, ATHEROSCLEROSIS, V209, P42, DOI 10.1016/j.atherosclerosis.2009.09.070
   Sanz C, 2010, DIABETES METAB, V36, P346, DOI 10.1016/j.diabet.2010.06.001
   St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024
   Stessman J, 2009, ARCH INTERN MED, V169, P1476, DOI 10.1001/archinternmed.2009.248
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106
   Wolf SA, 2011, BRAIN BEHAV IMMUN, V0, P0
NR 43
TC 53
Z9 59
U1 0
U2 19
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2044-5040
EI 
J9 SKELET MUSCLE
JI Skeletal Muscle
PD JAN 31
PY 2016
VL 6
IS 
BP 
EP 
DI 10.1186/s13395-016-0075-9
PG 17
WC Cell Biology
SC Cell Biology
GA DC5BW
UT WOS:000369236600001
PM 26834962
DA 2024-11-01
ER

PT J
AU Leslie, N
   Wang, XJ
   Peng, YY
   Valencia, CA
   Khuchua, Z
   Hata, J
   Witte, D
   Huang, TS
   Bove, KE
AF Leslie, Nancy
   Wang, Xinjian
   Peng, Yanyan
   Valencia, C. Alexander
   Khuchua, Zaza
   Hata, Jessica
   Witte, David
   Huang, Taosheng
   Bove, Kevin E.
TI Neonatal multiorgan failure due to <i>ACAD9</i> mutation and complex I deficiency with mitochondrial hyperplasia in liver, cardiac myocytes, skeletal muscle, and renal tubules
SO HUMAN PATHOLOGY
LA English
DT Article
DE Mitochondriopathy; Complex I deficiency; ACAD9 defect; Lethal neonatal lactic acidosis; Multiorgan failure; Metabolic disease; Mitochondrial hyperplasia; Whole-exome sequencing
ID cardiomyopathy; expression; diagnosis; gene; dna
AB Complex I deficiency causes Leigh syndrome, fatal infant lactic acidosis, and neonatal cardiomyopathy. Mutations in more than 100 nuclear DNA and mitochondrial DNA genes miscode for complex I subunits or assembly factors. ACAD9 is an acyl-CoA dehydrogenase with a novel function in assembly of complex I; biallelic mutations cause progressive encephalomyopathy, recurrent Reye syndrome, and fatal cardiomyopathy. We describe the first autopsy in fatal neonatal lethal lactic acidosis due to mutations in ACAD9 that reduced complex I activity. We identified mitochondrial hyperplasia in cardiac myocytes, diaphragm muscle, and liver and renal tubules in formalin-fixed, paraffin-embedded tissue using immunohistochemistry for mitochondrial antigens. Whole-exome sequencing revealed compound heterozygous variants in the ACAD9 gene: c.187G>T (p.E63*) and c.941T>C (p.L314P). The nonsense mutation causes late infantile lethality; the missense variant is novel. Autopsy-derived fibroblasts had reduced complex I activity (53% of control) with normal activity in complexes II to IV, similar to reported cases of ACAD9 deficiency. (C) 2015 Elsevier Inc. All rights reserved.
C1 Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA.
   Cincinnati Childrens Hosp Med Ctr, Div Gastroenterol, Cincinnati, OH 45229 USA.
   [Bove, Kevin E.] Cincinnati Childrens Hosp Med Ctr, Div Pathol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.
C3 Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center
RP Bove, KE (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Pathol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.
EM kevin.bove@uc.edu
CR Fassone E, 2012, J MED GENET, V49, P578, DOI 10.1136/jmedgenet-2012-101159
   Fellman V, 2011, SEMIN FETAL NEONAT M, V16, P222, DOI 10.1016/j.siny.2011.05.002
   Goetzman ES, 2007, MOL GENET METAB, V91, P138, DOI 10.1016/j.ymgme.2007.01.013
   Goldstein JD, 1999, PEDIATR DEVEL PATHOL, V2, P78, DOI 10.1007/s100249900094
   Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846
   Li L, 2011, INVEST OPHTH VIS SCI, V52, P8393, DOI 10.1167/iovs.11-8139
   Mandel H, 2001, HEPATOLOGY, V34, P776, DOI 10.1053/jhep.2001.27664
   McClean Patricia, 2003, SEMIN NEONATOL, V8, P393, DOI 10.1016/S1084-2756(03)00095-2
   MULLERHOCKER J, 1991, VIRCHOWS ARCH A, V419, P355, DOI 10.1007/BF01606527
   Nouws J, 2010, CELL METAB, V12, P283, DOI 10.1016/j.cmet.2010.08.002
   Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0
   Schiff M, 2015, HUM MOL GENET, V24, P3238, DOI 10.1093/hmg/ddv074
   Simon M, 2015, PLOS GENET, V11, P0, DOI 10.1371/journal.pgen.1005097
   Tang S, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0004492
   Vilarinho S, 2014, J HEPATOL, V61, P1056, DOI 10.1016/j.jhep.2014.06.038
   Wong LJC, 2007, HEPATOLOGY, V46, P1218, DOI 10.1002/hep.21799
   Zhang CK, 2012, FASEB J, V26, P4914, DOI 10.1096/fj.12-206532
NR 17
TC 25
Z9 25
U1 0
U2 8
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0046-8177
EI 1532-8392
J9 HUM PATHOL
JI Hum. Pathol.
PD MAR 15
PY 2016
VL 49
IS 
BP 27
EP 32
DI 10.1016/j.humpath.2015.09.039
PG 6
WC Pathology
SC Pathology
GA DC8LC
UT WOS:000369470100005
PM 26826406
DA 2024-11-01
ER

PT J
AU Vincent, AE
   Ng, YS
   White, K
   Davey, T
   Mannella, C
   Falkous, G
   Feeney, C
   Schaefer, AM
   McFarland, R
   Gorman, GS
   Taylor, RW
   Turnbull, DM
   Picard, M
AF Vincent, Amy E.
   Ng, Yi Shiau
   White, Kathryn
   Davey, Tracey
   Mannella, Carmen
   Falkous, Gavin
   Feeney, Catherine
   Schaefer, Andrew M.
   McFarland, Robert
   Gorman, Grainne S.
   Taylor, Robert W.
   Turnbull, Doug M.
   Picard, Martin
TI The Spectrum of Mitochondrial Ultrastructural Defects in Mitochondrial Myopathy
SO SCIENTIFIC REPORTS
LA English
DT Article
ID progressive external ophthalmoplegia; skeletal-muscle; inner-membrane; atp synthase; respiratory-chain; cristae; morphology; topology; protein; inclusions
AB Mitochondrial functions are intrinsically linked to their morphology and membrane ultrastructure. Characterizing abnormal mitochondrial structural features may thus provide insight into the underlying pathogenesis of inherited and acquired mitochondrial diseases. Following a systematic literature review on ultrastructural defects in mitochondrial myopathy, we investigated skeletal muscle biopsies from seven subjects with genetically defined mtDNA mutations. Mitochondrial ultrastructure and morphology were characterized using two complimentary approaches: transmission electron microscopy (TEM) and serial block face scanning EM (SBF-SEM) with 3D reconstruction. Six ultrastructural abnormalities were identified including i) paracrystalline inclusions, ii) linearization of cristae and abnormal angular features, iii) concentric layering of cristae membranes, iv) matrix compartmentalization, v) nanotunelling, and vi) donut-shaped mitochondria. In light of recent molecular advances in mitochondrial biology, these findings reveal novel aspects of mitochondrial ultrastructure and morphology in human tissues with implications for understanding the mechanisms linking mitochondrial dysfunction to disease.
C1 [Vincent, Amy E.; Ng, Yi Shiau; Falkous, Gavin; Feeney, Catherine; Schaefer, Andrew M.; McFarland, Robert; Gorman, Grainne S.; Taylor, Robert W.; Turnbull, Doug M.] Newcastle Univ, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [White, Kathryn; Davey, Tracey] Newcastle Univ, EM Res Serv, Newcastle Upon Tyne, Tyne & Wear, England.
   [Mannella, Carmen] New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA.
   [Picard, Martin] Columbia Univ, Dept Psychiat, Div Behav Med, Med Ctr, New York, NY 10027 USA.
   [Picard, Martin] Columbia Univ, Dept Neurol, H Houston Merritt Ctr, Med Ctr, New York, NY 10027 USA.
   [Picard, Martin] Columbia Univ, Med Ctr, H Houston Merritt Ctr, Columbia Translat Neurosci Initiat, New York, NY 10027 USA.
C3 Newcastle University - UK; Newcastle University - UK; Wadsworth Center; State University of New York (SUNY) System; Columbia University; Columbia University; Columbia University
RP Picard, M (corresponding author), Columbia Univ, Dept Psychiat, Div Behav Med, Med Ctr, New York, NY 10027 USA.; Picard, M (corresponding author), Columbia Univ, Dept Neurol, H Houston Merritt Ctr, Med Ctr, New York, NY 10027 USA.; Picard, M (corresponding author), Columbia Univ, Med Ctr, H Houston Merritt Ctr, Columbia Translat Neurosci Initiat, New York, NY 10027 USA.
EM mp3484@columbia.edu
FU Biotechnology and Biological Sciences Research Council [BB/M012093/1]; Engineering and Physical Sciences Research Council; Economic and Social Research Council; Medical Research Council [G0700718]; Wellcome Trust Centre [G906919]; UK NIHR Biomedical Research Centre; MRC studentship as part of the MRC Centre [MR/K501074/1, MR/K000608/1]; BBSRC [BB/M012093/1] Funding Source: UKRI; MRC [MR/K000608/1, G0800674, MC_G0802536, G0700718, MR/L016354/1] Funding Source: UKRI
CR Ahmad T, 2013, CELL DEATH DIS, V4, P0, DOI 10.1038/cddis.2012.213
   AMCHENKOVA AA, 1988, J CELL BIOL, V107, P481, DOI 10.1083/jcb.107.2.481
   Barbot M, 2015, CELL METAB, V21, P756, DOI 10.1016/j.cmet.2015.04.006
   Bhandari P, 2014, CIRC RES, V114, P257, DOI 10.1161/CIRCRESAHA.114.302734
   Chae S, 2013, SCI SIGNAL, V6, P0, DOI 10.1126/scisignal.2003266
   CHANCE B, 1956, ADV ENZYMOL REL S BI, V17, P65
   Cogliati S, 2016, TRENDS BIOCH SCI, V0, P0
   Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032
   Daum B, 2013, P NATL ACAD SCI USA, V110, P15301, DOI 10.1073/pnas.1305462110
   De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230
   Deerinck TJ, 2010, MICROSCOPY, V1, P6
   Domènech O, 2007, BBA-BIOMEMBRANES, V1768, P100, DOI 10.1016/j.bbamem.2006.06.012
   Dudkina NV, 2005, FEBS LETT, V579, P5769, DOI 10.1016/j.febslet.2005.09.065
   Eisner V, 2014, J CELL BIOL, V205, P179, DOI 10.1083/jcb.201312066
   EPPENBERGEREBERHARDT M, 1991, J CELL BIOL, V113, P289, DOI 10.1083/jcb.113.2.289
   Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095
   Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025
   Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985
   Fujioka H, 2013, MICROSC RES TECHNIQ, V76, P237, DOI 10.1002/jemt.22158
   HAMMERSEN F, 1980, ACTA NEUROPATHOL, V49, P35, DOI 10.1007/BF00692217
   Hara Y, 2014, P NATL ACAD SCI USA, V111, P486, DOI 10.1073/pnas.1311310110
   Huang XH, 2013, P NATL ACAD SCI USA, V110, P2846, DOI 10.1073/pnas.1300741110
   HULSMANN WC, 1967, J NEUROL NEUROSUR PS, V30, P519, DOI 10.1136/jnnp.30.6.519
   Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199
   John GB, 2005, MOL BIOL CELL, V16, P1543, DOI 10.1091/mbc.E04-08-0697
   Kanazawa T, 2008, PLOS GENET, V4, P0, DOI 10.1371/journal.pgen.1000022
   Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185
   Leduc-Gaudet JP, 2015, ONCOTARGET, V6, P17923, DOI 10.18632/oncotarget.4235
   Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009
   Liu X, 2011, CELL DEATH DIFFER, V18, P1561, DOI 10.1038/cdd.2011.13
   Logan CV, 2014, NAT GENET, V46, P188, DOI 10.1038/ng.2851
   Mannella CA, 2006, BBA-MOL BASIS DIS, V1762, P140, DOI 10.1016/j.bbadis.2005.07.001
   Mannella CA, 2013, J MOL CELL CARDIOL, V62, P51, DOI 10.1016/j.yjmcc.2013.05.001
   Mears JA, 2011, NAT STRUCT MOL BIOL, V18, P20, DOI 10.1038/nsmb.1949
   Meimaridou E, 2012, NAT GENET, V44, P740, DOI 10.1038/ng.2299
   Melberg A, 1996, MUSCLE NERVE, V19, P751
   MITCHELL P, 1966, BIOL REV, V41, P445, DOI 10.1111/j.1469-185X.1966.tb01501.x
   MITSUMOTO H, 1983, NEUROLOGY, V33, P452, DOI 10.1212/WNL.33.4.452
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221
   PAYNE CM, 1975, J NEUROL SCI, V25, P99, DOI 10.1016/0022-510X(75)90190-2
   Pernas L, 2016, ANNU REV PHYSIOL, V78, P505, DOI 10.1146/annurev-physiol-021115-105011
   Pfanner N, 2014, J CELL BIOL, V204, P1083, DOI 10.1083/jcb.201401006
   Phan Minh D, 2015, BIOPHYS J, V108, P1977
   Picard M, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms7259
   Picard M, 2014, P NATL ACAD SCI USA, V111, PE4033, DOI 10.1073/pnas.1414028111
   Picard M, 2013, J APPL PHYSIOL, V114, P161, DOI 10.1152/japplphysiol.01096.2012
   Picard M, 2012, BIOESSAYS, V34, P272, DOI 10.1002/bies.201100179
   PRICE HM, 1967, J NEUROPATH EXP NEUR, V26, P475, DOI 10.1097/00005072-196707000-00009
   Rabl R, 2009, J CELL BIOL, V185, P1047, DOI 10.1083/jcb.200811099
   Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025
   Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512
   Shutt TE, 2013, BBA-MOL CELL RES, V1833, P417, DOI 10.1016/j.bbamcr.2012.05.024
   Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Tesson C, 2012, AM J HUM GENET, V91, P1051, DOI 10.1016/j.ajhg.2012.11.001
   van der Laan M, 2012, TRENDS CELL BIOL, V22, P185, DOI 10.1016/j.tcb.2012.01.004
   VANWIJNGAARDEN GK, 1967, BRAIN, V90, P577, DOI 10.1093/brain/90.3.577
   Varanita T, 2015, CELL METAB, V21, P834, DOI 10.1016/j.cmet.2015.05.007
   Wang C, 2015, CELL RES, V25, P1108, DOI 10.1038/cr.2015.89
   Weber TA, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0063683
   Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780
   Zick M, 2009, BBA-MOL CELL RES, V1793, P5, DOI 10.1016/j.bbamcr.2008.06.013
NR 63
TC 154
Z9 166
U1 1
U2 35
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
EI 
J9 SCI REP-UK
JI Sci Rep
PD AUG 10
PY 2016
VL 6
IS 
BP 
EP 
DI 10.1038/srep30610
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DS9RN
UT WOS:000381121100001
PM 27506553
DA 2024-11-01
ER

PT J
AU Marín-García, J
AF Marin-Garcia, Jose
TI Mitochondrial DNA repair: a novel therapeutic target for heart failure
SO HEART FAILURE REVIEWS
LA English
DT Article
DE CVD; HF; mtDNA repair; POL gamma; TFAM; Twinkle
ID base-excision-repair; progressive external ophthalmoplegia; mtdna copy number; strand break repair; oxidative stress; transcription-factor; gene-expression; human-cells; mammalian mitochondria; dilated cardiomyopathy
AB Mitochondria play a crucial role in a variety of cellular processes ranging from energy metabolism, generation of reactive oxygen species (ROS) and Ca2+ handling to stress responses, cell survival and death. Malfunction of the organelle may contribute to the pathogenesis of neuromuscular, cancer, premature aging and cardiovascular diseases (CVD), including myocardial ischemia, cardiomyopathy and heart failure (HF). Mitochondria contain their own genome organized into DNAprotein complexes, called "mitochondrial nucleoids," along with multiprotein machineries, which promote mitochondrial DNA (mtDNA) replication, transcription and repair. Although the mammalian organelle possesses almost all known nuclear DNA repair pathways, including base excision repair, mismatch repair and recombinational repair, the proximity of mtDNA to the main sites of ROS production and the lack of protective histones may result in increased susceptibility to various types of mtDNA damage. These include accumulation of mtDNA point mutations and/or deletions and decreased mtDNA copy number, which will impair mitochondrial function and finally, may lead to CVD including HF.
C1 [Marin-Garcia, Jose] Mol Cardiol & Neuromuscular Inst, 75 Raritan Ave, Highland Pk, NJ 08904 USA.
RP Marín-García, J (corresponding author), Mol Cardiol & Neuromuscular Inst, 75 Raritan Ave, Highland Pk, NJ 08904 USA.
EM tmci@att.net
CR Akbari M, 2008, DNA REPAIR, V7, P605, DOI 10.1016/j.dnarep.2008.01.002
   Alam TI, 2003, NUCLEIC ACIDS RES, V31, P1640, DOI 10.1093/nar/gkg251
   Alexeyev M, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a012641
   Almeida KH, 2007, DNA REPAIR, V6, P695, DOI 10.1016/j.dnarep.2007.01.009
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   Antozzi C, 1997, CARDIOVASC RES, V35, P184, DOI 10.1016/S0008-6363(97)00141-7
   Bacman SR, 2009, NUCLEIC ACIDS RES, V37, P4218, DOI 10.1093/nar/gkp348
   BANDY B, 1990, FREE RADICAL BIO MED, V8, P523, DOI 10.1016/0891-5849(90)90152-9
   Bogenhagen DF, 2012, BBA-GENE REGUL MECH, V1819, P914, DOI 10.1016/j.bbagrm.2011.11.005
   Bohr VA, 2002, FREE RADICAL BIO MED, V32, P804, DOI 10.1016/S0891-5849(02)00787-6
   Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380
   Chen PL, 2013, ONCOGENE, V32, P1193, DOI 10.1038/onc.2012.120
   Chen XJ, 2013, MICROBIOL MOL BIOL R, V77, P476, DOI 10.1128/MMBR.00007-13
   Cline SD, 2012, BBA-GENE REGUL MECH, V1819, P979, DOI 10.1016/j.bbagrm.2012.06.002
   Cohen BH, 2010, METHODS, V51, P364, DOI 10.1016/j.ymeth.2010.05.008
   Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev
   Copeland WC, 2014, DNA REPAIR, V19, P190, DOI 10.1016/j.dnarep.2014.03.010
   Croteau DL, 2012, AGING CELL, V11, P456, DOI 10.1111/j.1474-9726.2012.00803.x
   De S, 2012, J CELL SCI, V125, P2509, DOI 10.1242/jcs.101501
   Dizdaroglu M, 2005, MUTAT RES-FUND MOL M, V591, P45, DOI 10.1016/j.mrfmmm.2005.01.033
   Dodson ML, 2002, FREE RADICAL BIO MED, V32, P678, DOI 10.1016/S0891-5849(02)00767-0
   Druzhyna NM, 2008, MECH AGEING DEV, V129, P383, DOI 10.1016/j.mad.2008.03.002
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820
   FISHER RP, 1988, MOL CELL BIOL, V8, P3496, DOI 10.1128/MCB.8.8.3496
   Frahm T, 2005, MECH AGEING DEV, V126, P1192, DOI 10.1016/j.mad.2005.06.008
   Furda AM, 2012, DNA REPAIR, V11, P684, DOI 10.1016/j.dnarep.2012.06.002
   Garcia CCM, 2010, CHEM RES TOXICOL, V23, P1245, DOI 10.1021/tx1001018
   Garnier A, 2009, CIRC-HEART FAIL, V2, P342, DOI 10.1161/CIRCHEARTFAILURE.108.812099
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226
   Hansson A, 2004, P NATL ACAD SCI USA, V101, P3136, DOI 10.1073/pnas.0308710100
   Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8
   Hensen F, 2014, BIOCHIMIE, V100, P219, DOI 10.1016/j.biochi.2013.09.017
   Holmlund T, 2009, BBA-MOL BASIS DIS, V1792, P132, DOI 10.1016/j.bbadis.2008.11.009
   Huffman JL, 2005, MUTAT RES-FUND MOL M, V577, P55, DOI 10.1016/j.mrfmmm.2005.03.012
   Hunter SE, 2010, METHODS, V51, P444, DOI 10.1016/j.ymeth.2010.01.033
   Ikeuchi M, 2005, CIRCULATION, V112, P683, DOI 10.1161/CIRCULATIONAHA.104.524835
   Kajander OA, 2001, EMBO REP, V2, P1007, DOI 10.1093/embo-reports/kve233
   Karamanlidis G, 2010, CIRC RES, V106, P1541, DOI 10.1161/CIRCRESAHA.109.212753
   Kasiviswanathan R, 2012, BBA-GENE REGUL MECH, V1819, P970, DOI 10.1016/j.bbagrm.2011.12.005
   Kazak L, 2012, NAT REV MOL CELL BIO, V13, P659, DOI 10.1038/nrm3439
   Khambatta S, 2014, INT J GEN MED, V7, P325, DOI 10.2147/IJGM.S65560
   Khidr L, 2008, J BIOL CHEM, V283, P27064, DOI 10.1074/jbc.M802991200
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Kucej M, 2007, TRENDS CELL BIOL, V17, P586, DOI 10.1016/j.tcb.2007.08.007
   LEcuyer T, 2006, AM J PHYSIOL-HEART C, V291, PH1273, DOI 10.1152/ajpheart.00738.2005
   Larsen NB, 2005, MITOCHONDRION, V5, P89, DOI 10.1016/j.mito.2005.02.002
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Lebrecht D, 2007, CARDIOVASC TOXICOL, V7, P108, DOI 10.1007/s12012-007-0009-1
   LeDoux SP, 1999, MUTAT RES-DNA REPAIR, V434, P149, DOI 10.1016/S0921-8777(99)00026-9
   Lewis W, 2003, AM J PHYSIOL-HEART C, V284, PH1, DOI 10.1152/ajpheart.00814.2002
   Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523
   Li H, 2000, P NATL ACAD SCI USA, V97, P3467, DOI 10.1073/pnas.97.7.3467
   Liu P, 2008, MOL CELL BIOL, V28, P4975, DOI 10.1128/MCB.00457-08
   Liu PF, 2010, ENVIRON MOL MUTAGEN, V51, P417, DOI 10.1002/em.20576
   Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200
   Maniura-Weber K, 2004, NUCLEIC ACIDS RES, V32, P6015, DOI 10.1093/nar/gkh921
   Marin-Garcia J, 2001, CARDIOVASC RES, V49, P17, DOI 10.1016/S0008-6363(00)00241-8
   MarinGarcia J, 1997, J INHERIT METAB DIS, V20, P674, DOI 10.1023/A:1005322409330
   McKinney EA, 2013, GENET MOL BIOL, V36, P308, DOI 10.1590/s1415-47572013000300002
   McKinnon PJ, 2007, ANNU REV GENOM HUM G, V8, P37, DOI 10.1146/annurev.genom.7.080505.115648
   Milenkovic D, 2013, HUM MOL GENET, V22, P1983, DOI 10.1093/hmg/ddt051
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, P0, DOI 10.1093/nar/gng060
   Mott JL, 2001, MUTAT RES-FUND MOL M, V474, P35, DOI 10.1016/S0027-5107(00)00159-7
   Nakamura J, 1999, CANCER RES, V59, P2522
   Olivero OA, 1997, MUTAT RES-GEN TOX EN, V391, P79, DOI 10.1016/S0165-1218(97)00037-2
   Pascucci B, 1997, J MOL BIOL, V273, P417, DOI 10.1006/jmbi.1997.1268
   Pohjoismäki JLO, 2013, P NATL ACAD SCI USA, V110, P19408, DOI 10.1073/pnas.1303046110
   Pohjoismäki JLO, 2011, BIOESSAYS, V33, P290, DOI 10.1002/bies.201000137
   Pohjoismäki JLO, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0010426
   Pohjoismäki JLO, 2009, J BIOL CHEM, V284, P21446, DOI 10.1074/jbc.M109.016600
   ROBERTS NK, 1979, AM J CARDIOL, V44, P1396, DOI 10.1016/0002-9149(79)90459-4
   Sebastiani M, 2007, J AM COLL CARDIOL, V50, P1362, DOI 10.1016/j.jacc.2007.06.035
   Sen D, 2012, J BIOL CHEM, V287, P14545, DOI 10.1074/jbc.M111.309468
   Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2539, DOI 10.1093/nar/gkp100
   SINGER TP, 1990, FEBS LETT, V274, P1, DOI 10.1016/0014-5793(90)81315-F
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spelbrink JN, 2010, IUBMB LIFE, V62, P19, DOI 10.1002/iub.282
   Stuart JA, 2006, BBA-BIOENERGETICS, V1757, P79, DOI 10.1016/j.bbabio.2006.01.003
   Stumpf JD, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a011395
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   Svilar D, 2011, ANTIOXID REDOX SIGN, V14, P2491, DOI 10.1089/ars.2010.3466
   Sykora P, 2012, MECH AGEING DEV, V133, P169, DOI 10.1016/j.mad.2011.11.003
   Szczesny B, 2008, J BIOL CHEM, V283, P26349, DOI 10.1074/jbc.M803491200
   Tanaka A, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0061540
   Tann AW, 2011, J BIOL CHEM, V286, P31975, DOI 10.1074/jbc.M110.215715
   Thorslund T, 2002, DNA REPAIR, V1, P261, DOI 10.1016/S1568-7864(02)00003-4
   Thyagarajan B, 1996, J BIOL CHEM, V271, P27536, DOI 10.1074/jbc.271.44.27536
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365
   Wang JX, 2011, AM J PHYSIOL-HEART C, V301, PH2073, DOI 10.1152/ajpheart.00157.2011
   Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089
   Wang JM, 2001, P NATL ACAD SCI USA, V98, P4038, DOI 10.1073/pnas.061038798
   Wanrooij S, 2010, BBA-BIOENERGETICS, V1797, P1378, DOI 10.1016/j.bbabio.2010.04.015
   Williams SL, 2010, CELL METAB, V12, P675, DOI 10.1016/j.cmet.2010.11.012
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Yin HY, 2011, CHEM REV, V111, P5944, DOI 10.1021/cr200084z
   Zhang D, 2005, AM J PHYSIOL-HEART C, V288, PH2476, DOI 10.1152/ajpheart.00670.2004
   Zhang D, 2003, CARDIOVASC RES, V57, P147, DOI 10.1016/S0008-6363(02)00695-8
   Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024
NR 103
TC 32
Z9 34
U1 1
U2 11
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1382-4147
EI 1573-7322
J9 HEART FAIL REV
JI Heart Fail. Rev.
PD SEP 15
PY 2016
VL 21
IS 5
BP 475
EP 487
DI 10.1007/s10741-016-9543-x
PG 13
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EB2YG
UT WOS:000387227900002
PM 26940911
DA 2024-11-01
ER

PT J
AU Winter, L
   Wittig, I
   Peeva, V
   Eggers, B
   Heidler, J
   Chevessier, F
   Kley, RA
   Barkovits, K
   Strecker, V
   Berwanger, C
   Herrmann, H
   Marcus, K
   Kornblum, C
   Kunz, WS
   Schröder, R
   Clemen, CS
AF Winter, Lilli
   Wittig, Ilka
   Peeva, Viktoriya
   Eggers, Britta
   Heidler, Juliana
   Chevessier, Frederic
   Kley, Rudolf A.
   Barkovits, Katalin
   Strecker, Valentina
   Berwanger, Carolin
   Herrmann, Harald
   Marcus, Katrin
   Kornblum, Cornelia
   Kunz, Wolfram S.
   Schroeder, Rolf
   Clemen, Christoph S.
TI Mutant desmin substantially perturbs mitochondrial morphology, function and maintenance in skeletal muscle tissue
SO ACTA NEUROPATHOLOGICA
LA English
DT Article
DE Desminopathy; R350P desmin; R349P desmin knock-in; Desmin knock-out; Intermediate filament; Myofibrillar myopathy; Protein aggregate myopathy; Mitochondria; Proteome; mtDNA
ID epidermolysis-bullosa simplex; blue native electrophoresis; mice lacking desmin; muscular-dystrophy; complex-i; neurodegenerative diseases; oxidative-phosphorylation; protein complexes; myofibrillar myopathy; intermediate-filaments
AB Secondary mitochondrial dysfunction is a feature in a wide variety of human protein aggregate diseases caused by mutations in different proteins, both in the central nervous system and in striated muscle. The functional relationship between the expression of a mutated protein and mitochondrial dysfunction is largely unknown. In particular, the mechanism how this dysfunction drives the disease process is still elusive. To address this issue for protein aggregate myopathies, we performed a comprehensive, multi-level analysis of mitochondrial pathology in skeletal muscles of human patients with mutations in the intermediate filament protein desmin and in muscles of hetero- and homozygous knock-in mice carrying the R349P desmin mutation. We demonstrate that the expression of mutant desmin causes disruption of the extrasarcomeric desmin cytoskeleton and extensive mitochondrial abnormalities regarding subcellular distribution, number and shape. At the molecular level, we uncovered changes in the abundancy and assembly of the respiratory chain complexes and supercomplexes. In addition, we revealed a marked reduction of mtDNA- and nuclear DNA-encoded mitochondrial proteins in parallel with large-scale deletions in mtDNA and reduced mtDNA copy numbers. Hence, our data demonstrate that the expression of mutant desmin causes multi-level damage of mitochondria already in early stages of desminopathies.
C1 [Winter, Lilli; Chevessier, Frederic; Herrmann, Harald; Schroeder, Rolf] Univ Hosp Erlangen, Inst Neuropathol, Schwabachanlage 6, D-91054 Erlangen, Germany.
   [Wittig, Ilka; Heidler, Juliana; Strecker, Valentina] Goethe Univ Frankfurt, Sch Med, Core Unit SFB815, Funct Prote, D-60590 Frankfurt, Germany.
   [Wittig, Ilka] Partner Site RheinMain, German Ctr Cardiovasc Res DZHK, Frankfurt, Germany.
   [Peeva, Viktoriya; Kunz, Wolfram S.] Univ Hosp Bonn, Life & Brain Ctr, D-53127 Bonn, Germany.
   [Peeva, Viktoriya; Kunz, Wolfram S.] Univ Hosp Bonn, Dept Epileptol, D-53105 Bonn, Germany.
   [Eggers, Britta; Barkovits, Katalin; Marcus, Katrin] Ruhr Univ Bochum, Fac Med, Med Proteom Ctr, D-44801 Bochum, Germany.
   [Kley, Rudolf A.] Ruhr Univ Bochum, Univ Hosp Bergmannsheil, Dept Neurol, D-44789 Bochum, Germany.
   [Berwanger, Carolin; Clemen, Christoph S.] Univ Cologne, Inst Biochem 1, Fac Med, Ctr Biochem, Joseph Stelzmann Str 52, D-50931 Cologne, Germany.
   [Kornblum, Cornelia] Univ Hosp Bonn, Dept Neurol, D-53105 Bonn, Germany.
   [Kornblum, Cornelia] Univ Hosp Bonn, Ctr Rare Dis Bonn ZSEB, D-53105 Bonn, Germany.
C3 University of Erlangen Nuremberg; Goethe University Frankfurt; German Centre for Cardiovascular Research; University of Bonn; University of Bonn; Ruhr University Bochum; Ruhr University Bochum; University of Cologne; University of Bonn; University of Bonn
RP Schröder, R (corresponding author), Univ Hosp Erlangen, Inst Neuropathol, Schwabachanlage 6, D-91054 Erlangen, Germany.; Clemen, CS (corresponding author), Univ Cologne, Inst Biochem 1, Fac Med, Ctr Biochem, Joseph Stelzmann Str 52, D-50931 Cologne, Germany.
EM rolf.schroeder@uk-erlangen.de; christoph.clemen@uni-koeln.de
FU German Research Foundation (DFG) [SFB815, Z01, KU 911/21-1]; BMBF funded German Network for Mitochondrial Disorders [01GM1113B]; BONFOR; Faculty of Medicine, University of Bonn; P.U.R.E.; Protein Unit for Research in Europe, North Rhine-Westphalia; DFG within the framework of the multilocation research group [SCHR 562/13-1, FOR1228, CL 381/7-1]; German muscular dystrophy network [MD-NET2]; Deutsche Gesellschaft fur Muskelkranke e.V. (DGM)
CR Acín-Pérez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8
   [Anonymous], 2013, MUSCLE BIOPSY PRACTI, V0, P0
   Arbustini E, 1998, J AM COLL CARDIOL, V31, P645, DOI 10.1016/S0735-1097(98)00026-6
   Bär H, 2005, HUM MOL GENET, V14, P1251, DOI 10.1093/hmg/ddi136
   Bhat AH, 2015, BIOMED PHARMACOTHER, V74, P101, DOI 10.1016/j.biopha.2015.07.025
   Burté F, 2015, NAT REV NEUROL, V11, P11, DOI 10.1038/nrneurol.2014.228
   Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797
   Carmignac V, 2009, NEUROMUSCULAR DISORD, V19, P600, DOI 10.1016/j.nmd.2009.06.179
   Carrozzo R, 2006, ANN NEUROL, V59, P265, DOI 10.1002/ana.20729
   Cetin N, 2013, J MED GENET, V50, P437, DOI 10.1136/jmedgenet-2012-101487
   Chen J, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep11438
   Chevessier F, 2015, HUM MOL GENET, V24, P7207, DOI 10.1093/hmg/ddv421
   Chopard A, 2000, ELECTROPHORESIS, V21, P517, DOI 10.1002/(SICI)1522-2683(20000201)21:3<517::AID-ELPS517>3.0.CO;2-9
   Clemen CS, 2015, ACTA NEUROPATHOL, V129, P297, DOI 10.1007/s00401-014-1363-2
   Clemen CS, 2013, ACTA NEUROPATHOL, V125, P47, DOI 10.1007/s00401-012-1057-6
   Clemen CS, 2009, HUM MUTAT, V30, PE490, DOI 10.1002/humu.20941
   Corona JC, 2015, J BIOENERG BIOMEMBR, V47, P89, DOI 10.1007/s10863-014-9576-6
   Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591
   Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511
   Dahl R, 2015, ACTA PHYSIOL, V213, P145, DOI 10.1111/apha.12289
   Diaz F, 2006, MOL CELL BIOL, V26, P4872, DOI 10.1128/MCB.01767-05
   Durmus H, 2016, NEUROLOGY IN PRESS, V0, P0
   Fidzianska A, 2005, NEUROMUSCULAR DISORD, V15, P525, DOI 10.1016/j.nmd.2005.05.006
   Fountoulakis M, 2005, J MOL CELL CARDIOL, V38, P461, DOI 10.1016/j.yjmcc.2004.12.008
   Francis BM, 2014, J ALZHEIMERS DIS, V39, P347, DOI 10.3233/JAD-131499
   Genova ML, 2014, BBA-BIOENERGETICS, V1837, P427, DOI 10.1016/j.bbabio.2013.11.002
   Glancy B, 2015, NATURE, V523, P617, DOI 10.1038/nature14614
   Goldfarb LG, 1998, NAT GENET, V19, P402, DOI 10.1038/1300
   Heidler J, 2013, METHODS MOL BIOL, V1033, P363, DOI 10.1007/978-1-62703-487-6_23
   Henderson M, 2013, ACTA NEUROPATHOL, V125, P917, DOI 10.1007/s00401-013-1113-x
   Hong D, 2011, NEUROPATH APPL NEURO, V37, P257, DOI 10.1111/j.1365-2990.2010.01112.x
   Jackson S, 2015, EUR J NEUROL, V22, P1429, DOI 10.1111/ene.12814
   Joshi PR, 2014, CLIN NEUROPATHOL, V33, P134, DOI 10.5414/NP300693
   Katsetos CD, 2013, SEMIN PEDIATR NEUROL, V20, P202, DOI 10.1016/j.spen.2013.10.010
   Keogh MJ, 2015, BBA-BIOENERGETICS, V1847, P1401, DOI 10.1016/j.bbabio.2015.05.015
   Kley RA, 2007, BRAIN, V130, P3250, DOI 10.1093/brain/awm271
   Kostareva A, 2008, J MUSCLE RES CELL M, V29, P25, DOI 10.1007/s10974-008-9139-8
   KUNZ WS, 1993, BIOCHIM BIOPHYS ACTA, V1144, P46, DOI 10.1016/0005-2728(93)90029-F
   LI ZL, 1989, GENE, V78, P243
   Li ZL, 1996, DEV BIOL, V175, P362, DOI 10.1006/dbio.1996.0122
   Li ZL, 1997, J CELL BIOL, V139, P129, DOI 10.1083/jcb.139.1.129
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   Lindén M, 2001, J BIOENERG BIOMEMBR, V33, P333, DOI 10.1023/A:1010611408007
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Luan XH, 2010, NEUROMUSCULAR DISORD, V20, P390, DOI 10.1016/j.nmd.2010.03.009
   Maerkens A, 2016, ACTA NEUROPATHOL COM, V4, P0, DOI 10.1186/s40478-016-0280-0
   Malfatti E, 2013, J NEUROPATH EXP NEUR, V72, P833, DOI 10.1097/NEN.0b013e3182a23506
   Maranzana E, 2013, ANTIOXID REDOX SIGN, V19, P1469, DOI 10.1089/ars.2012.4845
   McCormick EM, 2015, FRONT GENET, V6, P0, DOI 10.3389/fgene.2015.00199
   McLaughlin HM, 2013, BMC MED GENET, V14, P0, DOI 10.1186/1471-2350-14-68
   Mena NP, 2015, MITOCHONDRION, V21, P92, DOI 10.1016/j.mito.2015.02.001
   Meng FJ, 2011, MOL NEURODEGENER, V6, P0, DOI 10.1186/1750-1326-6-34
   Milner DJ, 1996, J CELL BIOL, V134, P1255, DOI 10.1083/jcb.134.5.1255
   Milner DJ, 2000, J CELL BIOL, V150, P1283, DOI 10.1083/jcb.150.6.1283
   Muñoz-Mármol AM, 1998, P NATL ACAD SCI USA, V95, P11312, DOI 10.1073/pnas.95.19.11312
   Nardin RA, 2001, MUSCLE NERVE, V24, P170, DOI 10.1002/1097-4598(200102)24:2<170::AID-MUS30>3.0.CO;2-0
   Nübel E, 2009, PROTEOMICS, V9, P2408, DOI 10.1002/pmic.200800632
   Olivé M, 2005, BRAIN, V128, P2315, DOI 10.1093/brain/awh576
   Piñol-Ripoll G, 2009, NEUROMUSCULAR DISORD, V19, P418, DOI 10.1016/j.nmd.2009.04.004
   Pinto M, 2014, BBA-MOL BASIS DIS, V1842, P1198, DOI 10.1016/j.bbadis.2013.11.012
   Prior KK, 2016, J BIOL CHEM, V291, P7045, DOI 10.1074/jbc.M115.710772
   Reipert S, 1999, EXP CELL RES, V252, P479, DOI 10.1006/excr.1999.4626
   Rezniczek GA, 2007, J CELL BIOL, V176, P965, DOI 10.1083/jcb.200604179
   Schägger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777
   Schröder R, 2003, HUM MOL GENET, V12, P657, DOI 10.1093/hmg/ddg060
   Schröder R, 2002, J NEUROPATH EXP NEUR, V61, P520, DOI 10.1093/jnen/61.6.520
   Schröder R, 2007, HUM MOL GENET, V16, P2989, DOI 10.1093/hmg/ddm269
   Schröder R, 2013, ACTA NEUROPATHOL, V125, P1, DOI 10.1007/s00401-012-1071-8
   Stockburger C, 2014, J ALZHEIMERS DIS, V42, P395, DOI 10.3233/JAD-140381
   Strecker V, 2010, PROTEOMICS, V10, P3379, DOI 10.1002/pmic.201000343
   Su B, 2010, BBA-MOL BASIS DIS, V1802, P135, DOI 10.1016/j.bbadis.2009.09.013
   Thornell LE, 1997, J MOL CELL CARDIOL, V29, P2107, DOI 10.1006/jmcc.1997.0446
   Uszkoreit J, 2015, J PROTEOME RES, V14, P2988, DOI 10.1021/acs.jproteome.5b00121
   Vernengo L, 2010, NEUROMUSCULAR DISORD, V20, P178, DOI 10.1016/j.nmd.2010.01.001
   Winter L, 2016, ACTA NEUROPATHOL COM, V4, P0, DOI 10.1186/s40478-016-0314-7
   Winter L, 2015, HUM MOL GENET, V24, P4530, DOI 10.1093/hmg/ddv184
   Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200
   Wittig I, 2006, BBA-BIOENERGETICS, V1757, P1066, DOI 10.1016/j.bbabio.2006.05.006
   Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62
   Zerbetto E, 1997, ELECTROPHORESIS, V18, P2059, DOI 10.1002/elps.1150181131
   Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047
   Zsurka G, 2008, J NEUROPATH EXP NEUR, V67, P857, DOI 10.1097/NEN.0b013e3181839b2d
NR 82
TC 53
Z9 56
U1 0
U2 10
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0001-6322
EI 1432-0533
J9 ACTA NEUROPATHOL
JI Acta Neuropathol.
PD SEP 15
PY 2016
VL 132
IS 3
BP 453
EP 473
DI 10.1007/s00401-016-1592-7
PG 21
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA DU2AA
UT WOS:000382011300008
PM 27393313
DA 2024-11-01
ER

PT J
AU Hsu, YHR
   Yogasundaram, H
   Parajuli, N
   Valtuille, L
   Sergi, C
   Oudit, GY
AF Hsu, Ying-Han R.
   Yogasundaram, Haran
   Parajuli, Nirmal
   Valtuille, Lucas
   Sergi, Consolato
   Oudit, Gavin Y.
TI MELAS syndrome and cardiomyopathy: linking mitochondrial function to heart failure pathogenesis
SO HEART FAILURE REVIEWS
LA English
DT Article
DE Cardiomyopathy; Mitochondria; MELAS syndrome; HF
ID kearns-sayre-syndrome; stroke-like episodes; progressive external ophthalmoplegia; greater-than-g; clinical-features; lactic-acidosis; cardiac involvement; energy-metabolism; a3243g mutation; dna mutation
AB Heart failure remains an important clinical burden, and mitochondrial dysfunction plays a key role in its pathogenesis. The heart has a high metabolic demand, and mitochondrial function is a key determinant of myocardial performance. In mitochondrial disorders, hypertrophic remodeling is the early pattern of cardiomyopathy with progression to dilated cardiomyopathy, conduction defects and ventricular pre-excitation occurring in a significant proportion of patients. Cardiac dysfunction occurs in approximately a third of patients with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) syndrome, a stereotypical example of a mitochondrial disorder leading to a cardiomyopathy. We performed unique comparative ultrastructural and gene expression in a MELAS heart compared with non-failing controls. Our results showed a remarkable increase in mitochondrial inclusions and increased abnormal mitochondria in MELAS cardiomyopathy coupled with variable sarcomere thickening, heterogeneous distribution of affected cardiomyocytes and a greater elevation in the expression of disease markers. Investigation and management of patients with mitochondrial cardiomyopathy should follow the well-described contemporary heart failure clinical practice guidelines and include an important role of medical and device therapies. Directed metabolic therapy is lacking, but current research strategies are dedicated toward improving mitochondrial function in patients with mitochondrial disorders.
C1 [Hsu, Ying-Han R.; Sergi, Consolato] Univ Alberta, Dept Lab Med & Pathol, Mazankowski Alberta Heart Inst, Edmonton, AB, Canada.
   [Yogasundaram, Haran; Parajuli, Nirmal; Valtuille, Lucas; Oudit, Gavin Y.] Univ Alberta, Mazankowski Alberta Heart Inst, Dept Med, Div Cardiol, Edmonton, AB T6G 2B7, Canada.
C3 University of Alberta; University of Alberta
RP Oudit, GY (corresponding author), Univ Alberta, Mazankowski Alberta Heart Inst, Dept Med, Div Cardiol, 8440 112 St NW, Edmonton, AB T6G 2B7, Canada.
EM gavin.oudit@ualberta.ca
FU Heart and Stroke Foundation (HSF); Canadian Institutes of Health Research (CIHR); Alberta Innovates-Health Solutions (AIHS)
CR Ahuja P, 2013, CIRCULATION, V127, P1957, DOI 10.1161/CIRCULATIONAHA.112.001219
   Ahuja P, 2010, J CLIN INVEST, V120, P1494, DOI 10.1172/JCI38331
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Arany Z, 2006, P NATL ACAD SCI USA, V103, P10086, DOI 10.1073/pnas.0603615103
   ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cb.04.110188.001445
   Bates MGD, 2012, EUR HEART J, V33, P3023, DOI 10.1093/eurheartj/ehs275
   BOGOUSSLAVSKY J, 1982, J NEUROL SCI, V55, P351, DOI 10.1016/0022-510X(82)90132-0
   Bohlega S, 1996, NEUROLOGY, V46, P1329, DOI 10.1212/WNL.46.5.1329
   Bonnet D, 2001, HEART, V86, P570, DOI 10.1136/heart.86.5.570
   Brown DT, 2006, LANCET, V368, P87, DOI 10.1016/S0140-6736(06)68972-1
   Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423
   Chin J, 2014, MITOCHONDRION, V17, P34, DOI 10.1016/j.mito.2014.05.005
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   de Lonlay P, 2001, NAT GENET, V29, P57, DOI 10.1038/ng706
   DiMauro S, 2002, ADV NEUROL, V89, P217
   Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Fayssoil Abdallah, 2009, CONGEST HEART FAIL, V15, P284, DOI 10.1111/j.1751-7133.2009.00108.x
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013
   Finsterer J, 2014, INT J CARDIOL, V177, P754, DOI 10.1016/j.ijcard.2014.11.014
   FUJII T, 1991, J NEUROL SCI, V103, P37, DOI 10.1016/0022-510X(91)90280-K
   Gallagher D, 1998, AM J PHYSIOL-ENDOC M, V275, PE249, DOI 10.1152/ajpendo.1998.275.2.E249
   Guillausseau PJ, 2001, ANN INTERN MED, V134, P721, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00008
   Gunter TE, 2000, CELL CALCIUM, V28, P285, DOI 10.1054/ceca.2000.0168
   HAMAZAKI S, 1989, ACTA PATHOL JAPON, V39, P599
   Herrmann G, 1939, ANN INTERN MED, V12, P1233, DOI 10.7326/0003-4819-12-8-1233
   Hirano M, 2001, SEMIN CELL DEV BIOL, V12, P417, DOI 10.1006/scdb.2001.0279
   Huss JM, 2005, J CLIN INVEST, V115, P547, DOI 10.1172/JCI200524405
   Ichikawa Y, 2014, J CLIN INVEST, V124, P617, DOI 10.1172/JCI72931
   ISHIKAWA Y, 1995, PATHOL RES PRACT, V191, P64, DOI 10.1016/S0344-0338(11)80927-1
   Katayama Y, 2009, MITOCHONDRION, V9, P306, DOI 10.1016/j.mito.2009.04.002
   Khambatta S, 2014, INT J GEN MED, V7, P325, DOI 10.2147/IJGM.S65560
   Koeppen AH, 2011, J NEUROL SCI, V303, P1, DOI 10.1016/j.jns.2011.01.010
   Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478
   Lagedrost SJ, 2011, AM HEART J, V161, P639, DOI 10.1016/j.ahj.2010.10.038
   Laloi-Michelin M, 2006, DIABETES METAB, V32, P182, DOI 10.1016/S1262-3636(07)70267-7
   LEWIS W, 1995, NAT MED, V1, P417, DOI 10.1038/nm0595-417
   LINZBACH AJ, 1960, AM J CARDIOL, V5, P370, DOI 10.1016/0002-9149(60)90084-9
   Lodi R, 2001, CARDIOVASC RES, V52, P111, DOI 10.1016/S0008-6363(01)00357-1
   Lorenzoni PJ, 2011, MITOCHONDRION, V11, P528, DOI 10.1016/j.mito.2011.01.003
   Maassen JA, 2006, ENDOCRIN METAB CLIN, V35, P385, DOI 10.1016/j.ecl.2006.02.014
   Majamaa-Voltti Kirsi, 2002, BMC CARDIOVASC DISORD, V2, P12
   Malfatti E, 2013, NEUROLOGY, V80, P100, DOI 10.1212/WNL.0b013e31827b1a2f
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   Marín-García J, 2008, HEART FAIL REV, V13, P137, DOI 10.1007/s10741-007-9079-1
   Meyers DE, 2013, TEX HEART I J, V40, P385
   Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140
   Milone M, 2010, NEUROLOGIST, V16, P84, DOI 10.1097/NRL.0b013e3181c78a89
   Mori J, 2013, J MOL CELL CARDIOL, V63, P98, DOI 10.1016/j.yjmcc.2013.07.010
   MULLERHOCKER J, 1993, ARCH PATHOL LAB MED, V117, P202
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Murphy R, 2008, DIABETIC MED, V25, P383, DOI 10.1111/j.1464-5491.2008.02359.x
   Nakanishi M, 2007, CIRCULATION, V116, PE25, DOI 10.1161/CIRCULATIONAHA.107.691808
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052
   NISHIZAWA M, 1987, J NEUROL SCI, V78, P189, DOI 10.1016/0022-510X(87)90060-8
   Okajima Y, 1998, HEART, V80, P292, DOI 10.1136/hrt.80.3.292
   OLDFORS A, 1987, ACTA NEUROPATHOL, V74, P287, DOI 10.1007/BF00688194
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Pang CY, 2001, DIABETES RES CLIN PR, V54, PS45, DOI 10.1016/S0168-8227(01)00335-7
   Parkinson MH, 2013, J NEUROCHEM, V126, P103, DOI 10.1111/jnc.12317
   Pfeffer G, 2012, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD004426.pub3
   Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Reddy P, 2015, CELL, V161, P459, DOI 10.1016/j.cell.2015.03.051
   Ricci JE, 2003, J CELL BIOL, V160, P65, DOI 10.1083/jcb.200208089
   RIORDANEVA P, 1995, BRAIN, V118, P319, DOI 10.1093/brain/118.2.319
   ROBERTS NK, 1979, AM J CARDIOL, V44, P1396, DOI 10.1016/0002-9149(79)90459-4
   Rojo A, 2006, ACTA NEUROPATHOL, V111, P610, DOI 10.1007/s00401-006-0040-5
   Sanaker PS, 2007, ACTA NEUROL SCAND, V115, P64, DOI 10.1111/j.1600-0404.2007.00850.x
   Santorelli FM, 1997, NEUROLOGY, V49, P270, DOI 10.1212/WNL.49.1.270
   SATO W, 1994, AM HEART J, V128, P733, DOI 10.1016/0002-8703(94)90272-0
   Schmauss D, 2007, PEDIATR TRANSPLANT, V11, P560, DOI 10.1111/j.1399-3046.2007.00719.x
   Schwer B, 2008, CELL METAB, V7, P104, DOI 10.1016/j.cmet.2007.11.006
   Silvestri G, 1997, MUSCLE NERVE, V20, P221
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Sproule DM, 2007, ARCH NEUROL-CHICAGO, V64, P1625, DOI 10.1001/archneur.64.11.1625
   Stalder N, 2012, CIRC-HEART FAIL, V5, PE1, DOI 10.1161/CIRCHEARTFAILURE.111.963900
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
   Teodorescu C, 2010, CIRCULATION, V122, P2116, DOI 10.1161/CIRCULATIONAHA.110.966333
   Terauchi A, 1996, BRAIN DEV-JPN, V18, P224, DOI 10.1016/0387-7604(96)00015-0
   Tonska K, 2010, BBA-BIOENERGETICS, V1797, P1119, DOI 10.1016/j.bbabio.2010.02.032
   TRANCHANT C, 1993, NEUROMUSCULAR DISORD, V3, P561, DOI 10.1016/0960-8966(93)90116-2
   Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002
   Vardas PE, 2007, EUR HEART J, V28, P2256, DOI 10.1093/eurheartj/ehm305
   Wahbi K, 2010, NEUROLOGY, V74, P674, DOI 10.1212/WNL.0b013e3181d0ccf4
   Wahbi K, 2015, EUR HEART J, V36, P2886, DOI 10.1093/eurheartj/ehv307
   Weidemann F, 2012, CIRCULATION, V125, P1626, DOI 10.1161/CIRCULATIONAHA.111.059477
   WILLIAMS RS, 1995, CIRCULATION, V91, P1266, DOI 10.1161/01.CIR.91.4.1266
   Yancy CW, 2013, CIRCULATION, V128, P1810, DOI 10.1161/CIR.0b013e31829e8807
   Young TJ, 2005, PACE, V28, P454, DOI 10.1111/j.1540-8159.2005.40049.x
   Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492
NR 95
TC 38
Z9 46
U1 0
U2 10
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1382-4147
EI 1573-7322
J9 HEART FAIL REV
JI Heart Fail. Rev.
PD JAN 15
PY 2016
VL 21
IS 1
BP 103
EP 116
DI 10.1007/s10741-015-9524-5
PG 14
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DB0FH
UT WOS:000368183500008
PM 26712328
DA 2024-11-01
ER

PT J
AU Ben Rhouma, F
   Messai, H
   Hsouna, S
   Ben Halim, N
   Cherif, W
   Ben Fadhel, S
   Tiar, A
   Nagara, M
   Azzouz, H
   Sfar, MT
   Ben Dridi, MF
   Tebib, N
   Ayadi, A
   Abdelhak, S
   Kefi, R
AF Ben Rhouma, Faten
   Messai, Habib
   Hsouna, Sana
   Ben Halim, Nizar
   Cherif, Wafa
   Ben Fadhel, Sihem
   Tiar, Afaf
   Nagara, Majdi
   Azzouz, Hatem
   Sfar, Mohamed-Tahar
   Ben Dridi, Marie-Francoise
   Tebib, Neji
   Ayadi, Abdelkarim
   Abdelhak, Sonia
   Kefi, Rym
TI History of settlement of villages from Central Tunisia by studying families sharing a common founder Glycogenosis type III mutation
SO MITOCHONDRIAL DNA PART A
LA English
DT Article
DE Consanguinity; gene flow; haplotype; haplogroup; p.W1327X
ID high-resolution analysis; human mitochondrial-dna; disease type-iii; y-chromosome; north-africa; debranching enzyme; mtdna variation; ethnic-groups; diversity; gene
AB Glycogen storage disease type III (GSD III; Cori disease; Forbes disease) is an autosomal recessive inherited metabolic disorder resulting from deficient glycogen debrancher enzyme activity in liver and muscle. In this study, we focused on a single AGL gene mutation p.W1327X in 16 Tunisian patients from rural area surrounding the region of Mahdia in Central Tunisia. This constitutes the largest pool of patients with this mutation ever described. This study was performed to trace the history of the patients' ancestries in a single region. After extraction of genomic DNA, exon 31 of AGL gene was sequenced. The patients were investigated for the hypervariable segment 1 of mitochondrial DNA and 17 Y-STR markers. We found that the p.W1327X mutation was a founder mutation in Tunisia Analysis of maternal lineages shows an admixture of autochthonous North African, sub-Saharan and a predominance of Eurasian haplogroups. Heterogeneity of maternal haplogroups indicates an ancient settlement. However, paternal gene flow was highly homogeneous and originates from the Near East. We hypothesize that the p.W1327X mutation was introduced into the Tunisian population probably by a recent migration event; then the mutation was fixed in a small region due to the high rate of consanguineous marriages and genetic drift. The screening for this mutation should be performed in priority for GSD III molecular diagnosis, for patients from the region of Mahdia and those from regions sharing the same settlement history.
C1 [Ben Rhouma, Faten; Messai, Habib; Hsouna, Sana; Ben Halim, Nizar; Cherif, Wafa; Ben Fadhel, Sihem; Tiar, Afaf; Nagara, Majdi; Abdelhak, Sonia; Kefi, Rym] Inst Pasteur Tunis, Lab Genom Biomed & Oncogenet LR11IPT05, Tunis 1002, Belvedere, Tunisia.
   [Ben Rhouma, Faten; Messai, Habib; Hsouna, Sana; Ben Halim, Nizar; Cherif, Wafa; Ben Fadhel, Sihem; Tiar, Afaf; Nagara, Majdi; Abdelhak, Sonia; Kefi, Rym] Univ Tunis El Manar, Tunis, Tunisia.
   [Azzouz, Hatem; Ben Dridi, Marie-Francoise; Tebib, Neji] Hoop La Rabta Tunis, Dept Pediat, Unite Malad Metab Hereditaires, Tunis, Tunisia.
   [Azzouz, Hatem; Ben Dridi, Marie-Francoise; Tebib, Neji] Fac Med Tunis, Tunis, Tunisia.
   [Sfar, Mohamed-Tahar] Hop Tahar Sfar, Dept Pediat, Mahdia, Tunisia.
C3 Pasteur Network; Universite de Tunis-El-Manar; Institut Pasteur Tunis; Universite de Tunis-El-Manar; Universite de Tunis-El-Manar; Faculte de Medecine de Tunis (FMT); Universite de Monastir; Hopital Universitaire Tahar Sfar
RP Kefi, R (corresponding author), Pasteur Inst Tunis, Biomed Genom & Oncogenet Lab, BP74,13 Pl Pasteur, Tunis 1002, Belvedere, Tunisia.
EM rym.kefi@pasteur.rns.tn
FU Tunisian Ministry of Public Health; Ministry of Higher Education and Scientific Research
CR Al-Zahery N, 2003, MOL PHYLOGENET EVOL, V28, P458, DOI 10.1016/S1055-7903(03)00039-3
   Alonso S, 2005, EUR J HUM GENET, V13, P1293, DOI 10.1038/sj.ejhg.5201482
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   [Anonymous], 2005, J GENET GENEAL, V0, P0
   Arredi B, 2004, AM J HUM GENET, V75, P338, DOI 10.1086/423147
   Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036
   Ben Arab S, 2004, GENET EPIDEMIOL, V27, P74, DOI 10.1002/gepi.10321
   Ben Halim N, 2013, J COMMUN GENET, V4, P273, DOI 10.1007/s12687-012-0128-7
   Bosch E, 2001, AM J HUM GENET, V68, P1019, DOI 10.1086/319521
   Cadenas AM, 2008, EUR J HUM GENET, V16, P374, DOI 10.1038/sj.ejhg.5201934
   Cherni L, 2005, HUM BIOL, V77, P61, DOI 10.1353/hub.2005.0028
   Cherni L, 2005, FORENSIC SCI INT, V152, P95, DOI 10.1016/j.forsciint.2005.02.007
   Cherni L, 2005, FORENSIC SCI INT, V147, P101, DOI 10.1016/j.forsciint.2004.04.009
   Cherni L, 2009, AM J PHYS ANTHROPOL, V139, P253, DOI 10.1002/ajpa.20979
   Cruciani F, 2002, AM J HUM GENET, V70, P1197, DOI 10.1086/340257
   DIRIENZO A, 1991, P NATL ACAD SCI USA, V88, P1597, DOI 10.1073/pnas.88.5.1597
   El-Sibai M, 2009, ANN HUM GENET, V73, P568, DOI 10.1111/j.1469-1809.2009.00538.x
   Endo Y, 2005, J HUM GENET, V50, P538, DOI 10.1007/s10038-005-0291-3
   Ennafaa H, 2011, J HUM GENET, V56, P734, DOI 10.1038/jhg.2011.92
   Fadhlaoui-Zid K, 2004, ANN HUM GENET, V68, P222, DOI 10.1046/j.1529-8817.2004.00096.x
   Fadhlaoui-Zid K, 2011, AM J PHYS ANTHROPOL, V146, P271, DOI 10.1002/ajpa.21581
   Falchi A, 2006, J HUM GENET, V51, P9, DOI 10.1007/s10038-005-0324-y
   Hsouna S, 2014, MITOCHONDR DNA, V10, P1
   Kefi R, 2014, MITOCHONDRIAL DNA, V0, P0
   Kerkeni E, 2007, CROAT MED J, V48, P701
   Loueslati BY, 2006, AM J HUM BIOL, V18, P149, DOI 10.1002/ajhb.20473
   Mili A, 2012, J HUM GENET, V57, P170, DOI 10.1038/jhg.2011.122
   Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038
   Semino O, 2004, AM J HUM GENET, V74, P1023, DOI 10.1086/386295
   Shen JJ, 1996, J CLIN INVEST, V98, P352, DOI 10.1172/JCI118799
   YANG BZ, 1992, J BIOL CHEM, V267, P9294
   Zalloua PA, 2008, AM J HUM GENET, V83, P633, DOI 10.1016/j.ajhg.2008.10.012
   Zalloua PA, 2008, AM J HUM GENET, V82, P873, DOI 10.1016/j.ajhg.2008.01.020
NR 33
TC 2
Z9 2
U1 0
U2 1
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2470-1394
EI 2470-1408
J9 MITOCHONDRIAL DNA A
JI Mitochondrial DNA Part A
PD JUN 15
PY 2016
VL 27
IS 5
BP 3194
EP 3198
DI 10.3109/19401736.2015.1007331
PG 5
WC Genetics & Heredity
SC Genetics & Heredity
GA DO7IU
UT WOS:000377956700057
PM 26704523
DA 2024-11-01
ER

PT J
AU Thompson, K
   Majd, H
   Dallabona, C
   Reinson, K
   King, MS
   Alston, CL
   He, LP
   Lodi, T
   Jones, SA
   Fattal-Valevski, A
   Fraenkel, ND
   Saada, A
   Haham, A
   Isohanni, P
   Vara, R
   Barbosa, IA
   Simpson, MA
   Deshpande, C
   Puusepp, S
   Bonnen, PE
   Rodenburg, RJ
   Suomalainen, A
   Ounap, K
   Elpeleg, O
   Ferrero, I
   McFarland, R
   Kunji, ERS
   Taylor, RW
AF Thompson, Kyle
   Majd, Homa
   Dallabona, Christina
   Reinson, Karit
   King, Martin S.
   Alston, Charlotte L.
   He, Langping
   Lodi, Tiziana
   Jones, Simon A.
   Fattal-Valevski, Aviva
   Fraenkel, Nitay D.
   Saada, Ann
   Haham, Alon
   Isohanni, Pirjo
   Vara, Roshni
   Barbosa, Ines A.
   Simpson, Michael A.
   Deshpande, Charu
   Puusepp, Sanna
   Bonnen, Penelope E.
   Rodenburg, Richard J.
   Suomalainen, Anu
   Ounap, Katrin
   Elpeleg, Orly
   Ferrero, Ileana
   McFarland, Robert
   Kunji, Edmund R. S.
   Taylor, Robert W.
TI Recurrent De Novo Dominant Mutations in <i>SLC2SA4</i> Cause Severe Early-Onset Mitochondrial Disease and Loss of Mitochondrial DNA Copy Number
SO AMERICAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
ID adenine-nucleotide translocator; adp/atp carrier; respiratory-chain; functional-characterization; external ophthalmoplegia; saccharomyces-cerevisiae; bacterial expression; gene mutation; in-vivo; transport
AB Mutations in SLC25A4 encoding the mitochondrial ADP/ATP carrier AAC1 are well-recognized causes of mitochondrial disease. Several heterozygous SLC25A4 mutations cause adult-onset autosomal-dominant progressive external ophthalmoplegia associated with multiple mitochondrial DNA deletions, whereas recessive SLC25A4 mutations cause childhood-onset mitochondrial myopathy and cardiomyopathy. Here, we describe the identification by whole-exome sequencing of seven probands harboring dominant, de novo SLC25A4 mutations. All affected individuals presented at birth, were ventilator dependent and, where tested, revealed severe combined mitochondria' respiratory chain deficiencies associated with a marked loss of mitochondria' DNA copy number in skeletal muscle. Strikingly, an identical c.239G>A (p.Arg80His) mutation was present in four of the seven subjects, and the other three case subjects harbored the same c.703C>G (p.Arg235Gly) mutation. Analysis of skeletal muscle revealed a marked decrease of AAC1 protein levels and loss of respiratory chain complexes containing mitochondria' DNA-encoded subunits. We show that both recombinant AAC1 mutant proteins are severely impaired in ADP/ATP transport, affecting most likely the substrate binding and mechanics of the carrier, respectively. This highly reduced capacity for transport probably affects mitochondria' DNA maintenance and in turn respiration, causing a severe energy crisis. The confirmation of the pathogenicity of these de novo SLC25A4 mutations highlights a third distinct clinical phenotype associated with mutation of this gene and demonstrates that early-onset mitochondria' disease can be caused by recurrent de novo mutations, which has significant implications for the application and analysis of whole-exome sequencing data in mitochondrial disease.
C1 [Thompson, Kyle; Alston, Charlotte L.; He, Langping; McFarland, Robert; Taylor, Robert W.] Newcastle Univ, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Majd, Homa; King, Martin S.; Kunji, Edmund R. S.] MRC, Mitochondrial Biol Unit, Cambridge Biomed Campus,Wellcome Trust MRC Bldg, Cambridge CB2 0XY, England.
   [Dallabona, Christina; Lodi, Tiziana; Ferrero, Ileana] Univ Parma, Dept Life Sci, Parco Area Sci 11A, I-43124 Parma, Italy.
   [Reinson, Karit; Puusepp, Sanna; Ounap, Katrin] Univ Tartu, Dept Pediat, Inst Clin Med, EE-51014 Tartu, Estonia.
   [Reinson, Karit; Puusepp, Sanna; Ounap, Katrin] Tartu Univ Hosp, Dept Genet, United Labs, EE-51014 Tartu, Estonia.
   [Jones, Simon A.] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Ctr Genom Med, St Marys Hosp, Oxford Rd, Manchester M13 9WL, Lancs, England.
   [Fattal-Valevski, Aviva] Tel Aviv Univ, Sackler Fac Med, Paediat Neurol Unit, Dana Children Hosp,Tel Aviv Sourasky Med Ctr, IL-64239 Tel Aviv, Israel.
   [Fraenkel, Nitay D.] Alyn Hosp, Dept Resp Rehabil, IL-91090 Jerusalem, Israel.
   [Saada, Ann] Hadassah Hebrew Univ, Med Ctr, Metab Lab Dept Genet & Metab Dis, IL-91120 Jerusalem, Israel.
   [Haham, Alon] Lis Matern Hosp, Tel Aviv Sourasky Med Ctr, Neonatal Intens Care Unit, IL-64239 Tel Aviv, Israel.
   [Isohanni, Pirjo; Suomalainen, Anu] Univ Helsinki, Biomedicum Helsinki, Mol Neurol, Res Programs Unit, FIN-00290 Helsinki, Finland.
   [Isohanni, Pirjo] Helsinki Univ Hosp, Childrens Hosp, Dept Pediat Neurol, Helsinki 00290, Finland.
   [Isohanni, Pirjo; Suomalainen, Anu] Univ Helsinki, FIN-00290 Helsinki, Finland.
   [Vara, Roshni] Evelina Childrens Hosp, Dept Paediat Inherited Metab Dis, London SE1 7EH, England.
   [Barbosa, Ines A.; Simpson, Michael A.] Kings Coll London, Sch Med, Div Genet & Mol Med, London SE1 9RY, England.
   [Deshpande, Charu] Guys & St Thomas NHS Fdn Trust, Clin Genet Unit, London SE1 9RT, England.
   [Bonnen, Penelope E.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
   [Rodenburg, Richard J.] Radboud Univ Nijmegen, Med Ctr, Translat Metab Lab, Radboud Ctr Mitochondrial Med,Dept Paediat, NL-6525 GA Nijmegen, Netherlands.
   [Suomalainen, Anu] Helsinki Univ Hosp, Dept Neurosci, Helsinki, Finland.
   [Elpeleg, Orly] Hadassah Hebrew Univ, Med Ctr, Monique & Jacques Roboh Dept Genet Res, IL-91120 Jerusalem, Israel.
C3 Newcastle University - UK; University of Parma; University of Tartu; University of Manchester; Tel Aviv University; Tel Aviv Sourasky Medical Center; Hebrew University of Jerusalem; ALYN Hospital; Hebrew University of Jerusalem; Hadassah University Medical Center; Tel Aviv University; Tel Aviv Sourasky Medical Center; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Baylor College of Medicine; Radboud University Nijmegen; University of Helsinki; Helsinki University Central Hospital; Hebrew University of Jerusalem; Hadassah University Medical Center
RP Taylor, RW (corresponding author), Newcastle Univ, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM robert.taylor@ncl.ac.uk
FU Wellcome Trust [096919/Z/11/Z]; MRC Centre for Neuromuscular Diseases [G0601943]; Lily Foundation; UK NHS Highly Specialised "Rare Mitochondrial Disorders of Adults and Children" Service in Newcastle upon Tyne; NIHR/CSO Healthcare Science Research Fellowship from the National Institute for Health Research [NIHR-HCS-D12-03-04]; Department of Health via the NIHR comprehensive Biomedical Research Centre award to Guy's and St. Thomas' NHS Foundation Trust in partnership with the King's College London; Medical Research Council UK [MC_U105663139]; Fondazione Telethon (Italy) [GGP15041]; Estonian Science Foundation [8175, PUT355]; Jane and Aatos Erkko Foundation; Sigrid Juselius Foundation; Academy of Finland; Helsinki University Hospital Funds; National Institute of Neurological Disorders and Stroke of the National Institutes of Health [R01NS083726]; MRC [MC_U105663139] Funding Source: UKRI
CR Adzhubei Ivan, 2013, CURR PROTOC HUM GENET, VChapter 7, P0, DOI 10.1002/0471142905.hg0720s76
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Bamber L, 2007, P NATL ACAD SCI USA, V104, P10830, DOI 10.1073/pnas.0703969104
   Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1
   Baruffini E, 2010, METHODS, V51, P426, DOI 10.1016/j.ymeth.2010.02.023
   BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609
   Carroll CJ, 2013, J MED GENET, V50, P151, DOI 10.1136/jmedgenet-2012-101375
   Clémençon B, 2013, MOL ASPECTS MED, V34, P485, DOI 10.1016/j.mam.2012.05.006
   COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0
   Crichton PG, 2013, J BIOL CHEM, V288, P22163, DOI 10.1074/jbc.M113.484329
   deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996
   Deschauer M, 2005, NEUROMUSCULAR DISORD, V15, P311, DOI 10.1016/j.nmd.2004.12.004
   Dolce V, 2005, FEBS LETT, V579, P633, DOI 10.1016/j.febslet.2004.12.034
   Echaniz-Laguna A, 2012, J MED GENET, V49, P146, DOI 10.1136/jmedgenet-2011-100504
   Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820
   Fiermonte G, 2004, J BIOL CHEM, V279, P30722, DOI 10.1074/jbc.M400445200
   Fischer-Zirnsak B, 2015, AM J HUM GENET, V97, P483, DOI 10.1016/j.ajhg.2015.08.001
   Fontanesi F, 2004, HUM MOL GENET, V13, P923, DOI 10.1093/hmg/ddh108
   Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13
   Goffrini P, 2009, HUM MOL GENET, V18, P1860, DOI 10.1093/hmg/ddp102
   Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226
   Hashimoto M, 1999, BBA-BIOENERGETICS, V1409, P113, DOI 10.1016/S0005-2728(98)00155-8
   HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2
   IEEE, 2013, 2013 IEEE INT, V0, P0, DOI DOI 10.1155/2013/146860
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kearney JA, 2006, PEDIATR NEUROL, V34, P116, DOI 10.1016/j.pediatrneurol.2005.07.009
   King MS, 2016, BBA-BIOENERGETICS, V1857, P14, DOI 10.1016/j.bbabio.2015.09.013
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892
   Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011
   Komaki H, 2002, ANN NEUROL, V51, P645, DOI 10.1002/ana.10172
   Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396
   Körver-Keularts IMLW, 2015, JIMD REP, V22, P39, DOI 10.1007/8904_2015_409
   Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86
   Kunji ERS, 2006, BBA-BIOENERGETICS, V1757, P1237, DOI 10.1016/j.bbabio.2006.03.021
   Kunji ERS, 2016, BBA-MOL CELL RES, V1863, P2379, DOI 10.1016/j.bbamcr.2016.03.015
   Kunji ERS, 2010, BBA-BIOENERGETICS, V1797, P817, DOI 10.1016/j.bbabio.2010.03.023
   Kunji ERS, 2005, CURR OPIN BIOTECH, V16, P546, DOI 10.1016/j.copbio.2005.08.006
   Kunji ERS, 2004, FEBS LETT, V564, P239, DOI 10.1016/S0014-5793(04)00242-X
   Kunji ERS, 2003, J BIOL CHEM, V278, P36985, DOI 10.1074/jbc.C300304200
   LI K, 1989, J BIOL CHEM, V264, P13998
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   Liu YX, 2015, MOL BIOL CELL, V26, P1985, DOI 10.1091/mbc.E15-01-0030
   MAJANDER A, 1995, J NEUROL SCI, V134, P95, DOI 10.1016/0022-510X(95)00225-5
   Mandel H, 2016, J MED GENET, V0, P0
   Mifsud J, 2013, MOL MEMBR BIOL, V30, P160, DOI 10.3109/09687688.2012.745175
   Muona M, 2015, NAT GENET, V47, P39, DOI 10.1038/ng.3144
   Napoli L, 2001, NEUROLOGY, V57, P2295, DOI 10.1212/WNL.57.12.2295
   Nelson DR, 1998, J MOL BIOL, V277, P285, DOI 10.1006/jmbi.1997.1594
   Neveling K, 2013, HUM MUTAT, V34, P1721, DOI 10.1002/humu.22450
   Palmieri F, 2014, J INHERIT METAB DIS, V37, P565, DOI 10.1007/s10545-014-9708-5
   Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341
   Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056
   Robinson AJ, 2006, P NATL ACAD SCI USA, V103, P2617, DOI 10.1073/pnas.0509994103
   Robinson AJ, 2008, P NATL ACAD SCI USA, V105, P17766, DOI 10.1073/pnas.0809580105
   Rodenburg RJT, 2011, J INHERIT METAB DIS, V34, P283, DOI 10.1007/s10545-010-9081-y
   Ruprecht JJ, 2014, P NATL ACAD SCI USA, V111, PE426, DOI 10.1073/pnas.1320692111
   SARASTE M, 1982, FEBS LETT, V144, P250, DOI 10.1016/0014-5793(82)80648-0
   Schuurs-Hoeijmakers JHM, 2012, AM J HUM GENET, V91, P1122, DOI 10.1016/j.ajhg.2012.10.013
   Siciliano G, 2003, NEUROMUSCULAR DISORD, V13, P162, DOI 10.1016/S0960-8966(02)00221-3
   Simpson MA, 2011, NAT GENET, V43, P303, DOI 10.1038/ng.779
   Strauss KA, 2013, P NATL ACAD SCI USA, V110, P3453, DOI 10.1073/pnas.1300690110
   Sulonen AM, 2011, GENOME BIOL, V12, P0, DOI 10.1186/gb-2011-12-9-r94
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Tavtigian SV, 2006, J MED GENET, V43, P295, DOI 10.1136/jmg.2005.033878
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Thangaratnarajah C, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms6491
   THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9
   Wagnon JL, 2015, FRONT NEUROL, V6, P0, DOI 10.3389/fneur.2015.00104
   Wortmann SB, 2015, J INHERIT METAB DIS, V38, P437, DOI 10.1007/s10545-015-9823-y
NR 70
TC 88
Z9 91
U1 0
U2 5
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0002-9297
EI 1537-6605
J9 AM J HUM GENET
JI Am. J. Hum. Genet.
PD OCT 6
PY 2016
VL 99
IS 4
BP 860
EP 876
DI 10.1016/j.ajhg.2016.08.014
PG 17
WC Genetics & Heredity
SC Genetics & Heredity
GA DY7UB
UT WOS:000385333700006
PM 27693233
DA 2024-11-01
ER

PT J
AU Kaur, SJ
   McKeown, SR
   Rashid, S
AF Kaur, Simran J.
   McKeown, Stephanie R.
   Rashid, Shazia
TI Mutant SOD1 mediated pathogenesis of Amyotrophic Lateral Sclerosis
SO GENE
LA English
DT Review
DE Amyotrophic lateral sclerosis; SOD1; Neurodegeneration; Familial ALS; Mutations
ID superoxide-dismutase; oxidative stress; axonal-transport; motor-neurons; familial als; mutations; epidemiology; aggregation; diagnosis; toxicity
AB Amyotrophic lateral sclerosis (ALS) is a neural disorder that causes death of the motor neurons in the brain and spinal cord; this affects the voluntary muscles and gradually leads to paralysis of the whole body. Most ALS cases are sporadic, though about 5-10% are familial. ALS is caused by multiple factors including mutation in any one of a number of specific genes, one of the most frequently affected is superoxide dismutase (SOD) 1. Alterations in SOD 1 have been linked with several variants of familial ALS. SOD 1 is a powerful antioxidant enzyme that protects cells from the damaging effects of superoxide radicals. The enzyme binds both copper and zinc ions that are directly involved in the deactivation of toxic superoxide radicals. Mutated SOD1 gene can acquire both gain and loss of function mutations. The most commonly identified mutations in SOD1 that affect protein activity are D90A, A4V and G93A. Deleterious mutations have been shown to modify SOD1 activity, which leads to the accumulation of highly toxic hydroxyl radicals. Accumulation of these free radicals causes degradation of both nuclear and mitochondrial DNA and protein misfolding, features which can be used as pathological indicators associated with ALS. Numerous clinical trials have been carried out over last few years with limited success. In some patients advanced techniques like gene and stem cell therapy have been trialed. However no definitive treatment option can provide a cure and currently ALS is managed by drugs and other supportive therapies. Consequently there is a need to identify new approaches for treatment of this ultimately fatal disease. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Kaur, Simran J.; Rashid, Shazia] Amity Univ, Noida 201303, India.
   [McKeown, Stephanie R.] Univ Ulster, Coleraine BT52 1SA, Londonderry, North Ireland.
C3 Amity University Noida; Ulster University
RP Rashid, S (corresponding author), Amity Univ, Noida 201303, India.
EM simran.arora0905@gmail.com; sr.mckeown@ulster.ac.uk; srashid@amity.edu
CR Allen S, 2003, J BIOL CHEM, V278, P6371, DOI 10.1074/jbc.M209915200
   Andersen PM, 2006, CURR NEUROL NEUROSCI, V6, P37, DOI 10.1007/s11910-996-0008-9
   Arnesano F, 2004, J BIOL CHEM, V279, P47998, DOI 10.1074/jbc.M406021200
   Barber SC, 2010, FREE RADICAL BIO MED, V48, P629, DOI 10.1016/j.freeradbiomed.2009.11.018
   Battistini S, 2010, AMYOTROPH LATERAL SC, V11, P210, DOI 10.3109/17482960902995592
   Boillée S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018
   Chen S, 2013, MOL NEURODEGENER, V8, P0, DOI 10.1186/1750-1326-8-28
   Cudkowicz ME, 1997, ANN NEUROL, V41, P210, DOI 10.1002/ana.410410212
   De Vos KJ, 2007, HUM MOL GENET, V16, P2720, DOI 10.1093/hmg/ddm226
   DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011
   Dugdale DC, 2010, AMYOTROPHIC LATERAL, V0, P0
   Eisen A, 2001, CLIN NEUROPHYSIOL, V112, P2190, DOI 10.1016/S1388-2457(01)00692-7
   Eisen A, 1999, DRUG AGING, V14, P173, DOI 10.2165/00002512-199914030-00003
   Emery A E, 1982, ADV NEUROL, V36, P139
   Ferrera L, 2003, AMYOTROPH LATERAL SC, V4, P167, DOI 10.1080/aml.4.3.167.170
   García-Escudero V, 2015, J CELL MOL MED, V19, P1284, DOI 10.1111/jcmm.12488
   Ge WW, 2006, NEUROBIOL DIS, V23, P342, DOI 10.1016/j.nbd.2006.03.007
   Gibson SB, 2015, AMYOTROPH LATERAL SC, V0, P1
   Gordon PH, 2011, CNS DRUGS, V25, P1, DOI 10.2165/11586000-000000000-00000
   Graffmo KS, 2012, HUMAN MOLECULAR GENETICS, V0, P0
   Greenway MJ, 2006, NAT GENET, V38, P411, DOI 10.1038/ng1742
   Gros-Louis F, 2006, BBA-MOL BASIS DIS, V1762, P956, DOI 10.1016/j.bbadis.2006.01.004
   Hand CK, 2001, ANN NEUROL, V49, P267, DOI 10.1002/1531-8249(20010201)49:2<267::AID-ANA51>3.0.CO;2-D
   Hardiman O, 2011, NAT REV NEUROL, V7, P639, DOI 10.1038/nrneurol.2011.153
   Ikenaka K, 2012, INT J MOL SCI, V13, P1225, DOI 10.3390/ijms13011225
   Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164
   Irvin CW, 2015, FRONT CELL NEUROSCI, V9, P0, DOI 10.3389/fncel.2015.00248
   Kaspar BK, 2003, SCIENCE, V301, P839, DOI 10.1126/science.1086137
   Kelly Evelyn B, 2013, ENCY HUMAN GENETICS, V0, P79
   Liu J, 2004, NEURON, V43, P5, DOI 10.1016/j.neuron.2004.06.016
   Logroscino G, 2008, J NEUROL NEUROSUR PS, V79, P6, DOI 10.1136/jnnp.2006.104828
   Marc G, 2013, BIOMED RES INT, V2013, P0, DOI 10.1155/2013/845345
   Marin B, 2011, J NEUROL NEUROSUR PS, V82, P628, DOI 10.1136/jnnp.2010.211474
   Mazzini L, 2008, J NEUROL SCI, V265, P78, DOI 10.1016/j.jns.2007.05.016
   McAllum EJ, 2015, NEUROBIOL DIS, V81, P20, DOI 10.1016/j.nbd.2015.02.023
   MCCARTHY BG, 1995, NEUROLOGY, V45, P1848, DOI 10.1212/WNL.45.10.1848
   Miller RG, 2002, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD001447
   Münch C, 2011, P NATL ACAD SCI USA, V108, P3548, DOI 10.1073/pnas.1017275108
   Niemann S, 2004, J NEUROL NEUROSUR PS, V75, P1186, DOI 10.1136/jnnp.2003.028324
   PARDO CA, 1995, P NATL ACAD SCI USA, V92, P954, DOI 10.1073/pnas.92.4.954
   Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971
   Pouget J, 2000, AMYOTROPH LATERAL SC, V1, P0
   Prudencio M, 2009, HUM MOL GENET, V18, P3217, DOI 10.1093/hmg/ddp260
   Riancho J, 2015, FRONT CELL NEUROSCI, V9, P0, DOI 10.3389/fncel.2015.00250
   Robberecht W, 2000, J NEUROL, V247, P1
   Robelin L, 2014, BIOMED RES INT, V2014, P0, DOI 10.1155/2014/525097
   ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0
   Rothstein JD, 2009, ANN NEUROL, V65, PS3, DOI 10.1002/ana.21543
   Rowland LP, 2001, ARCH NEUROL-CHICAGO, V58, P512, DOI 10.1001/archneur.58.3.512
   Rutkove SB, 2007, CLIN NEUROPHYSIOL, V118, P2413, DOI 10.1016/j.clinph.2007.08.004
   Seetharaman SV, 2009, EXP BIOL MED, V234, P1140, DOI 10.3181/0903-MR-104
   Shaw BF, 2007, TRENDS BIOCHEM SCI, V32, P78, DOI 10.1016/j.tibs.2006.12.005
   Siddique T, 1994, AM J HUMAN GENETICS, V55, P0
   SMIRNOFF N, 1993, NEW PHYTOL, V125, P27, DOI 10.1111/j.1469-8137.1993.tb03863.x
   Soo KY, 2015, ACTA NEUROPATHOL, V0, P1
   Swash M, 2001, AMYOTROPH LATERAL SC, V2, PS3, DOI 10.1080/231-146608201300079355
   Therrien M, 2014, FRONT GENET, V5, P0, DOI 10.3389/fgene.2014.00085
   Tobisawa S, 2003, BIOCHEM BIOPH RES CO, V303, P496, DOI 10.1016/S0006-291X(03)00353-X
   Traynor BJ, 2000, ARCH NEUROL-CHICAGO, V57, P109, DOI 10.1001/archneur.57.1.109
   Urushitani M, 2006, NAT NEUROSCI, V9, P108, DOI 10.1038/nn1603
   Valentine JS, 2003, P NATL ACAD SCI USA, V100, P3617, DOI 10.1073/pnas.0730423100
   Yoon EJ, 2009, EXP MOL MED, V41, P611, DOI 10.3858/emm.2009.41.9.067
NR 62
TC 217
Z9 245
U1 1
U2 94
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-1119
EI 1879-0038
J9 GENE
JI Gene
PD FEB 15
PY 2016
VL 577
IS 2
BP 109
EP 118
DI 10.1016/j.gene.2015.11.049
PG 10
WC Genetics & Heredity
SC Genetics & Heredity
GA DC4LD
UT WOS:000369191500002
PM 26657039
DA 2024-11-01
ER

PT J
AU Rosado-Ruiz, FA
   So, M
   Kaguni, LS
AF Rosado-Ruiz, Fernando A.
   So, Minyoung
   Kaguni, Laurie S.
TI Purification and Comparative Assay of the Human Mitochondrial Replicative DNA Helicase
SO MITOCHONDRIAL DNA: METHODS AND PROTOCOLS, 3RD EDITION
LA English
DT Article; Book Chapter
DE Mitochondrial DNA replication; mtDNA helicase; Helicases; Mitochondrial single-stranded DNA-binding protein; Human
ID progressive external ophthalmoplegia; defects; twinkle; mutations; primase; cells
AB The replicative mitochondrial DNA (mtDNA) helicase is essential for mtDNA replication and maintenance of the mitochondrial genome. Despite substantial advances that have been made in its characterization, there is still much to be understood about the functional roles of its domains and its interactions with the other components of the minimal mitochondrial DNA replisome. Critical to achieving this is the ability to isolate the enzyme in a stable, active form. In this chapter we describe a modified, streamlined purification strategy for recombinant forms of the enzyme. We also present assays to assess its helix unwinding activity and the stimulatory effects of the mitochondrial single-stranded DNA-binding protein (mtSSB). Finally, we describe a concentration/buffer exchange method that we have employed to achieve greater enzyme stability and appropriate conditions for biochemical and biophysical studies.
C1 [Rosado-Ruiz, Fernando A.; So, Minyoung] Michigan State Univ, Dept Biochem & Mol Biol, Ctr Mitochondrial Sci & Med, E Lansing, MI 48824 USA.
   [Kaguni, Laurie S.] Univ Tampere, Inst Biosci & Med Technol, FIN-33101 Tampere, Finland.
   [Kaguni, Laurie S.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.
   [Kaguni, Laurie S.] Michigan State Univ, Ctr Mitochondrial Sci & Med, E Lansing, MI 48824 USA.
C3 Michigan State University; Tampere University; Michigan State University; Michigan State University
RP Rosado-Ruiz, FA (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, Ctr Mitochondrial Sci & Med, E Lansing, MI 48824 USA.
FU NIGMS NIH HHS [R01 GM045295, GM45295] Funding Source: Medline
CR Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763
   Holmlund T, 2009, BBA-MOL BASIS DIS, V1792, P132, DOI 10.1016/j.bbadis.2008.11.009
   ILYINA TV, 1992, J MOL EVOL, V34, P351, DOI 10.1007/BF00160243
   Korhonen J, 2003, J BIOL CHEM, V377, P691
   Matsushima Y, 2007, J BIOL CHEM, V282, P9436, DOI 10.1074/jbc.M610550200
   Matsushima Y, 2009, BBA-BIOENERGETICS, V1787, P290, DOI 10.1016/j.bbabio.2008.11.005
   Oliveira MT, 2011, J BIOL CHEM, V286, P40649, DOI 10.1074/jbc.M111.289983
   Oliveira MT, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0015379
   Sanchez-Martinez A, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0043954
   Shutt TE, 2006, J MOL EVOL, V62, P588, DOI 10.1007/s00239-005-0162-8
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Ziebarth TD, 2007, J MOL BIOL, V367, P1382, DOI 10.1016/j.jmb.2007.01.079
   Ziebarth TD, 2010, J BIOL CHEM, V285, P14639, DOI 10.1074/jbc.M109.099663
   Ziebarth TD, 2009, METHODS MOL BIOL, V554, P121, DOI 10.1007/978-1-59745-521-3_8
NR 14
TC 0
Z9 2
U1 0
U2 3
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA
SN 1064-3745
EI 
J9 METHODS MOL BIOL
JI Methods Mol. Biol.
PD JUN 15
PY 2016
VL 1351
IS 
BP 185
EP 198
DI 10.1007/978-1-4939-3040-1_14
PG 14
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA BE2DX
UT WOS:000369077400015
PM 26530683
DA 2024-11-01
ER

PT J
AU Kolarova, H
   Liskova, P
   Tesarova, M
   Vidrova, VK
   Forgac, M
   Zamecnik, J
   Hansikova, H
   Honzik, T
AF Kolarova, Hana
   Liskova, Petra
   Tesarova, Marketa
   Vidrova, Vendula Kucerova
   Forgac, Martin
   Zamecnik, Josef
   Hansikova, Hana
   Honzik, Tomas
TI Unique presentation of LHON/MELAS overlap syndrome caused by m.13046T&gt;C in <i>MTND5</i>
SO OPHTHALMIC GENETICS
LA English
DT Article
DE LHON; loss of vision; MELAS; mitochondrial DNA; ND5; overlap syndrome
ID stroke-like episodes; mitochondrial-dna; lactic-acidosis; common-cause; nd5 gene; mutation; disease; encephalopathy; myopathy; melas
AB Background: Leber hereditary optic neuropathy (LHON) and mitochondrial encephalopathy, myopathy, lactic acidosis and stroke-like episodes (MELAS) syndromes are mitochondrially inherited disorders characterized by acute visual failure and variable multiorgan system presentation, respectively. Materials and methods: A 12-year-old girl with otherwise unremarkable medical history presented with abrupt, painless loss of vision. Over the next few months, she developed moderate sensorineural hearing loss, vertigo, migraines, anhedonia and thyroiditis. Ocular examination confirmed bilateral optic nerve atrophy. Metabolic workup documented elevated cerebrospinal fluid lactate. Initial genetic analyses excluded the three most common LHON mutations. Subsequently, Sanger sequencing of the entire mitochondrial DNA (mtDNA) genome was performed. Results: Whole mtDNA sequencing revealed a pathogenic heteroplasmic mutation m.13046T>C in MTND5 encoding the ND5 subunit of complex I. This particular variant has previously been described in a single case report of MELAS/Leigh syndrome (subacute necrotizing encephalopathy). Based on the constellation of clinical symptoms in our patient, we diagnose the condition as LHON/MELAS overlap syndrome. Conclusions: We describe a unique presentation of LHON/MELAS overlap syndrome resulting from a m.13046T>C mutation in a 12-year-old girl. In patients with sudden vision loss in which three of the most prevalent LHON mitochondrial mutations have been ruled out, molecular genetic examination should be extended to other mtDNA-encoded subunits of MTND5 complex I. Furthermore, atypical clinical presentations must be considered, even in well-described phenotypes.
C1 [Kolarova, Hana; Tesarova, Marketa; Vidrova, Vendula Kucerova; Hansikova, Hana; Honzik, Tomas] Charles Univ Prague, Fac Med 1, Dept Pediat & Adolescent Med, Ke Karlovu 2, Prague 12808 2, Czech Republic.
   [Liskova, Petra] Charles Univ Prague, Fac Med 1, Inst Inherited Metab Disorders, Lab Biol & Pathol Eye, Prague, Czech Republic.
   [Liskova, Petra] Charles Univ Prague, Fac Med 1, Dept Ophthalmol, Prague, Czech Republic.
   [Forgac, Martin] Charles Univ Prague, Fac Med 1, Dept Neurol, Prague, Czech Republic.
   [Forgac, Martin] Charles Univ Prague, Fac Med 1, Ctr Clin Neurosci, Prague, Czech Republic.
   [Forgac, Martin] Gen Univ Hosp Prague, Ke Karlovu 2, Prague 12808 2, Czech Republic.
   [Zamecnik, Josef] Charles Univ Prague, Fac Med 2, Dept Pathol & Mol Med, Prague, Czech Republic.
   [Zamecnik, Josef] Univ Hosp Motol Prague, Prague, Czech Republic.
C3 Charles University Prague; Charles University Prague; Charles University Prague; Charles University Prague; Charles University Prague; General University Hospital Prague; Charles University Prague; Charles University Prague; Motol University Hospital; Motol University Hospital
RP Honzik, T (corresponding author), Charles Univ Prague, Fac Med 1, Dept Pediat & Adolescent Med, Ke Karlovu 2, Prague 12808 2, Czech Republic.; Honzik, T (corresponding author), Gen Univ Hosp Prague, Ke Karlovu 2, Prague 12808 2, Czech Republic.
EM tomas.honzik@vfn.cz
FU Charles University in Prague [PRVOUK P24/LF1/3, RVO-VFN 64165, SVV UK 260148/2015];  [IGA NT 14156/3];  [IGA NT 13114/4];  [GAUK 38515/2015]
CR Bai YD, 2000, MOL CELL BIOL, V20, P805, DOI 10.1128/MCB.20.3.805-815.2000
   Blakely EL, 2005, EUR J HUM GENET, V13, P623, DOI 10.1038/sj.ejhg.5201363
   Blok MJ, 2007, J MED GENET, V44, P0, DOI 10.1136/jmg.2006.045716
   Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003
   CAVANAGH JB, 1994, BRAIN, V117, P1357, DOI 10.1093/brain/117.6.1357
   Crimi M, 2003, NEUROLOGY, V60, P1857, DOI 10.1212/01.WNL.0000066048.72780.69
   Fraser JA, 2010, SURV OPHTHALMOL, V55, P299, DOI 10.1016/j.survophthal.2009.10.002
   HASEGAWA H, 1991, ANN NEUROL, V29, P601, DOI 10.1002/ana.410290606
   Hofman P, 2011, INVEST OPHTHALMOL, V42, P895
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   Mayorov V, 2005, ANN NEUROL, V58, P807, DOI 10.1002/ana.20669
   NIKOSKELAINEN EK, 1995, J NEUROL NEUROSUR PS, V59, P160, DOI 10.1136/jnnp.59.2.160
   Pulkes T, 1999, ANN NEUROL, V46, P916, DOI 10.1002/1531-8249(199912)46:6<916::AID-ANA16>3.0.CO;2-R
   Shanske S, 2008, ARCH NEUROL-CHICAGO, V65, P368, DOI 10.1001/archneurol.2007.67
   WALLACE DC, 1970, BRAIN, V93, P121, DOI 10.1093/brain/93.1.121
   Zhao D, 2011, J HUM GENET, V56, P759, DOI 10.1038/jhg.2011.96
NR 16
TC 10
Z9 11
U1 0
U2 5
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1381-6810
EI 1744-5094
J9 OPHTHALMIC GENET
JI Ophthalmic Genet.
PD JUN 15
PY 2016
VL 37
IS 4
BP 419
EP 423
DI 10.3109/13816810.2015.1092045
PG 5
WC Genetics & Heredity; Ophthalmology
SC Genetics & Heredity; Ophthalmology
GA EC0HQ
UT WOS:000387780700011
PM 26894521
DA 2024-11-01
ER

PT J
AU Alston, CL
   Howard, C
   Oláhová, M
   Hardy, SA
   He, LP
   Murray, PG
   O'Sullivan, S
   Doherty, G
   Shield, JPH
   Hargreaves, IP
   Monavari, AA
   Knerr, I
   McCarthy, P
   Morris, AAM
   Thorburn, DR
   Prokisch, H
   Clayton, PE
   McFarland, R
   Hughes, J
   Crushell, E
   Taylor, RW
AF Alston, Charlotte L.
   Howard, Caoimhe
   Olahova, Monika
   Hardy, Steven A.
   He, Langping
   Murray, Philip G.
   O'Sullivan, Siobhan
   Doherty, Gary
   Shield, Julian P. H.
   Hargreaves, Iain P.
   Monavari, Ardeshir A.
   Knerr, Ina
   McCarthy, Peter
   Morris, Andrew A. M.
   Thorburn, David R.
   Prokisch, Holger
   Clayton, Peter E.
   McFarland, Robert
   Hughes, Joanne
   Crushell, Ellen
   Taylor, Robert W.
TI A recurrent mitochondrial p.Trp22Arg <i>NDUFB3</i> variant causes a distinctive facial appearance, short stature and a mild biochemical and clinical phenotype
SO JOURNAL OF MEDICAL GENETICS
LA English
DT Article
DE mitochondrial disease; complex I deficiency; prognosis; dysmorphic features
ID complex-i deficiency; dna mutations; disease; nuclear; prevalence; diagnosis; spectrum
AB Background Isolated Complex I deficiency is the most common paediatric mitochondrial disease presentation, associated with poor prognosis and high mortality. Complex I comprises 44 structural subunits with at least 10 ancillary proteins; mutations in 29 of these have so far been associated with mitochondrial disease but there are limited genotype-phenotype correlations to guide clinicians to the correct genetic diagnosis. Methods Patients were analysed by whole-exome sequencing, targeted capture or candidate gene sequencing. Clinical phenotyping of affected individuals was performed. Results We identified a cohort of 10 patients from 8 families (7 families are of unrelated Irish ancestry) all of whom have short stature (<9th centile) and similar facial features including a prominent forehead, smooth philtrum and deep-set eyes associated with a recurrent homozygous c.64T>C, p.Trp22Arg NDUFB3 variant. Two sibs presented with primary short stature without obvious metabolic dysfunction. Analysis of skeletal muscle from three patients confirmed a defect in Complex I assembly. Conclusions Our report highlights that the long-term prognosis related to the p.Trp22Arg NDUFB3 mutation can be good, even for some patients presenting in acute metabolic crisis with evidence of an isolated Complex I deficiency in muscle. Recognition of the distinctive facial featuresparticularly when associated with markers of mitochondrial dysfunction and/or Irish ancestryshould suggest screening for the p.Trp22Arg NDUFB3 mutation to establish a genetic diagnosis, circumventing the requirement of muscle biopsy to direct genetic investigations.
C1 [Alston, Charlotte L.; Olahova, Monika; Hardy, Steven A.; He, Langping; McFarland, Robert; Taylor, Robert W.] Newcastle Univ, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [Howard, Caoimhe; Monavari, Ardeshir A.; Knerr, Ina; McCarthy, Peter; Hughes, Joanne; Crushell, Ellen] Temple St Childrens Univ Hosp, Natl Ctr Inherited Metab Disorders, Dublin, Ireland.
   [Murray, Philip G.; Clayton, Peter E.] Univ Manchester, Fac Med & Human Sci, Inst Human Dev, Ctr Paediat & Child Hlth, Manchester, Lancs, England.
   [Murray, Philip G.; Clayton, Peter E.] Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England.
   [O'Sullivan, Siobhan; Doherty, Gary] Royal Hosp Sick Children, Dept Metab Paediat, Belfast, Antrim, North Ireland.
   [Shield, Julian P. H.] Univ Bristol, Bristol, Avon, England.
   [Shield, Julian P. H.] Bristol Royal Hosp Children, Bristol, Avon, England.
   [Hargreaves, Iain P.] Natl Hosp Neurol & Neurosurg, Neurometab Unit, London, England.
   [Morris, Andrew A. M.] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester Ctr Genom Med, Manchester, Lancs, England.
   [Thorburn, David R.] Univ Melbourne, Murdoch Childrens Res Inst, Royal Childrens Hosp, Dept Paediat, Parkville, Vic, Australia.
   [Prokisch, Holger] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, Munich, Germany.
C3 Newcastle University - UK; Childrens University Hospital - Temple Street; University of Manchester; University of Manchester; University of Bristol; Bristol Royal Hospital For Children; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of Manchester; Royal Children's Hospital Melbourne; University of Melbourne; Murdoch Children's Research Institute; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health
RP Taylor, RW (corresponding author), Newcastle Univ, Sch Med, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM robert.taylor@ncl.ac.uk
FU Wellcome Trust Centre for Mitochondrial Research [096919Z/11/Z]; Medical Research Council (UK) Centre for Translational Muscle Disease Research [G0601943]; Lily Foundation; UK NHS Highly Specialised Commissioners; German Bundesministerium fur Bildung und Forschung (BMBF) through the German Network for mitochondrial disorders (mitoNET) [01GM1113C]; E-Rare project GENOMIT [01GM1207]; Early Career Grant from the Society for Endocrinology; National Institute for Health Research (NIHR) doctoral fellowship [NIHRHCS-D12-03-04]; MRC [G0601943] Funding Source: UKRI
CR Antonicka H, 2003, J BIOL CHEM, V278, P43081, DOI 10.1074/jbc.M304998200
   Bates MGD, 2012, EUR HEART J, V33, P3023, DOI 10.1093/eurheartj/ehs275
   Cain N, 2013, AM J CARDIOL, V112, P961, DOI 10.1016/j.amjcard.2013.05.035
   Calvo SE, 2012, SCI TRANSL MED, V4, P0, DOI 10.1126/scitranslmed.3003310
   Fassone E, 2012, J MED GENET, V49, P578, DOI 10.1136/jmedgenet-2012-101159
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846
   Huemer M, 2015, J INHERIT METAB DIS, V38, P905, DOI 10.1007/s10545-015-9836-6
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Kong X, 2005, BIOINFORMATICS, V21, P557, DOI 10.1093/bioinformatics/bti024
   Lazarou M, 2007, MOL CELL BIOL, V27, P4228, DOI 10.1128/MCB.00074-07
   Nishio SY, 2015, GENET TEST MOL BIOMA, V19, P209, DOI 10.1089/gtmb.2014.0252
   Oláhová M, 2015, BRAIN, V138, P3503, DOI 10.1093/brain/awv291
   Pagniez-Mammeri H, 2012, MOL GENET METAB, V105, P163, DOI 10.1016/j.ymgme.2011.11.188
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Swalwell H, 2011, EUR J HUM GENET, V19, P769, DOI 10.1038/ejhg.2011.18
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Ugalde C, 2004, HUM MOL GENET, V13, P2461, DOI 10.1093/hmg/ddh262
   Vogel RO, 2007, BBA-BIOENERGETICS, V1767, P1215, DOI 10.1016/j.bbabio.2007.07.008
   Yang H, 2015, NAT PROTOC, V10, P1556, DOI 10.1038/nprot.2015.105
   Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601
   Zeharia A, 2005, J CHILD NEUROL, V20, P449, DOI 10.1177/08830738050200051301
NR 24
TC 30
Z9 35
U1 0
U2 4
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-2593
EI 1468-6244
J9 J MED GENET
JI J. Med. Genet.
PD SEP 15
PY 2016
VL 53
IS 9
BP 634
EP 641
DI 10.1136/jmedgenet-2015-103576
PG 8
WC Genetics & Heredity
SC Genetics & Heredity
GA DV9TE
UT WOS:000383284200007
PM 27091925
DA 2024-11-01
ER

PT J
AU Mancuso, M
   Orsucci, D
   Angelini, C
   Bertini, E
   Carelli, V
   Comi, GP
   Federico, A
   Minetti, C
   Moggio, M
   Mongini, T
   Tonin, P
   Toscano, A
   Bruno, C
   Ienco, EC
   Filosto, M
   Lamperti, C
   Diodato, D
   Moroni, I
   Musumeci, O
   Pegoraro, E
   Spinazzi, M
   Ahmed, N
   Sciacco, M
   Vercelli, L
   Ardissone, A
   Zeviani, M
   Siciliano, G
AF Mancuso, Michelangelo
   Orsucci, Daniele
   Angelini, Corrado
   Bertini, Enrico
   Carelli, Valerio
   Comi, Giacomo Pietro
   Federico, Antonio
   Minetti, Carlo
   Moggio, Maurizio
   Mongini, Tiziana
   Tonin, Paola
   Toscano, Antonio
   Bruno, Claudio
   Ienco, Elena Caldarazzo
   Filosto, Massimiliano
   Lamperti, Costanza
   Diodato, Daria
   Moroni, Isabella
   Musumeci, Olimpia
   Pegoraro, Elena
   Spinazzi, Marco
   Ahmed, Naghia
   Sciacco, Monica
   Vercelli, Liliana
   Ardissone, Anna
   Zeviani, Massimo
   Siciliano, Gabriele
TI "Mitochondrial neuropathies": A survey from the large cohort of the Italian Network
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Disease registry; Mitochondrial myopathies; mtDNA; Neuropathy; Peripheral nerve
ID peripheral neuropathy; disorders; ophthalmoplegia; involvement; mutation; gene; dna
AB Involvement of the peripheral nervous system in mitochondrial disorders has been previously reported. However, the prevalence of peripheral neuropathy in mitochondrial disorders is still unclear. Based on the large database of the "Nation-wide Italian Collaborative Network of Mitochondrial Diseases", we reviewed the clinical data of 1200 patients, with special regard to peripheral neuropathy (mean age at onset 24.3 +/- 20.1 years; age at last evaluation 39.8 +/- 22.3 years; females 52.7%; childhood onset [before age, 16 years] 43.1%). Peripheral neuropathy was present in 143/1156 patients (12.4%), being one of the ten most common signs and symptoms. POLG mutations cause a potentially painful, axonal/mixed, mainly sensory polyneuropathy; TYMP mutations lead to a demyelinating sensory-motor polyneuropathy; SURF1 mutations are associated with a demyelinating/mixed sensory-motor polyneuropathy. The only mtDNA mutation consistently associated with peripheral neuropathy (although less severely than in the above-considered nuclear genes) was the m.8993T > G (or the rarer T > C) changes, which lead to an axonal, mainly sensory polyneuropathy. In conclusion, peripheral neuropathy is one of the most common features of a mitochondrial disorder, and may negatively impact on the quality of life of these patients. Furthermore, the presence or absence of peripheral neuropathy, as well as its specific forms and the association with neuropathic pain (indicative of a POLG-associated disease) can guide the molecular analysis. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Mancuso, Michelangelo; Orsucci, Daniele; Ienco, Elena Caldarazzo; Siciliano, Gabriele] Univ Pisa, Neurol Clin, Via Roma 67, I-56100 Pisa, Italy.
   [Angelini, Corrado] IRCCS S Camillo, Venice, Italy.
   [Bertini, Enrico; Diodato, Daria] Bambino Gesu Hosp IRCCS, Mol Med Lab, Unit Neuromuscular & Neurodegenerat Disorders, Rome, Italy.
   [Carelli, Valerio] Bellaria Hosp, IRCCS Inst Neurol Sci Bologna, Bologna, Italy.
   [Carelli, Valerio] Univ Bologna, Dept Biomed & Neuromotor Sci DIBINEM, Neurol Unit, Bologna, Italy.
   [Comi, Giacomo Pietro; Ahmed, Naghia] Univ Milan, Dino Ferrari Ctr, Dept Pathophysiol & Transplantat DEPT, Neurosci Sect, Milan, Italy.
   [Comi, Giacomo Pietro; Ahmed, Naghia] IRCCS Fdn Ca Granda Osped Maggiore Policlin, Neurol Unit, Milan, Italy.
   [Federico, Antonio] Univ Siena, Dept Med Surg & Neurosci, Via Laterina 8, I-53100 Siena, Italy.
   [Federico, Antonio] AOUS, Unit Clin Neurol & Neurometab Dis, Siena, Italy.
   [Minetti, Carlo] Univ Genoa, Neuropediat & Muscle Disorders Unit, Genoa, Italy.
   [Minetti, Carlo] G Gaslini Inst Children, Genoa, Italy.
   [Moggio, Maurizio; Sciacco, Monica] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Neuromuscular Unit, Milan, Italy.
   [Moggio, Maurizio; Sciacco, Monica] Univ Milan, Dino Ferrari Ctr, Milan, Italy.
   [Mongini, Tiziana; Vercelli, Liliana] Univ Turin, Dept Neurosci, Turin, Italy.
   [Tonin, Paola] Univ Verona, Neurol Clin, I-37100 Verona, Italy.
   [Toscano, Antonio; Musumeci, Olimpia] Univ Messina, Dept Clin & Expt Med, Messina, Italy.
   [Bruno, Claudio] G Gaslini Inst Children, Ctr Myol & Neurodegenerat Dis, Genoa, Italy.
   [Filosto, Massimiliano] Univ Hosp Spedali Civili, Neurol Clin, Brescia, Italy.
   [Lamperti, Costanza; Zeviani, Massimo] Fdn Carlo Besta Inst Neurol IRCCS, Unit Mol Neurogenet, Milan, Italy.
   [Moroni, Isabella; Ardissone, Anna] Fdn Carlo Besta Inst Neurol IRCCS, Child Neurol Unit, Milan, Italy.
   [Pegoraro, Elena; Spinazzi, Marco] Univ Padua, Neurol Clin, Padua, Italy.
C3 University of Pisa; IRCCS Ospedale San Camillo; IRCCS Bambino Gesu; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); AUSL di Bologna; University of Bologna; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Siena; University of Siena; University Hospital of Siena; University of Genoa; University of Genoa; IRCCS Istituto Giannina Gaslini; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Turin; University of Verona; University of Messina; University of Genoa; IRCCS Istituto Giannina Gaslini; Hospital Spedali Civili Brescia; Fondazione IRCCS Istituto Neurologico Carlo Besta; Fondazione IRCCS Istituto Neurologico Carlo Besta; University of Padua
RP Mancuso, M (corresponding author), Univ Pisa, Neurol Clin, Via Roma 67, I-56100 Pisa, Italy.
EM mancusomichelangelo@gmail.com
FU Telethon Grant [GUP09004]; MITOCON; MRC [MC_UP_1002/1] Funding Source: UKRI
CR Chu CC, 1997, EUR NEUROL, V37, P110, DOI 10.1159/000117420
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Finsterer J, 2005, CLIN NEUROL NEUROSUR, V107, P181, DOI 10.1016/j.clineuro.2004.07.001
   Girlanda P, 1999, CLIN NEUROPHYSIOL, V110, P1284, DOI 10.1016/S1388-2457(98)00041-8
   Hisama FM, 2005, AM J MED GENET A, V135A, P217, DOI 10.1002/ajmg.a.30672
   Horga A, 2014, BRAIN, V137, P3200, DOI 10.1093/brain/awu279
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   Mancuso M, 2009, CURR MOL MED, V9, P1095, DOI 10.2174/156652409789839099
   Mancuso M, 2015, J NEUROL, V262, P1301, DOI 10.1007/s00415-015-7710-y
   Mancuso M, 2012, NEUROL SCI, V33, P449, DOI 10.1007/s10072-011-0703-4
   Pareyson D, 2013, LANCET NEUROL, V12, P1011, DOI 10.1016/S1474-4422(13)70158-3
   Pineda M, 2004, PEDIATR RES, V56, P55, DOI 10.1203/01.PDR.0000130475.20571.98
NR 12
TC 38
Z9 38
U1 0
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD APR-MAY 15
PY 2016
VL 26
IS 4-5
BP 272
EP 276
DI 10.1016/j.nmd.2016.02.008
PG 5
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA DM2XT
UT WOS:000376212100003
PM 27020842
DA 2024-11-01
ER

PT J
AU Stiles, AR
   Simon, MT
   Stover, A
   Eftekharian, S
   Khanlou, N
   Wang, HLL
   Magaki, S
   Lee, H
   Partynski, K
   Dorrani, N
   Chang, R
   Martinez-Agosto, JA
   Abdenur, JE
AF Stiles, Ashlee R.
   Simon, Mariella T.
   Stover, Alexander
   Eftekharian, Shaya
   Khanlou, Negar
   Wang, Hanlin L.
   Magaki, Shino
   Lee, Hane
   Partynski, Kate
   Dorrani, Nagmeh
   Chang, Richard
   Martinez-Agosto, Julian A.
   Abdenur, Jose E.
TI Mutations in TFAM, encoding mitochondrial transcription factor A, cause neonatal liver failure associated with mtDNA depletion
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Article
DE TFAM mutation; mtDNA depletion syndrome; Liver failure; Newborn screening; Mitochondrial disease
ID dna depletion; disorders; maintenance; binding; gene; protein
AB In humans, mitochondrial DNA (mtDNA) depletion syndromes are a group of genetically and clinically heterogeneous autosomal recessive disorders that arise as a consequence of defects in mtDNA replication or nucleotide synthesis. Clinical manifestations are variable and include myopathic, encephalomyopathic, neurogastrointestinal or hepatocerebral phenotypes. Through clinical exome sequencing, we identified a homozygous missense variant (c.533C>T; p.Pro178Leu) in mitochondrial transcription factor A (TFAM) segregating in a consanguineous kindred of Colombian Basque descent in which two siblings presented with IUGR, elevated transaminases, conjugated hyperbilirubinemia and hypoglycemia with progression to liver failure and death in early infancy. Results of the liver biopsy in the proband revealed cirrhosis, micro-and macrovesicular steatosis, cholestasis and mitochondrial pleomorphism. Electron microscopy of muscle revealed abnormal mitochondrial morphology and distribution while enzyme histochemistry was underwhelming. Electron transport chain testing in muscle showed increased citrate synthase activity suggesting mitochondrial proliferation, while respiratory chain activities were at the lower end of normal. mtDNA content was reduced in liver and muscle (11% and 21% of normal controls respectively). While Tfam mRNA expression was upregulated in primary fibroblasts, Tfam protein level was significantly reduced. Furthermore, functional investigations of the mitochondria revealed reduced basal respiration and spare respiratory capacity, decreased mtDNA copy number and markedly reduced nucleoids. TFAM is essential for transcription, replication and packaging of mtDNA into nucleoids. Tfam knockout mice display embryonic lethality secondary to severe mtDNA depletion. In this report, for the first time, we associate a homozygous variant in TFAM with a novel mtDNA depletion syndrome. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Stiles, Ashlee R.; Khanlou, Negar; Wang, Hanlin L.; Magaki, Shino; Lee, Hane] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA.
   [Stiles, Ashlee R.; Lee, Hane; Martinez-Agosto, Julian A.] Univ Calif Los Angeles, Clin Genom Ctr, Los Angeles, CA 90095 USA.
   [Simon, Mariella T.; Stover, Alexander; Eftekharian, Shaya; Partynski, Kate; Chang, Richard; Abdenur, Jose E.] CHOC Childrens, Div Metab Disorders, Orange, CA 92868 USA.
   [Simon, Mariella T.] Univ Calif Irvine, Sch Biol Sci, Dept Dev & Cellular Biol, Irvine, CA 92697 USA.
   [Dorrani, Nagmeh; Martinez-Agosto, Julian A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA.
   [Martinez-Agosto, Julian A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.
   [Abdenur, Jose E.] Univ Calif Irvine, Dept Pediat, Orange, CA 92868 USA.
C3 University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Irvine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Irvine
RP Abdenur, JE (corresponding author), Div Metab Disorders, 1201 W La Veta Ave, Orange, CA 92868 USA.
EM jabdenur@choc.org
FU Fry Family Foundation [40031028]; Energy Laboratory
CR [Anonymous], 2013, MUSCLE BIOPSY PRACTI, V0, P0
   BENNETT RL, 1995, AM J HUM GENET, V56, P745, DOI 10.1007/BF01408073
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Bonnen PE, 2013, AM J HUM GENET, V93, P471, DOI 10.1016/j.ajhg.2013.07.017
   Cohen BH, 2010, METHODS, V51, P364, DOI 10.1016/j.ymeth.2010.05.008
   Debray FG, 2008, CURR OPIN PEDIATR, V20, P471, DOI 10.1097/MOP.0b013e328306ebb6
   Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549
   El-Hattab AW, 2016, CELL CALCIUM, V0, P0
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   El-Hattab AW, 2010, MOL GENET METAB, V99, P300, DOI 10.1016/j.ymgme.2009.10.003
   Fellman V, 2011, SEMIN FETAL NEONAT M, V16, P222, DOI 10.1016/j.siny.2011.05.002
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Freisinger P, 2006, ARCH NEUROL-CHICAGO, V63, P1129, DOI 10.1001/archneur.63.8.1129
   Gangelhoff TA, 2009, NUCLEIC ACIDS RES, V37, P3153, DOI 10.1093/nar/gkp157
   Kang D, 2007, MITOCHONDRION, V7, P39, DOI 10.1016/j.mito.2006.11.017
   Kasashima K, 2015, GENES CELLS, V0, P0
   Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478
   Kukat C, 2015, P NATL ACAD SCI USA, V112, P11288, DOI 10.1073/pnas.1512131112
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Lee H, 2014, JAMA-J AM MED ASSOC, V312, P1880, DOI 10.1001/jama.2014.14604
   Lu B, 2013, MOL CELL, V49, P121, DOI 10.1016/j.molcel.2012.10.023
   Müller-Höcker J, 2011, J CELL MOL MED, V15, P445, DOI 10.1111/j.1582-4934.2009.00819.x
   Ngo HB, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms4077
   Nobre S, 2012, BMJ CASE REP, V2012, P1
   Nogueira C, 2014, ITAL J PEDIATR, V40, P0, DOI 10.1186/1824-7288-40-34
   PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027
   Picca A, 2015, MITOCHONDRION, V25, P67, DOI 10.1016/j.mito.2015.10.001
   Prasad C, 2013, MOL GENET METAB, V108, P190, DOI 10.1016/j.ymgme.2012.12.007
   Pronicka E, 2011, J APPL GENET, V52, P61, DOI 10.1007/s13353-010-0008-y
   Rehm HL, 2013, GENET MED, V15, P733, DOI 10.1038/gim.2013.92
   RH H, 2008, MOL GENET METAB, V94, P16
   Rötig A, 2009, BBA-MOL BASIS DIS, V1792, P1103, DOI 10.1016/j.bbadis.2009.06.009
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Sezer T, 2015, J CHILD NEUROL, V30, P124, DOI 10.1177/0883073813517000
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55
   Tiranti VER, 1994, GENOMICS, V25, P6
   Wong LJC, 2007, MUSCLE NERVE, V36, P279, DOI 10.1002/mus.20807
   Wong LJC, 2007, MITOCHONDRION, V7, P45, DOI 10.1016/j.mito.2006.11.025
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
   Ye J, 2012, BMC BIOINFORMATICS, V13, P0, DOI 10.1186/1471-2105-13-134
   Young MJ, 2016, CURR OPIN GENET DEV, V38, P52, DOI 10.1016/j.gde.2016.03.005
NR 43
TC 85
Z9 93
U1 2
U2 20
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
EI 1096-7206
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD SEP-OCT 15
PY 2016
VL 119
IS 1-2
BP 91
EP 99
DI 10.1016/j.ymgme.2016.07.001
PG 9
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine
GA DX8IJ
UT WOS:000384631000013
PM 27448789
DA 2024-11-01
ER

PT J
AU Selim, L
   Van Coster, R
   Mehaney, D
   Hassan, F
   Vanlander, A
   Smet, J
   De Latter, E
   Vandemeulebroecke, K
   Abdou, DM
   Nakhla, G
   Mostafa, M
   Habets, D
   Bakker, J
   Baby, AA
AF Selim, L.
   Van Coster, R.
   Mehaney, D.
   Hassan, F.
   Vanlander, A.
   Smet, J.
   De Latter, E.
   Vandemeulebroecke, K.
   Abdou, D. Mohamed
   Nakhla, G.
   Mostafa, M.
   Habets, D.
   Bakker, J.
   Baby, A. Abdel
TI MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOPATHY: CLINICAL, BIOCHEMICAL AND MOLECULAR STUDY IN THREE EGYPTIAN PATIENTS
SO GENETIC COUNSELING
LA English
DT Article
DE Mitochondrial disease; Gastrointestinal; Encephalomyopathy; Thymidine Phosphorylase
ID thymidine phosphorylase-deficiency; encephalomyopathy mngie; gene-mutations; dna depletion; deoxyuridine; disorder; neuropathy; diagnosis; brothers; defects
AB Mitochondrial neurogastrointestinal encephalopathy: clinical, biochemical and molecular study in three Egyptian patients: Background: Mitochondrial Neurogastrointestinal Encephalopathy syndrome is a rare autosomal recessive disorder. The disease is caused by mutations in the thymidine phosphorylase gene. This article reports the clinical, biochemical and molecular findings in three Egyptian patients with Mitochondrial Neurogastrointestinal Encephalopathy syndrome from two different pedigrees. Subjects and Methods: The three patients were subjected to thorough neurologic examination, Brain Magnetic Resonance Imaging. Histochemical and biochemical assay of the mitochondrial respiratory chain complexes in muscle homogenate was performed (1/3). Thymidine Phosphorylase enzyme activity was performed in 2/3 patients and Thymidine Phosphorylase gene sequencing was done (2/3) to confirm the diagnosis. Results: All patients presented with symptoms of severe gastrointestinal dysmotility with progressive cachexia, neuropathy, sensory neural hearing loss, asymptomatic leukoencephalopathy. Histochemical analysis of the muscle biopsy revealed deficient Cytochrome C oxidase and mitochondrial respiratory chain enzyme assay revealed isolated complex I deficiency (1/3). Thymidine Phosphorylase enzyme activity revealed complete absence of enzyme activity in 2/3 patients. Direct sequencing of Thymidine Phosphorylase gene revealed c.3371A>C homozygous mutation. Molecular screening of both families revealed heterozygous mutation in both parents and 4 siblings. Conclusions: Mitochondrial Neurogastrointestinal Encephalopathy syndrome is a rare mitochondrial disorder with an important diagnostic delay. In case of pathogenic mutations in Thymidine Phosphorylase gene in the family, carrier testing and prenatal diagnosis of at risk members is recommended for early detection. The possibility of new therapeutic options makes it necessary to diagnose the disease in an early state.
C1 [Selim, L.; Hassan, F.; Mostafa, M.] Cairo Univ, Dept Pediat, Neurol Unit, Fac Med, Cairo, Egypt.
   [Selim, L.; Hassan, F.; Mostafa, M.] Cairo Univ, Dept Pediat, Neurometab Units, Fac Med, Cairo, Egypt.
   [Van Coster, R.; Vanlander, A.; Smet, J.; De Latter, E.; Vandemeulebroecke, K.] Ghent Univ Hosp, Dept Pediat, Div Pediat Neurol & Metab, Ghent, Belgium.
   [Mehaney, D.; Abdou, D. Mohamed] Cairo Univ, Clin & Chem Pathol Dept, Fac Med, Cairo, Egypt.
   [Nakhla, G.] Cairo Univ, Fac Med, Dept Pathol, Cairo 11562, Egypt.
   [Habets, D.] Maastricht Univ, Med Ctr, Dept Clin Genet, Maastricht, Netherlands.
   [Bakker, J.] Univ Med Ctr Leiden, Dept Clin Chem & Lab Med, Leiden, Netherlands.
   [Baby, A. Abdel] Cairo Univ, Fac Med, Dept Surg, Cairo, Egypt.
C3 Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University; Ghent University; Ghent University Hospital; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University; Maastricht University; Leiden University; Leiden University Medical Center (LUMC); Egyptian Knowledge Bank (EKB); Cairo University
RP Mehaney, D (corresponding author), Cairo Univ, Clin & Chem Pathol Dept, Kasr Al Ainy Fac Med, Cairo 11562, Egypt.
EM Drdinamehaney@kasralainy.edu.eg
FU Cairo University research fund; fund for scientific research Belgium [G.0666.06]
CR Bakker JA, 2010, J INHERIT METAB DIS, V33, PS139, DOI 10.1007/s10545-010-9049-y
   Baris Z, 2010, EUR J PEDIATR, V169, P1375, DOI 10.1007/s00431-010-1237-0
   Bedlack RS, 2004, MUSCLE NERVE, V29, P364, DOI 10.1002/mus.10546
   BIRCHMACHIN MA, 1988, J INHERIT METAB DIS, V11, P207, DOI 10.1007/BF01799876
   Debouverie M, 1997, REV NEUROL, V153, P547
   DiMauro S, 1997, JPN J HUM GENET, V42, P473, DOI 10.1007/BF02767024
   DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409
   Fairbanks LD, 2002, J INHERIT METAB DIS, V25, P603, DOI 10.1023/A:1022007827133
   Finsterer J, 2006, ACTA NEUROL SCAND, V114, P217, DOI 10.1111/j.1600-0404.2006.00671.x
   FISCHER JC, 1986, EUR J PEDIATR, V144, P441, DOI 10.1007/BF00441735
   Gamez J, 2005, J NEUROL SCI, V228, P35, DOI 10.1016/j.jns.2004.09.034
   Gamez J, 2002, NEUROLOGY, V59, P455, DOI 10.1212/WNL.59.3.455
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   Giordano C, 2008, AM J PATHOL, V173, P1120, DOI 10.2353/ajpath.2008.080252
   HAGIWARA K, 1991, MOL CELL BIOL, V11, P2125, DOI 10.1128/MCB.11.4.2125
   Hirano M, 2004, NUCLEOS NUCLEOT NUCL, V23, P1217, DOI 10.1081/NCN-200027485
   Hirano M, 2004, NEUROLOGIST, V10, P8, DOI 10.1097/01.nrl.0000106919.06469.04
   Kintarak J, 2007, CLIN NEUROL NEUROSUR, V109, P613, DOI 10.1016/j.clineuro.2007.04.008
   Kocaefe YÇ, 2003, EUR J HUM GENET, V11, P102, DOI 10.1038/sj.ejhg.5200908
   Labauge P, 2002, NEUROLOGY, V58, P1862, DOI 10.1212/WNL.58.12.1862
   Laforce R, 2009, CLIN NEUROL NEUROSUR, V111, P691, DOI 10.1016/j.clineuro.2009.05.005
   Libernini L, 2012, NEUROPEDIATRICS, V43, P201, DOI 10.1055/s-0032-1315431
   López LC, 2009, HUM MOL GENET, V18, P714, DOI 10.1093/hmg/ddn401
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Martí R, 2005, ANN NEUROL, V58, P649, DOI 10.1002/ana.20615
   Martí R, 2003, BIOCHEM BIOPH RES CO, V303, P14, DOI 10.1016/S0006-291X(03)00294-8
   Martí R, 2012, METHODS MOL BIOL, V837, P121, DOI 10.1007/978-1-61779-504-6_8
   Massa R, 2009, NEUROMUSCULAR DISORD, V19, P837, DOI 10.1016/j.nmd.2009.08.013
   Mihaylova V, 2013, J NEUROGENET, V27, P19, DOI 10.3109/01677063.2013.778256
   Monroy N, 2008, EUR J MED GENET, V51, P245, DOI 10.1016/j.ejmg.2007.12.007
   Nalini A, 2011, J NEUROL SCI, V309, P131, DOI 10.1016/j.jns.2011.06.052
   Nishigaki Y, 2003, J CLIN INVEST, V111, P1913, DOI 10.1172/JCI200317828
   Nishino I, 2000, ANN NEUROL, V47, P792
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Nishino I, 2001, NEUROMUSCULAR DISORD, V11, P7, DOI 10.1016/S0960-8966(00)00159-0
   Peedikayil Musthafa Chalikandy, 2015, HEMATOL ONCOL STEM CELL THER, V8, P85, DOI 10.1016/j.hemonc.2014.12.001
   Pontarin G, 2006, J BIOL CHEM, V281, P22720, DOI 10.1074/jbc.M604498200
   Poulton J, 2009, BBA-MOL BASIS DIS, V1792, P1109, DOI 10.1016/j.bbadis.2009.08.016
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Said G, 2005, J NEUROL, V252, P655, DOI 10.1007/s00415-005-0712-4
   Slama A, 2005, MOL GENET METAB, V84, P326, DOI 10.1016/j.ymgme.2004.12.004
   Spinazzola A, 2002, J BIOL CHEM, V277, P4128, DOI 10.1074/jbc.M111028200
   Suh BC, 2013, MOL MED REP, V8, P17, DOI 10.3892/mmr.2013.1479
   Szigeti K, 2004, J MED GENET, V41, P125, DOI 10.1136/jmg.2003.013789
   Teitelbaum JE, 2002, J PEDIATR GASTR NUTR, V35, P377, DOI 10.1097/00005176-200209000-00029
   Valentino ML, 2007, FEBS LETT, V581, P3410, DOI 10.1016/j.febslet.2007.06.042
   Van Coster R, 2001, PEDIATR RES, V50, P658, DOI 10.1203/00006450-200111000-00020
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   van Kuilenburg ABP, 2005, J CHROMATOGR B, V820, P271, DOI 10.1016/j.jchromb.2005.04.009
NR 49
TC 3
Z9 3
U1 2
U2 7
PU MEDECINE ET HYGIENE
PI CHENE-BOURG
PA CH DE LA MOUSSE 46, CASE POSTALE 475, CH-1225 CHENE-BOURG, SWITZERLAND
SN 1015-8146
EI 
J9 GENET COUNSEL
JI Genet. Couns.
PD JUN 15
PY 2016
VL 27
IS 2
BP 193
EP 205
DI 
PG 13
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Medical Ethics; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Medical Ethics; Research & Experimental Medicine
GA DR8WG
UT WOS:000380178500006
PM 29485812
DA 2024-11-01
ER

PT J
AU Narciso, L
   Parlanti, E
   Racaniello, M
   Simonelli, V
   Cardinale, A
   Merlo, D
   Dogliotti, E
AF Narciso, Laura
   Parlanti, Eleonora
   Racaniello, Mauro
   Simonelli, Valeria
   Cardinale, Alessio
   Merlo, Daniela
   Dogliotti, Eugenia
TI The Response to Oxidative DNA Damage in Neurons: Mechanisms and Disease
SO NEURAL PLASTICITY
LA English
DT Review
ID base excision-repair; strand break repair; differentiated muscle-cells; human polynucleotide kinase; dependent protein-kinase; alzheimers-disease; spinocerebellar ataxia; cerebellar atrophy; polymerases delta; mitochondrial-dna
AB There is a growing body of evidence indicating that the mechanisms that control genome stability are of key importance in the development and function of the nervous system. The major threat for neurons is oxidative DNA damage, which is repaired by the base excision repair (BER) pathway. Functional mutations of enzymes that are involved in the processing of single-strand breaks (SSB) that are generated during BER have been causally associated with syndromes that present important neurological alterations and cognitive decline. In this review, the plasticity of BER during neurogenesis and the importance of an efficient BER for correct brain function will be specifically addressed paying particular attention to the brain region and neuron-selectivity in SSB repair-associated neurological syndromes and age-related neurodegenerative diseases.
C1 [Narciso, Laura; Parlanti, Eleonora; Simonelli, Valeria; Dogliotti, Eugenia] Ist Super Sanita, Dept Environm & Hlth, Viale Regina Elena 299, I-00161 Rome, Italy.
   [Narciso, Laura] Ist Super Sanita, Dept Food Safety & Vet Publ Hlth, Viale Regina Elena 299, I-00161 Rome, Italy.
   [Racaniello, Mauro; Merlo, Daniela] Ist Super Sanita, Dept Cell Biol & Neurosci, Viale Regina Elena 299, I-00161 Rome, Italy.
   [Cardinale, Alessio] IRCCS San Raffaele Pisana, I-00166 Rome, Italy.
C3 Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); IRCCS San Raffaele Pisana
RP Dogliotti, E (corresponding author), Ist Super Sanita, Dept Environm & Hlth, Viale Regina Elena 299, I-00161 Rome, Italy.; Merlo, D (corresponding author), Ist Super Sanita, Dept Cell Biol & Neurosci, Viale Regina Elena 299, I-00161 Rome, Italy.
EM daniela.merlo@iss.it; eugenia.dogliotti@iss.it
CR Ahel I, 2006, NATURE, V443, P713, DOI 10.1038/nature05164
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   Andersen BB, 2003, J COMP NEUROL, V466, P356, DOI 10.1002/cne.10884
   Arai T, 2006, ACTA NEUROPATHOL, V112, P139, DOI 10.1007/s00401-006-0081-9
   Banerjee D, 2011, J BIOL CHEM, V286, P6006, DOI 10.1074/jbc.M110.198796
   Bauer NC, 2015, NUCLEIC ACIDS RES, V43, P10083, DOI 10.1093/nar/gkv1136
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bras J, 2015, AM J HUM GENET, V96, P474, DOI 10.1016/j.ajhg.2015.01.005
   Breslin C, 2009, MOL CELL BIOL, V29, P4653, DOI 10.1128/MCB.00677-09
   Caldecott KW, 2003, DNA REPAIR, V2, P955, DOI 10.1016/S1568-7864(03)00118-6
   Calvo JA, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003413
   Campalans A, 2015, MOL CELL BIOL, V35, P1648, DOI 10.1128/MCB.00134-15
   Canugovi C, 2014, NEUROBIOL AGING, V35, P1293, DOI 10.1016/j.neurobiolaging.2014.01.004
   Cardinale A, 2015, NEUROCHEM RES, V40, P59, DOI 10.1007/s11064-014-1465-1
   Cardinale A, 2012, J BIOL CHEM, V287, P2618, DOI 10.1074/jbc.M111.276550
   Cardozo-Pelaez F, 2012, NEUROCHEM INT, V61, P721, DOI 10.1016/j.neuint.2012.06.013
   Carlessi L, 2009, CELL DEATH DIFFER, V16, P795, DOI 10.1038/cdd.2009.10
   Chakraborty A, 2015, J BIOL CHEM, V290, P24636, DOI 10.1074/jbc.M115.658146
   Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029
   Chappell C, 2002, EMBO J, V21, P2827, DOI 10.1093/emboj/21.11.2827
   Cheng AW, 2007, J NEUROSCI, V27, P3722, DOI 10.1523/JNEUROSCI.0590-07.2007
   Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019
   Clements PM, 2004, DNA REPAIR, V3, P1493, DOI 10.1016/j.dnarep.2004.06.017
   Copani A, 2006, J NEUROSCI, V26, P10949, DOI 10.1523/JNEUROSCI.2793-06.2006
   Coppedè F, 2015, MUTAT RES-FUND MOL M, V776, P84, DOI 10.1016/j.mrfmmm.2014.11.010
   DArcangelo G, 2011, BRAIN RES, V1396, P11, DOI 10.1016/j.brainres.2011.04.020
   Date H, 2001, NAT GENET, V29, P184, DOI 10.1038/ng1001-184
   El-Khamisy SF, 2005, NATURE, V434, P108, DOI 10.1038/nature03314
   Ellenberger T, 2008, ANNU REV BIOCHEM, V77, P313, DOI 10.1146/annurev.biochem.77.061306.123941
   Enokido Y, 2010, J CELL BIOL, V189, P425, DOI 10.1083/jcb.200905138
   Fan JS, 2004, NUCLEIC ACIDS RES, V32, P2193, DOI 10.1093/nar/gkh556
   Fenech M, 2012, MUTAT RES-FUND MOL M, V733, P21, DOI 10.1016/j.mrfmmm.2011.11.003
   Fortini P, 2003, BIOCHIMIE, V85, P1053, DOI 10.1016/j.biochi.2003.11.003
   Fortini P, 2012, CELL DEATH DIFFER, V19, P1741, DOI 10.1038/cdd.2012.53
   Fortini P, 2010, MUTAT RES-FUND MOL M, V685, P38, DOI 10.1016/j.mrfmmm.2009.11.003
   Fortini P, 1999, J BIOL CHEM, V274, P15230, DOI 10.1074/jbc.274.21.15230
   Fortini P, 1998, BIOCHEMISTRY-US, V37, P3575, DOI 10.1021/bi972999h
   Fortini P, 2007, DNA REPAIR, V6, P398, DOI 10.1016/j.dnarep.2006.10.008
   Francis PT, 1999, J NEUROL NEUROSUR PS, V66, P137, DOI 10.1136/jnnp.66.2.137
   Fu D, 2012, NAT REV CANCER, V12, P104, DOI 10.1038/nrc3185
   Fukae J, 2005, ACTA NEUROPATHOL, V109, P256, DOI 10.1007/s00401-004-0937-9
   Furuta A, 2001, NEUROREPORT, V12, P2895, DOI 10.1097/00001756-200109170-00028
   Gao R, 2015, PLOS GENET, V11, P0, DOI 10.1371/journal.pgen.1004834
   Goula AV, 2009, PLOS GENET, V5, P0, DOI 10.1371/journal.pgen.1000749
   GOULIAN M, 1980, P NATL ACAD SCI-BIOL, V77, P1956, DOI 10.1073/pnas.77.4.1956
   GRAVELAND GA, 1985, SCIENCE, V227, P770, DOI 10.1126/science.3155875
   Gueven N, 2004, HUM MOL GENET, V13, P1081, DOI 10.1093/hmg/ddh122
   Guo J, 2013, NUCLEIC ACIDS RES, V41, P7700, DOI 10.1093/nar/gkt524
   Hayashi H, 2002, CURR BIOL, V12, P335, DOI 10.1016/S0960-9822(02)00686-3
   Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8
   Hegde ML, 2012, MECH AGEING DEV, V133, P157, DOI 10.1016/j.mad.2012.01.005
   Hernandes MS, 2012, CURR NEUROPHARMACOL, V10, P321, DOI 10.2174/157015912804143540
   Hirano R, 2007, EMBO J, V26, P4732, DOI 10.1038/sj.emboj.7601885
   Huang E, 2010, NAT CELL BIOL, V12, P563, DOI 10.1038/ncb2058
   Ichinoe A, 2004, NUCLEIC ACIDS RES, V32, P477, DOI 10.1093/nar/gkh214
   Imam SZ, 2006, NEUROBIOL AGING, V27, P1129, DOI 10.1016/j.neurobiolaging.2005.06.002
   Jacobs AL, 2012, CHROMOSOMA, V121, P1, DOI 10.1007/s00412-011-0347-4
   JENSEN PK, 1966, BIOCHIM BIOPHYS ACTA, V122, P167, DOI 10.1016/0926-6593(66)90058-0
   Jiang YL, 2008, CANCER RES, V68, P6425, DOI 10.1158/0008-5472.CAN-08-1173
   Jiang YL, 2009, DNA REPAIR, V8, P1273, DOI 10.1016/j.dnarep.2009.08.003
   Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907
   Karimi-Busheri F, 2007, CANCER RES, V67, P6619, DOI 10.1158/0008-5472.CAN-07-0480
   Khoronenkova SV, 2015, P NATL ACAD SCI USA, V112, P3997, DOI 10.1073/pnas.1416031112
   Kim K, 1998, J BIOL CHEM, V273, P8842, DOI 10.1074/jbc.273.15.8842
   Kisby GE, 2009, DNA REPAIR, V8, P400, DOI 10.1016/j.dnarep.2008.12.002
   Klungland A, 1997, EMBO J, V16, P3341, DOI 10.1093/emboj/16.11.3341
   Krokan HE, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a012583
   Krokeide SZ, 2013, DNA REPAIR, V12, P1159, DOI 10.1016/j.dnarep.2013.04.026
   Kronenberg G, 2008, J NEUROSCI, V28, P7219, DOI 10.1523/JNEUROSCI.0940-08.2008
   Kruman II, 2004, J BIOL CHEM, V279, P43952, DOI 10.1074/jbc.M408025200
   Kulkarni A, 2008, NUCLEIC ACIDS RES, V36, P5111, DOI 10.1093/nar/gkn480
   Lauritzen KH, 2011, MECH AGEING DEV, V132, P424, DOI 10.1016/j.mad.2011.02.006
   Le Ber I, 2003, BRAIN, V126, P2761, DOI 10.1093/brain/awg283
   Lee Y, 2009, NAT NEUROSCI, V12, P973, DOI 10.1038/nn.2375
   Liu D, 2011, J CEREBR BLOOD F MET, V31, P680, DOI 10.1038/jcbfm.2010.147
   Liu Y, 2005, J BIOL CHEM, V280, P3665, DOI 10.1074/jbc.M412922200
   Liu Y, 2009, J BIOL CHEM, V284, P28352, DOI 10.1074/jbc.M109.050286
   Loizou JI, 2004, CELL, V117, P17, DOI 10.1016/S0092-8674(04)00206-5
   Lovell MA, 2000, BRAIN RES, V855, P116, DOI 10.1016/S0006-8993(99)02335-5
   Madabhushi R, 2014, NEURON, V83, P266, DOI 10.1016/j.neuron.2014.06.034
   Markkanen E, 2012, CELL CYCLE, V11, P1070, DOI 10.4161/cc.11.6.19448
   Marteijn JA, 2014, NAT REV MOL CELL BIO, V15, P465, DOI 10.1038/nrm3822
   Mason AG, 2014, HUM MOL GENET, V23, P1606, DOI 10.1093/hmg/ddt551
   McKinnon PJ, 2013, NAT NEUROSCI, V16, P1523, DOI 10.1038/nn.3537
   McKinnon PJ, 2012, ANNU REV PATHOL-MECH, V7, P303, DOI 10.1146/annurev-pathol-011811-132509
   Mellor JR, 1998, J NEUROSCI, V18, P2822
   Mighore L, 2005, NEUROBIOL AGING, V26, P567, DOI 10.1016/j.neurobiolaging.2004.07.016
   Moreira MC, 2001, NAT GENET, V29, P189, DOI 10.1038/ng1001-189
   Nakashima M, 2014, J HUM GENET, V59, P471, DOI 10.1038/jhg.2014.51
   Narciso L, 2007, P NATL ACAD SCI USA, V104, P17010, DOI 10.1073/pnas.0701743104
   Nayernia Z, 2014, ANTIOXID REDOX SIGN, V20, P2815, DOI 10.1089/ars.2013.5703
   Nguyen D, 2011, CELL DEATH DIS, V2, P0, DOI 10.1038/cddis.2011.117
   Nilsen H, 1997, NUCLEIC ACIDS RES, V25, P750, DOI 10.1093/nar/25.4.750
   Nilsen L, 2012, NUCLEIC ACIDS RES, V40, P2000, DOI 10.1093/nar/gkr933
   Nishioka K, 1999, MOL BIOL CELL, V10, P1637, DOI 10.1091/mbc.10.5.1637
   Nouspikel T, 2000, MOL CELL BIOL, V20, P1562, DOI 10.1128/MCB.20.5.1562-1570.2000
   Nouspikel TP, 2006, MOL CELL BIOL, V26, P8722, DOI 10.1128/MCB.01263-06
   ODriscoll M, 2007, AM J HUM GENET, V81, P77, DOI 10.1086/518696
   Orii KE, 2006, P NATL ACAD SCI USA, V103, P10017, DOI 10.1073/pnas.0602436103
   Palau F, 2006, ORPHANET J RARE DIS, V1, P0, DOI 10.1186/1750-1172-1-47
   Parlanti E, 2002, ONCOGENE, V21, P5204, DOI 10.1038/sj.onc.1205561
   Pascucci B, 2002, NUCLEIC ACIDS RES, V30, P2124, DOI 10.1093/nar/30.10.2124
   Pascucci B, 1999, J BIOL CHEM, V274, P33696, DOI 10.1074/jbc.274.47.33696
   Pogozelski WK, 1998, CHEM REV, V98, P1089, DOI 10.1021/cr960437i
   Poulton C, 2013, NEUROGENETICS, V14, P43, DOI 10.1007/s10048-012-0351-8
   Prasad R, 2000, J BIOL CHEM, V275, P4460, DOI 10.1074/jbc.275.6.4460
   Ramamoorthy M, 2012, FREE RADICAL BIO MED, V53, P1371, DOI 10.1016/j.freeradbiomed.2012.07.018
   Regnell CE, 2012, CELL REPORTS, V2, P503, DOI 10.1016/j.celrep.2012.08.008
   Renovell A, 1996, INT. J. DEV. BIOL, V40, P0
   Reynolds JJ, 2009, MOL CELL BIOL, V29, P1354, DOI 10.1128/MCB.01471-08
   Rolseth V, 2008, DNA REPAIR, V7, P1578, DOI 10.1016/j.dnarep.2008.06.007
   Salvatore E, 2008, J NEUROL, V255, P45, DOI 10.1007/s00415-007-0657-x
   Saxena S, 2011, NEURON, V71, P35, DOI 10.1016/j.neuron.2011.06.031
   Schneider L, 2012, CELL DEATH DIFFER, V19, P582, DOI 10.1038/cdd.2011.129
   Segal-Raz H, 2011, EMBO REP, V12, P713, DOI 10.1038/embor.2011.96
   Sejersted Y, 2011, P NATL ACAD SCI USA, V108, P18802, DOI 10.1073/pnas.1106880108
   Sekijima Y, 1998, J NEUROL SCI, V158, P30, DOI 10.1016/S0022-510X(98)00103-8
   Shackelford DA, 2006, NEUROBIOL AGING, V27, P596, DOI 10.1016/j.neurobiolaging.2005.03.009
   Shen J, 2010, NAT GENET, V42, P245, DOI 10.1038/ng.526
   Sheng ZJ, 2012, J CLIN INVEST, V122, P4344, DOI 10.1172/JCI65053
   Shimada M, 2015, EMBO J, V34, P2465, DOI 10.15252/embj.201591363
   Silva ART, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0099897
   Simsek D, 2011, NATURE, V471, P245, DOI 10.1038/nature09794
   Sobol RW, 2000, NATURE, V405, P807, DOI 10.1038/35015598
   Stucki M, 1998, ONCOGENE, V17, P835, DOI 10.1038/sj.onc.1202001
   Sugawara M, 2008, EUR NEUROL, V59, P18, DOI 10.1159/000109256
   Sugo N, 2000, EMBO J, V19, P1397, DOI 10.1093/emboj/19.6.1397
   Sulzer D, 2013, MOVEMENT DISORD, V28, P41, DOI 10.1002/mds.25095
   Sung JS, 2006, FEBS J, V273, P1620, DOI 10.1111/j.1742-4658.2006.05192.x
   Sykora P, 2015, NUCLEIC ACIDS RES, V43, P943, DOI 10.1093/nar/gku1356
   Sykora P, 2013, NEUROBIOL AGING, V34, P1717, DOI 10.1016/j.neurobiolaging.2012.12.016
   Takashima H, 2002, NAT GENET, V32, P267, DOI 10.1038/ng987
   Tebbs RS, 1999, DEV BIOL, V208, P513, DOI 10.1006/dbio.1999.9232
   Tell G, 2009, ANTIOXID REDOX SIGN, V11, P601, DOI 10.1089/ars.2008.2194
   Vasko MR, 2005, DNA REPAIR, V4, P367, DOI 10.1016/j.dnarep.2004.11.006
   Wallace SS, 2013, ENVIRON MOL MUTAGEN, V54, P691, DOI 10.1002/em.21820
   Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831
   Wang JQ, 2006, J NEUROCHEM, V96, P825, DOI 10.1111/j.1471-4159.2005.03615.x
   Wang XK, 2007, GENOMICS, V90, P201, DOI 10.1016/j.ygeno.2007.03.007
   Wang XK, 2009, BMC NEUROSCI, V10, P0, DOI 10.1186/1471-2202-10-12
   Weissman L, 2007, NUCLEIC ACIDS RES, V35, P5545, DOI 10.1093/nar/gkm605
   Wilde GJC, 1997, J NEUROCHEM, V69, P883
   Yang JL, 2010, J BIOL CHEM, V285, P28191, DOI 10.1074/jbc.M109.082883
   Zhou T, 2009, DNA REPAIR, V8, P901, DOI 10.1016/j.dnarep.2009.05.003
   Zoccarato F, 2004, J BIOL CHEM, V279, P4166, DOI 10.1074/jbc.M308143200
   Zoghbi HY, 2000, NEUROBIOL DIS, V7, P523, DOI 10.1006/nbdi.2000.0346
   Zolner AE, 2011, NUCLEIC ACIDS RES, V39, P9224, DOI 10.1093/nar/gkr647
NR 147
TC 57
Z9 65
U1 0
U2 13
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2090-5904
EI 1687-5443
J9 NEURAL PLAST
JI Neural. Plast.
PD JUN 15
PY 2016
VL 2016
IS 
BP 
EP 
DI 10.1155/2016/3619274
PG 14
WC Neurosciences
SC Neurosciences & Neurology
GA DH2YK
UT WOS:000372653200001
PM 26942017
DA 2024-11-01
ER

PT J
AU Wawrzyniak, NR
   Joseph, AM
   Levin, DG
   Gundermann, DM
   Leeuwenburgh, C
   Sandesara, B
   Manini, TM
   Adhihetty, PJ
AF Wawrzyniak, Nicholas R.
   Joseph, Anna-Maria
   Levin, David G.
   Gundermann, David M.
   Leeuwenburgh, Christiaan
   Sandesara, Bhanuprasad
   Manini, Todd M.
   Adhihetty, Peter J.
TI Idiopathic chronic fatigue in older adults is linked to impaired mitochondrial content and biogenesis signaling in skeletal muscle
SO ONCOTARGET
LA English
DT Article
DE fatigue; skeletal muscle; mitochondria; PGC-1 alpha; Gerotarget
ID oxidative stress; functional assessment; apoptotic susceptibility; energy-metabolism; dna mutations; dysfunction; bioenergetics; plasticity; exercise; coactivators
AB Fatigue is a symptom of many diseases, but it can also manifest as a unique medical condition, such as idiopathic chronic fatigue (ICF). While the prevalence of ICF increases with age, mitochondrial content and function decline with age, which may contribute to ICF. The purpose of this study was to determine whether skeletal muscle mitochondrial dysregulation and oxidative stress is linked to ICF in older adults. Sedentary, old adults (n = 48, age 72.4 +/- 5.3 years) were categorized into ICF and non-fatigued (NF) groups based on the FACIT-Fatigue questionnaire. ICF individuals had a FACIT score one standard deviation below the mean for non-anemic adults >65 years and were excluded according to CDC diagnostic criteria for ICF. Vastus lateralis muscle biopsies were analyzed, showing reductions in mitochondrial content and suppression of mitochondrial regulatory proteins Sirt3, PGC-1 alpha, NRF-1, and cytochrome c in ICF compared to NF. Additionally, mitochondrial morphology proteins, antioxidant enzymes, and lipid peroxidation were unchanged in ICF individuals. Our data suggests older adults with ICF have reduced skeletal muscle mitochondrial content and biogenesis signaling that cannot be accounted for by increased oxidative damage.
C1 [Wawrzyniak, Nicholas R.; Levin, David G.; Adhihetty, Peter J.] Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL 32611 USA.
   [Joseph, Anna-Maria; Gundermann, David M.; Leeuwenburgh, Christiaan; Sandesara, Bhanuprasad; Manini, Todd M.] Univ Florida, Dept Aging & Geriatr Res, Div Biol Aging, Gainesville, FL 32611 USA.
C3 State University System of Florida; University of Florida; State University System of Florida; University of Florida
RP Adhihetty, PJ (corresponding author), Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL 32611 USA.; Manini, TM (corresponding author), Univ Florida, Dept Aging & Geriatr Res, Div Biol Aging, Gainesville, FL 32611 USA.
EM tmanini@ufl.edu; padhihetty@ufl.edu
FU National Institute on Aging [P30AG028740, R01 AG042525]; National Heart, Lung, Blood Institute [R01 HL121023]; National Institutes of Aging [R01 AG042525]; University of Florida's Claude D. Pepper Center [P30 AG028740]
CR Adhihetty PJ, 2009, AM J PHYSIOL-CELL PH, V297, PC217, DOI 10.1152/ajpcell.00070.2009
   Agudelo LZ, 2014, CELL, V159, P33, DOI 10.1016/j.cell.2014.07.051
   Alexander NB, 2010, J AM GERIATR SOC, V58, P967, DOI 10.1111/j.1532-5415.2010.02811.x
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381
   BERGSTROM J, 1975, SCAND J CLIN LAB INV, V35, P606
   Broderick JE, 2008, PAIN, V139, P146, DOI 10.1016/j.pain.2008.03.024
   Broskey NT, 2014, J CLIN ENDOCR METAB, V99, P1852, DOI 10.1210/jc.2013-3983
   Brown PJ, 2016, J GERONTOL A-BIOL, V71, P221, DOI 10.1093/gerona/glv156
   Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8
   Castro-Marrero J, 2013, ANTIOXID REDOX SIGN, V19, P1855, DOI 10.1089/ars.2013.5346
   Cella D, 2005, J RHEUMATOL, V32, P811
   Cella D, 2002, CANCER-AM CANCER SOC, V94, P528, DOI 10.1002/cncr.10245
   Chabi B, 2008, AGING CELL, V7, P2, DOI 10.1111/j.1474-9726.2007.00347.x
   Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529
   Chandran V, 2007, ANN RHEUM DIS, V66, P936, DOI 10.1136/ard.2006.065763
   Conley KE, 2000, J PHYSIOL-LONDON, V526, P203, DOI 10.1111/j.1469-7793.2000.t01-1-00203.x
   Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275
   Dirks AJ, 2006, AGEING RES REV, V5, P179, DOI 10.1016/j.arr.2006.03.002
   Donmez G, 2010, AGING CELL, V9, P285, DOI 10.1111/j.1474-9726.2010.00548.x
   Eldadah BA, 2010, PM&R, V2, P406, DOI 10.1016/j.pmrj.2010.03.022
   Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794
   FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6
   FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009
   Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047
   Fulle S, 2000, FREE RADICAL BIO MED, V29, P1252, DOI 10.1016/S0891-5849(00)00419-6
   Garnier A, 2003, J PHYSIOL-LONDON, V551, P491, DOI 10.1113/jphysiol.2003.045104
   Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037
   Hickie IB, 1996, MED J AUSTRALIA, V164, P585, DOI 10.5694/j.1326-5377.1996.tb122199.x
   Holloway GP, 2007, AM J PHYSIOL-ENDOC M, V292, PE1782, DOI 10.1152/ajpendo.00639.2006
   HOLMES GP, 1988, ANN INTERN MED, V108, P387, DOI 10.7326/0003-4819-108-3-387
   Hood DA, 2001, J APPL PHYSIOL, V90, P1137, DOI 10.1152/jappl.2001.90.3.1137
   Hoppeler H, 2003, MED SCI SPORT EXER, V35, P95, DOI 10.1097/00005768-200301000-00016
   Johnson ML, 2013, TRENDS ENDOCRIN MET, V24, P247, DOI 10.1016/j.tem.2012.12.003
   Joseph AM, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0069327
   Joseph AM, 2012, AGING CELL, V11, P801, DOI 10.1111/j.1474-9726.2012.00844.x
   Kang CH, 2013, EXP GERONTOL, V48, P1343, DOI 10.1016/j.exger.2013.08.004
   Kato K, 2006, ARCH GEN PSYCHIAT, V63, P1267, DOI 10.1001/archpsyc.63.11.1267
   Kennedy G, 2005, FREE RADICAL BIO MED, V39, P584, DOI 10.1016/j.freeradbiomed.2005.04.020
   Kong XX, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0011707
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lenaz G, 2000, BBA-BIOENERGETICS, V1459, P397, DOI 10.1016/S0005-2728(00)00177-8
   Lerdal A, 2005, SCAND J PUBLIC HEALT, V33, P123, DOI 10.1080/14034940410028406
   Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   Ljubicic V, 2009, AGING-US, V1, P818, DOI 10.18632/aging.100083
   Marzetti E, 2006, EXP GERONTOL, V41, P1234, DOI 10.1016/j.exger.2006.08.011
   Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863
   McArdle A, 2002, AGEING RES REV, V1, P79, DOI 10.1016/S0047-6374(01)00368-2
   Meissner C, 2007, Z GERONTOL GERIATR, V40, P325, DOI 10.1007/s00391-007-0481-z
   Menzies KJ, 2012, MITOCHONDRION, V12, P5, DOI 10.1016/j.mito.2011.03.001
   Morris G, 2014, METAB BRAIN DIS, V29, P19, DOI 10.1007/s11011-013-9435-x
   Nair KS, 2005, AM J CLIN NUTR, V81, P953
   Paradies G, 2010, FREE RADICAL BIO MED, V48, P1286, DOI 10.1016/j.freeradbiomed.2010.02.020
   Peterson Courtney M, 2012, J AGING RES, V2012, P194821, DOI 10.1155/2012/194821
   RADLOFF L S, 1977, APPLIED PSYCHOLOGICAL MEASUREMENT, V1, P385, DOI 10.1177/014662167700100306
   Sanz A, 2006, ANTIOXID REDOX SIGN, V8, P582, DOI 10.1089/ars.2006.8.582
   Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007
   Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019
   Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Smits B, 2011, MITOCHONDRION, V11, P735, DOI 10.1016/j.mito.2011.05.005
   Srinivasan S, 2012, FREE RADICAL BIO MED, V53, P1252, DOI 10.1016/j.freeradbiomed.2012.07.021
   Trifunovic A, 2008, J INTERN MED, V263, P167, DOI 10.1111/j.1365-2796.2007.01905.x
   Vestergaard S, 2009, J GERONTOL A-BIOL, V64, P76, DOI 10.1093/gerona/gln017
   Viña J, 2009, ADV DRUG DELIVER REV, V61, P1369, DOI 10.1016/j.addr.2009.06.006
   Wang CH, 2013, EXP BIOL MED, V238, P450, DOI 10.1177/1535370213493069
   Webster Kimberly, 2003, HEALTH QUAL LIFE OUTCOMES, V1, P79, DOI 10.1186/1477-7525-1-79
   Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106
   Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Yellen SB, 1997, J PAIN SYMPTOM MANAG, V13, P63, DOI 10.1016/S0885-3924(96)00274-6
   Yin F, 2015, ANTIOXID REDOX SIGN, V22, P961, DOI 10.1089/ars.2015.6313
   Zalli A, 2016, PSYCHOPHARMACOLOGY, V233, P1669, DOI 10.1007/s00213-015-3919-9
NR 74
TC 24
Z9 25
U1 1
U2 9
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 
EI 1949-2553
J9 ONCOTARGET
JI Oncotarget
PD AUG 16
PY 2016
VL 7
IS 33
BP 52695
EP 52709
DI 10.18632/oncotarget.10685
PG 15
WC Oncology; Cell Biology
SC Oncology; Cell Biology
GA DY9DG
UT WOS:000385433000008
PM 27447862
DA 2024-11-01
ER

PT J
AU Chou, SJ
   Tseng, WL
   Chen, CT
   Lai, YF
   Chien, CS
   Chang, YL
   Lee, HC
   Wei, YH
   Chiou, SH
AF Chou, Shih-Jie
   Tseng, Wei-Lien
   Chen, Chien-Tsun
   Lai, Yu-Fen
   Chien, Chian-Shiu
   Chang, Yuh-Lih
   Lee, Hsin-Chen
   Wei, Yau-Huei
   Chiou, Shih-Hwa
TI Impaired ROS Scavenging System in Human Induced Pluripotent Stem Cells Generated from Patients with MERRF Syndrome
SO SCIENTIFIC REPORTS
LA English
DT Article
ID mitochondrial diseases; myoclonic epilepsy; fibroblasts; mutations; differentiation; cardiomyopathy; melas
AB Myoclonus epilepsy associated with ragged-red fibers (MERRF) is a mitochondrial disorder characterized by myoclonus epilepsy, generalized seizures, ataxia and myopathy. MERRF syndrome is primarily due to an A to G mutation at mtDNA 8344 that disrupts the mitochondrial gene for tRNA(Lys). However, the detailed mechanism by which this tRNA(Lys) mutation causes mitochondrial dysfunction in cardiomyocytes or neurons remains unclear. In this study, we generated human induced pluripotent stem cells (hiPSCs) that carry the A8344G genetic mutation from patients with MERRF syndrome. Compared with mutation-free isogenic hiPSCs, MERRF-specific hiPSCs (MERRF-hiPSCs) exhibited reduced oxygen consumption, elevated reactive oxygen species (ROS) production, reduced growth, and fragmented mitochondrial morphology. We sought to investigate the induction ability and mitochondrial function of cardiomyocyte-like cells differentiated from MERRF-hiPSCs. Our data demonstrate that that cardiomyocyte-like cells (MERRF-CMs) or neural progenitor cells (MERRF-NPCs) differentiated from MERRF-iPSCs also exhibited increased ROS levels and altered antioxidant gene expression. Furthermore, MERRF-CMs or -NPCs contained fragmented mitochondria, as evidenced by MitoTracker Red staining and transmission electron microscopy. Taken together, these findings showed that MERRF-hiPSCs and MERRF-CM or -NPC harboring the A8344G genetic mutation displayed contained mitochondria with an abnormal ultrastructure, produced increased ROS levels, and expressed upregulated antioxidant genes.
C1 [Chou, Shih-Jie; Tseng, Wei-Lien; Chang, Yuh-Lih; Lee, Hsin-Chen; Chiou, Shih-Hwa] Natl Taiwan Univ, Coll Med, Inst Pharmacol, Taipei, Taiwan.
   [Lai, Yu-Fen; Chiou, Shih-Hwa] Inst Clin Med, Taipei, Taiwan.
   [Chien, Chian-Shiu; Lee, Hsin-Chen; Chiou, Shih-Hwa] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan.
   [Chen, Chien-Tsun; Wei, Yau-Huei] Mackay Med Coll, Dept Med, New Taipei, Taiwan.
   [Tseng, Wei-Lien; Lai, Yu-Fen; Chien, Chian-Shiu; Chang, Yuh-Lih; Chiou, Shih-Hwa] Taipei Vet Gen Hosp, Dept Med Res, Taipei, Taiwan.
C3 National Taiwan University; National Yang Ming Chiao Tung University; Mackay Medical College; Taipei Veterans General Hospital
RP Lee, HC; Chiou, SH (corresponding author), Natl Taiwan Univ, Coll Med, Inst Pharmacol, Taipei, Taiwan.; Chiou, SH (corresponding author), Inst Clin Med, Taipei, Taiwan.; Lee, HC; Chiou, SH (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan.; Wei, YH (corresponding author), Mackay Med Coll, Dept Med, New Taipei, Taiwan.; Chiou, SH (corresponding author), Taipei Vet Gen Hosp, Dept Med Res, Taipei, Taiwan.
EM hclee2@ym.edu.tw; joeman@mmc.edu.tw; shchiou@vghtpe.gov.tw
FU Department of Health Cancer Center Research of Excellence [DOH99-TD-C-111-007]; Taipei Veterans General Hospital (Stem Cell Project) [E104]; Yen-Tjing-Ling Medical Foundation [CI-100-15]; MOSTNRPB [3111-B-039, 3111-B-075-001-MY3, 2632-B-039-001, 2314-B-341-001-MY3]; Genomics Research Center, Academia Sinica, The Cancer Genomic Center Project of National Yang-Ming University (Ministry of Education, Aim for the Top University Plan)
CR ANAN R, 1995, CIRCULATION, V91, P955, DOI 10.1161/01.CIR.91.4.955
   Catteruccia M, 2015, J NEUROL, V262, P701, DOI 10.1007/s00415-014-7632-0
   Chen CY, 2011, MITOCHONDRION, V11, P739, DOI 10.1016/j.mito.2011.05.014
   Cherry ABC, 2013, STEM CELLS, V31, P1287, DOI 10.1002/stem.1354
   De la Mata M, 2012, NEUROTHERAPEUTICS, V9, P446, DOI 10.1007/s13311-012-0103-3
   Devine MJ, 2011, NAT COMMUN, V2, P0, DOI 10.1038/ncomms1453
   Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799
   Finsterer J, 2011, J NEUROL SCI, V304, P9, DOI 10.1016/j.jns.2011.02.012
   Folmes CDL, 2013, STEM CELLS, V31, P1298, DOI 10.1002/stem.1389
   Fujikura J, 2012, DIABETOLOGIA, V55, P1689, DOI 10.1007/s00125-012-2508-2
   HD iPSC Consortium, 2012, CELL STEM CELL, V11, P264, DOI 10.1016/j.stem.2012.04.027
   Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821
   James AM, 1999, EUR J BIOCHEM, V259, P462, DOI 10.1046/j.1432-1327.1999.00066.x
   James AM, 1996, BIOCHEM J, V318, P401, DOI 10.1042/bj3180401
   Kanaumi T, 2006, PEDIATR NEUROL, V34, P235, DOI 10.1016/j.pediatrneurol.2005.08.024
   Kelly RDW, 2013, STEM CELL REV REP, V9, P1, DOI 10.1007/s12015-011-9318-7
   Lian XJ, 2012, P NATL ACAD SCI USA, V109, PE1848, DOI 10.1073/pnas.1200250109
   Lu CY, 2002, CLIN CHIM ACTA, V318, P97, DOI 10.1016/S0009-8981(01)00809-9
   Ma YS, 2005, ANN NY ACAD SCI, V1042, P55, DOI 10.1196/annals.1338.006
   Maekawa M, 2011, NATURE, V474, P225, DOI 10.1038/nature10106
   Mandal S, 2011, STEM CELLS, V29, P486, DOI 10.1002/stem.590
   NOER AS, 1991, AM J HUM GENET, V49, P715
   Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Peng JY, 2011, PLOS COMPUT BIOL, V7, P0, DOI 10.1371/journal.pcbi.1002212
   Prigione A, 2010, STEM CELLS, V28, P721, DOI 10.1002/stem.404
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Takahashi K, 2007, INT J COLORECTAL DIS, V22, P313, DOI 10.1007/s00384-006-0148-z
   Vallance HD, 2004, PEDIATR CARDIOL, V25, P538, DOI 10.1007/s00246-003-0446-y
   Vives-Bauza C, 2006, NEUROSCI LETT, V391, P136, DOI 10.1016/j.neulet.2005.08.049
   von Kleist-Retzow JC, 2007, EXP CELL RES, V313, P3076, DOI 10.1016/j.yexcr.2007.04.015
   White HE, 2005, GENET TEST, V9, P190, DOI 10.1089/gte.2005.9.190
   Wu SB, 2010, MOL NEUROBIOL, V41, P256, DOI 10.1007/s12035-010-8123-7
   Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526
   Zhang J, 2011, EMBO J, V30, P4860, DOI 10.1038/emboj.2011.401
NR 36
TC 29
Z9 32
U1 0
U2 11
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
EI 
J9 SCI REP-UK
JI Sci Rep
PD MAR 30
PY 2016
VL 6
IS 
BP 
EP 
DI 10.1038/srep23661
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DH8KZ
UT WOS:000373043300003
PM 27025901
DA 2024-11-01
ER

PT J
AU Finsterer, J
   Mishra, A
   Wakil, S
   Pennuto, M
   Soraru, G
AF Finsterer, Josef
   Mishra, Anushree
   Wakil, Salma
   Pennuto, Maria
   Soraru, Gianni
TI Mitochondrial implications in bulbospinal muscular atrophy (Kennedy disease)
SO AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION
LA English
DT Review
DE Mitochondrial disorder; mitochondrial DNA; X-linked spinal muscular atrophy; bulbospinal neuronopathy; spinobulbar muscular atrophy; motor neuron disease
ID human androgen receptor; oxidative stress; skeletal-muscle; polyglutamine tract; dysfunction; biogenesis; deficiency; mutations; pathology; brain
AB There is increasing evidence that mitochondrial functions are secondarily disturbed in bulbospinal muscular atrophy (BSMA). This review focuses on the relation between BSMA and the effect of the expanded polyglutamine (poly-Q) androgen receptor (AR) on mitochondrial functions. Mitochondrial functions in bulbospinal muscular atrophy (SBMA) are affected on the molecular, clinical, and therapeutic level. On the molecular level there is down-regulation of various nuclear-DNA-encoded mitochondrial proteins by mutant androgen receptor (mAR), colocalization of the mAR with various mitochondrial proteins, association of mAR aggregates with mitochondria resulting in abnormal distribution of mitochondria, mtDNA depletion or multiple mtDNA deletions, mitochondrial membrane depolarization, increase in reactive oxidative species, and activation of the mitochondrial caspase pathway. On the clinical level various mitochondrial disorders mimic SBMA, and on the therapeutic level pioglitazone expresses PPAR-, cyclosporine-A restores mitochondrial membrane potentials, coenzyme-Q and idebenone reduce oxidative stress, and geldanamycin up-regulates protective mitochondrial heat shock proteins. In conclusion, in BSMA mitochondrial dysfunction results from various interactions of elongated poly-Q AR with mitochondria, mitochondrial proteins, nuclear or mitochondrial DNA, causing oxidative stress, decreased mitochondrial membrane potential, or activation of the mitochondrial caspase pathway. Additionally, mitochondrial disease may mimic BSMA and therapeutic approaches may depend on modifications of mitochondrial pathways.
C1 [Finsterer, Josef] Krankenanstalt Rudolfstiftung Wien, Vienna, Austria.
   [Mishra, Anushree] All India Inst Med Sci, Delhi, India.
   [Wakil, Salma] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia.
   [Pennuto, Maria] Univ Trento, Dulbecco Telethon Inst Lab Neurodegenerat Dis, Ctr Integrat Biol CIBIO, Trento, Italy.
   [Soraru, Gianni] Univ Padua, Dept Neurosci, I-35100 Padua, Italy.
C3 Rudolfstiftung Hospital; All India Institute of Medical Sciences (AIIMS) New Delhi; King Faisal Specialist Hospital & Research Center; University of Trento; University of Padua
RP Finsterer, J (corresponding author), Postfach 20, A-1180 Vienna, Austria.
EM fifigs1@yahoo.de
CR Beauchemin AMJ, 2001, BRAIN RES BULL, V56, P285, DOI 10.1016/S0361-9230(01)00583-4
   Beitel LK, 2013, FRONT NEUROL, V4, P0, DOI 10.3389/fneur.2013.00053
   Bellafante E, 2014, P NATL ACAD SCI USA, V111, PE4523, DOI 10.1073/pnas.1415279111
   Brum M, 2014, CASE REP NEUROL MED, V2014, P0, DOI 10.1155/2014/701761
   Chanprasert S, 2012, GENEREVIEWS, V0, P0
   Di Filippo M, 2010, J ALZHEIMERS DIS, V20, PS369, DOI 10.3233/JAD-2010-100543
   Ehinger JK, 2015, J NEUROL, V262, P1493, DOI 10.1007/s00415-015-7737-0
   Eschbach J, 2013, NEUROBIOL DIS, V58, P220, DOI 10.1016/j.nbd.2013.05.015
   Fischbeck KH, 2012, PROG NEUROBIOL, V99, P257, DOI 10.1016/j.pneurobio.2012.05.012
   Fukunaga K, 2015, J PHARMACOL SCI, V127, P36, DOI 10.1016/j.jphs.2014.12.012
   GANIE SA, 2015, REJUVENATIO IN PRESS, V0, P0
   Gavrilova-Jordan LP, 2007, SEMIN REPROD MED, V25, P154, DOI 10.1055/s-2007-973428
   Hayashi M, 2012, ADV EXP MED BIOL, V724, P278, DOI 10.1007/978-1-4614-0653-2_21
   Iida M, 2015, HUM MOL GENET, V24, P314, DOI 10.1093/hmg/ddu445
   Jordan CL, 2008, CURR OPIN PHARMACOL, V8, P752, DOI 10.1016/j.coph.2008.08.006
   Katsetos CD, 2013, SEMIN PEDIATR NEUROL, V20, P202, DOI 10.1016/j.spen.2013.10.010
   Katsuno M, 2012, PROG NEUROBIOL, V99, P246, DOI 10.1016/j.pneurobio.2012.05.007
   Katsuno M, 2012, ARCH NEUROL-CHICAGO, V69, P436, DOI 10.1001/archneurol.2011.2308
   KAZEMIESFARJANI P, 1995, HUM MOL GENET, V4, P523, DOI 10.1093/hmg/4.4.523
   Lee JS, 2007, PEDIATR NEUROL, V36, P45, DOI 10.1016/j.pediatrneurol.2006.07.007
   Liu CS, 2008, J NEUROL SCI, V264, P18, DOI 10.1016/j.jns.2007.07.016
   Mano T, 2012, MUSCLE NERVE, V46, P692, DOI 10.1002/mus.23413
   McMillan HJ, 2014, BMC MED GENET, V15, P0, DOI 10.1186/1471-2350-15-36
   MHATRE AN, 1993, NAT GENET, V5, P184, DOI 10.1038/ng1093-184
   Monks DA, 2007, P NATL ACAD SCI USA, V104, P18259, DOI 10.1073/pnas.0705501104
   Orsucci D, 2014, CURR MOL MED, V14, P598, DOI 10.2174/1566524014666140603100131
   Piccioni F, 2002, FASEB J, V16, P1418, DOI 10.1096/fj.01-1035fje
   Preisler N, 2009, NEUROLOGY, V72, P317, DOI 10.1212/01.wnl.0000341274.61236.02
   Pronicka E, 2013, MITOCHONDRION, V13, P810, DOI 10.1016/j.mito.2013.05.007
   Ranganathan S, 2010, TRENDS PHARMACOL SCI, V31, P523, DOI 10.1016/j.tips.2010.08.005
   Ranganathan S, 2009, HUM MOL GENET, V18, P27, DOI 10.1093/hmg/ddn310
   Ripolone M, 2015, JAMA NEUROL, V72, P666, DOI 10.1001/jamaneurol.2015.0178
   Sirianni AC, 2015, J NEUROCHEM, V134, P956, DOI 10.1111/jnc.13190
   Solakidi S, 2005, HUM REPROD, V20, P3481, DOI 10.1093/humrep/dei267
   Sopher BL, 2004, NEURON, V41, P687, DOI 10.1016/S0896-6273(04)00082-0
   Sorarù G, 2008, J NEUROL SCI, V264, P100, DOI 10.1016/j.jns.2007.08.012
   Stenoien DL, 1999, HUM MOL GENET, V8, P731, DOI 10.1093/hmg/8.5.731
   Su SL, 2010, CLIN CHIM ACTA, V411, P626, DOI 10.1016/j.cca.2009.12.007
   Tanaka F, 2012, NEURAL PLAST, V2012, P0, DOI 10.1155/2012/369284
   Trushina E, 2007, NEUROSCIENCE, V145, P1233, DOI 10.1016/j.neuroscience.2006.10.056
   Usui T, 2014, FEBS LETT, V588, P1935, DOI 10.1016/j.febslet.2014.03.051
   Wang RS, 2015, INT J MOL SCI, V16, P9831, DOI 10.3390/ijms16059831
   Weber JJ, 2014, BIOMED RES INT, V2014, P0, DOI 10.1155/2014/701758
   Yonutas HM, 2015, J BIOENERG BIOMEMBR, V47, P149, DOI 10.1007/s10863-014-9593-5
   Young JE, 2009, J NEUROSCI, V29, P1987, DOI 10.1523/JNEUROSCI.4072-08.2009
   Zoccolella S, 2012, EUR J NEUROL, V19, Pe63, DOI 10.1111/j.1468-1331.2012.03720.x
NR 46
TC 8
Z9 9
U1 0
U2 7
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2167-8421
EI 2167-9223
J9 AMYOTROPH LAT SCL FR
JI Amyotroph. Lateral Scher. Frontotemp. Degenerat.
PD FEB 17
PY 2016
VL 17
IS 1-2
BP 112
EP 118
DI 10.3109/21678421.2015.1089910
PG 7
WC Clinical Neurology
SC Neurosciences & Neurology
GA DB8BZ
UT WOS:000368742700014
PM 26428534
DA 2024-11-01
ER

PT J
AU Young, MJ
   Copeland, WC
AF Young, Matthew J.
   Copeland, William C.
TI Human mitochondrial DNA replication machinery and disease
SO CURRENT OPINION IN GENETICS & DEVELOPMENT
LA English
DT Article
ID progressive external ophthalmoplegia; structure-function defects; recessive twinkle mutations; polymerase gamma-subunits; impair mtdna replication; multiple deletions; accessory subunit; helicase twinkle; mammalian embryogenesis; rna-polymerase
AB The human mitochondrial genome is replicated by DNA polymerase gamma in concert with key components of the mitochondrial DNA (mtDNA) replication machinery. Defects in mtDNA replication or nucleotide metabolism cause deletions, point mutations, or depletion of mtDNA. The resulting loss of cellular respiration ultimately induces mitochondrial genetic diseases, including mtDNA depletion syndromes (MDS) such as Alpers or early infantile hepatocerebral syndromes, and mtDNA deletion disorders such as progressive external ophthalmoplegia, ataxia-neuropathy, or mitochondrial neurogastrointestinal encephalomyopathy. Here we review the current literature regarding human mtDNA replication and heritable disorders caused by genetic changes of the POLG, POLG2, Twinkle, RNASEH1, DNA2, and MGME1 genes.
C1 [Young, Matthew J.; Copeland, William C.] NIEHS, Genome Integr & Struct Biol Lab, POB 12233, Res Triangle Pk, NC 27709 USA.
   [Young, Matthew J.] Southern Illinois Univ, Dept Biochem & Mol Biol, Sch Med, Carbondale, IL 62901 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Southern Illinois University System; Southern Illinois University
RP Copeland, WC (corresponding author), NIEHS, Genome Integr & Struct Biol Lab, POB 12233, Res Triangle Pk, NC 27709 USA.
EM copelan1@niehs.nih.gov
FU Intramural Research Program of the NIH, National Institute of Environmental Health Sciences [ES 065078, ES 065080]; NIH Pathway to Independence Award [1K99ES022638-01]
CR Besse A, 2015, CELL METAB, V21, P417, DOI 10.1016/j.cmet.2015.02.008
   Carrodeguas JA, 2001, MOL CELL, V7, P43, DOI 10.1016/S1097-2765(01)00153-8
   Cerritelli SM, 2003, MOL CELL, V11, P807, DOI 10.1016/S1097-2765(03)00088-1
   Cerritelli SM, 2009, FEBS J, V276, P1494, DOI 10.1111/j.1742-4658.2009.06908.x
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   CHANG DD, 1985, P NATL ACAD SCI USA, V82, P351, DOI 10.1073/pnas.82.2.351
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   Cohen BH, 2010, GENEREVIEWS GENETEST, V0, P0
   Cohen BH, 2010, METHODS, V51, P364, DOI 10.1016/j.ymeth.2010.05.008
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Copeland WC, 2014, J CHILD NEUROL, V29, P1216, DOI 10.1177/0883073814537380
   Copeland WC, 2014, DNA REPAIR, V19, P190, DOI 10.1016/j.dnarep.2014.03.010
   Craig K, 2012, MITOCHONDRION, V12, P313, DOI 10.1016/j.mito.2011.11.006
   Duxin JP, 2009, MOL CELL BIOL, V29, P4274, DOI 10.1128/MCB.01834-08
   Euro L, 2011, NUCL ACIDS RES, V0, P0
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   Fan L, 2006, J MOL BIOL, V358, P1229, DOI 10.1016/j.jmb.2006.02.073
   Fernández-Millán P, 2015, NUCLEIC ACIDS RES, V43, P4284, DOI 10.1093/nar/gkv189
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   Fusté JM, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004832
   Fusté JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021
   García-Gómez S, 2013, MOL CELL, V52, P541, DOI 10.1016/j.molcel.2013.09.025
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   Hance N, 2005, HUM MOL GENET, V14, P1775, DOI 10.1093/hmg/ddi184
   Hensen F, 2014, BIOCHIMIE, V100, P219, DOI 10.1016/j.biochi.2013.09.017
   Hirano M, 2001, SEMIN CELL DEV BIOL, V12, P417, DOI 10.1006/scdb.2001.0279
   Holmes JB, 2015, P NATL ACAD SCI USA, V112, P9334, DOI 10.1073/pnas.1503653112
   Holmlund T, 2009, BBA-MOL BASIS DIS, V1792, P132, DOI 10.1016/j.bbadis.2008.11.009
   Holt IJ, 2014, BIOESSAYS, V36, P1024, DOI 10.1002/bies.201400052
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   Humble MM, 2013, HUM MOL GENET, V22, P1017, DOI 10.1093/hmg/dds506
   Jemt E, 2015, NUCLEIC ACIDS RES, V43, P9262, DOI 10.1093/nar/gkv804
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kalifa L, 2009, DNA REPAIR, V8, P1242, DOI 10.1016/j.dnarep.2009.07.008
   KASAMATSU H, 1974, ANNU REV BIOCHEM, V43, P695, DOI 10.1146/annurev.bi.43.070174.003403
   Kasiviswanathan R, 2011, J BIOL CHEM, V286, P31490, DOI 10.1074/jbc.M111.252460
   Keen BA, 2014, NUCLEIC ACIDS RES, V42, P12102, DOI 10.1093/nar/gku879
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Longley MJ, 2010, J BIOL CHEM, V285, P29690, DOI 10.1074/jbc.M110.151795
   Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029
   Lönnqvist T, 2009, BRAIN, V132, P1553, DOI 10.1093/brain/awp045
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Matsushima Y, 2007, J BIOL CHEM, V282, P9436, DOI 10.1074/jbc.M610550200
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, P0, DOI 10.1093/nar/gng060
   Ngo HB, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms4077
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   Reyes A, 2015, AM J HUM GENET, V97, P186, DOI 10.1016/j.ajhg.2015.05.013
   ROBBERSON DL, 1972, P NATL ACAD SCI USA, V69, P737, DOI 10.1073/pnas.69.3.737
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Saneto RP, 2010, DEV DISABIL RES REV, V16, P163, DOI 10.1002/ddrr.105
   Saneto RP, 2010, SEIZURE-EUR J EPILEP, V19, P140, DOI 10.1016/j.seizure.2010.01.002
   SERVIDEI S, 1991, NEUROLOGY, V41, P1053, DOI 10.1212/WNL.41.7.1053
   Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spelbrink JN, 2010, IUBMB LIFE, V62, P19, DOI 10.1002/iub.282
   Stumpf JD, 2010, HUM MOL GENET, V19, P2123, DOI 10.1093/hmg/ddq089
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   Szymanski MR, 2015, EMBO J, V34, P1959, DOI 10.15252/embj.201591520
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2009, EMBO REP, V10, P137, DOI 10.1038/embor.2008.242
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Hove JLK, 2009, AM J MED GENET A, V149A, P861, DOI 10.1002/ajmg.a.32731
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   Walter MC, 2010, J NEUROL, V257, P1517, DOI 10.1007/s00415-010-5565-9
   Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Wong LJC, 2008, HUM MUTAT, V29, PE150, DOI 10.1002/humu.20824
   Young MJ, 2015, HUM MOL GENET, V24, P5184, DOI 10.1093/hmg/ddv240
   Young MJ, 2011, HUM MOL GENET, V20, P3052, DOI 10.1093/hmg/ddr209
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zhang HL, 2014, NUCLEIC ACIDS RES, V42, P7259, DOI 10.1093/nar/gku384
   Zhao FX, 2013, HUM GENET, V132, P913, DOI 10.1007/s00439-013-1303-6
   Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024
NR 88
TC 132
Z9 150
U1 2
U2 24
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0959-437X
EI 1879-0380
J9 CURR OPIN GENET DEV
JI Curr. Opin. Genet. Dev.
PD JUN 15
PY 2016
VL 38
IS 
BP 52
EP 62
DI 10.1016/j.gde.2016.03.005
PG 11
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA EA6LH
UT WOS:000386740200009
PM 27065468
DA 2024-11-01
ER

PT J
AU Ng, YS
   Hardy, SA
   Shrier, V
   Quaghebeur, G
   Mole, DR
   Daniels, MJ
   Downes, SM
   Freebody, J
   Fratter, C
   Hofer, M
   Nemeth, AH
   Poulton, J
   Taylor, RW
AF Ng, Yi Shiau
   Hardy, Steven A.
   Shrier, Venice
   Quaghebeur, Gerardine
   Mole, David R.
   Daniels, Matthew J.
   Downes, Susan M.
   Freebody, Jane
   Fratter, Carl
   Hofer, Monika
   Nemeth, Andrea H.
   Poulton, Joanna
   Taylor, Robert W.
TI Clinical features of the pathogenic m.5540G&gt;A mitochondrial transfer RNA tryptophan gene mutation
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Mitochondrial DNA disease; Ataxia; Muscle biopsy; Proteinuria; Stroke
ID dna mutations; mtdna mutation; skeletal-muscle; disease; prevalence; management; disorders; melas
AB Mitochondrial DNA disease is one of the most common groups of inherited neuromuscular disorders and frequently associated with marked phenotypic and genotypic heterogeneity. We describe an adult patient who initially presented with childhood-onset ataxia without a family history and an unremarkable diagnostic muscle biopsy. Subsequent multi-system manifestations included basal ganglia calcification, proteinuria, cataract and retinitis pigmentosa, prompting a repeat muscle biopsy that showed features consistent with mitochondrial myopathy 13 years later. She had a stroke with restricted diffusion change in the basal ganglia and internal capsule at age 44 years. Molecular genetic testing identified a previously-reported pathogenic, heteroplasmic mutation in the mitochondrial-encoded transfer RNA tryptophan (MT-TW) gene which based on family studies was likely to have arisen de novo in our patient. Interestingly, we documented an increase in the mutant mtDNA heteroplasmy level in her second biopsy (72% compared to 56%), reflecting the progression of clinical disease. (C) 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
C1 [Ng, Yi Shiau; Hardy, Steven A.; Taylor, Robert W.] Newcastle Univ, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [Shrier, Venice; Poulton, Joanna] Womens Ctr, Nuffield Dept Obstet & Gynaecol, Oxford, England.
   [Quaghebeur, Gerardine] Oxford Univ Hosp NHS Fdn Trust, Dept Neuroradiol, Oxford, England.
   [Mole, David R.] Oxford Univ Hosp NHS Fdn Trust, Oxford Kidney Unit, Oxford, England.
   [Daniels, Matthew J.] Univ Oxford, Div Cardiovasc Med, BHF Oxbridge Ctr Regenerat Med, Oxford, England.
   [Downes, Susan M.] Oxford Eye Hosp, Oxford, England.
   [Freebody, Jane] Oxford Univ Hosp NHS Fdn Trust, John Radcliffe Hosp, Neurosci Off, Level 3 West Wing, Oxford, England.
   [Fratter, Carl] Churchill Hosp, Oxford Med Genet Labs, Oxford Univ Hosp NHS Trust, Oxford, England.
   [Hofer, Monika] John Radcliffe Hosp, Neuropathol & Ocular Pathol Dept, Oxford, England.
   [Nemeth, Andrea H.] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England.
   [Nemeth, Andrea H.] Churchill Hosp, Oxford, England.
C3 Newcastle University - UK; Oxford University Hospitals NHS Foundation Trust; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Oxford; University of Oxford
RP Taylor, RW (corresponding author), Newcastle Univ, Sch Med, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM robert.taylor@ncl.ac.uk
FU Medical Research Council [MR/J010448/1, G0800674, G0601943] Funding Source: Medline; Wellcome Trust [0948685/Z/10/Z, WT098519MA, 096919/Z/11/Z] Funding Source: Medline; MRC [G0601943, MR/J010448/1, G0800674] Funding Source: UKRI
CR Atale A, 2009, EUR J MED GENET, V52, P23, DOI 10.1016/j.ejmg.2008.10.003
   Bannwarth S, 2013, J MED GENET, V50, P704, DOI 10.1136/jmedgenet-2013-101604
   Che RC, 2014, AM J PHYSIOL-RENAL, V306, PF367, DOI 10.1152/ajprenal.00571.2013
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Elson JL, 2009, HUM MUTAT, V30, PE984, DOI 10.1002/humu.21113
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Granadillo JL, 2014, MOLEC GENET METAB RE, V1, P61, DOI 10.1016/j.ymgmr.2013.12.001
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   Marchington D, 2010, J MED GENET, V47, P257, DOI 10.1136/jmg.2009.072900
   MORAES CT, 1992, AM J HUM GENET, V50, P934
   Ng YS, 2016, J NEUROL, V263, P179, DOI 10.1007/s00415-015-7884-3
   POULTON J, 1993, HUM MOL GENET, V2, P23, DOI 10.1093/hmg/2.1.23
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Sallevelt SCEH, 2017, J MED GENET, V54, P114, DOI 10.1136/jmedgenet-2016-103876
   Silvestri G, 2000, NEUROLOGY, V54, P1693, DOI 10.1212/WNL.54.8.1693
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Weber K, 1997, AM J HUM GENET, V60, P373
   White HE, 2005, GENET TEST, V9, P190, DOI 10.1089/gte.2005.9.190
NR 19
TC 4
Z9 4
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD OCT 15
PY 2016
VL 26
IS 10
BP 702
EP 705
DI 10.1016/j.nmd.2016.08.009
PG 4
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA EA2FL
UT WOS:000386408100011
PM 27618137
DA 2024-11-01
ER

